10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

x  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2015

OR

o  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                              to                             

Commission File Number: 1-13991

MFA FINANCIAL, INC.

(Exact name of registrant as specified in its charter) 

Maryland (State or other jurisdiction of incorporation or organization)	13-3974868 (I.R.S. Employer Identification No.)
350 Park Avenue, 20th Floor, New York, New York (Address of principal executive offices)	10022 (Zip Code)

(212) 207-6400

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Name of Each Exchange on Which Registered
Common Stock, par value $0.01 per share	New York Stock Exchange
7.50% Series B Cumulative Redeemable Preferred Stock, par value $0.01 per share	New York Stock Exchange
8.00% Senior Notes due 2042	New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:  None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes  x  No  o

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.  Yes  o  No  x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  x  No  o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  x	Accelerated filer  o
Non-accelerated filer  o	Smaller reporting company  o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  o  No  x

On June 30, 2015, the aggregate market value of the registrant’s common stock held by non-affiliates of the registrant was $2.73 billion based on the closing sales price of our common stock on such date as reported on the New York Stock Exchange.

On February 12, 2016, the registrant had a total of 371,076,243 shares of Common Stock outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s proxy statement to be filed with the Securities and Exchange Commission in connection with the Annual Meeting of Stockholders scheduled to be held on or about May 25, 2016, are incorporated by reference into Part III of this Annual Report on Form 10-K.

TABLE OF CONTENTS

PART I
Item 1.	Business	1
Item 1A.	Risk Factors	5
Item 1B.	Unresolved Staff Comments	27
Item 2.	Properties	27
Item 3.	Legal Proceedings	27
Item 4.	Mine Safety Disclosures	27
PART II
Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	28
Item 6.	Selected Financial Data	32
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	34
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	74
Item 8.	Financial Statements and Supplementary Data	81
Item 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	143
Item 9A.	Controls and Procedures	143
Item 9B.	Other Information	146
PART III
Item 10.	Directors, Executive Officers and Corporate Governance	146
Item 11.	Executive Compensation	146
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	146
Item 13.	Certain Relationships and Related Transactions and Director Independence	146
Item 14.	Principal Accountant Fees and Services	146
PART IV
Item 15.	Exhibits and Financial Statement Schedules	147
Signatures		148

CAUTIONARY STATEMENT — This Annual Report on Form 10-K includes “forward-looking” statements within the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include information about possible or assumed future results with respect to the Company’s business, financial condition, liquidity, results of operations, plans and objectives.  You can identify forward-looking statements by such words as “will,” “believe,” expect,” “anticipate,” “estimate,” “plan,” “continue,” “intend,” “should,” “could,” “would,” “may” or similar expressions.  We caution that any such forward-looking statements made by us are not guarantees of future performance and that actual results may differ materially from these forward-looking statements.  We discuss certain factors that affect our business and that may cause our actual results to differ materially from these forward-looking statements under “Item 1A. Risk Factors” of this Annual Report on Form 10-K.  You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.  We undertake no obligation to update or revise any forward-looking statements except as may be required by law.

In this Annual Report on Form 10-K, references to “we,” “us,” “our” or “the Company” refer to MFA Financial, Inc. and its subsidiaries unless specifically stated otherwise or the context otherwise indicates.  The following defines certain of the commonly used terms in this Annual Report on Form 10-K:  MBS refers to mortgage-backed securities secured by pools of residential mortgage loans; Agency MBS refers to MBS that are issued or guaranteed by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae; Non-Agency MBS refers to residential MBS that are not guaranteed by any agency of the U.S. Government or any federally chartered corporation; Legacy Non-Agency MBS refers to MBS issued prior to 2008; RPL/NPL MBS refers to MBS collateralized by re-performing/non-performing loans; Hybrids refer to hybrid mortgage loans that have interest rates that are fixed for a specified period of time and, thereafter, generally adjust annually to an increment over a specified interest rate index; ARMs refer to adjustable-rate mortgage loans and to Hybrids that are past their fixed-rate period, both of which typically have interest rates that adjust annually to an increment over a specified interest rate index; Linked Transactions refer to Non-Agency MBS purchases which were financed with the same counterparty and for periods prior to 2015 considered linked for financial statement reporting purposes and were reported at fair value on a combined basis; and CRT securities refer to credit risk transfer securities which are general obligations of government-sponsored entities (Fannie Mae and Freddie Mac).

PART I

Item 1.  Business.

GENERAL

We are primarily engaged in the real estate finance business. We engage in our business through subsidiaries that invest, on a leveraged basis, in residential mortgage assets, including Agency MBS, Non-Agency MBS, residential whole loans and CRT securities.  Our principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. We selectively invest in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return.

We were incorporated in Maryland on July 24, 1997, and began operations on April 10, 1998.  We have elected to be treated as a real estate investment trust (or REIT) for U.S. federal income tax purposes.  In order to maintain our qualification as a REIT, we must comply with a number of requirements under federal tax law, including that we must distribute at least 90% of our annual REIT taxable income to our stockholders. We have elected to treat certain of our subsidiaries as a taxable REIT subsidiary (or TRS). In general, a TRS may hold assets and engage in activities that a REIT or qualified REIT subsidiary cannot hold or engage in directly and generally may engage in any real estate or non-real estate related business.

We are a holding company and conduct our real estate finance businesses primarily through wholly-owned subsidiaries, so as to maintain an exemption from registration under the Investment Company Act of 1940, as amended (or the Investment Company Act) by ensuring that less than 40% of the value of our total assets, exclusive of U.S. Government securities and cash items (which we refer to as our adjusted total assets for Investment Company Act purposes), on an unconsolidated basis consist of “investment securities” as defined by the Investment Company Act. We refer to this test as the “40% Test.”

INVESTMENT STRATEGY

As stated above, we primarily invest through subsidiaries in Agency MBS, Non-Agency MBS, residential whole loans and CRT securities. 

The mortgages collateralizing our Agency MBS portfolio are predominantly Hybrids, 15-year fixed-rate mortgages and ARMs.  Our selection of Agency MBS is largely designed to generate attractive returns relative to interest rate and prepayment risks. The Hybrid loans collateralizing our MBS typically have initial fixed-rate periods at origination of three, five, seven or ten years.  At the end of this fixed-rate period, these mortgages become adjustable and their interest rates adjust based on the London Interbank Offered Rate (or LIBOR) or in some cases the one-year constant maturity treasury rate (or CMT). These interest rate adjustments are typically limited by periodic caps (which limit the amount of the interest rate change from the prior rate) and lifetime caps (which are maximum interest rates permitted for the life of the mortgage). As coupons earned on Agency Hybrids and ARMs adjust over time as interest rates change, these assets are generally less sensitive to changes in interest rates than are fixed rate MBS. In general, Hybrid loans and ARMs have 30-year final maturities and they amortize over this 30-year period. While the coupons on 15-year fixed-rate mortgages do not adjust, they amortize according to a 15-year amortization schedule and have a 15-year final maturity. Due to their accelerated amortization and shorter final maturity, these assets are generally less sensitive to changes in long-term interest rates as compared to fixed-rate mortgages with a longer final maturity, such as 30-year mortgages.

1

Our Non-Agency MBS portfolio primarily consists of (i) Legacy Non-Agency MBS and (ii) MBS collateralized by re-performing and non-performing loans (or RPL/NPL MBS). In addition to Non-Agency MBS investments, during 2014 we began investing in re-performing and non-performing residential whole loans through our interests in certain consolidated trusts. Our strategy of combining investments in Agency MBS, Non-Agency MBS and residential whole loans is designed to generate attractive returns with less overall sensitivity to changes in the yield curve, the general level of interest rates and prepayments. We expect to continue to seek more credit sensitive assets in 2016, such as residential whole loans, while seeking to minimize sensitivity to interest rates.

Our Legacy Non-Agency MBS have been acquired primarily at discounts to face/par value, which we believe serves to mitigate our exposure to credit risk.  A portion of the purchase discount on substantially all of our Legacy Non-Agency MBS is designated as a non-accretable discount (also referred to hereafter as Credit Reserve), which effectively mitigates our risk of loss on the mortgages collateralizing such MBS and is not expected to be accreted into interest income.  The portion of the purchase discount that is designated as accretable discount is accreted into interest income over the life of the security.  The mortgages collateralizing our Legacy Non-Agency MBS consist primarily of ARMs, 30-year fixed rate mortgages and Hybrids. Legacy Non-Agency ARMs and Hybrids typically exhibit reduced interest rate sensitivity (as compared to fixed-rate Legacy Non-Agency MBS) due to their interest rate adjustments (similar to Agency ARMs and Hybrids). However, yields on Legacy Non-Agency MBS, unlike Agency MBS, also exhibit sensitivity to changes in credit performance.  If credit performance improves, the Credit Reserve may be decreased (and accretable discount increased), resulting in a higher yield over the remaining life of the security. Similarly, deteriorating credit performance could increase the Credit Reserve and decrease the yield over the remaining life of the security or other-than-temporary impairment could result. To the extent that higher interest rates in the future are indicative of an improving economy, better employment data and/or higher home prices, it is possible that these factors will improve the credit performance of Legacy Non-Agency MBS and therefore mitigate the interest rate sensitivity of these securities.

Our RPL/NPL MBS were purchased primarily through new issue at prices at or around par and represent the senior tranches of the related securitizations. These RPL/NPL MBS are structured with significant credit enhancement (typically approximately 50%) and the subordinate tranches absorb all credit losses (until those tranches are extinguished) and typically receive no cash flow (interest or principal) until the senior tranche is paid off. Prior to purchase, we analyze the deal structure in order to assess the associated credit risk. Subsequent to purchase, the ongoing credit risk associated with the deal is evaluated by analyzing the extent to which actual credit losses occur that result in a reduction in the amount of subordination enjoyed by our bond. Based on the recent performance of the collateral underlying our RPL/NPL MBS and current subordination levels, we do not believe that we are currently exposed to significant risk of credit loss on these investments. In addition, these deal structures contain an interest rate step-up feature, whereby the original coupon on the senior tranche increases by 300 basis points if the security that we hold has not been redeemed by the issuer after 36 months. We expect that the combination of the priority cash flow of the senior tranche and the 36-month step-up will result in these securities’ exhibiting short average lives and, accordingly, reduced interest rate sensitivity. Consequently, we believe that RPL/NPL MBS provide attractive returns given our assessment of the interest rate and credit risk associated with these securities.

In addition, during 2015, we continued to transition to more credit sensitive, less interest sensitive residential mortgage assets by acquiring residential whole loans through certain trusts that are consolidated on our balance sheet for financial reporting purposes. To date, we have focused on purchasing packages of both re-performing and non-performing whole loans. Re-performing loans are typically characterized by borrowers who have experienced payment delinquencies in the past and the amount owed on the mortgage may exceed the value of the property pledged as collateral. These loans are purchased at purchase prices that are discounted (often substantially so) to the contractual loan balance to reflect the credit history of the borrower, the loan-to-value (or LTV) of the loan and the coupon. Non-performing loans are typically characterized by borrowers who have defaulted on their obligations and/or have payment delinquencies of 60 days or more at the time we acquire the loan. These loans are also purchased at purchase prices that are discounted (often substantially so) to the contractual loan balance that reflects primarily the non-performing nature of the loan. Typically, this purchase price is a discount to the expected value of the collateral securing the loan, such value to be realized after foreclosure and liquidation of the property. All of the residential whole loans were purchased by the consolidated trusts on a servicing-released basis, i.e., the sellers of such loans transferred the right to service the loans as part of the sale. Because we do not directly service any loans, we have contracted with loan servicing companies with specific expertise in working with delinquent borrowers in an effort to cure delinquencies through, among other things, loan modification and third-party refinancing. To the extent these efforts are successful, we believe our investments in residential whole loans will yield attractive returns. In addition, to the extent that it is not possible to achieve a successful outcome for a particular borrower and the real property collateral must be foreclosed on and liquidated, we believe that the discounted purchase price at which the asset was acquired, provides us with a level of protection against financial loss.

2

FINANCING STRATEGY

Our financing strategy is designed to increase the size of our investment portfolio by borrowing against a substantial portion of the market value of the assets in our portfolio.  We primarily use repurchase agreements to finance our holdings of MBS, residential whole loans and CRT securities.  We enter into interest rate derivatives to hedge the interest rate risk associated with a portion of our repurchase agreement borrowings.  Going forward, in connection with our current and any future investment in residential whole loans, our financing strategy may expand to the use of securitization or other forms of structured financing.

Repurchase agreements, although legally structured as sale and repurchase transactions, are financing contracts (i.e., borrowings) under which we pledge our MBS, residential whole loans and CRT securities as collateral to secure loans with repurchase agreement counterparties (i.e., lenders).  Repurchase agreements involve the transfer of the pledged collateral to a lender at an agreed upon price in exchange for such lender’s simultaneous agreement to return the same security back to the borrower at a future date (i.e., the maturity of the borrowing) at a higher price.  The difference between the sale price that we receive and the repurchase price that we pay represents interest paid to the lender.  Our cost of borrowings under repurchase agreements is generally LIBOR based.  Under our repurchase agreements, we pledge our securities as collateral to secure the borrowing, which is equal in value to a specified percentage of the fair value of the pledged collateral, while we retain beneficial ownership of the pledged collateral.  At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, we are required to repay the loan including any accrued interest and concurrently receive back our pledged collateral from the lender. With the consent of the lender, we may renew a repurchase financing at the then prevailing financing terms.  Margin calls, whereby, a lender requires that we pledge additional securities or cash as collateral to secure borrowings under our repurchase financing with such lender, are routinely experienced by us when the value of the MBS pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions.  We also may make margin calls on counterparties when collateral values increase.

In order to reduce our exposure to counterparty-related risk, we generally seek to enter into repurchase agreements and other financing arrangements, and derivatives, with a diversified group of financial institutions.  At December 31, 2015, we had outstanding balances under repurchase agreements with 27 separate lenders.

In July 2015, the Company’s wholly-owned subsidiary, MFA Insurance, Inc. (or MFA Insurance), became a member of the Federal Home Loan Bank (or FHLB) of Des Moines. At December 31, 2015 and February 16, 2016, MFA Insurance had FHLB advances of approximately $1.500 billion and $1.200 billion, respectively. FHLB advances are secured financing transactions and are carried at their contractual amounts. The ability to borrow from the FHLB is subject to the Company’s continued creditworthiness, pledging of sufficient eligible collateral to secure advances, and compliance with certain agreements with the FHLB.

In January, 2016, the Federal Housing Finance Agency (or FHFA) released its final rule amending its regulation on FHLB membership, which, amongst other things, provided termination rules for current captive insurance members. As a result of such regulation, MFA Insurance will not be permitted new advances or renewal of existing advances and will be required to terminate its FHLB membership and repay any outstanding advances within one year of the rule’s effective date of February 19, 2016.

In addition to repurchase agreements, FHLB advances, securitized debt and 8% Senior Notes due 2042 (or Senior Notes), we may also use other sources of funding in the future to finance our MBS portfolio, including, but not limited to, other types of collateralized borrowings, loan agreements, lines of credit or the issuance of debt securities.

COMPETITION

We operate in the mortgage REIT industry.  We believe that our principal competitors in the business of acquiring and holding residential mortgage assets of the types in which we invest are financial institutions, such as banks, savings and loan institutions, life insurance companies, institutional investors, including mutual funds and pension funds, hedge funds, other mortgage-REITs as well as the U.S. Federal Reserve as part of its monetary policy activities.  Some of these entities may not be subject to the same regulatory constraints (i.e., REIT compliance or maintaining an exemption under the Investment Company Act) as us.  In addition, many of these entities have greater financial resources and access to capital than us.  The existence of these entities, as well as the possibility of additional entities forming in the future, may increase the competition for the acquisition of residential mortgage assets, resulting in higher prices and lower yields on such assets.

EMPLOYEES

At December 31, 2015, we had 50 full-time and three part-time employees.  We believe that our relationship with our employees is good.  None of our employees are unionized or represented under a collective bargaining agreement.

3

AVAILABLE INFORMATION

We maintain a Web site at www.mfafinancial.com.  We make available, free of charge, on our Web site our (a) Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K (including any amendments thereto), proxy statements and other information (or, collectively, the Company Documents) filed with, or furnished to, the Securities and Exchange Commission (or SEC), as soon as reasonably practicable after such documents are so filed or furnished, (b) Corporate Governance Guidelines, (c) Code of Business Conduct and Ethics and (d) written charters of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee of our Board of Directors (or our Board).  Our Company Documents filed with, or furnished to, the SEC are also available at the SEC’s Web site at www.sec.gov.  We also provide copies of the foregoing materials, free of charge, to stockholders who request them.  Requests should be directed to the attention of our General Counsel at MFA Financial, Inc., 350 Park Avenue, 20th Floor, New York, New York 10022.

4

Item 1A.  Risk Factors.

This section highlights specific risks that could affect our Company and its business. Readers should carefully consider each of the following risks and all of the other information set forth in this Annual Report on Form 10-K.  Based on the information currently known to us, we believe the following information identifies the most significant risk factors affecting our Company.  However, the risks and uncertainties we face are not limited to those described below.  Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business.

If any of the following risks and uncertainties develops into actual events or if the circumstances described in the risks and uncertainties occur or continue to occur, these events or circumstances could have a material adverse effect on our business, prospects, financial condition, results of operations, cash flows or liquidity.  These events could also have a negative effect on the trading price of our securities.

General

The results of our business operations are affected by a number of factors, many of which are beyond our control, and primarily depend on, among other things, the level of our net interest income, the market value of our assets, which is driven by numerous factors, including the supply and demand for residential mortgage assets in the marketplace, the terms and availability of adequate financing, general economic and real estate conditions (both on a national and local level), the impact of government actions in the real estate and mortgage sector, and the credit performance of our credit sensitive residential mortgage assets.  Our net interest income varies primarily as a result of changes in interest rates, the slope of the yield curve (i.e., the differential between long-term and short-term interest rates), borrowing costs (i.e., our interest expense) and prepayment speeds on our MBS, the behavior of which involves various risks and uncertainties.  Interest rates and conditional prepayment rates (or CPRs) (which measure the amount of unscheduled principal prepayment on a bond as a percentage of the bond balance), vary according to the type of investment, conditions in the financial markets, competition and other factors, none of which can be predicted with any certainty. Our operating results also depend upon our ability to effectively manage the risks associated with our business operations, including interest rate, prepayment, financing and credit risks, while maintaining our qualification as a REIT.

We may change our investment strategy, operating policies and/or asset allocations without stockholder consent, which could materially adversely affect our results of operations.

We may change our investment strategy, operating policies and/or asset allocation with respect to investments, acquisitions, leverage, growth, operations, indebtedness, capitalization and distributions at any time without the consent of our stockholders.  A change in our investment strategy may increase our exposure to interest rate risk, credit risk, default risk and/or real estate market fluctuations.  Furthermore, a change in our asset allocation could result in our making investments in asset categories different from our historical investments.  These changes could materially adversely affect our financial condition, results of operations, the market price of our common stock or our ability to pay dividends or make distributions.

Credit Risks

Our investments in Non-Agency MBS (including RPL/NPL MBS) involve credit risk, which could materially adversely affect our results of operations.

The holder of a mortgage or MBS assumes the risk that the related borrowers may default on their obligations to make full and timely payments of principal and interest.  Under our investment policy, we have the ability to acquire Non-Agency MBS, residential whole loans and other investment assets of lower credit quality.  In general, Legacy Non-Agency MBS and RPL/NPL MBS (which, as of December 31, 2015 represented 48.8% of our total assets) carry greater investment risk than Agency MBS because they are not guaranteed as to principal or interest by the U.S. Government, any federal agency or any federally chartered corporation.  Higher-than-expected rates of default and/or higher-than-expected loss severities on the mortgages underlying these investments could adversely affect the value of these assets.  Accordingly, defaults in the payment of principal and/or interest on our Legacy Non-Agency MBS, RPL/NPL MBS and other investment assets of less-than-high credit quality would likely result in our incurring losses of income from, and/or losses in market value relating to, these assets, which could materially adversely affect our results of operations.

Our investments in re-performing and non-performing residential whole loans involve credit risks, some of which are different from our Non-Agency MBS, which could materially adversely affect our results of operations.

Our investment in residential whole loans was relatively speaking our fastest growing asset class during 2015, and represented approximately 6.8% of our total assets as of December 31, 2015. We expect that our investment portfolio in residential whole

5

loans will continue to increase during 2016, as we seek opportunities in these credit sensitive assets. As a holder of residential whole loans, we are subject to the risk that the related borrowers may default or have defaulted on their obligations to make full and timely payments of principal and interest.  If actual results are different from our assumptions in determining the prices paid to acquire such loans, particularly if the market value of the underlying property decreases significantly subsequent to purchase, we may incur significant losses, which could materially adversely affect our results of operations.

A significant portion of our Non-Agency MBS and residential whole loans are secured by properties in a small number of geographic areas and may be disproportionately affected by economic or housing downturns, natural disasters, terrorist events, regulatory changes, adverse climate changes or other adverse events specific to those markets.

A significant number of the mortgages underlying our Non-Agency MBS and residential whole loan investments are concentrated in certain geographic areas.  For example, we have significantly higher exposure in California, Florida, New York, Virginia, Maryland and New Jersey.  (See “Credit Risk” included under Part II, Item 7A  “Quantitative and Qualitative Disclosures About Market Risk” in this Annual Report on Form 10-K.)  Certain markets within these states (particularly in California and Florida) experienced significant decreases in residential home values during the financial crisis of 2007-2008 and the years thereafter, although in more recent years some of these markets have experienced a recovery in home prices.  Any event that adversely affects the economy or real estate market in any of these states could have a disproportionately adverse effect on our Non-Agency MBS and residential whole loan investments.  In general, any material decline in the economy or significant problems in a particular real estate market would likely cause a decline in the value of residential properties securing the mortgages in that market, thereby increasing the risk of delinquency, default and foreclosure of re-performing loans and the loans underlying our Non-Agency MBS.  This could, in turn, have a material adverse effect on our credit loss experience on our Non-Agency MBS and residential whole loan investments in the affected market if higher-than-expected rates of default and/or higher-than-expected loss severities on our re-performing loan investments or the mortgages underlying our Non-Agency MBS were to occur.

The occurrence of a natural disaster (such as an earthquake, tornado, hurricane or a flood), terrorist attack or a significant adverse climate change may cause a sudden decrease in the value of real estate in the area or areas affected and would likely reduce the value of the properties securing the mortgages collateralizing our Non-Agency MBS or residential whole loans.  Because certain natural disasters are not typically covered by the standard hazard insurance policies maintained by borrowers (such as hurricanes or certain flooding), or the proceeds payable under any such policy is not sufficient to cover the related repairs, the affected borrowers may have to pay for any repairs themselves.  Under these circumstances, borrowers may decide not to repair their property or may stop paying their mortgages under those circumstances.  This would likely cause defaults and credit loss severities to increase.

Changes in governmental laws and regulations, fiscal policies, property taxes and zoning ordinances can also have a negative impact on property values, which could result in borrowers’ deciding to stop paying their mortgages. This circumstance could cause defaults and loss severities to increase, thereby adversely impacting our results of operations.

We have investments in Non-Agency MBS collateralized by Alt A loans and may also have investments collateralized by subprime mortgage loans, which, due to lower underwriting standards, are subject to increased risk of losses.

We have certain investments in Non-Agency MBS backed by collateral pools containing mortgage loans that were originated under underwriting standards that were less strict than those used in underwriting “prime mortgage loans.”  These lower standards permitted mortgage loans, often with LTV ratios in excess of 80%, to be made to borrowers having impaired credit histories, lower credit scores, higher debt-to-income ratios and/or unverified income.  Difficult economic conditions, including increased interest rates and lower home prices, can result in Alt A and subprime mortgage loans having increased rates of delinquency, foreclosure, bankruptcy and loss (including such as during the credit crisis of 2007-2008 and the housing crisis of the last few years), and are likely to otherwise experience delinquency, foreclosure, bankruptcy and loss rates that are higher, and that may be substantially higher, than those experienced by mortgage loans underwritten in a more traditional manner.  Thus, because of higher delinquency rates and losses associated with Alt A and subprime mortgage loans, the performance of our Non-Agency MBS that are backed by these types of loans could be correspondingly adversely affected, which could materially adversely impact our results of operations, financial condition and business.

We are subject to counterparty risk and may be unable to seek indemnity or require counterparties to repurchase residential whole loans if they breach representations and warranties, which could cause us to suffer losses.

In connection with our residential whole loan investments, we typically enter into a loan purchase agreement, as buyer, of the loans from a seller. When we invest in mortgage loans , sellers typically make very limited representations and warranties about such loans. Residential mortgage loan purchase agreements may entitle the purchaser of the loans to seek indemnity or demand repurchase or substitution of the loans in the event the seller of the loans breaches a representation or warranty given to

6

the purchaser. However, there can be no assurance that a mortgage loan purchase agreement will contain appropriate representations and warranties, that we or the trust that purchases the mortgage loans would be able to enforce a contractual right to repurchase or substitution, or that the seller of the loans will remain solvent or otherwise be able to honor its obligations under its mortgage loan purchase agreements. The inability to obtain or enforce an indemnity or require repurchase of a significant number of loans could require us to absorb the associated losses, and adversely affect our results of operations, financial condition and business.

To the extent that due diligence is conducted on potential assets, such due diligence may not reveal all of the risks associated with such assets and may not reveal other weaknesses in such assets, which could lead to losses.

Before making an investment, we typically, but not always, conduct (either directly or using third parties) certain due diligence. There can be no assurance that we will conduct any specific level of due diligence, or that, among other things, our due diligence processes will uncover all relevant facts, which could result in losses on these assets to the extent we ultimately acquire them, which, in turn, could adversely affect our results of operations, financial condition and business.

We have experienced, and may in the future experience, declines in the market value of certain of our investment securities resulting in our recording impairments, which have had, and may in the future have, an adverse effect on our results of operations and financial condition.

A decline in the market value of our MBS or other investment securities may require us to recognize an “other-than-temporary impairment” (or OTTI) against such assets under GAAP.  When the fair value of an available-for-sale (or AFS) investment security is less than its amortized cost at the balance sheet date, the security is considered impaired.  We assess our impaired securities on at least a quarterly basis and designate such impairments as either “temporary” or “other-than-temporary.”  If we intend to sell an impaired security, or it is more likely than not that we will be required to sell the impaired security before any anticipated recovery, then we must recognize an OTTI through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date.  If we do not expect to sell an other-than-temporarily impaired security, only the portion of the OTTI that is related to credit losses is required to be recognized through charges to earnings with the remainder recognized through accumulated other comprehensive income/(loss) (or AOCI) on our consolidated balance sheets.  Impairments recognized through other comprehensive income/(loss) (or OCI) do not impact earnings.  Following the recognition of an OTTI through earnings, a new cost basis is established for the security and may not be adjusted for subsequent recoveries in fair value through earnings.  However, OTTIs recognized through charges to earnings may be accreted back to the amortized cost basis of the security on a prospective basis through interest income.  The determination as to whether an OTTI exists and, if so, the amount of credit impairment recognized in earnings is subjective, as such determinations are based on factual information available at the time of assessment as well as on our estimates of the future performance and cash flow projections.  As a result, the timing and amount of OTTIs constitute material estimates that are susceptible to significant change.

Our use of models in connection with the valuation of our assets subjects us to potential risks in the event that such models are incorrect, misleading or based on incomplete information.

As part of our risk management process, we may use models to evaluate, depending on the asset class, house price appreciation and depreciation by county, region, prepayment speeds and foreclosure frequency, cost and timing. Certain assumptions used as inputs to the models may be based on historical trends. These trends may not be indicative of future results. Furthermore, the assumptions underlying the models may prove to be inaccurate, causing the model output also to be incorrect. In the event models and data prove to be incorrect, misleading or incomplete, any decisions made in reliance thereon expose us to potential risks. For example, by relying on incorrect models and data, we may be induced to buy certain assets at prices that are too high, to sell certain other assets at prices that are too low or to miss favorable opportunities altogether, which could have a material adverse impact on our business and growth prospects.

Valuations of some of our assets are subject to inherent uncertainty, may be based on estimates, may fluctuate over short periods of time and may differ from the values that would have been used if a ready market for these assets existed.

While the determination of the fair value of our investment assets takes into consideration valuations provided by third-party dealers and pricing services, the final determination of exit price fair values for our investment assets is based on our judgment, and such valuations may differ from those provided by third-party dealers and pricing services. Valuations of certain assets may be difficult to obtain or may not be reliable. In general, dealers and pricing services heavily disclaim their valuations as such valuations are not intended to be binding bid prices. Additionally, dealers may claim to furnish valuations only as an accommodation and without special compensation, and so they may disclaim any and all liability arising out of any inaccuracy or incompleteness in valuations. Depending on the complexity and illiquidity of an asset, valuations of the same asset can vary substantially from one dealer or pricing service to another.

7

Our results of operations, financial condition and business could be materially adversely affected if our fair value determinations of these assets were materially higher than the values that would exist if a ready market existed for these assets.

Mortgage loan modification and refinancing programs and future legislative action may materially adversely affect the value of, and the returns on, our MBS and residential whole loan investments.

The U.S. Government, through the Federal Reserve, the Treasury Department, the Federal Housing Administration (or the FHA) and other agencies implemented a number of federal programs designed to assist homeowners, including the Home Affordable Modification Program (or HAMP), which provides homeowners with assistance in avoiding residential mortgage loan foreclosures, the Hope for Homeowners Program (or H4H Program), which allows certain distressed borrowers to refinance their mortgages into FHA-insured loans in order to avoid foreclosure, and the Home Affordable Refinance Program (or HARP), which allows borrowers who are current on their mortgage payments to refinance and reduce their monthly mortgage payments without new mortgage insurance, up to an unlimited loan-to-value ratio for fixed-rate mortgages.  HAMP, the H4H Program and other loss mitigation programs may involve, among other things, the modification of mortgage loans to reduce the principal amount of the loans (through forbearance and/or forgiveness) and/or the rate of interest payable on the loans, or to extend the payment terms of the loans.  Especially with our Non-Agency MBS and residential whole loan investments, a continuing number of loan modifications with respect to a given underlying loan, including, but not limited to, those related to principal forgiveness and coupon reduction, could negatively impact the realized yields and cash flows on such investments.  These loan modification programs, future legislative or regulatory actions, including possible amendments to the bankruptcy laws, that result in the modification of outstanding residential mortgage loans, as well as changes in the requirements necessary to qualify for refinancing mortgage loans with Fannie Mae, Freddie Mac or Ginnie Mae, may materially adversely affect the value of, and the returns on, these assets.

Our investments in residential whole loans subject us to servicing-related risks, including those associated with foreclosure.

The residential whole loans that have been acquired to date were purchased together with the related mortgage servicing rights. We rely on unaffiliated servicing companies to service and manage the mortgages underlying our residential whole loans. If a servicer is not vigilant in seeing that borrowers make their required monthly payments, borrowers may be less likely to make these payments, resulting in a higher frequency of default. If a servicer takes longer to liquidate non-performing mortgages, our losses related to those loans may be higher than originally anticipated. Any failure by servicers to service these mortgages and related real estate owned (or REO) properties could negatively impact the value of these investments and our financial performance. In addition, while we have contracted with unaffiliated servicing companies to carry out the actual servicing of the loans (including all direct interface with the borrowers), we are nevertheless ultimately responsible, vis-à-vis the borrowers and state and federal regulators, for ensuring that the loans are serviced in accordance with the terms of the related notes and mortgages and applicable law and regulation. (See “Regulatory Risk and Risks Related to the Investment Company Act of 1940 -- Our business is subject to extensive regulation.) In light of the current regulatory environment, such exposure could be significant even though we might have contractual claims against our servicers for any failure to service the loans to the required standard.

When one of our residential whole loans is foreclosed upon, title to the underlying property is taken by a Company subsidiary. The foreclosure process, especially in judicial foreclosure states such as New York, Florida and New Jersey can be lengthy and expensive, and the delays and costs involved in completing a foreclosure, and then liquidating the property through sale, may materially increase any related loss. Finally, at such time as title is taken to a foreclosed property, it may require more extensive rehabilitation than we estimated at acquisition. Thus, a material amount of foreclosed residential mortgage loans, particularly in the states mentioned above, could result in significant losses in our residential whole loan portfolio and could materially adversely affect our results of operations.

The federal conservatorship of Fannie Mae and Freddie Mac and related efforts, along with any changes in laws and regulations affecting the relationship between Fannie Mae and Freddie Mac and the U.S. Government, may materially adversely affect our business.

The payments of principal and interest we receive on our Agency MBS, which depend directly upon payments on the mortgages underlying such securities, are guaranteed by Fannie Mae, Freddie Mac or Ginnie Mae.  Fannie Mae and Freddie Mac are U.S. Government-sponsored entities (or GSEs), but their guarantees are not backed by the full faith and credit of the United States (although the FHFA largely controls their actions through its conservatorship of the two GSEs, which occurred in the wake of the 2007-2008 financial crisis).  Ginnie Mae is part of a U.S. Government agency and its guarantees are backed by the full faith and credit of the United States.

Although since the financial crisis of 2007-2008 the U.S. Government has undertaken several measures to support the positive net worth of Fannie Mae and Freddie Mac, there is no guarantee of continuing capital support if such support were to become necessary.  These uncertainties lead to questions about the availability of, and trading market for, Agency MBS.  Despite the steps

8

taken by the U.S. Government, Fannie Mae and Freddie Mac could default on their guarantee obligations which would materially and adversely affect the value of our Agency MBS.  Accordingly, if these government actions are inadequate in the future and the GSEs were to suffer losses, be significantly reformed, or cease to exist (as discussed below), our business, operations and financial condition could be materially and adversely affected.

In addition, the problems faced by Fannie Mae and Freddie Mac resulting in their being placed into federal conservatorship and receiving significant U.S. Government support have sparked serious debate among federal policy makers regarding the continued role of the U.S. Government in providing liquidity for mortgage loans.  In 2011, the Obama administration proposed a plan to wind down the GSEs, and both houses of Congress have considered legislation to reform the GSEs, their functions and their missions. The future roles of Fannie Mae and Freddie Mac may be reduced (perhaps significantly) and the nature of their guarantee obligations could be limited relative to historical measurements.  Alternatively, it is still possible that Fannie Mae and Freddie Mac could be dissolved entirely or privatized, and, as mentioned above, the U.S. Government could determine to stop providing liquidity support of any kind to the mortgage market.  Any changes to the nature of the GSEs or their guarantee obligations could redefine what constitutes an Agency MBS and could have broad adverse implications for the market and our business, operations and financial condition.  If Fannie Mae or Freddie Mac were to be eliminated, or their structures were to change radically (in particular a limitation or removal of the guarantee obligation), we could be unable to acquire additional Agency MBS and our existing Agency MBS could be materially and adversely impacted.

We could be negatively affected in a number of ways depending on the manner in which events unfold for Fannie Mae and Freddie Mac.  We rely on our Agency MBS as collateral for a significant portion of our financings under our repurchase agreements.  Any decline in their value, or perceived market uncertainty about their value, would make it more difficult for us to obtain financing on our Agency MBS on acceptable terms or at all, or to maintain our compliance with the terms of any financing transactions.

As indicated above, future legislation could, among other things, reform the GSEs and their functions, or nationalize, privatize, or eliminate them entirely.  Any law affecting the GSEs may create market uncertainty and have the effect of reducing the actual or perceived credit quality of securities issued or guaranteed by Fannie Mae or Freddie Mac.  As a result, such laws could increase the risk of loss on our investments in Agency MBS guaranteed by Fannie Mae and/or Freddie Mac.  It also is possible that such laws could adversely impact the market for such securities and the spreads at which they trade.  All of the foregoing could materially and adversely affect our business, operations and financial condition.

Government use of eminent domain to seize underwater mortgages could materially adversely affect the value of, and the returns on, our MBS.

The mortgages securing our investments are located in many geographic regions across the United States, with significantly higher exposure in California, Florida, New York, Virginia and Maryland.  Several county and municipal governments have discussed using eminent domain to seize from mortgage holders the mortgages of borrowers who are underwater, but not in default. Legislation enacted in 2014 prohibits the FHFA and the Department of Housing and Urban Development from using federal funds to facilitate the seizure of mortgage loans by a state or local municipality. However, if definitive action were to be taken in the future by any local governments, and such actions withstand Constitutional and other legal challenges, resulting in mortgages securing certain of our investments being seized using eminent domain, the consideration received from the seizing authorities for such mortgages may be substantially less than the outstanding principal balance, which would result in a realized loss and a corresponding write-down of the principal balance of those mortgages. The result of these seizures would be that the amounts we receive on our investments would be less than we would otherwise have received if the mortgage loans had not been seized, which may result in a lower return on such assets or require charges for OTTI or loan loss reserves. If governments ultimately adopt such plans and mortgages securing certain of our investments are seized on a widespread scale, it could have a material adverse effect on the value of and/or returns on our assets and our results of operations more generally.

Prepayment and Reinvestment Risk

Prepayment rates on the mortgage loans underlying our MBS may materially adversely affect our profitability or result in liquidity shortfalls that could require us to sell assets in unfavorable market conditions.

The MBS that we acquire are secured by pools of mortgages on residential properties.  In general, the mortgages collateralizing our MBS may be prepaid at any time without penalty.  Prepayments on our MBS result when borrowers satisfy (i.e., pay off) the mortgage upon selling or refinancing their mortgaged property.  When we acquire a particular MBS, we anticipate that the underlying mortgage loans will prepay at a projected rate which, together with expected coupon income, provides us with an expected yield on that MBS.  If we purchase MBS at a premium to par value, and borrowers then prepay the underlying mortgage loans at a faster rate than we expected, the increased prepayments on the MBS would result in a yield lower than expected on such securities because we would be required to amortize the related premium on an accelerated basis.  Conversely, if we purchase

9

MBS at a discount to par value, and borrowers then prepay the underlying mortgage loans at a slower rate than we expected, the decreased prepayments on the MBS would result in a lower yield than expected on such securities and/or may result in OTTI if the fair value of the security is less than its amortized cost.

Prepayment rates on mortgage loans are influenced by changes in mortgage and market interest rates and a variety of economic, geographic, governmental and other factors beyond our control.  Consequently, prepayment rates cannot be predicted with certainty and no strategy can completely insulate us from prepayment risks.  In periods of declining interest rates, prepayment rates on mortgage loans generally increase. Because of prepayment risk, the market value of our MBS (and in particular our Agency MBS) may benefit less than other fixed income securities from a decline in interest rates.  If general interest rates decline at the same time, we would likely not be able to reinvest the proceeds of the prepayments that we receive in assets yielding as much as those yields on the assets that were prepaid.

With respect to Agency MBS, we have, at times, purchased securities that have a higher coupon rate than the prevailing market interest rates.  In exchange for a higher coupon rate, we typically pay a premium over par value to acquire such securities.  In accordance with U.S. generally accepted accounting principles (or GAAP), we amortize premiums on our MBS over the life of the related MBS.  If the underlying mortgage loans securing these securities prepay at a more rapid rate than anticipated, we will be required to amortize the related premiums on an accelerated basis, which could adversely affect our profitability.  Defaults on the mortgages underlying Agency MBS typically have the same effect as loan prepayments because of the underlying Agency guarantee. As of December 31, 2015, we had net purchase premiums on our Agency MBS of $172.0 million (or 3.8% of current par value) and net purchase discounts on our Non-Agency MBS of $1.100 billion (or 15.8% of current par value).

Prepayments, which are the primary feature of MBS that distinguishes them from other types of bonds, are difficult to predict and can vary significantly over time.  As the holder of MBS, we receive a monthly payment equal to a portion of our investment principal in a particular MBS as the underlying mortgages are prepaid.  With respect to Agency MBS, we typically receive notice of monthly principal prepayments on the fifth business day of each month (such day is commonly referred to as “factor day”) and receive the related scheduled payment on a specified later date, which for (a) our Agency ARM-MBS and fixed-rate Agency MBS guaranteed by Fannie Mae is the 25th day of the month (or next business day thereafter), (b) our Agency ARM-MBS guaranteed by Freddie Mac is the 15th day of the following month (or next business day thereafter), (c) our fixed-rate Agency MBS guaranteed by Freddie Mac is the 15th day of the month (or next business day thereafter), and (d) our Agency ARM-MBS guaranteed by Ginnie Mae is the 20th day of that month (or next business day thereafter).  With respect to our Non-Agency MBS, we typically receive notice of monthly principal prepayments and the related scheduled payment on the 25th day of each month (or next business day thereafter).  In general, on the date each month that principal prepayments are announced (i.e., factor day for Agency MBS), the value of our MBS pledged as collateral under our repurchase agreements is reduced by the amount of the prepaid principal and, as a result, our lenders will typically initiate a margin call that requires us to pledge additional collateral in the form of cash or additional MBS, in an amount equal to the prepaying principal, in order to re-establish the required ratio of borrowing to collateral value under such repurchase agreements.  Accordingly, in the case of Agency MBS, the announcement on factor day of principal prepayments occurs prior to our receipt of the related scheduled payment. This timing differential creates a short-term receivable for us in the amount of any such principal prepayments; however, under our repurchase agreements, we may receive a margin call in the amount of the related reduction in value of the Agency MBS and be required to post on or about factor day additional cash or other collateral in the amount of the prepaying principal to be received, which thereby would reduce our liquidity during the period in which the short-term receivable is outstanding.  As a result, in order to meet any such margin calls, we might be forced to sell assets in order to maintain adequate liquidity.  Forced sales, particularly under adverse market conditions, may result in lower sales prices than sales made under ordinary market conditions in the normal course of business.  If our MBS were to be liquidated at prices below our amortized cost (i.e., our cost basis) of such assets, we would incur losses, which could materially adversely affect our earnings.  In addition, in order to continue to earn a return on this prepaid principal, we must reinvest it in additional MBS or other assets; however, in a declining interest rate environment, we might earn a lower return on our reinvested funds as compared to the return earned on the MBS that had prepaid.

Prepayments may have a materially negative impact on our financial results, the effects of which depend on, among other things, the timing and amount of the prepayment delay on Agency MBS, the amount of unamortized premium on MBS prepayments, the rate at which prepayments are made on our Non-Agency MBS, the reinvestment lag and the availability of suitable reinvestment opportunities.

10

Risks Related to Our Use of Leverage

Our business strategy involves the use of leverage, and we may not achieve what we believe to be optimal levels of leverage or we may become overleveraged, which may materially adversely affect our liquidity, results of operations or financial condition.

Our business strategy involves the use of borrowing or “leverage.”  Pursuant to our leverage strategy, we borrow against a substantial portion of the market value of our MBS and our residential whole loans and use the borrowed funds to finance our investment portfolio and the acquisition of additional investment assets.  We are not required to maintain any particular debt-to-equity ratio.  Future increases in the amount by which the collateral value is required to contractually exceed the repurchase transaction loan amount, decreases in the market value of our MBS, increases in interest rate volatility and changes in the availability of acceptable financing could cause us to be unable to achieve the amount of leverage we believe to be optimal.  The return on our assets and cash available for distribution to our stockholders may be reduced to the extent that changes in market conditions prevent us from achieving the desired amount of leverage on our investments or cause the cost of our financing to increase relative to the income earned on our leveraged assets.  If the interest income on our MBS purchased with borrowed funds fails to cover the interest expense of the related borrowings, we will experience net interest losses and may experience net losses from operations.  Such losses could be significant as a result of our leveraged structure.  The use of leverage to finance our MBS and other assets involves a number of other risks, including, among other things, the following:

• Adverse developments involving major financial institutions or involving one of our lenders could result in a rapid reduction in our ability to borrow and materially adversely affect our business, profitability and liquidity.  As of December 31, 2015, we had amounts outstanding under repurchase agreements with 27 separate lenders.  A material adverse development involving one or more major financial institutions or the financial markets in general could result in our lenders reducing our access to funds available under our repurchase agreements or terminating such repurchase agreements altogether.  Because all of our repurchase agreements are uncommitted and renewable at the discretion of our lenders, our lenders could determine to reduce or terminate our access to future borrowings at virtually any time, which could materially adversely affect our business and profitability.  Furthermore, if a number of our lenders became unwilling or unable to continue to provide us with financing, we could be forced to sell assets, including MBS in an unrealized loss position, in order to maintain liquidity.  Forced sales, particularly under adverse market conditions may result in lower sales prices than ordinary market sales made in the normal course of business.  If our MBS were liquidated at prices below our amortized cost (i.e., the cost basis) of such assets, we would incur losses, which could adversely affect our earnings.

• Ourprofitability may be materially adversely affected by a reduction in our leverage.  As long as we earn a positive spread between interest and other income we earn on our leveraged assets and our borrowing costs, we believe that we can generally increase our profitability by using greater amounts of leverage.  There can be no assurance, however, that repurchase financing will remain an efficient source of long-term financing for our assets.  The amount of leverage that we use may be limited because our lenders might not make funding available to us at acceptable rates or they may require that we provide additional collateral to secure our borrowings.  If our financing strategy is not viable, we will have to find alternative forms of financing for our assets which may not be available to us on acceptable terms or at acceptable rates.  In addition, in response to certain interest rate and investment environments or to changes in market liquidity, we could adopt a strategy of reducing our leverage by selling assets or not reinvesting principal payments as MBS amortize and/or prepay, thereby decreasing the outstanding amount of our related borrowings.  Such an action could reduce interest income, interest expense and net income, the extent of which would be dependent on the level of reduction in assets and liabilities as well as the sale prices for which the assets were sold.

• If we are unable to renew our borrowings at acceptable interest rates, it may force us to sell assets under adverse market conditions, which may materially adversely affect our liquidity and profitability.  Since we rely primarily on borrowings under repurchase agreements to finance our MBS, our ability to achieve our investment objectives depends on our ability to borrow funds in sufficient amounts and on acceptable terms, and on our ability to renew or replace maturing borrowings on a continuous basis.  Our repurchase agreement credit lines are renewable at the discretion of our lenders and, as such, do not contain guaranteed roll-over terms.  Our ability to enter into repurchase transactions in the future will depend on the market value of our MBS pledged to secure the specific borrowings, the availability of acceptable financing and market liquidity and other conditions existing in the lending market at that time.  If we are not able to renew or replace maturing borrowings, we could be forced to sell assets, including MBS in an unrealized loss position, in order to maintain liquidity.  Forced sales, particularly under adverse market conditions could result in lower sales prices than ordinary market sales made in the normal course of business.  If our MBS were liquidated at prices below our amortized cost (i.e., the cost basis) of such assets, we would incur losses, which could materially adversely affect our earnings.

11

• A decline in the market value of our assets may result in margin calls that may force us to sell assets under adverse market conditions, which may materially adversely affect our liquidity and profitability.  In general, the market value of our MBS is impacted by changes in interest rates, prevailing market yields and other market conditions.  A decline in the market value of our MBS may limit our ability to borrow against such assets or result in lenders initiating margin calls, which require a pledge of additional collateral or cash to re-establish the required ratio of borrowing to collateral value, under our repurchase agreements.  Posting additional collateral or cash to support our credit will reduce our liquidity and limit our ability to leverage our assets, which could materially adversely affect our business.  As a result, we could be forced to sell a portion of our assets, including MBS in an unrealized loss position, in order to maintain liquidity.

• If a counterparty to our repurchase transactions defaults on its obligation to resell the underlying security back to us at the end of the transaction term or if we default on our obligations under the repurchase agreement, we could incur losses.  When we engage in repurchase transactions, we generally transfer securities to lenders (i.e., repurchase agreement counterparties) and receive cash from such lenders.  Because the cash we receive from the lender when we initially transfer the securities to the lender is less than the value of those securities (this difference is referred to as the “haircut”), if the lender defaults on its obligation to transfer the same securities back to us, we would incur a loss on the transaction equal to the amount of the haircut (assuming there was no change in the value of the securities).  See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of this Annual Report on Form 10-K, for further discussion regarding risks related to exposure to financial institution counterparties in light of recent market conditions.  Our exposure to defaults by counterparties may be more pronounced during periods of significant volatility in the market conditions for mortgages and mortgage-related assets as well as the broader financial markets.  At December 31, 2015, we had greater than 5% stockholders’ equity at risk to the following repurchase agreement counterparties: Credit Suisse (approximately 13.8%), Wells Fargo (approximately 11.3%), RBC (approximately 11.0%), UBS (approximately 7.2%) and Goldman Sachs (approximately 5.1%).

In addition, generally, if we default on one of our obligations under a repurchase transaction with a particular lender, that lender can elect to terminate the transaction and cease entering into additional repurchase transactions with us.  In addition, some of our repurchase agreements contain cross-default provisions, so that if a default occurs under any one agreement, the lenders under our other repurchase agreements could also declare a default.  Any losses we incur on our repurchase transactions could materially adversely affect our earnings and thus our cash available for distribution to our stockholders.

• Our use of repurchase agreements to borrow money may give our lenders greater rights in the event of bankruptcy.  Borrowings made under repurchase agreements may qualify for special treatment under the U.S. Bankruptcy Code.  If a lender under one of our repurchase agreements defaults on its obligations, it may be difficult for us to recover our assets pledged as collateral to such lender.  In the event of the insolvency or bankruptcy of a lender during the term of a repurchase agreement, the lender may be permitted, under applicable insolvency laws, to repudiate the contract, and our claim against the lender for damages may be treated simply as an unsecured creditor.  In addition, if the lender is a broker or dealer subject to the Securities Investor Protection Act of 1970, or an insured depository institution subject to the Federal Deposit Insurance Act, our ability to exercise our rights to recover our securities under a repurchase agreement or to be compensated for any damages resulting from the lender’s insolvency may be further limited by those statutes.  These claims would be subject to significant delay and, if and when received, may be substantially less than the damages we actually incur.  In addition, in the event of our insolvency or bankruptcy, certain repurchase agreements may qualify for special treatment under the Bankruptcy Code, the effect of which, among other things, would be to allow the creditor under the agreement to avoid the automatic stay provisions of the Bankruptcy Code and take possession of, and liquidate, our collateral under our repurchase agreements without delay.  Our risks associated with the insolvency or bankruptcy of a lender maybe more pronounced during periods of significant volatility in the market conditions for mortgages and mortgage-related assets as well as the broader financial markets.

An increase in our borrowing costs relative to the interest we receive on our MBS or our re-performing residential whole loans may materially adversely affect our profitability.

Our earnings are primarily generated from the difference between the interest income we earn on our investment portfolio, less net amortization of purchase premiums and discounts, and the interest expense we pay on our borrowings.  We rely primarily on borrowings under repurchase agreements to finance the acquisition of MBS which have longer-term contractual maturities.  Even though the majority of our investments have interest rates that adjust over time based on changes in corresponding interest rate indexes, the interest we pay on our borrowings may increase at a faster pace than the interest we earn on our investments.  In general, if the interest expense on our borrowings increases relative to the interest income we earn on our investments, our profitability may be materially adversely affected, including due to the following reasons:

12

• Changes in interest rates, cyclical or otherwise, may materially adversely affect our profitability.  Interest rates are highly sensitive to many factors, including fiscal and monetary policies and domestic and international economic and political conditions, as well as other factors beyond our control.  In general, we finance the acquisition of our investments through borrowings in the form of repurchase transactions, which exposes us to interest rate risk on the financed assets.  The cost of our borrowings is based on prevailing market interest rates.  Because the terms of our repurchase transactions typically range from one to six months at inception, the interest rates on our borrowings generally adjust more frequently (as new repurchase transactions are entered into upon the maturity of existing repurchase transactions) than the interest rates on our investments.  During a period of rising interest rates, our borrowing costs generally will increase at a faster pace than our interest earnings on the leveraged portion of our investment portfolio, which could result in a decline in our net interest spread and net interest margin.  The severity of any such decline would depend on our asset/liability composition, including the impact of hedging transactions, at the time as well as the magnitude and period over which interest rates increase.  Further, an increase in short-term interest rates could also have a negative impact on the market value of our MBS portfolio.  If any of these events happen, we could experience a decrease in net income or incur a net loss during these periods, which may negatively impact our distributions to stockholders.

• Interest rate caps on the mortgages collateralizing our MBS may materially adversely affect our profitability if short-term interest rates increase.  The coupons earned on ARM-MBS adjust over time as interest rates change (typically after an initial fixed-rate period for Hybrids).  The financial markets primarily determine the interest rates that we pay on the repurchase transactions used to finance the acquisition of our MBS; however, the level of adjustment to the interest rates earned on our ARM-MBS is typically limited by contract (or in certain cases by state or federal law).  The interim and lifetime interest rate caps on the mortgages collateralizing our MBS limit the amount by which the interest rates on such assets can adjust.  Interim interest rate caps limit the amount interest rates on a particular ARM can adjust during the next adjustment period.  Lifetime interest rate caps limit the amount interest rates can adjust upward from inception through maturity of a particular ARM.  Our repurchase transactions are not subject to similar restrictions.  Accordingly, in a sustained period of rising interest rates or a period in which interest rates rise rapidly, we could experience a decrease in net income or a net loss because the interest rates paid by us on our borrowings (excluding the impact of hedging transactions) could increase without limitation (as new repurchase transactions are entered into upon the maturity of existing repurchase transactions) while increases in the interest rates earned on the mortgages collateralizing our MBS could be limited due to interim or lifetime interest rate caps.

• Adjustments of interest rates on our borrowings may not be matched to interest rate indexes on our MBS.  In general, the interest rates on our repurchase transactions are based on LIBOR, while the interest rates on our ARM-MBS may be indexed to LIBOR or CMT rate.  Accordingly, any increase in LIBOR relative to one-year CMT rates will generally result in an increase in our borrowing costs that is not matched by a corresponding increase in the interest earned on our ARM-MBS tied to these other index rates.  Any such interest rate index mismatch could adversely affect our profitability, which may negatively impact our distributions to stockholders.

• A flat or inverted yield curve may adversely affect ARM-MBS prepayment rates and supply.  Our net interest income varies primarily as a result of changes in interest rates as well as changes in interest rates across the yield curve.  When the differential between short-term and long-term benchmark interest rates narrows, the yield curve is said to be “flattening.”  In addition, a flatter yield curve generally leads to fixed-rate mortgage rates that are closer to the interest rates available on ARMs, potentially decreasing the supply of ARM-MBS.  At times, short-term interest rates may increase and exceed long-term interest rates, causing an inverted yield curve.  When the yield curve is inverted, fixed-rate mortgage rates may approach or be lower than mortgage rates on ARMs, further increasing ARM-MBS prepayments and further negatively impacting ARM-MBS supply.  Increases in prepayments on our MBS portfolio cause our premium amortization to accelerate, lowering the yield on such assets.  If this happens, we could experience a decrease in net income or incur a net loss during these periods, which may negatively impact our distributions to stockholders.

Amendments to the Federal Home Loan Bank membership regulations will require us to terminate our membership with the FHLB, which could adversely affect our ability to finance our operations.

Our captive insurance subsidiary, MFA Insurance, is a member of the Federal Home Loan Bank of Des Moines (or FHLB Des Moines) and obtains advances from the FHLB Des Moines in the form of secured borrowings. On January 12, 2016, the FHFA amended its regulations governing FHLB membership. The amendments exclude captive insurers from the definition of “insurance company,” making MFA Insurance ineligible for FHLB membership, and, MFA Insurance is required to terminate its membership with the FHLB Des Moines by February 19, 2017. It is also required to repay its existing advances from the FHLB Des Moines by February 19, 2017 or, if earlier, the date it terminates its membership with the FHLB Des Moines, and it is prohibited from receiving new advances or renewing existing advances with the FHLB Des Moines. As of December 31, 2015 and February 16, 2016, MFA Insurance had approximately $1.500 billion and $1.200 billion, respectively, in outstanding secured advances from

13

the FHLB Des Moines. There is no guarantee that we will be able to find suitable counterparties, or any counterparties, to replace the advances received by the FHLB Des Moines or that such replacements will be made on comparable terms, which could adversely affect our ability to finance our operations.

Risks Associated With Adverse Developments in the Mortgage Finance and Credit Markets and Financial Markets Generally

Market conditions for mortgages and mortgage-related assets as well as the broader financial markets may materially adversely affect the value of the assets in which we invest.

Our results of operations are materially affected by conditions in the markets for mortgages and mortgage-related assets, including MBS, as well as the broader financial markets and the economy generally.  Significant adverse changes in financial market conditions leading to the forced sale of large quantities of mortgage-related and other financial assets, would result in significant volatility in the market for mortgages and mortgage-related assets and potentially significant losses for ourselves and certain other market participants.   In addition, concerns over actual or anticipated low economic growth rates higher levels of unemployment or uncertainty regarding future U.S. monetary policy may contribute to increased interest rate volatility.   Declines in the value of our investments, or perceived market uncertainty about their value, may make it difficult for us to obtain financing on favorable terms or at all, or maintain our compliance with terms of any financing arrangements already in place. Additionally, increased volatility and/or deterioration in the broader residential mortgage and MBS markets could materially adversely affect the performance and market value of our investments.

A lack of liquidity in our investments may materially adversely affect our business.

The assets that comprise our investment portfolio and that we acquire are not traded on an exchange.  A portion of our investments are subject to legal and other restrictions on resale and are otherwise generally less liquid than exchange-traded securities.  Any illiquidity of our investments may make it difficult for us to sell such investments if the need or desire arises.  In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we have previously recorded our investments.  Further, we may face other restrictions on our ability to liquidate an investment in a business entity to the extent that we have or could be attributed with material, non-public information regarding such business entity.  As a result, our ability to vary our portfolio in response to changes in economic and other conditions may be relatively limited, which could adversely affect our results of operations and financial condition.

Actions by the U.S. Government designed to stabilize or reform the financial markets may not achieve their intended effect or otherwise benefit our business, and could materially adversely affect our business.

In July 2010, the U.S. Congress enacted the Dodd-Frank Wall Street Reform and Consumer Protection Act (or the Dodd-Frank Act), in part to impose significant investment restrictions and capital requirements on banking entities and other organizations that are significant to U.S. financial markets.  For instance, the Dodd-Frank Act imposes significant restrictions on the proprietary trading activities of certain banking entities and subjects other systemically significant entities and activities regulated by the U.S. Federal Reserve to increased capital requirements and quantitative limits for engaging in such activities.  The Dodd-Frank Act also seeks to reform the asset-backed securitization market (including the MBS market) by requiring the retention of a portion of the credit risk inherent in the pool of securitized assets and by imposing additional registration and disclosure requirements.  The Dodd-Frank Act also imposes significant regulatory restrictions on the origination of residential mortgage loans.  The Dodd-Frank Act’s extensive requirements, and implementation by regulatory agencies such as the Commodity Futures Trading Commission (or CFTC), the Federal Deposit Insurance Corporation (or FDIC), Federal Reserve Board, and the SEC may have a significant effect on the financial markets, and may affect the availability or terms of financing from our lender counterparties and the availability or terms of MBS, both of which could have a material adverse effect on our business.

In addition, the U.S. Government, U.S. Federal Reserve, U.S. Treasury and other governmental and regulatory bodies have taken or are considering taking other actions to continue to address the fallout from the 2007-2008 financial and credit crisis domestically and internationally.  International financial regulators are examining standard setting for systemically significant entities, such as those considered by the Third Basel Accords (Basel III) to be incorporated by domestic entities. We cannot predict whether or when such actions may occur or what affect, if any, such actions could have on our business, results of operations and financial condition.

14

Deterioration in the condition of European banks and financial institutions could have a material adverse effect on our business.

In the years following the financial and credit crisis of 2007-2008, certain of our repurchase agreement counterparties in the United States and Europe experienced financial difficulty and were either rescued by government assistance or otherwise benefited from accommodative monetary policy of Central Banks.  Several European governments implemented measures to attempt to shore up their financial sectors through loans, credit guarantees, capital infusions, promises of continued liquidity funding and interest rate cuts.  Additionally, other governments of the world’s largest economic countries also implemented interest rate cuts.  Although economic and credit conditions have stabilized in the past few years, there is no assurance that these and other plans and programs will be successful in the longer term, and, in particular, when governments and central banks begin to significantly unwind or otherwise reverse these programs and policies.  If unsuccessful, this could materially adversely affect our financing and operations as well as those of the entire mortgage sector in general.

Several of our financing counterparties are European banks (or their U.S. based subsidiaries) that, have provided financing to us, particularly repurchase agreement financing for the acquisition of residential mortgage assets.  If European banks and financial institutions experienced a deterioration in financial condition, there is the possibility that this would also negatively affect the operations of their U.S. banking subsidiaries.  This could adversely affect our financing and operations as well as those of the entire mortgage sector in general.

Any downgrade, or perceived potential of a downgrade, of U.S. sovereign credit ratings or the credit ratings of the GSEs by the various credit rating agencies may materially adversely affect our the value of our Agency MBS and our business more generally.

During the summer of 2011, Standard & Poor’s Ratings Services (or S&P), one of the major credit rating agencies, downgraded the U.S. sovereign credit rating in response to the protracted debate over the “U.S. debt ceiling limit” and S&P’s perception of the U.S. Government’s ability to address its long-term budget deficit.  At the same time, S&P also lowered the credit ratings of the GSEs in response to the downgrade in the U.S. sovereign credit rating, as the value of the Agency MBS issued by the GSEs and their ability to meet their obligations under such Agency MBS are largely determined by the support provided to them by the U.S. Government and market perceptions of the strength of such support and the likelihood of its continuity. 

We could be adversely affected in a number of ways in the event of a default by the U.S. Government, a further downgrade by S&P or a downgrade of the U.S. sovereign credit rating by another credit rating agency   Such adverse effects could include higher financing costs and/or a reduction in the amount of financing provided based on the market value of collateral posted under our repurchase agreements and other financing arrangements.  In addition, although the rating agencies have more recently determined that the GSEs’ outlook is generally stable, to the extent that the credit rating of any or all of the GSEs were to be downgraded in the future, the value of our Agency MBS could be adversely affected. These outcomes could in turn materially adversely affect our operations and financial condition in a number of ways, including a reduction in the net interest spread between our assets and associated repurchase agreement borrowings or a decrease in our ability to obtain repurchase agreement financing on acceptable terms, or at all.

Regulatory Risk and Risks Related to the Investment Company Act of 1940

Our business is subject to extensive regulation.

Our business is subject to extensive regulation by federal and state governmental authorities, self-regulatory organizations and securities exchanges. We are required to comply with numerous federal and state laws. The laws, rules and regulations comprising this regulatory framework change frequently, as can the interpretation and enforcement of existing laws, rules and regulations. Some of the laws, rules and regulations to which we are subject are intended primarily to safeguard and protect consumers, rather than stockholders or creditors. From time to time, we may receive requests from federal and state agencies for records, documents and information regarding our policies, procedures and practices regarding our business activities. We incur significant ongoing costs to comply with these government regulations.

Although we do not originate or directly service residential mortgage loans, we must comply with various federal and state laws, rules and regulations as a result of owning MBS and residential whole loans. These rules generally focus on consumer protection and include, among others, rules promulgated under the Dodd-Frank Act, and the Gramm-Leach-Bliley Financial Modernization Act of 1999 (or Gramm-Leach-Bliley). These requirements can and do change as statutes and regulations are enacted, promulgated, amended and interpreted, and the recent trend among federal and state lawmakers and regulators has been toward increasing laws, regulations and investigative proceedings in relation to the mortgage industry generally. Although we believe that we have structured our operations and investments to comply with existing legal and regulatory requirements and

15

interpretations, changes in regulatory and legal requirements, including changes in their interpretation and enforcement by lawmakers and regulators, could materially and adversely affect our business and our financial condition, liquidity and results of operations.

Maintaining our exemption from registration under the Investment Company Act imposes significant limits on our operations.

We conduct our operations so that neither we nor any of our subsidiaries are required to register as an investment company under the Investment Company Act. Section 3(a)(1)(A) of the Investment Company Act defines an investment company as any issuer that is or holds itself out as being engaged primarily in the business of investing, reinvesting or trading in securities. Section 3(a)(1)(C) of the Investment Company Act defines an investment company as any issuer that is engaged or proposes to engage in the business of investing, reinvesting, owning, holding or trading in securities and owns or proposes to acquire investment securities having a value exceeding 40% of the value of the issuer’s total assets (exclusive of U.S. Government securities and cash items) on an unconsolidated basis. Excluded from the term “investment securities,” among other things, are U.S. Government securities and securities issued by majority-owned subsidiaries that are not themselves investment companies and are not relying on the exception from the definition of investment company for private funds set forth in Section 3(c)(1) or Section 3(c)(7) of the Investment Company Act.

We are a holding company and conduct our real estate businesses primarily through wholly-owned subsidiaries. We conduct our real estate business so that we do not come within the definition of an investment company because less than 40% of the value of our adjusted total assets on an unconsolidated basis will consist of “investment securities.” The securities issued by any wholly-owned or majority-owned subsidiaries that we may form in the future that are excepted from the definition of “investment company” based on Section 3(c)(1) or 3(c)(7) of the Investment Company Act, together with any other investment securities we may own, may not have a value in excess of 40% of the value of our adjusted total assets on an unconsolidated basis. We monitor our holdings to ensure continuing and ongoing compliance with this test. In addition, we believe we will not be considered an investment company under Section 3(a)(1)(A) of the Investment Company Act because we will not engage primarily or hold ourselves out as being engaged primarily in the business of investing, reinvesting or trading in securities. Rather, through our wholly-owned subsidiaries, we will be primarily engaged in the non-investment company businesses of these subsidiaries.

If the value of securities issued by our subsidiaries that are excepted from the definition of “investment company” by Section 3(c)(1) or 3(c)(7) of the Investment Company Act, together with any other investment securities we own, exceeds 40% of our adjusted total assets on an unconsolidated basis, or if one or more of such subsidiaries fail to maintain an exception or exemption from the Investment Company Act, we could, among other things, be required either (a) to substantially change the manner in which we conduct our operations to avoid being required to register as an investment company, (b) effect sales of our assets in a manner that, or at a time when, we would not otherwise choose to do so or (c) to register as an investment company under the Investment Company Act, either of which could have an adverse effect on us and the market price of our securities. If we were required to register as an investment company under the Investment Company Act, we would become subject to substantial regulation with respect to our capital structure (including our ability to use leverage), management, operations, transactions with affiliated persons (as defined in the Investment Company Act), portfolio composition, including restrictions with respect to diversification and industry concentration, and other matters.

We expect that our subsidiaries that invest in residential mortgage loans (whether through a consolidated trust or otherwise) will rely upon the exemption from registration as an investment company under the Investment Company Act pursuant to Section 3(c)(5)(C) of the Investment Company Act, which is available for entities “primarily engaged in the business of purchasing or otherwise acquiring mortgages and other liens on and interests in real estate.” This exemption generally requires that at least 55% of these subsidiaries’ assets must be comprised of qualifying real estate assets and at least 80% of each of their portfolios must be comprised of qualifying real estate assets and real estate-related assets under the Investment Company Act. Mortgage loans that were fully and exclusively secured by real property are generally qualifying real estate assets for purposes of the exemption. All, or substantially all, of our residential mortgage loans are fully and exclusively secured by real property with a loan-to-value ratio of less than 100%. As a result, we believe our residential mortgage loans that are fully and exclusively secured by real property meet the definition of qualifying real estate assets. To the extent we own any residential mortgage loans with a loan-to-value ratio of greater than 100%, we intend to classify, depending on guidance from the SEC staff, only the portion of the value of such loans that does not exceed the value of the real estate collateral as qualifying real estate assets and the excess as real estate-related assets.

In August 2011, the SEC issued a “concept release” pursuant to which they solicited public comments on a wide range of issues relating to companies engaged in the business of acquiring mortgages and mortgage-related instruments and that rely on Section 3(c)(5)(C) of the Investment Company Act. The concept release and the public comments thereto have not yet resulted in SEC rulemaking or interpretative guidance and we cannot predict what form any such rulemaking or interpretive guidance may take. There can be no assurance, however, that the laws and regulations governing the Investment Company Act status of REITs,

16

or guidance from the SEC or its staff regarding the exemption from registration as an investment company on which we rely, will not change in a manner that adversely affects our operations. We expect each of our subsidiaries relying on Section 3(c)(5)(C) to rely on guidance published by the SEC staff or on our analyses of guidance published with respect to other types of assets, if any, to determine which assets are qualifying real estate assets and real estate-related assets. To the extent that the SEC staff publishes new or different guidance with respect to these matters, we may be required to adjust our strategy accordingly. In addition, we may be limited in our ability to make certain investments and these limitations could result in us holding assets we might wish to sell or selling assets we might wish to hold.

Certain of our subsidiaries may rely on the exemption provided by Section 3(c)(6) to the extent that they hold residential mortgage loans through majority owned subsidiaries that rely on Section 3(c)(5)(C). The SEC staff has issued little interpretive guidance with respect to Section 3(c)(6) and any guidance published by the staff could require us to adjust our strategy accordingly.

To the extent that the SEC staff provides more specific guidance regarding any of the matters bearing upon the exceptions we and our subsidiaries rely on from the Investment Company Act, we may be required to adjust our strategy accordingly. Any additional guidance from the SEC staff could provide additional flexibility to us, or it could further inhibit our ability to pursue the strategies we have chosen.

There can be no assurance that the laws and regulations governing the Investment Company Act status of REITs, including the Division of Investment Management of the SEC providing more specific or different guidance regarding these exemptions, will not change in a manner that adversely affects our operations.

Risks Related to Our Use of Hedging Strategies

Our use of hedging strategies to mitigate our interest rate exposure may not be effective.

In accordance with our operating policies, we pursue various types of hedging strategies, including interest rate swap agreements (or Swaps), to seek to mitigate or reduce our exposure to losses from adverse changes in interest rates.  Our hedging activity will vary in scope based on the level and volatility of interest rates, the type of assets held and financing sources used and other changing market conditions.  No hedging strategy, however, can completely insulate us from the interest rate risks to which we are exposed and there is no guarantee that the implementation of any hedging strategy would have the desired impact on our results of operations or financial condition.  Certain of the U.S. federal income tax requirements that we must satisfy in order to qualify as a REIT may limit our ability to hedge against such risks.  We will not enter into derivative transactions if we believe that they will jeopardize our qualification as a REIT.

Interest rate hedging may fail to protect or could adversely affect us because, among other things:

• interest rate hedging can be expensive, particularly during periods of rising and volatile interest rates;

• available interest rate hedges may not correspond directly with the interest rate risk for which protection is sought;

• the duration of the hedge may not match the duration of the related liability;

• the credit quality of the party owing money on the hedge may be downgraded to such an extent that it impairs our ability to sell or assign our side of the hedging transaction; and

• the party owing money in the hedging transaction may default on its obligation to pay.

We primarily use Swaps to hedge against future increases in interest rates on our repurchase agreements.  Should a Swap counterparty be unable to make required payments pursuant to such Swap, the hedged liability would cease to be hedged for the remaining term of the Swap.  In addition, we may be at risk for any collateral held by a hedging counterparty to a Swap, should such counterparty become insolvent or file for bankruptcy.  Our hedging transactions, which are intended to limit losses, may actually adversely affect our earnings, which could reduce our cash available for distribution to our stockholders.

We may enter into hedging instruments that could expose us to contingent liabilities in the future, which could materially adversely affect our results of operations.

Subject to maintaining our qualification as a REIT, part of our financing strategy involves entering into hedging instruments that could require us to fund cash payments in certain circumstances (e.g., the early termination of a hedging instrument caused by an event of default or other voluntary or involuntary termination event or the decision by a hedging counterparty to request the

17

posting of collateral that it is contractually owed under the terms of a hedging instrument).  With respect to the termination of an existing Swap, the amount due would generally be equal to the unrealized loss of the open Swap position with the hedging counterparty and could also include other fees and charges.  These economic losses will be reflected in our financial results of operations and our ability to fund these obligations will depend on the liquidity of our assets and access to capital at the time.  Any losses we incur on our hedging instruments could materially adversely affect our earnings and thus our cash available for distribution to our stockholders.

The characteristics of hedging instruments present various concerns, including illiquidity, enforceability, and counterparty risks, which could adversely affect our business and results of operations.

As indicated above, from time to time we enter into Swaps. Entities entering into Swaps are exposed to credit losses in the event of non-performance by counterparties to these transactions. The CFTC, issued new rules that became effective in October 2012 regarding Swaps under the authority granted to it pursuant to the Dodd-Frank Act. Although the new rules do not directly affect the negotiations and terms of individual Swap transactions between counterparties, they do require that the clearing of all Swap transactions through registered derivatives clearing organizations, or swap execution facilities, through standardized documents under which each Swap counterparty transfers its position to another entity whereby the centralized clearinghouse effectively becomes the counterparty to each side of the Swap. It is the intent of the Dodd-Frank Act that the clearing of Swaps in this manner is designed to avoid concentration of swap risk in any single entity by spreading and centralizing the risk in the clearinghouse and its members. In addition to greater initial and periodic margin (collateral) requirements and additional transaction fees both by the swap execution facility and the clearinghouse, the Swap transactions are now subjected to greater regulation by both the CFTC and the SEC. These additional fees, costs, margin requirements, documentation, and regulation could adversely affect our business and results of operations. Additionally, for all Swaps we entered into prior to June 2013, we are not required to clear them through the central clearinghouse and these Swaps are still subject to the risks of non-performance by any of the individual counterparties with whom we entered into these transactions. If the Swap counterparty cannot perform under the terms of a Swap, we would not receive payments due under that agreement, we may lose any unrealized gain associated with the Swap, and the hedged liability would cease to be hedged by the Swap. We may also be at risk for any collateral we have pledged to secure our obligation under the Swap if the counterparty becomes insolvent or files for bankruptcy. Default by a party with whom we enter into a hedging transaction may result in a loss and force us to cover our commitments, if any, at the then-current market price. Although generally we will seek to reserve the right to terminate our hedging positions, it may not always be possible to dispose of or close out a hedging position without the consent of the hedging counterparty and we may not be able to enter into an offsetting contract in order to cover our risk. We cannot assure you that there will always be a liquid secondary market that will exist for hedging instruments purchased or sold and we may be required to maintain a position until exercise or expiration, which could result in losses.

Clearing facilities or exchanges upon which some of our hedging instruments are traded may increase margin requirements on our hedging instruments in the event of adverse economic developments.

In response to events having or expected to have adverse economic consequences or which create market uncertainty, clearing facilities or exchanges upon which some of our hedging instruments (i.e., interest rate swaps) are traded may require us to post additional collateral against our hedging instruments. For example, in response to the U.S. approaching its debt ceiling without resolution and the federal government shutdown, in October 2013, the Chicago Mercantile Exchange announced that it would increase margin requirements by 12% for all over-the-counter interest rate swap portfolios that its clearinghouse guaranteed. This increase was subsequently rolled back shortly thereafter upon the news that Congress passed legislation to temporarily suspend the national debt ceiling and reopen the federal government, and provide a time period for broader negotiations concerning federal budgetary issues. In the event that future adverse economic developments or market uncertainty (including those due to governmental, regulatory, or legislative action or inaction) result in increased margin requirements for our hedging instruments, it could materially adversely affect our liquidity position, business, financial condition and results of operations.

We may fail to qualify for hedge accounting treatment, which could materially adversely affect our results of operations.

We record derivative and hedge transactions in accordance with GAAP, specifically according to the Financial Accounting Standards Board (or FASB) Accounting Standards Codification Topic on Derivatives.  Under these standards, we may fail to qualify for hedge accounting treatment for a number of reasons, including if we use instruments that do not meet the definition of a derivative, we fail to satisfy hedge documentation and hedge effectiveness assessment requirements or our instruments are not highly effective.  If we fail to qualify for hedge accounting treatment, though the fundamental economic performance of our business would be unaffected, our operating results for financial reporting purposes may be materially adversely affected because losses on the derivatives we enter into would be recorded in net income, rather than AOCI, a component of stockholders’ equity.

18

Risks Related to Our Taxation as a REIT and the Taxation of Our Assets

If we fail to remain qualified as a REIT, we will be subject to tax as a regular corporation and could face a substantial tax liability, which would reduce the amount of cash available for distribution to our stockholders.

We have elected to qualify as a REIT and intend to comply with the provisions of the Internal Revenue Code of 1986, as amended (or the Code) related to REIT qualification.  Accordingly, we will not be subject to U.S. federal income tax to the extent we distribute 100% of our REIT taxable income (which is generally our taxable income, computed without regard to the dividends paid deduction, any net income from prohibited transactions, and any net income from foreclosure property) to stockholders within the timeframe permitted under the Code and provided that we comply with certain income, asset ownership and other tests applicable to REITs.  We believe that we currently meet all of the REIT requirements and intend to continue to qualify as a REIT under the provisions of the Code.  Many of the REIT requirements however are highly technical and complex.  The determination of whether we are a REIT requires an analysis of various factual matters and circumstances, some of which may not be totally within our control and some of which involve interpretation.  For example, if we are to qualify as a REIT, annually at least 75% of our gross income must come from, among other sources, interest on obligations secured by mortgages on real property or interests in real property, gain from the disposition of real property, including mortgages or interests in real property (other than sales or dispositions of real property, including mortgages on real property, or securities that are treated as mortgages on real property, that we hold primarily for sale to customers in the ordinary course of a trade or business (i.e., prohibited transactions)), dividends, other distributions on and gains from the disposition of shares in other REITs, commitment fees received for agreements to make real estate loans and certain temporary investment income.  In addition, the composition of our assets must meet qualified requirements at the close of each quarter.  There can be no assurance that we will be able to satisfy these or other requirements or that the Internal Revenue Service (or IRS) or a court would agree with any conclusions or positions we have taken in interpreting the REIT requirements.

Even a technical or inadvertent mistake could jeopardize our REIT qualification unless we meet certain statutory relief provisions.  If we were to fail to qualify as a REIT in any taxable year for any reason, we would be subject to U.S. federal income tax, including any applicable alternative minimum tax, on our taxable income at regular corporate rates, and dividends paid to our stockholders would not be deductible by us in computing our taxable income. Any resulting corporate tax liability could be substantial and would reduce the amount of cash available for distribution to our stockholders, which in turn could have an adverse impact on the value of our common stock. Unless we were entitled to relief under certain Code provisions, we also would be disqualified from taxation as a REIT for the four taxable years following the year in which we failed to qualify as a REIT.

We may lose our REIT status if the IRS successfully challenges our characterization of our income from foreign TRSs.

We have elected to treat a Cayman Islands company as a TRS. We will likely be required to include in our income, even without the receipt of actual distributions, earnings from our investment in the foreign TRS. Income inclusions from equity investments in foreign corporations are technically neither actual dividends nor any of the other enumerated categories of qualifying income for the 95% gross income test. However, the IRS, based on discretionary authority granted to it under the Code, has issued private letter rulings to other REITs holding that income inclusions from equity investments in foreign corporations would be treated as qualifying income for purposes of the 95% gross income test. Private letter rulings may be relied upon only by the taxpayers to whom they are issued and the IRS may revoke a private letter ruling. Based on those private letter rulings and advice of counsel, we generally intend to treat such income inclusions as qualifying income for purposes of the 95% gross income test. Nevertheless, no assurance can be provided that the IRS would not successfully challenge our treatment of such income as qualifying income. In the event that such income was determined not to qualify for the 95% gross income test, we could be subject to a penalty tax with respect to such income to the extent it exceeds 5% of our gross income or we could fail to continue to qualify as a REIT.

19

REIT distribution requirements could adversely affect our ability to execute our business plan.

To maintain our qualification as a REIT, we must distribute at least 90% of our REIT taxable income (determined without regard to the dividends paid deduction and excluding any net capital gain) to our stockholders within the timeframe permitted under the Code.  We generally must make these distributions in the taxable year to which they relate, or in the following taxable year if declared before we timely (including extensions) file our tax return for the year and if paid with or before the first regular dividend payment after such declaration.  To the extent that we satisfy this distribution requirement, but distribute less than 100% of our taxable income, we will be subject to U.S. federal income tax on our undistributed taxable income. In addition, if we should fail to distribute during each calendar year at least the sum of (a) 85% of our REIT ordinary income for such year, (b) 95% of our REIT capital gain net income for such year, and (c) any undistributed taxable income from prior periods, we would be subject to a non-deductible 4% excise tax on the excess of such required distribution over the sum of (x) the amounts actually distributed, plus (y) the amounts of income we retained and on which we have paid corporate income tax.

The dividend distribution requirement limits the amount of cash we have available for other business purposes, including amounts to fund our growth.  Also, it is possible that because of differences in timing between the recognition of taxable income and the actual receipt of cash, we may have to borrow funds on unfavorable terms, sell investments at disadvantageous prices or distribute amounts that would otherwise be invested in future acquisitions to make distributions sufficient to maintain our qualification as a REIT or avoid corporate income tax and the 4% excise tax in a particular year. These alternatives could increase our costs or reduce our stockholders’ equity. Thus, compliance with the REIT requirements may hinder our ability to grow, which could adversely affect the value of our common stock. 

Even if we remain qualified as a REIT, we may face other tax liabilities that reduce our cash flow.

Even if we qualify as a REIT for U.S. federal income tax purposes, we may be required to pay certain federal, state and local taxes on our income and assets, including taxes on any undistributed income, tax on income from some activities conducted as a result of a foreclosure, excise taxes, state or local income, property and transfer taxes, such as mortgage recording taxes, and other taxes. In addition, in order to meet the REIT qualification requirements, prevent the recognition of certain types of non-cash income, or to avert the imposition of a 100% tax that applies to certain gains derived by a REIT from dealer property or inventory, we may hold some of our assets through TRSs or other subsidiary corporations that will be subject to corporate level income tax at regular rates. In addition, if we lend money to a TRS, the TRS may be unable to deduct all or a portion of the interest paid to us, which could result in an even higher corporate level tax liability. Any of these taxes would reduce our operating cash flow and thus our cash available for distribution to our stockholders.

If our foreign TRSs are subject to U.S. federal income tax at the entity level, it would greatly reduce the amounts those entities would have available to distribute to us and that they would have available to pay their creditors.

There is a specific exemption from regular U.S. federal income tax for non-U.S. corporations that restrict their activities in the United States to trading stock and securities (or any activity closely related thereto) for their own account whether such trading (or such other activity) is conducted by the corporation or its employees through a resident broker, commission agent, custodian or other agent. We intend that our foreign TRS will rely on that exemption or otherwise operate in a manner so that it will not be subject to regular U.S. federal income tax on its net income at the entity level. If the IRS succeeded in challenging that tax treatment, it would greatly reduce the amount that the foreign TRS would have available to pay to their creditors and to distribute to us. In addition, even if our foreign TRS qualifies for that exemption, it may nevertheless be subject to U.S. federal withholding tax on certain types of income.

Complying with REIT requirements may cause us to forgo otherwise attractive opportunities.

To remain qualified as a REIT for U.S. federal income tax purposes, we must continually satisfy tests concerning, among other things, the sources of our income, the nature and diversification of our assets, the amounts that we distribute to our stockholders and the ownership of our stock. We may be required to make distributions to stockholders at disadvantageous times or when we do not have funds readily available for distribution, and may be unable to pursue investments that would be otherwise advantageous to us in order to satisfy the source-of-income or asset-diversification requirements for qualifying as a REIT. In addition, in certain cases, the modification of a debt instrument could result in the conversion of the instrument from a qualifying real estate asset to a wholly or partially non-qualifying asset that must be contributed to a TRS or disposed of in order for us to qualify or maintain our qualification as a REIT. Thus, compliance with the REIT requirements may hinder our ability to make and, in certain cases, to maintain ownership of, certain attractive investments.

20

We may generate taxable income that differs from our GAAP income on our Non-Agency MBS and residential whole loan investments purchased at a discount to par value, which may result in significant timing variances in the recognition of income and losses.

We have acquired and intend to continue to acquire Non-Agency MBS and residential whole loans at prices that reflect significant market discounts on their unpaid principal balances.  For financial statement reporting purposes, we generally establish a portion of the purchase discount on Non-Agency MBS as a Credit Reserve.  This Credit Reserve is generally not accreted into income for financial statement reporting purposes.  For tax purposes, however, we are not permitted to anticipate, or establish a reserve for, credit losses prior to their occurrence.  As a result, discount on securities acquired in the primary or secondary market is included in the determination of taxable income and is not impacted by losses until such losses are incurred.  Such differences in accounting for tax and GAAP can lead to significant timing variances in the recognition of income and losses.  Taxable income on Non-Agency MBS purchased at a discount to their par value may be higher than GAAP earnings in early periods (before losses are actually incurred) and lower than GAAP earnings in periods during and subsequent to when realized credit losses are incurred.  Dividends will be declared and paid at the discretion of our Board and will depend on REIT taxable earnings, our financial results and overall financial condition, maintenance of our REIT qualification and such other factors as our Board may deem relevant from time to time.

The “taxable mortgage pool” rules may increase the taxes that we or our stockholders may incur and may limit the manner in which we effect future securitizations.

Securitizations by us or our subsidiaries could result in the creation of taxable mortgage pools for U.S. federal income tax purposes.  The real estate mortgage investment conduit (or REMIC) provisions of the Code generally provide that REMICs are the only form of pass-through entity permitted to issue debt obligations with two or more maturities if the payments on those obligations bear a relationship to the mortgage obligations held by such entity.  If we engage in a non-REMIC securitization transaction, directly or indirectly through a qualified REIT subsidiary (or QRS), in which the assets held by the securitization vehicle consist largely of mortgage loans or MBS, in which the securitization vehicle issues to investors two or more classes of debt instruments that have different maturities, and in which the timing and amount of payments on the debt instruments is determined in large part by the amounts received on the mortgage loans or MBS held by the securitization vehicle, the securitization vehicle will be a taxable mortgage pool.  As long as we or another REIT hold a 100% interest in the equity interests in a taxable mortgage pool, either directly, or through a QRS, it will not be subject to tax.  A portion of the income that we realize with respect to the equity interest we hold in a taxable mortgage pool will, however, be considered to be excess inclusion income and, as a result, a portion of the dividends that we pay to our stockholders will be considered to consist of excess inclusion income.  Such excess inclusion income is treated as unrelated business taxable income (or UBTI) for tax-exempt stockholders, is subject to withholding for foreign stockholders (without the benefit of any treaty reduction), and is not subject to reduction by net operating loss carryovers.  In addition to the extent that our stock is owned by tax-exempt “disqualified organizations,” such as certain government-related entities and charitable remainder trusts that are not subject to tax on unrelated business income, we may incur a corporate level tax on a portion of our income from the taxable mortgage pool. In that case, we may reduce the amount of our distributions to any disqualified organization whose stock ownership gave rise to the tax. Historically, we have not generated excess inclusion income; however, despite our efforts, we may not be able to avoid creating or distributing excess inclusion income to our stockholders in the future.  In addition, we could face limitations in selling equity interests to outside investors in securitization transactions that are taxable mortgage pools or selling any debt securities issued in connection with these securitizations that might be considered to be equity interests for tax purposes.  These limitations may prevent us from using certain techniques to maximize our returns from securitization transactions.

We have not established a minimum dividend payment level, and there is no guarantee that we will maintain current dividend payment levels or pay dividends in the future.

In order to maintain our qualification as a REIT, we must comply with a number of requirements under U.S. federal tax law, including that we distribute at least 90% of our REIT taxable income within the timeframe permitted under the Code, which is calculated generally before the dividends paid deduction and excluding net capital gain.  Dividends will be declared and paid at the discretion of our Board and will depend on our REIT taxable earnings, our financial results and overall condition, maintenance of our REIT qualification and such other factors as our Board may deem relevant from time to time.  We have not established a minimum dividend payment level for our common stock and our ability to pay dividends may be negatively impacted by adverse changes in our operating results.  Therefore, our dividend payment level may fluctuate significantly, and, under some circumstances, we may not pay dividends at all.

21

Our reported GAAP net income may differ from the amount of REIT taxable income and dividend distribution requirements and, therefore, our GAAP results may not be an accurate indicator of future taxable income and dividend distributions.

Generally, the cumulative net income we report over the life of an asset will be the same for GAAP and tax purposes, although the timing of this income recognition over the life of the asset could be materially different.  Differences exist in the accounting for GAAP net income and REIT taxable income which can lead to significant variances in the amount and timing of when income and losses are recognized under these two measures.  Due to these differences, our reported GAAP financial results could materially differ from our determination of REIT taxable income, and our dividend distribution requirements, and, therefore, our GAAP results may not be an accurate indicator of future taxable income and dividend distributions.

Over time, accounting principles, conventions, rules, and interpretations may change, which could affect our reported GAAP and taxable earnings, and stockholders’ equity.

Accounting rules for the various aspects of our business change from time to time.  Changes in GAAP, or the accepted interpretation of these accounting principles, can affect our reported income, earnings, and stockholders’ equity.  In addition, changes in tax accounting rules or the interpretations thereof could affect our REIT taxable income and our dividend distribution requirements.  These changes may materially adversely affect our results of operations.

The failure of assets subject to repurchase agreements to qualify as real estate assets could adversely affect our ability to remain qualified as a REIT.

We enter into certain financing arrangements that are structured as sale and repurchase agreements pursuant to which we nominally sell certain of our assets to a counterparty and simultaneously enter into an agreement to repurchase these assets at a later date in exchange for a purchase price. Economically, these agreements are financings that are secured by the assets sold pursuant thereto. We generally believe that we would be treated for REIT asset and income test purposes as the owner of the assets that are the subject of any such sale and repurchase agreement notwithstanding that such agreement may transfer record ownership of the assets to the counterparty during the term of the agreement. It is possible, however, that the IRS could assert that we did not own the assets during the term of the sale and repurchase agreement, in which case we could fail to remain qualified as a REIT.

Complying with REIT requirements may limit our ability to hedge effectively and may cause us to incur tax liabilities.

The REIT provisions of the Code could substantially limit our ability to hedge our liabilities. Any income from a properly designated hedging transaction we enter into to manage risk of interest rate changes with respect to borrowings made or to be made, or ordinary obligations incurred or to be incurred, to acquire or carry real estate assets, or from certain other limited types of hedging transactions, generally does not constitute “gross income” for purposes of the 75% or 95% gross income tests. To the extent that we enter into other types of hedging transactions, the income from those transactions is likely to be treated as non-qualifying income for purposes of both of the gross income tests. As a result of these rules, we may have to limit our use of advantageous hedging techniques or implement those hedges through a TRS. This could increase the cost of our hedging activities because a TRS would be subject to tax on gains or expose us to greater risks associated with changes in interest rates than we would otherwise want to bear. In addition, losses in a TRS will generally not provide any tax benefit, except for being carried forward against future taxable income in the TRS.

We may be required to report taxable income for certain investments in excess of the economic income we ultimately realize from them.

We may acquire debt instruments in the secondary market for less than their face amount. The discount at which such debt instruments are acquired may reflect doubts about their ultimate collectibility rather than current market interest rates. The amount of such discount will nevertheless generally be treated as “market discount” for U.S. federal income tax purposes. Accrued market discount is reported as income when, and to the extent that, any payment of principal of the debt instrument is made. If we collect less on the debt instrument than our purchase price plus the market discount we had previously reported as income, we may not be able to benefit from any offsetting loss deductions.

Some of the debt instruments that we acquire may have been issued with original issue discount. We will be required to report such original issue discount based on a constant yield method and will be taxed based on the assumption that all future projected payments due on such debt instruments will be made. If such debt instruments turn out not to be fully collectible, an offsetting loss deduction will become available only in the later year that uncollectibility is provable.

In addition, we may acquire debt instruments that are subsequently modified by agreement with the borrower. If the amendments to the outstanding instrument are “significant modifications” under the applicable Treasury regulations, the modified

22

instrument will be considered to have been reissued to us in a debt-for-debt exchange with the borrower. In that event, we may be required to recognize taxable gain to the extent the principal amount of the modified instrument exceeds our adjusted tax basis in the unmodified instrument, even if the value of the instrument or the payment expectations have not changed. Following such a taxable modification, we would hold the modified loan with a cost basis equal to its principal amount for federal tax purposes.

Finally, in the event that any debt instruments acquired by us are delinquent as to mandatory principal and interest payments, or in the event payments with respect to a particular instrument are not made when due, we may nonetheless be required to continue to recognize the unpaid interest as taxable income as it accrues, despite doubt as to its ultimate collectibility. Similarly, we may be required to accrue interest income with respect to debt instruments at its stated rate regardless of whether corresponding cash payments are received or are ultimately collectible. In each case, while we would in general ultimately have an offsetting loss deduction available to us when such interest was determined to be uncollectible, the utility of that deduction could depend on our having taxable income in that later year or thereafter.

For these and other reasons, we may have difficulty making distributions sufficient to maintain our qualification as a REIT or avoid corporate income tax and the 4% excise tax in a particular year.

Dividends paid by REITs do not qualify for the reduced tax rates

The maximum regular U.S. federal income tax rate for dividends paid to domestic stockholders that are individuals, trusts and estates is currently 20%.  Dividends paid by REITs, however, are generally not eligible for the reduced rates.  Although this legislation does not adversely affect the taxation of REITs or dividends paid by REITs, the more favorable rates applicable to regular corporate dividends could cause investors who are individuals, trusts and estates to perceive investments in REITs to be relatively less attractive than investments in stock of non-REIT corporations that pay dividends, which could adversely affect the value of the stock of REITs, including our common stock.

We may enter into resecuritization transactions, the tax treatment of which could have a material adverse effect on our results of operations.

We have engaged in and may in the future, engage in resecuritization transactions in which we transfer Non-Agency MBS to a special purpose entity that has formed or will form a securitization vehicle that will issue multiple classes of securities secured by and payable from cash flows on the underlying Non-Agency MBS.  To date, we have structured two such transactions as a REMIC securitizations, which, to the extent we have transferred securities in a resecuritization, is viewed as the sale of securities for tax purposes.  Although such transactions are treated as sales for tax purposes, they have historically not given rise to any taxable gain so that the prohibited transactions tax rules have not been implicated (i.e., the tax only applies to net taxable gain from sales that are prohibited transactions); however, no assurance can be offered that the IRS will agree with such treatment.  In addition, to these REMIC securitization transactions, we have also engaged in two resecuritization transactions that we believe should be treated as financing transactions for tax purposes.  If a securitization transaction were to be considered to be a sale of property to customers in the ordinary course of a trade or business, and we recognized a gain on such transaction for tax purposes, then we could risk exposure to the 100% tax on net taxable income from prohibited transactions.  Moreover, even if we retained MBS resulting from a resecuritization transaction and then subsequently sold such securities at a tax gain, the gain could, absent an available safe-harbor provision, be characterized as net income from a prohibited transaction.  Under these circumstances, our results of operations could be materially adversely affected.

New legislation or administrative or judicial action, in each instance potentially with retroactive effect, could make it more difficult or impossible for us to remain qualified as a REIT.

The present U.S. federal income tax treatment of REITs may be modified, possibly with retroactive effect, by legislative, judicial or administrative action at any time, which could affect the U.S. federal income tax treatment of an investment in us. Revisions in U.S. federal tax laws and interpretations thereof could affect or cause us to change our investments and commitments and affect the tax considerations of an investment in us.

Risks Related to Our Corporate Structure

Our ownership limitations may restrict business combination opportunities.

To qualify as a REIT under the Code, no more than 50% of the value of our outstanding shares of capital stock may be owned, directly or under applicable attribution rules, by five or fewer individuals (as defined by the Code to include certain entities) during the last half of each taxable year.  To preserve our REIT qualification, among other things, our charter generally prohibits direct or indirect ownership by any person of more than 9.8% of the number or value of the outstanding shares of our capital stock. 

23

Generally, shares owned by affiliated owners will be aggregated for purposes of the ownership limit.  Any transfer of shares of our capital stock or other event that, if effective, would violate the ownership limit will be void as to that number of shares of capital stock in excess of the ownership limit and the intended transferee will acquire no rights in such shares.  Shares issued or transferred that would cause any stockholder to own more than the ownership limit or cause us to become “closely held” under Section 856(h) of the Code will automatically be converted into an equal number of shares of excess stock.  All excess stock will be automatically transferred, without action by the prohibited owner, to a trust for the exclusive benefit of one or more charitable beneficiaries that we select, and the prohibited owner will not acquire any rights in the shares of excess stock.  The restrictions on ownership and transfer contained in our charter could have the effect of delaying, deferring or preventing a change in control or other transaction in which holders of shares of common stock might receive a premium for their shares of common stock over the then current market price or that such holders might believe to be otherwise in their best interests.  The ownership limit provisions also may make our shares of common stock an unsuitable investment vehicle for any person seeking to obtain, either alone or with others as a group, ownership of more than 9.8% of the number or value of our outstanding shares of capital stock.

Provisions of Maryland law and other provisions of our organizational documents may limit the ability of a third party to acquire control of the Company.

Certain provisions of the Maryland General Corporation Law (or MGCL) may have the effect of delaying, deferring or preventing a transaction or a change in control of our company that might involve a premium price for holders of our common stock or otherwise be in their best interests, including:

• “business combination” provisions that, subject to limitations, prohibit certain business combinations between us and an “interested stockholder” (defined generally as any person who beneficially owns 10% or more of the voting power of our outstanding voting stock or an affiliate or associate of ours who, at any time within the two-year period immediately prior to the date in question, was the beneficial owner of 10% or more of the voting power of our then outstanding stock) or an affiliate of an interested stockholder for five years after the most recent date on which the stockholder becomes an interested stockholder, and thereafter impose two supermajority stockholder voting requirements to approve these combinations (unless our common stockholders receive a minimum price, as defined under Maryland law, for their shares in the form of cash or other consideration in the same form as previously paid by the interested stockholder for its shares); and

• “control share” provisions that provide that holders of “control shares” of our company (defined as voting shares of stock which, when aggregated with all other shares controlled by the acquiring stockholder, entitle the stockholder to exercise one of three increasing ranges of voting power in electing directors) acquired in a “control share acquisition” (defined as the direct or indirect acquisition of ownership or control of “control shares”) have no voting rights except to the extent approved by our stockholders by the affirmative vote of at least two-thirds of all the votes entitled to be cast on the matter, excluding all interested shares.

Our bylaws provide that we are not subject to the “control share” provisions of the MGCL.  However, our Board may elect to make the “control share” statute applicable to us at any time, and may do so without stockholder approval.

Title 3, Subtitle 8 of the MGCL permits our Board, without stockholder approval and regardless of what is currently provided in our charter or bylaws, to elect on behalf of our company to be subject to statutory provisions that may have the effect of delaying, deferring or preventing a transaction or a change in control of our company that might involve a premium price for holders of our common stock or otherwise be in their best interest.  Our Board may elect to opt in to any or all of the provisions of Title 3, Subtitle 8 of the MGCL without stockholder approval at any time.  In addition, without our having elected to be subject to Subtitle 8, our charter and bylaws already (1) provide for a classified board, (2) require the affirmative vote of the holders of at least 80% of the votes entitled to be cast in the election of directors for the removal of any director from our Board, which removal will be allowed only for cause, (3) vest in our Board the exclusive power to fix the number of directorships and (4) require, unless called by our Chairman of the Board, Chief Executive Officer or President or our Board, the written request of stockholders entitled to cast not less than a majority of all votes entitled to be cast at such a meeting to call a special meeting.  These provisions may delay or prevent a change of control of our company.

Future offerings of debt securities, which would rank senior to our common stock upon liquidation, and future offerings of equity securities, which would dilute our existing stockholders and may be senior to our common stock for the purposes of dividend and liquidating distributions, may adversely affect the market price of our common stock.

In the future, we may attempt to increase our capital resources by making offerings of debt or additional offerings of equity securities, including commercial paper, senior or subordinated notes and series or classes of preferred stock or common stock.  Upon liquidation, holders of our debt securities and shares of preferred stock, if any, and lenders with respect to other borrowings

24

will receive a distribution of our available assets prior to the holders of our common stock. Additional equity offerings may dilute the holdings of our existing stockholders or reduce the market price of our common stock, or both.  Preferred stock could have a preference on liquidating distributions or a preference on dividend payments or both that could limit our ability to make a dividend distribution to the holders of our common stock.  Because our decision to issue securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of our future offerings.  Thus, holders of our common stock bear the risk of our future offerings reducing the market price of our common stock and diluting their stock holdings in us.

Our Board may approve the issuance of capital stock with terms that may discourage a third party from acquiring the Company.

Our charter permits our Board to issue shares of preferred stock, issuable in one or more classes or series.  We may issue a class of preferred stock to individual investors in order to comply with the various REIT requirements or to finance our operations.  Our charter further permits our Board to classify or reclassify any unissued shares of preferred or common stock and establish the preferences and rights (including, among others, voting, dividend and conversion rights) of any such shares of stock, which rights may be superior to those of shares of our common stock.  Thus, our Board could authorize the issuance of shares of preferred or common stock with terms and conditions that could have the effect of discouraging a takeover or other transaction in which holders of the outstanding shares of our common stock might receive a premium for their shares over the then current market price of our common stock.

Future issuances or sales of shares could cause our share price to decline.

Sales of substantial numbers of shares of our common stock in the public market, or the perception that such sales might occur, could adversely affect the market price of our common stock.  In addition, the sale of these shares could impair our ability to raise capital through a sale of additional equity securities.  Other issuances of our common stock could have an adverse effect on the market price of our common stock.  In addition, future issuances of our common stock may be dilutive to existing stockholders.

Other Business Risks

We are dependent on our executive officers and other key personnel for our success, the loss of any of whom may materially adversely affect our business.

Our success is dependent upon the efforts, experience, diligence, skill and network of business contacts of our executive officers and key personnel.  The departure of any of our executive officers and/or key personnel could have a material adverse effect on our operations and performance.

We are dependent on information systems and their failure could significantly disrupt our business.

Our business is highly dependent on our information and communications systems.  Any failure or interruption of our systems or cyber-attacks or security breaches of our networks or systems could cause delays or other problems in our securities trading activities, which could have a material adverse effect on operating results, the market price of our common stock and other securities and our ability to pay dividends to our stockholders. In addition, we also face the risk of operational failure, termination or capacity constraints of any of the third parties with which we do business or that facilitate our business activities, including clearing agents or other financial intermediaries we use to facilitate our securities transactions.

Computer malware, viruses, and computer hacking and phishing and cyber attacks have become more prevalent in our industry and may occur on our systems in the future. We rely heavily on financial, accounting and other data processing systems. It is difficult to determine what, if any, negative impact may directly result from any specific interruption or cyber-attacks or security breaches of our networks or systems (or networks or systems of, among other third parties, our lenders) or any failure to maintain performance, reliability and security of our technical infrastructure. As a result, any such computer malware, viruses, and computer hacking and phishing attacks may negatively affect our operations.

25

We operate in a highly competitive market for investment opportunities and competition may limit our ability to acquire desirable investments, which could materially adversely affect our results of operations.

We operate in a highly competitive market for investment opportunities.  Our profitability depends, in large part, on our ability to acquire MBS or other investments at favorable prices.  In acquiring our investments, we compete with a variety of institutional investors, including other REITs, public and private funds, commercial and investment banks, commercial finance and insurance companies and other financial institutions.  Many of our competitors are substantially larger and have considerably greater financial, technical, marketing and other resources than we do.  Some competitors may have a lower cost of funds and access to funding sources that are not available to us.  Many of our competitors are not subject to the operating constraints associated with REIT compliance or maintenance of an exemption from the Investment Company Act.  In addition, some of our competitors may have higher risk tolerances or different risk assessments, which could allow them to consider a wider variety of investments and establish additional business relationships than us.  Furthermore, government or regulatory action and competition for investment securities of the types and classes which we acquire may lead to the price of such assets increasing, which may further limit our ability to generate desired returns.  We cannot assure you that the competitive pressures we face will not have a material adverse effect on our business, financial condition and results of operations.  Also, as a result of this competition, desirable investments may be limited in the future and we may not be able to take advantage of attractive investment opportunities from time to time, as we can provide no assurance that we will be able to identify and make investments that are consistent with our investment objectives.

26

Item 1B.  Unresolved Staff Comments.

None.

Item 2.Properties.

Office Leases

We pay monthly rent pursuant to two operating leases.  Our lease for our corporate headquarters in New York, New York extends through May 31, 2020.  The lease provides for aggregate cash payments ranging over time of approximately $2.5 million per year, paid on a monthly basis, exclusive of escalation charges.  In addition, as part of this lease agreement, we have provided the landlord a $785,000 irrevocable standby letter of credit fully collateralized by cash.  The letter of credit may be drawn upon by the landlord in the event that we default under certain terms of the lease.  In addition, we have a lease through December 31, 2016, for our off-site back-up facility located in Rockville Centre, New York, which provides for, among other things, lease payments totaling $30,000, annually.

Item 3.Legal Proceedings.

There are no material legal proceedings to which we are a party or to which any of our assets are subject.

To date, we have not been required to make any payments to the IRS as a penalty for failing to make disclosures required with respect to certain transactions that have been identified by the IRS as abusive or that have a significant tax avoidance purpose.

Item 4.Mine Safety Disclosures.

Not applicable.

27

PART II

Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Information

Our common stock is listed on the New York Stock Exchange, under the symbol “MFA.”  On February 12, 2016, the last sales price for our common stock on the New York Stock Exchange was $6.39 per share.  The following table sets forth the high and low sales prices per share of our common stock during each calendar quarter for the years ended December 31, 2015 and 2014:

	2015				2014
Quarter Ended	High		Low		High		Low
March 31	$	8.22	$	7.68	$	7.96	$	7.03
June 30	8.04		7.39		8.50		7.65
September 30	7.80		5.78		8.47		7.77
December 31	7.17		6.17		8.45		7.78

Holders

As of February 12, 2016, we had 611 registered holders of our common stock.  Such information was obtained through our registrar and transfer agent, based on the results of a broker search.

Dividends

No dividends may be paid on our common stock unless full cumulative dividends have been paid on our preferred stock.  We have paid full cumulative dividends on our preferred stock on a quarterly basis through December 31, 2015.  We have historically declared cash dividends on our common stock on a quarterly basis.  During 2015 and 2014, we declared total cash dividends to holders of our common stock of $296.4 million ($0.80 per share) and $294.8 million ($0.80 per share), respectively.  In general, our common stock dividends have been characterized as ordinary income to our stockholders for income tax purposes.  However, a portion of our common stock dividends may, from time to time, be characterized as capital gains or return of capital.  For the year ended December 31, 2015, a portion of our dividends were deemed to be capital gains. For the year ended December 31, 2014, our common stock dividends were characterized as ordinary income to stockholders.  (For additional dividend information, see Notes 13(a) and 13(b) to the consolidated financial statements, included under Item 8 of this Annual Report on Form 10-K.)

We elected to be taxed as a REIT for U.S. federal income tax purposes commencing with our taxable year ended December 31, 1998 and, as such, anticipate distributing at least 90% of our REIT taxable income within the timeframe permitted by the Code.  Although we may borrow funds to make distributions, cash for such distributions has generally been, and is expected to continue to be, largely generated from our results of our operations.

28

We declared and paid the following dividends on our common stock during the years 2015 and 2014:

Year	Declaration Date	Record Date	Payment Date	Dividend per Share
2015	December 9, 2015	December 28, 2015	January 29, 2016	$	0.20	(1)
	September 17, 2015	September 29, 2015	October 30, 2015	0.20
	June 15, 2015	June 29, 2015	July 31, 2015	0.20
	March 13, 2015	March 27, 2015	April 30, 2015	0.20
2014	December 9, 2014	December 26, 2014	January 30, 2015	$	0.20
	September 17, 2014	September 29, 2014	October 31, 2014	0.20
	June 13, 2014	June 27, 2014	July 31, 2014	0.20
	March 10, 2014	March 28, 2014	April 30, 2014	0.20

(1) At December 31, 2015, the Company had accrued dividends and dividend equivalents payable of $74.6 million related to the common stock dividend declared on December 9, 2015.

Dividends are declared and paid at the discretion of our Board and depend on our cash available for distribution, financial condition, ability to maintain our qualification as a REIT, and such other factors that our Board may deem relevant.  We have not established a minimum payout level for our common stock.  (See Part I, Item 1A., “Risk Factors”, and Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, of this Annual Report on Form 10-K, for information regarding the sources of funds used for dividends and for a discussion of factors, if any, which may adversely affect our ability to pay dividends.)

Purchases of Equity Securities

As previously disclosed, in August 2005, our Board authorized a stock repurchase program (or Repurchase Program), to repurchase up to 4.0 million shares of our outstanding common stock under the Repurchase Program.  The Board reaffirmed such authorization in May 2010.  In December 2013, our Board increased the number of shares authorized for repurchase to an aggregate of 10.0 million shares (under which approximately 6.6 million shares remain available for repurchase). Such authorization does not have an expiration date and, at present, there is no intention to modify or otherwise rescind such authorization.  Subject to applicable securities laws, repurchases of common stock under the Repurchase Program are made at times and in amounts as we deem appropriate (including, in our discretion, through the use of one or more plans adopted under Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended (or 1934 Act)), using available cash resources.  Shares of common stock repurchased by us under the Repurchase Program are cancelled and, until reissued by us, are deemed to be authorized but unissued shares of our common stock.  The Repurchase Program may be suspended or discontinued by us at any time and without prior notice.

We did not repurchase any shares of our common stock under the Repurchase Program during the years ended December 31, 2015 and 2014. 

29

We engaged in no share repurchase activity during the fourth quarter of 2015 pursuant to the Repurchase program.  We did, however, withhold restricted shares (under the terms of grants under our Equity Compensation Plan (or Equity Plan)) to offset tax withholding obligations that occur upon the vesting and release of restricted stock awards and/or RSUs.  The following table presents information with respect to (i) such withheld restricted shares, and (ii) eligible shares remaining for repurchase under the Repurchase Program:

Month	Total Number of Shares Purchased	Weighted Average Price Paid Per Share (1)		Total Number of Shares Repurchased as Part of Publicly Announced Repurchase Program or Employee Plan	Maximum Number of Shares that May Yet be Purchased Under the Repurchase Program or Employee Plan
October 1-31, 2015:
Repurchase Program (2)	—	$	—	—	6,616,355
Employee Transactions (3)	—	—		N/A	N/A
November 1-30, 2015:
Repurchase Program (2)	—	—		—	6,616,355
Employee Transactions (3)	—	—		N/A	N/A
December 1-31, 2015:
Repurchase Program (2)	—	—		—	6,616,355
Employee Transactions (3)	266,849	6.77		N/A	N/A
Total Repurchase Program(2)	—	$	—	—	6,616,355
Total Employee Transactions(3)	266,849	$	6.77	N/A	N/A

(1) Includes brokerage commissions.

(2) As of December 31, 2015, we had repurchased an aggregate of 3,383,645 shares under the Repurchase Program.

(3) Our Equity Plan provides that the value of the shares delivered or withheld be based on the price of our common stock on the date the relevant transaction occurs.

Discount Waiver, DirectStock Purchase and Dividend Reinvestment Plan

In September 2003, we initiated a Discount Waiver, Direct Stock Purchase and Dividend Reinvestment Plan (or the DRSPP) to provide existing stockholders and new investors with a convenient and economical way to purchase shares of our common stock.  Under the DRSPP, existing stockholders may elect to automatically reinvest all or a portion of their cash dividends in additional shares of our common stock and existing stockholders and new investors may make optional cash purchases of shares of our common stock in amounts ranging from $50 (or $1,000 for new investors) to $10,000 on a monthly basis and, with our prior approval, in excess of $10,000.  At our discretion, we may issue shares of our common stock under the DRSPP at discounts of up to 5% from the prevailing market price at the time of purchase.  Computershare Shareowner Services LLC is the administrator of the DRSPP (or the Plan Agent).  Stockholders who own common stock that is registered in their own name and who want to participate in the DRSPP must deliver a completed enrollment form to the Plan Agent.  Stockholders who own common stock that is registered in a name other than their own (e.g., broker, bank or other nominee) and who want to participate in the DRSPP must either request such nominee holder to participate on their behalf or request that such nominee holder re-register our common stock in the stockholder’s name and deliver a completed enrollment form to the Plan Agent. During the years ended 2015 and 2014, we issued 162,373 and 4,526,855 shares of common stock through the DRSPP generating net proceeds of approximately $1.2 million and $35.6 million, respectively.

30

Securities Authorized For Issuance Under Equity Compensation Plans

During 2015, we adopted the Equity Plan, as approved by our stockholders.  The Equity Plan amended and restated our 2010 Equity Compensation Plan. (For a description of the Equity Plan, see Note 15(a) to the consolidated financial statements included under Item 8 of this Annual Report on Form 10-K.)

The following table presents certain information with respect to our equity compensation plans as of December 31, 2015:

Award (1)	Number of securities to be issued upon exercise of outstanding options, warrants and rights	Weighted-average exercise price of outstanding options, warrants and rights		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in the first column of this table)
Restricted Stock Units (or RSUs)	1,875,730
Total	1,875,730		(2)	9,366,840	(3)

(1)  All equity based compensation is granted pursuant to plans that have been approved by our stockholders.

(2)  A weighted average exercise price is not applicable for our RSUs, as such equity awards result in the issuance of shares of our common stock provided that such awards vest and, as such, do not have an exercise price.  At December 31, 2015, 729,523 RSUs were vested, 584,907 RSUs were subject to time based vesting and 561,300 RSUs will vest subject to achieving a market condition.

(3) Number of securities remaining available for future issuance under equity compensation plans excludes RSUs presented in the table and110,920 shares of restricted stock, which were issued and outstanding at December 31, 2015.

31

Item 6.  Selected Financial Data.

Our selected financial data set forth below is derived from our audited financial statements and should be read in conjunction with our consolidated financial statements and the accompanying notes, included under Item 8 of this Annual Report on Form 10-K.

	At or/For the Year Ended December 31,
(Dollars in Thousands, Except per Share Amounts)	2015			2014			2013			2012			2011
Operating Data:
Interest Income	$	492,143		$	463,817		$	482,940		$	499,157		$	496,747
Interest expense	(176,948		)	(159,808		)	(164,013		)	(171,670		)	(149,411		)
Net impairment losses recognized in earnings (1)	(705		)	—			—			(1,200		)	(10,570		)
Gain on sales of MBS and U.S. Treasury securities, net (2)	34,900			37,497			25,825			9,001			6,730
Unrealized net gains and net interest income from Linked Transactions	—			17,092			3,225			12,610			3,015
Net gain on residential whole loans held at fair value	17,722			116			—			—			—
Other (loss)/income, net	(1,457		)	80			(7,298		)	10			1,082
Operating and other expense	(52,429		)	(45,290		)	(37,970		)	(41,069		)	(31,179		)
Net income	$	313,226		$	313,504		$	302,709		$	306,839		$	316,414
Preferred stock dividends	15,000			15,000			13,750			8,160			8,160
Issuance costs of redeemed preferred stock (3)	—			—			3,947			—			—
Net income available to common stock and participating securities	$	298,226		$	298,504		$	285,012		$	298,679		$	308,254
Earnings per share — basic and diluted	$	0.80		$	0.81		$	0.78		$	0.83		$	0.90
Dividends declared per share of common stock (4)	$	0.800		$	0.800		$	1.640		$	0.880		$	1.005
Dividends declared per share of preferred stock (5)	$	1.875		$	1.875		$	2.136		$	2.125		$	2.125
Balance Sheet Data:
MBS and CRT securities	$	11,356,643		$	10,762,622		$	11,371,358		$	12,607,625		$	10,912,977
Residential whole loans, at carrying value	271,845			207,923			—			—			—
Residential whole loans, at fair value	623,276			143,472			—			—			—
Cash and cash equivalents	165,007			182,437			565,370			401,293			394,022
Linked Transactions	—			398,336			28,181			12,704			55,801
Total assets	13,167,323			12,354,744			12,471,908			13,517,550			11,750,634
Repurchase agreements and other advances	9,388,902			8,267,388			8,339,297			8,752,472			7,813,159
Securitized debt	22,057			110,574			366,205			646,816			875,520
Swaps (in a liability position)	70,526			62,198			28,217			63,034			114,220
Total liabilities	10,200,062			9,151,472			9,329,657			10,206,544			9,252,874
Preferred stock, liquidation preference	200,000			200,000			200,000			96,000			96,000
Total stockholders’ equity	2,967,261			3,203,272			3,142,251			3,311,006			2,497,760
Other Data:
Average total assets	$	13,672,737		$	12,547,418		$	13,192,285		$	12,942,171		$	11,185,224
Average total stockholders’ equity	$	3,129,461		$	3,230,932		$	3,262,458		$	2,945,687		$	2,701,204
Return on average total assets (6)	2.18		%	2.38		%	2.16		%	2.31		%	2.76		%
Return on average total stockholders’ equity (7)	10.01		%	9.70		%	9.28		%	10.42		%	11.71		%
Total average stockholders’ equity to total average assets (8)	22.89		%	25.75		%	24.73		%	22.76		%	24.18		%
Dividend payout ratio (9)	1.00			0.99			1.10			1.06			1.09
Book value per share of common stock (10)	$	7.47		$	8.12		$	8.06		$	8.99		$	6.74

32

(1) Reflects OTTI recognized through earnings related to Non-Agency MBS. 

(2) 2015:  We sold Non-Agency MBS for $70.7 million, realizing gross gains of $34.9 million. 2014:  We sold Non-Agency MBS for $123.9 million, realizing gross gains of $37.5 million.  2013: We sold Non-Agency MBS for $152.6 million, realizing gross gains of $25.8 million and sold U.S. Treasury securities for $422.2 million, realizing net losses of approximately $24,000. 2012:  We sold Agency MBS for $168.9 million, realizing gross gains of $9.0 million.  2011:  We sold Agency MBS for $150.6 million, realizing gross gains of $6.7 million.

(3) Issuance costs of redeemed preferred stock represent the original offering costs related to the 8.50% Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”), which was redeemed on May 16, 2013.

(4) 2013: Includes special cash dividends paid totaling $0.78 per share. 2011: Includes a special cash dividend of $0.02 per share.

(5) 2013: Reflects dividends declared per share on Series A Preferred Stock and 7.50% Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”) of $0.80 and $1.33, respectively.

(6) Reflects net income available to common stock and participating securities divided by average total assets.

(7) Reflects net income divided by average total stockholders’ equity.

(8) Reflects total average stockholders’ equity divided by total average assets.

(9)  Reflects dividends declared per share of common stock (excluding special dividends) divided by earnings per share.

(10)  Reflects total stockholders’ equity less the preferred stock liquidation preference divided by total shares of common stock outstanding.

33

Item7.Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion should be read in conjunction with our financial statements and accompanying notes included in Item 8 of this Annual Report on Form 10-K.

GENERAL

We are a REIT primarily engaged in the business of investing, on a leveraged basis, in residential mortgage assets, including Agency MBS, Non-Agency MBS, residential whole loans and CRT securities.  Our principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. We selectively invest in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return.

At December 31, 2015, we had total assets of approximately $13.167 billion, of which $11.173 billion, or 84.9%, represented our MBS portfolio.  At such date, our MBS portfolio was comprised of $4.752 billion of Agency MBS and $6.421 billion of Non-Agency MBS which includes $3.795 billion of Legacy Non-Agency MBS and $2.626 billion of RPL/NPL MBS. In addition, at December 31, 2015, we had approximately $895.1 million in residential whole loans acquired through our consolidated trusts, which represented approximately 6.8% of our total assets. Our remaining investment-related assets were primarily comprised of collateral obtained in connection with reverse repurchase agreements, cash and cash equivalents (including restricted cash), CRT securities, MBS-related receivables, derivative instruments, and REO.

The results of our business operations are affected by a number of factors, many of which are beyond our control, and primarily depend on, among other things, the level of our net interest income, the market value of our assets, which is driven by numerous factors, including the supply and demand for residential mortgage assets in the marketplace, the terms and availability of adequate financing, general economic and real estate conditions (both on a national and local level), the impact of government actions in the real estate and mortgage sector, and the credit performance of our credit sensitive residential mortgage assets.  Our net interest income varies primarily as a result of changes in interest rates, the slope of the yield curve (i.e., the differential between long-term and short-term interest rates), borrowing costs (i.e., our interest expense) and prepayment speeds on our MBS, the behavior of which involves various risks and uncertainties.  Interest rates and conditional prepayment rates (or CPRs) (which measure the amount of unscheduled principal prepayment on a bond as a percentage of the bond balance), vary according to the type of investment, conditions in the financial markets, competition and other factors, none of which can be predicted with any certainty.

With respect to our business operations, increases in interest rates, in general, may over time cause:  (i) the interest expense associated with our borrowings to increase; (ii) the value of our MBS portfolio and, correspondingly, our stockholders’ equity to decline; (iii) coupons on our ARM-MBS to reset, on a delayed basis, to higher interest rates; (iv) prepayments on our MBS to decline, thereby slowing the amortization of our MBS purchase premiums and the accretion of our purchase discounts; and (v) the value of our derivative hedging instruments and, correspondingly, our stockholders’ equity to increase.  Conversely, decreases in interest rates, in general, may over time cause:  (i) the interest expense associated with our borrowings to decrease; (ii) the value of our MBS portfolio and, correspondingly, our stockholders’ equity to increase; (iii) coupons on our ARM-MBS to reset, on a delayed basis, to lower interest rates; (iv) prepayments on our MBS to increase, thereby accelerating the amortization of our MBS purchase premiums and the accretion of our purchase discounts; and (v) the value of our derivative hedging instruments and, correspondingly, our stockholders’ equity to decrease.  In addition, our borrowing costs and credit lines are further affected by the type of collateral we pledge and general conditions in the credit market.

We are exposed to credit risk in our Non-Agency MBS and residential whole loans, generally meaning that we are subject to credit losses in these portfolios that correspond to the risk of delinquency, default and foreclosure on the underlying real estate collateral.  (See Part I, Item 1A., “Risk Factors - Credit Risks”, of this Annual Report on Form 10-K), We believe the discounted purchase prices paid on certain of these investments mitigates our risk of loss in the event that, as we expect on most such investments, we receive less than 100% of the par value of these securities or loans. Our investment process for credit sensitive assets involves analysis focused primarily on quantifying and pricing credit risk. 

34

The table below presents the composition of our MBS portfolios with respect to repricing characteristics as of December 31, 2015:

	December 31, 2015
Underlying Mortgages	Agency MBS Fair Value (1)		Non-Agency MBS Fair Value (2)		Total MBS (1)(2)		Percent of Total
(In Thousands)
Hybrids in contractual fixed-rate period	$	1,411,282	$	416,390	$	1,827,672	21.4	%
Hybrids in adjustable period	1,489,452		2,104,432		3,593,884		42.1
15-year fixed rate	1,780,746		7,728		1,788,474		20.9
Greater than 15-year fixed rate	—		1,206,565		1,206,565		14.1
Floaters	69,733		59,836		129,569		1.5
Total	$	4,751,213	$	3,794,951	$	8,546,164	100.0	%

(1)  Does not include principal payments receivable in the amount of $1.0 million.

(2) Does not reflect $2.626 billion of RPL/NPL MBS, which are re-performing deals with both fixed rate and hybrid re-performing loans. These deal structures contain a coupon step-up of 300 basis points at 36 months or sooner from issuance.

As of December 31, 2015, approximately $7.449 billion, or 66.7%, of our MBS portfolio was in its contractual fixed-rate period or were fixed-rate MBS and approximately $3.723 billion, or 33.3%, was in its contractual adjustable-rate period, or were floating rate MBS with interest rates that reset monthly.  Our ARM-MBS in their contractual adjustable-rate period primarily include MBS collateralized by Hybrids for which the initial fixed-rate period has elapsed, such that the interest rate will typically adjust on an annual or semiannual basis.

Premiums arise when we acquire MBS at a price in excess of the principal balance of the mortgages securing such MBS (i.e., par value).  Conversely, discounts arise when we acquire MBS at a price below the principal balance of the mortgages securing such MBS or acquire residential whole loans at a price below the principal balance of the mortgage.  Premiums paid on our MBS are amortized against interest income and accretable purchase discounts on these investments are accreted to interest income.  Purchase premiums on our MBS, which are primarily carried on our Agency MBS, are amortized against interest income over the life of each security using the effective yield method, adjusted for actual prepayment activity.  An increase in the prepayment rate, as measured by the CPR, will typically accelerate the amortization of purchase premiums, thereby reducing the internal rate of return (or IRR)/interest income earned on such assets. 

CPR levels are impacted by, among other things, conditions in the housing market, new regulations, government and private sector initiatives, interest rates, availability of credit to home borrowers, underwriting standards and the economy in general.  In particular, CPR reflects the conditional repayment rate (or CRR), which measures voluntary prepayments of mortgages collateralizing a particular MBS, and the conditional default rate (or CDR), which measures involuntary prepayments resulting from defaults.  CPRs on Agency MBS and Legacy Non-Agency MBS may differ significantly.  For the year ended December 31, 2015, our Agency MBS portfolio experienced a weighted average CPR of 13.2%, and our Legacy Non-Agency MBS portfolio experienced a CPR of 14.1%. For the year ended December 31, 2014, our Agency MBS portfolio experienced a weighted average CPR of 13.0%, and our Legacy Non-Agency MBS portfolio (including Legacy Non-Agency MBS underlying our Linked Transactions) experienced a CPR of 12.3%. Over the last consecutive eight quarters, ending with December 31, 2015, the monthly fair value weighted average CPR on our Agency and Legacy Non-Agency MBS portfolios ranged from a high of 16.7% experienced during the month ended July 31, 2015 to a low of 10.4%, experienced during each of the months ended March 31, 2015 and March 31, 2014, with an average CPR over such quarters of 13.1%.

Our method of accounting for Non-Agency MBS purchased at significant discounts to par value, requires us to make assumptions with respect to each security.  These assumptions include, but are not limited to, future interest rates, voluntary prepayment rates, default rates, mortgage modifications and loss severities.  As part of our Non-Agency MBS surveillance process, we track and compare each security’s actual performance over time to the performance expected at the time of purchase or, if we have modified our original purchase assumptions, to our revised performance expectations.  To the extent that actual performance or our expectation of future performance of our Non-Agency MBS deviates materially from our expected performance parameters, we may revise our performance expectations, such that the amount of purchase discount designated as credit discount may be increased or decreased over time.  Nevertheless, credit losses greater than those anticipated or in excess of the recorded purchase discount could occur, which could materially adversely impact our operating results.

35

It is our business strategy to hold our MBS as long-term investments.  On at least a quarterly basis, we assess our ability and intent to continue to hold each security and, as part of this process, we monitor our securities for other-than-temporary impairment.  A change in our ability and/or intent to continue to hold any of our securities that are in an unrealized loss position, or a deterioration in the underlying characteristics of these securities, could result in our recognizing future impairment charges or a loss upon the sale of any such security.  At December 31, 2015, we had net unrealized gains of $28.8 million on our Agency MBS, comprised of gross unrealized gains of $69.2 million and gross unrealized losses of $40.4 million, and net unrealized gains on our Non-Agency MBS of $559.0 million, comprised of gross unrealized gains of $587.3 million and gross unrealized losses of $28.4 million.  At December 31, 2015, we did not intend to sell any of our MBS that were in an unrealized loss position, and we believe it is more likely than not that we will not be required to sell those securities before recovery of their amortized cost basis, which may be at their maturity.

We rely primarily on borrowings under repurchase agreements to finance our Agency MBS and Non-Agency MBS.  Our MBS have longer-term contractual maturities than our borrowings under repurchase agreements. Even though the majority of our MBS have interest rates that adjust over time based on short-term changes in corresponding interest rate indices (typically following an initial fixed-rate period for our Hybrids), the interest rates we pay on our borrowings will typically change at a faster pace than the interest rates we earn on our MBS.  In order to reduce this interest rate risk exposure, we may enter into derivative instruments, which at December 31, 2015 were comprised of Swaps.

Our Swap derivative instruments are designated as cash-flow hedges against a portion of our current and forecasted LIBOR-based repurchase agreements.  Our Swaps do not extend the maturities of our repurchase agreements; they do, however, lock in a fixed rate of interest over their term for the notional amount of the Swap corresponding to the hedged item.  During 2015, we did not enter into any new Swaps and had Swaps with an aggregate notional amount of $710.2 million and a weighted average fixed-pay rate of 1.96% amortize and/or expire.  At December 31, 2015, we had Swaps designated in hedging relationships with an aggregate notional amount of $3.050 billion with a weighted average fixed-pay rate of 1.82% and a weighted average variable interest rate received of 0.34%.

Recent Market Conditions and Our Strategy

During 2015, we continued to invest in residential mortgage assets, including both MBS and, through consolidated trusts, residential whole loans.  At December 31, 2015, our MBS portfolio was approximately $11.173 billion compared to $12.573 billion (including $1.913 billion MBS reported as components of Linked Transactions) at December 31, 2014.

At December 31, 2015, $6.421 billion, or 57.5% of our MBS portfolios was invested in Non-Agency MBS. During the year ended December 31, 2015, the fair value of our Non-Agency MBS holdings increased by $1.665 billion. The primary components of the change during the year in these Non-Agency MBS include the reclassification of $1.913 billion of Non-Agency MBS that were previously reported as a component of Linked Transactions and $1.734 billion of purchases (at a weighted average purchase price of 99.9%). Partially offsetting these increases were $1.845 billion of principal repayments and other principal reductions, a decrease reflecting Non-Agency MBS price changes of $66.3 million and the sale of Non-Agency MBS with a fair value of $70.8 million.

At December 31, 2015, $4.752 billion, or 42.5% of our MBS portfolio was invested in Agency MBS.  During the year ended 2015, the fair value of our Agency MBS decreased by $1.152 billion. This was due to $1.059 billion of principal repayments,$41.2 million of premium amortization and a $51.3 milliondecrease in net unrealized gains.

In this low interest rate environment, we continue to transition to more credit sensitive, less interest sensitive residential mortgage assets. During the year ended December 31, 2015, we purchased through consolidated trusts residential whole loans of approximately $608.3 million, with an unpaid principal balance of approximately $770.5 million. At December 31, 2015, our total recorded investment in residential whole loans was $895.1 million. Of this amount, $271.8 million is presented as residential whole loans at carrying value and $623.3 million as residential whole loans at fair value in our consolidated balance sheets. For the year ended December 31, 2015, we recognized approximately $16.0 million of income on residential whole loans held at carrying value in Interest Income on our consolidated statement of operations, representing an effective yield of 6.63% (excluding servicing costs). In addition, we recorded net gains on residential whole loans held at fair value of $17.7 million in Other Income, net in our consolidated statement of operations for the year ended December 31, 2015.

We currently expect to continue to seek more credit sensitive, less interest rate sensitive residential mortgage assets during 2016, particularly residential whole loans and Non-Agency MBS (including RPL/NPL MBS). In order to achieve our current investment strategy, we may continue to permit more interest rate sensitive Agency MBS to pay down.

36

In addition to our investments in Agency MBS, Non-Agency MBS and residential whole loans, we invest in CRT securities, which are debt obligations issued by Fannie Mae and Freddie Mac. At December 31, 2015, our investments in these securities totaled $183.6 million.

New accounting guidance that was effective at the beginning of the year prospectively eliminated the use of Linked Transaction accounting. Accordingly, on adoption of the new standard on January 1, 2015, we reclassified $1.913 billion of Non-Agency MBS and $4.6 million of CRT securities that were previously reported as a component of Linked Transactions to Non-Agency MBS and CRT securities respectively on the consolidated balance sheets. In addition, liabilities of $1.520 billion that were previously presented as a component of Linked Transactions were reclassified to Repurchase agreements on the consolidated balance sheets. Furthermore, an amount of $4.5 million representing net unrealized gains on securities previously reported as a component of Linked Transactions as of December 31, 2014 was reclassified from Accumulated deficit to AOCI (See Notes 2(t) and 6 to the consolidated financial statements, included under Item 8 of this Annual Report on Form 10-K).

Our book value per common share was $7.47 as of December 31, 2015. Book value per common share decreased from $8.12 as of December 31, 2014 due primarily to the impact of realized gains on sales and discount accretion income on Legacy Non-Agency MBS that was recognized and paid as dividends during the year, the change in the value of our Swaps, and lower unrealized gains on our Agency MBS and Legacy Non-Agency MBS, resulting from lower asset values.

At the end of 2015, the average coupon on mortgages underlying our Agency MBS was lower compared to the end of 2014, due to prepayments on higher yielding assets and downward resets on Hybrid and ARM-MBS within the portfolio.  As a result, the coupon yield on our Agency MBS portfolio declined 18 basis points to 2.78% for 2015 from 2.96% for 2014.  The net Agency MBS yield decreased to 2.00% for 2015, from 2.23% for 2014.  The net yield for our Legacy Non-Agency MBS portfolio was 7.62% for 2015 compared to 7.74% for 2014.  The decrease in the net yield on our Legacy Non-Agency MBS portfolio is primarily due to prepayments on higher yielding assets in the portfolio, partially offset by increases in accretable discount due to the impact of credit reserve releases, in the current and prior year, that have occurred as a result of the improved credit performance of loans underlying the Legacy Non-Agency MBS portfolio. The net yield for our RPL/NPL MBS portfolio was 3.68% for the year ended December 31, 2015 compared to 3.69% for the year ended December 31, 2014.  In the comparable prior period, the majority of our RPL/NPL MBS were reported as Linked Transactions.

We believe that our $787.5 million Credit Reserve and OTTI appropriately factors in remaining uncertainties regarding underlying mortgage performance and the potential impact on future cash flows for our existing Legacy Non-Agency MBS portfolio.  Home price appreciation and underlying mortgage loan amortization have decreased the LTV for many of the mortgages underlying our Legacy Non-Agency MBS portfolio. Home price appreciation during the past few years has generally been driven by a combination of limited housing supply, low mortgage rates, capital flows into own-to-rent foreclosure purchases and demographic-driven U.S. household formation. We estimate that the average LTV of mortgage loans underlying our Legacy Non-Agency MBS has declined from approximately 105% as of January 2012 to approximately 71% as of December 31, 2015.   In addition, we estimate that the percentage of non-delinquent loans underlying our Legacy Non-Agency MBS that are underwater (with LTVs greater than 100%), has declined from approximately 52% as of January 2012 to 7% at December 31, 2015. Lower LTVs lessen the likelihood of defaults and simultaneously decrease loss severities. Further, during 2014 and 2015, we have also observed faster voluntary prepayment (i.e. prepayment of loans in full with no loss) speeds than originally projected. The yields on our Legacy Non-Agency MBS that were purchased at a discount are generally positively impacted if prepayment rates on these securities exceed our prepayment assumptions. Based on these current conditions, we have reduced estimated future losses within our Legacy Non-Agency portfolio. As a result, during the year ended 2015, $41.1 million was transferred from Credit Reserve to accretable discount. This increase in accretable discount is expected to increase the interest income realized over the remaining life of our Legacy Non-Agency MBS. The remaining average contractual life of such assets is approximately 20 years, but based on scheduled loan amortization and prepayments (both voluntary and involuntary), loan balances will decline substantially over time. Consequently, we believe that the majority of the impact on interest income from the reduction in Credit Reserve will occur over the next ten years.

At December 31, 2015, we have access to various sources of liquidity which we estimate to be in excess of $571.0 million. This amount includes (i) $165.0 million of cash and cash equivalents; (ii) $241.7 million in estimated financing available from unpledged Agency MBS and from other Agency MBS collateral that is currently pledged in excess of contractual requirements; and (iii) $164.3 million in estimated financing available from unpledged Non-Agency MBS. Consequently, we believe that we are positioned to continue to take advantage of investment opportunities within the residential mortgage marketplace.  In 2016, we intend to continue to selectively acquire MBS and residential whole loans. In addition, while the majority of our Legacy Non-Agency MBS will not return their full face value due to loan defaults, we believe that they will deliver attractive loss adjusted yields due to our discounted average amortized cost of 75% of face value at December 31, 2015.

37

Repurchase agreement funding for both Agency MBS and Non-Agency MBS continues to be available to us from multiple counterparties.  Typically, repurchase agreement funding involving Non-Agency MBS is available from fewer counterparties, at terms requiring higher collateralization and higher interest rates, than for repurchase agreement funding involving Agency MBS.  In July 2015, our wholly-owned subsidiary, MFA Insurance, became a member of the FHLB of Des Moines, further diversifying our potential sources of funding for residential mortgage investments. However, in January, 2016, the FHFA released its final rule amending its regulation on FHLB membership, which, amongst other things, provided termination rules for current captive insurance members. As a result of such regulation, MFA Insurance will not be permitted new advances or renewal of existing advances and will be required to terminate its FHLB membership within one year of the rule’s effective date of February 19, 2016. At December 31, 2015, our debt consisted of borrowings under repurchase agreements with 27 counterparties, FHLB advances, securitized debt, Senior Notes outstanding and obligation to return securities obtained as collateral, resulting in a debt-to-equity multiple of 3.4 times.  (See table on page 55 under Results of Operations that presents our quarterly leverage multiples since March 31, 2014.)

Information About Our Assets

The tables below present certain information about our asset allocation at December 31, 2015.

ASSET ALLOCATION

	Agency MBS			Legacy Non-Agency MBS			RPL/NPL MBS (1)			MBS Portfolio			Residential Whole Loans, at Carrying Value (2)			Residential Whole Loans, at Fair Value			Other, net (3)			Total
(Dollars in Thousands)
Fair Value/Carrying Value	$	4,752,244		$	3,794,951		$	2,625,866		$	11,173,061		$	271,845		$	623,276		$	479,437		$	12,547,619
Less Repurchase Agreements	(2,727,542		)	(2,464,982		)	(2,080,163		)	(7,272,687		)	(67,989		)	(419,761		)	(128,465		)	(7,888,902		)
Less FHLB advances	(1,500,000		)	—			—			(1,500,000		)	—			—			—			(1,500,000		)
Less Securitized Debt	—			(22,057		)	—			(22,057		)	—			—			—			(22,057		)
Less Senior Notes	—			—			—			—			—			—			(100,000		)	(100,000		)
Equity Allocated	$	524,702		$	1,307,912		$	545,703		$	2,378,317		$	203,856		$	203,515		$	250,972		$	3,036,660
Less Swaps at Market Value	—			—			—			—			—			—			(69,399		)	(69,399		)
Net Equity Allocated	$	524,702		$	1,307,912		$	545,703		$	2,378,317		$	203,856		$	203,515		$	181,573		$	2,967,261
Debt/Net Equity Ratio (4)	8.06		x	1.90		x	3.81		x				0.33		x	2.06		x				3.38		x

(1) Represents private-label MBS issued in 2013, 2014 and 2015 in which the underlying collateral consists of re-performing/non-performing loans that were originated in prior years. Included with the balance of Non-Agency MBS reported on our consolidated balance sheets.

(2) The carrying value of such loans reflects the purchase price, accretion of income, cash received and provision for loan losses since acquisition. At December 31, 2015, the fair value of such loans is estimated to be $289.7 million.

(3) Includes cash and cash equivalents and restricted cash, securities obtained and pledged as collateral, CRT securities, interest receivable, goodwill, prepaid and other assets, obligation to return securities obtained as collateral of $507.4 million, interest payable, dividends payable and accrued expenses and other liabilities.

(4) Represents the sum of borrowings under repurchase agreements, FHLB advances and securitized debt as a multiple of net equity allocated.  The numerator of our Total Debt/Net Equity ratio also includes the obligation to return securities obtained as collateral of $507.4 million, and Senior Notes.

38

Agency MBS

The following table presents certain information regarding the composition of our Agency MBS portfolio as of December 31, 2015 and 2014:

December 31, 2015

(Dollars in Thousands)	Current Face		Weighted Average Purchase Price		Weighted Average Market Price		Fair Value (1)		Weighted Average Loan Age (Months) (2)	Weighted Average Coupon (2)		3 Month Average CPR
15-Year Fixed Rate:
Low Loan Balance (3)	$	1,430,258	104.3	%	103.1	%	$	1,475,086	44	2.99	%	8.4	%
HARP (4)	146,821		104.7		103.1		151,387		43	2.98		7.9
Other (Post June 2009) (5)	144,596		103.9		106.1		153,477		63	4.14		16.1
Other (Pre June 2009) (6)	745		104.9		106.8		796		79	4.50		28.9
Total 15-Year Fixed Rate	$	1,722,420	104.3	%	103.4	%	$	1,780,746	45	3.09	%	9.1	%
Hybrid:
Other (Post June 2009) (5)	$	1,811,007	104.4	%	104.8	%	$	1,897,030	56	2.89	%	15.6	%
Other (Pre June 2009) (6)	899,185		101.7		105.7		950,666		109	2.60		9.3
Total Hybrid	$	2,710,192	103.5	%	105.1	%	$	2,847,696	73	2.80	%	13.5	%
CMO/Other	$	117,791	102.5	%	104.2	%	$	122,771	175	2.52	%	12.2	%
Total Portfolio	$	4,550,403	103.8	%	104.4	%	$	4,751,213	65	2.90	%	11.8	%

December 31, 2014

(Dollars in Thousands)	Current Face		Weighted Average Purchase Price		Weighted Average Market Price		Fair Value (1)		Weighted Average Loan Age (Months) (2)	Weighted Average Coupon (2)		3 Month Average CPR
15-Year Fixed Rate:
Low Loan Balance (3)	$	1,705,386	104.3	%	104.0	%	$	1,773,255	32	3.01	%	7.7	%
HARP (4)	177,193		104.7		104.0		184,192		31	2.99		6.5
Other (Post June 2009) (5)	192,325		103.9		107.2		206,132		51	4.15		13.0
Other (Pre June 2009) (6)	1,069		104.9		107.7		1,151		67	4.50		0.8
Total 15-Year Fixed Rate	$	2,075,973	104.3	%	104.3	%	$	2,164,730	34	3.12	%	8.1	%
Hybrid:
Other (Post June 2009) (5)	$	2,343,186	104.4	%	105.4	%	$	2,469,714	44	3.15	%	17.9	%
Other (Pre June 2009) (6)	1,049,495		101.7		106.8		1,120,830		97	2.82		8.8
Total Hybrid	$	3,392,681	103.6	%	105.8	%	$	3,590,544	60	3.04	%	15.1	%
CMO/Other	$	141,639	102.5	%	104.8	%	$	148,391	163	2.41	%	8.9	%
Total Portfolio	$	5,610,293	103.8	%	105.2	%	$	5,903,665	53	3.06	%	12.3	%

(1)  Does not include principal payments receivable of $1.0 million and $542,000 at December 31, 2015 and 2014, respectively.

(2)  Weighted average is based on MBS current face at December 31, 2015 and 2014, respectively.

(3)  Low loan balance represents MBS collateralized by mortgages with original loan balance of less than or equal to $175,000.

(4)  Home Affordable Refinance Program (or HARP) MBS are backed by refinanced loans with LTVs greater than or equal to 80% at origination.

(5)  MBS issued in June 2009 or later. Majority of underlying loans are ineligible to refinance through the HARP program.

(6)  MBS issued before June 2009.

39

The following table presents certain information regarding our 15-year fixed-rate Agency MBS as of December 31, 2015 and 2014:

December 31, 2015

Coupon	Current Face		Weighted Average Purchase Price		Weighted Average Market Price		Fair Value (1)		Weighted Average Loan Age (Months) (2)	Weighted Average Loan Rate		Low Loan Balance and/or HARP (3)		3 Month Average CPR
(Dollars in Thousands)
15-Year Fixed Rate:
2.5%	$	834,689	104.0	%	101.5	%	$	846,925	36	3.04	%	100	%	6.9	%
3.0%	355,439		105.9		103.4		367,471		42	3.49		100		8.0
3.5%	9,238		103.5		104.9		9,691		62	4.18		100		12.6
4.0%	448,064		103.5		106.4		476,793		61	4.40		79		13.1
4.5%	74,990		105.2		106.5		79,866		65	4.88		33		13.3
Total 15-Year Fixed Rate	$	1,722,420	104.3	%	103.4	%	$	1,780,746	45	3.57	%	92	%	9.1	%

December 31, 2014

Coupon	Current Face		Weighted Average Purchase Price		Weighted Average Market Price		Fair Value (1)		Weighted Average Loan Age (Months) (2)	Weighted Average Loan Rate		Low Loan Balance and/or HARP (3)		3 Month Average CPR
(Dollars in Thousands)
15-Year Fixed Rate:
2.5%	$	969,213	104.0	%	102.2	%	$	990,328	24	3.04	%	100	%	6.1	%
3.0%	420,623		105.9		104.2		438,377		30	3.49		100		4.4
3.5%	11,990		103.5		106.0		12,706		50	4.17		100		11.7
4.0%	575,040		103.5		107.2		616,662		49	4.40		79		12.4
4.5%	99,107		105.2		107.6		106,657		53	4.88		32		16.9
Total 15-Year Fixed Rate	$	2,075,973	104.3	%	104.3	%	$	2,164,730	34	3.60	%	91	%	8.1	%

(1)  Does not include principal payments receivable of $1.0 million and $542,000 at December 31, 2015 and 2014, respectively.

(2)  Weighted average is based on MBS current face at December 31, 2015 and 2014, respectively.

(3)  Low Loan Balance represents MBS collateralized by mortgages with an original loan balance less than or equal to $175,000.  HARP MBS are backed by refinanced loans with LTVs greater than or equal to 80% at origination.

40

The following table presents certain information regarding our Hybrid Agency MBS as of December 31, 2015 and 2014:

December 31, 2015

(Dollars in Thousands)	Current Face		Weighted Average Purchase Price		Weighted Average Market Price		Fair Value (1)		Weighted Average Coupon (2)		Weighted Average Loan Age (Months) (2)	Weighted Average Months to Reset (3)	Interest Only (4)		3 Month Average CPR
Hybrid Post June 2009:
Agency 5/1	$	723,853	104.2	%	105.7	%	$	765,426	2.62	%	64	7	23	%	15.6	%
Agency 7/1	838,505		104.5		104.2		873,765		3.04		51	32	22		16.7
Agency 10/1	248,649		104.7		103.7		257,839		3.18		47	72	61		11.5
Total Hybrids Post June 2009	$	1,811,007	104.4	%	104.8	%	$	1,897,030	2.89	%	56	27	28	%	15.6	%
Hybrid Pre June 2009:
Coupon < 4.5% (5)	$	853,168	101.7	%	105.7	%	$	901,870	2.43	%	109	6	59	%	8.9	%
Coupon >= 4.5% (6)	46,017		101.5		106.0		48,796		5.73		102	18	73		17.4
Total Hybrids Pre June 2009	$	899,185	101.7	%	105.7	%	$	950,666	2.60	%	109	6	60	%	9.3	%
Total Hybrids	$	2,710,192	103.5	%	105.1	%	$	2,847,696	2.80	%	73	20	39	%	13.5	%

December 31, 2014

(Dollars in Thousands)	Current Face		Weighted Average Purchase Price		Weighted Average Market Price		Fair Value (1)		Weighted Average Coupon (2)		Weighted Average Loan Age (Months) (2)	Weighted Average Months to Reset (3)	Interest Only (4)		3 Month Average CPR
Hybrid Post June 2009:
Agency 5/1	$	953,410	104.2	%	106.4	%	$	1,014,865	3.21	%	51	11	22	%	22.9	%
Agency 7/1	1,091,645		104.5		104.7		1,143,315		3.07		40	43	20		14.8
Agency 10/1	298,131		104.7		104.5		311,534		3.22		36	83	59		12.7
Total Hybrids Post June 2009	$	2,343,186	104.4	%	105.4	%	$	2,469,714	3.15	%	44	35	26	%	17.9	%
Hybrid Pre June 2009:
Coupon < 4.5% (5)	$	864,414	101.8	%	106.7	%	$	922,639	2.29	%	99	6	57	%	7.2	%
Coupon >= 4.5% (6)	185,081		101.2		107.1		198,191		5.26		84	13	80		15.6
Total Hybrids Pre June 2009	$	1,049,495	101.7	%	106.8	%	$	1,120,830	2.82	%	97	7	61	%	8.8	%
Total Hybrids	$	3,392,681	103.6	%	105.8	%	$	3,590,544	3.04	%	60	26	37	%	15.1	%

(1)  Does not include principal payments receivable of $1.0 million and $542,000 at December 31, 2015 and 2014, respectively.

(2)  Weighted average is based on MBS current face at December 31, 2015 and 2014, respectively.

(3)  Weighted average months to reset is the number of months remaining before the coupon interest rate resets.  At reset, the MBS coupon will adjust based upon the underlying benchmark interest rate index, margin and periodic or lifetime caps.  The months to reset do not reflect scheduled amortization or prepayments.

(4)  Interest only represents MBS backed by mortgages currently in their interest only period.  Percentage is based on MBS current face at December 31, 2015 and 2014, respectively.

(5)  Agency 3/1, 5/1, 7/1 and 10/1 Hybrid ARM-MBS with coupon less than 4.5%.

(6)  Agency 3/1, 5/1, 7/1 and 10/1 Hybrid ARM-MBS with coupon greater than or equal to 4.5%.

41

Non-Agency MBS

The following table presents information with respect to our Non-Agency MBS at December 31, 2015 and December 31, 2014. As previously discussed, new accounting guidance that was effective on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting and as a result we did not have any Linked Transactions effective January 1, 2015. Accordingly, on adoption of the new standard on January 1, 2015, we reclassified $1.913 billion of Non-Agency MBS and $4.6 million of CRT securities that had previously been reported as a component of Linked Transactions to Non-Agency MBS and CRT securities, respectively on our consolidated balance sheets. Non-Agency MBS at December 31, 2014 is presented: (i) excluding Linked Transactions and reported in accordance with GAAP; (ii) underlying our Linked Transactions and reflected consistent with GAAP reporting requirements (effective on such date); and (iii) on a combined basis (Non-GAAP).

	December 31,
(In Thousands)	2015				2014
(i)  Non-Agency MBS (GAAP)
Face/Par	$	6,961,493			$	5,319,901
Fair Value	6,420,817				4,755,432
Amortized Cost	5,861,843				4,020,241
Purchase Discount Designated as Credit Reserve and OTTI	(787,541		)	(1)	(900,557		)	(2)
Purchase Discount Designated as Accretable	(312,182		)		(399,564		)
Purchase Premiums	73				461
(ii)  Non-Agency MBS Underlying Linked Transactions
Face/Par					$	1,922,487
Fair Value					1,913,189
Amortized Cost					1,908,776
Purchase Discount Designated as Credit Reserve					(15,543		)
Purchase Discount Designated as Accretable					1,832
(iii)  Combined Non-Agency MBS and MBS Underlying Linked Transactions (Non-GAAP)
Face/Par					$	7,242,388
Fair Value					6,668,621
Amortized Cost					5,929,017
Purchase Discount Designated as Credit Reserve and OTTI					(916,100		)	(3)
Purchase Discount Designated as Accretable					(397,732		)
Purchase Premiums					461

(1)  Includes discount designated as Credit Reserve of $766.0 million and OTTI of $21.5 million.

(2)  Includes discount designated as Credit Reserve of $877.6 million and OTTI of $23.0 million.

(3)  Includes discount designated as Credit Reserve of $893.1 million and OTTI of $23.0 million.

42

Purchase Discounts on Non-Agency MBS and Securities Underlying Linked Transactions

The following table presents the changes in the components of purchase discount on Non-Agency MBS with respect to purchase discount designated as Credit Reserve and OTTI, and accretable purchase discount for the years ended December 31, 2015 and 2014. As previously discussed, new accounting guidance that was effective for us on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting and as a result we did not have any Linked Transactions effective January 1, 2015. The information presented for the year ended December 31, 2014 includes securities underlying Linked Transactions and is presented on both a GAAP and Non-GAAP basis (effective on such date):  

	For the Year Ended December 31,
	2015						2014
GAAP Basis	Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)			Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)
(In Thousands)
Balance at beginning of period	$	(900,557	)	$	(399,564	)	$	(1,043,037	)	$	(460,039	)
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	(15,543		)	1,832			—			—
Accretion of discount	—			93,173			—			103,653
Realized credit losses	80,821			—			89,481			—
Purchases	(1,200		)	(4,925		)	(80,256		)	30,003
Sales	8,525			38,420			44,692			20,360
Net impairment losses recognized in earnings	(705		)	—			—			—
Unlinking of Linked Transactions	—			—			(6,414		)	1,436
Transfers/release of credit reserve	41,118			(41,118		)	94,977			(94,977		)
Balance at end of period	$	(787,541	)	$	(312,182	)	$	(900,557	)	$	(399,564	)

Non-GAAP Adjustments	Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)
(In Thousands)
Balance at beginning of period	$	(4,721	)	$	(3,212	)
Accretion of discount	—			1,004
Realized credit losses	783			—
Purchases	(17,801		)	4,950
Unlinking of Linked Transactions	6,414			(1,128		)
Transfers/release of credit reserve	(218		)	218
Balance at end of period	$	(15,543	)	$	1,832

Non-GAAP Basis	Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)
(In Thousands)
Balance at beginning of period	$	(1,047,758	)	$	(463,251	)
Accretion of discount	—			104,657
Realized credit losses	90,264			—
Purchases	(98,057		)	34,953
Sales	44,692			20,360
Unlinking of Linked Transactions	—			308
Transfers/release of credit reserve	94,759			(94,759		)
Balance at end of period	$	(916,100	)	$	(397,732	)

(1)  Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.

43

The following table presents information with respect to the yield components of our Non-Agency MBS for the periods presented:

	For the Year Ended December 31,
	2015				2014				2013
	Legacy Non-Agency MBS		RPL/NPL  MBS		Legacy Non-Agency MBS		RPL/NPL MBS		Legacy Non-Agency MBS		RPL/NPL MBS
Non-Agency MBS
Coupon Yield (1)	5.08	%	3.61	%	5.19	%	3.55	%	5.63	%	4.56	%
Effective Yield Adjustment (2)	2.54		0.07		2.55		0.14		1.62		—
Net Yield	7.62	%	3.68	%	7.74	%	3.69	%	7.25	%	4.56	%

(1) Reflects coupon interest income divided by the average amortized cost.  The discounted purchase price on Legacy Non-Agency MBS causes the coupon yield to be higher than the pass-through coupon interest rate.

(2) The effective yield adjustment is the difference between the net yield, calculated utilizing management’s estimates of timing and amount of future cash flows for Legacy Non-Agency MBS and RPL/NPL MBS, less the current coupon yield.

The information presented as of December 31, 2014 in the above tables on pages 42-43, includes certain underlying Non-Agency MBS and the associated repurchase agreement borrowings that were disclosed both separately and/or on a combined basis with our Non-Agency MBS portfolio. Prior to January 1, 2015, for GAAP financial reporting purposes, we were required to account for these items as Linked Transactions.  Consequently, the presentation of this information in the above tables constitutes Non-GAAP financial measures within the meaning of Regulation G, as promulgated by the SEC.

In assessing the performance of our Non-Agency MBS portfolio prior to January 1, 2015, we did not view these transactions as linked, but rather viewed the performance of the underlying Non-Agency MBS and the related repurchase agreement borrowings as we would any other Non-Agency MBS that was not part of a linked transaction.  Accordingly, as Linked Transaction accounting was discontinued on January 1, 2015, we consider that the Non-GAAP information disclosed in the above table for prior periods provides appropriate comparability to current period disclosures for our Non-Agency MBS portfolio.

Actual maturities of MBS are generally shorter than stated contractual maturities because actual maturities of MBS are affected by the contractual lives of the underlying mortgage loans, periodic payments of principal, and prepayments of principal.  The following table presents certain information regarding the amortized costs, weighted average yields and contractual maturities of our MBS at December 31, 2015 and does not reflect the effect of prepayments or scheduled principal amortization on our MBS:

	One to Five Years				Five to Ten Years				Over Ten Years				Total MBS (1)
(Dollars in Thousands)	Amortized Cost		Weighted Average Yield		Amortized Cost		Weighted Average Yield		Amortized Cost		Weighted Average Yield		Total Amortized Cost		Total Fair Value		Weighted Average Yield
Agency MBS:
Fannie Mae	$	653	2.60	%	$	189,916	3.21	%	$	3,638,635	2.13	%	$	3,829,204	$	3,865,485	2.19	%
Freddie Mac	—		—		130,538		2.80		754,260		2.02		884,798		877,109		2.13
Ginnie Mae	—		—		—		—		9,460		1.71		9,460		9,650		1.71
Total Agency MBS	$	653	2.60	%	$	320,454	3.04	%	$	4,402,355	2.11	%	$	4,723,462	$	4,752,244	2.18	%
Non-Agency MBS	$	358,034	4.08	%	$	4,124	8.36	%	$	5,499,685	6.05	%	$	5,861,843	$	6,420,817	5.93	%
Total MBS	$	358,687	4.07	%	$	324,578	3.11	%	$	9,902,040	4.30	%	$	10,585,305	$	11,173,061	4.25	%

(1)  We did not have any MBS with contractual maturities of less than one year at December 31, 2015.

At December 31, 2015, our CRT securities had an amortized cost of $186.3 million, a fair value of $183.6 million, a weighted average yield of 5.09% and weighted average time to maturity of 9.0 years.

44

Residential Whole Loans

The following table presents the contractual maturities of the residential whole loans held by consolidated trusts at December 31, 2015 and does not reflect estimates of prepayments or scheduled amortization. For residential whole loans at carrying value, amounts presented are estimated based on the underlying loan contractual amounts.

(In Thousands)	Residential Whole Loans at Carrying Value		Residential Whole Loans at Fair Value
Amount due:
Within one year	$	2,319	$	5,760
After one year:
Over one to five years	3,197		5,437
Over five years	266,329		612,079
Total due after one year	$	269,526	$	617,516
Total residential whole loans	$	271,845	$	623,276

The following table presents at December 31, 2015, the dollar amount of our residential whole loans at fair value, contractually maturing after one year, and indicates whether the loans have fixed interest rates or adjustable interest rates:

(In Thousands)	Residential Whole Loans at Fair Value (1)
Interest rates:
Fixed	$	342,702
Adjustable	274,814
Total	$	617,516

(1) Includes loans on which borrowers have defaulted and are not making payments of principal and/or interest as of December 31, 2015.

Information is not presented for residential whole loans at carrying value as income is recognized based on pools of assets with similar risk characteristics using an estimated yield based on cash flows expected to be collected over the lives of the loans in such pools rather than on the contractual coupons of the underlying loans.

The following table presents additional information regarding our residential whole loans at fair value at December 31, 2015 and 2014:

	Residential Whole Loans at Fair Value
(Dollars in Thousands)	December 31, 2015		December 31, 2014
Loans 90 days or more past due:
Number of Loans	2,426		779
Aggregate Amount Outstanding	$	493,640	$	128,591

Income on residential whole loans at carrying value is recognized based on pools of assets with similar credit risk characteristics using an estimated yield based on cash flows expected to be collected over the lives of the loans in such pools rather than the contractual coupons of the underlying loans. As the unit of account is at the pool level rather than the individual loan level, none of our residential whole loans at carrying value are currently considered 90 days or more past due.

45

Exposure to Financial Counterparties

We finance a significant portion of our MBS and CRT securities with repurchase agreements and other advances.  In connection with these financing arrangements, we pledge our securities as collateral to secure the borrowing.  The amount of collateral pledged will typically exceed the amount of the financing with the extent of over-collateralization ranging from 1%-6% of the amount borrowed (U.S. Treasury and Agency MBS collateral) to up to 64% (Non-Agency MBS collateral).  Consequently, while repurchase agreement financing results in us recording a liability to the counterparty in our consolidated balance sheets, we are exposed to the counterparty, if during the term of the repurchase agreement financing, a lender should default on its obligation and we are not able to recover our pledged assets.  The amount of this exposure is the difference between the amount loaned to us plus interest due to the counterparty and the fair value of the collateral pledged by us to the lender including accrued interest receivable on such collateral.

In addition, we use interest rate Swaps to manage interest rate risk exposure in connection with our repurchase agreement financings.  We will make cash payments or pledge securities as collateral as part of a margin arrangement in connection with interest rate Swaps that are in an unrealized loss position.  In the event that a counterparty for a Swap that is not subject to central clearing were to default on its obligation, we would be exposed to a loss to a Swap counterparty to the extent that the amount of cash or securities pledged exceeded the unrealized loss on the associated Swaps and we were not able to recover the excess collateral.

The table below summarizes our exposure to our counterparties at December 31, 2015, by country of domicile:

Country	Number of Counterparties	Repurchase Agreement Financing and Other Advances			Swaps at Fair Value			Exposure (1)		Exposure as a Percentage of MFA Total Assets
(Dollars in Thousands)
European Countries: (2)
Switzerland	2	$	2,141,858		$	—		$	638,992	4.85	%
United Kingdom	2	307,622			—			109,518		0.83
France	2	259,761			—			42,832		0.33
Holland	1	245,494			396			12,934		0.10
Germany	1	—			357			130		—
Total	8	2,954,735			753			804,406		6.11	%
Other Countries:
United States (3)	13	$	5,141,035		$	(70,152	)	$	1,032,057	7.62	%
Canada (4)	4	997,405			—			359,307		2.73
Japan	3	459,332			—			26,371		0.20
China	1	336,395			—			7,108		0.05
Total	21	6,934,167			(70,152		)	1,424,843		10.60	%
Total Counterparty Exposure	29	$	9,888,902	(5)	$	(69,399	)	$	2,229,249	16.71	%

(1) Represents for each counterparty the amount of cash and/or securities pledged as collateral less the aggregate of repurchase agreement financing and other advances, Swaps at fair value, and net interest receivable/payable on all such instruments.

(2) Includes European-based counterparties as well as U.S.-domiciled subsidiaries of the European parent entity.

(3) Includes one counterparty that is a central clearing house for our Swaps.

(4) Includes exposure to foreign based affiliates of the Canadian parent entity.

(5) Includes $500.0 million of repurchase agreements entered into in connection with contemporaneous repurchase and reverse repurchase agreements with a single counterparty

At December 31, 2015, we did not use credit default swaps or other forms of credit protection to hedge the exposures summarized in the table above.

Weak economic conditions in Europe could potentially impact our major European financial counterparties, with the possibility that this would also impact the operations of their U.S. domiciled subsidiaries. This could adversely affect our financing and operations as well as those of the entire mortgage sector in general. Management monitors our exposure to our repurchase agreement and Swap counterparties on a regular basis, using various methods, including review of recent rating agency actions

46

or other developments and by monitoring the amount of cash and securities collateral pledged and the associated loan amount under repurchase agreements and/or the fair value of Swaps with our counterparties. We intend to make reverse margin calls on our counterparties to recover excess collateral as permitted by the agreements governing our financing arrangements, or take other necessary actions to reduce the amount of our exposure to a counterparty when such actions are considered necessary.

Tax Considerations

Current period estimated taxable and items expected to impact future taxable income

We estimate that for 2015, our taxable income was approximately $307.5 million. Based on dividends paid or declared during 2015, we have undistributed taxable income of approximately $7.6 million, or $0.02 per share. We have until the filing of our 2015 tax return (due not later than September 15, 2016) to declare the distribution of any 2015 REIT taxable income not previously distributed.

Certain events that are expected to occur over the next few quarters are anticipated to impact the amount of taxable income generated, including (i) the unwind of a resecuritization transaction, which is currently expected to generate taxable income of approximately $0.19 per share, and (ii) the receipt of our share of settlement proceeds in connection with the $8.5 billion settlement of the Bank of America/Countrywide MBS litigation, which is expected to generate taxable income of approximately $0.05 per share.

Key differences between GAAP net income and REIT Taxable Income for Non-Agency MBS and Residential Whole Loans

Our total Non-Agency MBS portfolio for tax differs from our portfolio reported for GAAP primarily due to the fact that for tax purposes; (i) certain of the MBS contributed to the variable interest entities (or VIEs) used to facilitate resecuritization transactions were deemed to be sold; and (ii) the tax portfolio includes certain securities issued by these VIEs.  In addition, for our Non-Agency MBS tax portfolio, potential timing differences arise with respect to the accretion of market discount into income and recognition of realized losses for tax purposes as compared to GAAP.  Consequently, our REIT taxable income calculated in a given period may differ significantly from our GAAP net income.

The determination of taxable income attributable to Non-Agency MBS and residential whole loans is dependent on a number of factors, including principal payments, defaults, loss mitigation efforts and loss severities.  In projecting taxable income for Non-Agency MBS and residential whole loans during the year, management considers estimates of the amount of discount expected to be accreted.  Such estimates require significant judgment and actual results may differ from these estimates.  Moreover, the deductibility of realized losses from Non-Agency MBS and residential whole loans, and their effect on market discount accretion is analyzed on an asset-by-asset basis and while they will result in a reduction of taxable income, this reduction tends to occur gradually and primarily in periods after the realized losses are reported.

Resecuritization transactions result in differences between GAAP net income and REIT Taxable Income

For tax purposes, depending on the transaction structure, a resecuritization transaction may be treated either as a sale or a financing of the underlying MBS.  Income recognized from resecuritization transactions will differ for tax and GAAP.  For tax purposes, we own and may in the future acquire interests in resecuritization trusts, in which several of the classes of securities are or will be issued with Original Issue Discount (or OID).  As the holder of the retained interests in the trust, we generally will be required to include OID in our current gross interest income over the term of the applicable securities as the OID accrues.  The rate at which the OID is recognized into taxable income is calculated using a constant rate of yield to maturity, with realized losses impacting the amount of OID recognized in REIT taxable income once they are actually incurred.  For tax purposes, REIT taxable income may be recognized in excess of economic income (i.e., OID) or in advance of the corresponding cash flow from these assets, thereby effecting our dividend distribution requirement to stockholders.

Regulatory Developments

The U.S. Congress, Board of Governors of the Federal Reserve System, U.S. Treasury, FDIC, SEC and other governmental and regulatory bodies have taken and continue to consider additional actions in response to the 2007-2008 financial crisis.  In particular, the Dodd-Frank Act created a new regulator, an independent bureau housed within the Federal Reserve System, and known as the Consumer Financial Protection Bureau (or the CFPB). The CFPB has broad authority over a wide range of consumer financial products and services, including mortgage lending.  One portion of the Dodd-Frank Act, the Mortgage Reform and Anti-Predatory Lending Act (or Mortgage Reform Act), contains new underwriting and servicing standards for the mortgage industry, as well as restrictions on compensation for mortgage originators.  In addition, the Mortgage Reform Act grants broad discretionary regulatory authority to the CFPB to prohibit or condition terms, acts or practices relating to residential mortgage loans that the

47

CFPB finds abusive, unfair, deceptive or predatory, as well as to take other actions that the CFPB finds are necessary or proper to ensure responsible affordable mortgage credit remains available to consumers.  The Dodd-Frank Act also affects the securitization of mortgages (and other assets) with requirements for risk retention by securitizers and requirements for regulating Rating Agencies.

The Dodd-Frank Act requires that numerous regulations, many of which (including those mentioned above regarding underwriting and mortgage originator compensation) have only recently been implemented and operationalized.  As a result, we are unable to fully predict at this time how the Dodd-Frank Act, as well as other laws that may be adopted in the future, will affect our business, results of operations and financial condition, or the environment for repurchase financing and other forms of borrowing, the investing environment for Agency MBS, Non-Agency MBS and/or residential mortgage loans, the securitization industry, Swaps and other derivatives.  However, at a minimum, we believe that the Dodd-Frank Act and the regulations promulgated thereunder are likely to continue to increase the economic and compliance costs for participants in the mortgage and securitization industries, including us.

In addition to the regulatory actions being implemented under the Dodd-Frank Act, on August 31, 2011, the SEC issued a concept release under which it is reviewing interpretive issues related to Section 3(c)(5)(C) of the Investment Company Act.  Section 3(c)(5)(C) excludes from the definition of “investment company” entities that are primarily engaged in, among other things, “purchasing or otherwise acquiring mortgages and other liens on and interests in real estate.” Many companies that engage in the business of acquiring mortgages and mortgage-related instruments seek to rely on existing interpretations of the SEC Staff with respect to Section 3(c)(5)(C) so as not to be deemed an investment company for the purpose of regulation under the Investment Company Act. In connection with the concept release, the SEC requested comments on, among other things, whether it should reconsider its existing interpretation of Section 3(c)(5)(C). To date the SEC has not taken or otherwise announced any further action in connection with the concept release. (For additional discussion of the SEC’s concept release and its potential impact on us, please see Part I, Item 1A. “Risk Factors” of this Annual Report on Form 10-K.)

Congress may continue to consider legislation that would significantly reform the country’s mortgage finance system, including, among other things, eliminating Freddie Mac and Fannie Mae and replacing them with a single new MBS insurance agency. Many details remain unsettled, including the scope and costs of the agencies’s guarantee and their affordable housing mission, some of which could be addressed even in the absence of large-scale reform.  While the likelihood of enactment of major mortgage finance system reform in the short term remains uncertain, it is possible that the adoption of any such reforms could adversely affect the types of assets we can buy, the costs of these assets and our business operations.  As the FHFA and both houses of Congress continue to consider various measures intended to dramatically restructure the U.S. housing finance system and the operations of Fannie Mae and Freddie Mac, we expect debate and discussion on the topic to continue throughout 2016.

Results of Operations

Year Ended December 31, 2015 Compared to the Year Ended December 31, 2014

General

For 2015, our net income available to our common stock and participating securities was $298.2 million, or $0.80 per basic and diluted common share, relatively unchanged compared to net income available to common stock and participating securities for 2014 of $298.5 million, or $0.81 per basic and diluted common share.

Net Interest Income

Net interest income represents the difference between income on interest-earning assets and expense on interest-bearing liabilities.  Net interest income depends primarily upon the volume of interest-earning assets and interest-bearing liabilities and the corresponding interest rates earned or paid.  Our net interest income varies primarily as a result of changes in interest rates, the slope of the yield curve (i.e., the differential between long-term and short-term interest rates), borrowing costs (i.e., our interest expense) and prepayment speeds on our MBS.  Interest rates and CPRs (which measure the amount of unscheduled principal prepayment on a bond as a percentage of the bond balance) vary according to the type of investment, conditions in the financial markets, and other factors, none of which can be predicted with any certainty.

 The changes in average interest-earning assets and average interest-bearing liabilities and their related yields and costs are discussed in greater detail below under “Interest Income” and “Interest Expense.”

For 2015, our net interest spread and margin were 2.33% and 2.65%, respectively, compared to a net interest spread and margin of 2.40% and 2.78%, respectively, for 2014. Our net interest income increased by $11.2 million, or 3.7%, to $315.2 million from $304.0 million for 2014. For 2015, net interest income on RPL/NPL MBS and CRT securities increased by approximately

48

$60.3 million. Prior to January 1, 2015, the majority of these assets and associated repurchase agreement financings were reported as components of Linked Transactions with net income reported in Other Income, net in our consolidated statement of operations. This increase was partially offset by the $58.9 million decline in net interest income from Agency and Legacy Non-Agency MBS compared to 2014, primarily due to lower average balances of these MBS and associated Agency repurchase financings. In addition, net interest income for 2015 compared to 2014 was approximately $6.2 million higher due to higher investments in residential whole loans at carrying value and lower outstanding balances of securitized debt.

The net interest spread on our Agency MBS portfolio declined to 0.88% for 2015 compared to 1.08% for 2014. The net interest spread on our Legacy Non-Agency MBS portfolio increased to 4.80% for 2015 compared to 4.73% for 2014. The net interest spread on our RPL/NPL MBS portfolio was 2.01% for 2015 compared to 2.10% for 2014. In the comparable prior period, the majority of our RPL/NPL MBS were reported as Linked Transactions with net interest income reported in Other Income, net.

49

Analysis of Net Interest Income

The following table sets forth certain information about the average balances of our assets and liabilities and their related yields and costs for the years ended December 31, 2015, 2014 and 2013.  Average yields are derived by dividing interest income by the average amortized cost of the related assets, and average costs are derived by dividing interest expense by the daily average balance of the related liabilities, for the periods shown.  The yields and costs include premium amortization and purchase discount accretion which are considered adjustments to interest rates.

	For the Year Ended December 31,
	2015							2014							2013
	Average Balance			Interest		Average Yield/Cost		Average Balance			Interest		Average Yield/Cost		Average Balance			Interest		Average Yield/Cost
(Dollars in Thousands)
Assets:
Interest-earning assets:
Agency MBS (1)	$	5,282,198		$	105,835	2.00	%	$	6,388,112		$	142,543	2.23	%	$	6,841,082		$	156,046	2.28	%
Legacy Non-Agency MBS (1)	3,600,339			274,352		7.62		4,072,237			314,998		7.74		4,507,039			326,749		7.25
RPL/NPL MBS (1)	2,423,808			89,218		3.68		36,065			1,332		3.69		461			21		4.56
Total MBS	11,306,345			469,405		4.15		10,496,414			458,873		4.37		11,348,582			482,816		4.25
CRT securities (1)	133,458			6,572		4.92		16,972			772		4.55		—			—		—
Residential whole loans, at carrying value (2)	241,801			16,036		6.63		58,762			4,083		6.95		—			—		—
Cash and cash equivalents (3)	212,917			130		0.06		358,576			89		0.02		475,287			124		0.03
Total interest-earning assets	11,894,521			492,143		4.14		10,930,724			463,817		4.24		11,823,869			482,940		4.08
Total non-interest-earning assets (2)	1,778,216							1,616,694							1,368,416
Total assets	$	13,672,737						$	12,547,418						$	13,192,285
Liabilities and stockholders’ equity:
Interest-bearing liabilities:
Agency repurchase agreements (4)	$	4,465,949		$	51,891	1.16		$	5,662,872		$	65,128	1.15		$	6,116,468		$	72,856	1.19
Legacy Non-Agency repurchase agreements (4)	2,629,059			74,062		2.82		2,625,403			79,302		3.01		2,596,663			71,029		2.74
RPL/NPL repurchase agreements	1,928,392			32,246		1.67		17,200			273		1.59		—			—		—
CRT securities repurchase agreements	92,860			1,614		1.74		11,323			189		1.67		—			—		—
Residential whole loan repurchase agreements	222,336			6,108		2.75		16,060			352		2.19		—			—		—
FHLB advances	257,811			997		0.39		—			—		—		—			—		—
Total repurchase agreements and other advances	9,596,407			166,918		1.74		8,332,858			145,244		1.74		8,713,131			143,885		1.65
Securitized debt	65,681			1,996		3.04		231,828			6,533		2.82		487,476			12,100		2.48
Senior Notes	100,000			8,034		8.03		100,000			8,031		8.03		100,000			8,028		8.03
Total interest-bearing liabilities	9,762,088			176,948		1.81		8,664,686			159,808		1.84		9,300,607			164,013		1.76
Total non-interest-bearing liabilities	781,188							651,800							629,220
Total liabilities	10,543,276							9,316,486							9,929,827
Stockholders’ equity	3,129,461							3,230,932							3,262,458
Total liabilities and stockholders’ equity	$	13,672,737						$	12,547,418						$	13,192,285
Net interest income/net interest    rate spread (5)				$	315,195	2.33	%				$	304,009	2.40	%				$	318,927	2.32	%
Net interest-earning assets/net    interest margin (6)	$	2,132,433				2.65	%	$	2,266,038				2.78	%	$	2,523,262				2.70	%
Ratio of interest-earning assets to    interest-bearing liabilities	1.22		x					1.26		x					1.27		x

(1) Yields presented throughout this Annual Report on Form 10-K are calculated using average amortized cost data for securities which excludes unrealized gains and losses and includes principal payments receivable on securities.  For GAAP reporting purposes, purchases and sales are reported on the trade date. Average amortized cost data used to determine yields is calculated based on the settlement date of the associated purchase or sale as interest income is not earned on purchased assets and continues to be earned on sold assets until settlement date.   Includes Non-Agency MBS transferred to consolidated VIEs.

(2) Excludes residential whole loans held at fair value that are reported as a component of total non-interest-earning assets.

(3) Includes average interest-earning cash, cash equivalents and restricted cash.

(4) Average cost of repurchase agreements includes the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration.

(5) Net interest rate spread reflects the difference between the yield on average interest-earning assets and average cost of funds.

(6) Net interest margin reflects net interest income divided by average interest-earning assets.

50

Rate/Volume Analysis

The following table presents the extent to which changes in interest rates (yield/cost) and changes in the volume (average balance) of interest-earning assets and interest-bearing liabilities have affected our interest income and interest expense during the periods indicated.  Information is provided in each category with respect to: (i) the changes attributable to changes in volume (changes in average balance multiplied by prior rate); (ii) the changes attributable to changes in rate (changes in rate multiplied by prior average balance); and (iii) the net change.  The changes attributable to the combined impact of volume and rate have been allocated proportionately, based on absolute values, to the changes due to rate and volume.

	Year Ended December 31, 2015									Year Ended December 31, 2014
	Compared to									Compared to
	Year Ended December 31, 2014									Year Ended December 31, 2013
	Increase/(Decrease) due to						Total Net Change in Interest Income/Expense			Increase/(Decrease) due to						Total Net Change in Interest Income/Expense
(In Thousands)	Volume			Rate						Volume			Rate
Interest-earning assets:
Agency MBS	$	(23,092	)	$	(13,616	)	$	(36,708	)	$	(10,163	)	$	(3,340	)	$	(13,503	)
Legacy Non-Agency MBS	(36,021		)	(4,625		)	(40,646		)	(32,895		)	21,123			(11,772		)
RPL/NPL MBS (1)	87,884			2			87,886			1,337			(5		)	1,332
CRT securities	5,731			69			5,800			772			—			772
Residential whole loans at carrying value (1)	11,872			81			11,953			4,083			—			4,083
Cash and cash equivalents	(5		)	46			41			(29		)	(6		)	(35		)
Total net change in income from interest-earning assets	$	46,369		$	(18,043	)	$	28,326		$	(36,895	)	$	17,772		$	(19,123	)
Interest-bearing liabilities:
Agency repurchase agreements	$	(13,900	)	$	663		$	(13,237	)	$	(5,275	)	$	(2,453	)	$	(7,728	)
Legacy Non-Agency repurchase agreements	110			(5,350		)	(5,240		)	832			7,441			8,273
RPL/NPL repurchase agreements	31,957			16			31,973			273			—			273
CRT securities repurchase agreements	1,417			8			1,425			189			—			189
Residential whole loan repurchase agreements	5,645			111			5,756			352			—			352
FHLB advances	997			—			997			—			—			—
Securitized debt	(5,013		)	476			(4,537		)	(7,041		)	1,474			(5,567		)
Senior Notes	—			3			3			—			3			3
Total net change in expense of interest-bearing liabilities	$	21,213		$	(4,073	)	$	17,140		$	(10,670	)	$	6,465		$	(4,205	)
Net change in net interest income	$	25,156		$	(13,970	)	$	11,186		$	(26,225	)	$	11,307		$	(14,918	)

(1) Excludes residential whole loans held at fair value which are reported as a component of non-interest-earning assets.

51

The following table presents certain quarterly information regarding our net interest spread and net interest margin for the quarterly periods presented:

	Total Interest-Earning Assets and Interest- Bearing Liabilities
Quarter Ended	Net Interest Spread (1)		Net Interest Margin (2)
December 31, 2015	2.22	%	2.54	%
September 30, 2015	2.24		2.58
June 30, 2015	2.33		2.66
March 31, 2015	2.44		2.77
December 31, 2014	2.41		2.76
September 30, 2014	2.32		2.70
June 30, 2014	2.42		2.80
March 31, 2014	2.44		2.84

(1) Reflects the difference between the yield on average interest-earning assets and average cost of funds.

(2) Reflects annualized net interest income divided by average interest-earning assets.

The following table presents the components of the net interest spread earned on our Agency, Legacy Non-Agency MBS and RPL/NPL MBS for the quarterly periods presented:

	Agency MBS						Legacy Non-Agency MBS						RPL /NPL MBS						Total MBS
Quarter Ended	Net Yield (1)		Cost of Funding (2)		Net  Interest Spread (3)		Net Yield (1)		Cost of Funding (2)		Net  Interest Spread (3)		Net Yield (1)		Cost of Funding (2)		Net  Interest Spread (3)		Net Yield (1)		Cost of Funding (2)		Net  Interest Spread (3)
December 31, 2015	2.04	%	1.17	%	0.87	%	7.64	%	2.90	%	4.74	%	3.70	%	1.81	%	1.89	%	4.17	%	1.81	%	2.36	%
September 30, 2015	1.84		1.13		0.71		7.60		2.76		4.84		3.74		1.73		2.01		4.08		1.73		2.35
June 30, 2015	1.89		1.06		0.83		7.59		2.77		4.82		3.66		1.60		2.06		4.09		1.65		2.44
March 31, 2015	2.22		1.13		1.09		7.64		2.85		4.79		3.62		1.52		2.10		4.26		1.69		2.57
December 31, 2014	2.17		1.12		1.05		7.68		2.95		4.73		3.19		1.60		1.59		4.33		1.76		2.57
September 30, 2014	2.09		1.14		0.95		7.70		2.97		4.73		3.53		1.49		2.04		4.28		1.75		2.53
June 30, 2014	2.26		1.13		1.13		7.72		3.11		4.61		4.16		—		4.16		4.36		1.77		2.59
March 31, 2014	2.39		1.21		1.18		7.80		3.04		4.76		4.30		—		4.30		4.50		1.80		2.70

(1) Reflects annualized interest income on MBS divided by average amortized cost of MBS.

(2) Reflects annualized interest expense divided by average balance of repurchase agreements and other advances, including the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration and securitized debt. Agency cost of funding includes 74, 74, 70, 78, 79, 82, 81 and 85 basis points and Legacy Non-Agency cost of funding includes 69, 66, 68,78, 84, 89, 88 and 74 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the quarters ended December 31, 2015, September 30, 2015, June 30, 2015, March 31, 2015, December 31, 2014, September 30, 2014, June 30, 2014 and March 31, 2014, respectively.

(3) Reflects the difference between the net yield on average MBS and average cost of funds on MBS.

Interest Income

Interest income on our Agency MBS for 2015decreased by $36.7 million, or 25.8% to $105.8 million from $142.5 million for 2014.  This change primarily reflects a $1.106 billiondecrease in the average amortized cost of our Agency MBS portfolio to $5.282 billion for 2015 from $6.388 billion for 2014. In addition, the net yield on our Agency MBS decreased to 2.00% for 2015 from 2.23% for 2014.  At the end of 2015, the average coupon on mortgages underlying our Agency MBS was lower compared to the end of 2014, as a result of prepayments on higher yielding assets and downward resets on Hybrid and ARM-MBS within the portfolio.  As a result, the coupon yield on our Agency MBS portfolio declined 18 basis points to 2.78% for 2015 from 2.96% for 2014.  During 2015, our Agency MBS portfolio experienced a 13.2% CPR and we recognized a $41.2 million of net premium

52

amortization compared to a CPR of 13.0% and $46.8 million of net premium amortization in 2014. At December 31, 2015, we had net purchase premiums on our Agency MBS of $172.0 million, or 3.8% of current par value, compared to net purchase premiums of $213.3 million, or 3.8% of par value at December 31, 2014.

Interest income on our Non-Agency MBS (which includes Non-Agency MBS transferred to consolidated VIEs) increased$47.2 million, or 14.9%, for 2015 to $363.6 million compared to $316.3 million for 2014. Non-Agency MBS interest income reflected the inclusion of MBS that, prior to January 1, 2015, were accounted for as components of Linked Transactions and income from such securities was reported in Other Income, net in prior periods. In addition, primarily due to the accounting change for Linked Transactions, the average amortized cost of our Non-Agency MBS increased by $1.916 billion or 46.6%, to $6.024 billion for 2015, from $4.108 billion for 2014.  Our Legacy Non-Agency MBS portfolio yielded 7.62% for 2015 compared to 7.74% for 2014. The decrease in the yield on our Legacy Non-Agency MBS is primarily due to prepayments on higher yielding assets in the portfolio, partially offset by increases in accretable discount due to the impact of credit reserve releases, in the current and prior year, that have occurred as a result of the improved credit performance of loans underlying the Legacy Non-Agency MBS portfolio. Our RPL/NPL MBS portfolio yielded 3.68% for 2015 compared to 3.69% for 2014. During 2015, we recognized net purchase discount accretion of $92.8 million on our Non-Agency MBS, compared to $103.4 million for 2014.  At December 31, 2015, we had net purchase discounts of $1.096 billion, including Credit Reserve and previously recognized OTTI of $787.5 million, on our Legacy Non-Agency MBS, or 25.4% of par value.  During 2015 we reallocated $41.1 million of purchased discount designated as Credit Reserve to accretable purchase discount.

The following table presents the components of the coupon yield and net yields earned on our Agency MBS, Legacy Non-Agency MBS and RPL/NPL MBS and weighted average CPR experienced for such MBS for the quarterly periods presented:

	Agency MBS						Legacy Non-Agency MBS						RPL/NPL MBS
Quarter Ended	Coupon Yield (1)		Net Yield (2)		3 Month Average CPR (3)		Coupon Yield (1)		Net Yield (2)		3 Month Average CPR (3)		Coupon Yield (1)		Net Yield (2)		3 Month Average Bond CPR (4)
December 31, 2015	2.76	%	2.04	%	11.8	%	5.09	%	7.64	%	14.6	%	3.68	%	3.70	%	21.5	%
September 30, 2015	2.74		1.84		15.4		5.10		7.60		16.3		3.62		3.74		29.5
June 30, 2015	2.77		1.89		14.8		5.06		7.59		14.8		3.57		3.66		28.6
March 31, 2015	2.99		2.22		10.9		5.11		7.64		11.1		3.56		3.62		19.6
December 31, 2014	2.91		2.17		12.3		5.13		7.68		12.5		3.91		3.19		17.6
September 30, 2014	2.94		2.09		15.1		5.18		7.70		12.7		3.53		3.53		19.7
June 30, 2014	2.99		2.26		13.0		5.27		7.72		12.1		4.16		4.16		15.8
March 31, 2014	3.01		2.39		11.5		5.19		7.80		11.9		4.30		4.30		16.0

(1) Reflects the annualized coupon interest income divided by the average amortized cost. The discounted purchase price on Legacy Non-Agency MBS causes the coupon yield to be higher than the pass-through coupon interest rate.

(2) Reflects annualized interest income on MBS divided by average amortized cost of MBS.

(3) 3 month average CPR weighted by positions as of the beginning of each month in the quarter.

(4) All principal payments are considered to be prepayments for CPR purposes.

Interest Expense

Our interest expense for 2015increased by $17.1 million, or 10.7% to $176.9 million, from $159.8 million for 2014.  This increase primarily reflects an increase in our average borrowings to finance RPL/NPL MBS (primarily due to the reclassification of repurchase agreements previously reported as a component of Linked Transactions as discussed above), residential whole loans and CRT securities, and utilization of FHLB advances, which was partially offset by a decrease in our average repurchase agreement borrowings to finance Agency MBS, lower financing rates on Legacy Non-Agency MBS, and a decrease in the average balance of securitized debt.

At December 31, 2015, we had repurchase agreement borrowings of $7.889 billion of which $3.050 billion was hedged with Swaps, FHLB advances of $1.500 billion and securitized debt of $22.1 million.  At December 31, 2015, our Swaps designated in hedging relationships had a weighted average fixed-pay rate of 1.82% and extended 45 months on average with a maximum remaining term of approximately 92 months.

53

The effective interest rate paid on our borrowings decreased to 1.81% for 2015 from 1.84% for 2014.  This decrease reflectsthe lower average balance of Agency repurchase agreements and securitized debt, the lower financing rates associated with our Legacy Non-Agency MBS portfolio (including the allocation of Swap expense), partially offset by the increase in our average balance of repurchase agreements used to finance RPL/NPL MBS.

Payments made and/or received on our Swaps are a component of our borrowing costs and accounted for interest expense of $53.8 million or 57 basis points, for 2015, compared to interest expense of $69.8 million, or 81 basis points, for 2014.  The weighted average fixed-pay rate on our Swaps designated as hedges decreased to 1.86% for 2015 from 1.93% for 2014.  The weighted average variable interest rate received on our Swaps increased to 0.19% for 2015 from 0.16% for 2014.  During 2015, we did not enter into any new Swaps and had Swaps with an aggregate notional amount of $710.2 million and a weighted average fixed-pay rate of 1.96% amortize and/or expire.

We expect that our interest expense and funding costs for 2016 will be impacted by market interest rates, the amount of our borrowings and incremental hedging activity, existing and future interest rates on our hedging instruments and the extent to which we execute additional longer-term structured financing transactions.  As a result of these variables, our borrowing costs cannot be predicted with any certainty.  (See Notes 6, 8 and 16 to the accompanying consolidated financial statements, included under Item 8 of this Annual Report on Form 10-K.) 

OTTI

During 2015 we recognized OTTI charges through earnings of $705,000 against certain of our Non-Agency MBS. These impairment charges reflected changes in our estimated cash flows for such securities based on an updated assessment of the estimated future performance of the underlying collateral, including the expected principal loss over the term of the securities and changes in the expected timing of receipt of cash flows. We did not recognize any OTTI charges through earnings against our Non-Agency MBS during 2014. At December 31, 2015, we had 336 Agency MBS with a gross unrealized loss of $40.4 million, 59 RPL/NPL MBS with a gross unrealized loss of $19.3 million and 58 Legacy Non-Agency MBS with a gross unrealized loss of $9.1 million.  Impairments on Agency MBS in an unrealized loss position at December 31, 2015 are considered temporary and not credit related.  Unrealized losses on Non-Agency MBS for which no OTTI was recorded during the year are considered temporary based on an assessment of changes in the expected cash flows for such securities, which considers recent bond performance and expected future performance of the underlying collateral.  Significant judgment is used both in our analysis of expected cash flows for our Legacy Non-Agency MBS and any determination of the credit component of OTTI. (See “Critical Accounting Policies and Estimates” for more information regarding OTTI.)

Other Income, net

For 2015, Other income, net, decreased by $3.6 million to $51.2 million from $54.8 million for 2014. Other income, net for 2015 primarily reflects $34.9 million of gross gains realized on the sale of $70.7 million Non-Agency MBS, a $17.7 million net gain recorded on residential whole loans held at fair value, and $1.8 million of net losses related to loans transferred to REO during the year. During 2014, we sold Non-Agency MBS for $123.9 million and realized gross gains of $37.5 million.  In addition, the year ended 2014 included unrealized net gains and net interest income on Linked Transactions of $17.1 million, which included interest income of $24.4 million on the underlying Non-Agency MBS, interest expense of $8.0 million on borrowings under repurchase agreements and an increase of $677,000 in the fair value of the underlying securities. As previously mentioned, new accounting guidance effective on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting and as a result we did not have any Linked Transactions effective January 1, 2015 (See Note 6 to the accompanying consolidated financial statements, included under Item 8 of this Annual Report on Form 10-K).

Operating and Other Expense

For 2015, we had compensation and benefits and other general and administrative expense of $42.0 million, or 1.34% of average equity, compared to $40.7 million, or 1.26% of average equity, for 2014.  Compensation and benefits expense increased$712,000 to $26.3 million for 2015, compared to $25.6 million for 2014, primarily reflecting higher costs associated with our wider residential asset strategy. Our other general and administrative expenses increased by $588,000 to $15.8 million for 2015 compared to $15.2 million for 2014.  The increase was primarily due to higher IT development and related costs, data analytics and pricing services related expenses and costs associated with our attaining FHLB membership, partially offset by lower professional services related costs.

Operating and Other Expense during 2015 also includes $10.4 million of loan servicing and other related operating expenses related to our residential whole loan activities. These expenses increased compared to the prior year period by approximately $7.0 million, consistent with the overall growth in this asset class during 2015. The overall increase is primarily due to loan servicing

54

and due diligence related expenses associated with acquisitions closed over the past year. Also included in this expense category is the impact of loan loss provisions and non-recoverable REO maintenance and other loan related expenses that are incurred in connection with our investments in this asset class.

Operating and Other Expense for 2014 also included a $1.2 million accrual of interest with respect to prior years undistributed taxable income. No such expense was incurred in 2015.

Selected Financial Ratios

The following table presents information regarding certain of our financial ratios at or for the dates presented:

At or for the Quarter Ended	Return on Average Total Assets (1)		Return on Average Total Stockholders’ Equity (2)		Total Average Stockholders’ Equity to Total Average Assets (3)		Dividend Payout Ratio (4)	Leverage Multiple (5)	Book Value per Share of Common Stock (6)
December 31, 2015	2.10	%	9.80	%	22.56	%	1.05	3.4	$	7.47
September 30, 2015	2.22		10.21		22.85		1.00	3.3	7.70
June 30, 2015	2.16		9.78		23.18		1.00	3.3	7.96
March 31, 2015	2.25		10.26		22.97		0.95	3.3	8.13
December 31, 2014	2.44		9.91		25.78		1.00	2.8	8.12
September 30, 2014	2.41		9.62		26.27		1.00	2.7	8.28
June 30, 2014	2.38		9.25		25.69		1.00	2.8	8.37
March 31, 2014	2.30		9.10		25.27		1.00	2.9	8.20

(1) Reflects annualized net income available to common stock and participating securities divided by average total assets. The decrease for the quarter ended March 31, 2015 compared to the quarter ended December 31, 2014 is primarily due to the reclassification of $1.918 billion of MBS previously reported as a component of Linked Transactions.

(2) Reflects annualized net income divided by average total stockholders’ equity.

(3) Reflects total average stockholders’ equity divided by total average assets. The decrease for the quarter ended March 31, 2015 compared to the quarter ended December 31, 2014 is primarily due to the reclassification of $1.918 billion of MBS previously reported as a component of Linked Transactions.

(4) Reflects dividends declared per share of common stock divided by earnings per share.

(5) Represents the sum of borrowings under repurchase agreements, FHLB advances, securitized debt, payable for unsettled MBS purchases, and obligations to return securities obtained as collateral and Senior Notes divided by stockholders’ equity. The increase in our leverage multiple for the quarter ended March 31, 2015 from the quarter ended December 31, 2014 is primarily due to the reclassification of $1.520 billion of repurchase agreements previously reported as a component of Linked Transactions.

(6) Reflects total stockholders’ equity less the preferred stock liquidation preference divided by total shares of common stock outstanding.

Year Ended December 31, 2014 Compared to the Year Ended December 31, 2013

General

For 2014, we had net income available to our common stock and participating securities of $298.5 million, or $0.81 per basic and diluted common share, compared to net income available to common stock and participating securities of $285.0 million, or $0.78 per basic and diluted common share, for 2013.  The increase in net income available to our common stock and participating securities, and the increase of this item on a per share basis primarily reflected an increase in unrealized net gains and net interest income from Linked Transactions, higher gains on sales of MBS partially offset by a reduction in net interest income. Yields on Agency MBS were lower for 2014 compared to 2013 and were impacted by lower coupon yields. Non-Agency MBS yields were higher compared to the prior year period due primarily to the impact of credit reserve releases. In addition, during 2013, we had $7.5 million of unrealized losses on forward contracts for the sale of Agency MBS securities on a generic pool, or to-be-announced basis (or TBA short positions), a $3.9 million write-off of issuance costs on the redemption of the Series A Preferred Stock (see Note 13 to the accompanying consolidated financial statements, included under Item 8 of this Annual Report on Form 10-K) and a $2.0 million charge related to the impairment of resecuritization related costs. None of these items re-occurred in 2014.

55

Net Interest Income

Net interest income represents the difference between income on interest-earning assets and expense on interest-bearing liabilities.  Net interest income depends primarily upon the volume of interest-earning assets and interest-bearing liabilities and the corresponding interest rates earned or paid.  Our net interest income varies primarily as a result of changes in interest rates, the slope of the yield curve (i.e., the differential between long-term and short-term interest rates), borrowing costs (i.e., our interest expense) and prepayment speeds on our MBS.  Interest rates and CPRs (which measure the amount of unscheduled principal prepayment on a bond as a percentage of the bond balance), vary according to the type of investment, conditions in the financial markets, and other factors, none of which can be predicted with any certainty.

The changes in average interest-earning assets and average interest-bearing liabilities and their related yields and costs are discussed in greater detail below under “Interest Income” and “Interest Expense.”

For 2014, our net interest spread and margin were 2.40% and 2.78%, respectively, compared to a net interest spread and margin of 2.32% and 2.70%, respectively, for 2013. Although our net interest spread and margin increased, our net interest income decreased by $14.9 million, or 4.7%, to $304.0 million from $318.9 million for 2013.  This decrease primarily reflected the impact of the lower average balance of our MBS portfolio as measured by amortized cost, increased Non-Agency MBS borrowing costs (including the impact of allocated Swap expense), partially offset by higher yielding Non-Agency MBS due to improved credit performance, a decrease in the average balance of securitized debt and lower Agency MBS borrowing costs.  It should be noted that our reported net interest income for 2014 and 2013 excluded the interest income on Non-Agency MBS and CRT securities and the interest expense on repurchase agreements financings that had been accounted for as Linked Transactions and for which the net interest income was reported in Other income, net in our consolidated statement of operations. For 2014, the net interest earned on our investments accounted for as Linked Transactions increased by approximately $13.5 million to $16.4 million compared to $2.9 million for 2013. The net interest spread on our Agency MBS portfolio declined slightly to 1.08% for 2014 compared to 1.09% for 2013. The net interest spread on our Non-Agency MBS portfolio increased to 4.70% for 2014 compared to 4.55% for 2013.

The following table presents certain quarterly information regarding our net interest spread and net interest margin for the quarterly periods presented:

	Total Interest-Earning Assets and Interest- Bearing Liabilities
Quarter Ended	Net Interest Spread (1)		Net Interest Margin (2)
December 31, 2014	2.41	%	2.76	%
September 30, 2014	2.32		2.70
June 30, 2014	2.42		2.80
March 31, 2014	2.44		2.84
December 31, 2013	2.34		2.75
September 30, 2013	2.24		2.63
June 30, 2013	2.38		2.73
March 31, 2013	2.32		2.69

(1) Reflected the difference between the yield on average interest-earning assets and average cost of funds.

(2) Reflected annualized net interest income divided by average interest-earning assets.

56

The following table presents the components of the net interest spread earned on our Agency and Non-Agency MBS for the quarterly periods presented:

	Agency MBS						Non-Agency MBS						Total MBS
Quarter Ended	Net Yield (1)		Cost of Funding (2)		Net  Interest Spread (3)		Net Yield (1)		Cost of Funding (2)		Net  Interest Spread (3)		Net Yield (1)		Cost of Funding (2)		Net  Interest Spread (3)
December 31, 2014	2.17	%	1.12	%	1.05	%	7.59	%	2.92	%	4.66	%	4.33	%	1.76	%	2.57	%
September 30, 2014	2.09		1.14		0.95		7.68		2.96		4.72		4.28		1.75		2.53
June 30, 2014	2.26		1.13		1.13		7.71		3.11		4.60		4.36		1.77		2.59
March 31, 2014	2.39		1.21		1.18		7.80		2.99		4.81		4.50		1.80		2.70
December 31, 2013	2.37		1.26		1.11		7.77		3.01		4.76		4.48		1.85		2.63
September 30, 2013	2.13		1.12		1.01		7.33		2.91		4.42		4.20		1.74		2.46
June 30, 2013	2.19		1.15		1.04		7.15		2.41		4.74		4.18		1.56		2.62
March 31, 2013	2.42		1.24		1.18		6.80		2.45		4.35		4.17		1.63		2.54

(1) Reflected annualized interest income on MBS divided by average amortized cost of MBS.

(2) Reflected annualized interest expense divided by average balance of repurchase agreements, including the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration, and securitized debt. Agency cost of funding included 79, 82, 81, 85, 86 and 74 basis points and Non-Agency cost of funding included 84, 89, 88, 74, 72 and 57 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the quarters ended December 31, 2014, September 30, 2014, June 30, 2014, March 31, 2014, December 31, 2013 and September 30, 2013, respectively. Agency cost of funding includes 100 and 88 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the quarters ended June 30, 2013 and March 31, 2013, respectively. Non-Agency funding cost did not include any costs associated with Swaps in those periods.

(3) Reflected the difference between the net yield on average MBS and average cost of funds on MBS.

Interest Income

Interest income on our Agency MBS for 2014 decreased by $13.5 million, or 8.7% to $142.5 million from $156.0 million for 2013.  This change primarily reflected a $453.0 million decrease in the average amortized cost of our Agency MBS portfolio to $6.388 billion for 2014 from $6.841 billion for 2013 and a decrease in the net yield on our Agency MBS to 2.23% for 2014 from 2.28% for 2013.  At the end of 2014, the average coupon on mortgages underlying our Agency MBS was lower compared to the end of 2013, due to acquisition of assets in the marketplace at generally lower coupons and as a result of prepayments on higher yielding assets and downward resets on Hybrid and ARM-MBS within the portfolio.  As a result, the coupon yield on our Agency MBS portfolio declined 17 basis points to 2.96% for 2014 from 3.13% for 2013.  During 2014, our Agency MBS portfolio experienced a 13.0% CPR and we recognized a $46.8 million of net premium amortization compared to a CPR of 17.9% and $57.9 million of net premium amortization in 2013. At December 31, 2014, we had net purchase premiums on our Agency MBS of $213.3 million, or 3.8% of current par value, compared to net purchase premiums of $226.8 million, or 3.6% of par value at December 31, 2013.

Interest income on our Non-Agency MBS (which includes Non-Agency MBS transferred to consolidated VIEs) decreased $10.4 million, or 3.2%, for 2014 to $316.3 million compared to $326.8 million for 2013, primarily due to the decrease in the amortized cost of our Non-Agency MBS portfolio, partially offset by the increase in the net yield on our Non-Agency MBS portfolio. For 2014, the average amortized cost of our Non-Agency MBS (excluding Non-Agency MBS reported as a component of Linked Transactions) decreased by $399.2 million or 8.9%, to $4.108 billion, from $4.508 billion for 2013.  Our Non-Agency MBS portfolio yielded 7.70% for 2014 compared to 7.25% for 2013. The increase in the yield on our Non-Agency MBS was primarily due to the impact of credit reserve releases, in the then current and prior year, that had occurred as a result of the improved credit performance of loans underlying the Legacy Non-Agency MBS portfolio. During 2014, we recognized net purchase discount accretion of $103.4 million on our Non-Agency MBS, compared to $73.2 million for 2013.  At December 31, 2014, we had net purchase discounts of $1.300 billion, including Credit Reserve and previously recognized OTTI of $900.6 million, on our Non-Agency MBS, or 24.4% of par value.  During 2014 we reallocated $95.0 million of purchased discount designated as Credit Reserve to accretable purchase discount.

57

The following table presents the components of the coupon yield and net yields earned on our Agency MBS and Non-Agency MBS and weighted average CPR experienced for such MBS for the quarterly periods presented:

	Agency MBS						Non-Agency MBS						Total MBS
Quarter Ended	Coupon Yield (1)		Net Yield (2)		3 Month Average CPR		Coupon Yield (1)		Net Yield (2)		3 Month Average CPR		Coupon Yield (1)		Net Yield (2)		3 Month Average CPR
December 31, 2014	2.91	%	2.17	%	12.34	%	5.10	%	7.59	%	12.53	%	3.78	%	4.34	%	12.43	%
September 30, 2014	2.94		2.09		15.11		5.17		7.68		12.71		3.81		4.28		13.94
June 30, 2014	2.99		2.26		13.05		5.27		7.71		12.05		3.87		4.36		12.58
March 31, 2014	3.01		2.39		11.54		5.19		7.80		11.90		3.86		4.50		11.71
December 31, 2013	3.04		2.37		12.87		5.40		7.77		14.16		3.96		4.48		13.42
September 30, 2013	3.07		2.13		19.25		5.59		7.33		18.15		4.07		4.20		18.77
June 30, 2013	3.14		2.19		20.19		5.71		7.15		16.37		4.17		4.18		18.53
March 31, 2013	3.25		2.42		19.08		5.78		6.80		15.06		4.26		4.17		17.34

(1) Reflected the annualized coupon interest income divided by the average amortized cost. The discounted purchase price on Non-Agency MBS causes the coupon yield to be higher than the pass-through coupon interest rate. (Does not include MBS underlying our Linked Transactions. See Note 6 to the accompanying consolidated financial statements, included under Item 8 of this Annual Report on Form 10-K.)

(2) Reflected annualized interest income on MBS divided by average amortized cost of MBS.

Interest Expense

Our interest expense for 2014 decreased by $4.2 million, or 2.6% to $159.8 million, from $164.0 million for 2013.  This decrease primarily reflected a decrease in the average balance of securitized debt, a decrease in our average borrowings to finance Agency MBS and the lower effective interest rate paid on borrowings to finance Agency MBS, which was partially offset by higher effective funding costs associated with Non-Agency MBS, including allocated Swap financing costs, and securitized debt.

At December 31, 2014, we had repurchase agreement borrowings of $8.267 billion of which $3.760 billion was hedged with Swaps, and securitized debt of $110.6 million.  At December 31, 2014, our Swaps designated in hedging relationships had a weighted average fixed-pay rate of 1.85% and extended 47 months on average with a maximum remaining term of approximately 104 months.

The following table presents information about our securitized debt at December 31, 2014:

	At December 31, 2014
Benchmark Interest Rate	Securitized Debt		Interest Rate
(Dollars in Thousands)
Fixed Rate	$	57,288	2.85	%
Weighted Average Coupon Rate	53,286		3.82
Total	$	110,574	3.31	%

The effective interest rate paid on our borrowings increased to 1.84% for 2014 from 1.76% for 2013.  This increase reflected additional higher cost financing (including the impact of allocated Swap expense) associated with our Non-Agency MBS portfolio partially offset by the lower average balance of securitized debt and Agency repurchase agreements.  Payments made and/or received on our Swaps are a component of our borrowing costs and accounted for interest expense of $69.8 million or 81 basis points, for 2014, compared to interest expense of $59.0 million, or 63 basis points, for 2013.  The weighted average fixed-pay rate on our Swaps decreased to 1.93% for 2014 from 2.08% for 2013.  The weighted average variable interest rate received on our Swaps decreased to 0.16% for 2014 from 0.19% for 2013.  During 2014, we entered into four new Swaps with an aggregate notional amount of $400.0 million, a weighted average fixed-pay rate of 1.95% with initial maturities ranging from five to seven years, and had Swaps with an aggregate notional amount of $685.0 million and a weighted average fixed-pay rate of 2.28% amortize and/or expire.

58

The following table presents our leverage multiples, as measured by debt-to-equity, at the dates presented:

At the Period Ended	GAAP Leverage Multiple (1)	Non-GAAP Leverage Multiple (2)
December 31, 2014	2.8	3.3
September 30, 2014	2.7	3.0
June 30, 2014	2.8	2.9
March 31, 2014	2.9	3.0
December 31, 2013	2.9	3.0
September 30, 2013	3.0	3.1
June 30, 2013	3.1	3.1
March 31, 2013	3.1	3.1

(1)  Represented the sum of borrowings under repurchase agreements, securitized debt, payable for unsettled MBS purchases, and obligations to return securities obtained as collateral and Senior Notes divided by stockholders’ equity.

(2)  The Non-GAAP Leverage Multiple reflected the sum of our borrowings under repurchase agreements, securitized debt, payable for unsettled MBS purchases, obligations to return securities obtained as collateral, Senior Notes and borrowings that were reported on our consolidated balance sheets as a component of Linked Transactions of $1.520 billion, $791.8 million, $387.5 million, $206.0 million, $102.7 million, $82.4 million, $33.2 million and $34.1 million at December 31, 2014, September 30, 2014, June 30, 2014, March 31, 2014, December 31, 2013, September 30, 2013, June 30, 2013 and March 31, 2013 respectively.  We presented a Non-GAAP leverage multiple since repurchase agreement borrowings that were a component of Linked Transactions may not be linked in the future and, if no longer linked, would be reported as repurchase agreement borrowings, which would increase our leverage multiple.  (See Note 6 to the accompanying consolidated financial statements, included under Item 8 of this Annual Report on Form 10-K.)

OTTI

During 2014 and 2013, we did not recognize any OTTI charges through earnings against our Non-Agency MBS. At December 31, 2014, we had 271 Agency MBS with a gross unrealized loss of $33.6 million and 45 Non-Agency MBS and CRT securities with a gross unrealized loss of $5.8 million.  Impairments on Agency MBS in an unrealized loss position at December 31, 2014 are considered temporary and not credit related.  Unrealized losses on Non-Agency MBS and CRT securities for which no OTTI was recorded during the year were considered temporary based on an assessment of changes in the expected cash flows for such securities, which considered recent bond performance and expected future performance of the underlying collateral.  Significant judgment was used both in the Company’s analysis of expected cash flows for its Legacy Non-Agency MBS and any determination of the credit component of OTTI. (See “Critical Accounting Policies and Estimates” for more information regarding OTTI.)

Other Income, net

For 2014, Other income, net, increased by $33.0 million to $54.8 million from $21.8 million for 2013. In  2014 Other income, net primarily reflected $37.5 million of net gains realized on the sale of certain Non-Agency MBS and unrealized net gains and net interest income of $17.1 million on our Linked Transactions. In addition, during 2014 we recorded net gains on residential whole loans held at fair value of $116,000, primarily reflecting changes in market value of the underlying loans since acquisition. During 2014, we sold Non-Agency MBS for $123.9 million, realizing gross gains of $37.5 million. During 2013, we sold Non-Agency MBS for $152.6 million, and realized gross gains of $25.8 million and sold U.S. Treasury securities for $422.2 million, realizing net losses of approximately $24,000. The unrealized net gains and net interest income from Linked Transactions of $17.1 million for 2014 included interest income of $24.4 million on the underlying Non-Agency MBS, interest expense of $8.0 million on the borrowings under repurchase agreements and an increase of $677,000 in the fair value of the underlying securities.  The unrealized net gains and net interest income on Linked Transactions of $3.2 million for 2013 included interest income of $3.9 million on the underlying Non-Agency MBS, interest expense of $925,000 on borrowings under repurchase agreements and an increase of $281,000 in the fair value of the underlying securities.  During 2014, certain of our Linked Transactions became unlinked, resulting in our recording Non-Agency MBS with a fair value of $86.4 million on our consolidated balance sheets. The $7.5 million of losses realized on TBA short positions for 2013 reflected losses on the sale of $350.0 million notional of TBA securities.

59

Operating and Other Expense

For 2014, we had compensation and benefits and other general and administrative expense of $40.7 million, or 1.26% of average equity, compared to $33.7 million, or 1.03% of average equity, for 2013.  The $5.3 million increase in our compensation and benefits expense to $25.6 million for 2014, compared to $20.3 million for 2013, primarily reflected increases in equity-based compensation expense, salary and bonus expense, and payroll taxes. Our other general and administrative expenses increased by $1.8 million to $15.2 million for 2014 compared to $13.4 million for 2013.  The increase was primarily comprised of increases in professional services, board of director expenses and the cost of data and analytical systems.

During 2014, we recorded $3.4 million of other investment related operating expenses related to our residential whole loan activities. In addition, during 2014, an interest accrual of $1.2 million was recorded, reflecting an additional accrual of interest with respect to prior years undistributed taxable income. During 2013, we recorded an excise tax and interest accrual of $2.0 million reflecting an updated estimate of excise tax payable in respect of undistributed REIT taxable income for the 2012 tax year and an additional accrual of interest with respect to prior years undistributed taxable income and recorded $250,000 reflecting an estimate of excise tax payable in respect of undistributed REIT taxable income for the 2013 tax year. In addition, for 2013, we realized a $2.0 million charge related to the impairment of resecuritization related costs.

Selected Financial Ratios

The following table presents information regarding certain of our financial ratios at or for the dates presented:

At or for the Quarter Ended	Return on Average Total Assets (1)		Return on Average Total Stockholders’ Equity (2)		Total Average Stockholders’ Equity to Total Average Assets (3)		Dividend Payout Ratio (4)		Book Value per Share of Common Stock (5)
December 31, 2014	2.44	%	9.91	%	25.78	%	1.00		$	8.12
September 30, 2014	2.41		9.62		26.27		1.00		8.28
June 30, 2014	2.38		9.25		25.69		1.00		8.37
March 31, 2014	2.30		9.10		25.27		1.00		8.20
December 31, 2013	2.37		9.55		24.80		1.00		8.06
September 30, 2013	2.10		8.71		24.12		1.16	(6)	7.85
June 30, 2013	2.10		8.29		25.35		1.16		8.19
March 31, 2013	2.20		8.92		24.63		1.05	(7)	8.84

(1) Reflected annualized net income available to common stock and participating securities divided by average total assets.

(2) Reflected annualized net income divided by average total stockholders’ equity.

(3) Reflected total average stockholders’ equity divided by total average assets.

(4) Reflected dividends declared per share of common stock divided by earnings per share.

(5) Reflected total stockholders’ equity less the preferred stock liquidation preference divided by total shares of common stock outstanding.

(6) Excluded the special common stock dividend declared on August 1, 2013.

(7) Excluded the special common stock dividend declared on March 4, 2013.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our consolidated financial statements include our accounts and all majority owned and controlled subsidiaries.  In addition, we consolidate the special purpose entities (or SPEs) created to facilitate the resecuritization transactions completed in prior years and the acquisition of residential whole loans.  The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements.  In preparing these consolidated financial statements, management has made estimates and judgments of certain amounts included in the consolidated financial statements, giving due consideration to materiality.  Application of these accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties and, as a result, actual results could differ from these estimates.

Our accounting policies are described in Note 2 to the consolidated financial statements, included under Item 8 of this Annual Report on Form 10-K.  Management believes the more significant of these to be as follows:

60

Classifications of Investment Securities and Assessment for Other-Than-Temporary Impairments

Our investments in securities are primarily comprised of Agency MBS and Non-Agency MBS, as discussed and detailed in Notes 2(b) and 3 to the consolidated financial statements, included under Item 8 of this Annual Report on Form 10-K.  All of our MBS are designated as available-for-sale (or AFS) and, accordingly, are carried on our consolidated balance sheets at their fair value with unrealized gains and losses excluded from earnings (except when an OTTI is recognized, as discussed below) and reported in AOCI, a component of Stockholders’ Equity.  We do not intend to hold any of our investment securities for trading purposes; however, if available-for-sale securities were classified as trading securities, there could be substantially greater volatility in our earnings.

When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired.  We assess our impaired securities on at least a quarterly basis and designate such impairments as either “temporary” or “other-than-temporary.”  If we intend to sell an impaired security, or it is more likely than not that we will be required to sell the impaired security before its anticipated recovery, then we must recognize an OTTI through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date.  If we do not expect to sell an other-than-temporarily impaired security, only the portion of the OTTI related to credit losses is recognized through charges to earnings with the remainder recognized through AOCI on the consolidated balance sheets.

In making our assessments about OTTIs, we review and consider certain information relating to our financial position and the impaired securities, including the nature of such securities, the contractual collateral requirements impacting us and our investment and leverage strategies, as well as subjective information, including our current and targeted liquidity position, the credit quality and expected cash flows of the underlying assets collateralizing such securities, and current and anticipated market conditions.  In determining the OTTI related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, we compare the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date.  The determination as to whether an OTTI exists and, if so, the amount of credit impairment recognized in earnings is subjective, as such determinations are based on factual information available at the time of assessment as well as management’s estimates of the future performance and cash flow projections.  As a result, the timing and amount of OTTIs constitute material estimates that may be susceptible to significant change.

During 2015, we recognized credit-related OTTI losses through earnings related to our Non-Agency MBS of $705,000.  At December 31, 2015, we did not intend to sell any MBS that were in an unrealized loss position, and it is “more likely than not” that we will not be required to sell these MBS before recovery of their amortized cost basis, which may be at their maturity.

Gross unrealized losses on our Agency MBS were $40.4 million at December 31, 2015.  Agency MBS are issued by GSEs and enjoy either the implicit or explicit backing of the full faith and credit of the U.S. Government. While our Agency MBS are not rated by any rating agency, they are currently perceived by market participants to be of high credit quality, with risk of default limited to the unlikely event that the U.S. Government would not continue to support the GSEs. Given the credit quality inherent in Agency MBS, we do not consider any of the current impairments on our Agency MBS to be credit related.  In assessing whether it is more likely than not that we will be required to sell any impaired security before its anticipated recovery, which may be at its maturity, we consider for each impaired security, the significance of each investment, the amount of impairment, the projected future performance of such impaired securities, as well as our current and anticipated leverage capacity and liquidity position.  Based on these analyses, we determined that at December 31, 2015 any unrealized losses on our Agency MBS were temporary.

The payments of principal and interest we receive on our Agency MBS, which depend directly upon payments on the mortgages underlying such securities, are guaranteed by Fannie Mae, Freddie Mac and Ginnie Mae.  Fannie Mae and Freddie Mac are GSEs, but their guarantees are not explicitly backed by the full faith and credit of the United States.  Ginnie Mae is part of a U.S. Government agency and its guarantees are explicitly backed by the full faith and credit of the United States.  We believe that the stronger backing for the guarantors of Agency MBS resulting from the conservatorship of Fannie Mae and Freddie Mac has further strengthened their credit worthiness; however, there can be no assurance that these actions will be adequate for their needs.  Accordingly, if these government actions are inadequate and the GSEs suffer losses in the future or cease to exist, our view of the credit worthiness of our Agency MBS could materially change, which may affect our assessment of OTTI for Agency MBS in future periods.  (See Part I, Item 1A., Risk Factors, “The federal conservatorship of Fannie Mae and Freddie Mac and related efforts, along with any changes in laws and regulations affecting the relationship between Fannie Mae and Freddie Mac and the U.S. Government, may materially adversely affect our business.”)

Unrealized losses on our Non-Agency MBS (including Non-Agency MBS transferred to consolidated VIEs) were $28.4 million, of which $19.3 million were RPL/NPL MBS and $9.1 million were Legacy Non-Agency MBS at December 31, 2015.  Based upon the most recent evaluation, we do not consider these unrealized losses to be indicative of OTTI and do not believe

61

that these unrealized losses are credit related, but are rather a reflection of current market yields and/or market place bid-ask spreads.  We have reviewed our Non-Agency MBS that are in an unrealized loss position to identify those securities with losses that are other-than-temporary based on an assessment of changes in expected cash flows for such securities, which considers recent bond performance, where possible, and expected future performance of the underlying collateral.

Our expectations with respect to our securities in an unrealized loss position may change over time, given, among other things, the dynamic nature of markets and other variables.  Future sales or changes in our expectations with respect to securities in an unrealized loss position could result in us recognizing OTTI charges or realizing losses on sales of MBS in the future.  (See Notes 2(b) and 3 to the consolidated financial statements, included under Item 8 of this Annual Report on Form 10-K.)

Fair Value Measurements

A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.  The three levels of valuation hierarchy are defined as follows:

Level 1 — inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2 — inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level 3 — inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The following describes the valuation methodologies used for our financial instruments measured at fair value on a recurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy.

Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral

The fair value of U.S. Treasury securities obtained as collateral and the associated obligation to return securities obtained as collateral are based upon prices obtained from a third-party pricing service, which are indicative of market activity.  Securities obtained as collateral are classified as Level 1 in the fair value hierarchy.

MBS and CRT Securities

We determine the fair value of our Agency MBS, based upon prices obtained from third-party pricing services, which are indicative of market activity and repurchase agreement counterparties.

For Agency MBS, the valuation methodology of our third-party pricing services incorporate commonly used market pricing methods, trading activity observed in the market place and other data inputs.  The methodology also considers the underlying characteristics of each security, which are also observable inputs, including: collateral vintage, coupon, maturity date, loan age, reset date, collateral type, periodic and life cap, geography, and prepayment speeds.  Management analyzes pricing data received from third-party pricing services and compares it to other indications of fair value including data received from repurchase agreement counterparties and its own observations of trading activity observed in the market place.

In determining the fair value of our Non-Agency MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants.  In valuing Non-Agency MBS, we understand that pricing services use observable inputs that include, in addition to trading activity observed in the market place, loan delinquency data, credit enhancement levels and vintage, which are taken into account to assign pricing factors such as spread and prepayment assumptions.  For tranches of Legacy Non-Agency MBS that are cross-collateralized, performance of all collateral groups involved in the tranche are considered.  We collect and consider current market intelligence on all major markets, including benchmark security evaluations and bid-lists from various sources, when available.

Our MBS and CRT securities are valued using various market data points as described above, which management considers directly or indirectly observable parameters.  Accordingly, our MBS and CRT securities are classified as Level 2 in the fair value hierarchy.

62

Residential Whole Loans, at Fair Value

We determine the fair value of our residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. The Company’s residential whole loans held at fair value are classified as Level 3 in the fair value hierarchy.

Swaps

We determine the fair value of our non-centrally cleared Swaps considering valuations obtained from a third-party pricing service. For Swaps that are cleared by a central clearing house, valuations provided by the clearing house are used. All valuations obtained are tested with internally developed models that apply readily observable market parameters.We consider the creditworthiness of both us and our counterparties, along with collateral provisions contained in each derivative agreement, from the perspective of both us and our counterparties.  All of our Swaps are subject either to bilateral collateral arrangements, or for cleared Swaps, to the clearing house’s margin requirements.  Consequently, no credit valuation adjustment was made in determining the fair value of such instruments.  Our Swaps are classified as Level 2 in the fair value hierarchy.

Interest Income on our Non-Agency MBS

Interest income on the Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the security’s effective interest rate which is the security’s IRR.  The IRR is determined using management’s estimate of the projected cash flows for each security, which are based on our observation of current information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the timing and amount of credit losses.  On at least a quarterly basis, we review and, if appropriate, make adjustments to our cash flow projections based on input and analysis received from external sources, internal models, and our judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors.  Changes in cash flows from those originally projected, or from those estimated at the last evaluation, may result in a prospective change in the IRR/interest income recognized on these securities or in the recognition of OTTIs.

Based on the projected cash flows for our Non-Agency MBS purchased at a discount to par value, a portion of the purchase discount may be designated as Credit Reserve, which effectively mitigates our risk of loss on the mortgages collateralizing such MBS and is not expected to be accreted into interest income.  The amount designated as Credit Reserve may be adjusted over time, based on the actual performance of the security, its underlying collateral, actual and projected cash flow from such collateral, economic conditions and other factors.  If the performance of a security with a Credit Reserve is more favorable than forecasted, a portion of the amount designated as Credit Reserve may be reallocated to accretable discount and recognized into interest income over time.  Conversely, if the performance of a security with a Credit Reserve is less favorable than forecasted, the amount designated as Credit Reserve may be increased, or impairment charges and write-downs of such securities to a new cost basis could result.

Residential Whole Loans

Residential whole loans included in our consolidated balance sheets are generally comprised of pools of fixed and adjustable rate residential mortgage loans acquired through consolidated trusts in secondary market transactions at discounted purchase prices. The accounting model utilized by us is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below under “Residential Whole Loans at Carrying Value” is typically utilized by us for loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The accounting model described below under “Residential Whole Loans at Fair Value” is typically utilized by us for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed.

Our residential whole loans pledged as collateral against repurchase agreements are included in the consolidated balance sheets with the fair value of the loans pledged disclosed parenthetically.  Purchases and sales of residential whole loans are recorded on the trade date, with amounts recorded reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing.

63

Residential Whole Loans at Carrying Value

Notwithstanding that majority of these loans are considered to be performing substantially in accordance with their current contractual terms and conditions, we have elected to account for these loans as credit impaired as they were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of the borrowers have previously experienced payment delinquencies and the amount owed on the mortgage loan may exceed the value of the property pledged as collateral. Consequently, we have assessed that these loans have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to credit worthy borrowers. We believe that amounts paid to acquire these loans represent fair market value at the date of acquisition. Such loans are initially recorded at fair value with no allowance for loan losses. Subsequent to acquisition, the recorded amount reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on our consolidated balance sheets at carrying value, which reflects the recorded amount reduced by any allowance for loan losses established subsequent to acquisition.

Under the application of this accounting model we may aggregate into pools loans acquired in the same fiscal quarter that are assessed as having similar risk characteristics. For each pool established, or on an individual loans basis for loans not aggregated into pools, we estimate at acquisition and periodically on at least a quarterly basis, the principal and interest cash flows expected to be collected. The difference between the cash flows expected to be collected and the carrying amount of the loans is referred to as the “accretable yield.” This amount is accreted as interest income over the life of the loans using an effective interest rate (level yield) methodology. Interest income recorded each period reflects the amount of accretable yield recognized and not the coupon interest payments received on the underlying loans. The difference between contractually required principal and interest payments and the cash flows expected to be collected, referred to as the “non-accretable difference,” and includes estimates of both the effect of prepayments and expected credit losses over the life of the underlying loans.

A decrease in expected cash flows in subsequent periods may indicate impairment at the pool and/or individual loan level thus requiring the establishment of an allowance for loan losses by a charge to the provision for loan losses. The allowance for loan losses represents the present value of cash flows expected at acquisition, adjusted for any increases due to changes in estimated cash flows that are subsequently no longer expected to be received at the relevant measurement date. A significant increase in expected cash flows in subsequent periods first reduces any previously recognized allowance for loan losses and then will result in a recalculation in the amount of accretable yield. The adjustment of accretable yield due to a significant increase in expected cash flows is accounted for prospectively as a change in estimate and results in reclassification from non-accretable difference to accretable yield.

Residential Whole Loans at Fair Value

Certain of our residential whole loans are presented at fair value on our consolidated balance sheets as a result of a fair value election made at time of acquisition. Given the significant uncertainty associated with estimating the timing of and amount of cash flows associated with these loans that will be collected, and that the cash flows ultimately collected may be dependent on the value of the property securing the loan, we consider that accounting for these loans at fair value should result in a better reflection over time of the economic returns from these loans. We determine the fair value of our residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on our consolidated statements of operations.

Cash received reflecting coupon payments on residential whole loans held at fair value is not included in Interest Income, but rather is presented in Net gain on residential whole loans held at fair value on our consolidated statements of operations.

Hedging Activities

We may use a variety of derivative instruments to economically hedge a portion of our exposure to market risks, including interest rate risk and prepayment risk. The objective of our risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, we attempt to mitigate the risk of the cost of our variable rate liabilities increasing during a period of rising interest rates. Our derivative instruments are currently comprised of Swaps, which are designated as cash flow hedges against the interest rate risk associated with certain of our borrowings. Prior to 2015, our derivative financial instruments also included Linked Transactions, which were not designated as hedging instruments. New accounting guidance that was effective for us on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. During 2013, we also entered into TBA short positions which were not designated as hedging instruments.

64

Our Swaps designated as hedging transactions have the effect of modifying the repricing characteristics of our repurchase agreements and cash flows for such liabilities.  Under each Swap, we agree to pay a fixed rate of interest and receive a variable interest rate, generally based on one-month or three-month LIBOR, on the notional amount of the Swap.  We document our risk-management policies, including objectives and strategies, as they relate to our hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions.  We assess, both at inception of a hedge and on a quarterly basis thereafter, whether or not the hedge relationship is “highly effective.”

We discontinue hedge accounting on a prospective basis and recognize changes in the fair value of the derivative through earnings when:  (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate.

Swaps are carried on our consolidated balance sheets at fair value, as assets, if their fair value is positive, or as liabilities, if their fair value is negative.  Changes in the fair value of our Swaps designated in hedging transactions are recorded in OCI provided that the hedge remains effective.  Changes in fair value for any ineffective amount of a Swap are recognized in earnings.  We have not recognized any change in the value of our existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness.

During 2013, we entered into TBA short positions as a means of managing interest rate risk and MBS basis risk associated with our investment and financing activities. A TBA short position is a forward contract for sale of Agency MBS at a predetermined price, face amount, issuer, coupon and stated maturity on an agreed-upon future date. The specific Agency MBS that could be delivered into the contract upon the settlement date, published each month by the Securities Industry and Financial Markets Association (or SIFMA), are not known at the time of the transaction.

TBA short positions were accounted for as derivative instruments since we could not assert that it was probable at inception and throughout the term of the TBA contract that we would physically deliver the Agency security upon settlement of the contract. TBA short positions were presented as either derivative assets or liabilities, at fair value on our consolidated balance sheets. Gains and losses associated with TBA short positions were reported in Other income, net on our consolidated statements of operations.

Although permitted under certain circumstances, we do not offset cash collateral receivables or payables against our net derivative positions.

Income Taxes

We believe that we operate in, and intend to continue to operate in, a manner that allows and will continue to allow us to be taxed as a REIT.  Provided that we distribute all of our REIT taxable income (including net long-term capital gains) to stockholders in the timeframe permitted by the Code, we do not generally expect to pay corporate level taxes and/or excise taxes.  However, such taxes may arise from time to time in the normal course of our business.  Many of the REIT requirements, however, are highly technical and complex.  In addition, REIT taxable income calculated at the time our financial statements are prepared is based on certain estimates that may be revised as our tax return, which is not required to be filed until September in the following year, is completed.  If we were to fail to meet certain of the REIT requirements, we would be subject to U.S. federal, state and local income taxes.

In addition, we have elected to treat certain of our subsidiaries as a TRS. In general, a TRS may hold assets and engage in activities that we cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of our business may be conducted through one or more TRS, our income earned by TRS may be subject to corporate income taxation. To maintain our REIT election, no more than 25% (or, for 2018 and subsequent taxable years, 20%) of the value of a REIT’s assets at the end of each quarter may consist of stock or securities in a TRS. For purposes of the determination of U. S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as a TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. No deferred tax benefit was recorded by the Company in 2015 or 2014, as a valuation allowance for the full amount of the associated deferred tax asset was recognized as its recovery is not considered more likely than not.

65

Accounting for Stock-Based Compensation

We expense our equity-based compensation awards that are subject to vesting conditions, ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date.  Compensation expense for equity-based awards is recorded net of estimated forfeitures expected to occur over the vesting period. (See Notes 2(l) and 15 to the consolidated financial statements, included under Item 8 of this Annual Report on Form 10-K.)

During 2010, we granted certain RSUs that vested after either two or four years of service and provided that certain criteria were met, which were based on a formula that included changes in our closing stock price over a two- or four-year period and dividends declared on our common stock during those periods. From 2011 through 2013, we granted certain RSUs that vested annually over a one or three-year period, provided that certain criteria were met, which were based on a formula tied to our achievement of average total stockholder return during that three-year period.  During 2014 and 2015, we made grants of RSUs certain of which cliff vest after a three-year period and certain of which cliff vest after a three-year period, subject to the achievement of certain performance criteria, based on a formula tied to our achievement of average total stockholder return during that three-year period. The features in these awards related to the attainment of total stockholder return over a specified period constitute a “market condition” which impacts the amount of compensation expense recognized for these awards. Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which in addition to estimates regarding the amount of RSUs expected to be forfeited during the associated service period, determined the amount of compensation expense recognized.  The amount of compensation expense recognized was not dependent on whether the market condition was or will be achieved, while differences in actual forfeiture experience relative to estimated forfeitures results in adjustments to the timing and amount of compensation expense recognized.

We have awarded dividend equivalents that may be granted as a separate instrument or may be a right associated with the grant of another equity-based award.  Compensation expense for separately awarded dividend equivalents is based on the grant date fair value of such awards and is recognized over the vesting period.  Payments pursuant to these dividend equivalents are charged to Stockholders’ Equity.  Payments pursuant to dividend equivalents that are attached to equity-based awards are charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest.  Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards do not or are not expected to vest and grantees are not required to return payments of dividends or dividend equivalents to the Company.  

RECENT ACCOUNTING STANDARDS TO BE ADOPTED IN FUTURE PERIODS

Financial Instruments - Overall - Recognition and Measurement of Financial Assets and Financial Liabilities

In January 2016, the FASB issued Accounting Standards Update (or ASU) 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (or ASU 2016-01).The amendments in this ASU affect all entities that hold financial assets or owe financial liabilities, and address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments.  The classification and measurement guidance of investments in debt securities and loans are not affected by the amendments in this ASU. ASU 2016-01 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017.  Early adoption is not permitted for public business entities, except for a provision related to financial statements of fiscal years or interim periods that have not yet been issued, to recognize in other comprehensive income, the change in fair value of a liability resulting from a change in the instrument-specific credit risk measured using the fair value option. Entities should apply the amendments in this ASU by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. We are currently evaluating the effect that ASU 2016-01 will have on our consolidated financial statements and related disclosures.

Interest - Imputation of Interest - Simplifying the Presentation of Debt Issuance Costs

In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs (or ASU 2015-03).  The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with the presentation of debt issued at a discount. The recognition and measurement guidance of debt issuance costs are not affected by the amendments in this ASU. ASU 2015-03 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted for financial statements that have not previously been issued and entities should apply the new guidance on a retrospective basis. We do not expect adoption of ASU 2015-03 to have a significant impact on our financial position or financial statement disclosures.

66

Consolidation - Amendments to the Consolidation Analysis

In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis (or ASU 2015-02).  The amendments in this ASU change the way reporting enterprises evaluate whether (a) they should consolidate limited partnerships and similar entities, (b) fees paid to a decision maker or service provider are variable interests in a VIE, and (c) variable interests in a VIE held by related parties of the reporting enterprise require the reporting enterprise to consolidate the VIE. It also eliminates the VIE consolidation model based on majority exposure to variability that applied to certain investment companies and similar entities. ASU 2015-02 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015.  At the effective date, all previous consolidation analyses that the guidance affects must be reconsidered. Early adoption is permitted, including adoption in an interim period. If an entity adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. A reporting entity may apply the amendments in this ASU using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. A reporting entity also may apply the amendments retrospectively. We are currently evaluating the effect that ASU 2015-02 will have on our consolidated financial statements and related disclosures.  While we have not yet selected a transition method, we do not expect adoption of ASU 2015-2 to have a significant impact on our financial position.

Revenue from Contracts with Customers

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (or ASU 2014-09).  The ASU requires an entity to recognize revenue in an amount that reflects the consideration to which it expects to be entitled for the transfer of promised goods or services to customers.  ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. ASU 2014-09 originally would have been effective for public business entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2016.  Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. On April 29, 2015, the FASB proposed a one-year deferral of the effective date for ASU 2014-09. On July 9, 2015 the FASB affirmed its proposal to defer the effective date of the new revenue standard for all entities by one year. As a result, public entities would apply the new revenue standard to annual reporting periods beginning after December 15, 2017 and interim periods therein. The FASB would also permit entities to adopt the standard early, but not before the original public entity effective date. We are currently evaluating the effect that ASU 2014-09 will have on our consolidated financial statements and related disclosures.  We have not yet selected a transition method nor have we determined the effect of the standard on our ongoing financial reporting.

Presentation of Financial Statements - Going Concern

In August 2014, the FASB issued ASU 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (or ASU 2014-15). The amendments in this ASU provide guidance in GAAP about management’s responsibility to evaluate whether there is a substantial doubt about an entity’s going concern and to provide related footnote disclosures. In connection with preparing financial statements for each annual and interim reporting period, an entity’s management should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable). The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We do not expect adoption of ASU 2014-15 to have a significant impact on our financial position or financial statement disclosures.

LIQUIDITY AND CAPITAL RESOURCES

Our principal sources of cash generally consist of borrowings under repurchase agreements and other collateralized financings, payments of principal and interest we receive on our MBS portfolio, cash generated from our operating results and, to the extent such transactions are entered into, proceeds from capital market and structured financing transactions.  Our most significant uses of cash are generally to pay principal and interest on our financing transactions, to purchase MBS and residential whole loans, to make dividend payments on our capital stock, to fund our operations and to make other investments that we consider appropriate.

We seek to employ a diverse capital raising strategy under which we may issue capital stock and other types of securities.  To the extent we raise additional funds through capital market transactions, we currently anticipate using the net proceeds from such transactions to acquire additional MBS and residential whole loans, consistent with our investment policy, and for working capital, which may include, among other things, the repayment of our financing transactions.  There can be no assurance, however, that we will be able to access the capital markets at any particular time or on any particular terms.  We have available for issuance

67

an unlimited amount (subject to the terms and limitations of our charter) of common stock, preferred stock, depositary shares representing preferred stock, warrants, debt securities, rights and/or units pursuant to our automatic shelf registration statement and, at December 31, 2015, we had 6.8 million shares of common stock available for issuance pursuant to our DRSPP shelf registration statement.  During 2015, we issued 162,373 shares of common stock through our DRSPP, raising net proceeds of approximately $1.2 million.

On April 15, 2013, we completed the issuance of 8.0 million shares of our Series B Preferred Stock with a par value of $0.01 per share and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The aggregate net proceeds to us from the offering of the Series B Preferred Stock were approximately $193.3 million, after deducting the underwriting discount and related offering expenses. We used a portion of the net proceeds to redeem all of our outstanding Series A Preferred Stock (as discussed below), and used the remaining net proceeds of the offering for general corporate purposes, including, without limitation, to acquire additional MBS consistent with our investment policy, and for working capital, which included, among other things, the repayment of our repurchase agreements.

On May 16, 2013, we redeemed all 3,840,000 outstanding shares of our Series A Preferred Stock at an aggregate redemption price of approximately $97.0 million, or $25.27153 per share, including all accrued and unpaid dividends to the Redemption Date. The redemption value of the Series A Preferred Stock exceeded its carrying value by $3.9 million, which represents the original offering costs for the Series A Preferred Stock.

Our borrowings under repurchase agreements are uncommitted and renewable at the discretion of our lenders and, as such, our lenders could determine to reduce or terminate our access to future borrowings at virtually any time.  The terms of the repurchase transaction borrowings under our master repurchase agreements, as such terms relate to repayment, margin requirements and the segregation of all securities that are the subject of repurchase transactions, generally conform to the terms contained in the standard master repurchase agreement published by SIFMA or the global master repurchase agreement published by SIFMA and the International Capital Market Association.  In addition, each lender typically requires that we include supplemental terms and conditions to the standard master repurchase agreement.  Typical supplemental terms and conditions, which differ by lender, may include changes to the margin maintenance requirements, required haircuts (as defined below), purchase price maintenance requirements, requirements that all controversies related to the repurchase agreement be litigated in a particular jurisdiction and cross default and setoff provisions.

With respect to margin maintenance requirements for repurchase agreements with Non-Agency MBS as collateral, margin calls are typically determined by our counterparties based on their assessment of changes in the fair value of the underlying collateral and in accordance with the agreed upon haircuts specified in the transaction confirmation with the counterparty.  We address margin call requests in accordance with the required terms specified in the applicable repurchase agreement and such requests are typically satisfied by posting additional cash or collateral on the same business day.  We review margin calls made by counterparties and assess them for reasonableness by comparing the counterparty valuation against our valuation determination.  When we believe that a margin call is unnecessary because our assessment of collateral value differs from the counterparty valuation, we typically hold discussions with the counterparty and are able to resolve the matter.  In the unlikely event that resolution cannot be reached, we will look to resolve the dispute based on the remedies available to us under the terms of the repurchase agreement, which in some instances may include the engagement of a third party to review collateral valuations.   For other agreements that do not include such provisions, we could resolve the matter by substituting collateral as permitted in accordance with the agreement or otherwise request the counterparty to return the collateral in exchange for cash to unwind the financing.

68

The following table presents information regarding the margin requirements, or the percentage amount by which the collateral value is contractually required to exceed the loan amount (this difference is referred to as the “haircut”), on our repurchase agreements at December 31, 2015 and December 31, 2014:

At December 31, 2015	Weighted Average Haircut		Low		High
Repurchase agreement borrowings secured by:
Agency MBS	4.67	%	3.00	%	6.00	%
Legacy Non-Agency MBS	25.42		10.00		63.50
RPL/NPL MBS	21.37		20.00		30.00
U.S. Treasury securities	1.60		1.00		2.00
CRT securities	25.04		20.00		30.00
Residential whole loans	27.69		25.00		36.00
At December 31, 2014	Weighted Average Haircut		Low		High
Repurchase agreement borrowings secured by:
Agency MBS	4.79	%	3.00	%	6.00	%
Legacy Non-Agency MBS	28.88		10.00		60.00
RPL/NPL MBS	20.00		20.00		20.00
U.S. Treasury securities	1.62		1.00		2.00
CRT securities	25.00		25.00		25.00
Residential whole loans	33.43		30.00		35.00

The weighted average haircut requirements for the respective underlying collateral types for our repurchase agreements have not significantly changed since December 31, 2014, with the exception of Residential whole loans and Legacy Non-Agency MBS. During 2015, the Company has increased the number of counterparties providing repurchase agreement financing for residential whole loans resulting in a lower overall weighted average haircut. The decrease in the weighted average haircut for Legacy Non-Agency MBS results from the unwind during 2015 of certain re-securitization transactions and subsequent refinancing of the underlying MBS at lower haircut levels.

During 2015, the financial market environment was impacted by continued accommodative monetary policy.  Repurchase agreement funding for both Agency MBS and Non-Agency MBS has been available to us at generally attractive market terms from multiple counterparties.  Typically, due to the credit risk inherent to Non-Agency MBS, repurchase agreement funding involving Non-Agency MBS is available from fewer counterparties, at terms requiring higher collateralization and higher interest rates, than repurchase agreement funding secured by Agency MBS and U.S. Treasury securities.  Therefore, we generally expect to be able to finance our acquisitions of Agency MBS on more favorable terms than financing for Non-Agency MBS.

In July 2015, our wholly-owned subsidiary, MFA Insurance became a member of the FHLB. As a member of the FHLB, MFA Insurance had access to a variety of products and services offered by the FHLB, including secured advances (subject to our continued creditworthiness, pledging of sufficient eligible collateral to secure advances, and compliance with certain agreements with the FHLB). The weighted average haircut on our FHLB advances at December 31, 2015 was 7.00%. However, in January, 2016, the FHFA amended its regulation on FHLB membership, which, among other things, provided termination rules for current captive insurance members. As a result, MFA Insurance will not be permitted new advances or renewal of existing advances and will be required to terminate its FHLB membership and repay any outstanding advances by no later than February 19, 2017. As of December 31, 2015 and February 16, 2016, MFA Insurance had approximately $1.500 billion and $1.200 billion, respectively, in outstanding advances (backed by Agency MBS).

We maintain cash and cash equivalents, unpledged Agency and Non-Agency MBS and collateral in excess of margin requirements held by our counterparties (or collectively, “cash and other unpledged collateral”) to meet routine margin calls and protect against unforeseen reductions in our borrowing capabilities.  Our ability to meet future margin calls will be impacted by our ability to use cash or obtain financing from unpledged collateral, which can vary based on the market value of such collateral, our cash position and margin requirements.  Our cash position fluctuates based on the timing of our operating, investing and

69

financing activities and is managed based on our anticipated cash needs.  (See “Interest Rate Risk” included under Item 7A. of this Annual Report on Form 10-K and our Consolidated Statements of Cash Flows, included under Item 8 of this Annual Report on Form 10-K.)

At December 31, 2015, we had a total of $11.339 billion of MBS, U.S. Treasury securities, CRT securities and residential whole loans and $71.5 million of restricted cash pledged against our repurchase agreements and Swaps.  In addition, at December 31, 2015, we had $1.612 billion of Agency MBS pledged against our FHLB advances. At December 31, 2015 we have access to various sources of liquidity which we estimate exceeds $571.0 million. This includes (i) $165.0 million of cash and cash equivalents; (ii) $241.7 million in estimated financing available from unpledged Agency MBS and other Agency MBS collateral that is currently pledged in excess of contractual requirements; and (iii) $164.3 million in estimated financing available from unpledged Non-Agency MBS. 

The table below presents certain information about our borrowings under repurchase agreements and other advances, and securitized debt:

	Repurchase Agreements and Other Advances												Securitized Debt
Quarter Ended (1)	Quarterly Average  Balance				End of Period Balance				Maximum Balance at Any  Month-End				Quarterly Average  Balance		End of Period Balance		Maximum Balance at Any  Month-End
(In Thousands)
December 31, 2015	$	9,428,224			$	9,388,902			$	9,413,189			$	28,252	$	22,057	$	27,927
September 30, 2015	9,422,882				9,475,834				9,475,834				51,021		32,217		50,269
June 30, 2015	9,720,193				9,635,036				9,746,825				80,754		62,320		80,744
March 31, 2015	9,820,548		(2	)	9,809,586		(2	)	9,863,779		(2	)	103,688		91,280		104,299
December 31, 2014	8,190,491				8,267,388				8,271,123				137,503		110,574		138,026
September 30, 2014	8,267,905				8,125,723				8,272,039				190,753		156,276		190,423
June 30, 2014	8,464,135				8,384,101				8,501,978				264,806		214,048		267,740
March 31, 2014	8,412,045				8,606,129				8,606,129				336,893		292,526		338,965
December 31, 2013	8,462,138				8,339,297				8,504,593				399,762		366,205		398,384
September 30, 2013	8,679,410				8,568,171				8,721,573				440,665		419,693		462,207
June 30, 2013	8,842,018				8,909,283				8,909,283				505,409		443,748		508,893
March 31, 2013	8,873,852				8,902,827				8,956,951				606,858		542,014		609,707

(1)  The information presented in the table above excludes Senior Notes issued in April 2012.  The outstanding balance of Senior Notes has been unchanged at $100.0 million since issuance.

(2)  The increase from December 31, 2014 reflects the reclassification of $1.520 billion of repurchase agreements previously presented as components of Linked Transactions. New accounting guidance that was effective on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting and as a result we did not have any Linked Transactions effective January 1, 2015.

Cash Flows and Liquidity For the Year Ended December 31, 2015

Our cash and cash equivalents decreased by $17.4 million during the year ended December 31, 2015, reflecting: $849.7 million used by our financing activities; $550.1 million provided by our investing activities, primarily from payments on our MBS; and $282.2 million provided by our operating activities.

At December 31, 2015, our debt-to-equity multiple was 3.4 times compared to 2.8 times at December 31, 2014.  After adjusting the reported debt-to-equity ratio at December 31, 2014 to reflect new accounting standards that became effective January 1, 2015, which eliminated Linked Transaction accounting and resulted in the reclassification of $1.520 billion of liabilities relating to repurchase agreements that had been previously reported as a component of Linked Transactions, the debt to equity ratio at December 31, 2014 would have been 3.3 times. At December 31, 2015, we had borrowings under repurchase agreements of $7.889 billion with 27 counterparties, of which $2.728 billion was secured by Agency MBS, $1.960 billion was secured by Legacy Non-Agency MBS, $2.080 billion was secured by RPL/NPL MBS, $504.8 million was secured by U.S. Treasuries, $128.5 million was secured by CRT securities and $487.8 million were secured by residential whole loans.  We continue to have available capacity under our repurchase agreement credit lines.  At December 31, 2014, we had borrowings under repurchase agreements of $8.267

70

billion with 25 counterparties of which $5.178 billion was secured by Agency MBS, $2.233 billion was secured by Legacy Non-Agency MBS, $130.9 million was secured by RPL/NPL MBS, $507.1 million was secured by U.S. Treasuries, $76.0 million was secured by CRT securities and $142.3 million were secured by residential whole loans.

As of December 31, 2015 and February 16, 2016, we had approximately $1.500 billion and $1.200 billion, respectively, in outstanding secured FHLB advances, which had a weighted average term to maturity of 4.79 years. As a result of the previously mentioned final FHFA rule released in January, 2016, MFA Insurance will be required to terminate its FHLB membership and repay the outstanding advances within one year of the rule’s effective date of February 19, 2016.

At December 31, 2015, outstanding securitized debt was $22.1 million, which had a weighted average expected remaining term of 0.35 years. During the year ended December 31, 2015, securitized debt was reduced by principal payments of $88.3 million.

During 2015, we received $550.1 million through our investing activities.  We received cash of $2.917 billion from prepayments and scheduled amortization on our MBS, of which $1.857 billion was from Non-Agency MBS and $1.060 billion was attributable to Agency MBS.  We purchased $1.734 billion of Non-Agency MBS and $76.3 million of CRT securities funded with cash and repurchase agreement borrowings.  While we generally intend to hold our MBS as long-term investments, we may sell certain of our securities in order to manage our interest rate risk and liquidity needs, meet other operating objectives and adapt to market conditions.  In addition, during 2015 we sold certain of our Non-Agency MBS for $70.7 million, realizing gross gains of $34.9 million.

In connection with our repurchase agreement borrowings and Swaps, we routinely receive margin calls/reverse margin calls from our counterparties and make margin calls to our counterparties.  Margin calls and reverse margin calls, which requirements vary over time, may occur daily between us and any of our counterparties when the value of collateral pledged changes from the amount contractually required.  The value of securities pledged as collateral fluctuates reflecting changes in:  (i) the face (or par) value of our for MBS;  (ii) market interest rates and/or other market conditions; and (iii) the market value of our Swaps.  Margin calls/reverse margin calls are satisfied when we pledge/receive additional collateral in the form of additional securities and/or cash.

The table below summarizes our margin activity with respect to our repurchase agreement financings and derivative hedging instruments for the quarterly periods presented:

	Collateral Pledged to Meet Margin Calls						Cash and Securities Received For Reverse  Margin Calls		Net Assets Received/(Pledged) For Margin Activity
For the Quarter Ended	Fair Value of Securities Pledged		Cash Pledged		Aggregate Assets Pledged For Margin Calls
(In Thousands)
December 31, 2015	$	225,323	$	32,200	$	257,523	$	276,596	$	19,073
September 30, 2015	397,763		86,300		484,063		433,003		(51,060		)
June 30, 2015	391,088		50,700		441,788		408,968		(32,820		)
March 31, 2015	309,114		98,000		407,114		350,036		(57,078		)

We are subject to various financial covenants under our repurchase agreements and derivative contracts, which include minimum net worth and/or profitability requirements, maximum debt-to-equity ratios and minimum market capitalization requirements.  We have maintained compliance with all of our financial covenants through December 31, 2015.

During 2015, we paid $297.4 million for cash dividends on our common stock and dividend equivalents and paid cash dividends of $15.0 million on our preferred stock.  On December 9, 2015, we declared our fourth quarter 2015 dividend on our common stock of $0.20 per share; on January 29, 2016, we paid this dividend, which totaled $74.4 million, including dividend equivalents of approximately $263,000.

We believe that we have adequate financial resources to meet our current obligations, including margin calls, as they come due, to fund dividends we declare and to actively pursue our investment strategies.  However, should the value of our MBS suddenly decrease, significant margin calls on our repurchase agreement borrowings could result and our liquidity position could be materially and adversely affected.  Further, should market liquidity tighten, our repurchase agreement counterparties may increase our margin requirements on new financings, reducing our ability to use leverage.  Access to financing may also be negatively impacted by the ongoing volatility in the world financial markets, potentially adversely impacting our current or potential lenders’ ability or

71

willingness to provide us with financing.  In addition, there is no assurance that favorable market conditions will continue to permit us to consummate additional securitization transactions if we determine to seek that form of financing.

OFF-BALANCE SHEET ARRANGEMENTS

We do not have any material off-balance-sheet arrangements. 

AGGREGATE CONTRACTUAL OBLIGATIONS

The following table summarizes the effect on our liquidity and cash flows of contractual obligations for the principal and interest amounts due at December 31, 2015:

	Due During the Year Ending December 31,
(In Thousands)	2016		2017		2018		2019		2020		Thereafter		Total
Repurchase agreements	$	7,694,793	$	194,109	$	—	$	—	$	—	$	—	$	7,888,902
Interest expense on repurchase agreements (1)	30,552		10,574		—		—		—		—		41,126
FHLB advances (2)	—		1,500,000		—		—		—		—		1,500,000
Interest expense on FHLB advances (1)(2)	7,501		1,025		—		—		—		—		8,526
Securitized debt (3)	6,219		7,259		7,362		1,217		—		—		22,057
Interest expense on securitized debt (1)	551		356		148		5		—		—		1,060
Senior Notes (4)	—		—		—		—		—		100,000		100,000
Interest expense on Senior Notes (1)	8,000		8,000		8,000		8,000		8,000		171,911		211,911
Long-term lease obligations	2,552		2,522		2,522		2,522		1,050		—		11,168
Total	$	7,750,168	$	1,723,845	$	18,032	$	11,744	$	9,050	$	271,911	$	9,784,750

(1)  Interest expense based on the interest rate in effect at December 31, 2015.

(2)  As a result of the previously mentioned final FHFA rule adopted in January, 2016, MFA Insurance’s FHLB membership will terminate one year from the rules effective date of February 19, 2016, requiring any outstanding advances and associated interest to be repaid by February 19, 2017. As a result, the contractual obligations in the table above are reflected as due during the year ended December 31, 2017.

(3)  Securitized debt is contractually scheduled to mature by November 2022.  However, the weighted average life of the securitized debt is estimated to be 0.35 years assuming a 12.0% weighted average CPR.

(4)  Senior Notes mature April 2042 but may be redeemed, in whole or in part, at any time on or after April 15, 2017.

INFLATION

Substantially all of our assets and liabilities are financial in nature.  As a result, changes in interest rates and other factors impact our performance far more than does inflation.  Our financial statements are prepared in accordance with GAAP and dividends declared are based upon net ordinary income as calculated for tax purposes.  In each case, our results of operations and reported assets, liabilities and equity are measured with reference to historical cost or fair value without considering inflation.

72

CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS

This Annual Report on Form 10-K includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties.  The forward-looking statements contain words such as “will,” “believe,” “expect,” “anticipate,” “estimate,” “plan,” “continue,” “intend,” “should,” “could,” “would,” “may” or similar expressions.

These forward-looking statements include information about possible or assumed future results with respect to our business, financial condition, liquidity, results of operations, plans and objectives.  Statements regarding the following subjects, among others, may be forward-looking: changes in interest rates and the market value of our MBS; changes in the prepayment rates on the mortgage loans securing our MBS, an increase of which could result in a reduction of the yield on MBS in our portfolio and an increase of which could require us to reinvest the proceeds received by us as a result of such prepayments in MBS with lower coupons; credit risks underlying our assets, including changes in the default rates and management’s assumptions regarding default rates on the mortgage loans securing our Non-Agency MBS and as related to our residential whole loan portfolio; our ability to borrow to finance our assets and the terms, including the cost, maturity and other terms, of any such borrowings; implementation of or changes in government regulations or programs affecting our business; our estimates regarding taxable income the actual amount of which is dependent on a number of factors, including, but not limited to, changes in the amount of interest income and financing costs, the method elected by us to accrete the market discount on Non-Agency MBS and the extent of prepayments, realized losses and changes in the composition of our Agency MBS and Non-Agency MBS portfolios that may occur during the applicable tax period, including gain or loss on any MBS disposals; the timing and amount of distributions to stockholders, which are declared and paid at the discretion of our Board of Directors and will depend on, among other things, our taxable income, our financial results and overall financial condition and liquidity, maintenance of our REIT qualification and such other factors as the Board deems relevant; our ability to maintain our qualification as a REIT for federal income tax purposes; our ability to maintain our exemption from registration under the Investment Company Act, including statements regarding the concept release issued by the SEC relating to interpretive issues under the Investment Company Act with respect to the status under the Investment Company Act of certain companies that are in engaged in the business of acquiring mortgages and mortgage-related interests; our ability to successfully implement our strategy to grow our residential whole loan portfolio; expected returns on our investments in non-performing residential whole loans (or NPLs), which are affected by, among other things, the length of time required to foreclose upon, sell, liquidate or otherwise reach a resolution of the property underlying the NPL, home price values, amounts advanced to carry the asset (e.g., taxes, insurance, maintenance expenses, etc. on the underlying property) and the amount ultimately realized upon resolution of the asset; and risks associated with investing in real estate assets, including changes in business conditions and the general economy.  These and other risks, uncertainties and factors, including those described in the annual, quarterly and current reports that we file with the SEC, could cause our actual results to differ materially from those projected in any forward-looking statements we make.  All forward-looking statements are based on beliefs, assumptions and expectations of our future performance, taking into account all information currently available.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made.  New risks and uncertainties arise over time and it is not possible to predict those events or how they may affect us.  Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.  (See Part I, Item 1A. “Risk Factors” of this Annual Report on Form 10-K)

73

Item 7A.  Quantitative and Qualitative Disclosures About Market Risk.

We seek to manage our risks related to interest rates, liquidity, prepayment speeds, market value and the credit quality of our assets while, at the same time, seeking to provide an opportunity to stockholders to realize attractive total returns through ownership of our capital stock.  While we do not seek to avoid risk, we seek, consistent with our investment policies, to:  assume risk that can be quantified based on management’s judgment and experience and actively manage such risk; earn sufficient returns to justify the taking of such risks; and maintain capital levels consistent with the risks that we undertake.

INTEREST RATE RISK

We generally acquire interest-rate sensitive assets and fund them with interest-rate sensitive liabilities, a portion of which are hedged with Swaps. We are exposed to interest rate risk on our residential mortgage assets, as well as on our liabilities (repurchase agreements, FHLB advances and securitized debt). Changes in interest rates can affect our net interest income and the fair value of our assets and liabilities.

We finance the majority of our investments in Agency, Legacy Non-Agency and RPL/NPL MBS with short-term repurchase agreements. In general, when interest rates change, the borrowing costs of our repurchase agreements (net of the impact of Swaps) change more quickly than the yields on our assets. In a rising interest rate environment the borrowing costs of our repurchase agreements may increase faster than the interest income on our assets, thereby reducing our net income. In order to mitigate compression in net income based on such interest rate movements, we use Swaps and other hedging instruments to lock in a portion of the net interest spread between assets and liabilities.

When interest rates change, the fair value of our residential mortgage assets could change at a different rate than the fair value of our liabilities. We measure the sensitivity of our portfolio to changes in interest rates by estimating the duration of our assets and liabilities. Duration is the approximate percentage change in fair value for a 100 basis point parallel shift in the yield curve. In general, our assets have higher duration than our liabilities and in order to reduce this exposure we use Swaps and other hedging instruments to reduce the gap in duration between our assets and liabilities.

In calculating the duration of our Agency MBS we take into account the characteristics of the underlying mortgage loans including whether the underlying loans are fixed rate, adjustable or hybrid; coupon, expected prepayment rates and lifetime and periodic caps. We use third-party financial models, combined with management’s assumptions and observed empirical data when estimating the duration of our Agency MBS.

In analyzing the interest rate sensitivity of our Legacy Non-Agency MBS we take into account the characteristics of the underlying mortgage loans, including credit quality and whether the underlying loans are fixed-rate, adjustable or hybrid. We estimate the duration of our Legacy Non-Agency MBS using management’s assumptions.

Our RPL/NPL MBS deal structures contain an interest rate step-up feature whereby the original coupon increases by 300 basis points if the bond is not redeemed by the issuer after 36 months. Therefore, we believe their fair value exhibits little sensitivity to changes in interest rates. We estimate the duration of our RPL/NPL MBS using management’s assumptions.

The fair value of our re-performing residential whole loans is dependent on the value of the underlying real estate collateral, past and expected delinquency status of the borrower as well as the level of interest rates. Because the borrower is not delinquent on their mortgage payments but is less likely to prepay the loan due to weak credit history and/or high LTV, we believe our re-performing residential whole loans exhibit positive duration. We estimate the duration of our re-performing residential whole loans using management’s assumptions.

The fair value of our non-performing residential whole loans is primarily dependent on the value of the underlying real estate collateral and the time until collateral liquidation. Since neither the value of the collateral nor the liquidation timeline is generally sensitive to interest rates, we believe their fair value exhibits little sensitivity to interest rates. We estimate the duration of our non-performing residential whole loans using management’s assumptions.

We use Swaps as part of our overall interest rate risk management strategy. Such derivative financial instruments are intended to act as a hedge against future interest rate increases on our repurchase agreement financings, which rates are typically highly correlated with LIBOR. While our derivatives do not extend the maturities of our borrowings under repurchase agreements, they do, in effect, lock in a fixed rate of interest over their term for a corresponding amount of our repurchase agreement financing that are hedged.

74

At December 31, 2015, MFA’s $8.546 billion of Agency MBS and Legacy Non-Agency MBS were backed by Hybrid, adjustable and fixed-rate mortgages.  Additional information about these MBS, including average months to reset and three-month average CPR, is presented below:

	Agency MBS					Legacy Non-Agency MBS (1)					Total (1)
	Fair Value (2)		Average Months to Reset (3)	3 Month Average CPR (4)		Fair Value		Average Months to Reset (3)	3 Month Average CPR (4)		Fair Value (2)		Average Months to Reset (3)	3 Month Average CPR (4)
Time to Reset
(Dollars in Thousands)
< 2 years (5)	$	1,977,308	6	12.7	%	$	2,580,658	6	13.7	%	$	4,557,966	6	13.4	%
2-5 years	772,627		36	15.7		—		—	—		772,627		36	15.7
> 5 years	220,532		75	11.7		—		—	—		220,532		75	11.7
ARM-MBS Total	$	2,970,467	19	13.4	%	$	2,580,658	6	13.7	%	$	5,551,125	13	13.6	%
15-year fixed (6)	$	1,780,746		9.1	%	$	7,728		4.3	%	$	1,788,474		9.0	%
30-year fixed (6)	—			—		1,199,794			16.4		1,199,794			16.4
40-year fixed (6)	—			—		6,771			14.1		6,771			14.1
Fixed-Rate Total	$	1,780,746		9.1	%	$	1,214,293		16.4	%	$	2,995,039		12.3	%
MBS Total	$	4,751,213		11.8	%	$	3,794,951		14.6	%	$	8,546,164		13.1	%

(1) Excludes $2.626 billion of RPL/NPL MBS. Refer to table below for further information on RPL/NPL MBS.

(2) Does not include principal payments receivable of $1.0 million.

(3) Months to reset is the number of months remaining before the coupon interest rate resets.  At reset, the MBS coupon will adjust based upon the underlying benchmark interest rate index, margin and periodic and/or lifetime caps.  The months to reset do not reflect scheduled amortization or prepayments.

(4) 3 month average CPR weighted by positions as of the beginning of each month in the quarter.

(5) Includes floating rate MBS that may be collateralized by fixed-rate mortgages.

(6) Information presented based on data available at time of loan origination.

The following table presents certain information about our RPL/NPL MBS portfolio at December 31, 2015:

	Fair Value		Net Coupon		Months to Step-Up (1)	Current Credit Support (2)		Original Credit Support		3 Month Average Bond CPR (3)
(Dollars in Thousands)
Re-Performing MBS	$	490,566	3.69	%	18	47	%	40	%	24.4	%
Non-Performing MBS	2,135,300		3.71		24	49		48		20.7
Total RPL/NPL MBS	$	2,625,866	3.71	%	23	49	%	47	%	21.5	%

(1) Months to step-up is the weighted average number of months remaining before the coupon interest rate increases pursuant to the first coupon reset. We anticipate that the securities will be redeemed prior to the step-up date.

(2) Credit Support for a particular security is expressed as a percentage of all outstanding mortgage loan collateral. A particular security will not be subject to principal loss as long as credit enhancement is greater than zero.

(3) All principal payments are considered to be prepayments for CPR purposes.

At December 31, 2015, our CRT securities had a fair value of $183.6 million and reset monthly based on one-month LIBOR.

75

The information presented in the following “Shock Tables” projects the potential impact of sudden parallel changes in interest rates on our net interest income and portfolio value, including the impact of Swaps, over the next 12 months based on the assets in our investment portfolio at December 31, 2015 and December 31, 2014.  All changes in income and value are measured as the percentage change from the projected net interest income and portfolio value at the base interest rate scenario at December 31, 2015 and 2014.

December 31, 2015

Change in Interest Rates	Estimated Value of Assets (1)		Estimated Value of Swaps			Estimated Value of Financial Instruments		Change in Estimated Value			Percentage Change in Net Interest Income		Percentage Change in Portfolio Value
(Dollars in Thousands)
+100 Basis Point Increase	$	12,318,148	$	33,313		$	12,351,461	$	(85,300	)	(8.98	)%	(0.69	)%
+ 50 Basis Point Increase	$	12,415,124	$	(18,043	)	$	12,397,081	$	(39,680	)	(5.82	)%	(0.32	)%
Actual at December 31, 2015	$	12,506,160	$	(69,399	)	$	12,436,761	$	—		—		—
- 50 Basis Point Decrease	$	12,591,257	$	(120,756	)	$	12,470,501	$	33,740		(1.01	)%	0.27	%
-100 Basis Point Decrease	$	12,670,416	$	(172,112	)	$	12,498,304	$	61,543		(8.20	)%	0.49	%

December 31, 2014

Change in Interest Rates	Estimated Value of Assets (2)		Estimated Value of Swaps			Estimated Value of Financial Instruments		Change in Estimated Value			Percentage Change in Net Interest Income (3)		Percentage Change in Portfolio Value
(Dollars in Thousands)
+100 Basis Point Increase	$	13,067,430	$	73,379		$	13,140,809	$	(91,114	)	(5.66	)%	(0.69	)%
+ 50 Basis Point Increase	$	13,183,505	$	7,159		$	13,190,664	$	(41,259	)	(3.01	)%	(0.31	)%
Actual at December 31, 2014	$	13,290,985	$	(59,062	)	$	13,231,923	$	—		—		—
- 50 Basis Point Decrease	$	13,390,860	$	(125,282	)	$	13,265,578	$	33,655		(3.36	)%	0.25	%
-100 Basis Point Decrease	$	13,482,139	$	(191,503	)	$	13,290,636	$	58,713		(9.48	)%	0.44	%

(1) At December 31, 2015 such assets include MBS and CRT securities, residential whole loans, cash and cash equivalents and restricted cash

(2) At December 31, 2014 such assets include MBS and CRT securities, including linked MBS and CRT securities that were reported as a component of our Linked Transactions on our consolidated balance sheets, residential whole loans, cash and cash equivalents and restricted cash. New accounting guidance that was effective on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting and as a result we did not have any Linked Transactions effective January 1, 2015.

(3) Includes underlying interest income and interest expense associated with MBS and repurchase agreement borrowings underlying our Linked Transactions. 

Certain assumptions have been made in connection with the calculation of the information set forth in the Shock Table and, as such, there can be no assurance that assumed events will occur or that other events will not occur that would affect the outcomes.  The base interest rate scenario assumes interest rates at December 31, 2015 and December 31, 2014.  The analysis presented utilizes assumptions and estimates based on management’s judgment and experience.  Furthermore, while we generally expect to retain the majority of our assets and the associated interest rate risk to maturity, future purchases and sales of assets could materially change our interest rate risk profile.  It should be specifically noted that the information set forth in the above table and all related disclosure constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (or 1933 Act) and Section 21E of the 1934 Act.  Actual results could differ significantly from those estimated in the Shock Table above.

The Shock Table quantifies the potential changes in net interest income and portfolio value, which includes the value of our Swaps (which are carried at fair value), should interest rates immediately change (i.e., are shocked).  The Shock Table presents the estimated impact of interest rates instantaneously rising 50 and 100 basis points, and falling 50 and 100 basis points.  The cash flows associated with our portfolio of MBS for each rate shock are calculated based on assumptions, including, but not limited to, prepayment speeds, yield on replacement assets, the slope of the yield curve and composition of our portfolio.  Assumptions with respect to interest rate sensitive liabilities (assumed to be repurchase agreement financings and securitized debt) include anticipated interest rates, collateral requirements as a percent of the repurchase agreement financings, and the amounts and terms of borrowing.  At December 31, 2015 and December 31, 2014, we applied a floor of 0% for all anticipated interest rates included in our assumptions. Due to this floor, it is anticipated that any hypothetical interest rate shock decrease would have a limited positive impact on our funding costs; however, because prepayments speeds are unaffected by this floor, it is expected that any increase in our prepayment speeds (occurring as a result of any interest rate shock decrease or otherwise) could result in an

76

acceleration of our premium amortization on our Agency MBS and discount accretion on our Non-Agency MBS and in the reinvestment of principal repayments in lower yielding assets.  As a result, because the presence of this floor limits the positive impact of interest rate decrease on our funding costs, hypothetical interest rate shock decreases could cause a decline in the fair value of our financial instruments and our net interest income to decline.

At December 31, 2015, the impact on portfolio value was approximated using estimated effective duration (i.e., the price sensitivity to changes in interest rates), including the effect of Swaps, of 0.59 which is the weighted average of 1.97 for our Agency MBS, 1.10 for our Non-Agency investments, (3.45) for our Swaps and zero for our cash and cash equivalents. Estimated convexity (i.e., the approximate change in duration relative to the change in interest rates) of the portfolio was (0.19), which is the weighted average of (0.50) for our Agency MBS, zero for our Swaps, zero for our Non-Agency MBS and zero for our cash and cash equivalents. At December 31, 2014, the impact on portfolio value was approximated using a calculated effective duration (i.e., the price sensitivity to changes in interest rates), including the effect of Swaps, of 0.56 which is the weighted average of 2.02 for our Agency MBS, 1.23 for our Non-Agency MBS, (3.58) for our Swaps and zero for our cash and cash equivalents. Estimated convexity (i.e., the approximate change in duration relative to the change in interest rates) of the portfolio was (0.25), which is the weighted average of (0.56) for our Agency MBS, zero for our Swaps, zero for our Non-Agency MBS and zero for our cash and cash equivalents.  The impact on our net interest income is driven mainly by the difference between portfolio yield and cost of funding of our repurchase agreements (including those underlying our Linked Transactions), which includes the cost and/or benefit from Swaps.  Our asset/liability structure is generally such that an increase in interest rates would be expected to result in a decrease in net interest income, as our borrowings are generally shorter in term than our interest-earning assets.  When interest rates are shocked, prepayment assumptions are adjusted based on management’s expectations along with the results from the prepayment model.

CREDIT RISK

Although we do not believe that we are exposed to credit risk in our Agency MBS portfolio, we are exposed to credit risk through our credit-sensitive residential mortgage investments, in particular Legacy Non-Agency MBS and residential whole loans and to a lesser extent our investments in RPL/NPL MBS and CRT securities. Our exposure to credit risk from our credit sensitive investments is discussed in more detail below:

Legacy Non-Agency MBS

In the event of the return of less than 100% of par on our Legacy Non-Agency MBS, credit support contained in the MBS deal structures and the discount purchase prices we paid mitigate our risk of loss on these investments.  Over time, we expect the level of credit support remaining in certain MBS deal structures to decrease, which will result in an increase in the amount of realized credit loss experienced by our Legacy Non-Agency MBS portfolio.  Our investment process for Legacy Non-Agency MBS involves analysis focused primarily on quantifying and pricing credit risk.  When we purchase Legacy Non-Agency MBS, we assign certain assumptions to each of the MBS, including but not limited to, future interest rates, voluntary prepayment rates, mortgage modifications, default rates and loss severities, and generally allocate a portion of the purchase discount as a Credit Reserve which provides credit protection for such securities.  As part of our surveillance process, we review our Legacy Non-Agency MBS by tracking their actual performance compared to the securities’ expected performance at purchase or, if we have modified our original purchase assumptions, compared to our revised performance expectations.  To the extent that actual performance of a Legacy Non-Agency MBS is less favorable than the expected performance, we may revise our performance expectations.  As a result, we could reduce the accretable discount on such security and/or recognize an other-than-temporary impairment through earnings, which could have a material adverse impact on our operating results. 

In evaluating our asset/liability management and Legacy Non-Agency MBS credit performance, we consider the credit characteristics underlying our Legacy Non-Agency MBS.  The following table presents certain information about our Legacy Non-Agency MBS portfolio at December 31, 2015.  Information presented with respect to the weighted average FICO scores and other information aggregated based on information reported at the time of mortgage origination are historical and, as such, does not reflect the impact of the general decline in home prices or changes in a borrowers’ credit scores or the current use of the mortgaged properties.

77

The information in the table below is presented as of December 31, 2015:

	Securities with Average Loan FICO of 715 or Higher (1)									Securities with Average Loan FICO Below 715 (1)
Year of Securitization (2)	2007			2006			2005 and Prior			2007			2006			2005 and Prior			Total
(Dollars in Thousands)
Number of securities	92			76			100			26			56			65			415
MBS current face (3)	$	1,197,872		$	810,849		$	903,183		$	220,865		$	577,275		$	603,444		$	4,313,488
Total purchase discounts, net (3)	$	(305,408	)	$	(216,915	)	$	(158,605	)	$	(64,305	)	$	(194,306	)	$	(156,903	)	$	(1,096,442	)
Purchase discount designated as Credit Reserve and OTTI (3)(4)	$	(202,963	)	$	(112,556	)	$	(76,834	)	$	(62,550	)	$	(212,521	)	$	(120,116	)	$	(787,540	)
Purchase discount designated as Credit Reserve and OTTI as percentage of current face	16.9		%	13.9		%	8.5		%	28.3		%	36.8		%	19.9		%	18.3		%
MBS amortized cost (3)	$	892,464		$	593,934		$	744,578		$	156,560		$	382,969		$	446,541		$	3,217,046
MBS fair value (3)	$	1,056,600		$	699,347		$	824,482		$	189,823		$	480,532		$	544,167		$	3,794,951
Weighted average fair value to current face	88.2		%	86.2		%	91.3		%	85.9		%	83.2		%	90.2		%	88.0		%
Weighted average coupon (5)	3.89		%	3.40		%	3.01		%	4.83		%	4.85		%	4.30		%	3.85		%
Weighted average loan age (months) (5)(6)	105			114			128			109			116			128			116
Weighted average current loan size (5)(6)	$	518		$	499		$	319		$	393		$	263		$	257		$	396
Percentage amortizing (7)	60		%	73		%	100		%	69		%	80		%	100		%	79		%
Weighted average FICO score at origination (5)(8)	731			729			727			706			704			705			721
Owner-occupied loans	90.5		%	90.9		%	85.8		%	83.9		%	85.1		%	83.9		%	87.6		%
Rate-term refinancings	28.6		%	20.2		%	15.0		%	21.3		%	15.7		%	14.9		%	20.1		%
Cash-out refinancings	34.4		%	35.4		%	26.7		%	43.9		%	42.3		%	37.7		%	35.0		%
3 Month CPR (6)	14.9		%	15.6		%	16.3		%	14.4		%	14.4		%	14.9		%	15.2		%
3 Month CRR (6)(9)	11.5		%	12.3		%	13.6		%	10.7		%	10.7		%	12.4		%	12.1		%
3 Month CDR (6)(9)	3.8		%	3.9		%	3.2		%	4.4		%	4.3		%	3.1		%	3.7		%
3 Month loss severity	55.7		%	49.5		%	46.1		%	63.0		%	63.3		%	62.8		%	55.2		%
60+ days delinquent (8)	12.5		%	11.8		%	10.8		%	18.7		%	18.3		%	15.3		%	13.5		%
Percentage of always current borrowers (Lifetime) (10)	40.8		%	39.9		%	46.4		%	34.1		%	28.5		%	34.4		%	38.9		%
Percentage of always current borrowers (12M) (11)	77.7		%	76.5		%	77.3		%	68.6		%	65.3		%	68.0		%	73.9		%
Weighted average credit enhancement (8)(12)	0.2		%	0.8		%	4.5		%	0.1		%	1.1		%	3.3		%	1.8		%

(1) FICO score is used by major credit bureaus to indicate a borrower’s creditworthiness at time of loan origination.

(2) Information presented based on the initial year of securitization of the underlying collateral. Certain of our Non-Agency MBS have been resecuritized.  The historical information presented in the table is based on the initial securitization date and data available at the time of original securitization (and not the date of resecuritization). No information has been updated with respect to any MBS that have been resecuritized.

(3) Excludes Non-Agency MBS issued in 2013, 2014 and 2015 in which the underlying collateral consists of RPL/NPL MBS. These Non-Agency MBS have a current face of $2.648 billion, amortized cost of $2.645 billion, fair value of $2.626 billion and purchase discounts of $3.2 million at December 31, 2015.

(4) Purchase discounts designated as Credit Reserve and OTTI are not expected to be accreted into interest income.

(5) Weighted average is based on MBS current face at December 31, 2015.

(6) Information provided based on loans for individual groups owned by us.

(7) Percentage of face amount for which the original mortgage note contractually calls for principal amortization in the current period.

(8) Information provided is based on loans for all groups that provide credit enhancement for MBS with credit enhancement.

(9) CRR represents voluntary prepayments and CDR represents involuntary prepayments.

(10) Percentage of face amount of loans for which the borrower has not been delinquent since origination.

(11) Percentage of face amount of loans for which the borrower has not been delinquent in the last twelve months.

(12) Credit enhancement for a particular security is expressed as a percentage of all outstanding mortgage loan collateral.  A particular security will not be subject to principal loss as long as its credit enhancement is greater than zero.  As of December 31, 2015, a total of 282 Non-Agency MBS in our portfolio representing approximately $3.134 billion or 73% of the current face amount of the portfolio had no credit enhancement.

78

The mortgages securing our Legacy Non-Agency MBS are located in many geographic regions across the United States.  The following table presents the five largest geographic concentrations of the mortgages collateralizing our Legacy Non-Agency MBS at December 31, 2015:

Property Location	Percent
California	43.9	%
Florida	7.5	%
New York	5.7	%
Virginia	4.0	%
Maryland	3.8	%

RPL/NPL MBS

Our RPL/NPL MBS were purchased primarily through new issue at prices at or around par and represent the senior tranches of the related securitizations. These RPL/NPL MBS are structured with significant credit enhancement (typically approximately 50%) and the subordinate tranches absorb all credit losses (until those tranches are extinguished) and typically receive no cash flow (interest or principal) until the senior tranche is paid off. Prior to purchase, we analyze the deal structure in order to assess the associated credit risk. Subsequent to purchase, the ongoing credit risk associated with the deal is evaluated by analyzing the extent to which actual credit losses occur that result in a reduction in the amount of subordination enjoyed by our bond. Based on the recent performance of the collateral underlying our RPL/NPL MBS and the current subordination levels, we do not believe that we are currently exposed to significant risk of credit loss on these investments.

CRT Securities

We are exposed to potential credit losses from our investments in CRT securities issued by Fannie Mae and Freddie Mac. While CRT securities are debt obligations of these GSEs, payment of principal on these securities is not guaranteed. As an investor in a CRT security, we may incur a loss if the loans in the associated reference pool experience delinquencies exceeding specified thresholds or other specified credit events occur. We assess the credit risk associated with our investment in CRT securities by assessing the current performance of the loans in the associated reference pool.

Furthermore, as discussed in Part I, Item 1A., “Risk Factors,” and in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” of this Annual Report on Form 10-K, we are potentially exposed to repurchase agreement counterparties should they default on their obligations and we are unable to recover any excess collateral pledged to them.

Residential Whole Loans

We are also exposed to credit risk from our investments in residential whole loans. Our investment process for residential whole loans is generally similar to that used for Legacy Non-Agency MBS and is likewise focused on quantifying and pricing credit risk. Consequently, these loans are acquired at purchase prices that generally are discounted (often substantially) to the contractual loan balances reflecting a number of factors, including the impaired credit history of the borrower and the value of the collateral securing the loan. In addition, as the owner of the servicing rights, our process is also focused on selecting a sub-servicer with the appropriate expertise to mitigate losses and maximize our overall return. This involves, among other things, performing due diligence on the sub-servicer prior to their engagement as well as ongoing oversight and surveillance. To the extent that loan delinquencies and defaults are higher than our expectation at the time the loans were purchased, the discounted purchase price at which the asset is acquired is intended to provide a level of protection against financial loss.

79

The following table presents the five largest geographic concentrations by state of our credit sensitive residential whole loan portfolio at December 31, 2015:

Property Location	Percent of Interest-Bearing Unpaid Principal Balance
California	16.7	%
New York	16.3	%
New Jersey	8.6	%
Florida	7.8	%
Maryland	5.2	%

LIQUIDITY RISK

The primary liquidity risk we face arises from financing long-maturity assets with shorter-term borrowings primarily in the form of repurchase agreements.  We pledge residential mortgage assets and cash to secure our repurchase agreements, FHLB advances and Swaps.  At December 31, 2015, we had access to various sources of liquidity which we estimate exceeds $571.0 million, an amount that includes (i) $165.0 million of cash and cash equivalents; (ii) $241.7 million in estimated financing available from unpledged Agency MBS and other Agency MBS collateral that are currently pledged in excess of contractual requirements; and (iii) $164.3 million in estimated financing available from currently unpledged Non-Agency MBS.   Should the value of our residential mortgage assets pledged as collateral suddenly decrease, margin calls under our repurchase agreements would likely increase, causing an adverse change in our liquidity position. Additionally, if one or more of our financing counterparties chose not to provide ongoing funding, our ability to finance our long-maturity assets would decline or be available on possibly less advantageous terms. As such, we cannot assure you that we will always be able to roll over our repurchase agreement financings and other advances. Further, should market liquidity tighten, our repurchase agreement counterparties may increase our margin requirements on new financings, including repurchase agreement borrowings that we roll with the same counterparty, reducing our ability to use leverage.

PREPAYMENT RISK

Premiums arise when we acquire a MBS at a price in excess of the aggregate principal balance of the mortgages securing the MBS (i.e., par value).  Conversely, discounts arise when we acquire a MBS at a price below the aggregate principal balance of the mortgages securing the MBS or when we acquire residential whole loans at a price below their aggregate principal balance.  Premiums paid on our MBS are amortized against interest income and accretable purchase discounts on our MBS are accreted to interest income.  Purchase premiums on our MBS, which are primarily carried on our Agency MBS, are amortized against interest income over the life of each security using the effective yield method, adjusted for actual prepayment activity.  An increase in the prepayment rate, as measured by the CPR, will typically accelerate the amortization of purchase premiums, thereby reducing the IRR/interest income earned on these assets.  Generally, if prepayments on Non-Agency MBS and residential whole loans purchased at significant discounts and not accounted for at fair value are less than anticipated, we expect that the income recognized on these assets will be reduced and impairments and/or loan loss reserves could result.

80

Item 8.  Financial Statements and Supplementary Data.

Index to Financial Statements and Schedule

	Page
Report of Independent Registered Public Accounting Firm	82
Financial Statements:
Consolidated Balance Sheets at December 31, 2015 and December 31, 2014	83
Consolidated Statements of Operations for the years ended December 31, 2015, 2014 and 2013	84
Consolidated Statements of Comprehensive (Loss)/Income for the years ended December 31, 2015, 2014 and 2013	85
Consolidated Statements of Changes in Stockholders’ Equity for the years ended December 31, 2015, 2014 and 2013	86
Consolidated Statements of Cash Flows for the years ended December 31, 2015, 2014 and 2013	88
Notes to the Consolidated Financial Statements	90
Schedule IV - Mortgage Loans on Real Estate	142

All other financial statement schedules are omitted because the required information is not applicable or deemed not material, or the required information is included in the consolidated financial statements and/or notes thereto.

81

Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders

MFA Financial, Inc.:

We have audited the accompanying consolidated balance sheets of MFA Financial, Inc. and subsidiaries (the Company) as of December 31, 2015 and 2014, and the related consolidated statements of operations, comprehensive (loss)/income, changes in stockholders’ equity and cash flows for each of the years in the three-year period ended December 31, 2015. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of MFA Financial, Inc. and subsidiaries as of December 31, 2015 and 2014, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2015, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company’s internal control over financial reporting as of December 31, 2015, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated February 18, 2016 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

/s/ KPMG LLP

New York, New York

February 18, 2016

82

MFA FINANCIAL, INC.

CONSOLIDATED BALANCE SHEETS

(In Thousands, Except Per Share Amounts)	December 31, 2015			December 31, 2014
Assets:
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:
Agency MBS, at fair value ($4,532,094 and $5,519,813 pledged as collateral, respectively)	$	4,752,244		$	5,904,207
Non-Agency MBS, at fair value ($4,874,372 and $2,377,343 pledged as collateral, respectively)	5,822,519			3,358,426
Non-Agency MBS transferred to consolidated variable interest entities (“VIEs”), at fair value (1)	598,298			1,397,006
CRT securities, at fair value ($170,352 and $94,610 pledged as collateral, respectively)	183,582			102,983
Securities obtained and pledged as collateral, at fair value	507,443			512,105
Residential whole loans, at carrying value ($93,692 and $67,536 pledged as collateral, respectively)	271,845			207,923
Residential whole loans, at fair value ($585,971, and $143,072 pledged as collateral, respectively)	623,276			143,472
Cash and cash equivalents	165,007			182,437
Restricted cash	71,538			67,255
Interest receivable	29,002			32,581
Derivative instruments:
MBS linked transactions, net (“Linked Transactions”), at fair value	—			398,336
Interest rate swap agreements (“Swaps”), at fair value	1,127			3,136
Goodwill	7,189			7,189
Prepaid and other assets	134,253			37,688
Total Assets	$	13,167,323		$	12,354,744
Liabilities:
Repurchase agreements and other advances	$	9,388,902		$	8,267,388
Securitized debt (2)	22,057			110,574
Obligation to return securities obtained as collateral, at fair value	507,443			512,105
8% Senior Notes due 2042 (“Senior Notes”)	100,000			100,000
Accrued interest payable	16,949			13,095
Swaps, at fair value	70,526			62,198
Dividends and dividend equivalents payable	74,575			74,529
Accrued expenses and other liabilities	19,610			11,583
Total Liabilities	$	10,200,062		$	9,151,472
Commitments and contingencies (See Note 12)
Stockholders’ Equity:
Preferred stock, $.01 par value; 7.50% Series B cumulative redeemable; 8,050 shares authorized; 8,000 shares issued and outstanding ($200,000 aggregate liquidation preference)	$	80		$	80
Common stock, $.01 par value; 886,950 shares authorized; 370,584 and 370,084 shares issued and outstanding, respectively	3,706			3,701
Additional paid-in capital, in excess of par	3,019,956			3,013,634
Accumulated deficit	(572,332		)	(568,596		)
Accumulated other comprehensive income	515,851			754,453
Total Stockholders’ Equity	$	2,967,261		$	3,203,272
Total Liabilities and Stockholders’ Equity	$	13,167,323		$	12,354,744

(1) Non-Agency MBS transferred to consolidated VIEs represent assets of consolidated VIEs that can be used only to settle the obligations of each respective VIE.

(2)  Securitized Debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that eliminate on consolidation.  The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company.  (See Notes 12 and 17 for further discussion.)

The accompanying notes are an integral part of the consolidated financial statements.

83

MFA FINANCIAL, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

	For the Year Ended December 31,
(In Thousands, Except Per Share Amounts)	2015			2014		2013
Interest Income:
Agency MBS	$	105,835		$	142,543	$	156,046
Non-Agency MBS	317,821			185,806		170,485
Non-Agency MBS transferred to consolidated VIEs	45,749			130,524		156,285
CRT securities	6,572			772		—
Residential whole loans held at carrying value	16,036			4,083		—
Cash and cash equivalent investments	130			89		124
Interest Income	$	492,143		$	463,817	$	482,940
Interest Expense:
Repurchase agreements and other advances	$	166,918		$	145,244	$	143,885
Securitized debt	1,996			6,533		12,100
Senior Notes	8,034			8,031		8,028
Interest Expense	$	176,948		$	159,808	$	164,013
Net Interest Income	$	315,195		$	304,009	$	318,927
Other-Than-Temporary Impairments:
Total other-than-temporary impairment losses	$	(525	)	$	—	$	—
Portion of loss reclassed from other comprehensive income	(180		)	—		—
Net Impairment Losses Recognized in Earnings	$	(705	)	$	—	$	—
Other Income, net:
Unrealized net gains and net interest income from Linked Transactions	$	—		$	17,092	$	3,225
Net gain on residential whole loans held at fair value	17,722			116		—
Losses on TBA short positions	—			—		(7,517		)
Gain on sales of MBS and U.S. Treasury securities, net	34,900			37,497		25,825
Other, net	(1,457		)	80		219
Other Income, net	$	51,165		$	54,785	$	21,752
Operating and Other Expense:
Compensation and benefits	$	26,293		$	25,581	$	20,328
Other general and administrative expense	15,752			15,164		13,361
Loan servicing and other related operating expenses	10,384			3,383		—
Excise tax and interest	—			1,162		2,250
Impairment of resecuritization related costs	—			—		2,031
Operating and Other Expense	$	52,429		$	45,290	$	37,970
Net Income	$	313,226		$	313,504	$	302,709
Less Preferred Stock Dividends	15,000			15,000		13,750
Less Issuance Costs of Redeemed Preferred Stock	—			—		3,947
Net Income Available to Common Stock and Participating Securities	$	298,226		$	298,504	$	285,012
Earnings per Common Share - Basic and Diluted	$	0.80		$	0.81	$	0.78

The accompanying notes are an integral part of the consolidated financial statements.

84

MFA FINANCIAL, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS)/INCOME

	For the Year Ended December 31,
(In Thousands)	2015			2014			2013
Net Income	$	313,226		$	313,504		$	302,709
Other Comprehensive (Loss)/Income:
Unrealized (loss)/gain on Agency MBS, net	(51,332		)	65,739			(186,568		)
Unrealized (loss)/gain on Non-Agency MBS, net	(143,558		)	29,812			134,505
Reclassification adjustment for MBS sales included in net income	(37,207		)	(34,948		)	(19,833		)
Reclassification adjustment for other-than-temporary impairments included in net income	(705		)	—			—
Unrealized (loss)/gain on derivative hedging instruments, net	(10,337		)	(44,292		)	47,614
Reclassification of unrealized loss on de-designated derivative hedging instruments	—			447			—
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	4,537			—			—
Other Comprehensive (Loss)/Income	(238,602		)	16,758			(24,282		)
Comprehensive Income before preferred stock dividends and issuance costs of redeemed preferred stock	$	74,624		$	330,262		$	278,427
Dividends declared on preferred stock	(15,000		)	(15,000		)	(13,750		)
Issuance costs of redeemed preferred stock	—			—			(3,947		)
Comprehensive Income Available to Common Stock and Participating Securities	$	59,624		$	315,262		$	260,730

The accompanying notes are an integral part of the consolidated financial statements.

85

MFA FINANCIAL, INC. CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY
	For the Year Ended December 31, 2015
(In Thousands,  Except Per Share Amounts)	Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share			Common Stock				Additional Paid-in Capital			Accumulated Deficit			Accumulated Other Comprehensive Income			Total
	Shares	Amount		Shares		Amount
Balance at December 31, 2014	8,000	$	80	370,084		$	3,701	$	3,013,634		$	(568,596	)	$	754,453		$	3,203,272
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	—	—		—		—		—			(4,537		)	4,537			—
Net income	—	—		—		—		—			313,226			—			313,226
Issuance of common stock, net of expenses (1)	—	—		809		5		1,216			—			—			1,221
Repurchase of shares of common stock (1)	—	—		(309	)	—		(2,273		)	—			—			(2,273		)
Equity based compensation expense	—	—		—		—		7,829			—			—			7,829
Accrued dividends attributable to stock-based awards	—	—		—		—		(450		)	—			—			(450		)
Dividends declared on common stock	—	—		—		—		—			(296,384		)	—			(296,384		)
Dividends declared on preferred stock	—	—		—		—		—			(15,000		)	—			(15,000		)
Dividends attributable to dividend equivalents	—	—		—		—		—			(1,041		)	—			(1,041		)
Change in unrealized losses on MBS, net	—	—		—		—		—			—			(232,802		)	(232,802		)
Change in unrealized losses on derivative hedging instruments, net	—	—		—		—		—			—			(10,337		)	(10,337		)
Balance at December 31, 2015	8,000	$	80	370,584		$	3,706	$	3,019,956		$	(572,332	)	$	515,851		$	2,967,261

	For the Year Ended December 31, 2014
(In Thousands,  Except Per Share Amounts)	Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share			Common Stock				Additional Paid-in Capital			Accumulated Deficit			Accumulated Other Comprehensive Income			Total
	Shares	Amount		Shares		Amount
Balance at December 31, 2013	8,000	$	80	365,125		$	3,651	$	2,972,369		$	(571,544	)	$	737,695		$	3,142,251
Net income	—	—		—		—		—			313,504			—			313,504
Issuance of common stock, net of expenses (1)	—	—		5,305		50		35,590			—			—			35,640
Repurchase of shares of common stock (1)	—	—		(346	)	—		(2,688		)	—			—			(2,688		)
Equity based compensation expense	—	—		—		—		8,581			—			—			8,581
Accrued dividends attributable to stock-based awards	—	—		—		—		(218		)	—			—			(218		)
Dividends declared on common stock	—	—		—		—		—			(294,792		)	—			(294,792		)
Dividends declared on preferred stock	—	—		—		—		—			(15,000		)	—			(15,000		)
Dividends attributable to dividend equivalents	—	—		—		—		—			(764		)	—			(764		)
Change in unrealized gains on MBS, net	—	—		—		—		—			—			60,603			60,603
Change in unrealized losses on derivative hedging instruments, net	—	—		—		—		—			—			(43,845		)	(43,845		)
Balance at December 31, 2014	8,000	$	80	370,084		$	3,701	$	3,013,634		$	(568,596	)	$	754,453		$	3,203,272

86

						For the Year Ended December 31, 2013
(In Thousands,  Except Per Share Amounts)	Preferred Stock 8.50% Series A Cumulative Redeemable - Liquidation Preference $25.00 per Share					Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share			Common Stock					Additional Paid-in Capital			Accumulated Deficit			Accumulated Other Comprehensive Income			Total
	Shares		Amount			Shares	Amount		Shares		Amount
Balance at December 31, 2012	3,840		$	38		—	$	—	357,546		$	3,575		$	2,805,724		$	(260,308	)	$	761,977		$	3,311,006
Net income	—		—			—	—		—		—			—			302,709			—			302,709
Issuance of common stock, net of expenses (1)	—		—			—	—		9,855		97			77,528			—			—			77,625
Redemption of Series A Preferred Stock	(3,840	)	(38		)	—	—		—		—			(92,015		)	—			—			(92,053		)
Issuance of Series B Preferred Stock, net of expenses	—		—			8,000	80		—		—			193,236			—			—			193,316
Repurchase of shares of common stock (1)	—		—			—	—		(2,276	)	(21		)	(16,260		)	—			—			(16,281		)
Equity based compensation expense	—		—			—	—		—		—			4,156			—			—			4,156
Dividends declared on common stock	—		—			—	—		—		—			—			(594,318		)	—			(594,318		)
Dividends declared on preferred stock	—		—			—	—		—		—			—			(13,750		)	—			(13,750		)
Dividends attributable to dividend equivalents	—		—			—	—		—		—			—			(1,930		)	—			(1,930		)
Issuance cost of redeemed Preferred stock	—		—			—	—		—		—			—			(3,947		)	—			(3,947		)
Change in unrealized losses on MBS, net	—		—			—	—		—		—			—			—			(71,896		)	(71,896		)
Change in unrealized gains on derivative hedging instruments, net	—		—			—	—		—		—			—			—			47,614			47,614
Balance at December 31, 2013	—		$	—		8,000	$	80	365,125		$	3,651		$	2,972,369		$	(571,544	)	$	737,695		$	3,142,251

(1)  For the year ended December 31, 2015, includes approximately $2.3 million (309,206 shares) surrendered for tax purposes related to equity-based compensation awards. For the year ended December 31, 2014, includes approximately $2.7 million (345,559 shares) surrendered for tax purposes related to equity-based compensation awards. For the year ended December 31, 2013, includes approximately $15.4 million (2,143,354 shares) repurchased through the Company’s publicly announced stock repurchase program and approximately $849,000 (132,276 shares) surrendered for tax purposes related to equity-based compensation awards.

The accompanying notes are an integral part of the consolidated financial statements.

87

MFA FINANCIAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

	For the Year Ended December 31,
(In Thousands)	2015			2014			2013
Cash Flows From Operating Activities:
Net income	$	313,226		$	313,504		$	302,709
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on sales of MBS and U.S. Treasury securities	(34,900		)	(37,497		)	(25,825		)
Other-than-temporary impairment charges	705			—			—
Accretion of purchase discounts on MBS and CRT securities and residential whole loans	(95,377		)	(89,182		)	(73,447		)
Amortization of purchase premiums on MBS	41,624			32,052			58,207
Depreciation and amortization on real estate, fixed assets and other assets	860			1,191			5,831
Equity-based compensation expense	7,832			8,581			4,158
Unrealized (gain)/loss on residential whole loans at fair value	(6,532		)	96			—
Unrealized gains on derivative instruments	—			(1,673		)	(1,111		)
Decrease in interest receivable	4,844			4,561			8,180
Increase in prepaid and other assets	(6,278		)	(12,684		)	(5,549		)
Realized loss on TBA short positions	—			—			7,517
Increase/(decrease) in accrued expenses and other liabilities, and excise tax and interest	5,425			(8,301		)	3,610
Increase in accrued interest payable on financial instruments	50,745			45,165			13,808
Net cash provided by operating activities	$	282,174		$	255,813		$	298,088
Cash Flows From Investing Activities:
Principal payments on MBS and CRT securities	$	2,916,807		$	1,939,948		$	2,770,710
Proceeds from sale of MBS and U.S. Treasury securities	70,747			123,910			574,869
Purchases of MBS and CRT securities	(1,810,303		)	(1,261,646		)	(1,744,605		)
Purchases of residential whole loans	(617,017		)	(356,440		)	—
Principal payments on residential whole loans	51,427			6,017			—
Purchases of Federal Home Loan Bank stock	(60,017		)	—			—
Additions to leasehold improvements, furniture and fixtures	(1,560		)	(786		)	(373		)
Net cash provided by investing activities	$	550,084		$	451,003		$	1,600,601
Cash Flows From Financing Activities:
Principal payments on repurchase agreements and other advances	$	(92,012,931	)	$	(75,939,948	)	$	(69,851,602	)
Proceeds from borrowings under repurchase agreements and other advances	91,614,851			75,868,039			69,438,427
Proceeds from issuance of securitized debt	—			—			129,314
Principal payments on securitized debt	(88,347		)	(254,078		)	(409,606		)
Payments made on obligation to return securities obtained as collateral	—			—			(246,850		)
Maturity of obligation to return securities obtained as collateral	—			—			(275,402		)
Cash disbursements on financial instruments underlying Linked Transactions	—			(6,750,803		)	(419,802		)
Cash received from financial instruments underlying Linked Transactions	—			6,336,872			405,436
Payments made for margin calls on repurchase agreements and Swaps	(267,200		)	(208,600		)	(69,902		)
Proceeds from reverse margin calls on repurchase agreements and Swaps	215,100			132,800			22,809
Settlement of TBA short positions	—			—			(7,517		)
Proceeds from issuances of common stock	1,218			35,639			77,625
Payments made for redemption of Series A Preferred Stock	—			—			(96,000		)
Proceeds from issuance of Series B Preferred Stock	—			—			200,000
Payments made for preferred stock offering costs	—			—			(6,684		)
Payments made to repurchase common stock	—			—			(16,281		)
Dividends paid on preferred stock	(15,000		)	(15,000		)	(13,750		)
Dividends paid on common stock and dividend equivalents	(297,379		)	(294,670		)	(594,827		)
Net cash used in financing activities	$	(849,688	)	$	(1,089,749	)	$	(1,734,612	)

88

Net (decrease)/increase in cash and cash equivalents	$	(17,430	)	$	(382,933	)	$	164,077
Cash and cash equivalents at beginning of period	$	182,437		$	565,370		$	401,293
Cash and cash equivalents at end of period	$	165,007		$	182,437		$	565,370
Supplemental Disclosure of Cash Flow Information:
Interest paid	$	172,919		$	160,935		$	162,186
Non-cash Investing and Financing Activities:
MBS and CRT securities recorded upon adoption of revised accounting standard for repurchase agreement financing	$	1,917,813		$	—		$	—
Repurchase agreements recorded upon adoption of revised accounting standard for repurchase agreement financing	$	1,519,593		$	—		$	—
MBS recorded upon de-linking of Linked Transactions	$	—		$	86,449		$	—
Repurchase agreements recorded upon de-linking of Linked Transactions	$	—		$	49,095		$	—
Net increase in securities obtained as collateral/obligation to return securities obtained as collateral	$	32,670		$	135,165		$	401,135
Transfer from residential whole loans to real estate owned	$	30,104		$	2,904		$	—
Dividends and dividend equivalents declared and unpaid	$	74,575		$	74,529		$	73,643

The accompanying notes are an integral part of the consolidated financial statements.

89

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

1.      Organization

MFA Financial, Inc. (the “Company”) was incorporated in Maryland on July 24, 1997 and began operations on April 10, 1998.  The Company has elected to be treated as a real estate investment trust (“REIT”) for U.S. federal income tax purposes.  In order to maintain its qualification as a REIT, the Company must comply with a number of requirements under federal tax law, including that it must distribute at least 90% of its annual REIT taxable income to its stockholders.  The Company has elected to treat certain of its subsidiaries as a taxable REIT subsidiary (“TRS”). In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. (See Notes 2(o) and 13)

2.      Summary of Significant Accounting Policies

(a)  Basis of Presentation and Consolidation

The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with U.S. generally accepted accounting principles (“GAAP”).  The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could be worse than anticipated in those estimates, which could materially impact the Company’s results of operations and its financial condition.  Management has made significant estimates in several areas, including other-than-temporary impairment (“OTTI”) on MBS (See Note 3), valuation of MBS and CRT securities (See Notes 3 and 16), income recognition and valuation of residential whole loans (See Notes 4 and 16), valuation of derivative instruments (See Notes 6 and 16) and income recognition on certain Non-Agency MBS purchased at a discount (See Note 3).  In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest (See Note 2(o)).  Actual results could differ from those estimates.

The Company has one reportable segment as we manage our business and analyze and report our results of operations on the basis of one operating segment - investing, on a leveraged basis, in residential mortgage assets.

The consolidated financial statements of the Company include the accounts of all subsidiaries; significant intercompany accounts and transactions have been eliminated. In addition, the Company consolidates the special purpose entities created to facilitate the resecuritization transactions completed in prior years and the acquisition of residential whole loans. Certain prior period amounts have been reclassified to conform to the current period presentation.

(b)  MBS (including Non-Agency MBS transferred to consolidated VIEs) and CRT Securities

The Company has investments in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any U.S. Government agency or any federally chartered corporation (“Non-Agency MBS”). In addition, the Company has investments in CRT securities, that are issued by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by Fannie Mae and Freddie Mac and the principal payments received are based on the performance of loans in a reference pool of recently securitized MBS. As the loans in the underlying reference pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including if the loans in the reference pool experience delinquencies exceeding specified thresholds.

Designation

The Company generally intends to hold its MBS until maturity; however, from time to time, it may sell any of its securities as part of the overall management of its business.  As a result, all of the Company’s MBS are designated as “available-for-sale” (“AFS”) and, accordingly, are carried at their fair value with unrealized gains and losses excluded from earnings (except when an OTTI is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity.

90

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method.

The Company has elected the fair value option for certain of its CRT securities as it considers this method of accounting more appropriately reflects the risk sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statement of operations.

Revenue Recognition, Premium Amortization and Discount Accretion

Interest income on securities is accrued based on the outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity.

Interest income on the Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the security’s effective interest rate which is the security’s internal rate of return (“IRR”). The IRR is determined using management’s estimate of the projected cash flows for each security, which are based on the Company’s observation of current information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the timing and amount of credit losses. On at least a quarterly basis, the Company reviews and, if appropriate, makes adjustments to its cash flow projections based on input and analysis received from external sources, internal models, and its judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Changes in cash flows from those originally projected, or from those estimated at the last evaluation, may result in a prospective change in the IRR/ interest income recognized on these securities or in the recognition of OTTIs.  (See Note 3)

Based on the projected cash flows from the Company’s Non-Agency MBS purchased at a discount to par value, a portion of the purchase discount may be designated as non-accretable purchase discount (“Credit Reserve”), which effectively mitigates the Company’s risk of loss on the mortgages collateralizing such MBS and is not expected to be accreted into interest income.  The amount designated as Credit Reserve may be adjusted over time, based on the actual performance of the security, its underlying collateral, actual and projected cash flow from such collateral, economic conditions and other factors.  If the performance of a security with a Credit Reserve is more favorable than forecasted, a portion of the amount designated as Credit Reserve may be reallocated to accretable discount and recognized into interest income over time.  Conversely, if the performance of a security with a Credit Reserve is less favorable than forecasted, the amount designated as Credit Reserve may be increased, or impairment charges and write-downs of such securities to a new cost basis could result.

Determination of Fair Value for MBS and CRT Securities

In determining the fair value of the Company’s MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity.  (See Note 16)

91

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

Impairments/OTTI

When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired.  The Company assesses its impaired securities on at least a quarterly basis and designates such impairments as either “temporary” or “other-than-temporary.”  If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize an OTTI through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date.  If the Company does not expect to sell an other-than-temporarily impaired security, only the portion of the OTTI related to credit losses is recognized through charges to earnings with the remainder recognized through AOCI on the consolidated balance sheets.  Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings.  Following the recognition of an OTTI through earnings, a new cost basis is established for the security and may not be adjusted for subsequent recoveries in fair value through earnings.  However, OTTIs recognized through charges to earnings may be accreted back to the amortized cost basis of the security on a prospective basis through interest income.  The determination as to whether an OTTI exists and, if so, the amount of credit impairment recognized in earnings is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of the future performance and cash flow projections.  As a result, the timing and amount of OTTIs constitute material estimates that may be susceptible to significant change.  (See Note 3)

Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS.  The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, Fair Isaac Corporation (“FICO”) scores at loan origination, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations, as well as reports by credit rating agencies, such as Moody’s Investors Services, Inc. (“Moody’s”), Standard & Poor’s Corporation (“S&P”), or Fitch, Inc. (collectively, “Rating Agencies”), general market assessments, and dialogue with market participants.  As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS.  In determining the OTTI related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date.  The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes.  Impairment assessment for Non-Agency MBS and CRT securities that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date.  The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR.

Balance Sheet Presentation

The Company’s MBS and CRT securities pledged as collateral against repurchase agreements, Federal Home Loan Bank advances and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically.  Purchases and sales of securities are recorded on the trade date. 

(c)  Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral

The Company has obtained securities as collateral under collateralized financing arrangements in connection with its financing strategy for Non-Agency MBS.  Securities obtained as collateral in connection with these transactions are recorded on the Company’s consolidated balance sheets as an asset along with a liability representing the obligation to return the collateral obtained, at fair value.  While beneficial ownership of securities obtained remains with the counterparty, the Company has the right to sell the collateral obtained or to pledge it as part of a subsequent collateralized financing transaction.  (See Note 2(k) for Repurchase Agreements and Reverse Repurchase Agreements)

(d)  Residential Whole Loans

Residential whole loans included in the Company’s consolidated balance sheets are generally comprised of pools of fixed and adjustable rate residential mortgage loans acquired through consolidated trusts in secondary market transactions at discounted purchase prices. The accounting model utilized by the Company is determined at the time each loan package is initially acquired

92

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below under “Residential Whole Loans at Carrying Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The accounting model described below under “Residential Whole Loans at Fair Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed.

The Company’s residential whole loans pledged as collateral against repurchase agreements are included in the consolidated balance sheets with the fair value of the loans pledged disclosed parenthetically.  Purchases and sales of residential whole loans are recorded on the trade date, with amounts recorded reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing.

Residential Whole Loans at Carrying Value

Notwithstanding that the majority of these loans are considered to be performing substantially in accordance with their current contractual terms and conditions, the Company has elected to account for these loans as credit impaired as they were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of the borrowers have previously experienced payment delinquencies and the amount owed on the mortgage loan may exceed the value of the property pledged as collateral. Consequently, the Company has assessed that these loans have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to credit worthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Such loans are initially recorded at fair value with no allowance for loan losses. Subsequent to acquisition, the recorded amount reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded amount reduced by any allowance for loan losses established subsequent to acquisition.

Under the application of this accounting model the Company may aggregate into pools loans acquired in the same fiscal quarter that are assessed as having similar risk characteristics. For each pool established, or on an individual loan basis for loans not aggregated into pools, the Company estimates at acquisition and periodically on at least a quarterly basis, the principal and interest cash flows expected to be collected. The difference between the cash flows expected to be collected and the carrying amount of the loans is referred to as the “accretable yield.” This amount is accreted as interest income over the life of the loans using an effective interest rate (level yield) methodology. Interest income recorded each period reflects the amount of accretable yield recognized and not the coupon interest payments received on the underlying loans. The difference between contractually required principal and interest payments and the cash flows expected to be collected is referred to as the “non-accretable difference,” and includes estimates of both the effect of prepayments and expected credit losses over the life of the underlying loans.

A decrease in expected cash flows in subsequent periods may indicate impairment at the pool and/or individual loan level thus requiring the establishment of an allowance for loan losses by a charge to the provision for loan losses. The allowance for loan losses represents the present value of cash flows expected at acquisition, adjusted for any increases due to changes in estimated cash flows, that are subsequently no longer expected to be received at the relevant measurement date. A significant increase in expected cash flows in subsequent periods first reduces any previously recognized allowance for loan losses and then will result in a recalculation in the amount of accretable yield. The adjustment of accretable yield due to a significant increase in expected cash flows is accounted for prospectively as a change in estimate and results in reclassification from nonaccretable difference to accretable yield. (See Notes 4 and 17)

Residential Whole Loans at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Given the significant uncertainty associated with estimating the timing of and amount of cash flows associated with these loans that will be collected, and that the cash flows ultimately collected may be dependent on the value of the property securing the loan, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns from these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations.

93

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

Cash received reflecting coupon payments on residential whole loans held at fair value is not included in Interest Income, but rather is presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. (See Notes 4 and 16)

(e)  Cash and Cash Equivalents

Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less.  Cash and cash equivalents may also include cash pledged as collateral to the Company by its repurchase agreement and/or Swap counterparties as a result of reverse margin calls (i.e., margin calls made by the Company).  The Company did not hold any cash pledged by its counterparties at December 31, 2015 or 2014.  The Company’s investments in overnight money market funds, which are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency were $120.4 million and $182.4 million at December 31, 2015 and 2014, respectively.  (See Notes 9 and 16)

(f) Restricted Cash

Restricted cash represents the Company’s cash held by its counterparties as collateral or otherwise in connection with the Company’s Swaps and/or repurchase agreements.  Restricted cash is not available to the Company for general corporate purposes, but may be applied against amounts due to counterparties to the Company’s repurchase agreements and/or Swaps, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the Swap or repurchase agreement.  The Company had aggregate restricted cash held as collateral or otherwise in connection with its Swaps and repurchase agreements of $71.5 million and $67.3 million at December 31, 2015 and 2014, respectively. (See Notes 6, 8, 9 and 16)

(g)  Goodwill

At December 31, 2015 and 2014, the Company had goodwill of $7.2 million, which represents the unamortized portion of the excess of the fair value of its common stock issued over the fair value of net assets acquired in connection with its formation in 1998.  Goodwill is tested for impairment at least annually, or more frequently under certain circumstances, at the entity level.  Through December 31, 2015, the Company had not recognized any impairment against its goodwill.

(h) Real Estate Owned (“REO”)

REO represents real estate acquired by the Company, including through foreclosure or deed in lieu of foreclosure, and is initially recorded at fair value less estimated selling costs. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Prepaid and other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported value of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on the Company’s consolidated statements of operations. (See Note 7)

(i)  Depreciation

Leasehold Improvements and Other Depreciable Assets

Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term.  Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase.

(j)  Resecuritization and Senior Notes Related Costs

Resecuritization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various resecuritization transactions completed by the Company.  Senior Notes related costs are costs incurred by the Company in connection with the issuance of its Senior Notes in April, 2012.  These costs may include underwriting, rating agency, legal, accounting and other fees.  Such costs, which reflect deferred charges, are included on the Company’s consolidated balance sheets in Prepaid and other assets.  These deferred charges are amortized as an adjustment to interest expense using the effective interest method, based upon the actual repayments of the associated beneficial interests issued

94

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

to third parties and over the stated legal maturity of the Senior Notes. The Company periodically reviews the recoverability of these deferred costs and in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

(k)  Repurchase Agreements and Other Advances

Repurchase Agreements

The Company finances the holdings of a significant portion of its MBS and CRT securities with repurchase agreements.  Under repurchase agreements, the Company sells securities to a lender and agrees to repurchase the same securities in the future for a price that is higher than the original sale price.  The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender.  Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements, the Company pledges its securities as collateral to secure the borrowing, which is equal in value to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral.  At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan including any accrued interest and concurrently receives back its pledged collateral from the lender.  With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms.  Margin calls, whereby a lender requires that the Company pledge additional securities or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the MBS pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions.  The Company also may make margin calls on counterparties when collateral values increase.

The Company’s repurchase financings typically have terms ranging from one month to six months at inception, but may also have longer or shorter terms.  Should a counterparty decide not to renew a repurchase financing at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation.  If, during the term of a repurchase financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable on such collateral.  (See Notes 8, 9 and 16)

In addition to the repurchase agreement financing arrangements discussed above, as part of its financing strategy for Non-Agency MBS, the Company has entered into contemporaneous repurchase and reverse repurchase agreements with a single counterparty.  Under a typical reverse repurchase agreement, the Company buys securities from a borrower for cash and agrees to sell the same securities in the future for a price that is higher than the original purchase price.  The difference between the purchase price the Company originally paid and the sale price represents interest received from the borrower.  In contrast, the contemporaneous repurchase and reverse repurchase transactions effectively resulted in the Company pledging Non-Agency MBS as collateral to the counterparty in connection with the repurchase agreement financing and obtaining U.S. Treasury securities as collateral from the same counterparty in connection with the reverse repurchase agreement.  No net cash was exchanged between the Company and counterparty at the inception of the transactions.  Securities obtained and pledged as collateral are recorded as an asset on the Company’s consolidated balance sheets.  Interest income is recorded on the reverse repurchase agreement and interest expense is recorded on the repurchase agreement on an accrual basis.  Both the Company and the counterparty have the right to make daily margin calls based on changes in the value of the collateral obtained and/or pledged.  The Company’s liability to the counterparty in connection with this financing arrangement is recorded on the Company’s consolidated balance sheets and disclosed as “Obligation to return securities obtained as collateral, at fair value.”  (See Note 2(c))

Federal Home Loan Bank (“FHLB”) Advances

FHLB advances are secured financing transactions and are carried at their contractual amounts. The ability to borrow from the FHLB is subject to the Company’s continued creditworthiness, pledging of sufficient eligible collateral to secure advances, and compliance with certain agreements with the FHLB. The amount of collateral pledged to the FHLB to secure advances is subject to periodic adjustment based on changes in the fair value of the collateral. Accrued interest payable on FHLB advances is included in Accrued interest payable on the Company’s consolidated balance sheets. (See Notes 8, 9, 16 and 18)

In addition, as a condition to membership in the FHLB, the Company’s wholly-owned subsidiary, MFA Insurance, Inc. (“MFA Insurance”) is required to purchase and hold a certain amount of FHLB stock, which is based, in part, upon the outstanding principal

95

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

balance of advances from the FHLB. FHLB stock is considered a non-marketable investment, is carried at cost and is subject to recoverability testing under applicable accounting standards. This stock can only be redeemed or sold at its par value, and only to the FHLB. Accordingly, when evaluating FHLB stock for impairment, the Company considers the ultimate recoverability of the par value rather than recognizing temporary declines in value. FHLB stock is included in Prepaid and other assets on the Company’s consolidated balance sheets.

(l)  Equity-Based Compensation

Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date.  With respect to awards granted in 2009 and prior years, the Company applied a zero forfeiture rate for these awards, as they were granted to a limited number of employees, and historical forfeitures have been minimal.  Forfeitures, or an indication that forfeitures are expected to occur, may result in a revised forfeiture rate and would be accounted for prospectively as a change in estimate.

During 2010, the Company granted certain restricted stock units (“RSUs”) that vested after either two or four years of service and provided that certain criteria were met, which were based on a formula that included changes in the Company’s closing stock price over a two- or four-year period and dividends declared on the Company’s common stock during those periods.  From 2011 through 2013, the Company granted certain RSUs that vested annually over a one or three-year period, provided that certain criteria were met, which were based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period. During 2014 and 2015, the Company made grants of RSUs certain of which cliff vest after a three-year period and certain of which cliff vest after a three-year period, subject to the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period. The features in these awards related to the attainment of total stockholder return over a specified period constitute a “market condition” which impacts the amount of compensation expense recognized for these awards. Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which in addition to estimates regarding the amount of RSUs expected to be forfeited during the associated service period, determined the amount of compensation expense recognized.  The amount of compensation expense recognized was not dependent on whether the market condition was or will be achieved, while differences in actual forfeiture experience relative to estimated forfeitures results in adjustments to the timing and amount of compensation expense recognized.

The Company has awarded dividend equivalents that may be granted as a separate instrument or may be a right associated with the grant of another equity-based award.  Compensation expense for separately awarded dividend equivalents is based on the grant date fair value of such awards and is recognized over the vesting period.  Payments pursuant to these dividend equivalents are charged to Stockholders’ Equity.  Payments pursuant to dividend equivalents that are attached to equity-based awards are charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest.  Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards do not or are not expected to vest and grantees are not required to return payments of dividends or dividend equivalents to the Company.  (See Notes 2(m) and 15)

(m)  Earnings per Common Share (“EPS”)

Basic EPS is computed using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and other securities that participate in dividends, such as the Company’s unvested restricted stock and RSUs that have non-forfeitable rights to dividends and dividend equivalents attached to/associated with RSUs and vested stock options to arrive at total common equivalent shares.  In applying the two-class method, earnings are allocated to both shares of common stock and securities that participate in dividends based on their respective weighted-average shares outstanding for the period.  For the diluted EPS calculation, common equivalent shares are further adjusted for the effect of dilutive unexercised stock options and RSUs outstanding that are unvested and have dividends that are subject to forfeiture using the treasury stock method.  Under the treasury stock method, common equivalent shares are calculated assuming that all dilutive common stock equivalents are exercised and the proceeds, along with future compensation expenses associated with such instruments, are used to repurchase shares of the Company’s outstanding common stock at the average market price during the reported period.  (See Note 14)

96

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

(n)  Comprehensive Income/(Loss)

The Company’s comprehensive income/(loss) available to common stock and participating securities includes net income, the change in net unrealized gains/(losses) on its AFS securities and derivative hedging instruments, (to the extent that such changes are not recorded in earnings), adjusted by realized net gains/(losses) reclassified out of AOCI for sold AFS securities and de-designated derivative hedging instruments and is reduced by dividends declared on the Company’s preferred stock and issuance costs of redeemed preferred stock.

(o)  U.S. Federal Income Taxes

The Company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code of 1986, as amended, (the “Code”) and the corresponding provisions of state law.  The Company expects to operate in a manner that will enable it to satisfy the various requirements to maintain its status as a REIT. In order to maintain its status as a REIT, the Company must, among other things, distribute at least 90% of its REIT taxable income (excluding net long-term capital gains) to stockholders in the timeframe permitted by the Code.  As long as the Company maintains its status as a REIT, the Company will not be subject to regular federal income tax to the extent that it distributes 100% of its REIT taxable income (including net long-term capital gains) to its stockholders within the permitted timeframe.  Should this not occur, the Company would be subject to federal taxes at prevailing corporate tax rates on the difference between its REIT taxable income and the amounts deemed to be distributed for that tax year.  As the Company’s objective is to distribute 100% of its REIT taxable income to its stockholders within the permitted timeframe, no provision for current or deferred income taxes has been made in the accompanying consolidated financial statements.  Should the Company incur a liability for corporate income tax, such amounts would be recorded as REIT income tax expense on the Company’s consolidated statements of operations. Furthermore, if the Company fails to distribute during each calendar year, or by the end of January following the calendar year in the case of distributions with declaration and record dates falling in the last three months of the calendar year, at least the sum of (i) 85% its REIT ordinary income for such year, (ii) 95% of its REIT capital gain income for such year, and (iii) any undistributed taxable income from prior periods, the Company would be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed. To the extent that the Company incurs interest, penalties or related excise taxes in connection with its tax obligations, including as a result of its assessment of uncertain tax positions, such amounts will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

In addition, the Company has elected to treat certain of its subsidiaries as a TRS. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of the Company’s business may be conducted through one or more TRS, its income earned by TRS may be subject to corporate income taxation. To maintain the Company’s REIT election, no more than 25% (or, for 2018 and subsequent taxable years, 20%) of the value of a REIT’s assets at the end of each calendar quarter may consist of stock or securities in TRS. For purposes of the determination of U. S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as a TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. No deferred tax benefit was recorded by the Company in 2015 or 2014, as a valuation allowance for the full amount of the associated deferred tax asset was recognized as its recovery is not considered more likely than not.

Based on its analysis of any potential uncertain tax positions, the Company concluded that it does not have any material uncertain tax positions that meet the relevant recognition or measurement criteria as of December 31, 2015, 2014 or 2013. The Company filed its 2014 tax return prior to September 15, 2015. The Company’s tax returns for tax years 2010 through 2014 are open to examination.

97

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

(p)  Derivative Financial Instruments

The Company may use a variety of derivative instruments to economically hedge a portion of its exposure to market risks, including interest rate risk and prepayment risk. The objective of the Company’s risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, the Company attempts to mitigate the risk of the cost of its variable rate liabilities increasing during a period of rising interest rates. The Company’s derivative instruments are currently comprised of Swaps, which are designated as cash flow hedges against the interest rate risk associated with certain of its borrowings. Prior to 2015, the Company’s derivative financial instruments also included Linked Transactions, which were not designated as hedging instruments. New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 6) During 2013, the Company also entered into forward contracts for the sale of Agency MBS securities on a generic pool, or to-be-announced basis (“TBA short positions”) which were not designated as hedging instruments.

Linked Transactions

Prior to 2015, it was presumed that the initial transfer of a financial asset (i.e., the purchase of an MBS by the Company) and contemporaneous repurchase financing of such security with the same counterparty were considered part of the same arrangement, or a “linked transaction,” unless certain criteria were met.  The two components of a linked transaction (security purchase and repurchase financing) were not reported separately but were evaluated on a combined basis and reported as a forward (derivative) contract and were presented as “Linked Transactions” on the Company’s consolidated balance sheets.  Changes in the fair value of the assets and liabilities underlying Linked Transactions and associated interest income and expense were reported as “Unrealized net gains/(losses) and net interest income from Linked Transactions” on the Company’s consolidated statements of operations and were not included in OCI.  However, if certain criteria were met, the initial transfer (i.e., the purchase of a security by the Company) and repurchase financing were not treated as a Linked Transaction and would have been evaluated and reported separately as an MBS purchase and MBS repurchase financing.  When or if a transaction was no longer considered to be linked, the security and repurchase financing were reported on a gross basis.  In this case, the fair value of the MBS at the time the transactions were no longer considered linked became the cost basis of the MBS, and the income recognition yield for such MBS was calculated prospectively using this new cost basis. 

New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting as described above. This resulted in changes subsequent to January 1, 2015 to the presentation of assets and liabilities, and revenues and expenses of Non-Agency MBS and associated repurchase agreements that had been accounted for as Linked Transactions prior to that date. The changes include the presentation of Non-Agency MBS and associated repurchase agreements as separate assets and liabilities, rather than on a combined basis on the Company’s consolidated balance sheets. In addition, starting in 2015, interest income related to the securities and interest expense related to the associated repurchase agreements are separately presented and included in the determination of the Company’s net interest income on its consolidated statement of operations. Further, the previous treatment of Linked Transactions as forward (derivative) instruments recorded at fair value at the end of each period, with changes in fair value included in net income, was discontinued and effective January 1, 2015 MBS that were previously accounted for as components of Linked Transactions are accounted for on a consistent basis with other MBS held by the Company as AFS securities.  (See Notes 2(t), 6 and 16)

Swaps

The Company documents its risk-management policies, including objectives and strategies, as they relate to its hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions.  The Company assesses, both at inception of a hedge and on a quarterly basis thereafter, whether or not the hedge is “highly effective.”

Swaps are carried on the Company’s consolidated balance sheets at fair value, as assets, if their fair value is positive, or as liabilities, if their fair value is negative.  Changes in the fair value of the Company’s Swaps designated in hedging transactions are recorded in OCI provided that the hedge remains effective.  Changes in fair value for any ineffective amount of a Swap are recognized in earnings.  The Company has not recognized any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness.

The Company discontinues hedge accounting on a prospective basis and recognizes changes in the fair value through earnings when:  (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted

98

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate.

Although permitted under certain circumstances, the Company does not offset cash collateral receivables or payables against its net derivative positions.  (See Notes 6, 9 and 16)

TBA Short Positions

During 2013, the Company entered into TBA short positions as a means of managing interest rate risk and MBS basis risk associated with its investment and financing activities. A TBA short position is a forward contract for the sale of Agency MBS at a predetermined price, face amount, issuer, coupon and maturity on an agreed-upon future date. The specific Agency MBS that could be delivered into the contract upon the settlement date, published each month by the Securities Industry and Financial Markets Association (“SIFMA”), are not known at the time of the transaction.

TBA short positions were accounted for as derivative instruments since the Company could not assert that it was probable at inception and throughout the term of the TBA contract, that it would physically deliver the Agency security upon settlement of the contract. TBA short positions were presented as either derivative assets or liabilities, at fair value on its consolidated balance sheets. Gains and losses associated with TBA short positions were reported in Other Income, net on the Company’s consolidated statements of operations. (See Note 6)

The Company did not have any TBA short positions at December 31, 2015 and 2014.

(q)  Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities

The Company’s presentation of fair value for its financial assets and liabilities is determined within a framework that stipulates that the fair value of a financial asset or liability is an exchange price in an orderly transaction between market participants to sell the asset or transfer the liability in the market in which the reporting entity would transact for the asset or liability, that is, the principal or most advantageous market for the asset or liability.  The transaction to sell the asset or transfer the liability is a hypothetical transaction at the measurement date, considered from the perspective of a market participant that holds the asset or owes the liability.  This definition of fair value focuses on exit price and prioritizes the use of market-based inputs over entity-specific inputs when determining fair value.  In addition, the framework for measuring fair value establishes a three-level hierarchy for fair value measurements based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. 

In addition to the financial instruments that it is required to report at fair value, the Company has elected the fair value option for certain of its residential whole loans and CRT securities at time of acquisition. Subsequent changes in the fair value of these loans and CRT securities are reported in Net gain on residential whole loans held at fair value and Other Income, net respectively on the Company’s consolidated statements of operations.  A decision to elect the fair value option for an eligible financial instrument, which may be made on an instrument by instrument basis, is irrevocable. (See Notes 2(d), 4 and 16)

(r)  Variable Interest Entities

An entity is referred to as a VIE if it meets at least one of the following criteria:  (i) the entity has equity that is insufficient to permit the entity to finance its activities without additional subordinated financial support of other parties; or (ii) as a group, the holders of the equity investment at risk lack (a) the power to direct the activities of an entity that most significantly impact the entity’s economic performance; (b) the obligation to absorb the expected losses; or (c) the right to receive the expected residual returns; or (iii) have disproportional voting rights and the entity’s activities are conducted on behalf of the investor that has disproportionally few voting rights.

The Company consolidates a VIE when it has both the power to direct the activities that most significantly impact the economic performance of the VIE and a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.   The Company is required to reconsider its evaluation of whether to consolidate a VIE each reporting period, based upon changes in the facts and circumstances pertaining to the VIE.

The Company has entered into resecuritization transactions which result in the Company consolidating the VIEs that were created to facilitate the transactions and to which the underlying assets in connection with the resecuritizations were transferred. 

99

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

In determining the accounting treatment to be applied to these resecuritization transactions, the Company concluded that the entities used to facilitate these transactions were VIEs and that they should be consolidated. If the Company had determined that consolidation was not required, it would have then assessed whether the transfer of the underlying assets would qualify as a sale or should be accounted for as secured financings under GAAP.

Prior to the completion of its initial resecuritization transaction in October 2010, the Company had not transferred assets to VIEs or Qualifying Special Purpose Entities (“QSPEs”) and other than acquiring MBS issued by such entities, had no other involvement with VIEs or QSPEs.  (See Note 17)

The Company also includes in its consolidated balance sheets certain financial assets and liabilities that are acquired/issued by trusts and /or other special purpose entities that have been evaluated as being required to be consolidated by the Company under the applicable accounting guidance.

(s)  Offering Costs Related to Issuance and Redemption of Preferred Stock

Offering costs related to issuance of preferred stock are recorded as a reduction in Additional paid-in capital, a component of Stockholders’ Equity, at the time such preferred stock is issued. On redemption of preferred stock, any excess of the fair value of the consideration transferred to the holders of the preferred stock over the carrying amount of the preferred stock in the Company’s consolidated balance sheets is included in the determination of Net Income Available to Common Stock and Participating Securities in the calculation of EPS. (See Notes 13 and 14)

(t)  New Accounting Standards and Interpretations

Accounting Standards Adopted in 2015

Receivables - Recognition of Residential Real Estate upon Foreclosure

In January 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-04, Reclassification of Residential Real Estate Collateralized Consumer Mortgage Loans upon Foreclosure (“ASU 2014-04”).  This ASU applies to all creditors who obtain physical possession (resulting from an in substance repossession or foreclosure) of residential real estate property collateralizing a consumer mortgage loan in satisfaction of a receivable.  The ASU clarifies that an in substance repossession or foreclosure occurs, and a creditor is considered to have received physical possession of residential real estate property collateralizing a consumer mortgage loan, upon either (i) the creditor obtaining legal title to the residential real estate property upon completion of a foreclosure or (ii) the borrower conveying all interest in the residential real estate property to the creditor to satisfy that loan through completion of a deed in lieu of foreclosure or through a similar legal agreement. Additionally, the amendments require interim and annual disclosure of both (i) the amount of foreclosed residential real estate property held by the creditor and (ii) the recorded investment in consumer mortgage loans collateralized by residential real estate property that are in the process of foreclosure according to local requirements of the applicable jurisdiction.

ASU 2014-04 was effective for the Company for reporting periods beginning after December 15, 2014.  The Company has elected to adopt the amendments in this ASU using a prospective transition method.  The Company’s adoption of ASU 2014-04 beginning on January 1, 2015, did not have a material impact on the Company’s consolidated financial statements.

Transfers and Servicing

In June 2014, the FASB issued ASU 2014-11, Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures (“ASU 2014-11”). The amendments of ASU 2014-11 require two accounting changes. First, the amendments in this ASU change the accounting for repurchase-to-maturity transactions to secured borrowing accounting. Second, for repurchase financing arrangements, the amendments require separate accounting for a transfer of a financial asset executed contemporaneously with a repurchase agreement with the same counterparty, which will result in secured borrowing accounting for the repurchase agreement. In addition, the amendments in ASU 2014-11 require disclosures for certain transactions comprising (i) a transfer of a financial asset accounted for as a sale and (ii) an agreement with the same transferee entered into in contemplation of the initial transfer that results in the transferor retaining substantially all of the exposure to the economic return on the transferred asset throughout the term of the transaction. ASU 2014-11 also requires disclosures for repurchase agreements, securities lending transactions, and repurchase-to-maturity transactions that are accounted for as secured borrowings.

100

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

ASU 2014-11 was effective for the Company for reporting periods beginning after December 15, 2014. An entity is required to present changes in accounting for transactions outstanding on the effective date as a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. Accordingly, on adoption of the new standard on January 1, 2015, the Company reclassified $1.913 billion of Non-Agency MBS and $4.6 million of CRT securities, that were previously reported on the Company’s consolidated balance sheets as a component of Linked Transactions to Non-Agency MBS and CRT securities, respectively. In addition, liabilities of $1.520 billion that were previously presented on the Company’s consolidated balance sheets as a component of Linked Transactions were reclassified to Repurchase agreements. Furthermore, an amount of $4.5 million representing net unrealized gains on securities previously reported as a component of Linked Transactions as of December 31, 2014 was reclassified from Accumulated deficit to AOCI. These reclassification adjustments had no net impact on the Company’s overall Total Stockholders’ Equity. While the Company’s adoption of this new standard beginning on January 1, 2015, did not have a material impact on the Company’s consolidated financial statements, it did result in changes, subsequent to adoption, to the presentation of assets and liabilities and revenues and expenses of Non-Agency MBS and CRT securities and associated repurchase agreements that had been accounted for as MBS Linked Transactions prior to that date. These changes include the presentation, as noted above, of Non-Agency MBS and CRT securities and associated repurchase agreements as separate assets and liabilities, rather than on a combined basis. In addition, subsequent to the date of adoption the interest income related to the securities and the interest expense related to the associated repurchase agreements are separately presented and included in the determination of the Company’s Net Interest Income. Further, the prior accounting requirement for MBS Linked Transactions, which involved treating the combined transaction as a derivative that was recorded at fair value each period, with changes in fair value included in net income, was discontinued and effective January 1, 2015. MBS that were previously accounted for as components of Linked Transactions are accounted for in a manner consistent with other MBS held by the Company as AFS securities.

101

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

3.MBS and CRT Securities

Agency and Non-Agency MBS

The Company’s MBS are comprised of Agency MBS and Non-Agency MBS which include MBS issued prior to 2008 (“Legacy Non-Agency MBS”) .  These MBS are secured by:  (i) hybrid mortgages (“Hybrids”), which have interest rates that are fixed for a specified period of time and, thereafter, generally adjust annually to an increment over a specified interest rate index; (ii) adjustable-rate mortgages (“ARMs”); (iii) mortgages that have interest rates that reset more frequently (collectively, “ARM-MBS”); and (iv) 15 year and longer-term fixed rate mortgages.  In addition, the Company’s MBS are also comprised of MBS secured by re-performing/non-performing loans (“RPL/NPL MBS”), where the cash flows of the bond may not reflect the contractual cash flows of the underlying collateral. RPL/NPL MBS contain a feature where the coupon steps-up 300 basis points at 36 months from issuance or sooner.

The Company pledges a significant portion of its MBS as collateral against its borrowings under repurchase agreements, FHLB advances and Swaps.  Non-Agency MBS that were accounted for as components of Linked Transactions prior to 2015 are not reflected in the tables for prior periods set forth in this note, as they were accounted for as derivatives. New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting.  (See Notes 2(t), 6 and 9)

Agency MBS: Agency MBS are guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae.  The payment of principal and/or interest on Ginnie Mae MBS is explicitly backed by the full faith and credit of the U.S. Government.  Since the third quarter of 2008, Fannie Mae and Freddie Mac have been under the conservatorship of the Federal Housing Finance Agency, which significantly strengthened the backing for these government-sponsored entities.

Non-Agency MBS (including Non-Agency MBS transferred to consolidated VIEs):  The Company’s Non-Agency MBS are secured by pools of residential mortgages, which are not guaranteed by an agency of the U.S. Government or any federally chartered corporation.  Credit risk associated with Non-Agency MBS is regularly assessed as new information regarding the underlying collateral becomes available and based on updated estimates of cash flows generated by the underlying collateral.

CRT Securities

CRT securities are debt obligations issued by Fannie Mae and Freddie Mac. While the coupon payments are paid by Fannie Mae or Freddie Mac on a monthly basis, the payment of principal is dependent on the performance of loans in a reference pool of MBS securitized by Fannie Mae or Freddie Mac. As principal on loans in the reference pool are paid, principal payments on the securities are made and the principal balances of the securities are reduced. Consequently, CRT securities mirror the payment and prepayment behavior of the mortgage loans in the reference pool. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including if the loans in the reference pool experience delinquencies exceeding specified thresholds. The Company assesses the credit risk associated with CRT securities by assessing the current and expected future performance of the associated reference pool. CRT securities that were accounted for as components of Linked Transactions prior to 2015 are not reflected in the tables for prior periods set forth in this note, as they were accounted for as derivatives. (See Notes 2(t), 6 and 9)

102

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following tables present certain information about the Company’s MBS and CRT securities at December 31, 2015 and 2014:

December 31, 2015

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts			Discount Designated as Credit Reserve and  OTTI (1)			Amortized Cost (2)		Fair Value		Gross Unrealized Gains		Gross Unrealized Losses			Net Unrealized Gain/(Loss)
Agency MBS:
Fannie Mae	$	3,690,020	$	139,243	$	(59	)	$	—		$	3,829,204	$	3,865,485	$	62,111	$	(25,830	)	$	36,281
Freddie Mac	851,087		32,680		—			—			884,798		877,109		6,906		(14,595		)	(7,689		)
Ginnie Mae	9,296		164		—			—			9,460		9,650		190		—			190
Total Agency MBS	4,550,403		172,087		(59		)	—			4,723,462		4,752,244		69,207		(40,425		)	28,782
Non-Agency MBS:
Expected to Recover Par (3)(4)	2,906,878		73		(31,576		)	—			2,875,375		2,878,532		23,300		(20,143		)	3,157
Expected to Recover Less than Par (3)	4,054,615		—		(280,606		)	(787,541		)	2,986,468		3,542,285		564,031		(8,214		)	555,817
Total Non-Agency MBS (5)	6,961,493		73		(312,182		)	(787,541		)	5,861,843		6,420,817		587,331		(28,357		)	558,974
Total MBS	11,511,896		172,160		(312,241		)	(787,541		)	10,585,305		11,173,061		656,538		(68,782		)	587,756
CRT securities (6)	192,000		—		(5,689		)	—			186,311		183,582		418		(3,147		)	(2,729		)
Total MBS and CRT securities	$	11,703,896	$	172,160	$	(317,930	)	$	(787,541	)	$	10,771,616	$	11,356,643	$	656,956	$	(71,929	)	$	585,027

December 31, 2014

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts			Discount Designated as Credit Reserve and  OTTI (1)			Amortized Cost (2)		Fair Value		Gross Unrealized Gains		Gross Unrealized Losses			Net Unrealized Gain/(Loss)
Agency MBS:
Fannie Mae	$	4,587,823	$	174,245	$	(71	)	$	—		$	4,761,997	$	4,843,084	$	102,187	$	(21,100	)	$	81,087
Freddie Mac	1,011,659		38,895		—			—			1,051,096		1,049,854		11,280		(12,522		)	(1,242		)
Ginnie Mae	10,811		189		—			—			11,000		11,269		269		—			269
Total Agency MBS	5,610,293		213,329		(71		)	—			5,824,093		5,904,207		113,736		(33,622		)	80,114
Non-Agency MBS:
Expected to Recover Par (3)(4)	431,788		461		(29,501		)	—			402,748		428,431		26,735		(1,052		)	25,683
Expected to Recover Less than Par (3)	4,888,113		—		(370,063		)	(900,557		)	3,617,493		4,327,001		712,168		(2,660		)	709,508
Total Non-Agency MBS (5)	5,319,901		461		(399,564		)	(900,557		)	4,020,241		4,755,432		738,903		(3,712		)	735,191
Total MBS	10,930,194		213,790		(399,635		)	(900,557		)	9,844,334		10,659,639		852,639		(37,334		)	815,305
CRT securities	109,500		—		(4,727		)	—			104,773		102,983		324		(2,114		)	(1,790		)
Total MBS and CRT securities	$	11,039,694	$	213,790	$	(404,362	)	$	(900,557	)	$	9,949,107	$	10,762,622	$	852,963	$	(39,448	)	$	813,515

(1) Discount designated as Credit Reserve and amounts related to OTTI are generally not expected to be accreted into interest income. Amounts disclosed at December 31, 2015 reflect Credit Reserve of $766.0 million and OTTI of $21.5 million. Amounts disclosed at December 31, 2014 reflect Credit Reserve of $877.6 million and OTTI of $23.0 million.

(2) Includes principal payments receivable of $1.0 million and $542,000 at December 31, 2015 and 2014, respectively, which are not included in the Principal/Current Face.

(3) Based on management’s current estimates of future principal cash flows expected to be received.

(4) At December 31, 2015 RPL/NPL MBS had a $2.648 billion Principal/Current face, $2.645 billion amortized cost and $2.626 billion fair value. At December 31, 2014, RPL/NPL MBS had a $161.0 million Principal/Current face, $161.0 million amortized cost and $161.0 million fair value (excludes RPL/NPL MBS with $1.850 billion Principal/Current face, $1.847 billion amortized cost and $1.847 billion fair value that were presented as a component of Linked Transactions at December 31, 2014).

(5) At December 31, 2015 and 2014, the Company expected to recover approximately 89% and 83%, respectively, of the then-current face amount of Non-Agency MBS.

(6) Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $62.2 million for which the fair value option has been elected. Such securities have gross unrealized gains of approximately $332,000, gross unrealized losses of approximately $555,000 and net unrealized losses of approximately $223,000 at December 31, 2015.

103

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

Unrealized Losses on MBS and CRT Securities

The following table presents information about the Company’s MBS and CRT securities that were in an unrealized loss position at December 31, 2015:

	Unrealized Loss Position For:
	Less than 12 Months					12 Months or more					Total
(Dollars in Thousands)	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses
Agency MBS:
Fannie Mae	$	856,602	$	7,548	121	$	813,485	$	18,282	109	$	1,670,087	$	25,830
Freddie Mac	298,768		5,463		42	315,566		9,132		64	614,334		14,595
Total Agency MBS	1,155,370		13,011		163	1,129,051		27,414		173	2,284,421		40,425
Non-Agency MBS:
Expected to Recover Par (1)	2,239,418		16,717		59	212,584		3,426		12	2,452,002		20,143
Expected to Recover Less than Par (1)	184,664		4,348		35	64,081		3,866		11	248,745		8,214
Total Non-Agency MBS	2,424,082		21,065		94	276,665		7,292		23	2,700,747		28,357
Total MBS	3,579,452		34,076		257	1,405,716		34,706		196	4,985,168		68,782
CRT securities (2)	137,585		2,672		33	4,525		475		1	142,110		3,147
Total MBS and CRT securities	$	3,717,037	$	36,748	290	$	1,410,241	$	35,181	197	$	5,127,278	$	71,929

(1) Based on management’s current estimates of future principal cash flows expected to be received.  

(2) Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $54.1 million for which the fair value option has been elected. Such securities have unrealized losses of $555,000 at December 31, 2015.

At December 31, 2015, the Company did not intend to sell any of its investments that were in an unrealized loss position, and it is “more likely than not” that the Company will not be required to sell these securities before recovery of their amortized cost basis, which may be at their maturity.  With respect to Non-Agency MBS held by consolidated VIEs, the ability of any entity to cause the sale to a third-party by the VIE prior to the maturity of these Non-Agency MBS is either specifically precluded, or is limited to specified events of default, none of which has occurred to date.

Gross unrealized losses on the Company’s Agency MBS were $40.4 million at December 31, 2015.  Agency MBS are issued by Government Sponsored Entities (“GSEs”) and enjoy either the implicit or explicit backing of the full faith and credit of the U.S. Government. While the Company’s Agency MBS are not rated by any rating agency, they are currently perceived by market participants to be of high credit quality, with risk of default limited to the unlikely event that the U.S. Government would not continue to support the GSEs. Given the credit quality inherent in Agency MBS, the Company does not consider any of the current impairments on its Agency MBS to be credit related. In assessing whether it is more likely than not that it will be required to sell any impaired security before its anticipated recovery, which may be at its maturity, the Company considers for each impaired security, the significance of each investment, the amount of impairment, the projected future performance of such impaired securities, as well as the Company’s current and anticipated leverage capacity and liquidity position. Based on these analyses, the Company determined that at December 31, 2015 any unrealized losses on its Agency MBS were temporary.

Unrealized losses on the Company’s Non-Agency MBS (including Non-Agency MBS transferred to consolidated VIEs) were $28.4 million, of which $19.3 million were RPL/NPL MBS and $9.1 million were Legacy Non-Agency MBS at December 31, 2015.  Based upon the most recent evaluation, the Company does not consider these unrealized losses to be indicative of OTTI and does not believe that these unrealized losses are credit related, but are rather a reflection of current market yields and/or market place bid-ask spreads.  The Company has reviewed its Non-Agency MBS that are in an unrealized loss position to identify those securities with losses that are other-than-temporary based on an assessment of changes in expected cash flows for such securities, which considers recent bond performance and, where possible, expected future performance of the underlying collateral.

The Company recognized credit-related OTTI losses through earnings related to its Non-Agency MBS of $705,000 during the year ended December 31, 2015. The Company did not recognize any credit-related OTTI losses through earnings related to its investments during the years ended December 31, 2014 and 2013.

104

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

Non-Agency MBS on which OTTI is recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for these Non-Agency MBS is based on its review of the underlying mortgage loans securing these MBS.  The Company considers information available about the structure of the securitization, including structural credit enhancement, if any, and the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, FICO scores at loan origination, year of origination, LTVs, geographic concentrations, as well as Rating Agency reports, general market assessments, and dialogue with market participants.  Changes in the Company’s evaluation of each of these factors impacts the cash flows expected to be collected at the OTTI assessment date. For Non-Agency MBS purchased at a discount to par that were assessed for and had no OTTI recorded this period, such cash flow estimates indicated that the amount of expected losses decreased compared to the previous OTTI assessment date. These positive cash flow changes are primarily driven by recent improvements in LTVs due to loan amortization and home price appreciation, which, in turn, positively impacts the Company’s estimates of default rates and loss severities for the underlying collateral. In addition, voluntary prepayments (i.e. loans that prepay in full with no loss) have generally trended higher for these MBS which also positively impacts the Company’s estimate of expected loss. Overall, the combination of higher voluntary prepayments and lower LTVs supports the Company’s assessment that such MBS are not other-than-temporarily impaired.

The following table presents the composition of OTTI charges recorded by the Company for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014		2013
Total OTTI losses	$	(525	)	$	—	$	—
OTTI reclassified from OCI	(180		)	—		—
OTTI recognized in earnings	$	(705	)	$	—	$	—

The following table presents a roll-forward of the credit loss component of OTTI on the Company’s Non-Agency MBS for which a non-credit component of OTTI was previously recognized in OCI.  Changes in the credit loss component of OTTI are presented based upon whether the current period is the first time OTTI was recorded on a security or a subsequent OTTI charge was recorded.

	For the Year Ended December 31,
(In Thousands)	2015		2014		2013
Credit loss component of OTTI at beginning of period	$	36,115	$	36,115	$	36,115
Additions for credit related OTTI not previously recognized	461		—		—
Subsequent additional credit related OTTI recorded	244		—		—
Credit loss component of OTTI at end of period	$	36,820	$	36,115	$	36,115

105

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

Purchase Discounts on Non-Agency MBS

The following table presents the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and OTTI and accretable purchase discount for the years ended December 31, 2015 and 2014:

	For the Year Ended December 31,
	2015						2014
(In Thousands)	Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)			Discount Designated as Credit Reserve and OTTI (2)			Accretable Discount (1)(2)
Balance at beginning of period	$	(900,557	)	$	(399,564	)	$	(1,043,037	)	$	(460,039	)
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	(15,543		)	1,832			—			—
Accretion of discount	—			93,173			—			103,653
Realized credit losses	80,821			—			89,481			—
Purchases	(1,200		)	(4,925		)	(80,256		)	30,003
Sales	8,525			38,420			44,692			20,360
Net impairment losses recognized in earnings	(705		)	—			—			—
Unlinking of Linked Transactions	—			—			(6,414		)	1,436
Transfers/release of credit reserve	41,118			(41,118		)	94,977			(94,977		)
Balance at end of period	$	(787,541	)	$	(312,182	)	$	(900,557	)	$	(399,564	)

(1) Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.

(2)  The Company reallocated $218,000 of purchase discount designated as Credit Reserve to accretable purchase discount on Non-Agency MBS underlying Linked Transactions for the year ended December 31, 2014.

Impact of AFS Securities on AOCI

The following table presents the impact of the Company’s AFS securities on its AOCI for the years ended December 31, 2015, 2014, and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014			2013
AOCI from AFS securities:
Unrealized gain on AFS securities at beginning of period	$	813,515		$	752,912		$	824,808
Unrealized (loss)/gain on Agency MBS, net	(51,332		)	65,739			(186,568		)
Unrealized (loss)/gain on Non-Agency MBS, net	(143,558		)	29,812			134,505
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	4,537			—			—
Reclassification adjustment for MBS sales included in net income	(37,207		)	(34,948		)	(19,833		)
Reclassification adjustment for OTTI included in net income	(705		)	—			—
Change in AOCI from AFS securities	(228,265		)	60,603			(71,896		)
Balance at end of period	$	585,250		$	813,515		$	752,912

Sales of MBS

During 2015, the Company sold certain Non-Agency MBS for $70.7 million, realizing gross gains of $34.9 million.  During 2014, the Company sold certain Non-Agency MBS for $123.9 million, realizing gross gains of $37.5 million.  During 2013, the

106

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

Company sold certain Non-Agency MBS for $152.6 million realizing gross gains of $25.8 million. The Company has no continuing involvement with any of the sold MBS.

Interest Income on MBS and CRT Securities

The following table presents components of interest income on the Company’s MBS and CRT securities for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014			2013
Agency MBS
Coupon interest	$	147,066		$	189,355		$	213,995
Effective yield adjustment (1)	(41,231		)	(46,812		)	(57,949		)
Interest income	$	105,835		$	142,543		$	156,046
Legacy Non-Agency MBS
Coupon interest	$	183,349		$	212,073		$	253,560
Effective yield adjustment (2)	91,003			103,491			73,189
Interest income	$	274,352		$	315,564		$	326,749
RPL/NPL MBS
Coupon interest	$	87,429		$	898		$	21
Effective yield adjustment (2)	1,789			(132		)	—
Interest income	$	89,218		$	766		$	21
CRT securities
Coupon interest	$	5,844		$	665		$	—
Effective yield adjustment (2)	728			107			—
Interest income	$	6,572		$	772		$	—

(1)  Includes amortization of premium paid net of accretion of purchase discount.  For Agency MBS, interest income is recorded at an effective yield, which reflects net premium amortization based on actual prepayment activity.

(2)  The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield.

4. Residential Whole Loans

Included on the Company’s consolidated balance sheets as of December 31, 2015 and 2014 are approximately $895.1 million and $351.4 million, respectively, of residential whole loans arising from the Company’s 100% equity interest in certificates issued by certain trusts established to acquire the loans. Based on its evaluation of these interests and other factors, the Company has determined that the trusts are required to be consolidated for financial reporting purposes.

Residential Whole Loans at Carrying Value

Residential whole loans at carrying value totaled approximately $271.8 million and $207.9 million at December 31, 2015 and 2014, respectively. The carrying value reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. The carrying value is reduced by any allowance for loan losses established subsequent to acquisition.

For the years ended December 31, 2015 and 2014, a net provision for loan losses of approximately $1.0 million and $137,000, respectively, was recorded, which is included in Operating and Other expense on the Company’s consolidated statement of operations.

107

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following table presents the activity in the Company’s allowance for loan losses on its residential whole loan pools at carrying value for the years ended December 31, 2015 and 2014:

(In Thousands)	For the Year Ended December 31,
	2015		2014
Balance at the beginning of period	$	137	$	—
Provisions for loan losses	1,028		137
Balance at the end of period	$	1,165	$	137

The following table presents information regarding estimates of the contractually required payments, the cash flows expected to be collected, and the estimated fair value of the residential whole loans held at carrying value acquired by the Company for the years ended December 31, 2015 and 2014:

(In Thousands)	For the Year Ended December 31,
	2015			2014
Contractually required principal and interest	$	160,806		$	448,453
Contractual cash flows not expected to be collected (non-accretable yield)	(27,040		)	(100,466		)
Expected cash flows to be collected	133,766			347,987
Interest component of expected cash flows (accretable yield)	(51,413		)	(135,425		)
Fair value at the date of acquisition	$	82,353		$	212,562

The following table presents accretable yield activity for the Company’s residential whole loans held at carrying value for the years ended December 31, 2015 and 2014:

(In Thousands)	For the Year Ended December 31,
	2015			2014
Balance at beginning of period	$	133,012		$	—
Additions	51,413			135,425
Accretion	(15,511		)	(3,996		)
Reclassifications to non-accretable difference, net	6,357			1,583
Balance at end of period	$	175,271		$	133,012

Accretable yield for residential whole loans is the excess of loan cash flows expected to be collected over the purchase price. The cash flows expected to be collected represents the Company’s estimate of the amount and timing of undiscounted principal and interest cash flows. Additions include accretable yield estimates for purchases made during the period and reclassification to accretable yield from non-accretable yield. Accretable yield is reduced by accretion during the period. The reclassifications between accretable and non-accretable yield and the accretion of interest income are based on changes in estimates regarding loan performance and the value of the underlying real estate securing the loans. In future periods, as the Company updates estimates of cash flows expected to be collected from the loans and the underlying collateral, the accretable yield may change. Therefore, the amount of accretable income recorded during the year ended December 31, 2015 is not necessarily indicative of future results.

Residential Whole Loans at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations.

108

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following table presents information regarding the Company’s residential whole loans at fair value at December 31, 2015 and 2014:

(Dollars in Thousands)	December 31, 2015		December 31, 2014
Outstanding principal balance	$	786,330	$	182,613
Aggregate fair value	$	623,276	$	143,472
Number of loans	3,143		885

During the years ended December 31, 2015 and 2014, the Company recorded net gains on residential whole loans held at fair value of $17.7 million and $116,000, respectively.

The following table presents the components of Net gain on residential whole loans held at fair value for the years ended December 31, 2015 and 2014:

	For the Year Ended December 31,
(In Thousands)	2015		2014
Coupon payments and other income received	$	9,303	$	504
Net unrealized gains	6,540		(427		)
Net gain on payoff/liquidation of loans	1,879		39
Total	$	17,722	$	116

5.      Interest Receivable

The following table presents the Company’s interest receivable by investment category at December 31, 2015 and 2014:

	December 31,
(In Thousands)	2015		2014
MBS interest receivable:
Fannie Mae	$	8,999	$	11,761
Freddie Mac	2,177		2,598
Ginnie Mae	15		17
Non-Agency MBS	15,438		16,794
Total MBS interest receivable	26,629		31,170
Residential whole loans	2,259		1,324
CRT securities	92		66
Money market and other investments	22		21
Total interest receivable	$	29,002	$	32,581

109

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

6.      Derivative Instruments

The Company’s derivative instruments are currently comprised of Swaps, which are designated as cash flow hedges against the interest rate risk associated with its borrowings. Prior to 2015, the Company had also entered into Linked Transactions, which were not designated as hedging instruments. (See Notes 2(p), 2(t) and below) The following table presents the fair value of the Company’s derivative instruments and their balance sheet location at December 31, 2015 and 2014:

			December 31,
			2015					2014
Derivative Instrument	Designation	Balance Sheet Location	Notional Amount		Fair Value			Notional Amount		Fair Value
(In Thousands)
Linked Transactions	Non-Hedging	Assets	N/A		N/A			N/A		$	398,336
Non-cleared legacy Swaps (1)	Hedging	Assets	$	450,000	$	1,127		$	450,000	$	3,136
Non-cleared legacy Swaps (1)	Hedging	Liabilities	$	50,000	$	(59	)	$	760,170	$	(4,263	)
Cleared Swaps (2)	Hedging	Liabilities	$	2,550,000	$	(70,467	)	$	2,550,000	$	(57,935	)

(1)  Non-cleared legacy Swaps include Swaps executed and settled bilaterally with counterparties without the use of an organized exchange or central clearing house.

(2) Cleared Swaps include Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties.

Linked Transactions

Prior to January 1, 2015, the Company’s Linked Transactions had been evaluated on a combined basis, reported as forward (derivative) instruments and presented as assets on the Company’s consolidated balance sheets at fair value.  The fair value of Linked Transactions reflected the value of the underlying Non-Agency MBS, linked repurchase agreement borrowings and accrued interest receivable/payable on such instruments.  The Company’s Linked Transactions were not designated as hedging instruments and, as a result, the change in the fair value and net interest income from Linked Transactions had been reported in Other Income, net on the Company’s consolidated statements of operations.

New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. An entity is required to present changes in accounting for transactions outstanding on the effective date as a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. Accordingly, on adoption of the new standard on January 1, 2015, the Company reclassified $1.913 billion of Non-Agency MBS and $4.6 million of CRT securities that were previously reported as a component of Linked Transactions to Non-Agency MBS and CRT securities, respectively on the consolidated balance sheet. In addition, liabilities of $1.520 billion that were previously presented as a component of Linked Transactions were reclassified to Repurchase agreements on the consolidated balance sheet. Furthermore, an amount of $4.5 million representing net unrealized gains on securities previously reported as a component of Linked Transactions as of December 31, 2014 was reclassified from Accumulated deficit to AOCI. These reclassification adjustments had no net impact on the Company’s overall Total Stockholders’ Equity.

110

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following tables present certain information about the Legacy Non-Agency MBS, RPL/NPL MBS, CRT securities and repurchase agreements underlying the Company’s Linked Transactions at December 31, 2014:

Linked Transactions at December 31, 2014

Linked Repurchase Agreements					Linked MBS/CRT Securities
Maturity or Repricing	Balance		Weighted Average Interest Rate			Fair Value		Amortized Cost		Par/Current Face		Weighted Average Coupon Rate
(Dollars in Thousands)					(Dollars in Thousands)
Within 30 days	$	1,514,393	1.47	%	Legacy Non-Agency MBS	$	66,382	$	61,658	$	72,513	4.20	%
>30 days to 90 days	5,200		1.35		RPL/NPL MBS	1,846,807		1,847,118		1,849,974		3.49
Total	$	1,519,593	1.47	%	CRT securities	4,624		4,500		4,500		4.56
					Total	$	1,917,813	$	1,913,276	$	1,926,987	3.52	%

At December 31, 2014, Linked Transactions also included approximately $1.3 million of associated accrued interest receivable and $1.1 million of accrued interest payable.

The following table presents certain information about the components of the unrealized net gains and net interest income from Linked Transactions included in the Company’s consolidated statements of operations for the years ended December 31, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2014			2013
Interest income attributable to MBS underlying Linked Transactions	$	24,443		$	3,869
Interest expense attributable to linked repurchase agreement borrowings underlying Linked Transactions	(8,028		)	(925		)
Change in fair value of Linked Transactions included in earnings	677			281
Unrealized net gains and net interest income from Linked Transactions	$	17,092		$	3,225

Swaps

Consistent with market practice, the Company has agreements with its Swap counterparties that provide for the posting of collateral based on the fair values of its derivative contracts.  Through this margining process, either the Company or its derivative counterparty may be required to pledge cash or securities as collateral.  In addition, Swaps novated to and cleared by a central clearing house are subject to initial margin requirements. Certain derivative contracts provide for cross collateralization with repurchase agreements with the same counterparty.

A number of the Company’s Swap contracts include financial covenants, which, if breached, could cause an event of default or early termination event to occur under such agreements.  Such financial covenants include minimum net worth requirements and maximum debt-to-equity ratios.  If the Company were to cause an event of default or trigger an early termination event pursuant to one of its Swap contracts, the counterparty to such agreement may have the option to terminate all of its outstanding Swap contracts with the Company and, if applicable, any close-out amount due to the counterparty upon termination of the Swap contracts would be immediately payable by the Company.  The Company was in compliance with all of its financial covenants through December 31, 2015.  At December 31, 2015, the aggregate fair value of assets needed to immediately settle Swap contracts that were in a liability position to the Company, if so required, was approximately $72.0 million, including accrued interest payable of approximately $1.5 million.

111

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following table presents the assets pledged as collateral against the Company’s Swap contracts at December 31, 2015 and December 31, 2014:

	December 31,
(In Thousands)	2015		2014
Agency MBS, at fair value	$	38,569	$	57,247
Restricted cash	70,573		66,486
Total assets pledged against Swaps	$	109,142	$	123,733

The use of derivative hedging instruments exposes the Company to counterparty credit risk.  In the event of a default by a derivative counterparty, the Company may not receive payments to which it is entitled under its derivative agreements, and may have difficulty recovering its assets pledged as collateral against such agreements.  If, during the term of a derivative contract, a counterparty should file for bankruptcy, the Company may experience difficulty recovering its assets pledged as collateral which could result in the Company having an unsecured claim against such counterparty’s assets for the difference between the fair value of the derivative and the fair value of the collateral pledged to such counterparty.

The Company’s derivative hedging instruments, or a portion thereof, could become ineffective in the future if the associated repurchase agreements that such derivatives hedge fail to exist or fail to have terms that match those of the derivatives that hedge such borrowings.  At December 31, 2015, all of the Company’s derivatives were deemed effective for hedging purposes and no derivatives were terminated during the years ended December 31, 2015 and 2014.

The Company’s Swaps designated as hedging transactions have the effect of modifying the repricing characteristics of the Company’s repurchase agreements and cash flows for such liabilities.  To date, no cost has been incurred at the inception of a Swap (except for certain transaction fees related to entering into Swaps cleared though a central clearing house), pursuant to which the Company agrees to pay a fixed rate of interest and receive a variable interest rate, generally based on one-month or three-month London Interbank Offered Rate (“LIBOR”), on the notional amount of the Swap. The Company did not recognize any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness during any of the three years ended December 31, 2015.

At December 31, 2015, the Company had Swaps designated in hedging relationships with an aggregate notional amount of $3.050 billion, which had net unrealized losses of $69.4 million, and extended 45 months on average with a maximum term of approximately 92 months. 

The following table presents certain information with respect to the Company’s Swap activity during the year ended December 31, 2015:

(Dollars in Thousands)	December 31, 2015
New Swaps:
Aggregate notional amount	$	—
Weighted average fixed-pay rate	—		%
Initial maturity date	N/A
Number of new Swaps	—
Swaps amortized/expired:
Aggregate notional amount	$	710,170
Weighted average fixed-pay rate	1.96		%

112

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following table presents information about the Company’s Swaps at December 31, 2015 and 2014:

	December 31, 2015						December 31, 2014
Maturity (1)	Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)		Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)
(Dollars in Thousands)
Within 30 days	$	50,000	2.13	%	0.42	%	$	22,290	3.63	%	0.23	%
Over 30 days to 3 months	—		—		—		387,880		1.80		0.16
Over 3 months to 6 months	—		—		—		300,000		2.06		0.17
Over 6 months to 12 months	100,000		0.48		0.32		—		—		—
Over 12 months to 24 months	350,000		0.58		0.27		150,000		1.03		0.16
Over 24 months to 36 months	550,000		1.49		0.32		350,000		0.58		0.16
Over 36 months to 48 months	200,000		1.71		0.42		550,000		1.49		0.16
Over 48 months to 60 months	1,500,000		2.22		0.36		200,000		1.71		0.17
Over 60 months to 72 months	200,000		2.20		0.30		1,500,000		2.22		0.16
Over 72 months to 84 months	—		—		—		200,000		2.20		0.17
Over 84 months (3)	100,000		2.75		0.40		100,000		2.75		0.16
Total Swaps	$	3,050,000	1.82	%	0.34	%	$	3,760,170	1.85	%	0.16	%

(1)  Each maturity category reflects contractual amortization and/or maturity of notional amounts.

(2)  Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively. 

(3) Reflects one Swap with a maturity date of July 2023.

The following table presents the net impact of the Company’s derivative hedging instruments on its interest expense and the weighted average interest rate paid and received for such Swaps for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(Dollars in Thousands)	2015			2014			2013
Interest expense attributable to Swaps	$	53,759		$	69,842		$	59,031
Weighted average Swap rate paid	1.86		%	1.93		%	2.08		%
Weighted average Swap rate received	0.19		%	0.16		%	0.19		%

TBA Short Positions

During 2013, the Company entered into TBA short positions as a means of managing interest rate risk and MBS basis risk associated with its investment and financing activities. A TBA short position is a forward contract for the sale of Agency MBS at a predetermined price, face amount, issuer, coupon and stated maturity on an agreed-upon future date. The specific Agency MBS that could be delivered into the contract upon the settlement date, published each month by SIFMA, are not known at the time of the transaction.

TBA short positions were accounted for as derivative instruments since the Company could not assert that it is probable at inception, and throughout the term of the TBA contract, that it would physically deliver the Agency security upon settlement of the contract. The Company presented TBA short positions as either derivative assets or liabilities, at fair value on its consolidated balance sheets. Gains and losses associated with TBA short positions were reported in Other income, net on the Company’s consolidated statements of operations. During 2013, the Company sold short $350.0 million notional of 15-year Agency MBS 2.5% TBA Securities and realized a loss of $7.5 million on close out of this position. The Company did not have any TBA short positions at December 31, 2015 and 2014.

113

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

Impact of Derivative Hedging Instruments on AOCI

The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014			2013
AOCI from derivative hedging instruments:
Balance at beginning of period	$	(59,062	)	$	(15,217	)	$	(62,831	)
Unrealized (loss)/gain on Swaps, net	(10,337		)	(44,292		)	47,614
Reclassification of unrealized loss on de-designated Swaps	—			447			—
Balance at end of period	$	(69,399	)	$	(59,062	)	$	(15,217	)

Counterparty Credit Risk from Use of Swaps

By using Swaps, the Company is exposed to counterparty credit risk if counterparties to the derivative contracts do not perform as expected.  If a counterparty fails to perform, the Company’s counterparty credit risk is equal to the amount reported as a derivative asset on its consolidated balance sheets to the extent that amount exceeds collateral obtained from the counterparty or, if in a net liability position, the extent to which collateral posted exceeds the liability to the counterparty.  The amounts reported as a derivative asset/(liability) are derivative contracts in a gain/(loss) position, and to the extent subject to master netting arrangements, net of derivatives in a loss/(gain) position with the same counterparty and collateral received/(pledged).  The Company attempts to minimize counterparty credit risk through credit approvals, limits, monitoring procedures, executing master netting arrangements and obtaining collateral, where appropriate.  Counterparty credit risk related to the Company’s Swaps is considered in determining the fair value of such derivatives and in its assessment of hedge effectiveness.

7. Real Estate Owned

At December 31, 2015, the Company had 182 REO properties with an aggregate carrying value of $28.0 million. At December 31, 2014, the Company had 46 REO properties with an aggregate carrying value of $5.5 million. During the years ended December 31, 2015 and 2014, the Company acquired 13 and 24 residential properties, for approximately $1.7 million and $2.6 million, respectively, in connection with the acquisition of residential whole loans.

During the years ended December 31, 2015 and 2014, the Company reclassified 186 and 22 mortgage loans to REO at an aggregate estimated fair value of $30.1 million and $2.9 million, respectively at the time of transfer. Such transfers occur when the Company takes possession of the property by foreclosing on the borrower or completes a “deed-in-lieu of foreclosure” transaction.

At December 31, 2015, $26.1 million of residential real estate property was held by the Company that was acquired either through a completed foreclosure proceeding or from completion of a deed-in-lieu of foreclosure or similar legal agreement. In addition, formal foreclosure proceedings were in process with respect to $17.3 million of residential whole loans at carrying value and $394.9 million of residential whole loans at fair value at December 31, 2015.

During the year ended December 31, 2015, the Company sold 63 REO properties for consideration of $6.5 million, realizing net gains of approximately $76,000 which are included in Other, net on the Company’s consolidated statements of operations. The Company did not sell any REO properties during the year ended December 31, 2014. In addition, following an updated assessment of liquidation amounts expected to be realized that was performed on all REO held at the end of each quarter during the year ended December 31, 2015, an aggregate adjustment of approximately $3.5 million was recorded to reflect certain REO properties at the lower of cost or estimated fair value for the year ended December 31, 2015.

114

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following table presents the activity in the Company’s REO for the years ended December 31, 2015 and 2014. The Company did not have REO prior to 2014.

	For the Year Ended December 31,
(In Thousands)	2015			2014
Balance at beginning of period	$	5,492		$	—
Adjustments to record at lower of cost or fair value	(3,475		)	—
Transfer from residential whole loans (1)	30,104			2,904
Purchases and capital improvements	2,461			2,588
Disposals	(6,556		)	—
Balance at end of period	$	28,026		$	5,492

(1)  Includes net gain recorded on transfer of approximately $1.7 million and $331,000, respectively, for the years ended December 31, 2015 and 2014.

Real estate owned is included in Prepaid and other assets in the Company’s consolidated balance sheets.

8.      Repurchase Agreements and Other Advances

Repurchase Agreements

The Company’s repurchase agreements are accounted for as secured borrowings and are collateralized by the Company’s MBS, U.S. Treasury securities (obtained as part of a reverse repurchase agreement), CRT securities, residential whole loans and cash, and bear interest that is generally LIBOR-based.  (See Notes 2(k) and 9)  At December 31, 2015, the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 21 days and an effective repricing period of 18 months, including the impact of related Swaps.  At December 31, 2014, the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 25 days and an effective repricing period of 21 months, including the impact of related Swaps.

115

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following table presents information with respect to the Company’s borrowings under repurchase agreements and associated assets pledged as collateral at December 31, 2015 and 2014:

(Dollars in Thousands)	December 31, 2015			December 31, 2014
Repurchase agreement borrowings secured by Agency MBS	$	2,727,542		$	5,177,835
Fair value of Agency MBS pledged as collateral under repurchase agreements	$	2,881,049		$	5,462,566
Weighted average haircut on Agency MBS (1)	4.67		%	4.79		%
Repurchase agreement borrowings secured by Legacy Non-Agency MBS (2)	$	1,960,222		$	2,233,236
Fair value of Legacy Non-Agency MBS pledged as collateral under repurchase   agreements (2)(3)	$	2,818,968		$	3,491,312
Weighted average haircut on Legacy Non-Agency MBS (1)	25.42		%	28.88		%
Repurchase agreement borrowings secured by RPL/NPL MBS (2)	$	2,080,163		$	130,919
Fair value of RPL/NPL MBS pledged as collateral under repurchase agreements (2)	$	2,625,866		$	160,688
Weighted average haircut on RPL/NPL MBS (1)	21.37		%	20.00		%
Repurchase agreements secured by U.S. Treasuries	$	504,760		$	507,114
Fair value of U.S. Treasuries pledged as collateral under repurchase agreements	$	507,443		$	512,105
Weighted average haircut on U.S. Treasuries (1)	1.60		%	1.62		%
Repurchase agreements secured by CRT securities (2)	$	128,465		$	75,960
Fair value of CRT securities pledged as collateral under repurchase agreements (2)	$	170,352		$	94,610
Weighted average haircut on CRT securities (1)	25.04		%	25.00		%
Repurchase agreements secured by residential whole loans	$	487,750		$	142,324
Fair value of residential whole loans pledged as collateral under repurchase agreements	$	684,136		$	212,986
Weighted average haircut on residential whole loans (1)	27.69		%	33.43		%

(1)  Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount.

(2)  Does not reflect Legacy Non-Agency MBS, RPL/NPL MBS, CRT securities and repurchase agreement borrowings that were components of Linked Transactions at December 31, 2014. As previously discussed, new accounting guidance effective January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 6)

(3)  Includes $570.5 million and $1.275 billion of Legacy Non-Agency MBS acquired from consolidated VIEs at December 31, 2015 and 2014, respectively, that are eliminated from the Company’s consolidated balance sheets.

The following table presents repricing information about the Company’s borrowings under repurchase agreements, which does not reflect the impact of associated derivative hedging instruments, at December 31, 2015 and 2014:

	December 31, 2015				December 31, 2014
Time Until Interest Rate Reset	Balance		Weighted Average Interest Rate		Balance (1)		Weighted Average Interest Rate
(Dollars in Thousands)
Within 30 days	$	7,054,483	1.44	%	$	7,144,737	0.72	%
Over 30 days to 3 months	734,955		1.79		1,000,313		1.12
Over 3 months to 12 months	99,464		2.36		122,338		1.98
Total	$	7,888,902	1.48	%	$	8,267,388	0.79	%

(1)  At December 31, 2014, the Company had repurchase agreements of $1.520 billion that were linked to securities purchased and accounted for as Linked Transactions, and as such, the linked repurchase agreements are not included in the above table. As previously discussed, new accounting guidance effective January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 6)

116

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following table presents contractual maturity information about the Company’s borrowings under repurchase agreements, all of which are accounted for as secured borrowings, at December 31, 2015 and does not reflect the impact of derivative contracts that hedge such repurchase agreements:

	December 31, 2015
Contractual Maturity	Agency MBS		Legacy Non-Agency MBS		RPL/NPL MBS		U.S. Treasuries		CRT Securities		Residential Whole Loans		Total		Weighted  Average Interest Rate
(Dollars in Thousands)
Overnight	$	—	$	—	$	—	$	—	$	—	$	—	$	—	—	%
Within 30 days	2,563,741		892,341		1,670,586		504,760		110,921		—		5,742,349		1.27
Over 30 days to 3 months	163,801		613,131		143,705		—		17,544		—		938,181		1.71
Over 3 months to 12 months	—		454,750		265,872		—		—		293,641		1,014,263		2.19
Over 12 months	—		—		—		—		—		194,109		194,109		3.11
Total	$	2,727,542	$	1,960,222	$	2,080,163	$	504,760	$	128,465	$	487,750	$	7,888,902	1.48	%
Gross amount of recognized liabilities for repurchase agreements in Note 10													$	7,888,902
Amounts related to repurchase agreements not included in offsetting disclosure in Note 10													$	—

The Company had repurchase agreements with 27 and 25 counterparties at December 31, 2015 and 2014, respectively.  The following table presents information with respect to each counterparty under repurchase agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at December 31, 2015:

	December 31, 2015
Counterparty	Counterparty Rating (1)	Amount at Risk (2)		Weighted Average Months to Maturity for Repurchase Agreements	Percent of Stockholders’ Equity
(Dollars in Thousands)
Credit Suisse	BBB+/Aa2/A	$	410,814	1	13.8	%
Wells Fargo (3)	AA-/Aa2/AA	334,613		6	11.3
RBC (4)	AA-/Aa3/AA	327,400		2	11.0
UBS (5)	A/A1/A	214,107		19	7.2
Goldman Sachs	BBB+/A3/A	152,055		9	5.1

(1) As rated at December 31, 2015 by S&P, Moody’s and Fitch, Inc., respectively.  The counterparty rating presented is the lowest published for these entities.

(2) The amount at risk reflects the difference between (a) the amount loaned to the Company through repurchase agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities.

(3)  Includes $269.7 million at risk with Wells Fargo Bank, NA and $64.9 million at risk with Wells Fargo Securities LLC. 

(4) Includes $309.8 million at risk with RBC Barbados, $10.7 million at risk with Royal Bank of Canada and $6.8 million at risk with RBC Capital Markets LLC. Counterparty ratings are not published for RBC Barbados and RBC Capital Markets LLC.

(5) Includes Non-Agency MBS pledged as collateral with contemporaneous repurchase and reverse repurchase agreements.

FHLB Advances

As of December 31, 2015, MFA Insurance had $1.500 billion in outstanding long-term secured FHLB advances with a weighted average borrowing rate of 0.50% and a weighted average term to maturity of 4.79 years. However, MFA Insurance is required by recent amendments to FHLB membership regulations to terminate its membership and repay the outstanding advances by February 19, 2017. (See Note 18) Interest payable on outstanding FHLB advances at December 31, 2015 totaled approximately $508,000, and is included in Accrued interest payable on the Company’s consolidated balance sheets.

117

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

9.      Collateral Positions

The Company pledges securities or cash as collateral to its counterparties pursuant to its borrowings under repurchase agreements, FHLB advances and its derivative contracts that are in an unrealized loss position, and it receives securities or cash as collateral pursuant to financing provided under reverse repurchase agreements and certain of its derivative contracts in an unrealized gain position.  The Company exchanges collateral with its counterparties based on changes in the fair value, notional amount and term of the associated repurchase agreements, FHLB advances and derivative contracts, as applicable.  Through this margining process, either the Company or its counterparty may be required to pledge cash or securities as collateral.  In addition, Swaps novated to and cleared by a central clearing house are subject to initial margin requirements. When the Company’s pledged collateral exceeds the required margin, the Company may initiate a reverse margin call, at which time the counterparty may either return the excess collateral, or provide collateral to the Company in the form of cash or equivalent securities.

The following table summarizes the fair value of the Company’s collateral positions, which includes collateral pledged and collateral held, with respect to its borrowings under repurchase agreements, reverse repurchase agreements, derivative hedging instruments and FHLB advances at December 31, 2015 and 2014: 

	December 31, 2015				December 31, 2014
(In Thousands)	Assets Pledged		Collateral Held		Assets Pledged		Collateral Held
Derivative Hedging Instruments:
Agency MBS	$	38,569	$	—	$	57,247	$	—
Cash (1)	70,573		—		66,486		—
	109,142		—		123,733		—
Repurchase Agreement Borrowings:
Agency MBS	2,881,049		—		5,462,566		—
Legacy Non-Agency MBS (2)(3)	2,818,968		—		3,491,312		—
RPL/NPL MBS	2,625,866		—		160,688		—
U.S. Treasury securities	507,443		—		512,105		—
CRT securities	170,352		—		94,610		—
Residential whole loans	684,136		—		212,986		—
Cash (1)	965		—		769		—
	9,688,779		—		9,935,036		—
FHLB Advances:
Agency MBS	1,612,476		—		—		—
	1,612,476		—		—		—
Reverse Repurchase Agreements:
U.S. Treasury securities	—		507,443		—		512,105
	—		507,443		—		512,105
Total	$	11,410,397	$	507,443	$	10,058,769	$	512,105

(1) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets.

(2) Includes $570.5 million and $1.275 billion of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at December 31, 2015 and 2014, respectively, that are eliminated from the Company’s consolidated balance sheets.

(3) In addition, at December 31, 2015 and 2014, $726.7 million and $731.0 million of Legacy Non-Agency MBS, respectively, are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty.

118

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following table presents detailed information about the Company’s assets pledged as collateral pursuant to its borrowings under repurchase agreements and other advances, and derivative hedging instruments at December 31, 2015:

	December 31, 2015
	Assets Pledged Under Repurchase Agreements and Other Advances						Assets Pledged Against Derivative Hedging Instruments						Total Fair Value of Assets Pledged and Accrued Interest
(In Thousands)	Fair Value		Amortized Cost		Accrued Interest on Pledged Assets		Fair Value/ Carrying Value		Amortized Cost		Accrued Interest on Pledged Assets
Agency MBS (1)	$	4,493,525	$	4,465,081	$	10,593	$	38,569	$	39,460	$	80	$	4,542,767
Legacy Non-Agency MBS(2)(3)	2,818,968		2,278,870		10,241		—		—		—		2,829,209
RPL/NPL MBS	2,625,866		2,644,797		1,592		—		—		—		2,627,458
U.S. Treasuries	507,443		507,443		—		—		—		—		507,443
CRT securities	170,352		173,367		83		—		—		—		170,435
Residential whole loans	684,136		673,788		952		—		—		—		685,088
Cash (4)	965		965		—		70,573		70,573		—		71,538
Total	$	11,301,255	$	10,744,311	$	23,461	$	109,142	$	110,033	$	80	$	11,433,938

(1)  Includes Agency MBS pledged under FHLB advances with an aggregate fair value of $1.612 billion, aggregate amortized cost of $1.606 billion and aggregate accrued interest of approximately $3.9 million at December 31, 2015.

(2) Includes $570.5 million of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at December 31, 2015, that are eliminated from the Company’s consolidated balance sheets.

(3)  In addition, at December 31, 2015, $726.7 million of Legacy Non-Agency MBS are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty.

(4) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets.

119

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

10.      Offsetting Assets and Liabilities

The following tables present information about certain assets and liabilities that are subject to master netting arrangements (or similar agreements) and may potentially be offset on the Company’s consolidated balance sheets at December 31, 2015 and 2014:

Offsetting of Financial Assets and Derivative Assets

	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Consolidated Balance Sheets		Net Amounts of Assets Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in  the Consolidated Balance Sheets					Net Amount
(In Thousands)							Financial Instruments			Cash  Collateral  Received
December 31, 2015
Swaps, at fair value	$	1,127	$	—	$	1,127	$	(1,127	)	$	—	$	—
Total	$	1,127	$	—	$	1,127	$	(1,127	)	$	—	$	—
December 31, 2014
Swaps, at fair value	$	3,136	$	—	$	3,136	$	(3,136	)	$	—	$	—
Total	$	3,136	$	—	$	3,136	$	(3,136	)	$	—	$	—

Offsetting of Financial Liabilities and Derivative Liabilities

	Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Consolidated Balance Sheets		Net Amounts of Liabilities Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in the  Consolidated Balance Sheets						Net Amount
(In Thousands)							Financial  Instruments (1)			Cash  Collateral  Pledged (1)
December 31, 2015
Swaps, at fair value (2)	$	70,526	$	—	$	70,526	$	—		$	(70,526	)	$	—
Repurchase agreements and   other advances (3)	9,388,902		—		9,388,902		(9,387,937		)	(965		)	—
Total	$	9,459,428	$	—	$	9,459,428	$	(9,387,937	)	$	(71,491	)	$	—
December 31, 2014
Swaps, at fair value (2)	$	62,198	$	—	$	62,198	$	—		$	(62,198	)	$	—
Repurchase agreements (3)	8,267,388		—		8,267,388		(8,266,619		)	(769		)	—
Total	$	8,329,586	$	—	$	8,329,586	$	(8,266,619	)	$	(62,967	)	$	—

(1) Amounts disclosed in the Financial Instruments column of the table above represent collateral pledged that is available to be offset against liability balances associated with repurchase agreements and other advances, and derivative transactions.  Amounts disclosed in the Cash Collateral Pledged column of the table above represent amounts pledged as collateral against derivative transactions and repurchase agreements, and exclude excess collateral of $47,000 and $4.3 million at December 31, 2015 and 2014, respectively.

(2) The fair value of securities pledged against the Company’s Swaps was $38.6 million and $57.2 million at December 31, 2015 and 2014, respectively.

(3) The fair value of financial instruments pledged against the Company’s repurchase agreements and other advances was $11.300 billion and $9.934 billion at December 31, 2015 and 2014, respectively.

120

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

Nature of Setoff Rights

In the Company’s consolidated balance sheets, all balances associated with the repurchase agreement and derivative transactions are presented on a gross basis.

Certain of the Company’s repurchase agreement and derivative transactions are governed by underlying agreements that generally provide for a right of setoff in the event of default or in the event of a bankruptcy of either party to the transaction.  For one repurchase agreement counterparty, the underlying agreements provide for an unconditional right of setoff.  

11.      Senior Notes

On April 11, 2012 the Company issued $100.0 million in aggregate principal amount of its Senior Notes in an underwritten public offering.  The total net proceeds to the Company from the offering of the Senior Notes were approximately $96.6 million, after deducting offering expenses and the underwriting discount.  The Senior Notes bear interest at a fixed rate of 8.00% per year, paid quarterly in arrears on January 15, April 15, July 15 and October 15 of each year and will mature on April 15, 2042.  The Company may redeem the Senior Notes, in whole or in part, at any time on or after April 15, 2017 at a redemption price equal to 100% of the principal amount redeemed plus accrued and unpaid interest to, but not excluding, the redemption date.

The Senior Notes are the Company’s senior unsecured obligations and are subordinate to all of the Company’s secured indebtedness, which includes the Company’s repurchase agreements, obligation to return securities obtained as collateral, and other financing arrangements, to the extent of the value of the collateral securing such indebtedness.

12.    Commitments and Contingencies

(a)  Lease Commitments

The Company pays monthly rent pursuant to two operating leases.  The lease term for the Company’s headquarters in New York, New York extends through May 31, 2020.  The lease provides for aggregate cash payments ranging over time of approximately $2.5 million per year, paid on a monthly basis, exclusive of escalation charges.  In addition, as part of this lease agreement, the Company has provided the landlord a $785,000 irrevocable standby letter of credit fully collateralized by cash.  The letter of credit may be drawn upon by the landlord in the event that the Company defaults under certain terms of the lease.  In addition, the Company has a lease through December 31, 2016 for its off-site back-up facility located in Rockville Centre, New York, which provides for, among other things, lease payments totaling $30,000, annually.

The Company recognized lease expense of $2.6 million, $2.5 million and $2.7 million for the years ended December 31, 2015, 2014 and 2013, respectively, which is included in Other general and administrative expense within the consolidated statements of operations.  At December 31, 2015, the contractual minimum rental payments (exclusive of possible rent escalation charges and normal recurring charges for maintenance, insurance and taxes) were as follows:

Year Ended December 31,	Minimum Rental Payments
(In Thousands)
2016	$	2,552
2017	2,522
2018	2,522
2019	2,522
2020	1,050
Total	$	11,168

(b)  Representations and Warranties in Connection with Resecuritization Transactions

In connection with the resecuritization transactions engaged in by the Company (See Note 17 for further discussion), the Company has the obligation under certain circumstances to repurchase assets from its VIEs upon breach of certain representations and warranties.

121

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

13.    Stockholders’ Equity

(a) Preferred Stock

Redemption of 8.50% Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”)

On May 16, 2013 (the “Redemption Date”), the Company redeemed all 3,840,000 outstanding shares of its Series A Preferred Stock at an aggregate redemption price of approximately $97.0 million, or $25.27153 per share, including all accrued and unpaid dividends to the Redemption Date. The redemption value of the Series A Preferred Stock exceeded its carrying value by $3.9 million, which represents the original offering costs for the Series A Preferred Stock. This amount was included in the determination of net income available to common stock and participating securities from the Redemption Date through the year ended December 31, 2013.  In addition, as part of the redemption price on its Series A Preferred Stock, the Company paid a dividend of $0.27153 per share, which reflected accrued and unpaid dividends for the period from April 1, 2013 through and including the Redemption Date.

Issuance of 7.50% Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”)

On April 15, 2013, the Company filed articles supplementary amending its charter to reclassify 8,050,000 shares of the Company’s authorized but unissued common stock as shares of the Company’s Series B Preferred Stock. On the same date, the Company completed the issuance of 8.0 million shares of its Series B Preferred Stock with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The aggregate net proceeds to the Company from the offering of the Series B Preferred Stock were approximately $193.3 million, after deducting the underwriting discount and related offering expenses. The Company used a portion of the net proceeds to redeem all of its outstanding Series A Preferred Stock (as discussed above), and used the remaining net proceeds of the offering for general corporate purposes, including, without limitation, to acquire additional MBS consistent with its investment policy, and for working capital, which included, among other things, the repayment of its repurchase agreements.

The Company’s Series B Preferred Stock is entitled to receive a dividend at a rate of 7.50% per year on the $25.00 liquidation preference before the Company’s common stock is paid any dividends and is senior to the Company’s common stock with respect to distributions upon liquidation, dissolution or winding up. Dividends on the Series B Preferred Stock are payable quarterly in arrears on or about March 31, June 30, September 30 and December 31 of each year. The Series B Preferred Stock is redeemable at $25.00 per share plus accrued and unpaid dividends (whether or not authorized or declared) exclusively at the Company’s option commencing on April 15, 2018 (subject to the Company’s right, under limited circumstances, to redeem the Series B Preferred Stock prior to that date in order to preserve its qualification as a REIT and upon certain specified change in control transactions in which the Company’s common stock and the acquiring or surviving entity common securities would not be listed on the New York Stock Exchange (the “NYSE”), the NYSE MKT or NASDAQ, or any successor exchanges).

On May 20, 2013, the Company declared the first dividend payable on the Series B Preferred Stock, which was paid on July 1, 2013 to preferred stockholders of record as of June 3, 2013. The amount of such dividend payable was $0.39583 per share, and was paid in respect of the partial period commencing on April 15, 2013, the date of original issue of the Series B Preferred Stock, and ending on, and including, June 30, 2013.

The Series B Preferred Stock generally does not have any voting rights, subject to an exception in the event the Company fails to pay dividends on such stock for six or more quarterly periods (whether or not consecutive).  Under such circumstances, the Series B Preferred Stock will be entitled to vote to elect two additional directors to the Company’s Board of Directors (the “Board”), until all unpaid dividends have been paid or declared and set apart for payment.  In addition, certain material and adverse changes to the terms of the Series B Preferred Stock cannot be made without the affirmative vote of holders of at least 66 2/3% of the outstanding shares of Series B Preferred Stock.

122

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2013 through December 31, 2015:

Year	Declaration Date	Record Date	Payment Date	Dividend Per Share
2015	November 19, 2015	December 3, 2015	December 31, 2015	$0.46875
	August 24, 2015	September 9, 2015	September 30, 2015	0.46875
	May 18, 2015	June 2, 2015	June 30, 2015	0.46875
	February 13, 2015	February 27, 2015	March 31, 2015	0.46875
2014	November 21, 2014	December 5, 2014	December 31, 2014	$0.46875
	August 25, 2014	September 8, 2014	September 30, 2014	0.46875
	May 19, 2014	June 10, 2014	June 30, 2014	0.46875
	February 14, 2014	February 28, 2014	March 31, 2014	0.46875
2013	November 19, 2013	December 3, 2013	December 31, 2013	$0.46875
	August 22, 2013	September 5, 2013	September 30, 2013	0.46875
	May 20, 2013	June 3, 2013	July 1, 2013	0.39583

(b)  Dividends on Common Stock

The following table presents cash dividends declared by the Company on its common stock from January 1, 2013 through December 31, 2015:

Year	Declaration Date	Record Date	Payment Date	Dividend Per Share
2015	December 9, 2015	December 28, 2015	January 29, 2016	$0.20	(1)
	September 17, 2015	September 29, 2015	October 30, 2015	0.20
	June 15, 2015	June 29, 2015	July 31, 2015	0.20
	March 13, 2015	March 27, 2015	April 30, 2015	0.20
2014	December 9, 2014	December 26, 2014	January 30, 2015	$0.20
	September 17, 2014	September 29, 2014	October 31, 2014	0.20
	June 13, 2014	June 27, 2014	July 31, 2014	0.20
	March 10, 2014	March 28, 2014	April 30, 2014	0.20
2013	December 11, 2013	December 31, 2013	January 31, 2014	$0.20
	September 26, 2013	October 11, 2013	October 31, 2013	0.22
	August 1, 2013	August 12, 2013	August 30, 2013	0.28	(2)
	June 28, 2013	July 12, 2013	July 31, 2013	0.22
	March 28, 2013	April 12, 2013	April 30, 2013	0.22
	March 4, 2013	March 18, 2013	April 10, 2013	0.50	(3)

(1)  At December 31, 2015, the Company had accrued dividends and dividend equivalents payable of $74.6 million related to the common stock dividend declared on December 9, 2015.

(2) Reflects the special cash dividend on common stock declared on August 1, 2013.

(3) Reflects the special cash dividend on common stock declared on March 4, 2013.

123

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

In general, the Company’s common stock dividends have been characterized as ordinary income to its stockholders for income tax purposes.  However, a portion of the Company’s common stock dividends may, from time to time, be characterized as capital gains or return of capital.  For the year ended December 31, 2015, a portion of the Company’s common stock dividends were deemed to be capitalized gains. For the years ended December 31, 2014 and 2013, our common stock dividends were characterized as ordinary income to stockholders.

(c) Discount Waiver, Direct Stock Purchase and Dividend Reinvestment Plan (“DRSPP”)

On August 8, 2013, the Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (“SEC”) under the Securities Act of 1933, as amended (the “1933 Act”), for the purpose of registering additional common stock for sale through its DRSPP.  Pursuant to Rule 462(e) of the 1933 Act, this shelf registration statement became effective automatically upon filing with the SEC and, when combined with the unused portion of the Company’s previous DRSPP shelf registration statements, registered an aggregate of 15 million shares of common stock.  The Company’s DRSPP is designed to provide existing stockholders and new investors with a convenient and economical way to purchase shares of common stock through the automatic reinvestment of dividends and/or optional cash investments.  At December 31, 2015, 6.8 million shares of common stock remained available for issuance pursuant to the DRSPP shelf registration statement.

During the years ended December 31, 2015, 2014 and 2013, the Company issued 162,373, 4,526,855 and 9,511,739 shares of common stock through the DRSPP, raising net proceeds of approximately $1.2 million, $35.6 million and $77.6 million, respectively.  From the inception of the DRSPP in September 2003 through December 31, 2015, the Company issued 30,728,992 shares pursuant to the DRSPP, raising net proceeds of $258.3 million.

(d)  Stock Repurchase Program

As previously disclosed, in August 2005, the Company’s Board authorized a stock repurchase program (the “Repurchase Program”) to repurchase up to 4.0 million shares of its outstanding common stock. The Board reaffirmed such authorization in May 2010.  In December 2013, the Board increased the number of shares authorized under the Repurchase Program to an aggregate of 10.0 million. Such authorization does not have an expiration date and, at present, there is no intention to modify or otherwise rescind such authorization.  Subject to applicable securities laws, repurchases of common stock under the Repurchase Program are made at times and in amounts as the Company deems appropriate, (including, in our discretion, through the use of one or more plans adopted under Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended (the “1934 Act”)) using available cash resources.  Shares of common stock repurchased by the Company under the Repurchase Program are cancelled and, until reissued by the Company, are deemed to be authorized but unissued shares of the Company’s common stock.  The Repurchase Program may be suspended or discontinued by the Company at any time and without prior notice. The Company did not repurchase any shares of its common stock during the years ended December 31, 2015 and 2014. During the year ended December 31, 2013, the Company repurchased 2,143,354 shares of its common stock at a total cost of approximately $15.4 million and an average cost of $7.20 per share. At December 31, 2015, 6,616,355 shares remained authorized for repurchase under the Repurchase Program.

124

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

(e) Accumulated Other Comprehensive Income/(Loss)

The following table presents changes in the balances of each component of the Company’s AOCI for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
	2015									2014									2013
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities			Net  Unrealized Gain/(Loss) on Swaps			Total  AOCI			Net  Unrealized Gain/(Loss) on AFS Securities			Net  Unrealized Gain/(Loss) on Swaps			Total  AOCI			Net  Unrealized Gain/(Loss) on AFS Securities			Net  Unrealized Gain/(Loss) on Swaps			Total  AOCI
Balance at beginning of period	$	813,515		$	(59,062	)	$	754,453		$	752,912		$	(15,217	)	$	737,695		$	824,808		$	(62,831	)	$	761,977
OCI before reclassifications	(194,890		)	(10,337		)	(205,227		)	95,551			(44,292		)	51,259			(52,063		)	47,614			(4,449		)
Amounts reclassified from   AOCI (1)	(37,912		)	—			(37,912		)	(34,948		)	447			(34,501		)	(19,833		)	—			(19,833		)
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	4,537			—			4,537			—			—			—			—			—			—
Net OCI during period (2)	(228,265		)	(10,337		)	(238,602		)	60,603			(43,845		)	16,758			(71,896		)	47,614			(24,282		)
Balance at end of period	$	585,250		$	(69,399	)	$	515,851		$	813,515		$	(59,062	)	$	754,453		$	752,912		$	(15,217	)	$	737,695

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the years ended December 31, 2015, 2014, and 2013:

	For the Year Ended December 31,
	2015			2014			2013
Details about AOCI Components	Amounts Reclassified from AOCI									Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(37,207	)	$	(34,948	)	$	(19,833	)	Gain on sales of MBS and U.S. Treasury securities, net
OTTI recognized in earnings	(705		)	—			—			Net impairment losses recognized in earnings
Total AFS Securities	(37,912		)	(34,948		)	(19,833		)
Swaps designated as cash flow hedges:
De-designated Swaps	—			447			—			Other, net
Total Swaps designated as cash flow hedges	—			447			—
Total reclassifications for period	$	(37,912	)	$	(34,501	)	$	(19,833	)

At December 31, 2015, and 2014 the Company had unrealized losses recorded in AOCI of $1.3 million, and $629,000, respectively, on securities for which OTTI had been recognized in earnings in prior periods.

125

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

14.    EPS Calculation

The following table presents a reconciliation of the earnings and shares used in calculating basic and diluted EPS for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands, Except Per Share Amounts)	2015			2014			2013
Numerator:
Net income	$	313,226		$	313,504		$	302,709
Dividends declared on preferred stock	(15,000		)	(15,000		)	(13,750		)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities	(1,539		)	(1,106		)	(1,080		)
Issuance costs of redeemed preferred stock (1)	—			—			(3,947		)
Net income available to common stockholders - basic and diluted	$	296,687		$	297,398		$	283,932
Denominator:
Weighted average common shares for basic and diluted earnings per share (2)	372,114			369,048			362,399
Basic and diluted earnings per share	$	0.80		$	0.81		$	0.78

(1) Issuance costs of redeemed preferred stock represent the original offering costs related to the Series A Preferred Stock, which was redeemed on May 16, 2013. (See Note 13)

(2) At December 31, 2015, the Company had an aggregate of 2.0 million equity instruments outstanding that were not included in the calculation of diluted EPS for the year ended December 31, 2015, as their inclusion would have been anti-dilutive.  These equity instruments were comprised of approximately 111,000 shares of restricted common stock with a weighted average grant date fair value of $7.41 and approximately $1.9 million RSUs with a weighted average grant date fair value of $6.90.  These equity instruments may have a dilutive impact on future EPS.

15.Equity Compensation, Employment Agreements and Other Benefit Plans

(a)  Equity Compensation Plan

In accordance with the terms of the Company’s Equity Compensation Plan (the “Equity Plan”), which was adopted by the Company’s stockholders on May 21, 2015 (and which amended and restated the Company’s 2010 Equity Compensation Plan, directors, officers and employees of the Company and any of its subsidiaries and other persons expected to provide significant services for the Company and any of its subsidiaries are eligible to receive grants of stock options (“Options”), restricted stock, RSUs, dividend equivalent rights and other stock-based awards under the Equity Plan.

 Subject to certain exceptions, stock-based awards relating to a maximum of 12.0 million shares of common stock may be granted under the Equity Plan; forfeitures and/or awards that expire unexercised do not count towards this limit.  At December 31, 2015, approximately 9.4 million shares of common stock remained available for grant in connection with stock-based awards under the Equity Plan.  A participant may generally not receive stock-based awards in excess of 1,500,000 shares of common stock in any one year and no award may be granted to any person who, assuming exercise of all Options and payment of all awards held by such person, would own or be deemed to own more than 9.8% of the outstanding shares of the Company’s common stock.  Unless previously terminated by the Board, awards may be granted under the Equity Plan until May 20, 2025.

Dividend Equivalents

A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock. Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Equity Plan, and they are paid in cash or other consideration at such times and in accordance with such rules, as the Compensation Committee of the Board (the “Compensation Committee”) shall determine in its discretion. Payments made on the Company’s outstanding dividend equivalent rights that have been granted as a separate instrument are charged to Stockholders’ Equity when common stock dividends are declared to the extent that such equivalents are

126

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

expected to vest.  The Company made payments in respect of such separate instruments of approximately $16,000, $69,000 and $412,000 during the years ended December 31, 2015, 2014 and 2013, respectively.  The dividend equivalent payments made in respect of such separate instruments for the year ended December 31, 2013, reflect special cash dividends paid of $0.78 per share, or approximately $194,000. At December 31, 2015, there were 8,215 dividend equivalent rights outstanding, which had been awarded separately from, but in connection with, grants of RSUs made in prior years. A 0% forfeiture rate was assumed with respect to such dividend equivalent rights outstanding at December 31, 2015.  At December 31, 2015, the Company had unrecognized compensation expense of approximately $44,000 related to such dividend equivalent rights, which are scheduled to elapse over a weighted average period of 6 months.

The following table presents information about the Company’s dividend equivalents rights awarded as separate instruments at and for each of the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
	2015		2014		2013
	Number of Dividend Equivalent Rights
Outstanding at beginning of year:	24,402		218,225		266,075
Granted	—		—		—
Cancelled, forfeited or expired	(16,187	)	(193,823	)	(47,850	)
Outstanding at end of year	8,215		24,402		218,225

The weighted average grant date fair value of the dividend equivalent rights in the above table is $2.77. The determination of the weighted average grant date fair value of these awards required the Company to estimate certain valuation inputs.  In determining the fair value for these awards granted in 2011, the Company applied:  (i) a weighted average volatility estimate of approximately 31%, which was determined considering historic volatility in the price of Company’s common stock over the six-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 2.23% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 13%.

Options

Pursuant to Section 422(b) of the Code, in order for Options granted under the Equity Plan and vesting in any one calendar year to qualify as an incentive stock option (“ISO”) for tax purposes, the market value of the common stock to be received upon exercise of such Options as determined on the date of grant shall not exceed $100,000 during such calendar year.  The exercise price of an ISO may not be lower than 100% (or 110% in the case of an ISO granted to a 10% stockholder) of the fair market value of the Company’s common stock on the date of grant.  The exercise price for any other type of Option issued under the Equity Plan may not be less than the fair market value on the date of grant.  Each Option is exercisable after the period or periods specified in the award agreement, which will generally not exceed ten years from the date of grant.

127

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

At December 31, 2015, the Company had no Options outstanding.  The following table presents information about the Company’s Options at and for each of the years ended December 31, 2014 and 2013:

	For the Year Ended December 31,
	2014				2013
	Number of Options		Weighted Average Exercise Price		Number of Options		Weighted Average Exercise Price
Outstanding at beginning of year:	5,000		$	8.40	427,000		$	10.14
Granted	—		—		—		—
Cancelled, forfeited or expired	(5,000	)	8.40		(402,000	)	10.25
Exercised (1)	—		—		(20,000	)	8.40
Outstanding at end of year	—		$	—	5,000		$	8.40
Options exercisable at end of year	—		$	—	5,000		$	8.40

(1) For the year ended December 31, 2013, the intrinsic value of Options exercised was approximately $19,000.

Restricted Stock

At December 31, 2015 and December 31, 2014, the Company had unrecognized compensation expense of approximately $807,000 and $1.8 million, respectively, related to the unvested shares of restricted common stock.  The Company had accrued dividends payable of approximately $193,000 and $312,000 on unvested shares of restricted stock at December 31, 2015 and December 31, 2014, respectively. The total fair value of restricted shares vested during the years ended December 31, 2015, 2014 and 2013 was approximately $4.3 million, $5.7 million and $2.1 million, respectively.  The unrecognized compensation expense at December 31, 2015 is expected to be recognized over a weighted average period of 1.5 years.

The following table presents information with respect to the Company’s restricted stock for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
	2015				2014				2013
	Shares of Restricted Stock		Weighted Average Grant Date Fair Value (1)		Shares of Restricted Stock		Weighted Average Grant Date Fair Value (1)		Shares of Restricted Stock		Weighted Average Grant Date Fair Value (1)
Outstanding at beginning of year:	243,948		$	7.48	443,967		$	7.50	483,442		$	7.74
Granted	497,007		6.83		491,797		8.29		231,531		7.33
Vested (2)	(629,212	)	6.98		(690,397	)	8.07		(270,456	)	7.77
Cancelled/forfeited	(823	)	7.74		(1,419	)	7.58		(550	)	7.72
Outstanding at end of year	110,920		$	7.41	243,948		$	7.48	443,967		$	7.50

(1) The grant date fair value of restricted stock awards is based on the closing market price of the Company’s common stock at the grant date.

(2) All restrictions associated with restricted stock are removed on vesting.

Restricted Stock Units

Under the terms of the Equity Plan, RSUs are instruments that provide the holder with the right to receive, subject to the satisfaction of conditions set by the Compensation Committee at the time of grant, a payment of a specified value, which may be a share of the Company’s common stock, the fair market value of a share of the Company’s common stock, or such fair market value to the extent in excess of an established base value, on the applicable settlement date.  Although the Equity Plan permits the Company to issue RSUs that can settle in cash, all of the Company’s outstanding RSUs as of December 31, 2015 are designated to be settled in shares of the Company’s common stock.  All RSUs outstanding at December 31, 2015 may be entitled to receive dividend equivalent payments depending on the terms and conditions of the award either in cash at the time dividends are paid by

128

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

the Company, or for certain performance-based RSU awards, as a grant of stock at the time such awards are settled. At December 31, 2015 and December 31, 2014, the Company had unrecognized compensation expense of $4.0 million and $2.7 million, respectively, related to RSUs.   The unrecognized compensation expense at December 31, 2015 is expected to be recognized over a weighted average period of 1.7 years.  A 0% forfeiture rate was assumed with respect to unvested RSUs at December 31, 2015.

129

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following table presents information with respect to the Company’s RSUs during the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31, 2015
	RSUs With Service Condition		Weighted Average Grant Date Fair Value		RSUs With Market and Service Conditions		Weighted Average Grant Date Fair Value		Total RSUs		Total  Weighted Average  Grant Date  Fair Value
Outstanding at beginning of year:	769,174		$	7.55	449,300		$	5.61	1,218,474		$	6.84
Granted (1)	390,804		7.96		291,250		5.73		682,054		7.01
Settled	(17,298	)	6.60		—		—		(17,298	)	6.60
Cancelled/forfeited	(3,750	)	7.97		(3,750	)	5.73		(7,500	)	6.85
Outstanding at end of year	1,138,930		$	7.71	736,800		$	5.66	1,875,730		$	6.90
RSUs vested but not settled at end of year	554,023		$	7.83	175,500		$	5.21	729,523		$	7.20
RSUs unvested at end of year	584,907		$	7.59	561,300		$	5.80	1,146,207		$	6.71

	For the Year Ended December 31, 2014
	RSUs With Service Condition		Weighted Average Grant Date Fair Value		RSUs With Market and Service Conditions		Weighted Average Grant Date Fair Value		Total RSUs		Total  Weighted Average  Grant Date  Fair Value
Outstanding at beginning of year:	490,099		$	7.75	287,719		$	4.32	777,818		$	6.48
Granted (2)	357,015		7.22		273,800		5.87		630,815		6.64
Settled	(72,873	)	7.28		(14,465	)	4.71		(87,338	)	6.86
Cancelled/forfeited	(5,067	)	7.36		(97,754	)	2.67		(102,821	)	2.90
Outstanding at end of year	769,174		$	7.55	449,300		$	5.61	1,218,474		$	6.84
RSUs vested but not settled at end of year	467,638		$	7.81	175,500		$	5.21	643,138		$	7.10
RSUs unvested at end of year	301,536		$	7.15	273,800		$	5.87	575,336		$	6.54

	For the Year Ended December 31, 2013
	RSUs With Service Condition		Weighted Average Grant Date Fair Value		RSUs With Market and Service Conditions		Weighted Average Grant Date Fair Value		Total RSUs		Total  Weighted Average  Grant Date  Fair Value
Outstanding at beginning of year:	448,141		$	7.61	279,507		$	4.55	727,648		$	6.43
Granted (3)	64,483		8.23		48,341		2.59		112,824		5.82
Settled	(21,025	)	6.20		(32,066	)	2.80		(53,091	)	4.15
Cancelled/forfeited	(1,500	)	7.77		(8,063	)	7.89		(9,563	)	7.88
Outstanding at end of year	490,099		$	7.75	287,719		$	4.32	777,818		$	6.48
RSUs vested but not settled at end of year	84,199		$	8.50	14,625		$	4.69	98,824		$	7.93
RSUs unvested at end of year	405,900		$	7.60	273,094		$	4.30	678,994		$	6.27

(1) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs.  In determining the fair value for 582,500 of these awards granted in 2015, the Company applied:  (i) a weighted average volatility estimate of approximately 18%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted

130

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

average risk-free rate of 0.90% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 9%.  The weighted average grant date fair value for the remaining 99,554 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date ranging from $7.93 to $7.97. There are no post vesting conditions on these awards.

(2) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs.  In determining the fair value for 547,600 of these awards granted in 2014, the Company applied:  (i) a weighted average volatility estimate of approximately 22%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.73% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 8%.  The weighted average grant date fair value for the remaining 83,215 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date ranging from $7.19 to $8.16. There are no post vesting conditions on these awards.

(3) The determination of the weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs.  In determining the fair value for awards granted in 2013, the Company applied:  (i) a weighted average volatility estimate of approximately 23%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.65% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 13%.  There are no post vesting conditions on these awards.

Expense Recognized for Equity-Based Compensation Instruments

The following table presents the Company’s expenses related to its equity-based compensation instruments for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015		2014		2013
Restricted shares of common stock	$	4,373	$	5,553	$	2,150
RSUs (1)	3,377		2,886		1,813
Dividend equivalent rights	82		146		195
Total	$	7,832	$	8,585	$	4,158

(1) RSU expense for the year ended December 31, 2014 includes approximately $500,000 for a one-time grant to the Company’s chief executive officer.

(b)  Employment Agreements

At December 31, 2015, the Company had employment agreements with four of its officers, with varying terms that provide for, among other things, base salary, bonus and change-in-control payments upon the occurrence of certain triggering events.

(c)  Deferred Compensation Plans

The Company administers deferred compensation plans for its senior officers and non-employee directors (collectively, the “Deferred Plans”), pursuant to which participants may elect to defer up to 100% of certain cash compensation.  The Deferred Plans are designed to align participants’ interests with those of the Company’s stockholders.

Amounts deferred under the Deferred Plans are considered to be converted into “stock units” of the Company.  Stock units do not represent stock of the Company, but rather are a liability of the Company that changes in value as would equivalent shares of the Company’s common stock.  Deferred compensation liabilities are settled in cash at the termination of the deferral period, based on the value of the stock units at that time.  The Deferred Plans are non-qualified plans under the Employee Retirement Income Security Act of 1974 and, as such, are not funded.  Prior to the time that the deferred accounts are settled, participants are unsecured creditors of the Company.

131

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The Company’s liability for stock units in the Deferred Plans is based on the market price of the Company’s common stock at the measurement date.  The following table presents the Company’s expenses related to its Deferred Plans for its non-employee directors and senior officers for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014		2013
Non-employee directors	$	(59	)	$	69	$	17
Total	$	(59	)	$	69	$	17

The Company distributed cash of $109,000, $119,000 and $12,000 to the participants of the Deferred Plans during the years ended December 31, 2015, 2014 and 2013, respectively.  The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through December 31, 2015 and 2014 that had not been distributed and the Company’s associated liability for such deferrals at December 31, 2015 and 2014:

	December 31, 2015				December 31, 2014
(In Thousands)	Undistributed Income Deferred (1)		Liability Under Deferred Plans		Undistributed Income Deferred (1)		Liability Under Deferred Plans
Non-employee directors	$	601	$	614	$	324	$	446
Total	$	601	$	614	$	324	$	446

(1)  Represents the cumulative amounts that were deferred by participants through December 31, 2015 and 2014, which had not been distributed through such respective date.

(d)  Savings Plan

The Company sponsors a tax-qualified employee savings plan (the “Savings Plan”) in accordance with Section 401(k) of the Code.  Subject to certain restrictions, all of the Company’s employees are eligible to make tax deferred contributions to the Savings Plan subject to limitations under applicable law.  Participant’s accounts are self-directed and the Company bears the costs of administering the Savings Plan.  The Company matches 100% of the first 3% of eligible compensation deferred by employees and 50% of the next 2%, subject to a maximum as provided by the Code.  The Company has elected to operate the Savings Plan under the applicable safe harbor provisions of the Code, whereby among other things, the Company must make contributions for all participating employees and all matches contributed by the Company immediately vest 100%.  For the years ended December 31, 2015, 2014 and 2013, the Company recognized expenses for matching contributions of $309,000, $237,000 and $250,000, respectively.

16.  Fair Value of Financial Instruments

A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.  The three levels of valuation hierarchy are defined as follows:

Level 1 — Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2 — Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level 3 — Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The following describes the valuation methodologies used for the Company’s financial instruments measured at fair value on a recurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy.

132

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral

The fair value of U.S. Treasury securities obtained as collateral and the associated obligation to return securities obtained as collateral are based upon prices obtained from a third-party pricing service, which are indicative of market activity.  Securities obtained as collateral are classified as Level 1 in the fair value hierarchy.

MBS and CRT securities

The Company determines the fair value of its Agency MBS, based upon prices obtained from third-party pricing services, which are indicative of market activity and repurchase agreement counterparties.

For Agency MBS, the valuation methodology of the Company’s third-party pricing services incorporate commonly used market pricing methods, trading activity observed in the marketplace and other data inputs.  The methodology also considers the underlying characteristics of each security, which are also observable inputs, including: collateral vintage, coupon, maturity date, loan age, reset date, collateral type, periodic and life cap, geography, and prepayment speeds.  Management analyzes pricing data received from third-party pricing services and compares it to other indications of fair value including data received from repurchase agreement counterparties and its own observations of trading activity observed in the marketplace.

In determining the fair value of its Non-Agency MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants.  In valuing Non-Agency MBS, the Company understands that pricing services use observable inputs that include, in addition to trading activity observed in the marketplace, loan delinquency data, credit enhancement levels and vintage, which are taken into account to assign pricing factors such as spread and prepayment assumptions.  For tranches of Legacy Non-Agency MBS that are cross-collateralized, performance of all collateral groups involved in the tranche are considered.  The Company collects and considers current market intelligence on all major markets, including benchmark security evaluations and bid-lists from various sources, when available.

The Company’s MBS and CRT securities are valued using various market data points as described above, which management considers directly or indirectly observable parameters.  Accordingly, the Company’s MBS and CRT securities are classified as Level 2 in the fair value hierarchy.

Residential Whole Loans, at Fair Value

The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans trading activity observed in the market place. The Company’s residential whole loans held at fair value are classified as Level 3 in the fair value hierarchy.

Swaps

The Company determines the fair value of non-centrally cleared Swaps considering valuations obtained from a third-party pricing service. For Swaps that are cleared by a central clearing house valuations provided by the clearing house are used. All valuations obtained are tested with internally developed models that apply readily observable market parameters.  The Company considers the creditworthiness of both the Company and its counterparties, along with collateral provisions contained in each derivative agreement, from the perspective of both the Company and its counterparties.  All of the Company’s Swaps are subject either to bilateral collateral arrangements, or for cleared Swaps, to the clearing house’s margin requirements.  Consequently, no credit valuation adjustment was made in determining the fair value of such instruments.  Swaps are classified as Level 2 in the fair value hierarchy.

133

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following table presents the Company’s financial instruments carried at fair value on a recurring basis as of December 31, 2015 and 2014, on the consolidated balance sheets by the valuation hierarchy, as previously described:

Fair Value at December 31, 2015

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Agency MBS	$	—	$	4,752,244	$	—	$	4,752,244
Non-Agency MBS, including MBS transferred to consolidated VIEs	—		6,420,817		—		6,420,817
CRT securities	—		183,582		—		183,582
Securities obtained and pledged as collateral	507,443		—		—		507,443
Residential whole loans, at fair value	—		—		623,276		623,276
Swaps	—		1,127		—		1,127
Total assets carried at fair value	$	507,443	$	11,357,770	$	623,276	$	12,488,489
Liabilities:
Swaps	$	—	$	70,526	$	—	$	70,526
Obligation to return securities obtained as collateral	507,443		—		—		507,443
Total liabilities carried at fair value	$	507,443	$	70,526	$	—	$	577,969

Fair Value at December 31, 2014

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Agency MBS	$	—	$	5,904,207	$	—	$	5,904,207
Non-Agency MBS, including MBS transferred to consolidated VIEs	—		4,755,432		—		4,755,432
CRT securities	—		102,983		—		102,983
Securities obtained and pledged as collateral	512,105		—		—		512,105
Residential whole loans, at fair value	—		—		143,472		143,472
Linked Transactions	—		398,336		—		398,336
Swaps	—		3,136		—		3,136
Total assets carried at fair value	$	512,105	$	11,164,094	$	143,472	$	11,819,671
Liabilities:
Swaps	$	—	$	62,198	$	—	$	62,198
Obligation to return securities obtained as collateral	512,105		—		—		512,105
Total liabilities carried at fair value	$	512,105	$	62,198	$	—	$	574,303

134

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following table presents additional information for the years ended December 31, 2015 and 2014 about the Company’s Residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis.

Changes in Level 3 Assets Measured at Fair Value on a Recurring Basis

	Residential Whole Loans, at Fair Value
	For the Year Ended December 31,
(In Thousands)	2015			2014
Balance at beginning of period	$	143,472		$	—
Purchases and capitalized advances	534,574			147,471
Changes in fair value recorded in Net gain on residential whole loans held at fair value	6,539			(388		)
Collection of principal, net of liquidation gains/losses	(34,767		)	(1,038		)
Transfer to REO	(26,542		)	(2,573		)
Balance at end of period	$	623,276		$	143,472

The Company did not transfer any assets or liabilities from one level to another during the years ended December 31, 2015 and 2014.

The following table presents a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of December 31, 2015 and 2014:

Fair Value Methodology for Level 3 Financial Instruments

	December 31, 2015
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Range	Weighted Average
Residential whole loans, at fair value	$	113,166	Discounted cash flow	Discount rate	6.00-8.70%	7.00		%
				Prepayment rate	0.25-11.10%	6.59		%
				Default rate	0.00-9.10%	3.10		%
				Loss severity	10.00-79.40%	17.03		%
	$	392,557	Liquidation model	Discount rate	6.75-10.02%	6.85		%
				Annual change in home prices	(5.51)-6.08%	1.28		%
				Liquidation timeline (in years)	0.67-4.42	1.56
				Current value of underlying properties	$14-$3,500		$626
Total	$	505,723

(1) Excludes approximately $117.6 million of loans for which management considers the purchase price continues to reflect the fair value of such loans at December 31, 2015.

135

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

	December 31, 2014
(Dollars in Thousands)	Fair Value		Valuation Technique	Unobservable Input	Range	Weighted Average
Residential whole loans, at fair value	$	36,101	Discounted cash flow	Discount rate	6.00-8.00%	7.52		%
				Prepayment rate	0.25-8.20%	4.79		%
				Default rate	0.00-20.30%	7.01		%
				Loss severity	10.00-61.69%	18.88		%
	$	107,371	Liquidation model	Discount rate	7.00-7.00%	7.00		%
				Annual change in home prices	(4.73)-3.56%	0.26		%
				Liquidation timeline (in years)	0.83-4.42	1.94
				Current value of underlying properties	$29-$4,000		$397
Total	$	143,472

The following table presents the difference between the fair value and the aggregate unpaid principal balance of the Company’s residential whole loans for which the fair value option was elected at December 31, 2015 and 2014:

	December 31, 2015							December 31, 2014
(In Thousands)	Fair Value		Unpaid Principal Balance		Difference			Fair Value		Unpaid Principal Balance		Difference
Residential whole loans, at fair value
Total loans	$	623,276	$	786,330	$	(163,054	)	$	143,472	$	182,613	$	(39,141	)
Loans 90 days or more past due	$	493,640	$	637,459	$	(143,819	)	$	128,591	$	165,358	$	(36,767	)

Changes to the valuation methodologies used with respect to the Company’s financial instruments are reviewed by management to ensure any such changes result in appropriate exit price valuations.  The Company will refine its valuation methodologies as markets and products develop and pricing methodologies evolve.  The methods described above may produce fair value estimates that may not be indicative of net realizable value or reflective of future fair values.  Furthermore, while the Company believes its valuation methods are appropriate and consistent with those used by market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.  The Company uses inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced.  The Company reviews the classification of its financial instruments within the fair value hierarchy on a quarterly basis, and management may conclude that its financial instruments should be reclassified to a different level in the future.

136

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following table presents the carrying values and estimated fair values of the Company’s financial instruments at December 31, 2015 and 2014:

	December 31, 2015				December 31, 2014
(In Thousands)	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
Financial Assets:
Agency MBS	$	4,752,244	$	4,752,244	$	5,904,207	$	5,904,207
Non-Agency MBS, including MBS transferred to consolidated VIEs	6,420,817		6,420,817		4,755,432		4,755,432
CRT securities	183,582		183,582		102,983		102,983
Securities obtained and pledged as collateral	507,443		507,443		512,105		512,105
Residential whole loans, at carrying value	271,845		289,696		207,923		217,386
Residential whole loans, at fair value	623,276		623,276		143,472		143,472
Cash and cash equivalents	165,007		165,007		182,437		182,437
Restricted cash	71,538		71,538		67,255		67,255
Linked Transactions	—		—		398,336		398,336
Swaps	1,127		1,127		3,136		3,136
Financial Liabilities:
Repurchase agreements	7,888,902		7,828,115		8,267,388		8,266,699
FHLB advances	1,500,000		1,500,000		—		—
Securitized debt	22,057		22,057		110,574		110,791
Obligation to return securities obtained as collateral	507,443		507,443		512,105		512,105
Senior Notes	100,000		99,391		100,000		103,031
Swaps	70,526		70,526		62,198		62,198

In addition to the methodologies used to determine the fair value of the Company’s financial assets and liabilities reported at fair value on a recurring basis, as previously described, the following methods and assumptions were used by the Company in arriving at the fair value of the Company’s other financial instruments presented in the above table:

Residential Whole Loans at Carrying Value:  The Company determines the fair value of its residential whole loans held at carrying value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. The Company’s residential whole loans held at carrying value are classified as Level 3 in the fair value hierarchy.

Cash and Cash Equivalents and Restricted Cash:  Cash and cash equivalents and restricted cash are comprised of cash held in overnight money market investments and demand deposit accounts.  At December 31, 2015 and 2014, the Company’s money market funds were invested in securities issued by the U.S. Government, or its agencies, instrumentalities, and sponsored entities, and repurchase agreements involving the securities described above.  Given the overnight term and assessed credit risk, the Company’s investments in money market funds are determined to have a fair value equal to their carrying value.

Linked Transactions: As previously discussed, new accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting, and as a result, the Company did not have any Linked Transactions at December 31, 2015. The Non-Agency MBS that prior to January 1, 2015 were accounted for as a component of Linked Transactions were valued using similar techniques to those used for the Company’s other Non-Agency MBS.  The value of the underlying MBS was then netted against the carrying amount (which approximates fair value) of the repurchase agreement borrowing at the valuation date.  The fair value of Linked Transactions also included accrued interest receivable on the MBS and accrued interest payable on the underlying repurchase agreement borrowings.  The Company’s Linked Transactions were classified as Level 2 in the fair value hierarchy at December 31, 2014.

137

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

Repurchase Agreements:  The fair value of repurchase agreements reflects the present value of the contractual cash flows discounted at market interest rates at the valuation date for repurchase agreements with a term equivalent to the remaining term to interest rate repricing, which may be at maturity.  Such interest rates are estimated based on LIBOR rates observed in the market.  The Company’s repurchase agreements are classified as Level 2 in the fair value hierarchy.

FHLB Advances: FHLB advances reflect collateralized borrowings at variable market interest rates that reset on a monthly basis. Accordingly, the carrying amount of FHLB advances are considered to approximate fair value. The Company’s FHLB advances are classified as Level 2 in the fair value hierarchy.

Securitized Debt: In determining the fair value of securitized debt, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants. Accordingly, the Company’s securitized debt is classified as Level 2 in the fair value hierarchy.

Senior Notes:  The fair value of the Senior Notes is determined using the end of day market price quoted on the NYSE at the reporting date.  The Company’s Senior Notes are classified as Level 1 in the fair value hierarchy.

17.  Use of Special Purpose Entities and Variable Interest Entities

A Special Purpose Entity (“SPE”) is an entity designed to fulfill a specific limited need of the company that organized it.  SPEs are often used to facilitate transactions that involve securitizing financial assets or resecuritizing previously securitized financial assets.  The objective of such transactions may include obtaining non-recourse financing, obtaining liquidity or refinancing the underlying securitized financial assets on improved terms.  Securitization involves transferring assets to a SPE to convert all or a portion of those assets into cash before they would have been realized in the normal course of business, through the SPE’s issuance of debt or equity instruments.  Investors in an SPE usually have recourse only to the assets in the SPE and, depending on the overall structure of the transaction, may benefit from various forms of credit enhancement such as over-collateralization in the form of excess assets in the SPE, priority with respect to receipt of cash flows relative to holders of other debt or equity instruments issued by the SPE, or a line of credit or other form of liquidity agreement that is designed with the objective of ensuring that investors receive principal and/or interest cash flow on the investment in accordance with the terms of their investment agreement.

Resecuritization transactions

The Company has entered into several resecuritization transactions that resulted in the Company consolidating as VIEs the SPEs that were created to facilitate the transactions and to which the underlying assets in connection with the resecuritizations were transferred. See Note 2(r) for a discussion of the accounting policies applied to the consolidation of VIEs and transfers of financial assets in connection with resecuritization transactions.

138

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

The following table summarizes the key details of the resecuritization transactions in which the Company participated as of December 31, 2015:

(Dollars in Thousands)	February 2012			October 2010
Name of Trust (Consolidated as a VIE)	WFMLT Series 2012-RR1			DMSI 2010-RS2
Principal value of Non-Agency MBS sold	$	433,347		$	985,228
Face amount of Bonds issued by the VIE and purchased by 3rd party investors (1)	$	186,691		$	373,577
Outstanding amount of Senior Bonds at December 31, 2015 (1)	$	22,057		$	—
Pass-through rate for Senior Bonds issued	2.85		%	—		%
Face amount of Senior Support Certificates received by the Company (2)	$	217,103		$	455,063
Cash received	$	186,691		$	375,621
Notional amount acquired of non-rated, interest only senior certificates (1)	$	186,691		$	—
Unamortized deferred costs	$	190		$	—

(1) Amount disclosed reflects principal balances of the DMSI 2010-RS A1, A2 and A3 bonds. The DMSI 2010-RS2 A2 and A3 bonds were sold to third party investors during 2013. The principal balance of the DMSI 2010-RS2 A1 Bond and associated interest only Senior certificate was paid off during 2013. The principal balances of the DMSI 2010-RS2 A2 and A3 Bonds were paid off in January 2015 and September 2015, respectively.

(2)  Provides credit support for the sequential Senior Non-Agency MBS sold to third-party investors in resecuritization transactions (“Senior Bonds”).

The Company engaged in these transactions primarily for the purpose of obtaining non-recourse financing on a portion of its Non-Agency MBS portfolio, as well as refinancing a portion of its Non-Agency MBS portfolio on improved terms. Notwithstanding the Company’s participation in these transactions, the risks facing the Company are largely unchanged as the Company remains economically exposed to the first loss position on the underlying MBS transferred to the VIEs.

The activities that can be performed by an entity created to facilitate a resecuritization transaction are generally specified in the entity’s formation documents. Those documents do not permit the entity, any beneficial interest holder in the entity, or any other party associated with the entity to cause the entity to sell or replace the assets held by the entity, or limit such ability to when specific events of default occur.

The Company concluded that the entities created to facilitate these resecuritization transactions are VIEs.  The Company then completed an analysis of whether each VIE created to facilitate the resecuritization transaction should be consolidated by the Company, based on consideration of its involvement in each VIE, including the design and purpose of the SPE, and whether its involvement reflected a controlling financial interest that resulted in the Company being deemed the primary beneficiary of each VIE.  In determining whether the Company would be considered the primary beneficiary, the following factors were assessed:

• Whether the Company has both the power to direct the activities that most significantly impact the economic performance of the VIE;  and

• Whether the Company has a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.

Based on its evaluation of the factors discussed above, including its involvement in the purpose and design of the entity, the Company determined that it was required to consolidate each VIE created to facilitate these resecuritization transactions.

As of December 31, 2015 and 2014, the aggregate fair value of the Non-Agency MBS that were resecuritized as described above was $598.3 million and $1.397 billion, respectively.  These assets are included in the Company’s consolidated balance sheets and disclosed as “Non-Agency MBS transferred to consolidated VIEs, at fair value”.  As of December 31, 2015 and 2014, the aggregate outstanding balance of Senior Bonds issued by consolidated VIEs was $22.1 million and $110.6 million, respectively.  These Senior Bonds are included in the Company’s consolidated balance sheets and disclosed as “Securitized debt.”  The holders of the Senior Bonds have no recourse to the general credit of the Company, but the Company does have the obligation, under certain circumstances to repurchase assets from the VIE upon the breach of certain representations and warranties in relation to the Non-Agency MBS sold to the VIE.  In the absence of such a breach, the Company has no obligation to provide any other explicit or implicit support to any VIE.

139

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

Subsequent to the repayment of the outstanding balance of Senior Bonds issued by the CSMC Series 2011-1R Trust (the “Trust”), this resecuritization financing structure was terminated during 2015. The termination was effected through an exchange of the remaining beneficial interests previously issued by the Trust and held by the Company for the underlying securities that had previously been transferred to and held by the Trust at the date of termination. Following the exchange, the beneficial interests were cancelled by the trustee and the Trust was terminated. The exchange and termination of this financing structure did not result in any gain or loss to the Company. As a result of the termination, the underlying securities originally transferred as part of this resecuritization are reported as Non-Agency MBS in the Company’s consolidated balance sheets at December 31, 2015 and interest income from the underlying securities from the date of termination through December 31, 2015 is reported as Interest income from Non-Agency MBS in the Company’s consolidated statements of operations.

Prior to the completion of the Company’s first resecuritization transaction in October 2010, the Company had not transferred assets to VIEs or QSPEs and other than acquiring MBS issued by such entities, had no other involvement with VIEs or QSPEs.

Residential Whole Loans

Included on the Company’s consolidated balance sheets as of December 31, 2015 and 2014 is a total of $895.1 million and $351.4 million of residential whole loans, of which approximately $271.8 million and $207.9 million are reported at carrying value and $623.3 million and $143.5 million are reported at fair value, respectively. The inclusion of these assets arises from the Company’s 100% equity interest in certain trusts established to acquire the loans. Based on its evaluation of its 100% interest in these trusts and other factors, the Company has determined that the trusts are required to be consolidated for financial reporting purposes. During 2015 and 2014, approximately $16.0 million and $4.1 million of interest income was recognized from residential whole loans reported at carrying value, respectively, which is included in Interest Income on the Company’s consolidated statements of operations. In addition, the Company recognized net gains of approximately $17.7 million and $116,000, on residential whole loans held at fair value during 2015 and 2014, respectively, which amounts are included in Other Income, net on the Company’s consolidated statements of operations. (See Note 4)

18.  Subsequent Events

Federal Housing Finance Agency (“FHFA”) Final Rule on FHLB Membership

In January, 2016, the FHFA released its final rule amending its regulation on FHLB membership, which, amongst other things, provided termination rules for current captive insurance members. As a result of such regulation, MFA Insurance will not be permitted new advances or renewal of existing advances and will be required to terminate its FHLB membership within one year of the rule’s effective date of February 19, 2016.

Unwind of resecuritization structure

On February 9, 2016, the Company entered into an agreement to amend the DMSI 2010-RS2 Trust Agreement in order to facilitate the unwind of a resecuritization transaction in which the Company originally participated in 2010. Concurrent with the amendment to the Trust Agreement, the Company entered into a transaction to exchange the remaining beneficial interests issued by the DMSI 2010-RS2 Trust (the “Trust”) that were held by the Company for the underlying securities that had previously been transferred to and held by the Trust. The Company expects, following completion of any final Trust distributions, the remaining beneficial interests will be cancelled and the Trust terminated.

For financial reporting purposes, the exchange transaction will not result in any gain or loss to the Company as this resecuritization was accounted for as a financing transaction. However, for purposes of determining REIT taxable income, this resecuritization transaction was originally accounted for as a sale of the underlying securities to the Trust and acquisition by the Company of beneficial interests issued by the Trust. Because the fair value of the underlying securities received exceeded the Company’s tax basis in the remaining beneficial interests at the exchange date, the unwind of this resecuritization structure will result in the Company recognizing taxable income currently estimated to be approximately $70.9 million or $0.19 per common share.

In addition, the unwind of this resecuritization transaction will result in an increase in the Company’s available sources of liquidity as immediately following the exchange transaction, estimated financing from unpledged Non-Agency MBS is increased by approximately $90 million.

140

MFA FINANCIAL, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2015

19.  Summary of Quarterly Results of Operations (Unaudited)

	2015 Quarter Ended
(In Thousands, Except per Share Amounts)	March 31			June 30			September 30			December 31
Interest income	$	129,943		$	123,995		$	119,706		$	118,499
Interest expense	(43,940		)	(42,849		)	(43,703		)	(46,456		)
Net interest income	86,003			81,146			76,003			72,043
Net impairment losses recognized in earnings	(407		)	(298		)	—			—
Gain on sales of MBS	6,435			7,617			11,196			9,652
Net gain on residential whole loans held at fair value	2,034			3,224			5,565			6,899
Other income/(loss)	311			(678		)	(259		)	(831		)
Operating and other expense	(12,202		)	(12,940		)	(12,995		)	(14,292		)
Net income	82,174			78,071			79,510			73,471
Preferred stock dividends	(3,750		)	(3,750		)	(3,750		)	(3,750		)
Net income available to common stock and participating securities	$	78,424		$	74,321		$	75,760		$	69,721
Earnings per Common Share - Basic and Diluted	$	0.21		$	0.20		$	0.20		$	0.19

	2014 Quarter Ended
(In Thousands, Except per Share Amounts)	March 31			June 30			September 30			December 31
Interest income	$	121,174		$	119,294		$	112,157		$	111,192
Interest expense	(40,921		)	(40,569		)	(39,358		)	(38,960		)
Net interest income	80,253			78,725			72,799			72,232
Gain on sales of MBS	3,571			7,852			13,880			12,194
Unrealized net gains and net interest income from Linked Transactions	3,251			3,776			2,559			7,506
Net gain on residential whole loans held at fair value	—			—			—			116
Other (loss)/income	(416		)	56			54			386
Operating and other expense	(10,471		)	(11,683		)	(10,410		)	(12,726		)
Net income	76,188			78,726			78,882			79,708
Preferred stock dividends	(3,750		)	(3,750		)	(3,750		)	(3,750		)
Net income available to common stock and participating securities	$	72,438		$	74,976		$	75,132		$	75,958
Earnings per Common Share - Basic and Diluted	$	0.20		$	0.20		$	0.20		$	0.20

141

Schedule IV - Mortgage Loans on Real Estate

December 31, 2015

Asset Type	Number	Interest Rate	Maturity Date Range	Balance Sheet Reported Amount		Principal Amount of Loans Subject to Delinquent Principal or Interest
(Dollars in Thousands)
Residential whole loans at carrying value	1,993	0.00%-14.00%	5/20/2015-11/1/2064	$	271,845	$	116,370
Residential whole loans at fair value	3,143	1.00%-14.00%	2/1/2004-12/1/2055	623,276		679,353
				$	895,121	$	795,723

The following table summarizes the changes in the carrying amounts of residential whole loans during the year ended December 31, 2015.

Reconciliation of Balance Sheet Reported Amounts of Mortgage Loans on Real Estate

	For the Year Ended December 31, 2015
(In Thousands)	Residential whole loans at carrying value			Residential whole loans at fair value
Beginning Balance	$	207,923		$	143,472
Additions during period:
Purchases and capitalized advances	82,338			534,574
Accretion of purchase discount	15,511			N/A
Deductions during period:
Collection of principal	(17,029		)	(34,767		)
Collection of interest	(14,053		)	—
Changes in fair value recorded in Gain on loans recorded at fair value	N/A			6,539
Provision for loan loss	(1,028		)	N/A
Transfer to REO	(1,817		)	(26,542		)
Ending Balance	$	271,845		$	623,276

142

Item 9.  Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

None.

Item 9A.  Controls and Procedures.

(a) Evaluation of Disclosure Controls and Procedures

Management, under the direction of its Chief Executive Officer and Chief Financial Officer, is responsible for maintaining disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the 1934 Act that are designed to ensure that information required to be disclosed in reports filed or submitted under the 1934 Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosures.

In connection with the preparation of this Annual Report on Form 10-K, management reviewed and evaluated the Company’s disclosure controls and procedures.  The evaluation was performed under the direction of the Company’s Chief Executive Officer and Chief Financial Officer to determine the effectiveness, as of December 31, 2015, of the design and operation of the Company’s disclosure controls and procedures.  Based on that review and evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that the Company’s current disclosure controls and procedures, as designed and implemented, were effective as of December 31, 2015. Notwithstanding the foregoing, a control system, no matter how well designed, implemented and operated can provide only reasonable, not absolute, assurance that it will detect or uncover failures within the Company to disclose material information otherwise required to be set forth in the Company’s periodic reports.

(b) Management’s Report on Internal Control Over Financial Reporting

Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting for the Company.  Internal control over financial reporting is defined in Rules 13a-15(f) and 15d-15(f) promulgated under the 1934 Act as a process designed by, or under the supervision of, the Company’s principal executive and principal financial officers and effected by the Company’s board of directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP, and includes those policies and procedures that:

•pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;

•provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

•provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

The Company’s management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2015.  In making this assessment, the Company’s management used criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework 2013 (the “2013 COSO Framework”). As a result of this assessment, management concluded that, as of December 31, 2015, our internal control over financial reporting was effective in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP.

The Company’s independent registered public accounting firm, KPMG LLP, have issued an attestation report on the effectiveness of the Company’s internal control over financial reporting.  This report appears on page 145 of this Annual Report on Form 10-K.

143

(c) Changes in Internal Control Over Financial Reporting

There have been no changes in the Company’s internal control over financial reporting that occurred during the fourth quarter of 2015 that materially affected, or are reasonably likely to materially affect, its internal control over financial reporting. 

144

Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders

MFA Financial, Inc.:

We have audited MFA Financial, Inc.’s (the Company’s) internal control over financial reporting as of December 31, 2015, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2015, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of MFA Financial, Inc. and subsidiaries as of December 31, 2015 and 2014, and the related consolidated statements of operations, comprehensive (loss)/income, changes in stockholders’ equity and cash flows for each of the years in the three-year period ended December 31, 2015, and our report dated February 18, 2016 expressed an unqualified opinion on those consolidated financial statements.

/s/ KPMG LLP

New York, New York

February 18, 2016

145

Item 9B.  Other Information.

None.

PART III

Item 10.  Directors, Executive Officers and Corporate Governance.

We expect to file with the SEC, in April 2016 (and, in any event, not later than 120 days after the close of our last fiscal year), a definitive proxy statement (the “Proxy Statement”), pursuant to SEC Regulation 14A in connection with our Annual Meeting of Stockholders to be held on or about May 25, 2016.  The information to be included in the Proxy Statement regarding the Company’s directors, executive officers, and certain other matters required by Item 401 of Regulation S-K is incorporated herein by reference.

The information to be included in the Proxy Statement regarding compliance with Section 16(a) of the 1934 Act required by Item 405 of Regulation S-K is incorporated herein by reference.

The information to be included in the Proxy Statement regarding the Company’s Code of Business Conduct and Ethics required by Item 406 of Regulation S-K is incorporated herein by reference.

The information to be included in the Proxy Statement regarding certain matters pertaining to the Company’s corporate governance required by Item 407(c)(3), (d)(4) and (d)(5) of Regulation S-K is incorporated by reference.

We have adopted a set of Corporate Governance Guidelines, which together with the charters of the three standing committees of our Board of Directors (Audit, Compensation, and Nominating and Corporate Governance), and our Code of Business Conduct and Ethics (which constitutes the Company’s code of ethics), provide the framework for the governance of the Company.  A complete copy of our Corporate Governance Guidelines, the charters of each of the Board committees and the Code of Business Conduct and Ethics (which applies not only to our Chief Executive Officer, Chief Financial Officer and Chief Accounting Officer, but also to all other employees of the Company) may be found by clicking on the “Company Information” link found at the top of our homepage at www.mfafinancial.com and then clicking on the “Corporate Governance” link. (Information from such site is not incorporated by reference into this Annual Report on Form 10-K.)  You may also obtain free copies of these materials by writing to our General Counsel at the Company’s headquarters.

Item 11.  Executive Compensation.

The information to be included in the Proxy Statement regarding executive compensation and other compensation related matters required by Items 402 and 407(e)(4) and (e)(5) of Regulation S-K is incorporated herein by reference.

Item 12.  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The tables to be included in the Proxy Statement, which will contain information relating to the Company’s equity compensation and beneficial ownership of the Company required by Items 201(d) and 403 of Regulation S-K, are incorporated herein by reference.

Item 13.  Certain Relationships and Related Transactions and Director Independence.

The information to be included in the Proxy Statement regarding transactions with related persons, promoters and certain control persons and director independence required by Items 404 and 407(a) of Regulation S-K is incorporated herein by reference.

Item 14.  Principal Accountant Fees and Services.

The information to be included in the Proxy Statement concerning principal accounting fees and services and the Audit Committee’s pre-approval policies and procedures required by Item 14 is incorporated herein by reference.

146

PART IV

Item 15.  Exhibits and Financial Statement Schedules.

(a)Documents filed as part of the report

The following documents are filed as part of this Annual Report on Form 10-K:

(1)  Financial Statements.  The consolidated financial statements of the Company, together with the independent registered public accounting firm’s report thereon, are set forth on pages 81 through 141 of this Annual Report on Form 10-K and are incorporated herein by reference.

(b)Exhibits required by Item 601 of Regulation S-K

The information required by this Item is set forth on the Exhibit Index that follows the signature page of this report.

(c)   Financial Statement Schedules required by Regulation S-X

Schedule IV - Mortgage Loans on Real Estate as of December 31, 2015.

All other financial statement schedules have been omitted because the required information is not applicable or deemed not material, or the required information is presented in the consolidated financial statements and/or in the notes to consolidated financial statements filed in response to Item 8 of this Annual Report on Form 10-K.

147

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MFA Financial, Inc.
Date: February 18, 2016	By	/s/	Stephen D. Yarad
			Stephen D. Yarad
			Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

148

Date: February 18, 2016	By	/s/	William S. Gorin
			William S. Gorin
			Chief Executive Officer and Director
			(Principal Executive Officer)
Date: February 18, 2016	By	/s/	Stephen D. Yarad
			Stephen D. Yarad
			Chief Financial Officer
			(Principal Financial Officer)
Date: February 18, 2016	By	/s/	Kathleen A. Hanrahan
			Kathleen A. Hanrahan
			Senior Vice President and
			Chief Accounting Officer
			(Principal Accounting Officer)
Date: February 18, 2016	By	/s/	George H. Krauss
			George H. Krauss
			Chairman and Director
Date: February 18, 2016	By	/s/	Stephen R. Blank
			Stephen R. Blank
			Director
Date: February 18, 2016	By	/s/	James A. Brodsky
			James A. Brodsky
			Director
Date: February 18, 2016	By	/s/	Richard J. Byrne
			Richard J. Byrne
			Director
Date: February 18, 2016	By	/s/	Laurie Goodman
			Laurie Goodman
			Director
Date: February 18, 2016	By	/s/	Alan L. Gosule
			Alan L. Gosule
			Director
Date: February 18, 2016	By	/s/	Robin Josephs
			Robin Josephs
			Director

149

EXHIBIT INDEX

The following exhibits are filed as part of this Annual Report on Form 10-K.  The exhibit numbers followed by an asterisk (*) indicate exhibits electronically filed herewith.  All other exhibit numbers indicate exhibits previously filed and are hereby incorporated herein by reference.  Exhibits numbered 10.1 through 10.22 are management contracts or compensatory plans or arrangements.

3.1    Amended and Restated Articles of Incorporation of the Company, dated April 8, 1998 (incorporated herein by reference to Exhibit 3.1 to the Company’s Form 8-K, dated April 24, 1998 (Commission File No. 1-13991)).

3.2Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company, dated August 5, 2002 (incorporated herein by reference to Exhibit 3.1 to the Company’s Form 8-K, dated August 13, 2002 (Commission File No. 1-13991)).

3.3Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company, dated August 13, 2002 (incorporated herein by reference to Exhibit 3.3 to the Company’s Form 10-Q for the quarter ended September 30, 2002 (Commission File No. 1-13991)).

3.4Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company, dated December 29, 2008 (incorporated herein by reference to Exhibit 3.1 to the Company’s Form 8-K, dated December 29, 2008 (Commission File No. 1-13991)).

3.5Articles of Amendment (Articles Supplementary) to the Amended and Restated Articles of Incorporation of the Company, dated January 1, 2010 (incorporated herein by reference to Exhibit 3.1 to the Company’s Form 8-K, dated January 5, 2010 (Commission File No. 1-13991)).

3.6Articles Supplementary of the Company, dated March 8, 2011 (incorporated herein by reference to Exhibit 3.1 to the Company’s Form 8-K, dated March 11, 2011 (Commission File No. 1-13991)).

3.7Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company, dated May 24, 2011 (incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K, dated May 26, 2011 (Commission File No. 1-13991)).

3.8Articles Supplementary of the Company, dated April 22, 2004, designating the Company’s 8.50% Series A Cumulative Redeemable Preferred Stock (incorporated herein by reference to Exhibit 3.4 to the Company’s Form 8-A, dated April 23, 2004 (Commission File No. 1-13991)).

3.9Articles Supplementary of the Company, dated April 12, 2013, designating the Company’s 7.50% Series B Cumulative Redeemable Preferred Stock (incorporated herein by reference to Exhibit 3.1 to the Company’s Form 8-K, dated April 15, 2013 (Commission File No. 1-13991)).

3.10Amended and Restated Bylaws of the Company, effective January 1, 2014 (incorporated herein by reference to Exhibit 3.1 to the Company’s Form 8-K, dated December 18, 2013 (Commission File No. 1-13991)).

4.1Specimen of Common Stock Certificate of the Company (incorporated herein by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-4, dated February 12, 1998 (Commission File No. 333-46179)). 

4.2Specimen of certificate representing the 7.50% Series B Cumulative Redeemable Preferred Stock (incorporated herein by reference to Exhibit 4.1 to the Company’s Form 8-K, dated April 15, 2013 (Commission File No. 1-13991)).

4.3Indenture, dated as of April 11, 2012, between the Company and Wilmington Trust, National Association, as Trustee (incorporated herein by reference to Exhibit 4.1 to the Company’s Form 8-K, dated April 11, 2012 (Commission File No. 1-13991)).

4.4First Supplemental Indenture, dated as of April 11, 2012, between the Company and Wilmington Trust, National Association, as Trustee (incorporated herein by reference to Exhibit 4.2 to the Company’s Form 8-K, dated April 11, 2012 (Commission File No. 1-13991)).

4.5Form of 8.00% Senior Notes due 2042 (incorporated herein by reference to Exhibit 4.3 to the Company’s Form 8-K, dated April 11, 2012 (Commission File No. 1-13991)). 

150

10.1    Employment Agreement, entered into as of January 21, 2014, by and between the Company and William S. Gorin (incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K, dated January 24, 2014 (Commission File No. 1-13991)).

10.2    Employment Agreement, entered into as of January 21, 2014, by and between the Company and Craig L. Knutson (incorporated herein by reference to Exhibit 10.2 to the Company’s Form 8-K, dated January 24, 2014 (Commission File No. 1-13991)).

10.3    Employment Agreement, entered into as of March 1, 2010, by and between the Company and Gudmundur Kristjansson (incorporated herein by reference to Exhibit 10.3 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 (Commission File No. 1-13991)).

10.4    Amendment No. 1, dated February 9, 2015, to Employment Agreement, entered into as of March 1, 2010, by and between the Company and Gudmundur Kristjansson (incorporated herein by reference to Exhibit 10.4 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 (Commission File No. 1-13991)).

10.5    Employment Agreement, entered into as of March 1, 2010, by and between the Company and Sunil Yadav (incorporated herein by reference to Exhibit 10.5 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 (Commission File No. 1-13991)).

10.6    Amendment No. 1, dated February 9, 2015, to Employment Agreement, entered into as of March 1, 2010, by and between the Company and Sunil Yadav (incorporated herein by reference to Exhibit 10.6 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 (Commission File No. 1-13991)).

10.72010 Equity Compensation Plan, dated May 10, 2010 (incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K, dated May 10, 2010 (Commission File No. 1-13991)).

10.8    MFA Financial, Inc. Equity Compensation Plan (which is an amendment and restatement of the Company’s 2010 Equity Compensation Plan) (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K dated May 22, 2015 (Commission File No. 1-13991)).

10.9Senior Officers Deferred Bonus Plan, dated December 10, 2008 (incorporated herein by reference to Exhibit 10.2 to the Company’s Form 8-K, dated December 12, 2008 (Commission File No. 1-13991)).

10.10*    Fourth Amended and Restated 2003 Non-Employee Directors Deferred Compensation Plan, as amended and restated through December 15, 2014.

10.11Form of Incentive Stock Option Award Agreement relating to the Company’s Amended and Restated 2010 Equity Compensation Plan (incorporated herein by reference to Exhibit 10.9 to the Company’s Form 10-Q for the quarter ended September 30, 2004 (Commission File No. 1-13991)).

10.12Form of Non-Qualified Stock Option Award Agreement relating to the Company’s Amended and Restated 2010 Equity Compensation Plan (incorporated herein by reference to Exhibit 10.10 to the Company’s Form 10-Q for the quarter ended September 30, 2004 (Commission File No. 1-13991)).

10.13Form of Restricted Stock Award Agreement relating to the Company’s Amended and Restated 2010 Equity Compensation Plan (incorporated herein by reference to Exhibit 10.11 to the Company’s Form 10-Q for the quarter ended September 30, 2004 (Commission File No. 1-13991)). 

10.14Form of Phantom Share Award Agreement (Time-Based Vesting) relating to the Company’s Amended and Restated 2010 Equity Compensation Plan (incorporated herein by reference to Exhibit 10.4 to the Company’s Form 8-K, dated July 7, 2011 (Commission File No. 1-13991)).

10.15Form of Phantom Share Award Agreement (Performance-Based Vesting) relating to the Company’s Amended and Restated 2010 Equity Compensation Plan (incorporated herein by reference to Exhibit 10.5 to the Company’s Form 8-K, dated July 7, 2011 (Commission File No. 1-13991)).

151

10.16    Form of Phantom Share Award Agreement (Time-Based Vesting) (Gorin and Knutson) relating to the Company’s Amended and Restated 2010 Equity Compensation Plan (incorporated herein by reference to Exhibit 10.3 to the Company’s Form 8-K, dated January 24, 2014 (Commission File No. 1-13991)).

10.17    Form of Phantom Share Award Agreement (Performance-Based Vesting) (Gorin and Knutson) relating to the Company’s Amended and Restated 2010 Equity Compensation Plan (incorporated herein by reference to Exhibit 10.4 to the Company’s Form 8-K, dated January 24, 2014 (Commission File No. 1-13991)).

10.18    Form of Phantom Share Award Agreement (Vested Award) relating to the Company’s Amended and Restated 2010 Equity Compensation Plan (incorporated herein by reference to Exhibit 10.5 to the Company’s Form 8-K, dated January 24, 2014 (Commission File No. 1-13991)).

10.19    Form of Phantom Share Award Agreement (Time-Based Vesting) relating to each of the Company’s Equity Compensation Plan and the Company’s Amended and Restated 2010 Equity Compensation Plan (incorporated herein by reference to Exhibit 10.7 to the Company’s Form 8-K, dated January 24, 2014 (Commission File No. 1-13991)).

10.20    Form of Phantom Share Award Agreement (Performance-Based Vesting) relating to each of the Company’s Equity Compensation Plan and the Company’s Amended and Restated 2010 Equity Compensation Plan (incorporated herein by reference to Exhibit 10.8 to the Company’s Form 8-K, dated January 24, 2014 (Commission File No. 1-13991)).

10.21Form of Dividend Equivalent Rights Agreement relating to the Company’s Amended and Restated 2010 Equity Compensation Plan (incorporated herein by reference to Exhibit 10.6 to the Company’s Form 8-K, dated July 7, 2011 (Commission File No. 1-13991)).

10.22Summary Description of Compensation Payable to Non-Employee Directors (incorporated herein by reference to Exhibit 10.1 to the Company’s Form 10-Q for the quarter ended June 30, 2014 (Commission File No. 1-13991)).

12.1*Computation of Ratio of Debt-to-Equity.

21*Subsidiaries of the Company.

23.1*Consent of KPMG LLP.

31.1*Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS** XBRL Instance Document

101.SCH** XBRL Taxonomy Extension Schema Document

101.CAL** XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF** XBRL Taxonomy Extension Definition Linkbase Document

101.LAB** XBRL Taxonomy Extension Label Linkbase Document

101.PRE** XBRL Taxonomy Extension Presentation Linkbase Document

* Filed herewith.

152

**These interactive data files are furnished and deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

153

EX-10.10

Exhibit 10.10

MFA FINANCIAL, INC.
FOURTH AMENDED AND RESTATED

2003 NONEMPLOYEE DIRECTORS’ DEFERRED COMPENSATION PLAN

(as amended and restated through December 15, 2014)

1.Purpose

The purpose of the Plan is to provide Nonemployee Directors of the Corporation with an opportunity to defer 100% or 50% of their Compensation or to defer Equity Awards while at the same time aligning their interests more closely with the interests of the stockholders of the Corporation. This Plan was an amendment and complete restatement of the Amended and Restated 2003 Nonemployee Directors’ Deferred Compensation Plan and became effective as of November 1, 2012. The Plan is hereby further amended as of December 15, 2014.

2.Effective Date

This Plan became effective on November 1, 2012 and is hereby amended as of the Amendment Effective Date. Compensation and Equity Awards deferred under the Plan with respect to services performed on or before December 31, 2014 shall be governed by the terms of the Plan in effect for such Compensation and Equity Awards prior to the Amendment Effective Date.

3.Definitions

In this Plan, the following definitions shall apply:

“Administrator” - the person, persons or entity appointed by the Board from time to time to manage and administer the Plan.

“Amendment Effective Date” – December 15, 2014

“Annual Meeting” - annual meetings of stockholders of the Corporation at which directors of the Board are elected.

“Board” - the Board of Directors of the Corporation.

“Code” - the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.

“Common Stock” - the Corporation’s common stock, $0.01 par value per share.

“Compensation” - the aggregate value of all annual cash compensation payable to a Nonemployee Director for service on the Board (exclusive of any reimbursable expenses relating to such Nonemployee Director’s service on the Board).

“CompensationAccount” - the account maintained by the Corporation for Deferred Stock Units credited in accordance with Section 6 of the Plan.

“Corporation” - MFA Financial, Inc., a Maryland corporation, and its successors.

“Deferral Period” - the five-year period, if so elected, during which Compensation for a particular year is to be deferred. At the conclusion of the Deferral Period, such deferred Compensation will be paid out in a lump sum or, if so elected, in a specified number of annual installments not to exceed five years. If the deferred Compensation is paid out in annual installments, such installment payments shall be treated as a series of separate payments for purposes of Section 409A of the Code. Except as otherwise provided in Section 8(a) of the Plan, payment(s) will commence, or be made in a lump sum, no earlier than January 15 of the year first following the five-year anniversary of the applicable election date. For example, if during 2012 a Participant elects the Deferral Period (i.e., 5 years) for Compensation deferred in 2013, the payment(s) shall be made/commence on or after January 15, 2018.

“Deferred Stock Unit” - a credit to a Participant’s Compensation Account under Section 6(a) that represents the right to receive a cash payment equal to the Fair Market Value of one Share on settlement of the Compensation Account.

“Equity Account” - the account maintained by the Corporation for Restricted Stock Units credited in accordance with Section 9 of the Plan.

“Equity Award” - either fully vested Shares or fully vested Restricted Stock Units granted pursuant to the Equity Incentive Plan, or any successor plan.

“Equity Incentive Plan” – the MFA Financial, Inc. Amended and Restated 2010 Equity Compensation Plan, as amended from time to time.

“Fair Market Value” - for any date, the average of the high and low sales prices for Shares of the Corporation’s Common Stock, as reported by the New York Stock Exchange or such other relevant exchange on which the Corporation’s Common Stock is traded.

“Incumbent Directors” - persons who, as of the Effective Date, constitute the Board.

“Nonemployee Director” - a member of the Board who is not also an employee of the Corporation and/or an employee of any affiliate of the Corporation.

“Participant” - each Nonemployee Director who elects to defer 50% or 100% of his or her Compensation or defers an Equity Award under this Plan.

“Plan” - MFA Financial, Inc. Third Amended and Restated 2003 Nonemployee Directors’ Deferred Compensation Plan, as it may be amended from time to time.

“Restricted Stock Unit” - a phantom interest granted pursuant to the Equity Incentive Plan or any successor thereto that represents the right to receive one Share on settlement, in accordance with the Restricted Stock Unit Agreement.

“Restricted Stock Unit Agreement” - a written agreement to be entered into between the Corporation and the Participant in connection with the grant of Restricted Stock Units.

“Second Election” – (a) with respect to Compensation, an election pursuant to Section 5(c)(4) of the Plan which changes the Nonemployee Director’s prior deferral election, or (b) with respect to Restricted Stock Units, an election pursuant to Section 9(b)(4), which defers the settlement date of the Restricted Stock Units.

“Share” - a share of Common Stock of the Corporation.

“Termination of Service” - termination of service with the Corporation, which shall be interpreted in a manner that is consistent with the definition of a “separation from service” under Section 409A of the Code and Treasury Regulation 1.409A-1(h).

4.Administration

(a)    Subject to the oversight of the Board, the Administrator shall have authority to administer the Plan, including conclusive authority to construe and interpret the Plan, to establish rules, policies, procedures, forms and notices for use in carrying out the Plan, and to make all other determinations necessary or desirable for administration of the Plan. The Administrator may delegate some or all of its functions to another person(s) as it may deem appropriate.

(b)    Notwithstanding any other provision herein to the contrary, the Corporation intends that the Plan comply with the requirements of Section 409A of the Code, and the Administrator shall administer the Plan and exercise authority and discretion under the Plan to satisfy the requirements of Section 409A of the Code or any exemption thereto.

-2-

5.Elections to Defer Compensation

(a)Amount of Deferral. A Nonemployee Director may elect to defer receipt of 50% or 100% of such Nonemployee Director’s Compensation otherwise thereafter payable to such Nonemployee Director.

(b)Manner of Electing Deferral. An election to defer Compensation shall be made by each Participant by giving written notice to the Administrator in the form approved by the Administrator. Such notice shall address, without limitation:

(1)    the percentage of Compensation for the next calendar year to be deferred;

(2)    if applicable, an election for the Compensation Account to be settled following a five-year Deferral Period; and

(3)    an election for the Compensation Account to be settled in either a lump-sum payment or in a specified number of annual installments (not to exceed five).

(c)Time of Election; Effectiveness; Change of Election.

(1)    An election to defer Compensation shall be made by a Nonemployee Director no later than the end of the calendar year preceding the year for which the Compensation was earned. Notwithstanding the foregoing, a Nonemployee Director who first becomes eligible to participate in the Plan may make an election to defer any future Compensation within 30 days after the date of such eligibility; provided, however, that such deferral election shall only apply to the pro rata portion of the Compensation that is earned from the date of such election through the remainder of the year.

(2)    An election made prior to the year for which the Compensation is earned shall be irrevocable as of the last day of the calendar year in which the election is made and shall continue in effect until the end of the calendar year for which Compensation is earned.

(3)    A Nonemployee Director may elect to defer Compensation annually by submitting an Annual Participant Election Form provided by the Administrator, and the election submitted shall only be effective prospectively for the calendar year commencing immediately after the time of such submission.

(4)    Notwithstanding the foregoing, with respect to any previously deferred Compensation, a Nonemployee Director may make a Second Election, which must, except as may otherwise be permitted under the rules applicable under Section 409A of the Code, (A) be effective at least one year after it is made, or, in the case of payments to commence at a specific time, be made at least one year before the first scheduled payment, and (B) defer the commencement of distributions (and each affected distribution) for at least five years.

6.Deferred Compensation Account

(a)Establishment of Compensation Account. The Corporation will maintain Compensation Account(s) for each Participant for each year in which they elect to participate in the Plan, which will reflect the Compensation deferred by such Participant for a given calendar year. Compensation Accounts under this Plan shall be unfunded and shall represent only an unsecured claim against the general assets of the Corporation.

(b)Deferred Stock Units. In any given calendar year, a Participant’s election to defer either 50% or 100% of the Compensation earned by such Participant shall be in the form of Deferred Stock Units. Such deferral election shall be made in accordance with the provisions of Sections 5(b) and 5(c) of the Plan. The number of Deferred Stock Units credited to the Participant’s Compensation Account, at the time such Compensation would otherwise have been payable absent the election to defer, will be equal to (i) the otherwise payable amount divided by (ii) the Fair Market Value of a Share on the last trading day preceding the credit date. In addition, on each date on which a cash dividend is payable on the Shares, the Participant’s Compensation Account shall be credited with a number of Deferred Stock Units equal to (i) the per Share cash dividend times the number of Deferred Stock Units then credited to the Compensation Account, divided by (ii) the Fair Market Value of a Share on the last trading day preceding the dividend

-3-

payment date. Compensation Accounts shall be credited with fractional Deferred Stock Units, rounded to the third decimal place. Such additional Deferred Stock Units shall be paid to the Participant at the same time as Deferred Stock Units are received by the Participant with respect to the deferral of Compensation.

(c)    Adjustments. In case of a stock split, stock dividend, or other relevant change in capitalization of the Corporation, the number of Deferred Stock Units credited to a Participant’s Compensation Account shall be adjusted in such manner as the Administrator deems appropriate.

7.Valuation

The value of a Compensation Account as of any date on which a settlement payment is to be made under Section 8 shall be the amount equal to the number of Deferred Stock Units then credited to the Participant’s Compensation Account times the Fair Market Value of a Share on the last trading day preceding the payment date.

8.Settlement

(a)General. The Deferred Stock Units credited to a Participant’s Compensation Account shall be distributed or commence distribution to a Participant on the earlier of (i) the year first following the year in which a Termination of Service occurs, or (ii) with respect to any particular Compensation Account, the year first following the year in which the five-year Deferral Period elected by such Participant for such Compensation Account expires. To the extent that a Compensation Account is to be distributed to a Participant in accordance with this Section 8, such distribution shall occur on or about, but no earlier than, January 15 of the applicable distribution year.

(b)Lump Sum. If a Participant elects lump sum settlement, an amount of cash equal to the value of the Deferred Stock Units credited to the Compensation Account determined in accordance with Section 7 shall be paid to the Participant in accordance with Section 8(a).

(c)Installment Payments. If a Participant elects settlement in installments, an amount of cash determined as hereafter provided shall be paid to the Participant in accordance with Section 8(a) in each year of the installment payment period elected. The amount of each installment shall be equal to (i) the value of the Deferred Stock Units credited to the Participant’s Compensation Account as of the payment date for such installment, determined in accordance with Section 7, divided by (ii) the number of unpaid installments. Each installment payment shall be debited to the Deferred Stock Units in a Participant’s Compensation Account.

(d)Payment on Death. Notwithstanding a Participant’s settlement election, in the event of a Participant’s death an amount of cash equal to the remaining value of the Compensation Account determined as provided in Section 7 shall be paid in a single payment to the Participant’s estate as soon as possible, without undue delay, but in no event later than 90 days after the date of the Participant’s death.

(e)No Withdrawal. A Participant may not withdraw from the Participant’s Compensation Account, and no amounts shall be distributed with respect to a Participant’s Account, prior to the applicable distribution date.

(f)Cash Settlement Only. Settlement of a Compensation Account under this Plan shall be made only in cash, via wire transfer or check in U.S. dollars.

9.Equity Awards.

(a)Type of Equity Awards. Nonemployee Directors shall also be eligible to receive for service on the Board annual Equity Awards in an amount and on such terms and conditions as prescribed by the Board or Compensation Committee of the Board. Unless the Board or Compensation Committee determines otherwise, such Equity Awards shall be, as elected by the Participant in accordance with this Plan, granted in the form of fully vested Shares or fully vested Restricted Stock Units.

-4-

(b)Election of Form and Distribution of Equity Awards.

(1)    The Participant may elect to receive each applicable Equity Award in the form of fully vested Shares or fully vested Restricted Stock Units. Such election shall be made no later than the end of the calendar year preceding the applicable Annual Meeting. Notwithstanding the foregoing, a Participant who first becomes eligible to participate in the Plan may make an election as to the form of the applicable Equity Award within 30 days after the date of such eligibility; provided, however, that, with respect to the then-current annual period, the Participant may elect to receive Restricted Stock Units only with respect to the pro rata portion of the number of Shares included in the Equity Award that are earned from the date of such election through the remainder of the year.

(2)    The election described in Section 9(b)(1) shall be made by giving written notice to the Administrator in the form approved by the Administrator. The Participant’s election as to the form of the Equity Award to be received at the next annual meeting shall be irrevocable as of December 31 of the year preceding the year of the applicable Annual Meeting. Unless a new election is submitted in accordance with this Section 9(b)(2), the previous election submitted to the Corporation shall continue in effect from period to period and from meeting to meeting, as applicable. The Equity Award for any Participant who fails to make an election shall be granted in the form of fully vested Shares of Common Stock.

(3)    With respect to each Participant who elects to receive Restricted Stock Units, such Restricted Stock Units shall be credited to an Equity Account maintained by the Company on behalf of such Participant. Equity Accounts under this Plan shall be unfunded and shall represent only an unsecured claim against the general assets of the Corporation.

(4)    Shares pursuant to Restricted Stock Units shall be distributed in a lump sum on the earlier of (i) the calendar year first following the year in which a Termination of Service occurs, or (ii) the calendar year first following the fifth anniversary of the grant date of such Restricted Stock Units. To the extent that Shares are to be distributed to a Participant in accordance with this Section 9, such distribution shall occur on or about, but no earlier than, January 15 of the applicable distribution year. Notwithstanding the foregoing, a Nonemployee Director may make a Second Election with respect to Restricted Stock Units, which must, except as may otherwise be permitted under the rules applicable under Section 409A of the Code, (A) be effective at least one year after it is made, or, in the case of payment to be made at a specific time, be made at least one year before settlement, and (B) defer the settlement of Restricted Stock Units for at least five years.

(5)    All Restricted Stock Units shall be settled in Shares, and all Shares issued with respect to Restricted Stock Units shall be issued under the Equity Incentive Plan.

(c)Payment on Death. Notwithstanding a Participant’s settlement election, in the event of a Participant’s death, Shares pursuant to Restricted Stock Units shall be distributed in a single lump sum to the Participant’s estate as soon as possible, without undue delay, but in no event later than 90 days after the date of the Participant’s death.

10.Non-Assignability

The right of a Participant to receive any unpaid portion of the Participant’s Compensation Account or Equity Account may not be assigned or transferred except by will or the laws of descent and distribution, and may not be pledged or encumbered or be subject to attachment, execution, or levy of any kind.

11.Amendment and Termination

This Plan may be amended, modified or terminated by the Board at any time (taking into account, without limitation, Section 409A of the Code as the Board may deem appropriate), provided that no such amendment, modification or termination shall, without the consent of a Participant, adversely affect such Participant’s rights with respect to amounts accrued in the Participant’s Compensation Account or Equity Account.

-5-

12.Governing Law

This Plan and all actions taken under it shall be governed by the laws of the State of New York, without reference to conflict of law principles.

13.Severability

If any provision of this Plan shall be deemed illegal or invalid for any reason, such illegality or invalidity shall not affect the remaining provisions of the Plan but shall be fully severable.

14.Compliance

The Administrator is authorized to take such steps as may be necessary including, without limitation, delaying effectiveness of a Participant’s election or delaying settlement of a Compensation Account or Equity Account, in order to ensure that this Plan and all actions taken under it comply with any law, regulation, or listing requirement which the Administrator deems applicable or desirable, including the exemption provided by Rule 16b-3 under the Securities Exchange Act of 1934, as amended. The Plan is intended to be construed and administered in compliance with Section 409A of the Code. Notwithstanding the foregoing, the Corporation makes no representation that the Plan complies with Section 409A of the Code and shall have no liability to any Participant for any failure to comply with Section 409A of the Code. .

15.Withholding

If the Corporation concludes that any tax is owing with respect to any deferral of income or payment hereunder, the Corporation shall withhold such amounts from any payments due the Participant, or otherwise make appropriate arrangements with the Participant for satisfaction of such obligation.

-6-

EX-12.1

Exhibit 12.1

Computation of Ratio of Debt-to-Equity

(Dollars in Thousands)	At December 31, 2015
Repurchase agreements and other advances	$	9,388,902
Securitized debt	22,057
Obligation to return securities obtained as collateral, at fair value	507,443
Senior Notes	100,000
Total Debt	$	10,018,402
Stockholders' Equity	$	2,967,261
Ratio of Debt-to-Equity	3.4		:1
Debt-to-Equity Multiple	3.4		x

EX-21

Exhibit 21

Subsidiaries of Registrant	Jurisdiction
MFA Securities Holdings LLC	Delaware
MFA Securitization Holdings LLC	Delaware
MFResidential Assets I, LLC	Delaware
MFResidential Assets Holding Corp.	Delaware
MFA Kittiwake Investments Ltd.	Cayman Islands

EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

MFA Financial, Inc.:

We consent to the incorporation by reference in the registration statements (Nos. 333-190489 and 333-191851) on Form S-3 and in the registration statement (No. 333-205105) on Form S-8 of MFA Financial, Inc., of our reports dated February 18, 2016, with respect to the consolidated balance sheets of MFA Financial, Inc. as of December 31, 2015 and 2014, and the related consolidated statements of operations, comprehensive (loss)/income, changes in stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2015, and all related financial statement schedules, and the effectiveness of internal control over financial reporting as of December 31, 2015, which reports appear in the December 31, 2015 annual report on Form 10-K of MFA Financial, Inc.

/s/ KPMG LLP

New York, New York

February 18, 2016

EX-31.1

Exhibit 31.1

CERTIFICATION

I, William S. Gorin, certify that:

1. I have reviewed this Annual Report on Form 10-K of MFA Financial, Inc. (the “Registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors:

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: February 18, 2016
By:	/s/ William S. Gorin
	Name: William S. Gorin
	Title: Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Stephen D. Yarad, certify that:

1. I have reviewed this Annual Report on Form 10-K of MFA Financial, Inc. (the “Registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors:

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: February 18, 2016
By:	/s/ Stephen D. Yarad
	Name: Stephen D. Yarad
	Title: Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification of Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350, as Adopted

Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002

In connection with the annual report on Form 10-K of MFA Financial, Inc. (the “Company”) for the fiscal year ended December 31, 2015 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, William S. Gorin, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ William S. Gorin	Date: February 18, 2016
	Name: William S. Gorin
	Title: Chief Executive Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes—Oxley Act of 2002, and is not being “filed” as part of the Form 10-K or as a separate disclosure document for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section. This certification shall not be deemed to be incorporated by reference to any filing under the Securities Act of 1933, as amended, or the Exchange Act except to the extent that this Exhibit 32.1 is expressly and specifically incorporated by reference in any such filing.

EX-32.2

Exhibit 32.2

Certification of Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350, as Adopted

Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002

In connection with the annual report on Form 10-K of MFA Financial, Inc. (the “Company”) for the fiscal year ended December 31, 2015 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, Stephen D. Yarad, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ Stephen D. Yarad	Date: February 18, 2016
	Name: Stephen D. Yarad
	Title: Chief Financial Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes—Oxley Act of 2002, and is not being “filed” as part of the Form 10-K or as a separate disclosure document for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section. This certification shall not be deemed to be incorporated by reference to any filing under the Securities Act of 1933, as amended, or the Exchange Act except to the extent that this Exhibit 32.2 is expressly and specifically incorporated by reference in any such filing.

XML

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Feb. 12, 2016	Jun. 30, 2015
Document and Entity Information
Entity Registrant Name	MFA FINANCIAL, INC.
Entity Central Index Key	0001055160
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 2,730
Entity Common Stock, Shares Outstanding (in shares)		371,076,243
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	FY

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Dec. 31, 2015		Dec. 31, 2014
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:
MBS and CRT securities		$ 11,356,643		$ 10,762,622
Securities obtained and pledged as collateral, at fair value		507,443		512,105
Residential whole loans, at carrying value ($93,692 and $67,536 pledged as collateral, respectively)		271,845		207,923
Residential whole loans, at fair value ($585,971, and $143,072 pledged as collateral, respectively)		623,276		143,472
Cash and cash equivalents		165,007		182,437
Restricted cash		71,538		67,255
Interest receivable		29,002		32,581
Derivative instruments:
MBS linked transactions, net (“Linked Transactions”), at fair value		0		398,336
Interest rate swap agreements (“Swaps”), at fair value		1,127		3,136
Goodwill		7,189		7,189
Prepaid and other assets		134,253		37,688
Total Assets		13,167,323		12,354,744
Liabilities:
Repurchase agreements and other advances	[1]	9,388,902		8,267,388
Securitized debt	[2]	22,057		110,574
Obligation to return securities obtained as collateral, at fair value		507,443		512,105
8% Senior Notes due 2042 (“Senior Notes”)		100,000		100,000
Accrued interest payable		16,949		13,095
Swaps, at fair value	[3]	70,526		62,198
Dividends and dividend equivalents payable		74,575		74,529
Accrued expenses and other liabilities		19,610		11,583
Total Liabilities		$ 10,200,062		$ 9,151,472
Commitments and contingencies
Stockholders’ Equity:
Preferred stock, $.01 par value; 7.50% Series B cumulative redeemable; 8,050 shares authorized; 8,000 shares issued and outstanding ($200,000 aggregate liquidation preference)		$ 80		$ 80
Common stock, $.01 par value; 886,950 shares authorized; 370,584 and 370,084 shares issued and outstanding, respectively		3,706		3,701
Additional paid-in capital, in excess of par		3,019,956		3,013,634
Accumulated deficit		(572,332)		(568,596)
Accumulated other comprehensive income		515,851		754,453
Total Stockholders’ Equity		2,967,261		3,203,272
Total Liabilities and Stockholders’ Equity		13,167,323		12,354,744
Agency MBS
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:
MBS and CRT securities		4,752,244		5,904,207
Non-Agency MBS
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:
MBS and CRT securities	[4]	6,420,817		4,755,432
Non-Agency MBS | Non-Agency MBS
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:
MBS and CRT securities		5,822,519		3,358,426
Non-Agency MBS | Non-Agency MBS Transfered to Consolidated VIEs
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:
MBS and CRT securities	[5]	598,298		1,397,006
CRT securities
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:
MBS and CRT securities		$ 183,582	[6]	$ 102,983

[1] The fair value of financial instruments pledged against the Company’s repurchase agreements and other advances was $11.300 billion and $9.934 billion at December 31, 2015 and 2014, respectively.

[2] Securitized Debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that eliminate on consolidation. The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company. (See Notes 12 and 17 for further discussion.)

[3] The fair value of securities pledged against the Company’s Swaps was $38.6 million and $57.2 million at December 31, 2015 and 2014, respectively.

[4] At December 31, 2015 and 2014, the Company expected to recover approximately 89% and 83%, respectively, of the then-current face amount of Non-Agency MBS.

[5] Non-Agency MBS transferred to consolidated VIEs represent assets of consolidated VIEs that can be used only to settle the obligations of each respective VIE.

[6] Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $62.2 million for which the fair value option has been elected. Such securities have gross unrealized gains of approximately $332,000, gross unrealized losses of approximately $555,000 and net unrealized losses of approximately $223,000 at December 31, 2015.

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Residential whole loans, pledged as collateral	$ 93,692,000	$ 67,536,000
Residential whole loans, pledged as collateral, fair value	$ 585,971,000	$ 143,072,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	8,050,000	8,050,000
Preferred stock, dividend rate (as a percent)	7.50%	7.50%
Preferred stock, shares issued (in shares)	8,000,000	8,000,000
Preferred stock, shares outstanding (in shares)	8,000,000	8,000,000
Preferred stock, aggregate liquidation preference (in dollars)	$ 200,000,000	$ 200,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	886,950,000	886,950,000
Common stock, shares issued (in shares)	370,584,000	370,084,000
Common stock, shares outstanding (in shares)	370,584,000	370,084,000
Agency MBS
Mortgage backed securities pledged as collateral	$ 4,532,094,000	$ 5,519,813,000
Non-Agency MBS
Mortgage backed securities pledged as collateral	4,874,372,000	2,377,343,000
CRT securities
Mortgage backed securities pledged as collateral	$ 170,352,000	$ 94,610,000

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Interest Income:
Residential whole loans held at carrying value		$ 16,036	$ 4,083	$ 0
Cash and cash equivalent investments		130	89	124
Interest Income		492,143	463,817	482,940
Interest Expense:
Repurchase agreements and other advances		166,918	145,244	143,885
Securitized debt		1,996	6,533	12,100
Senior Notes		8,034	8,031	8,028
Interest Expense		176,948	159,808	164,013
Net Interest Income		315,195	304,009	318,927
Other-Than-Temporary Impairments:
Total other-than-temporary impairment losses		(525)	0	0
Portion of loss reclassed from other comprehensive income		(180)	0	0
Net Impairment Losses Recognized in Earnings		(705)	0	0
Other Income, net:
Unrealized net gains and net interest income from Linked Transactions		0	17,092	3,225
Net gain on residential whole loans held at fair value		17,722	116	0
Losses on TBA short positions		0	0	(7,517)
Gain on sales of MBS and U.S. Treasury securities, net		34,900	37,497	25,825
Other, net		(1,457)	80	219
Other Income, net		51,165	54,785	21,752
Operating and Other Expense:
Compensation and benefits		26,293	25,581	20,328
Other general and administrative expense		15,752	15,164	13,361
Loan servicing and other related operating expenses		10,384	3,383	0
Excise tax and interest		0	1,162	2,250
Impairment of resecuritization related costs		0	0	2,031
Operating and Other Expense		52,429	45,290	37,970
Net Income		313,226	313,504	302,709
Less Preferred Stock Dividends		15,000	15,000	13,750
Less Issuance Costs of Redeemed Preferred Stock	[1]	0	0	3,947
Net Income Available to Common Stock and Participating Securities		$ 298,226	$ 298,504	$ 285,012
Earnings per Common Share - Basic and Diluted (in dollars per share)		$ 0.80	$ 0.81	$ 0.78
Agency MBS
Interest Income:
Mortgage backed securities		$ 105,835	$ 142,543	$ 156,046
Non-Agency MBS | Non-Agency MBS
Interest Income:
Mortgage backed securities		317,821	185,806	170,485
Non-Agency MBS | Non-Agency MBS Transfered to Consolidated VIEs
Interest Income:
Mortgage backed securities		45,749	130,524	156,285
CRT securities
Interest Income:
Mortgage backed securities		$ 6,572	$ 772	$ 0

[1] Issuance costs of redeemed preferred stock represent the original offering costs related to the Series A Preferred Stock, which was redeemed on May 16, 2013. (See Note 13)

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS)/INCOME - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Net Income		$ 313,226	$ 313,504	$ 302,709
Other Comprehensive (Loss)/Income:
Reclassification adjustment for MBS sales included in net income		(37,207)	(34,948)	(19,833)
Reclassification adjustment for other-than-temporary impairments included in net income		(705)	0	0
Unrealized (loss)/gain on derivative hedging instruments, net		(10,337)	(44,292)	47,614
Reclassification of unrealized loss on de-designated derivative hedging instruments		0	447	0
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing		4,537	0	0
Other Comprehensive (Loss)/Income		(238,602)	16,758	(24,282)
Comprehensive Income before preferred stock dividends and issuance costs of redeemed preferred stock		74,624	330,262	278,427
Dividends declared on preferred stock		(15,000)	(15,000)	(13,750)
Issuance costs of redeemed preferred stock	[1]	0	0	(3,947)
Comprehensive Income Available to Common Stock and Participating Securities		59,624	315,262	260,730
Agency MBS
Other Comprehensive (Loss)/Income:
Unrealized (loss)/gain on MBS and CRT securities, net		(51,332)	65,739	(186,568)
Non-Agency MBS
Other Comprehensive (Loss)/Income:
Unrealized (loss)/gain on MBS and CRT securities, net		$ (143,558)	$ 29,812	$ 134,505

[1] Issuance costs of redeemed preferred stock represent the original offering costs related to the Series A Preferred Stock, which was redeemed on May 16, 2013. (See Note 13)

XML

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands		Total		Series A Preferred Stock	Series B Preferred Stock	Preferred Stock, Cumulative Redeemable - Liquidation Preference $25.00 per Share: Series A Preferred Stock	Preferred Stock, Cumulative Redeemable - Liquidation Preference $25.00 per Share: Series B Preferred Stock	Common Stock		Additional Paid-in Capital		Additional Paid-in Capital Series A Preferred Stock	Additional Paid-in Capital Series B Preferred Stock	Accumulated Deficit	Accumulated Other Comprehensive Income
Balance at Dec. 31, 2012		$ 3,311,006				$ 38	$ 0	$ 3,575		$ 2,805,724				$ (260,308)	$ 761,977
Balance (in shares) at Dec. 31, 2012						3,840	0	357,546
Increase (Decrease) in Stockholders' Equity
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing		0													0
Net income		302,709												302,709
Issuance of stock, net of expenses		77,625	[1]		$ 193,316		$ 80	$ 97	[1]	77,528	[1]		$ 193,236
Issuance of common stock, net of expenses (in shares)							8,000	9,855	[1]
Redemption of Series A Preferred Stock				$ (92,053)		$ (38)						$ (92,015)
Redemption of Series A Preferred Stock (in shares)						(3,840)
Repurchase of shares of common stock	[1]	(16,281)						$ (21)		(16,260)
Repurchase of shares of common stock (in shares)	[1]							(2,276)
Equity based compensation expense		4,156								4,156
Dividends declared on common stock		(594,318)												(594,318)
Dividends declared on preferred stock		(13,750)												(13,750)
Dividends attributable to dividend equivalents		(1,930)												(1,930)
Issuance cost of redeemed Preferred stock		(3,947)												(3,947)
Change in unrealized gains/(losses) on MBS and CRT securities, net		(71,896)													(71,896)
Change in unrealized gains/(losses) on derivative hedging instruments, net		47,614													47,614
Balance at Dec. 31, 2013		3,142,251				$ 0	$ 80	$ 3,651		2,972,369				(571,544)	737,695
Balance (in shares) at Dec. 31, 2013						0	8,000	365,125
Increase (Decrease) in Stockholders' Equity
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing		0													0
Net income		313,504												313,504
Issuance of stock, net of expenses	[1]	35,640						$ 50		35,590
Issuance of common stock, net of expenses (in shares)	[1]							5,305
Repurchase of shares of common stock	[1]	(2,688)								(2,688)
Repurchase of shares of common stock (in shares)	[1]							(346)
Equity based compensation expense		8,581								8,581
Accrued dividends attributable to stock-based awards		(218)								(218)
Dividends declared on common stock		(294,792)												(294,792)
Dividends declared on preferred stock		(15,000)												(15,000)
Dividends attributable to dividend equivalents		(764)												(764)
Change in unrealized gains/(losses) on MBS and CRT securities, net		60,603													60,603
Change in unrealized gains/(losses) on derivative hedging instruments, net		(43,845)													(43,845)
Balance at Dec. 31, 2014		3,203,272					$ 80	$ 3,701		3,013,634				(568,596)	754,453
Balance (in shares) at Dec. 31, 2014							8,000	370,084
Increase (Decrease) in Stockholders' Equity
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing		4,537												(4,537)	4,537
Net income		313,226												313,226
Issuance of stock, net of expenses	[1]	1,221						$ 5		1,216
Issuance of common stock, net of expenses (in shares)	[1]							809
Repurchase of shares of common stock	[1]	(2,273)								(2,273)
Repurchase of shares of common stock (in shares)	[1]							(309)
Equity based compensation expense		7,829								7,829
Accrued dividends attributable to stock-based awards		(450)								(450)
Dividends declared on common stock		(296,384)												(296,384)
Dividends declared on preferred stock		(15,000)												(15,000)
Dividends attributable to dividend equivalents		(1,041)												(1,041)
Change in unrealized gains/(losses) on MBS and CRT securities, net		(232,802)													(232,802)
Change in unrealized gains/(losses) on derivative hedging instruments, net		(10,337)													(10,337)
Balance at Dec. 31, 2015		$ 2,967,261					$ 80	$ 3,706		$ 3,019,956				$ (572,332)	$ 515,851
Balance (in shares) at Dec. 31, 2015							8,000	370,584

[1] For the year ended December 31, 2015, includes approximately $2.3 million (309,206 shares) surrendered for tax purposes related to equity-based compensation awards. For the year ended December 31, 2014, includes approximately $2.7 million (345,559 shares) surrendered for tax purposes related to equity-based compensation awards. For the year ended December 31, 2013, includes approximately $15.4 million (2,143,354 shares) repurchased through the Company’s publicly announced stock repurchase program and approximately $849,000 (132,276 shares) surrendered for tax purposes related to equity-based compensation awards.

XML

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Preferred Stock, Cumulative Redeemable - dividend rate (as a percent)	7.50%	7.50%
Adjustments related to tax withholding for share-based compensation	$ 2,300	$ 2,700	$ 849
Shares surrendered for tax purposes related to equity-based compensation awards (in shares)	309,206	345,559	132,276
Value of shares repurchased through the Company's publicly announced stock repurchase program (in dollars)			$ 15,400
Number of shares repurchased through the Company's publicly announced stock repurchase program (in shares)	0	0	2,143,354
Series A Preferred Stock
Preferred Stock, Cumulative Redeemable - dividend rate (as a percent)			8.50%
Preferred Stock, Cumulative Redeemable - Liquidation Preference per Share (in dollars per share)			$ 25
Series B Preferred Stock
Preferred Stock, Cumulative Redeemable - dividend rate (as a percent)	7.50%	7.50%	7.50%
Preferred Stock, Cumulative Redeemable - Liquidation Preference per Share (in dollars per share)	$ 25.00	$ 25.00	$ 25

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS $ in Thousands	12 Months Ended
	Dec. 31, 2015 USD ($)		Dec. 31, 2014 USD ($)		Dec. 31, 2013 USD ($)
Cash Flows From Operating Activities:
Net income	$ 313,226		$ 313,504		$ 302,709
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on sales of MBS and U.S. Treasury securities	(34,900)		(37,497)		(25,825)
Other-than-temporary impairment charges	705		0		0
Accretion of purchase discounts on MBS and CRT securities and residential whole loans	(95,377)		(89,182)		(73,447)
Amortization of purchase premiums on MBS	41,624		32,052		58,207
Depreciation and amortization on real estate, fixed assets and other assets	860		1,191		5,831
Equity-based compensation expense	7,832		8,581		4,158
Unrealized (gain)/loss on residential whole loans at fair value	(6,532)		96		0
Unrealized gains on derivative instruments	0		(1,673)		(1,111)
Decrease in interest receivable	4,844		4,561		8,180
Increase in prepaid and other assets	(6,278)		(12,684)		(5,549)
Realized loss on TBA short positions	0		0		7,517
Increase/(decrease) in accrued expenses and other liabilities, and excise tax and interest	5,425		(8,301)		3,610
Increase in accrued interest payable on financial instruments	50,745		45,165		13,808
Net cash provided by operating activities	282,174		255,813		298,088
Cash Flows From Investing Activities:
Principal payments on MBS and CRT securities	2,916,807		1,939,948		2,770,710
Proceeds from sale of MBS and U.S. Treasury securities	70,747		123,910		574,869
Purchases of MBS and CRT securities	(1,810,303)		(1,261,646)		(1,744,605)
Purchases of residential whole loans	(617,017)		(356,440)		0
Principal payments on residential whole loans	51,427		6,017		0
Purchases of Federal Home Loan Bank stock	(60,017)		0		0
Additions to leasehold improvements, furniture and fixtures	(1,560)		(786)		(373)
Net cash provided by investing activities	550,084		451,003		1,600,601
Cash Flows From Financing Activities:
Principal payments on repurchase agreements and other advances	(92,012,931)		(75,939,948)		(69,851,602)
Proceeds from borrowings under repurchase agreements and other advances	91,614,851		75,868,039		69,438,427
Proceeds from issuance of securitized debt	0		0		129,314
Principal payments on securitized debt	(88,347)		(254,078)		(409,606)
Payments made on obligation to return securities obtained as collateral	0		0		(246,850)
Maturity of obligation to return securities obtained as collateral	0		0		(275,402)
Cash disbursements on financial instruments underlying Linked Transactions	0		(6,750,803)		(419,802)
Cash received from financial instruments underlying Linked Transactions	0		6,336,872		405,436
Payments made for margin calls on repurchase agreements and Swaps	(267,200)		(208,600)		(69,902)
Proceeds from reverse margin calls on repurchase agreements and Swaps	215,100		132,800		22,809
Settlement of TBA short positions	0		0		(7,517)
Proceeds from issuances of common stock	1,218		35,639		77,625
Payments made for redemption of Series A Preferred Stock	0		0		(96,000)
Proceeds from issuance of Series B Preferred Stock	0		0		200,000
Payments made for preferred stock offering costs	0		0		(6,684)
Payments made to repurchase common stock	0		0		(16,281)
Dividends paid on preferred stock	(15,000)		(15,000)		(13,750)
Dividends paid on common stock and dividend equivalents	(297,379)		(294,670)		(594,827)
Net cash used in financing activities	(849,688)		(1,089,749)		(1,734,612)
Net (decrease)/increase in cash and cash equivalents	(17,430)		(382,933)		164,077
Cash and cash equivalents at beginning of period	182,437		565,370		401,293
Cash and cash equivalents at end of period	165,007		182,437		565,370
Supplemental Disclosure of Cash Flow Information:
Interest paid	172,919		160,935		162,186
Non-cash Investing and Financing Activities:
MBS and CRT securities recorded upon adoption of revised accounting standard for repurchase agreement financing	1,917,813		0		0
Repurchase agreements recorded upon adoption of revised accounting standard for repurchase agreement financing	1,519,593		0		0
MBS recorded upon de-linking of Linked Transactions	0		86,449		0
Repurchase agreements recorded upon de-linking of Linked Transactions	0		49,095		0
Net increase in securities obtained as collateral/obligation to return securities obtained as collateral	32,670		135,165		401,135
Transfer from residential whole loans to real estate owned	30,104	[1]	2,904	[1]	0
Dividends and dividend equivalents declared and unpaid	$ 74,575		$ 74,529		$ 73,643

[1] Includes net gain recorded on transfer of approximately $1.7 million and $331,000, respectively, for the years ended December 31, 2015 and 2014.

XML

Organization

12 Months Ended

Dec. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization

Organization

MFA Financial, Inc. (the “Company”) was incorporated in Maryland on July 24, 1997 and began operations on April 10, 1998.  The Company has elected to be treated as a real estate investment trust (“REIT”) for U.S. federal income tax purposes.  In order to maintain its qualification as a REIT, the Company must comply with a number of requirements under federal tax law, including that it must distribute at least 90% of its annual REIT taxable income to its stockholders.  The Company has elected to treat certain of its subsidiaries as a taxable REIT subsidiary (“TRS”). In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. (See Notes 2(o) and 13)

XML

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

(a)  Basis of Presentation and Consolidation

The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with U.S. generally accepted accounting principles (“GAAP”).  The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could be worse than anticipated in those estimates, which could materially impact the Company’s results of operations and its financial condition.  Management has made significant estimates in several areas, including other-than-temporary impairment (“OTTI”) on MBS (See Note 3), valuation of MBS and CRT securities (See Notes 3 and 16), income recognition and valuation of residential whole loans (See Notes 4 and 16), valuation of derivative instruments (See Notes 6 and 16) and income recognition on certain Non-Agency MBS purchased at a discount (See Note 3).  In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest (See Note 2(o)).  Actual results could differ from those estimates.

The Company has one reportable segment as we manage our business and analyze and report our results of operations on the basis of one operating segment - investing, on a leveraged basis, in residential mortgage assets.

The consolidated financial statements of the Company include the accounts of all subsidiaries; significant intercompany accounts and transactions have been eliminated. In addition, the Company consolidates the special purpose entities created to facilitate the resecuritization transactions completed in prior years and the acquisition of residential whole loans. Certain prior period amounts have been reclassified to conform to the current period presentation.

(b)  MBS (including Non-Agency MBS transferred to consolidated VIEs) and CRT Securities

The Company has investments in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any U.S. Government agency or any federally chartered corporation (“Non-Agency MBS”). In addition, the Company has investments in CRT securities, that are issued by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by Fannie Mae and Freddie Mac and the principal payments received are based on the performance of loans in a reference pool of recently securitized MBS. As the loans in the underlying reference pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including if the loans in the reference pool experience delinquencies exceeding specified thresholds.

Designation

The Company generally intends to hold its MBS until maturity; however, from time to time, it may sell any of its securities as part of the overall management of its business.  As a result, all of the Company’s MBS are designated as “available-for-sale” (“AFS”) and, accordingly, are carried at their fair value with unrealized gains and losses excluded from earnings (except when an OTTI is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity.

Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method.

The Company has elected the fair value option for certain of its CRT securities as it considers this method of accounting more appropriately reflects the risk sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statement of operations.

Revenue Recognition, Premium Amortization and Discount Accretion

Interest income on securities is accrued based on the outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity.

Interest income on the Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the security’s effective interest rate which is the security’s internal rate of return (“IRR”). The IRR is determined using management’s estimate of the projected cash flows for each security, which are based on the Company’s observation of current information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the timing and amount of credit losses. On at least a quarterly basis, the Company reviews and, if appropriate, makes adjustments to its cash flow projections based on input and analysis received from external sources, internal models, and its judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Changes in cash flows from those originally projected, or from those estimated at the last evaluation, may result in a prospective change in the IRR/ interest income recognized on these securities or in the recognition of OTTIs.  (See Note 3)

Based on the projected cash flows from the Company’s Non-Agency MBS purchased at a discount to par value, a portion of the purchase discount may be designated as non-accretable purchase discount (“Credit Reserve”), which effectively mitigates the Company’s risk of loss on the mortgages collateralizing such MBS and is not expected to be accreted into interest income.  The amount designated as Credit Reserve may be adjusted over time, based on the actual performance of the security, its underlying collateral, actual and projected cash flow from such collateral, economic conditions and other factors.  If the performance of a security with a Credit Reserve is more favorable than forecasted, a portion of the amount designated as Credit Reserve may be reallocated to accretable discount and recognized into interest income over time.  Conversely, if the performance of a security with a Credit Reserve is less favorable than forecasted, the amount designated as Credit Reserve may be increased, or impairment charges and write-downs of such securities to a new cost basis could result.

Determination of Fair Value for MBS and CRT Securities

In determining the fair value of the Company’s MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity.  (See Note 16)

Impairments/OTTI

When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired.  The Company assesses its impaired securities on at least a quarterly basis and designates such impairments as either “temporary” or “other-than-temporary.”  If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize an OTTI through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date.  If the Company does not expect to sell an other-than-temporarily impaired security, only the portion of the OTTI related to credit losses is recognized through charges to earnings with the remainder recognized through AOCI on the consolidated balance sheets.  Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings.  Following the recognition of an OTTI through earnings, a new cost basis is established for the security and may not be adjusted for subsequent recoveries in fair value through earnings.  However, OTTIs recognized through charges to earnings may be accreted back to the amortized cost basis of the security on a prospective basis through interest income.  The determination as to whether an OTTI exists and, if so, the amount of credit impairment recognized in earnings is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of the future performance and cash flow projections.  As a result, the timing and amount of OTTIs constitute material estimates that may be susceptible to significant change.  (See Note 3)

Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS.  The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, Fair Isaac Corporation (“FICO”) scores at loan origination, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations, as well as reports by credit rating agencies, such as Moody’s Investors Services, Inc. (“Moody’s”), Standard & Poor’s Corporation (“S&P”), or Fitch, Inc. (collectively, “Rating Agencies”), general market assessments, and dialogue with market participants.  As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS.  In determining the OTTI related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date.  The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes.  Impairment assessment for Non-Agency MBS and CRT securities that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date.  The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR.

Balance Sheet Presentation

The Company’s MBS and CRT securities pledged as collateral against repurchase agreements, Federal Home Loan Bank advances and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically.  Purchases and sales of securities are recorded on the trade date. 

(c)  Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral

The Company has obtained securities as collateral under collateralized financing arrangements in connection with its financing strategy for Non-Agency MBS.  Securities obtained as collateral in connection with these transactions are recorded on the Company’s consolidated balance sheets as an asset along with a liability representing the obligation to return the collateral obtained, at fair value.  While beneficial ownership of securities obtained remains with the counterparty, the Company has the right to sell the collateral obtained or to pledge it as part of a subsequent collateralized financing transaction.  (See Note 2(k) for Repurchase Agreements and Reverse Repurchase Agreements)

(d)  Residential Whole Loans

Residential whole loans included in the Company’s consolidated balance sheets are generally comprised of pools of fixed and adjustable rate residential mortgage loans acquired through consolidated trusts in secondary market transactions at discounted purchase prices. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below under “Residential Whole Loans at Carrying Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The accounting model described below under “Residential Whole Loans at Fair Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed.

The Company’s residential whole loans pledged as collateral against repurchase agreements are included in the consolidated balance sheets with the fair value of the loans pledged disclosed parenthetically.  Purchases and sales of residential whole loans are recorded on the trade date, with amounts recorded reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing.

Residential Whole Loans at Carrying Value

Notwithstanding that the majority of these loans are considered to be performing substantially in accordance with their current contractual terms and conditions, the Company has elected to account for these loans as credit impaired as they were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of the borrowers have previously experienced payment delinquencies and the amount owed on the mortgage loan may exceed the value of the property pledged as collateral. Consequently, the Company has assessed that these loans have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to credit worthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Such loans are initially recorded at fair value with no allowance for loan losses. Subsequent to acquisition, the recorded amount reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded amount reduced by any allowance for loan losses established subsequent to acquisition.

Under the application of this accounting model the Company may aggregate into pools loans acquired in the same fiscal quarter that are assessed as having similar risk characteristics. For each pool established, or on an individual loan basis for loans not aggregated into pools, the Company estimates at acquisition and periodically on at least a quarterly basis, the principal and interest cash flows expected to be collected. The difference between the cash flows expected to be collected and the carrying amount of the loans is referred to as the “accretable yield.” This amount is accreted as interest income over the life of the loans using an effective interest rate (level yield) methodology. Interest income recorded each period reflects the amount of accretable yield recognized and not the coupon interest payments received on the underlying loans. The difference between contractually required principal and interest payments and the cash flows expected to be collected is referred to as the “non-accretable difference,” and includes estimates of both the effect of prepayments and expected credit losses over the life of the underlying loans.

A decrease in expected cash flows in subsequent periods may indicate impairment at the pool and/or individual loan level thus requiring the establishment of an allowance for loan losses by a charge to the provision for loan losses. The allowance for loan losses represents the present value of cash flows expected at acquisition, adjusted for any increases due to changes in estimated cash flows, that are subsequently no longer expected to be received at the relevant measurement date. A significant increase in expected cash flows in subsequent periods first reduces any previously recognized allowance for loan losses and then will result in a recalculation in the amount of accretable yield. The adjustment of accretable yield due to a significant increase in expected cash flows is accounted for prospectively as a change in estimate and results in reclassification from nonaccretable difference to accretable yield. (See Notes 4 and 17)

Residential Whole Loans at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Given the significant uncertainty associated with estimating the timing of and amount of cash flows associated with these loans that will be collected, and that the cash flows ultimately collected may be dependent on the value of the property securing the loan, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns from these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations.

Cash received reflecting coupon payments on residential whole loans held at fair value is not included in Interest Income, but rather is presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. (See Notes 4 and 16)

(e)  Cash and Cash Equivalents

Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less.  Cash and cash equivalents may also include cash pledged as collateral to the Company by its repurchase agreement and/or Swap counterparties as a result of reverse margin calls (i.e., margin calls made by the Company).  The Company did not hold any cash pledged by its counterparties at December 31, 2015 or 2014.  The Company’s investments in overnight money market funds, which are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency were $120.4 million and $182.4 million at December 31, 2015 and 2014, respectively.  (See Notes 9 and 16)

(f) Restricted Cash

Restricted cash represents the Company’s cash held by its counterparties as collateral or otherwise in connection with the Company’s Swaps and/or repurchase agreements.  Restricted cash is not available to the Company for general corporate purposes, but may be applied against amounts due to counterparties to the Company’s repurchase agreements and/or Swaps, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the Swap or repurchase agreement.  The Company had aggregate restricted cash held as collateral or otherwise in connection with its Swaps and repurchase agreements of $71.5 million and $67.3 million at December 31, 2015 and 2014, respectively. (See Notes 6, 8, 9 and 16)

(g)  Goodwill

At December 31, 2015 and 2014, the Company had goodwill of $7.2 million, which represents the unamortized portion of the excess of the fair value of its common stock issued over the fair value of net assets acquired in connection with its formation in 1998.  Goodwill is tested for impairment at least annually, or more frequently under certain circumstances, at the entity level.  Through December 31, 2015, the Company had not recognized any impairment against its goodwill.

(h) Real Estate Owned (“REO”)

REO represents real estate acquired by the Company, including through foreclosure or deed in lieu of foreclosure, and is initially recorded at fair value less estimated selling costs. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Prepaid and other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported value of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on the Company’s consolidated statements of operations. (See Note 7)

(i)  Depreciation

Leasehold Improvements and Other Depreciable Assets

Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term.  Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase.

(j)  Resecuritization and Senior Notes Related Costs

Resecuritization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various resecuritization transactions completed by the Company.  Senior Notes related costs are costs incurred by the Company in connection with the issuance of its Senior Notes in April, 2012.  These costs may include underwriting, rating agency, legal, accounting and other fees.  Such costs, which reflect deferred charges, are included on the Company’s consolidated balance sheets in Prepaid and other assets.  These deferred charges are amortized as an adjustment to interest expense using the effective interest method, based upon the actual repayments of the associated beneficial interests issued to third parties and over the stated legal maturity of the Senior Notes. The Company periodically reviews the recoverability of these deferred costs and in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

(k)  Repurchase Agreements and Other Advances

Repurchase Agreements

The Company finances the holdings of a significant portion of its MBS and CRT securities with repurchase agreements.  Under repurchase agreements, the Company sells securities to a lender and agrees to repurchase the same securities in the future for a price that is higher than the original sale price.  The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender.  Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements, the Company pledges its securities as collateral to secure the borrowing, which is equal in value to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral.  At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan including any accrued interest and concurrently receives back its pledged collateral from the lender.  With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms.  Margin calls, whereby a lender requires that the Company pledge additional securities or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the MBS pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions.  The Company also may make margin calls on counterparties when collateral values increase.

The Company’s repurchase financings typically have terms ranging from one month to six months at inception, but may also have longer or shorter terms.  Should a counterparty decide not to renew a repurchase financing at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation.  If, during the term of a repurchase financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable on such collateral.  (See Notes 8, 9 and 16)

In addition to the repurchase agreement financing arrangements discussed above, as part of its financing strategy for Non-Agency MBS, the Company has entered into contemporaneous repurchase and reverse repurchase agreements with a single counterparty.  Under a typical reverse repurchase agreement, the Company buys securities from a borrower for cash and agrees to sell the same securities in the future for a price that is higher than the original purchase price.  The difference between the purchase price the Company originally paid and the sale price represents interest received from the borrower.  In contrast, the contemporaneous repurchase and reverse repurchase transactions effectively resulted in the Company pledging Non-Agency MBS as collateral to the counterparty in connection with the repurchase agreement financing and obtaining U.S. Treasury securities as collateral from the same counterparty in connection with the reverse repurchase agreement.  No net cash was exchanged between the Company and counterparty at the inception of the transactions.  Securities obtained and pledged as collateral are recorded as an asset on the Company’s consolidated balance sheets.  Interest income is recorded on the reverse repurchase agreement and interest expense is recorded on the repurchase agreement on an accrual basis.  Both the Company and the counterparty have the right to make daily margin calls based on changes in the value of the collateral obtained and/or pledged.  The Company’s liability to the counterparty in connection with this financing arrangement is recorded on the Company’s consolidated balance sheets and disclosed as “Obligation to return securities obtained as collateral, at fair value.”  (See Note 2(c))

Federal Home Loan Bank (“FHLB”) Advances

FHLB advances are secured financing transactions and are carried at their contractual amounts. The ability to borrow from the FHLB is subject to the Company’s continued creditworthiness, pledging of sufficient eligible collateral to secure advances, and compliance with certain agreements with the FHLB. The amount of collateral pledged to the FHLB to secure advances is subject to periodic adjustment based on changes in the fair value of the collateral. Accrued interest payable on FHLB advances is included in Accrued interest payable on the Company’s consolidated balance sheets. (See Notes 8, 9, 16 and 18)

In addition, as a condition to membership in the FHLB, the Company’s wholly-owned subsidiary, MFA Insurance, Inc. (“MFA Insurance”) is required to purchase and hold a certain amount of FHLB stock, which is based, in part, upon the outstanding principal balance of advances from the FHLB. FHLB stock is considered a non-marketable investment, is carried at cost and is subject to recoverability testing under applicable accounting standards. This stock can only be redeemed or sold at its par value, and only to the FHLB. Accordingly, when evaluating FHLB stock for impairment, the Company considers the ultimate recoverability of the par value rather than recognizing temporary declines in value. FHLB stock is included in Prepaid and other assets on the Company’s consolidated balance sheets.

(l)  Equity-Based Compensation

Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date.  With respect to awards granted in 2009 and prior years, the Company applied a zero forfeiture rate for these awards, as they were granted to a limited number of employees, and historical forfeitures have been minimal.  Forfeitures, or an indication that forfeitures are expected to occur, may result in a revised forfeiture rate and would be accounted for prospectively as a change in estimate.

During 2010, the Company granted certain restricted stock units (“RSUs”) that vested after either two or four years of service and provided that certain criteria were met, which were based on a formula that included changes in the Company’s closing stock price over a two- or four-year period and dividends declared on the Company’s common stock during those periods.  From 2011 through 2013, the Company granted certain RSUs that vested annually over a one or three-year period, provided that certain criteria were met, which were based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period. During 2014 and 2015, the Company made grants of RSUs certain of which cliff vest after a three-year period and certain of which cliff vest after a three-year period, subject to the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period. The features in these awards related to the attainment of total stockholder return over a specified period constitute a “market condition” which impacts the amount of compensation expense recognized for these awards. Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which in addition to estimates regarding the amount of RSUs expected to be forfeited during the associated service period, determined the amount of compensation expense recognized.  The amount of compensation expense recognized was not dependent on whether the market condition was or will be achieved, while differences in actual forfeiture experience relative to estimated forfeitures results in adjustments to the timing and amount of compensation expense recognized.

The Company has awarded dividend equivalents that may be granted as a separate instrument or may be a right associated with the grant of another equity-based award.  Compensation expense for separately awarded dividend equivalents is based on the grant date fair value of such awards and is recognized over the vesting period.  Payments pursuant to these dividend equivalents are charged to Stockholders’ Equity.  Payments pursuant to dividend equivalents that are attached to equity-based awards are charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest.  Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards do not or are not expected to vest and grantees are not required to return payments of dividends or dividend equivalents to the Company.  (See Notes 2(m) and 15)

(m)  Earnings per Common Share (“EPS”)

Basic EPS is computed using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and other securities that participate in dividends, such as the Company’s unvested restricted stock and RSUs that have non-forfeitable rights to dividends and dividend equivalents attached to/associated with RSUs and vested stock options to arrive at total common equivalent shares.  In applying the two-class method, earnings are allocated to both shares of common stock and securities that participate in dividends based on their respective weighted-average shares outstanding for the period.  For the diluted EPS calculation, common equivalent shares are further adjusted for the effect of dilutive unexercised stock options and RSUs outstanding that are unvested and have dividends that are subject to forfeiture using the treasury stock method.  Under the treasury stock method, common equivalent shares are calculated assuming that all dilutive common stock equivalents are exercised and the proceeds, along with future compensation expenses associated with such instruments, are used to repurchase shares of the Company’s outstanding common stock at the average market price during the reported period.  (See Note 14)

(n)  Comprehensive Income/(Loss)

The Company’s comprehensive income/(loss) available to common stock and participating securities includes net income, the change in net unrealized gains/(losses) on its AFS securities and derivative hedging instruments, (to the extent that such changes are not recorded in earnings), adjusted by realized net gains/(losses) reclassified out of AOCI for sold AFS securities and de-designated derivative hedging instruments and is reduced by dividends declared on the Company’s preferred stock and issuance costs of redeemed preferred stock.

(o)  U.S. Federal Income Taxes

The Company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code of 1986, as amended, (the “Code”) and the corresponding provisions of state law.  The Company expects to operate in a manner that will enable it to satisfy the various requirements to maintain its status as a REIT. In order to maintain its status as a REIT, the Company must, among other things, distribute at least 90% of its REIT taxable income (excluding net long-term capital gains) to stockholders in the timeframe permitted by the Code.  As long as the Company maintains its status as a REIT, the Company will not be subject to regular federal income tax to the extent that it distributes 100% of its REIT taxable income (including net long-term capital gains) to its stockholders within the permitted timeframe.  Should this not occur, the Company would be subject to federal taxes at prevailing corporate tax rates on the difference between its REIT taxable income and the amounts deemed to be distributed for that tax year.  As the Company’s objective is to distribute 100% of its REIT taxable income to its stockholders within the permitted timeframe, no provision for current or deferred income taxes has been made in the accompanying consolidated financial statements.  Should the Company incur a liability for corporate income tax, such amounts would be recorded as REIT income tax expense on the Company’s consolidated statements of operations. Furthermore, if the Company fails to distribute during each calendar year, or by the end of January following the calendar year in the case of distributions with declaration and record dates falling in the last three months of the calendar year, at least the sum of (i) 85% its REIT ordinary income for such year, (ii) 95% of its REIT capital gain income for such year, and (iii) any undistributed taxable income from prior periods, the Company would be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed. To the extent that the Company incurs interest, penalties or related excise taxes in connection with its tax obligations, including as a result of its assessment of uncertain tax positions, such amounts will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

In addition, the Company has elected to treat certain of its subsidiaries as a TRS. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of the Company’s business may be conducted through one or more TRS, its income earned by TRS may be subject to corporate income taxation. To maintain the Company’s REIT election, no more than 25% (or, for 2018 and subsequent taxable years, 20%) of the value of a REIT’s assets at the end of each calendar quarter may consist of stock or securities in TRS. For purposes of the determination of U. S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as a TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. No deferred tax benefit was recorded by the Company in 2015 or 2014, as a valuation allowance for the full amount of the associated deferred tax asset was recognized as its recovery is not considered more likely than not.

Based on its analysis of any potential uncertain tax positions, the Company concluded that it does not have any material uncertain tax positions that meet the relevant recognition or measurement criteria as of December 31, 2015, 2014 or 2013. The Company filed its 2014 tax return prior to September 15, 2015. The Company’s tax returns for tax years 2010 through 2014 are open to examination.

(p)  Derivative Financial Instruments

The Company may use a variety of derivative instruments to economically hedge a portion of its exposure to market risks, including interest rate risk and prepayment risk. The objective of the Company’s risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, the Company attempts to mitigate the risk of the cost of its variable rate liabilities increasing during a period of rising interest rates. The Company’s derivative instruments are currently comprised of Swaps, which are designated as cash flow hedges against the interest rate risk associated with certain of its borrowings. Prior to 2015, the Company’s derivative financial instruments also included Linked Transactions, which were not designated as hedging instruments. New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 6) During 2013, the Company also entered into forward contracts for the sale of Agency MBS securities on a generic pool, or to-be-announced basis (“TBA short positions”) which were not designated as hedging instruments.

Linked Transactions

Prior to 2015, it was presumed that the initial transfer of a financial asset (i.e., the purchase of an MBS by the Company) and contemporaneous repurchase financing of such security with the same counterparty were considered part of the same arrangement, or a “linked transaction,” unless certain criteria were met.  The two components of a linked transaction (security purchase and repurchase financing) were not reported separately but were evaluated on a combined basis and reported as a forward (derivative) contract and were presented as “Linked Transactions” on the Company’s consolidated balance sheets.  Changes in the fair value of the assets and liabilities underlying Linked Transactions and associated interest income and expense were reported as “Unrealized net gains/(losses) and net interest income from Linked Transactions” on the Company’s consolidated statements of operations and were not included in OCI.  However, if certain criteria were met, the initial transfer (i.e., the purchase of a security by the Company) and repurchase financing were not treated as a Linked Transaction and would have been evaluated and reported separately as an MBS purchase and MBS repurchase financing.  When or if a transaction was no longer considered to be linked, the security and repurchase financing were reported on a gross basis.  In this case, the fair value of the MBS at the time the transactions were no longer considered linked became the cost basis of the MBS, and the income recognition yield for such MBS was calculated prospectively using this new cost basis. 

New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting as described above. This resulted in changes subsequent to January 1, 2015 to the presentation of assets and liabilities, and revenues and expenses of Non-Agency MBS and associated repurchase agreements that had been accounted for as Linked Transactions prior to that date. The changes include the presentation of Non-Agency MBS and associated repurchase agreements as separate assets and liabilities, rather than on a combined basis on the Company’s consolidated balance sheets. In addition, starting in 2015, interest income related to the securities and interest expense related to the associated repurchase agreements are separately presented and included in the determination of the Company’s net interest income on its consolidated statement of operations. Further, the previous treatment of Linked Transactions as forward (derivative) instruments recorded at fair value at the end of each period, with changes in fair value included in net income, was discontinued and effective January 1, 2015 MBS that were previously accounted for as components of Linked Transactions are accounted for on a consistent basis with other MBS held by the Company as AFS securities.  (See Notes 2(t), 6 and 16)

Swaps

The Company documents its risk-management policies, including objectives and strategies, as they relate to its hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions.  The Company assesses, both at inception of a hedge and on a quarterly basis thereafter, whether or not the hedge is “highly effective.”

Swaps are carried on the Company’s consolidated balance sheets at fair value, as assets, if their fair value is positive, or as liabilities, if their fair value is negative.  Changes in the fair value of the Company’s Swaps designated in hedging transactions are recorded in OCI provided that the hedge remains effective.  Changes in fair value for any ineffective amount of a Swap are recognized in earnings.  The Company has not recognized any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness.

The Company discontinues hedge accounting on a prospective basis and recognizes changes in the fair value through earnings when:  (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate.

Although permitted under certain circumstances, the Company does not offset cash collateral receivables or payables against its net derivative positions.  (See Notes 6, 9 and 16)

TBA Short Positions

During 2013, the Company entered into TBA short positions as a means of managing interest rate risk and MBS basis risk associated with its investment and financing activities. A TBA short position is a forward contract for the sale of Agency MBS at a predetermined price, face amount, issuer, coupon and maturity on an agreed-upon future date. The specific Agency MBS that could be delivered into the contract upon the settlement date, published each month by the Securities Industry and Financial Markets Association (“SIFMA”), are not known at the time of the transaction.

TBA short positions were accounted for as derivative instruments since the Company could not assert that it was probable at inception and throughout the term of the TBA contract, that it would physically deliver the Agency security upon settlement of the contract. TBA short positions were presented as either derivative assets or liabilities, at fair value on its consolidated balance sheets. Gains and losses associated with TBA short positions were reported in Other Income, net on the Company’s consolidated statements of operations. (See Note 6)

The Company did not have any TBA short positions at December 31, 2015 and 2014.

(q)  Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities

The Company’s presentation of fair value for its financial assets and liabilities is determined within a framework that stipulates that the fair value of a financial asset or liability is an exchange price in an orderly transaction between market participants to sell the asset or transfer the liability in the market in which the reporting entity would transact for the asset or liability, that is, the principal or most advantageous market for the asset or liability.  The transaction to sell the asset or transfer the liability is a hypothetical transaction at the measurement date, considered from the perspective of a market participant that holds the asset or owes the liability.  This definition of fair value focuses on exit price and prioritizes the use of market-based inputs over entity-specific inputs when determining fair value.  In addition, the framework for measuring fair value establishes a three-level hierarchy for fair value measurements based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. 

In addition to the financial instruments that it is required to report at fair value, the Company has elected the fair value option for certain of its residential whole loans and CRT securities at time of acquisition. Subsequent changes in the fair value of these loans and CRT securities are reported in Net gain on residential whole loans held at fair value and Other Income, net respectively on the Company’s consolidated statements of operations.  A decision to elect the fair value option for an eligible financial instrument, which may be made on an instrument by instrument basis, is irrevocable. (See Notes 2(d), 4 and 16)

(r)  Variable Interest Entities

An entity is referred to as a VIE if it meets at least one of the following criteria:  (i) the entity has equity that is insufficient to permit the entity to finance its activities without additional subordinated financial support of other parties; or (ii) as a group, the holders of the equity investment at risk lack (a) the power to direct the activities of an entity that most significantly impact the entity’s economic performance; (b) the obligation to absorb the expected losses; or (c) the right to receive the expected residual returns; or (iii) have disproportional voting rights and the entity’s activities are conducted on behalf of the investor that has disproportionally few voting rights.

The Company consolidates a VIE when it has both the power to direct the activities that most significantly impact the economic performance of the VIE and a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.   The Company is required to reconsider its evaluation of whether to consolidate a VIE each reporting period, based upon changes in the facts and circumstances pertaining to the VIE.

The Company has entered into resecuritization transactions which result in the Company consolidating the VIEs that were created to facilitate the transactions and to which the underlying assets in connection with the resecuritizations were transferred.  In determining the accounting treatment to be applied to these resecuritization transactions, the Company concluded that the entities used to facilitate these transactions were VIEs and that they should be consolidated. If the Company had determined that consolidation was not required, it would have then assessed whether the transfer of the underlying assets would qualify as a sale or should be accounted for as secured financings under GAAP.

Prior to the completion of its initial resecuritization transaction in October 2010, the Company had not transferred assets to VIEs or Qualifying Special Purpose Entities (“QSPEs”) and other than acquiring MBS issued by such entities, had no other involvement with VIEs or QSPEs.  (See Note 17)

The Company also includes in its consolidated balance sheets certain financial assets and liabilities that are acquired/issued by trusts and /or other special purpose entities that have been evaluated as being required to be consolidated by the Company under the applicable accounting guidance.

(s)  Offering Costs Related to Issuance and Redemption of Preferred Stock

Offering costs related to issuance of preferred stock are recorded as a reduction in Additional paid-in capital, a component of Stockholders’ Equity, at the time such preferred stock is issued. On redemption of preferred stock, any excess of the fair value of the consideration transferred to the holders of the preferred stock over the carrying amount of the preferred stock in the Company’s consolidated balance sheets is included in the determination of Net Income Available to Common Stock and Participating Securities in the calculation of EPS. (See Notes 13 and 14)

(t)  New Accounting Standards and Interpretations

Accounting Standards Adopted in 2015

Receivables - Recognition of Residential Real Estate upon Foreclosure

In January 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-04, Reclassification of Residential Real Estate Collateralized Consumer Mortgage Loans upon Foreclosure (“ASU 2014-04”).  This ASU applies to all creditors who obtain physical possession (resulting from an in substance repossession or foreclosure) of residential real estate property collateralizing a consumer mortgage loan in satisfaction of a receivable.  The ASU clarifies that an in substance repossession or foreclosure occurs, and a creditor is considered to have received physical possession of residential real estate property collateralizing a consumer mortgage loan, upon either (i) the creditor obtaining legal title to the residential real estate property upon completion of a foreclosure or (ii) the borrower conveying all interest in the residential real estate property to the creditor to satisfy that loan through completion of a deed in lieu of foreclosure or through a similar legal agreement. Additionally, the amendments require interim and annual disclosure of both (i) the amount of foreclosed residential real estate property held by the creditor and (ii) the recorded investment in consumer mortgage loans collateralized by residential real estate property that are in the process of foreclosure according to local requirements of the applicable jurisdiction.

ASU 2014-04 was effective for the Company for reporting periods beginning after December 15, 2014.  The Company has elected to adopt the amendments in this ASU using a prospective transition method.  The Company’s adoption of ASU 2014-04 beginning on January 1, 2015, did not have a material impact on the Company’s consolidated financial statements.

Transfers and Servicing

In June 2014, the FASB issued ASU 2014-11, Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures (“ASU 2014-11”). The amendments of ASU 2014-11 require two accounting changes. First, the amendments in this ASU change the accounting for repurchase-to-maturity transactions to secured borrowing accounting. Second, for repurchase financing arrangements, the amendments require separate accounting for a transfer of a financial asset executed contemporaneously with a repurchase agreement with the same counterparty, which will result in secured borrowing accounting for the repurchase agreement. In addition, the amendments in ASU 2014-11 require disclosures for certain transactions comprising (i) a transfer of a financial asset accounted for as a sale and (ii) an agreement with the same transferee entered into in contemplation of the initial transfer that results in the transferor retaining substantially all of the exposure to the economic return on the transferred asset throughout the term of the transaction. ASU 2014-11 also requires disclosures for repurchase agreements, securities lending transactions, and repurchase-to-maturity transactions that are accounted for as secured borrowings.

ASU 2014-11 was effective for the Company for reporting periods beginning after December 15, 2014. An entity is required to present changes in accounting for transactions outstanding on the effective date as a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. Accordingly, on adoption of the new standard on January 1, 2015, the Company reclassified $1.913 billion of Non-Agency MBS and $4.6 million of CRT securities, that were previously reported on the Company’s consolidated balance sheets as a component of Linked Transactions to Non-Agency MBS and CRT securities, respectively. In addition, liabilities of $1.520 billion that were previously presented on the Company’s consolidated balance sheets as a component of Linked Transactions were reclassified to Repurchase agreements. Furthermore, an amount of $4.5 million representing net unrealized gains on securities previously reported as a component of Linked Transactions as of December 31, 2014 was reclassified from Accumulated deficit to AOCI. These reclassification adjustments had no net impact on the Company’s overall Total Stockholders’ Equity. While the Company’s adoption of this new standard beginning on January 1, 2015, did not have a material impact on the Company’s consolidated financial statements, it did result in changes, subsequent to adoption, to the presentation of assets and liabilities and revenues and expenses of Non-Agency MBS and CRT securities and associated repurchase agreements that had been accounted for as MBS Linked Transactions prior to that date. These changes include the presentation, as noted above, of Non-Agency MBS and CRT securities and associated repurchase agreements as separate assets and liabilities, rather than on a combined basis. In addition, subsequent to the date of adoption the interest income related to the securities and the interest expense related to the associated repurchase agreements are separately presented and included in the determination of the Company’s Net Interest Income. Further, the prior accounting requirement for MBS Linked Transactions, which involved treating the combined transaction as a derivative that was recorded at fair value each period, with changes in fair value included in net income, was discontinued and effective January 1, 2015. MBS that were previously accounted for as components of Linked Transactions are accounted for in a manner consistent with other MBS held by the Company as AFS securities.

XML

MBS and CRT Securities

12 Months Ended

Dec. 31, 2015

Investments, Debt and Equity Securities [Abstract]

MBS and CRT Securities

MBS and CRT Securities

Agency and Non-Agency MBS

The Company’s MBS are comprised of Agency MBS and Non-Agency MBS which include MBS issued prior to 2008 (“Legacy Non-Agency MBS”) .  These MBS are secured by:  (i) hybrid mortgages (“Hybrids”), which have interest rates that are fixed for a specified period of time and, thereafter, generally adjust annually to an increment over a specified interest rate index; (ii) adjustable-rate mortgages (“ARMs”); (iii) mortgages that have interest rates that reset more frequently (collectively, “ARM-MBS”); and (iv) 15 year and longer-term fixed rate mortgages.  In addition, the Company’s MBS are also comprised of MBS secured by re-performing/non-performing loans (“RPL/NPL MBS”), where the cash flows of the bond may not reflect the contractual cash flows of the underlying collateral. RPL/NPL MBS contain a feature where the coupon steps-up 300 basis points at 36 months from issuance or sooner.

The Company pledges a significant portion of its MBS as collateral against its borrowings under repurchase agreements, FHLB advances and Swaps.  Non-Agency MBS that were accounted for as components of Linked Transactions prior to 2015 are not reflected in the tables for prior periods set forth in this note, as they were accounted for as derivatives. New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting.  (See Notes 2(t), 6 and 9)

Agency MBS: Agency MBS are guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae.  The payment of principal and/or interest on Ginnie Mae MBS is explicitly backed by the full faith and credit of the U.S. Government.  Since the third quarter of 2008, Fannie Mae and Freddie Mac have been under the conservatorship of the Federal Housing Finance Agency, which significantly strengthened the backing for these government-sponsored entities.

Non-Agency MBS (including Non-Agency MBS transferred to consolidated VIEs):  The Company’s Non-Agency MBS are secured by pools of residential mortgages, which are not guaranteed by an agency of the U.S. Government or any federally chartered corporation.  Credit risk associated with Non-Agency MBS is regularly assessed as new information regarding the underlying collateral becomes available and based on updated estimates of cash flows generated by the underlying collateral.

CRT Securities

CRT securities are debt obligations issued by Fannie Mae and Freddie Mac. While the coupon payments are paid by Fannie Mae or Freddie Mac on a monthly basis, the payment of principal is dependent on the performance of loans in a reference pool of MBS securitized by Fannie Mae or Freddie Mac. As principal on loans in the reference pool are paid, principal payments on the securities are made and the principal balances of the securities are reduced. Consequently, CRT securities mirror the payment and prepayment behavior of the mortgage loans in the reference pool. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including if the loans in the reference pool experience delinquencies exceeding specified thresholds. The Company assesses the credit risk associated with CRT securities by assessing the current and expected future performance of the associated reference pool. CRT securities that were accounted for as components of Linked Transactions prior to 2015 are not reflected in the tables for prior periods set forth in this note, as they were accounted for as derivatives. (See Notes 2(t), 6 and 9)

The following tables present certain information about the Company’s MBS and CRT securities at December 31, 2015 and 2014:

December 31, 2015

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts			Discount Designated as Credit Reserve and  OTTI (1)			Amortized Cost (2)		Fair Value		Gross Unrealized Gains		Gross Unrealized Losses			Net Unrealized Gain/(Loss)
Agency MBS:
Fannie Mae	$	3,690,020	$	139,243	$	(59	)	$	—		$	3,829,204	$	3,865,485	$	62,111	$	(25,830	)	$	36,281
Freddie Mac	851,087		32,680		—			—			884,798		877,109		6,906		(14,595		)	(7,689		)
Ginnie Mae	9,296		164		—			—			9,460		9,650		190		—			190
Total Agency MBS	4,550,403		172,087		(59		)	—			4,723,462		4,752,244		69,207		(40,425		)	28,782
Non-Agency MBS:
Expected to Recover Par (3)(4)	2,906,878		73		(31,576		)	—			2,875,375		2,878,532		23,300		(20,143		)	3,157
Expected to Recover Less than Par (3)	4,054,615		—		(280,606		)	(787,541		)	2,986,468		3,542,285		564,031		(8,214		)	555,817
Total Non-Agency MBS (5)	6,961,493		73		(312,182		)	(787,541		)	5,861,843		6,420,817		587,331		(28,357		)	558,974
Total MBS	11,511,896		172,160		(312,241		)	(787,541		)	10,585,305		11,173,061		656,538		(68,782		)	587,756
CRT securities (6)	192,000		—		(5,689		)	—			186,311		183,582		418		(3,147		)	(2,729		)
Total MBS and CRT securities	$	11,703,896	$	172,160	$	(317,930	)	$	(787,541	)	$	10,771,616	$	11,356,643	$	656,956	$	(71,929	)	$	585,027

December 31, 2014

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts			Discount Designated as Credit Reserve and  OTTI (1)			Amortized Cost (2)		Fair Value		Gross Unrealized Gains		Gross Unrealized Losses			Net Unrealized Gain/(Loss)
Agency MBS:
Fannie Mae	$	4,587,823	$	174,245	$	(71	)	$	—		$	4,761,997	$	4,843,084	$	102,187	$	(21,100	)	$	81,087
Freddie Mac	1,011,659		38,895		—			—			1,051,096		1,049,854		11,280		(12,522		)	(1,242		)
Ginnie Mae	10,811		189		—			—			11,000		11,269		269		—			269
Total Agency MBS	5,610,293		213,329		(71		)	—			5,824,093		5,904,207		113,736		(33,622		)	80,114
Non-Agency MBS:
Expected to Recover Par (3)(4)	431,788		461		(29,501		)	—			402,748		428,431		26,735		(1,052		)	25,683
Expected to Recover Less than Par (3)	4,888,113		—		(370,063		)	(900,557		)	3,617,493		4,327,001		712,168		(2,660		)	709,508
Total Non-Agency MBS (5)	5,319,901		461		(399,564		)	(900,557		)	4,020,241		4,755,432		738,903		(3,712		)	735,191
Total MBS	10,930,194		213,790		(399,635		)	(900,557		)	9,844,334		10,659,639		852,639		(37,334		)	815,305
CRT securities	109,500		—		(4,727		)	—			104,773		102,983		324		(2,114		)	(1,790		)
Total MBS and CRT securities	$	11,039,694	$	213,790	$	(404,362	)	$	(900,557	)	$	9,949,107	$	10,762,622	$	852,963	$	(39,448	)	$	813,515

(1) Discount designated as Credit Reserve and amounts related to OTTI are generally not expected to be accreted into interest income. Amounts disclosed at December 31, 2015 reflect Credit Reserve of $766.0 million and OTTI of $21.5 million. Amounts disclosed at December 31, 2014 reflect Credit Reserve of $877.6 million and OTTI of $23.0 million.

(2) Includes principal payments receivable of $1.0 million and $542,000 at December 31, 2015 and 2014, respectively, which are not included in the Principal/Current Face.

(3) Based on management’s current estimates of future principal cash flows expected to be received.

(4) At December 31, 2015 RPL/NPL MBS had a $2.648 billion Principal/Current face, $2.645 billion amortized cost and $2.626 billion fair value. At December 31, 2014, RPL/NPL MBS had a $161.0 million Principal/Current face, $161.0 million amortized cost and $161.0 million fair value (excludes RPL/NPL MBS with $1.850 billion Principal/Current face, $1.847 billion amortized cost and $1.847 billion fair value that were presented as a component of Linked Transactions at December 31, 2014).

(5) At December 31, 2015 and 2014, the Company expected to recover approximately 89% and 83%, respectively, of the then-current face amount of Non-Agency MBS.

(6) Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $62.2 million for which the fair value option has been elected. Such securities have gross unrealized gains of approximately $332,000, gross unrealized losses of approximately $555,000 and net unrealized losses of approximately $223,000 at December 31, 2015.

Unrealized Losses on MBS and CRT Securities

The following table presents information about the Company’s MBS and CRT securities that were in an unrealized loss position at December 31, 2015:

	Unrealized Loss Position For:
	Less than 12 Months					12 Months or more					Total
(Dollars in Thousands)	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses
Agency MBS:
Fannie Mae	$	856,602	$	7,548	121	$	813,485	$	18,282	109	$	1,670,087	$	25,830
Freddie Mac	298,768		5,463		42	315,566		9,132		64	614,334		14,595
Total Agency MBS	1,155,370		13,011		163	1,129,051		27,414		173	2,284,421		40,425
Non-Agency MBS:
Expected to Recover Par (1)	2,239,418		16,717		59	212,584		3,426		12	2,452,002		20,143
Expected to Recover Less than Par (1)	184,664		4,348		35	64,081		3,866		11	248,745		8,214
Total Non-Agency MBS	2,424,082		21,065		94	276,665		7,292		23	2,700,747		28,357
Total MBS	3,579,452		34,076		257	1,405,716		34,706		196	4,985,168		68,782
CRT securities (2)	137,585		2,672		33	4,525		475		1	142,110		3,147
Total MBS and CRT securities	$	3,717,037	$	36,748	290	$	1,410,241	$	35,181	197	$	5,127,278	$	71,929

(1) Based on management’s current estimates of future principal cash flows expected to be received.  

(2) Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $54.1 million for which the fair value option has been elected. Such securities have unrealized losses of $555,000 at December 31, 2015.

At December 31, 2015, the Company did not intend to sell any of its investments that were in an unrealized loss position, and it is “more likely than not” that the Company will not be required to sell these securities before recovery of their amortized cost basis, which may be at their maturity.  With respect to Non-Agency MBS held by consolidated VIEs, the ability of any entity to cause the sale to a third-party by the VIE prior to the maturity of these Non-Agency MBS is either specifically precluded, or is limited to specified events of default, none of which has occurred to date.

Gross unrealized losses on the Company’s Agency MBS were $40.4 million at December 31, 2015.  Agency MBS are issued by Government Sponsored Entities (“GSEs”) and enjoy either the implicit or explicit backing of the full faith and credit of the U.S. Government. While the Company’s Agency MBS are not rated by any rating agency, they are currently perceived by market participants to be of high credit quality, with risk of default limited to the unlikely event that the U.S. Government would not continue to support the GSEs. Given the credit quality inherent in Agency MBS, the Company does not consider any of the current impairments on its Agency MBS to be credit related. In assessing whether it is more likely than not that it will be required to sell any impaired security before its anticipated recovery, which may be at its maturity, the Company considers for each impaired security, the significance of each investment, the amount of impairment, the projected future performance of such impaired securities, as well as the Company’s current and anticipated leverage capacity and liquidity position. Based on these analyses, the Company determined that at December 31, 2015 any unrealized losses on its Agency MBS were temporary.

Unrealized losses on the Company’s Non-Agency MBS (including Non-Agency MBS transferred to consolidated VIEs) were $28.4 million, of which $19.3 million were RPL/NPL MBS and $9.1 million were Legacy Non-Agency MBS at December 31, 2015.  Based upon the most recent evaluation, the Company does not consider these unrealized losses to be indicative of OTTI and does not believe that these unrealized losses are credit related, but are rather a reflection of current market yields and/or market place bid-ask spreads.  The Company has reviewed its Non-Agency MBS that are in an unrealized loss position to identify those securities with losses that are other-than-temporary based on an assessment of changes in expected cash flows for such securities, which considers recent bond performance and, where possible, expected future performance of the underlying collateral.

The Company recognized credit-related OTTI losses through earnings related to its Non-Agency MBS of $705,000 during the year ended December 31, 2015. The Company did not recognize any credit-related OTTI losses through earnings related to its investments during the years ended December 31, 2014 and 2013.

Non-Agency MBS on which OTTI is recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for these Non-Agency MBS is based on its review of the underlying mortgage loans securing these MBS.  The Company considers information available about the structure of the securitization, including structural credit enhancement, if any, and the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, FICO scores at loan origination, year of origination, LTVs, geographic concentrations, as well as Rating Agency reports, general market assessments, and dialogue with market participants.  Changes in the Company’s evaluation of each of these factors impacts the cash flows expected to be collected at the OTTI assessment date. For Non-Agency MBS purchased at a discount to par that were assessed for and had no OTTI recorded this period, such cash flow estimates indicated that the amount of expected losses decreased compared to the previous OTTI assessment date. These positive cash flow changes are primarily driven by recent improvements in LTVs due to loan amortization and home price appreciation, which, in turn, positively impacts the Company’s estimates of default rates and loss severities for the underlying collateral. In addition, voluntary prepayments (i.e. loans that prepay in full with no loss) have generally trended higher for these MBS which also positively impacts the Company’s estimate of expected loss. Overall, the combination of higher voluntary prepayments and lower LTVs supports the Company’s assessment that such MBS are not other-than-temporarily impaired.

The following table presents the composition of OTTI charges recorded by the Company for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014		2013
Total OTTI losses	$	(525	)	$	—	$	—
OTTI reclassified from OCI	(180		)	—		—
OTTI recognized in earnings	$	(705	)	$	—	$	—

The following table presents a roll-forward of the credit loss component of OTTI on the Company’s Non-Agency MBS for which a non-credit component of OTTI was previously recognized in OCI.  Changes in the credit loss component of OTTI are presented based upon whether the current period is the first time OTTI was recorded on a security or a subsequent OTTI charge was recorded.

	For the Year Ended December 31,
(In Thousands)	2015		2014		2013
Credit loss component of OTTI at beginning of period	$	36,115	$	36,115	$	36,115
Additions for credit related OTTI not previously recognized	461		—		—
Subsequent additional credit related OTTI recorded	244		—		—
Credit loss component of OTTI at end of period	$	36,820	$	36,115	$	36,115

Purchase Discounts on Non-Agency MBS

The following table presents the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and OTTI and accretable purchase discount for the years ended December 31, 2015 and 2014:

	For the Year Ended December 31,
	2015						2014
(In Thousands)	Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)			Discount Designated as Credit Reserve and OTTI (2)			Accretable Discount (1)(2)
Balance at beginning of period	$	(900,557	)	$	(399,564	)	$	(1,043,037	)	$	(460,039	)
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	(15,543		)	1,832			—			—
Accretion of discount	—			93,173			—			103,653
Realized credit losses	80,821			—			89,481			—
Purchases	(1,200		)	(4,925		)	(80,256		)	30,003
Sales	8,525			38,420			44,692			20,360
Net impairment losses recognized in earnings	(705		)	—			—			—
Unlinking of Linked Transactions	—			—			(6,414		)	1,436
Transfers/release of credit reserve	41,118			(41,118		)	94,977			(94,977		)
Balance at end of period	$	(787,541	)	$	(312,182	)	$	(900,557	)	$	(399,564	)

(1) Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.

(2)  The Company reallocated $218,000 of purchase discount designated as Credit Reserve to accretable purchase discount on Non-Agency MBS underlying Linked Transactions for the year ended December 31, 2014.

Impact of AFS Securities on AOCI

The following table presents the impact of the Company’s AFS securities on its AOCI for the years ended December 31, 2015, 2014, and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014			2013
AOCI from AFS securities:
Unrealized gain on AFS securities at beginning of period	$	813,515		$	752,912		$	824,808
Unrealized (loss)/gain on Agency MBS, net	(51,332		)	65,739			(186,568		)
Unrealized (loss)/gain on Non-Agency MBS, net	(143,558		)	29,812			134,505
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	4,537			—			—
Reclassification adjustment for MBS sales included in net income	(37,207		)	(34,948		)	(19,833		)
Reclassification adjustment for OTTI included in net income	(705		)	—			—
Change in AOCI from AFS securities	(228,265		)	60,603			(71,896		)
Balance at end of period	$	585,250		$	813,515		$	752,912

Sales of MBS

During 2015, the Company sold certain Non-Agency MBS for $70.7 million, realizing gross gains of $34.9 million.  During 2014, the Company sold certain Non-Agency MBS for $123.9 million, realizing gross gains of $37.5 million.  During 2013, the Company sold certain Non-Agency MBS for $152.6 million realizing gross gains of $25.8 million. The Company has no continuing involvement with any of the sold MBS.

Interest Income on MBS and CRT Securities

The following table presents components of interest income on the Company’s MBS and CRT securities for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014			2013
Agency MBS
Coupon interest	$	147,066		$	189,355		$	213,995
Effective yield adjustment (1)	(41,231		)	(46,812		)	(57,949		)
Interest income	$	105,835		$	142,543		$	156,046
Legacy Non-Agency MBS
Coupon interest	$	183,349		$	212,073		$	253,560
Effective yield adjustment (2)	91,003			103,491			73,189
Interest income	$	274,352		$	315,564		$	326,749
RPL/NPL MBS
Coupon interest	$	87,429		$	898		$	21
Effective yield adjustment (2)	1,789			(132		)	—
Interest income	$	89,218		$	766		$	21
CRT securities
Coupon interest	$	5,844		$	665		$	—
Effective yield adjustment (2)	728			107			—
Interest income	$	6,572		$	772		$	—

(1)  Includes amortization of premium paid net of accretion of purchase discount.  For Agency MBS, interest income is recorded at an effective yield, which reflects net premium amortization based on actual prepayment activity.

(2)  The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield.

XML

Residential Whole Loans

12 Months Ended

Dec. 31, 2015

Residential Whole Loans [Abstract]

Residential Whole Loans

Residential Whole Loans

Included on the Company’s consolidated balance sheets as of December 31, 2015 and 2014 are approximately $895.1 million and $351.4 million, respectively, of residential whole loans arising from the Company’s 100% equity interest in certificates issued by certain trusts established to acquire the loans. Based on its evaluation of these interests and other factors, the Company has determined that the trusts are required to be consolidated for financial reporting purposes.

Residential Whole Loans at Carrying Value

Residential whole loans at carrying value totaled approximately $271.8 million and $207.9 million at December 31, 2015 and 2014, respectively. The carrying value reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. The carrying value is reduced by any allowance for loan losses established subsequent to acquisition.

For the years ended December 31, 2015 and 2014, a net provision for loan losses of approximately $1.0 million and $137,000, respectively, was recorded, which is included in Operating and Other expense on the Company’s consolidated statement of operations.

The following table presents the activity in the Company’s allowance for loan losses on its residential whole loan pools at carrying value for the years ended December 31, 2015 and 2014:

(In Thousands)	For the Year Ended December 31,
	2015		2014
Balance at the beginning of period	$	137	$	—
Provisions for loan losses	1,028		137
Balance at the end of period	$	1,165	$	137

The following table presents information regarding estimates of the contractually required payments, the cash flows expected to be collected, and the estimated fair value of the residential whole loans held at carrying value acquired by the Company for the years ended December 31, 2015 and 2014:

(In Thousands)	For the Year Ended December 31,
	2015			2014
Contractually required principal and interest	$	160,806		$	448,453
Contractual cash flows not expected to be collected (non-accretable yield)	(27,040		)	(100,466		)
Expected cash flows to be collected	133,766			347,987
Interest component of expected cash flows (accretable yield)	(51,413		)	(135,425		)
Fair value at the date of acquisition	$	82,353		$	212,562

The following table presents accretable yield activity for the Company’s residential whole loans held at carrying value for the years ended December 31, 2015 and 2014:

(In Thousands)	For the Year Ended December 31,
	2015			2014
Balance at beginning of period	$	133,012		$	—
Additions	51,413			135,425
Accretion	(15,511		)	(3,996		)
Reclassifications to non-accretable difference, net	6,357			1,583
Balance at end of period	$	175,271		$	133,012

Accretable yield for residential whole loans is the excess of loan cash flows expected to be collected over the purchase price. The cash flows expected to be collected represents the Company’s estimate of the amount and timing of undiscounted principal and interest cash flows. Additions include accretable yield estimates for purchases made during the period and reclassification to accretable yield from non-accretable yield. Accretable yield is reduced by accretion during the period. The reclassifications between accretable and non-accretable yield and the accretion of interest income are based on changes in estimates regarding loan performance and the value of the underlying real estate securing the loans. In future periods, as the Company updates estimates of cash flows expected to be collected from the loans and the underlying collateral, the accretable yield may change. Therefore, the amount of accretable income recorded during the year ended December 31, 2015 is not necessarily indicative of future results.

Residential Whole Loans at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations.

The following table presents information regarding the Company’s residential whole loans at fair value at December 31, 2015 and 2014:

(Dollars in Thousands)	December 31, 2015		December 31, 2014
Outstanding principal balance	$	786,330	$	182,613
Aggregate fair value	$	623,276	$	143,472
Number of loans	3,143		885

During the years ended December 31, 2015 and 2014, the Company recorded net gains on residential whole loans held at fair value of $17.7 million and $116,000, respectively.

The following table presents the components of Net gain on residential whole loans held at fair value for the years ended December 31, 2015 and 2014:

	For the Year Ended December 31,
(In Thousands)	2015		2014
Coupon payments and other income received	$	9,303	$	504
Net unrealized gains	6,540		(427		)
Net gain on payoff/liquidation of loans	1,879		39
Total	$	17,722	$	116

XML

Interest Receivable

12 Months Ended

Dec. 31, 2015

Receivables [Abstract]

Interest Receivable

Interest Receivable

The following table presents the Company’s interest receivable by investment category at December 31, 2015 and 2014:

	December 31,
(In Thousands)	2015		2014
MBS interest receivable:
Fannie Mae	$	8,999	$	11,761
Freddie Mac	2,177		2,598
Ginnie Mae	15		17
Non-Agency MBS	15,438		16,794
Total MBS interest receivable	26,629		31,170
Residential whole loans	2,259		1,324
CRT securities	92		66
Money market and other investments	22		21
Total interest receivable	$	29,002	$	32,581

XML

Derivative Instruments

12 Months Ended

Dec. 31, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments

Derivative Instruments

The Company’s derivative instruments are currently comprised of Swaps, which are designated as cash flow hedges against the interest rate risk associated with its borrowings. Prior to 2015, the Company had also entered into Linked Transactions, which were not designated as hedging instruments. (See Notes 2(p), 2(t) and below) The following table presents the fair value of the Company’s derivative instruments and their balance sheet location at December 31, 2015 and 2014:

			December 31,
			2015					2014
Derivative Instrument	Designation	Balance Sheet Location	Notional Amount		Fair Value			Notional Amount		Fair Value
(In Thousands)
Linked Transactions	Non-Hedging	Assets	N/A		N/A			N/A		$	398,336
Non-cleared legacy Swaps (1)	Hedging	Assets	$	450,000	$	1,127		$	450,000	$	3,136
Non-cleared legacy Swaps (1)	Hedging	Liabilities	$	50,000	$	(59	)	$	760,170	$	(4,263	)
Cleared Swaps (2)	Hedging	Liabilities	$	2,550,000	$	(70,467	)	$	2,550,000	$	(57,935	)

(1)  Non-cleared legacy Swaps include Swaps executed and settled bilaterally with counterparties without the use of an organized exchange or central clearing house.

(2) Cleared Swaps include Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties.

Linked Transactions

Prior to January 1, 2015, the Company’s Linked Transactions had been evaluated on a combined basis, reported as forward (derivative) instruments and presented as assets on the Company’s consolidated balance sheets at fair value.  The fair value of Linked Transactions reflected the value of the underlying Non-Agency MBS, linked repurchase agreement borrowings and accrued interest receivable/payable on such instruments.  The Company’s Linked Transactions were not designated as hedging instruments and, as a result, the change in the fair value and net interest income from Linked Transactions had been reported in Other Income, net on the Company’s consolidated statements of operations.

New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. An entity is required to present changes in accounting for transactions outstanding on the effective date as a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. Accordingly, on adoption of the new standard on January 1, 2015, the Company reclassified $1.913 billion of Non-Agency MBS and $4.6 million of CRT securities that were previously reported as a component of Linked Transactions to Non-Agency MBS and CRT securities, respectively on the consolidated balance sheet. In addition, liabilities of $1.520 billion that were previously presented as a component of Linked Transactions were reclassified to Repurchase agreements on the consolidated balance sheet. Furthermore, an amount of $4.5 million representing net unrealized gains on securities previously reported as a component of Linked Transactions as of December 31, 2014 was reclassified from Accumulated deficit to AOCI. These reclassification adjustments had no net impact on the Company’s overall Total Stockholders’ Equity.

The following tables present certain information about the Legacy Non-Agency MBS, RPL/NPL MBS, CRT securities and repurchase agreements underlying the Company’s Linked Transactions at December 31, 2014:

Linked Transactions at December 31, 2014

Linked Repurchase Agreements					Linked MBS/CRT Securities
Maturity or Repricing	Balance		Weighted Average Interest Rate			Fair Value		Amortized Cost		Par/Current Face		Weighted Average Coupon Rate
(Dollars in Thousands)					(Dollars in Thousands)
Within 30 days	$	1,514,393	1.47	%	Legacy Non-Agency MBS	$	66,382	$	61,658	$	72,513	4.20	%
>30 days to 90 days	5,200		1.35		RPL/NPL MBS	1,846,807		1,847,118		1,849,974		3.49
Total	$	1,519,593	1.47	%	CRT securities	4,624		4,500		4,500		4.56
					Total	$	1,917,813	$	1,913,276	$	1,926,987	3.52	%

At December 31, 2014, Linked Transactions also included approximately $1.3 million of associated accrued interest receivable and $1.1 million of accrued interest payable.

The following table presents certain information about the components of the unrealized net gains and net interest income from Linked Transactions included in the Company’s consolidated statements of operations for the years ended December 31, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2014			2013
Interest income attributable to MBS underlying Linked Transactions	$	24,443		$	3,869
Interest expense attributable to linked repurchase agreement borrowings underlying Linked Transactions	(8,028		)	(925		)
Change in fair value of Linked Transactions included in earnings	677			281
Unrealized net gains and net interest income from Linked Transactions	$	17,092		$	3,225

Swaps

Consistent with market practice, the Company has agreements with its Swap counterparties that provide for the posting of collateral based on the fair values of its derivative contracts.  Through this margining process, either the Company or its derivative counterparty may be required to pledge cash or securities as collateral.  In addition, Swaps novated to and cleared by a central clearing house are subject to initial margin requirements. Certain derivative contracts provide for cross collateralization with repurchase agreements with the same counterparty.

A number of the Company’s Swap contracts include financial covenants, which, if breached, could cause an event of default or early termination event to occur under such agreements.  Such financial covenants include minimum net worth requirements and maximum debt-to-equity ratios.  If the Company were to cause an event of default or trigger an early termination event pursuant to one of its Swap contracts, the counterparty to such agreement may have the option to terminate all of its outstanding Swap contracts with the Company and, if applicable, any close-out amount due to the counterparty upon termination of the Swap contracts would be immediately payable by the Company.  The Company was in compliance with all of its financial covenants through December 31, 2015.  At December 31, 2015, the aggregate fair value of assets needed to immediately settle Swap contracts that were in a liability position to the Company, if so required, was approximately $72.0 million, including accrued interest payable of approximately $1.5 million.

The following table presents the assets pledged as collateral against the Company’s Swap contracts at December 31, 2015 and December 31, 2014:

	December 31,
(In Thousands)	2015		2014
Agency MBS, at fair value	$	38,569	$	57,247
Restricted cash	70,573		66,486
Total assets pledged against Swaps	$	109,142	$	123,733

The use of derivative hedging instruments exposes the Company to counterparty credit risk.  In the event of a default by a derivative counterparty, the Company may not receive payments to which it is entitled under its derivative agreements, and may have difficulty recovering its assets pledged as collateral against such agreements.  If, during the term of a derivative contract, a counterparty should file for bankruptcy, the Company may experience difficulty recovering its assets pledged as collateral which could result in the Company having an unsecured claim against such counterparty’s assets for the difference between the fair value of the derivative and the fair value of the collateral pledged to such counterparty.

The Company’s derivative hedging instruments, or a portion thereof, could become ineffective in the future if the associated repurchase agreements that such derivatives hedge fail to exist or fail to have terms that match those of the derivatives that hedge such borrowings.  At December 31, 2015, all of the Company’s derivatives were deemed effective for hedging purposes and no derivatives were terminated during the years ended December 31, 2015 and 2014.

The Company’s Swaps designated as hedging transactions have the effect of modifying the repricing characteristics of the Company’s repurchase agreements and cash flows for such liabilities.  To date, no cost has been incurred at the inception of a Swap (except for certain transaction fees related to entering into Swaps cleared though a central clearing house), pursuant to which the Company agrees to pay a fixed rate of interest and receive a variable interest rate, generally based on one-month or three-month London Interbank Offered Rate (“LIBOR”), on the notional amount of the Swap. The Company did not recognize any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness during any of the three years ended December 31, 2015.

At December 31, 2015, the Company had Swaps designated in hedging relationships with an aggregate notional amount of $3.050 billion, which had net unrealized losses of $69.4 million, and extended 45 months on average with a maximum term of approximately 92 months. 

The following table presents certain information with respect to the Company’s Swap activity during the year ended December 31, 2015:

(Dollars in Thousands)	December 31, 2015
New Swaps:
Aggregate notional amount	$	—
Weighted average fixed-pay rate	—		%
Initial maturity date	N/A
Number of new Swaps	—
Swaps amortized/expired:
Aggregate notional amount	$	710,170
Weighted average fixed-pay rate	1.96		%

The following table presents information about the Company’s Swaps at December 31, 2015 and 2014:

	December 31, 2015						December 31, 2014
Maturity (1)	Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)		Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)
(Dollars in Thousands)
Within 30 days	$	50,000	2.13	%	0.42	%	$	22,290	3.63	%	0.23	%
Over 30 days to 3 months	—		—		—		387,880		1.80		0.16
Over 3 months to 6 months	—		—		—		300,000		2.06		0.17
Over 6 months to 12 months	100,000		0.48		0.32		—		—		—
Over 12 months to 24 months	350,000		0.58		0.27		150,000		1.03		0.16
Over 24 months to 36 months	550,000		1.49		0.32		350,000		0.58		0.16
Over 36 months to 48 months	200,000		1.71		0.42		550,000		1.49		0.16
Over 48 months to 60 months	1,500,000		2.22		0.36		200,000		1.71		0.17
Over 60 months to 72 months	200,000		2.20		0.30		1,500,000		2.22		0.16
Over 72 months to 84 months	—		—		—		200,000		2.20		0.17
Over 84 months (3)	100,000		2.75		0.40		100,000		2.75		0.16
Total Swaps	$	3,050,000	1.82	%	0.34	%	$	3,760,170	1.85	%	0.16	%

(1)  Each maturity category reflects contractual amortization and/or maturity of notional amounts.

(2)  Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively. 

(3) Reflects one Swap with a maturity date of July 2023.

The following table presents the net impact of the Company’s derivative hedging instruments on its interest expense and the weighted average interest rate paid and received for such Swaps for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(Dollars in Thousands)	2015			2014			2013
Interest expense attributable to Swaps	$	53,759		$	69,842		$	59,031
Weighted average Swap rate paid	1.86		%	1.93		%	2.08		%
Weighted average Swap rate received	0.19		%	0.16		%	0.19		%

TBA Short Positions

During 2013, the Company entered into TBA short positions as a means of managing interest rate risk and MBS basis risk associated with its investment and financing activities. A TBA short position is a forward contract for the sale of Agency MBS at a predetermined price, face amount, issuer, coupon and stated maturity on an agreed-upon future date. The specific Agency MBS that could be delivered into the contract upon the settlement date, published each month by SIFMA, are not known at the time of the transaction.

TBA short positions were accounted for as derivative instruments since the Company could not assert that it is probable at inception, and throughout the term of the TBA contract, that it would physically deliver the Agency security upon settlement of the contract. The Company presented TBA short positions as either derivative assets or liabilities, at fair value on its consolidated balance sheets. Gains and losses associated with TBA short positions were reported in Other income, net on the Company’s consolidated statements of operations. During 2013, the Company sold short $350.0 million notional of 15-year Agency MBS 2.5% TBA Securities and realized a loss of $7.5 million on close out of this position. The Company did not have any TBA short positions at December 31, 2015 and 2014.

Impact of Derivative Hedging Instruments on AOCI

The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014			2013
AOCI from derivative hedging instruments:
Balance at beginning of period	$	(59,062	)	$	(15,217	)	$	(62,831	)
Unrealized (loss)/gain on Swaps, net	(10,337		)	(44,292		)	47,614
Reclassification of unrealized loss on de-designated Swaps	—			447			—
Balance at end of period	$	(69,399	)	$	(59,062	)	$	(15,217	)

Counterparty Credit Risk from Use of Swaps

By using Swaps, the Company is exposed to counterparty credit risk if counterparties to the derivative contracts do not perform as expected.  If a counterparty fails to perform, the Company’s counterparty credit risk is equal to the amount reported as a derivative asset on its consolidated balance sheets to the extent that amount exceeds collateral obtained from the counterparty or, if in a net liability position, the extent to which collateral posted exceeds the liability to the counterparty.  The amounts reported as a derivative asset/(liability) are derivative contracts in a gain/(loss) position, and to the extent subject to master netting arrangements, net of derivatives in a loss/(gain) position with the same counterparty and collateral received/(pledged).  The Company attempts to minimize counterparty credit risk through credit approvals, limits, monitoring procedures, executing master netting arrangements and obtaining collateral, where appropriate.  Counterparty credit risk related to the Company’s Swaps is considered in determining the fair value of such derivatives and in its assessment of hedge effectiveness.

XML

Real Estate Owned

12 Months Ended

Dec. 31, 2015

Real Estate [Abstract]

Real Estate Owned

Real Estate Owned

At December 31, 2015, the Company had 182 REO properties with an aggregate carrying value of $28.0 million. At December 31, 2014, the Company had 46 REO properties with an aggregate carrying value of $5.5 million. During the years ended December 31, 2015 and 2014, the Company acquired 13 and 24 residential properties, for approximately $1.7 million and $2.6 million, respectively, in connection with the acquisition of residential whole loans.

During the years ended December 31, 2015 and 2014, the Company reclassified 186 and 22 mortgage loans to REO at an aggregate estimated fair value of $30.1 million and $2.9 million, respectively at the time of transfer. Such transfers occur when the Company takes possession of the property by foreclosing on the borrower or completes a “deed-in-lieu of foreclosure” transaction.

At December 31, 2015, $26.1 million of residential real estate property was held by the Company that was acquired either through a completed foreclosure proceeding or from completion of a deed-in-lieu of foreclosure or similar legal agreement. In addition, formal foreclosure proceedings were in process with respect to $17.3 million of residential whole loans at carrying value and $394.9 million of residential whole loans at fair value at December 31, 2015.

During the year ended December 31, 2015, the Company sold 63 REO properties for consideration of $6.5 million, realizing net gains of approximately $76,000 which are included in Other, net on the Company’s consolidated statements of operations. The Company did not sell any REO properties during the year ended December 31, 2014. In addition, following an updated assessment of liquidation amounts expected to be realized that was performed on all REO held at the end of each quarter during the year ended December 31, 2015, an aggregate adjustment of approximately $3.5 million was recorded to reflect certain REO properties at the lower of cost or estimated fair value for the year ended December 31, 2015.

The following table presents the activity in the Company’s REO for the years ended December 31, 2015 and 2014. The Company did not have REO prior to 2014.

	For the Year Ended December 31,
(In Thousands)	2015			2014
Balance at beginning of period	$	5,492		$	—
Adjustments to record at lower of cost or fair value	(3,475		)	—
Transfer from residential whole loans (1)	30,104			2,904
Purchases and capital improvements	2,461			2,588
Disposals	(6,556		)	—
Balance at end of period	$	28,026		$	5,492

(1)  Includes net gain recorded on transfer of approximately $1.7 million and $331,000, respectively, for the years ended December 31, 2015 and 2014.

Real estate owned is included in Prepaid and other assets in the Company’s consolidated balance sheets.

XML

Repurchase Agreements and Other Advances

12 Months Ended

Dec. 31, 2015

Repurchase Agreements

Repurchase Agreements and Other Advances

Repurchase Agreements and Other Advances

Repurchase Agreements

The Company’s repurchase agreements are accounted for as secured borrowings and are collateralized by the Company’s MBS, U.S. Treasury securities (obtained as part of a reverse repurchase agreement), CRT securities, residential whole loans and cash, and bear interest that is generally LIBOR-based.  (See Notes 2(k) and 9)  At December 31, 2015, the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 21 days and an effective repricing period of 18 months, including the impact of related Swaps.  At December 31, 2014, the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 25 days and an effective repricing period of 21 months, including the impact of related Swaps.

The following table presents information with respect to the Company’s borrowings under repurchase agreements and associated assets pledged as collateral at December 31, 2015 and 2014:

(Dollars in Thousands)	December 31, 2015			December 31, 2014
Repurchase agreement borrowings secured by Agency MBS	$	2,727,542		$	5,177,835
Fair value of Agency MBS pledged as collateral under repurchase agreements	$	2,881,049		$	5,462,566
Weighted average haircut on Agency MBS (1)	4.67		%	4.79		%
Repurchase agreement borrowings secured by Legacy Non-Agency MBS (2)	$	1,960,222		$	2,233,236
Fair value of Legacy Non-Agency MBS pledged as collateral under repurchase   agreements (2)(3)	$	2,818,968		$	3,491,312
Weighted average haircut on Legacy Non-Agency MBS (1)	25.42		%	28.88		%
Repurchase agreement borrowings secured by RPL/NPL MBS (2)	$	2,080,163		$	130,919
Fair value of RPL/NPL MBS pledged as collateral under repurchase agreements (2)	$	2,625,866		$	160,688
Weighted average haircut on RPL/NPL MBS (1)	21.37		%	20.00		%
Repurchase agreements secured by U.S. Treasuries	$	504,760		$	507,114
Fair value of U.S. Treasuries pledged as collateral under repurchase agreements	$	507,443		$	512,105
Weighted average haircut on U.S. Treasuries (1)	1.60		%	1.62		%
Repurchase agreements secured by CRT securities (2)	$	128,465		$	75,960
Fair value of CRT securities pledged as collateral under repurchase agreements (2)	$	170,352		$	94,610
Weighted average haircut on CRT securities (1)	25.04		%	25.00		%
Repurchase agreements secured by residential whole loans	$	487,750		$	142,324
Fair value of residential whole loans pledged as collateral under repurchase agreements	$	684,136		$	212,986
Weighted average haircut on residential whole loans (1)	27.69		%	33.43		%

(1)  Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount.

(2)  Does not reflect Legacy Non-Agency MBS, RPL/NPL MBS, CRT securities and repurchase agreement borrowings that were components of Linked Transactions at December 31, 2014. As previously discussed, new accounting guidance effective January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 6)

(3)  Includes $570.5 million and $1.275 billion of Legacy Non-Agency MBS acquired from consolidated VIEs at December 31, 2015 and 2014, respectively, that are eliminated from the Company’s consolidated balance sheets.

The following table presents repricing information about the Company’s borrowings under repurchase agreements, which does not reflect the impact of associated derivative hedging instruments, at December 31, 2015 and 2014:

	December 31, 2015				December 31, 2014
Time Until Interest Rate Reset	Balance		Weighted Average Interest Rate		Balance (1)		Weighted Average Interest Rate
(Dollars in Thousands)
Within 30 days	$	7,054,483	1.44	%	$	7,144,737	0.72	%
Over 30 days to 3 months	734,955		1.79		1,000,313		1.12
Over 3 months to 12 months	99,464		2.36		122,338		1.98
Total	$	7,888,902	1.48	%	$	8,267,388	0.79	%

(1)  At December 31, 2014, the Company had repurchase agreements of $1.520 billion that were linked to securities purchased and accounted for as Linked Transactions, and as such, the linked repurchase agreements are not included in the above table. As previously discussed, new accounting guidance effective January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 6)

The following table presents contractual maturity information about the Company’s borrowings under repurchase agreements, all of which are accounted for as secured borrowings, at December 31, 2015 and does not reflect the impact of derivative contracts that hedge such repurchase agreements:

	December 31, 2015
Contractual Maturity	Agency MBS		Legacy Non-Agency MBS		RPL/NPL MBS		U.S. Treasuries		CRT Securities		Residential Whole Loans		Total		Weighted  Average Interest Rate
(Dollars in Thousands)
Overnight	$	—	$	—	$	—	$	—	$	—	$	—	$	—	—	%
Within 30 days	2,563,741		892,341		1,670,586		504,760		110,921		—		5,742,349		1.27
Over 30 days to 3 months	163,801		613,131		143,705		—		17,544		—		938,181		1.71
Over 3 months to 12 months	—		454,750		265,872		—		—		293,641		1,014,263		2.19
Over 12 months	—		—		—		—		—		194,109		194,109		3.11
Total	$	2,727,542	$	1,960,222	$	2,080,163	$	504,760	$	128,465	$	487,750	$	7,888,902	1.48	%
Gross amount of recognized liabilities for repurchase agreements in Note 10													$	7,888,902
Amounts related to repurchase agreements not included in offsetting disclosure in Note 10													$	—

The Company had repurchase agreements with 27 and 25 counterparties at December 31, 2015 and 2014, respectively.  The following table presents information with respect to each counterparty under repurchase agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at December 31, 2015:

	December 31, 2015
Counterparty	Counterparty Rating (1)	Amount at Risk (2)		Weighted Average Months to Maturity for Repurchase Agreements	Percent of Stockholders’ Equity
(Dollars in Thousands)
Credit Suisse	BBB+/Aa2/A	$	410,814	1	13.8	%
Wells Fargo (3)	AA-/Aa2/AA	334,613		6	11.3
RBC (4)	AA-/Aa3/AA	327,400		2	11.0
UBS (5)	A/A1/A	214,107		19	7.2
Goldman Sachs	BBB+/A3/A	152,055		9	5.1

(1) As rated at December 31, 2015 by S&P, Moody’s and Fitch, Inc., respectively.  The counterparty rating presented is the lowest published for these entities.

(2) The amount at risk reflects the difference between (a) the amount loaned to the Company through repurchase agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities.

(3)  Includes $269.7 million at risk with Wells Fargo Bank, NA and $64.9 million at risk with Wells Fargo Securities LLC. 

(4) Includes $309.8 million at risk with RBC Barbados, $10.7 million at risk with Royal Bank of Canada and $6.8 million at risk with RBC Capital Markets LLC. Counterparty ratings are not published for RBC Barbados and RBC Capital Markets LLC.

(5) Includes Non-Agency MBS pledged as collateral with contemporaneous repurchase and reverse repurchase agreements.

FHLB Advances

As of December 31, 2015, MFA Insurance had $1.500 billion in outstanding long-term secured FHLB advances with a weighted average borrowing rate of 0.50% and a weighted average term to maturity of 4.79 years. However, MFA Insurance is required by recent amendments to FHLB membership regulations to terminate its membership and repay the outstanding advances by February 19, 2017. (See Note 18) Interest payable on outstanding FHLB advances at December 31, 2015 totaled approximately $508,000, and is included in Accrued interest payable on the Company’s consolidated balance sheets.

XML

Collateral Positions

12 Months Ended

Dec. 31, 2015

Collateral Positions

Collateral Positions

Collateral Positions

The Company pledges securities or cash as collateral to its counterparties pursuant to its borrowings under repurchase agreements, FHLB advances and its derivative contracts that are in an unrealized loss position, and it receives securities or cash as collateral pursuant to financing provided under reverse repurchase agreements and certain of its derivative contracts in an unrealized gain position.  The Company exchanges collateral with its counterparties based on changes in the fair value, notional amount and term of the associated repurchase agreements, FHLB advances and derivative contracts, as applicable.  Through this margining process, either the Company or its counterparty may be required to pledge cash or securities as collateral.  In addition, Swaps novated to and cleared by a central clearing house are subject to initial margin requirements. When the Company’s pledged collateral exceeds the required margin, the Company may initiate a reverse margin call, at which time the counterparty may either return the excess collateral, or provide collateral to the Company in the form of cash or equivalent securities.

The following table summarizes the fair value of the Company’s collateral positions, which includes collateral pledged and collateral held, with respect to its borrowings under repurchase agreements, reverse repurchase agreements, derivative hedging instruments and FHLB advances at December 31, 2015 and 2014: 

	December 31, 2015				December 31, 2014
(In Thousands)	Assets Pledged		Collateral Held		Assets Pledged		Collateral Held
Derivative Hedging Instruments:
Agency MBS	$	38,569	$	—	$	57,247	$	—
Cash (1)	70,573		—		66,486		—
	109,142		—		123,733		—
Repurchase Agreement Borrowings:
Agency MBS	2,881,049		—		5,462,566		—
Legacy Non-Agency MBS (2)(3)	2,818,968		—		3,491,312		—
RPL/NPL MBS	2,625,866		—		160,688		—
U.S. Treasury securities	507,443		—		512,105		—
CRT securities	170,352		—		94,610		—
Residential whole loans	684,136		—		212,986		—
Cash (1)	965		—		769		—
	9,688,779		—		9,935,036		—
FHLB Advances:
Agency MBS	1,612,476		—		—		—
	1,612,476		—		—		—
Reverse Repurchase Agreements:
U.S. Treasury securities	—		507,443		—		512,105
	—		507,443		—		512,105
Total	$	11,410,397	$	507,443	$	10,058,769	$	512,105

(1) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets.

(2) Includes $570.5 million and $1.275 billion of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at December 31, 2015 and 2014, respectively, that are eliminated from the Company’s consolidated balance sheets.

(3) In addition, at December 31, 2015 and 2014, $726.7 million and $731.0 million of Legacy Non-Agency MBS, respectively, are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty.

The following table presents detailed information about the Company’s assets pledged as collateral pursuant to its borrowings under repurchase agreements and other advances, and derivative hedging instruments at December 31, 2015:

	December 31, 2015
	Assets Pledged Under Repurchase Agreements and Other Advances						Assets Pledged Against Derivative Hedging Instruments						Total Fair Value of Assets Pledged and Accrued Interest
(In Thousands)	Fair Value		Amortized Cost		Accrued Interest on Pledged Assets		Fair Value/ Carrying Value		Amortized Cost		Accrued Interest on Pledged Assets
Agency MBS (1)	$	4,493,525	$	4,465,081	$	10,593	$	38,569	$	39,460	$	80	$	4,542,767
Legacy Non-Agency MBS(2)(3)	2,818,968		2,278,870		10,241		—		—		—		2,829,209
RPL/NPL MBS	2,625,866		2,644,797		1,592		—		—		—		2,627,458
U.S. Treasuries	507,443		507,443		—		—		—		—		507,443
CRT securities	170,352		173,367		83		—		—		—		170,435
Residential whole loans	684,136		673,788		952		—		—		—		685,088
Cash (4)	965		965		—		70,573		70,573		—		71,538
Total	$	11,301,255	$	10,744,311	$	23,461	$	109,142	$	110,033	$	80	$	11,433,938

(1)  Includes Agency MBS pledged under FHLB advances with an aggregate fair value of $1.612 billion, aggregate amortized cost of $1.606 billion and aggregate accrued interest of approximately $3.9 million at December 31, 2015.

(2) Includes $570.5 million of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at December 31, 2015, that are eliminated from the Company’s consolidated balance sheets.

(3)  In addition, at December 31, 2015, $726.7 million of Legacy Non-Agency MBS are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty.

(4) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets.

XML

Offsetting Assets and Liabilities

12 Months Ended

Dec. 31, 2015

Offsetting [Abstract]

Offsetting Assets and Liabilities

Offsetting Assets and Liabilities

The following tables present information about certain assets and liabilities that are subject to master netting arrangements (or similar agreements) and may potentially be offset on the Company’s consolidated balance sheets at December 31, 2015 and 2014:

Offsetting of Financial Assets and Derivative Assets

	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Consolidated Balance Sheets		Net Amounts of Assets Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in  the Consolidated Balance Sheets					Net Amount
(In Thousands)							Financial Instruments			Cash  Collateral  Received
December 31, 2015
Swaps, at fair value	$	1,127	$	—	$	1,127	$	(1,127	)	$	—	$	—
Total	$	1,127	$	—	$	1,127	$	(1,127	)	$	—	$	—
December 31, 2014
Swaps, at fair value	$	3,136	$	—	$	3,136	$	(3,136	)	$	—	$	—
Total	$	3,136	$	—	$	3,136	$	(3,136	)	$	—	$	—

Offsetting of Financial Liabilities and Derivative Liabilities

	Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Consolidated Balance Sheets		Net Amounts of Liabilities Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in the  Consolidated Balance Sheets						Net Amount
(In Thousands)							Financial  Instruments (1)			Cash  Collateral  Pledged (1)
December 31, 2015
Swaps, at fair value (2)	$	70,526	$	—	$	70,526	$	—		$	(70,526	)	$	—
Repurchase agreements and   other advances (3)	9,388,902		—		9,388,902		(9,387,937		)	(965		)	—
Total	$	9,459,428	$	—	$	9,459,428	$	(9,387,937	)	$	(71,491	)	$	—
December 31, 2014
Swaps, at fair value (2)	$	62,198	$	—	$	62,198	$	—		$	(62,198	)	$	—
Repurchase agreements (3)	8,267,388		—		8,267,388		(8,266,619		)	(769		)	—
Total	$	8,329,586	$	—	$	8,329,586	$	(8,266,619	)	$	(62,967	)	$	—

(1) Amounts disclosed in the Financial Instruments column of the table above represent collateral pledged that is available to be offset against liability balances associated with repurchase agreements and other advances, and derivative transactions.  Amounts disclosed in the Cash Collateral Pledged column of the table above represent amounts pledged as collateral against derivative transactions and repurchase agreements, and exclude excess collateral of $47,000 and $4.3 million at December 31, 2015 and 2014, respectively.

(2) The fair value of securities pledged against the Company’s Swaps was $38.6 million and $57.2 million at December 31, 2015 and 2014, respectively.

(3) The fair value of financial instruments pledged against the Company’s repurchase agreements and other advances was $11.300 billion and $9.934 billion at December 31, 2015 and 2014, respectively.

Nature of Setoff Rights

In the Company’s consolidated balance sheets, all balances associated with the repurchase agreement and derivative transactions are presented on a gross basis.

Certain of the Company’s repurchase agreement and derivative transactions are governed by underlying agreements that generally provide for a right of setoff in the event of default or in the event of a bankruptcy of either party to the transaction.  For one repurchase agreement counterparty, the underlying agreements provide for an unconditional right of setoff.

XML

Senior Notes

12 Months Ended

Dec. 31, 2015

Debt Disclosure [Abstract]

Senior Notes

Senior Notes

On April 11, 2012 the Company issued $100.0 million in aggregate principal amount of its Senior Notes in an underwritten public offering.  The total net proceeds to the Company from the offering of the Senior Notes were approximately $96.6 million, after deducting offering expenses and the underwriting discount.  The Senior Notes bear interest at a fixed rate of 8.00% per year, paid quarterly in arrears on January 15, April 15, July 15 and October 15 of each year and will mature on April 15, 2042.  The Company may redeem the Senior Notes, in whole or in part, at any time on or after April 15, 2017 at a redemption price equal to 100% of the principal amount redeemed plus accrued and unpaid interest to, but not excluding, the redemption date.

The Senior Notes are the Company’s senior unsecured obligations and are subordinate to all of the Company’s secured indebtedness, which includes the Company’s repurchase agreements, obligation to return securities obtained as collateral, and other financing arrangements, to the extent of the value of the collateral securing such indebtedness.

XML

Commitments and Contingencies

12 Months Ended

Dec. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

(a)  Lease Commitments

The Company pays monthly rent pursuant to two operating leases.  The lease term for the Company’s headquarters in New York, New York extends through May 31, 2020.  The lease provides for aggregate cash payments ranging over time of approximately $2.5 million per year, paid on a monthly basis, exclusive of escalation charges.  In addition, as part of this lease agreement, the Company has provided the landlord a $785,000 irrevocable standby letter of credit fully collateralized by cash.  The letter of credit may be drawn upon by the landlord in the event that the Company defaults under certain terms of the lease.  In addition, the Company has a lease through December 31, 2016 for its off-site back-up facility located in Rockville Centre, New York, which provides for, among other things, lease payments totaling $30,000, annually.

The Company recognized lease expense of $2.6 million, $2.5 million and $2.7 million for the years ended December 31, 2015, 2014 and 2013, respectively, which is included in Other general and administrative expense within the consolidated statements of operations.  At December 31, 2015, the contractual minimum rental payments (exclusive of possible rent escalation charges and normal recurring charges for maintenance, insurance and taxes) were as follows:

Year Ended December 31,	Minimum Rental Payments
(In Thousands)
2016	$	2,552
2017	2,522
2018	2,522
2019	2,522
2020	1,050
Total	$	11,168

(b)  Representations and Warranties in Connection with Resecuritization Transactions

In connection with the resecuritization transactions engaged in by the Company (See Note 17 for further discussion), the Company has the obligation under certain circumstances to repurchase assets from its VIEs upon breach of certain representations and warranties.

XML

Stockholders' Equity

12 Months Ended

Dec. 31, 2015

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders’ Equity

(a) Preferred Stock

Redemption of 8.50% Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”)

On May 16, 2013 (the “Redemption Date”), the Company redeemed all 3,840,000 outstanding shares of its Series A Preferred Stock at an aggregate redemption price of approximately $97.0 million, or $25.27153 per share, including all accrued and unpaid dividends to the Redemption Date. The redemption value of the Series A Preferred Stock exceeded its carrying value by $3.9 million, which represents the original offering costs for the Series A Preferred Stock. This amount was included in the determination of net income available to common stock and participating securities from the Redemption Date through the year ended December 31, 2013.  In addition, as part of the redemption price on its Series A Preferred Stock, the Company paid a dividend of $0.27153 per share, which reflected accrued and unpaid dividends for the period from April 1, 2013 through and including the Redemption Date.

Issuance of 7.50% Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”)

On April 15, 2013, the Company filed articles supplementary amending its charter to reclassify 8,050,000 shares of the Company’s authorized but unissued common stock as shares of the Company’s Series B Preferred Stock. On the same date, the Company completed the issuance of 8.0 million shares of its Series B Preferred Stock with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The aggregate net proceeds to the Company from the offering of the Series B Preferred Stock were approximately $193.3 million, after deducting the underwriting discount and related offering expenses. The Company used a portion of the net proceeds to redeem all of its outstanding Series A Preferred Stock (as discussed above), and used the remaining net proceeds of the offering for general corporate purposes, including, without limitation, to acquire additional MBS consistent with its investment policy, and for working capital, which included, among other things, the repayment of its repurchase agreements.

The Company’s Series B Preferred Stock is entitled to receive a dividend at a rate of 7.50% per year on the $25.00 liquidation preference before the Company’s common stock is paid any dividends and is senior to the Company’s common stock with respect to distributions upon liquidation, dissolution or winding up. Dividends on the Series B Preferred Stock are payable quarterly in arrears on or about March 31, June 30, September 30 and December 31 of each year. The Series B Preferred Stock is redeemable at $25.00 per share plus accrued and unpaid dividends (whether or not authorized or declared) exclusively at the Company’s option commencing on April 15, 2018 (subject to the Company’s right, under limited circumstances, to redeem the Series B Preferred Stock prior to that date in order to preserve its qualification as a REIT and upon certain specified change in control transactions in which the Company’s common stock and the acquiring or surviving entity common securities would not be listed on the New York Stock Exchange (the “NYSE”), the NYSE MKT or NASDAQ, or any successor exchanges).

On May 20, 2013, the Company declared the first dividend payable on the Series B Preferred Stock, which was paid on July 1, 2013 to preferred stockholders of record as of June 3, 2013. The amount of such dividend payable was $0.39583 per share, and was paid in respect of the partial period commencing on April 15, 2013, the date of original issue of the Series B Preferred Stock, and ending on, and including, June 30, 2013.

The Series B Preferred Stock generally does not have any voting rights, subject to an exception in the event the Company fails to pay dividends on such stock for six or more quarterly periods (whether or not consecutive).  Under such circumstances, the Series B Preferred Stock will be entitled to vote to elect two additional directors to the Company’s Board of Directors (the “Board”), until all unpaid dividends have been paid or declared and set apart for payment.  In addition, certain material and adverse changes to the terms of the Series B Preferred Stock cannot be made without the affirmative vote of holders of at least 66 2/3% of the outstanding shares of Series B Preferred Stock.

The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2013 through December 31, 2015:

Year	Declaration Date	Record Date	Payment Date	Dividend Per Share
2015	November 19, 2015	December 3, 2015	December 31, 2015	$0.46875
	August 24, 2015	September 9, 2015	September 30, 2015	0.46875
	May 18, 2015	June 2, 2015	June 30, 2015	0.46875
	February 13, 2015	February 27, 2015	March 31, 2015	0.46875
2014	November 21, 2014	December 5, 2014	December 31, 2014	$0.46875
	August 25, 2014	September 8, 2014	September 30, 2014	0.46875
	May 19, 2014	June 10, 2014	June 30, 2014	0.46875
	February 14, 2014	February 28, 2014	March 31, 2014	0.46875
2013	November 19, 2013	December 3, 2013	December 31, 2013	$0.46875
	August 22, 2013	September 5, 2013	September 30, 2013	0.46875
	May 20, 2013	June 3, 2013	July 1, 2013	0.39583

(b)  Dividends on Common Stock

The following table presents cash dividends declared by the Company on its common stock from January 1, 2013 through December 31, 2015:

Year	Declaration Date	Record Date	Payment Date	Dividend Per Share
2015	December 9, 2015	December 28, 2015	January 29, 2016	$0.20	(1)
	September 17, 2015	September 29, 2015	October 30, 2015	0.20
	June 15, 2015	June 29, 2015	July 31, 2015	0.20
	March 13, 2015	March 27, 2015	April 30, 2015	0.20
2014	December 9, 2014	December 26, 2014	January 30, 2015	$0.20
	September 17, 2014	September 29, 2014	October 31, 2014	0.20
	June 13, 2014	June 27, 2014	July 31, 2014	0.20
	March 10, 2014	March 28, 2014	April 30, 2014	0.20
2013	December 11, 2013	December 31, 2013	January 31, 2014	$0.20
	September 26, 2013	October 11, 2013	October 31, 2013	0.22
	August 1, 2013	August 12, 2013	August 30, 2013	0.28	(2)
	June 28, 2013	July 12, 2013	July 31, 2013	0.22
	March 28, 2013	April 12, 2013	April 30, 2013	0.22
	March 4, 2013	March 18, 2013	April 10, 2013	0.50	(3)

(1)  At December 31, 2015, the Company had accrued dividends and dividend equivalents payable of $74.6 million related to the common stock dividend declared on December 9, 2015.

(2) Reflects the special cash dividend on common stock declared on August 1, 2013.

(3) Reflects the special cash dividend on common stock declared on March 4, 2013.

In general, the Company’s common stock dividends have been characterized as ordinary income to its stockholders for income tax purposes.  However, a portion of the Company’s common stock dividends may, from time to time, be characterized as capital gains or return of capital.  For the year ended December 31, 2015, a portion of the Company’s common stock dividends were deemed to be capitalized gains. For the years ended December 31, 2014 and 2013, our common stock dividends were characterized as ordinary income to stockholders.

(c) Discount Waiver, Direct Stock Purchase and Dividend Reinvestment Plan (“DRSPP”)

On August 8, 2013, the Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (“SEC”) under the Securities Act of 1933, as amended (the “1933 Act”), for the purpose of registering additional common stock for sale through its DRSPP.  Pursuant to Rule 462(e) of the 1933 Act, this shelf registration statement became effective automatically upon filing with the SEC and, when combined with the unused portion of the Company’s previous DRSPP shelf registration statements, registered an aggregate of 15 million shares of common stock.  The Company’s DRSPP is designed to provide existing stockholders and new investors with a convenient and economical way to purchase shares of common stock through the automatic reinvestment of dividends and/or optional cash investments.  At December 31, 2015, 6.8 million shares of common stock remained available for issuance pursuant to the DRSPP shelf registration statement.

During the years ended December 31, 2015, 2014 and 2013, the Company issued 162,373, 4,526,855 and 9,511,739 shares of common stock through the DRSPP, raising net proceeds of approximately $1.2 million, $35.6 million and $77.6 million, respectively.  From the inception of the DRSPP in September 2003 through December 31, 2015, the Company issued 30,728,992 shares pursuant to the DRSPP, raising net proceeds of $258.3 million.

(d)  Stock Repurchase Program

As previously disclosed, in August 2005, the Company’s Board authorized a stock repurchase program (the “Repurchase Program”) to repurchase up to 4.0 million shares of its outstanding common stock. The Board reaffirmed such authorization in May 2010.  In December 2013, the Board increased the number of shares authorized under the Repurchase Program to an aggregate of 10.0 million. Such authorization does not have an expiration date and, at present, there is no intention to modify or otherwise rescind such authorization.  Subject to applicable securities laws, repurchases of common stock under the Repurchase Program are made at times and in amounts as the Company deems appropriate, (including, in our discretion, through the use of one or more plans adopted under Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended (the “1934 Act”)) using available cash resources.  Shares of common stock repurchased by the Company under the Repurchase Program are cancelled and, until reissued by the Company, are deemed to be authorized but unissued shares of the Company’s common stock.  The Repurchase Program may be suspended or discontinued by the Company at any time and without prior notice. The Company did not repurchase any shares of its common stock during the years ended December 31, 2015 and 2014. During the year ended December 31, 2013, the Company repurchased 2,143,354 shares of its common stock at a total cost of approximately $15.4 million and an average cost of $7.20 per share. At December 31, 2015, 6,616,355 shares remained authorized for repurchase under the Repurchase Program.

(e) Accumulated Other Comprehensive Income/(Loss)

The following table presents changes in the balances of each component of the Company’s AOCI for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
	2015									2014									2013
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities			Net  Unrealized Gain/(Loss) on Swaps			Total  AOCI			Net  Unrealized Gain/(Loss) on AFS Securities			Net  Unrealized Gain/(Loss) on Swaps			Total  AOCI			Net  Unrealized Gain/(Loss) on AFS Securities			Net  Unrealized Gain/(Loss) on Swaps			Total  AOCI
Balance at beginning of period	$	813,515		$	(59,062	)	$	754,453		$	752,912		$	(15,217	)	$	737,695		$	824,808		$	(62,831	)	$	761,977
OCI before reclassifications	(194,890		)	(10,337		)	(205,227		)	95,551			(44,292		)	51,259			(52,063		)	47,614			(4,449		)
Amounts reclassified from   AOCI (1)	(37,912		)	—			(37,912		)	(34,948		)	447			(34,501		)	(19,833		)	—			(19,833		)
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	4,537			—			4,537			—			—			—			—			—			—
Net OCI during period (2)	(228,265		)	(10,337		)	(238,602		)	60,603			(43,845		)	16,758			(71,896		)	47,614			(24,282		)
Balance at end of period	$	585,250		$	(69,399	)	$	515,851		$	813,515		$	(59,062	)	$	754,453		$	752,912		$	(15,217	)	$	737,695

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the years ended December 31, 2015, 2014, and 2013:

	For the Year Ended December 31,
	2015			2014			2013
Details about AOCI Components	Amounts Reclassified from AOCI									Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(37,207	)	$	(34,948	)	$	(19,833	)	Gain on sales of MBS and U.S. Treasury securities, net
OTTI recognized in earnings	(705		)	—			—			Net impairment losses recognized in earnings
Total AFS Securities	(37,912		)	(34,948		)	(19,833		)
Swaps designated as cash flow hedges:
De-designated Swaps	—			447			—			Other, net
Total Swaps designated as cash flow hedges	—			447			—
Total reclassifications for period	$	(37,912	)	$	(34,501	)	$	(19,833	)

At December 31, 2015, and 2014 the Company had unrealized losses recorded in AOCI of $1.3 million, and $629,000, respectively, on securities for which OTTI had been recognized in earnings in prior periods.

XML

EPS Calculation

12 Months Ended

Dec. 31, 2015

Earnings Per Share [Abstract]

EPS Calculation

EPS Calculation

The following table presents a reconciliation of the earnings and shares used in calculating basic and diluted EPS for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands, Except Per Share Amounts)	2015			2014			2013
Numerator:
Net income	$	313,226		$	313,504		$	302,709
Dividends declared on preferred stock	(15,000		)	(15,000		)	(13,750		)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities	(1,539		)	(1,106		)	(1,080		)
Issuance costs of redeemed preferred stock (1)	—			—			(3,947		)
Net income available to common stockholders - basic and diluted	$	296,687		$	297,398		$	283,932
Denominator:
Weighted average common shares for basic and diluted earnings per share (2)	372,114			369,048			362,399
Basic and diluted earnings per share	$	0.80		$	0.81		$	0.78

(1) Issuance costs of redeemed preferred stock represent the original offering costs related to the Series A Preferred Stock, which was redeemed on May 16, 2013. (See Note 13)

(2) At December 31, 2015, the Company had an aggregate of 2.0 million equity instruments outstanding that were not included in the calculation of diluted EPS for the year ended December 31, 2015, as their inclusion would have been anti-dilutive.  These equity instruments were comprised of approximately 111,000 shares of restricted common stock with a weighted average grant date fair value of $7.41 and approximately $1.9 million RSUs with a weighted average grant date fair value of $6.90.  These equity instruments may have a dilutive impact on future EPS.

XML

Equity Compensation, Employment Agreements and Other Benefit Plans

12 Months Ended

Dec. 31, 2015

Compensation Related Costs [Abstract]

Equity Compensation, Employment Agreements and Other Benefit Plans

Equity Compensation, Employment Agreements and Other Benefit Plans

(a)  Equity Compensation Plan

In accordance with the terms of the Company’s Equity Compensation Plan (the “Equity Plan”), which was adopted by the Company’s stockholders on May 21, 2015 (and which amended and restated the Company’s 2010 Equity Compensation Plan, directors, officers and employees of the Company and any of its subsidiaries and other persons expected to provide significant services for the Company and any of its subsidiaries are eligible to receive grants of stock options (“Options”), restricted stock, RSUs, dividend equivalent rights and other stock-based awards under the Equity Plan.

 Subject to certain exceptions, stock-based awards relating to a maximum of 12.0 million shares of common stock may be granted under the Equity Plan; forfeitures and/or awards that expire unexercised do not count towards this limit.  At December 31, 2015, approximately 9.4 million shares of common stock remained available for grant in connection with stock-based awards under the Equity Plan.  A participant may generally not receive stock-based awards in excess of 1,500,000 shares of common stock in any one year and no award may be granted to any person who, assuming exercise of all Options and payment of all awards held by such person, would own or be deemed to own more than 9.8% of the outstanding shares of the Company’s common stock.  Unless previously terminated by the Board, awards may be granted under the Equity Plan until May 20, 2025.

Dividend Equivalents

A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock. Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Equity Plan, and they are paid in cash or other consideration at such times and in accordance with such rules, as the Compensation Committee of the Board (the “Compensation Committee”) shall determine in its discretion. Payments made on the Company’s outstanding dividend equivalent rights that have been granted as a separate instrument are charged to Stockholders’ Equity when common stock dividends are declared to the extent that such equivalents are expected to vest.  The Company made payments in respect of such separate instruments of approximately $16,000, $69,000 and $412,000 during the years ended December 31, 2015, 2014 and 2013, respectively.  The dividend equivalent payments made in respect of such separate instruments for the year ended December 31, 2013, reflect special cash dividends paid of $0.78 per share, or approximately $194,000. At December 31, 2015, there were 8,215 dividend equivalent rights outstanding, which had been awarded separately from, but in connection with, grants of RSUs made in prior years. A 0% forfeiture rate was assumed with respect to such dividend equivalent rights outstanding at December 31, 2015.  At December 31, 2015, the Company had unrecognized compensation expense of approximately $44,000 related to such dividend equivalent rights, which are scheduled to elapse over a weighted average period of 6 months.

The following table presents information about the Company’s dividend equivalents rights awarded as separate instruments at and for each of the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
	2015		2014		2013
	Number of Dividend Equivalent Rights
Outstanding at beginning of year:	24,402		218,225		266,075
Granted	—		—		—
Cancelled, forfeited or expired	(16,187	)	(193,823	)	(47,850	)
Outstanding at end of year	8,215		24,402		218,225

The weighted average grant date fair value of the dividend equivalent rights in the above table is $2.77. The determination of the weighted average grant date fair value of these awards required the Company to estimate certain valuation inputs.  In determining the fair value for these awards granted in 2011, the Company applied:  (i) a weighted average volatility estimate of approximately 31%, which was determined considering historic volatility in the price of Company’s common stock over the six-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 2.23% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 13%.

Options

Pursuant to Section 422(b) of the Code, in order for Options granted under the Equity Plan and vesting in any one calendar year to qualify as an incentive stock option (“ISO”) for tax purposes, the market value of the common stock to be received upon exercise of such Options as determined on the date of grant shall not exceed $100,000 during such calendar year.  The exercise price of an ISO may not be lower than 100% (or 110% in the case of an ISO granted to a 10% stockholder) of the fair market value of the Company’s common stock on the date of grant.  The exercise price for any other type of Option issued under the Equity Plan may not be less than the fair market value on the date of grant.  Each Option is exercisable after the period or periods specified in the award agreement, which will generally not exceed ten years from the date of grant.

At December 31, 2015, the Company had no Options outstanding.  The following table presents information about the Company’s Options at and for each of the years ended December 31, 2014 and 2013:

	For the Year Ended December 31,
	2014				2013
	Number of Options		Weighted Average Exercise Price		Number of Options		Weighted Average Exercise Price
Outstanding at beginning of year:	5,000		$	8.40	427,000		$	10.14
Granted	—		—		—		—
Cancelled, forfeited or expired	(5,000	)	8.40		(402,000	)	10.25
Exercised (1)	—		—		(20,000	)	8.40
Outstanding at end of year	—		$	—	5,000		$	8.40
Options exercisable at end of year	—		$	—	5,000		$	8.40

(1) For the year ended December 31, 2013, the intrinsic value of Options exercised was approximately $19,000.

Restricted Stock

At December 31, 2015 and December 31, 2014, the Company had unrecognized compensation expense of approximately $807,000 and $1.8 million, respectively, related to the unvested shares of restricted common stock.  The Company had accrued dividends payable of approximately $193,000 and $312,000 on unvested shares of restricted stock at December 31, 2015 and December 31, 2014, respectively. The total fair value of restricted shares vested during the years ended December 31, 2015, 2014 and 2013 was approximately $4.3 million, $5.7 million and $2.1 million, respectively.  The unrecognized compensation expense at December 31, 2015 is expected to be recognized over a weighted average period of 1.5 years.

The following table presents information with respect to the Company’s restricted stock for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
	2015				2014				2013
	Shares of Restricted Stock		Weighted Average Grant Date Fair Value (1)		Shares of Restricted Stock		Weighted Average Grant Date Fair Value (1)		Shares of Restricted Stock		Weighted Average Grant Date Fair Value (1)
Outstanding at beginning of year:	243,948		$	7.48	443,967		$	7.50	483,442		$	7.74
Granted	497,007		6.83		491,797		8.29		231,531		7.33
Vested (2)	(629,212	)	6.98		(690,397	)	8.07		(270,456	)	7.77
Cancelled/forfeited	(823	)	7.74		(1,419	)	7.58		(550	)	7.72
Outstanding at end of year	110,920		$	7.41	243,948		$	7.48	443,967		$	7.50

(1) The grant date fair value of restricted stock awards is based on the closing market price of the Company’s common stock at the grant date.

(2) All restrictions associated with restricted stock are removed on vesting.

Restricted Stock Units

Under the terms of the Equity Plan, RSUs are instruments that provide the holder with the right to receive, subject to the satisfaction of conditions set by the Compensation Committee at the time of grant, a payment of a specified value, which may be a share of the Company’s common stock, the fair market value of a share of the Company’s common stock, or such fair market value to the extent in excess of an established base value, on the applicable settlement date.  Although the Equity Plan permits the Company to issue RSUs that can settle in cash, all of the Company’s outstanding RSUs as of December 31, 2015 are designated to be settled in shares of the Company’s common stock.  All RSUs outstanding at December 31, 2015 may be entitled to receive dividend equivalent payments depending on the terms and conditions of the award either in cash at the time dividends are paid by the Company, or for certain performance-based RSU awards, as a grant of stock at the time such awards are settled. At December 31, 2015 and December 31, 2014, the Company had unrecognized compensation expense of $4.0 million and $2.7 million, respectively, related to RSUs.   The unrecognized compensation expense at December 31, 2015 is expected to be recognized over a weighted average period of 1.7 years.  A 0% forfeiture rate was assumed with respect to unvested RSUs at December 31, 2015.

The following table presents information with respect to the Company’s RSUs during the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31, 2015
	RSUs With Service Condition		Weighted Average Grant Date Fair Value		RSUs With Market and Service Conditions		Weighted Average Grant Date Fair Value		Total RSUs		Total  Weighted Average  Grant Date  Fair Value
Outstanding at beginning of year:	769,174		$	7.55	449,300		$	5.61	1,218,474		$	6.84
Granted (1)	390,804		7.96		291,250		5.73		682,054		7.01
Settled	(17,298	)	6.60		—		—		(17,298	)	6.60
Cancelled/forfeited	(3,750	)	7.97		(3,750	)	5.73		(7,500	)	6.85
Outstanding at end of year	1,138,930		$	7.71	736,800		$	5.66	1,875,730		$	6.90
RSUs vested but not settled at end of year	554,023		$	7.83	175,500		$	5.21	729,523		$	7.20
RSUs unvested at end of year	584,907		$	7.59	561,300		$	5.80	1,146,207		$	6.71

	For the Year Ended December 31, 2014
	RSUs With Service Condition		Weighted Average Grant Date Fair Value		RSUs With Market and Service Conditions		Weighted Average Grant Date Fair Value		Total RSUs		Total  Weighted Average  Grant Date  Fair Value
Outstanding at beginning of year:	490,099		$	7.75	287,719		$	4.32	777,818		$	6.48
Granted (2)	357,015		7.22		273,800		5.87		630,815		6.64
Settled	(72,873	)	7.28		(14,465	)	4.71		(87,338	)	6.86
Cancelled/forfeited	(5,067	)	7.36		(97,754	)	2.67		(102,821	)	2.90
Outstanding at end of year	769,174		$	7.55	449,300		$	5.61	1,218,474		$	6.84
RSUs vested but not settled at end of year	467,638		$	7.81	175,500		$	5.21	643,138		$	7.10
RSUs unvested at end of year	301,536		$	7.15	273,800		$	5.87	575,336		$	6.54

	For the Year Ended December 31, 2013
	RSUs With Service Condition		Weighted Average Grant Date Fair Value		RSUs With Market and Service Conditions		Weighted Average Grant Date Fair Value		Total RSUs		Total  Weighted Average  Grant Date  Fair Value
Outstanding at beginning of year:	448,141		$	7.61	279,507		$	4.55	727,648		$	6.43
Granted (3)	64,483		8.23		48,341		2.59		112,824		5.82
Settled	(21,025	)	6.20		(32,066	)	2.80		(53,091	)	4.15
Cancelled/forfeited	(1,500	)	7.77		(8,063	)	7.89		(9,563	)	7.88
Outstanding at end of year	490,099		$	7.75	287,719		$	4.32	777,818		$	6.48
RSUs vested but not settled at end of year	84,199		$	8.50	14,625		$	4.69	98,824		$	7.93
RSUs unvested at end of year	405,900		$	7.60	273,094		$	4.30	678,994		$	6.27

(1) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs.  In determining the fair value for 582,500 of these awards granted in 2015, the Company applied:  (i) a weighted average volatility estimate of approximately 18%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.90% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 9%.  The weighted average grant date fair value for the remaining 99,554 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date ranging from $7.93 to $7.97. There are no post vesting conditions on these awards.

(2) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs.  In determining the fair value for 547,600 of these awards granted in 2014, the Company applied:  (i) a weighted average volatility estimate of approximately 22%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.73% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 8%.  The weighted average grant date fair value for the remaining 83,215 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date ranging from $7.19 to $8.16. There are no post vesting conditions on these awards.

(3) The determination of the weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs.  In determining the fair value for awards granted in 2013, the Company applied:  (i) a weighted average volatility estimate of approximately 23%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.65% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 13%.  There are no post vesting conditions on these awards.

Expense Recognized for Equity-Based Compensation Instruments

The following table presents the Company’s expenses related to its equity-based compensation instruments for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015		2014		2013
Restricted shares of common stock	$	4,373	$	5,553	$	2,150
RSUs (1)	3,377		2,886		1,813
Dividend equivalent rights	82		146		195
Total	$	7,832	$	8,585	$	4,158

(1) RSU expense for the year ended December 31, 2014 includes approximately $500,000 for a one-time grant to the Company’s chief executive officer.

(b)  Employment Agreements

At December 31, 2015, the Company had employment agreements with four of its officers, with varying terms that provide for, among other things, base salary, bonus and change-in-control payments upon the occurrence of certain triggering events.

(c)  Deferred Compensation Plans

The Company administers deferred compensation plans for its senior officers and non-employee directors (collectively, the “Deferred Plans”), pursuant to which participants may elect to defer up to 100% of certain cash compensation.  The Deferred Plans are designed to align participants’ interests with those of the Company’s stockholders.

Amounts deferred under the Deferred Plans are considered to be converted into “stock units” of the Company.  Stock units do not represent stock of the Company, but rather are a liability of the Company that changes in value as would equivalent shares of the Company’s common stock.  Deferred compensation liabilities are settled in cash at the termination of the deferral period, based on the value of the stock units at that time.  The Deferred Plans are non-qualified plans under the Employee Retirement Income Security Act of 1974 and, as such, are not funded.  Prior to the time that the deferred accounts are settled, participants are unsecured creditors of the Company.

The Company’s liability for stock units in the Deferred Plans is based on the market price of the Company’s common stock at the measurement date.  The following table presents the Company’s expenses related to its Deferred Plans for its non-employee directors and senior officers for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014		2013
Non-employee directors	$	(59	)	$	69	$	17
Total	$	(59	)	$	69	$	17

The Company distributed cash of $109,000, $119,000 and $12,000 to the participants of the Deferred Plans during the years ended December 31, 2015, 2014 and 2013, respectively.  The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through December 31, 2015 and 2014 that had not been distributed and the Company’s associated liability for such deferrals at December 31, 2015 and 2014:

	December 31, 2015				December 31, 2014
(In Thousands)	Undistributed Income Deferred (1)		Liability Under Deferred Plans		Undistributed Income Deferred (1)		Liability Under Deferred Plans
Non-employee directors	$	601	$	614	$	324	$	446
Total	$	601	$	614	$	324	$	446

(1)  Represents the cumulative amounts that were deferred by participants through December 31, 2015 and 2014, which had not been distributed through such respective date.

(d)  Savings Plan

The Company sponsors a tax-qualified employee savings plan (the “Savings Plan”) in accordance with Section 401(k) of the Code.  Subject to certain restrictions, all of the Company’s employees are eligible to make tax deferred contributions to the Savings Plan subject to limitations under applicable law.  Participant’s accounts are self-directed and the Company bears the costs of administering the Savings Plan.  The Company matches 100% of the first 3% of eligible compensation deferred by employees and 50% of the next 2%, subject to a maximum as provided by the Code.  The Company has elected to operate the Savings Plan under the applicable safe harbor provisions of the Code, whereby among other things, the Company must make contributions for all participating employees and all matches contributed by the Company immediately vest 100%.  For the years ended December 31, 2015, 2014 and 2013, the Company recognized expenses for matching contributions of $309,000, $237,000 and $250,000, respectively.

XML

Fair Value of Financial Instruments

12 Months Ended

Dec. 31, 2015

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.  The three levels of valuation hierarchy are defined as follows:

Level 1 — Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2 — Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level 3 — Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The following describes the valuation methodologies used for the Company’s financial instruments measured at fair value on a recurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy.

Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral

The fair value of U.S. Treasury securities obtained as collateral and the associated obligation to return securities obtained as collateral are based upon prices obtained from a third-party pricing service, which are indicative of market activity.  Securities obtained as collateral are classified as Level 1 in the fair value hierarchy.

MBS and CRT securities

The Company determines the fair value of its Agency MBS, based upon prices obtained from third-party pricing services, which are indicative of market activity and repurchase agreement counterparties.

For Agency MBS, the valuation methodology of the Company’s third-party pricing services incorporate commonly used market pricing methods, trading activity observed in the marketplace and other data inputs.  The methodology also considers the underlying characteristics of each security, which are also observable inputs, including: collateral vintage, coupon, maturity date, loan age, reset date, collateral type, periodic and life cap, geography, and prepayment speeds.  Management analyzes pricing data received from third-party pricing services and compares it to other indications of fair value including data received from repurchase agreement counterparties and its own observations of trading activity observed in the marketplace.

In determining the fair value of its Non-Agency MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants.  In valuing Non-Agency MBS, the Company understands that pricing services use observable inputs that include, in addition to trading activity observed in the marketplace, loan delinquency data, credit enhancement levels and vintage, which are taken into account to assign pricing factors such as spread and prepayment assumptions.  For tranches of Legacy Non-Agency MBS that are cross-collateralized, performance of all collateral groups involved in the tranche are considered.  The Company collects and considers current market intelligence on all major markets, including benchmark security evaluations and bid-lists from various sources, when available.

The Company’s MBS and CRT securities are valued using various market data points as described above, which management considers directly or indirectly observable parameters.  Accordingly, the Company’s MBS and CRT securities are classified as Level 2 in the fair value hierarchy.

Residential Whole Loans, at Fair Value

The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans trading activity observed in the market place. The Company’s residential whole loans held at fair value are classified as Level 3 in the fair value hierarchy.

Swaps

The Company determines the fair value of non-centrally cleared Swaps considering valuations obtained from a third-party pricing service. For Swaps that are cleared by a central clearing house valuations provided by the clearing house are used. All valuations obtained are tested with internally developed models that apply readily observable market parameters.  The Company considers the creditworthiness of both the Company and its counterparties, along with collateral provisions contained in each derivative agreement, from the perspective of both the Company and its counterparties.  All of the Company’s Swaps are subject either to bilateral collateral arrangements, or for cleared Swaps, to the clearing house’s margin requirements.  Consequently, no credit valuation adjustment was made in determining the fair value of such instruments.  Swaps are classified as Level 2 in the fair value hierarchy.

The following table presents the Company’s financial instruments carried at fair value on a recurring basis as of December 31, 2015 and 2014, on the consolidated balance sheets by the valuation hierarchy, as previously described:

Fair Value at December 31, 2015

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Agency MBS	$	—	$	4,752,244	$	—	$	4,752,244
Non-Agency MBS, including MBS transferred to consolidated VIEs	—		6,420,817		—		6,420,817
CRT securities	—		183,582		—		183,582
Securities obtained and pledged as collateral	507,443		—		—		507,443
Residential whole loans, at fair value	—		—		623,276		623,276
Swaps	—		1,127		—		1,127
Total assets carried at fair value	$	507,443	$	11,357,770	$	623,276	$	12,488,489
Liabilities:
Swaps	$	—	$	70,526	$	—	$	70,526
Obligation to return securities obtained as collateral	507,443		—		—		507,443
Total liabilities carried at fair value	$	507,443	$	70,526	$	—	$	577,969

Fair Value at December 31, 2014

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Agency MBS	$	—	$	5,904,207	$	—	$	5,904,207
Non-Agency MBS, including MBS transferred to consolidated VIEs	—		4,755,432		—		4,755,432
CRT securities	—		102,983		—		102,983
Securities obtained and pledged as collateral	512,105		—		—		512,105
Residential whole loans, at fair value	—		—		143,472		143,472
Linked Transactions	—		398,336		—		398,336
Swaps	—		3,136		—		3,136
Total assets carried at fair value	$	512,105	$	11,164,094	$	143,472	$	11,819,671
Liabilities:
Swaps	$	—	$	62,198	$	—	$	62,198
Obligation to return securities obtained as collateral	512,105		—		—		512,105
Total liabilities carried at fair value	$	512,105	$	62,198	$	—	$	574,303

The following table presents additional information for the years ended December 31, 2015 and 2014 about the Company’s Residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis.

Changes in Level 3 Assets Measured at Fair Value on a Recurring Basis

	Residential Whole Loans, at Fair Value
	For the Year Ended December 31,
(In Thousands)	2015			2014
Balance at beginning of period	$	143,472		$	—
Purchases and capitalized advances	534,574			147,471
Changes in fair value recorded in Net gain on residential whole loans held at fair value	6,539			(388		)
Collection of principal, net of liquidation gains/losses	(34,767		)	(1,038		)
Transfer to REO	(26,542		)	(2,573		)
Balance at end of period	$	623,276		$	143,472

The Company did not transfer any assets or liabilities from one level to another during the years ended December 31, 2015 and 2014.

The following table presents a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of December 31, 2015 and 2014:

Fair Value Methodology for Level 3 Financial Instruments

	December 31, 2015
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Range	Weighted Average
Residential whole loans, at fair value	$	113,166	Discounted cash flow	Discount rate	6.00-8.70%	7.00		%
				Prepayment rate	0.25-11.10%	6.59		%
				Default rate	0.00-9.10%	3.10		%
				Loss severity	10.00-79.40%	17.03		%
	$	392,557	Liquidation model	Discount rate	6.75-10.02%	6.85		%
				Annual change in home prices	(5.51)-6.08%	1.28		%
				Liquidation timeline (in years)	0.67-4.42	1.56
				Current value of underlying properties	$14-$3,500		$626
Total	$	505,723

(1) Excludes approximately $117.6 million of loans for which management considers the purchase price continues to reflect the fair value of such loans at December 31, 2015.

	December 31, 2014
(Dollars in Thousands)	Fair Value		Valuation Technique	Unobservable Input	Range	Weighted Average
Residential whole loans, at fair value	$	36,101	Discounted cash flow	Discount rate	6.00-8.00%	7.52		%
				Prepayment rate	0.25-8.20%	4.79		%
				Default rate	0.00-20.30%	7.01		%
				Loss severity	10.00-61.69%	18.88		%
	$	107,371	Liquidation model	Discount rate	7.00-7.00%	7.00		%
				Annual change in home prices	(4.73)-3.56%	0.26		%
				Liquidation timeline (in years)	0.83-4.42	1.94
				Current value of underlying properties	$29-$4,000		$397
Total	$	143,472

The following table presents the difference between the fair value and the aggregate unpaid principal balance of the Company’s residential whole loans for which the fair value option was elected at December 31, 2015 and 2014:

	December 31, 2015							December 31, 2014
(In Thousands)	Fair Value		Unpaid Principal Balance		Difference			Fair Value		Unpaid Principal Balance		Difference
Residential whole loans, at fair value
Total loans	$	623,276	$	786,330	$	(163,054	)	$	143,472	$	182,613	$	(39,141	)
Loans 90 days or more past due	$	493,640	$	637,459	$	(143,819	)	$	128,591	$	165,358	$	(36,767	)

Changes to the valuation methodologies used with respect to the Company’s financial instruments are reviewed by management to ensure any such changes result in appropriate exit price valuations.  The Company will refine its valuation methodologies as markets and products develop and pricing methodologies evolve.  The methods described above may produce fair value estimates that may not be indicative of net realizable value or reflective of future fair values.  Furthermore, while the Company believes its valuation methods are appropriate and consistent with those used by market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.  The Company uses inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced.  The Company reviews the classification of its financial instruments within the fair value hierarchy on a quarterly basis, and management may conclude that its financial instruments should be reclassified to a different level in the future.

The following table presents the carrying values and estimated fair values of the Company’s financial instruments at December 31, 2015 and 2014:

	December 31, 2015				December 31, 2014
(In Thousands)	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
Financial Assets:
Agency MBS	$	4,752,244	$	4,752,244	$	5,904,207	$	5,904,207
Non-Agency MBS, including MBS transferred to consolidated VIEs	6,420,817		6,420,817		4,755,432		4,755,432
CRT securities	183,582		183,582		102,983		102,983
Securities obtained and pledged as collateral	507,443		507,443		512,105		512,105
Residential whole loans, at carrying value	271,845		289,696		207,923		217,386
Residential whole loans, at fair value	623,276		623,276		143,472		143,472
Cash and cash equivalents	165,007		165,007		182,437		182,437
Restricted cash	71,538		71,538		67,255		67,255
Linked Transactions	—		—		398,336		398,336
Swaps	1,127		1,127		3,136		3,136
Financial Liabilities:
Repurchase agreements	7,888,902		7,828,115		8,267,388		8,266,699
FHLB advances	1,500,000		1,500,000		—		—
Securitized debt	22,057		22,057		110,574		110,791
Obligation to return securities obtained as collateral	507,443		507,443		512,105		512,105
Senior Notes	100,000		99,391		100,000		103,031
Swaps	70,526		70,526		62,198		62,198

In addition to the methodologies used to determine the fair value of the Company’s financial assets and liabilities reported at fair value on a recurring basis, as previously described, the following methods and assumptions were used by the Company in arriving at the fair value of the Company’s other financial instruments presented in the above table:

Residential Whole Loans at Carrying Value:  The Company determines the fair value of its residential whole loans held at carrying value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. The Company’s residential whole loans held at carrying value are classified as Level 3 in the fair value hierarchy.

Cash and Cash Equivalents and Restricted Cash:  Cash and cash equivalents and restricted cash are comprised of cash held in overnight money market investments and demand deposit accounts.  At December 31, 2015 and 2014, the Company’s money market funds were invested in securities issued by the U.S. Government, or its agencies, instrumentalities, and sponsored entities, and repurchase agreements involving the securities described above.  Given the overnight term and assessed credit risk, the Company’s investments in money market funds are determined to have a fair value equal to their carrying value.

Linked Transactions: As previously discussed, new accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting, and as a result, the Company did not have any Linked Transactions at December 31, 2015. The Non-Agency MBS that prior to January 1, 2015 were accounted for as a component of Linked Transactions were valued using similar techniques to those used for the Company’s other Non-Agency MBS.  The value of the underlying MBS was then netted against the carrying amount (which approximates fair value) of the repurchase agreement borrowing at the valuation date.  The fair value of Linked Transactions also included accrued interest receivable on the MBS and accrued interest payable on the underlying repurchase agreement borrowings.  The Company’s Linked Transactions were classified as Level 2 in the fair value hierarchy at December 31, 2014.

Repurchase Agreements:  The fair value of repurchase agreements reflects the present value of the contractual cash flows discounted at market interest rates at the valuation date for repurchase agreements with a term equivalent to the remaining term to interest rate repricing, which may be at maturity.  Such interest rates are estimated based on LIBOR rates observed in the market.  The Company’s repurchase agreements are classified as Level 2 in the fair value hierarchy.

FHLB Advances: FHLB advances reflect collateralized borrowings at variable market interest rates that reset on a monthly basis. Accordingly, the carrying amount of FHLB advances are considered to approximate fair value. The Company’s FHLB advances are classified as Level 2 in the fair value hierarchy.

Securitized Debt: In determining the fair value of securitized debt, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants. Accordingly, the Company’s securitized debt is classified as Level 2 in the fair value hierarchy.

Senior Notes:  The fair value of the Senior Notes is determined using the end of day market price quoted on the NYSE at the reporting date.  The Company’s Senior Notes are classified as Level 1 in the fair value hierarchy.

XML

Use of Special Purpose Entities and Variable Interest Entities

12 Months Ended

Dec. 31, 2015

Use of Special Purpose Entities and Variable Interest Entities

Use of Special Purpose Entities and Variable Interest Entities

Use of Special Purpose Entities and Variable Interest Entities

A Special Purpose Entity (“SPE”) is an entity designed to fulfill a specific limited need of the company that organized it.  SPEs are often used to facilitate transactions that involve securitizing financial assets or resecuritizing previously securitized financial assets.  The objective of such transactions may include obtaining non-recourse financing, obtaining liquidity or refinancing the underlying securitized financial assets on improved terms.  Securitization involves transferring assets to a SPE to convert all or a portion of those assets into cash before they would have been realized in the normal course of business, through the SPE’s issuance of debt or equity instruments.  Investors in an SPE usually have recourse only to the assets in the SPE and, depending on the overall structure of the transaction, may benefit from various forms of credit enhancement such as over-collateralization in the form of excess assets in the SPE, priority with respect to receipt of cash flows relative to holders of other debt or equity instruments issued by the SPE, or a line of credit or other form of liquidity agreement that is designed with the objective of ensuring that investors receive principal and/or interest cash flow on the investment in accordance with the terms of their investment agreement.

Resecuritization transactions

The Company has entered into several resecuritization transactions that resulted in the Company consolidating as VIEs the SPEs that were created to facilitate the transactions and to which the underlying assets in connection with the resecuritizations were transferred. See Note 2(r) for a discussion of the accounting policies applied to the consolidation of VIEs and transfers of financial assets in connection with resecuritization transactions.

The following table summarizes the key details of the resecuritization transactions in which the Company participated as of December 31, 2015:

(Dollars in Thousands)	February 2012			October 2010
Name of Trust (Consolidated as a VIE)	WFMLT Series 2012-RR1			DMSI 2010-RS2
Principal value of Non-Agency MBS sold	$	433,347		$	985,228
Face amount of Bonds issued by the VIE and purchased by 3rd party investors (1)	$	186,691		$	373,577
Outstanding amount of Senior Bonds at December 31, 2015 (1)	$	22,057		$	—
Pass-through rate for Senior Bonds issued	2.85		%	—		%
Face amount of Senior Support Certificates received by the Company (2)	$	217,103		$	455,063
Cash received	$	186,691		$	375,621
Notional amount acquired of non-rated, interest only senior certificates (1)	$	186,691		$	—
Unamortized deferred costs	$	190		$	—

(1) Amount disclosed reflects principal balances of the DMSI 2010-RS A1, A2 and A3 bonds. The DMSI 2010-RS2 A2 and A3 bonds were sold to third party investors during 2013. The principal balance of the DMSI 2010-RS2 A1 Bond and associated interest only Senior certificate was paid off during 2013. The principal balances of the DMSI 2010-RS2 A2 and A3 Bonds were paid off in January 2015 and September 2015, respectively.

(2)  Provides credit support for the sequential Senior Non-Agency MBS sold to third-party investors in resecuritization transactions (“Senior Bonds”).

The Company engaged in these transactions primarily for the purpose of obtaining non-recourse financing on a portion of its Non-Agency MBS portfolio, as well as refinancing a portion of its Non-Agency MBS portfolio on improved terms. Notwithstanding the Company’s participation in these transactions, the risks facing the Company are largely unchanged as the Company remains economically exposed to the first loss position on the underlying MBS transferred to the VIEs.

The activities that can be performed by an entity created to facilitate a resecuritization transaction are generally specified in the entity’s formation documents. Those documents do not permit the entity, any beneficial interest holder in the entity, or any other party associated with the entity to cause the entity to sell or replace the assets held by the entity, or limit such ability to when specific events of default occur.

The Company concluded that the entities created to facilitate these resecuritization transactions are VIEs.  The Company then completed an analysis of whether each VIE created to facilitate the resecuritization transaction should be consolidated by the Company, based on consideration of its involvement in each VIE, including the design and purpose of the SPE, and whether its involvement reflected a controlling financial interest that resulted in the Company being deemed the primary beneficiary of each VIE.  In determining whether the Company would be considered the primary beneficiary, the following factors were assessed:

• Whether the Company has both the power to direct the activities that most significantly impact the economic performance of the VIE;  and

• Whether the Company has a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.

Based on its evaluation of the factors discussed above, including its involvement in the purpose and design of the entity, the Company determined that it was required to consolidate each VIE created to facilitate these resecuritization transactions.

As of December 31, 2015 and 2014, the aggregate fair value of the Non-Agency MBS that were resecuritized as described above was $598.3 million and $1.397 billion, respectively.  These assets are included in the Company’s consolidated balance sheets and disclosed as “Non-Agency MBS transferred to consolidated VIEs, at fair value”.  As of December 31, 2015 and 2014, the aggregate outstanding balance of Senior Bonds issued by consolidated VIEs was $22.1 million and $110.6 million, respectively.  These Senior Bonds are included in the Company’s consolidated balance sheets and disclosed as “Securitized debt.”  The holders of the Senior Bonds have no recourse to the general credit of the Company, but the Company does have the obligation, under certain circumstances to repurchase assets from the VIE upon the breach of certain representations and warranties in relation to the Non-Agency MBS sold to the VIE.  In the absence of such a breach, the Company has no obligation to provide any other explicit or implicit support to any VIE.

Subsequent to the repayment of the outstanding balance of Senior Bonds issued by the CSMC Series 2011-1R Trust (the “Trust”), this resecuritization financing structure was terminated during 2015. The termination was effected through an exchange of the remaining beneficial interests previously issued by the Trust and held by the Company for the underlying securities that had previously been transferred to and held by the Trust at the date of termination. Following the exchange, the beneficial interests were cancelled by the trustee and the Trust was terminated. The exchange and termination of this financing structure did not result in any gain or loss to the Company. As a result of the termination, the underlying securities originally transferred as part of this resecuritization are reported as Non-Agency MBS in the Company’s consolidated balance sheets at December 31, 2015 and interest income from the underlying securities from the date of termination through December 31, 2015 is reported as Interest income from Non-Agency MBS in the Company’s consolidated statements of operations.

Prior to the completion of the Company’s first resecuritization transaction in October 2010, the Company had not transferred assets to VIEs or QSPEs and other than acquiring MBS issued by such entities, had no other involvement with VIEs or QSPEs.

Residential Whole Loans

Included on the Company’s consolidated balance sheets as of December 31, 2015 and 2014 is a total of $895.1 million and $351.4 million of residential whole loans, of which approximately $271.8 million and $207.9 million are reported at carrying value and $623.3 million and $143.5 million are reported at fair value, respectively. The inclusion of these assets arises from the Company’s 100% equity interest in certain trusts established to acquire the loans. Based on its evaluation of its 100% interest in these trusts and other factors, the Company has determined that the trusts are required to be consolidated for financial reporting purposes. During 2015 and 2014, approximately $16.0 million and $4.1 million of interest income was recognized from residential whole loans reported at carrying value, respectively, which is included in Interest Income on the Company’s consolidated statements of operations. In addition, the Company recognized net gains of approximately $17.7 million and $116,000, on residential whole loans held at fair value during 2015 and 2014, respectively, which amounts are included in Other Income, net on the Company’s consolidated statements of operations. (See Note 4)

XML

Subsequent Events

12 Months Ended

Dec. 31, 2015

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

Federal Housing Finance Agency (“FHFA”) Final Rule on FHLB Membership

In January, 2016, the FHFA released its final rule amending its regulation on FHLB membership, which, amongst other things, provided termination rules for current captive insurance members. As a result of such regulation, MFA Insurance will not be permitted new advances or renewal of existing advances and will be required to terminate its FHLB membership within one year of the rule’s effective date of February 19, 2016.

Unwind of resecuritization structure

On February 9, 2016, the Company entered into an agreement to amend the DMSI 2010-RS2 Trust Agreement in order to facilitate the unwind of a resecuritization transaction in which the Company originally participated in 2010. Concurrent with the amendment to the Trust Agreement, the Company entered into a transaction to exchange the remaining beneficial interests issued by the DMSI 2010-RS2 Trust (the “Trust”) that were held by the Company for the underlying securities that had previously been transferred to and held by the Trust. The Company expects, following completion of any final Trust distributions, the remaining beneficial interests will be cancelled and the Trust terminated.

For financial reporting purposes, the exchange transaction will not result in any gain or loss to the Company as this resecuritization was accounted for as a financing transaction. However, for purposes of determining REIT taxable income, this resecuritization transaction was originally accounted for as a sale of the underlying securities to the Trust and acquisition by the Company of beneficial interests issued by the Trust. Because the fair value of the underlying securities received exceeded the Company’s tax basis in the remaining beneficial interests at the exchange date, the unwind of this resecuritization structure will result in the Company recognizing taxable income currently estimated to be approximately $70.9 million or $0.19 per common share.

In addition, the unwind of this resecuritization transaction will result in an increase in the Company’s available sources of liquidity as immediately following the exchange transaction, estimated financing from unpledged Non-Agency MBS is increased by approximately $90 million.

XML

Summary of Quarterly Results of Operations (Unaudited)

12 Months Ended

Dec. 31, 2015

Quarterly Financial Information Disclosure [Abstract]

Summary of Quarterly Results of Operations (Unaudited)

Summary of Quarterly Results of Operations (Unaudited)

	2015 Quarter Ended
(In Thousands, Except per Share Amounts)	March 31			June 30			September 30			December 31
Interest income	$	129,943		$	123,995		$	119,706		$	118,499
Interest expense	(43,940		)	(42,849		)	(43,703		)	(46,456		)
Net interest income	86,003			81,146			76,003			72,043
Net impairment losses recognized in earnings	(407		)	(298		)	—			—
Gain on sales of MBS	6,435			7,617			11,196			9,652
Net gain on residential whole loans held at fair value	2,034			3,224			5,565			6,899
Other income/(loss)	311			(678		)	(259		)	(831		)
Operating and other expense	(12,202		)	(12,940		)	(12,995		)	(14,292		)
Net income	82,174			78,071			79,510			73,471
Preferred stock dividends	(3,750		)	(3,750		)	(3,750		)	(3,750		)
Net income available to common stock and participating securities	$	78,424		$	74,321		$	75,760		$	69,721
Earnings per Common Share - Basic and Diluted	$	0.21		$	0.20		$	0.20		$	0.19

	2014 Quarter Ended
(In Thousands, Except per Share Amounts)	March 31			June 30			September 30			December 31
Interest income	$	121,174		$	119,294		$	112,157		$	111,192
Interest expense	(40,921		)	(40,569		)	(39,358		)	(38,960		)
Net interest income	80,253			78,725			72,799			72,232
Gain on sales of MBS	3,571			7,852			13,880			12,194
Unrealized net gains and net interest income from Linked Transactions	3,251			3,776			2,559			7,506
Net gain on residential whole loans held at fair value	—			—			—			116
Other (loss)/income	(416		)	56			54			386
Operating and other expense	(10,471		)	(11,683		)	(10,410		)	(12,726		)
Net income	76,188			78,726			78,882			79,708
Preferred stock dividends	(3,750		)	(3,750		)	(3,750		)	(3,750		)
Net income available to common stock and participating securities	$	72,438		$	74,976		$	75,132		$	75,958
Earnings per Common Share - Basic and Diluted	$	0.20		$	0.20		$	0.20		$	0.20

XML

Schedule IV - Mortgage Loans on Real Estate

12 Months Ended

Dec. 31, 2015

Mortgage Loans on Real Estate [Abstract]

Schedule IV - Mortgage Loans on Real Estate

Mortgage Loans on Real Estate

December 31, 2015

Asset Type	Number	Interest Rate	Maturity Date Range	Balance Sheet Reported Amount		Principal Amount of Loans Subject to Delinquent Principal or Interest
(Dollars in Thousands)
Residential whole loans at carrying value	1,993	0.00%-14.00%	5/20/2015-11/1/2064	$	271,845	$	116,370
Residential whole loans at fair value	3,143	1.00%-14.00%	2/1/2004-12/1/2055	623,276		679,353
				$	895,121	$	795,723

The following table summarizes the changes in the carrying amounts of residential whole loans during the year ended December 31, 2015.

Reconciliation of Balance Sheet Reported Amounts of Mortgage Loans on Real Estate

	For the Year Ended December 31, 2015
(In Thousands)	Residential whole loans at carrying value			Residential whole loans at fair value
Beginning Balance	$	207,923		$	143,472
Additions during period:
Purchases and capitalized advances	82,338			534,574
Accretion of purchase discount	15,511			N/A
Deductions during period:
Collection of principal	(17,029		)	(34,767		)
Collection of interest	(14,053		)	—
Changes in fair value recorded in Gain on loans recorded at fair value	N/A			6,539
Provision for loan loss	(1,028		)	N/A
Transfer to REO	(1,817		)	(26,542		)
Ending Balance	$	271,845		$	623,276

XML

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

Basis of Presentation and Consolidation

Basis of Presentation and Consolidation

The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with U.S. generally accepted accounting principles (“GAAP”).  The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could be worse than anticipated in those estimates, which could materially impact the Company’s results of operations and its financial condition.  Management has made significant estimates in several areas, including other-than-temporary impairment (“OTTI”) on MBS (See Note 3), valuation of MBS and CRT securities (See Notes 3 and 16), income recognition and valuation of residential whole loans (See Notes 4 and 16), valuation of derivative instruments (See Notes 6 and 16) and income recognition on certain Non-Agency MBS purchased at a discount (See Note 3).  In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest (See Note 2(o)).  Actual results could differ from those estimates.

The Company has one reportable segment as we manage our business and analyze and report our results of operations on the basis of one operating segment - investing, on a leveraged basis, in residential mortgage assets.

The consolidated financial statements of the Company include the accounts of all subsidiaries; significant intercompany accounts and transactions have been eliminated. In addition, the Company consolidates the special purpose entities created to facilitate the resecuritization transactions completed in prior years and the acquisition of residential whole loans. Certain prior period amounts have been reclassified to conform to the current period presentation.

MBS (including Non-Agency MBS transferred to consolidated VIEs) and CRT Securities

MBS (including Non-Agency MBS transferred to consolidated VIEs) and CRT Securities

The Company has investments in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any U.S. Government agency or any federally chartered corporation (“Non-Agency MBS”). In addition, the Company has investments in CRT securities, that are issued by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by Fannie Mae and Freddie Mac and the principal payments received are based on the performance of loans in a reference pool of recently securitized MBS. As the loans in the underlying reference pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including if the loans in the reference pool experience delinquencies exceeding specified thresholds.

Designation

The Company generally intends to hold its MBS until maturity; however, from time to time, it may sell any of its securities as part of the overall management of its business.  As a result, all of the Company’s MBS are designated as “available-for-sale” (“AFS”) and, accordingly, are carried at their fair value with unrealized gains and losses excluded from earnings (except when an OTTI is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity.

Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method.

The Company has elected the fair value option for certain of its CRT securities as it considers this method of accounting more appropriately reflects the risk sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statement of operations.

Revenue Recognition, Premium Amortization and Discount Accretion

Interest income on securities is accrued based on the outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity.

Interest income on the Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the security’s effective interest rate which is the security’s internal rate of return (“IRR”). The IRR is determined using management’s estimate of the projected cash flows for each security, which are based on the Company’s observation of current information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the timing and amount of credit losses. On at least a quarterly basis, the Company reviews and, if appropriate, makes adjustments to its cash flow projections based on input and analysis received from external sources, internal models, and its judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Changes in cash flows from those originally projected, or from those estimated at the last evaluation, may result in a prospective change in the IRR/ interest income recognized on these securities or in the recognition of OTTIs.  (See Note 3)

Based on the projected cash flows from the Company’s Non-Agency MBS purchased at a discount to par value, a portion of the purchase discount may be designated as non-accretable purchase discount (“Credit Reserve”), which effectively mitigates the Company’s risk of loss on the mortgages collateralizing such MBS and is not expected to be accreted into interest income.  The amount designated as Credit Reserve may be adjusted over time, based on the actual performance of the security, its underlying collateral, actual and projected cash flow from such collateral, economic conditions and other factors.  If the performance of a security with a Credit Reserve is more favorable than forecasted, a portion of the amount designated as Credit Reserve may be reallocated to accretable discount and recognized into interest income over time.  Conversely, if the performance of a security with a Credit Reserve is less favorable than forecasted, the amount designated as Credit Reserve may be increased, or impairment charges and write-downs of such securities to a new cost basis could result.

Determination of Fair Value for MBS and CRT Securities

In determining the fair value of the Company’s MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity.  (See Note 16)

Impairments/OTTI

When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired.  The Company assesses its impaired securities on at least a quarterly basis and designates such impairments as either “temporary” or “other-than-temporary.”  If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize an OTTI through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date.  If the Company does not expect to sell an other-than-temporarily impaired security, only the portion of the OTTI related to credit losses is recognized through charges to earnings with the remainder recognized through AOCI on the consolidated balance sheets.  Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings.  Following the recognition of an OTTI through earnings, a new cost basis is established for the security and may not be adjusted for subsequent recoveries in fair value through earnings.  However, OTTIs recognized through charges to earnings may be accreted back to the amortized cost basis of the security on a prospective basis through interest income.  The determination as to whether an OTTI exists and, if so, the amount of credit impairment recognized in earnings is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of the future performance and cash flow projections.  As a result, the timing and amount of OTTIs constitute material estimates that may be susceptible to significant change.  (See Note 3)

Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS.  The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, Fair Isaac Corporation (“FICO”) scores at loan origination, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations, as well as reports by credit rating agencies, such as Moody’s Investors Services, Inc. (“Moody’s”), Standard & Poor’s Corporation (“S&P”), or Fitch, Inc. (collectively, “Rating Agencies”), general market assessments, and dialogue with market participants.  As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS.  In determining the OTTI related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date.  The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes.  Impairment assessment for Non-Agency MBS and CRT securities that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date.  The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR.

Balance Sheet Presentation

The Company’s MBS and CRT securities pledged as collateral against repurchase agreements, Federal Home Loan Bank advances and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically.  Purchases and sales of securities are recorded on the trade date. 

Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral

Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral

The Company has obtained securities as collateral under collateralized financing arrangements in connection with its financing strategy for Non-Agency MBS.  Securities obtained as collateral in connection with these transactions are recorded on the Company’s consolidated balance sheets as an asset along with a liability representing the obligation to return the collateral obtained, at fair value.  While beneficial ownership of securities obtained remains with the counterparty, the Company has the right to sell the collateral obtained or to pledge it as part of a subsequent collateralized financing transaction.  (See Note 2(k) for Repurchase Agreements and Reverse Repurchase Agreements)

Residential Whole Loans

Residential Whole Loans

Residential whole loans included in the Company’s consolidated balance sheets are generally comprised of pools of fixed and adjustable rate residential mortgage loans acquired through consolidated trusts in secondary market transactions at discounted purchase prices. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below under “Residential Whole Loans at Carrying Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The accounting model described below under “Residential Whole Loans at Fair Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed.

The Company’s residential whole loans pledged as collateral against repurchase agreements are included in the consolidated balance sheets with the fair value of the loans pledged disclosed parenthetically.  Purchases and sales of residential whole loans are recorded on the trade date, with amounts recorded reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing.

Residential Whole Loans at Carrying Value

Notwithstanding that the majority of these loans are considered to be performing substantially in accordance with their current contractual terms and conditions, the Company has elected to account for these loans as credit impaired as they were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of the borrowers have previously experienced payment delinquencies and the amount owed on the mortgage loan may exceed the value of the property pledged as collateral. Consequently, the Company has assessed that these loans have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to credit worthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Such loans are initially recorded at fair value with no allowance for loan losses. Subsequent to acquisition, the recorded amount reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded amount reduced by any allowance for loan losses established subsequent to acquisition.

Under the application of this accounting model the Company may aggregate into pools loans acquired in the same fiscal quarter that are assessed as having similar risk characteristics. For each pool established, or on an individual loan basis for loans not aggregated into pools, the Company estimates at acquisition and periodically on at least a quarterly basis, the principal and interest cash flows expected to be collected. The difference between the cash flows expected to be collected and the carrying amount of the loans is referred to as the “accretable yield.” This amount is accreted as interest income over the life of the loans using an effective interest rate (level yield) methodology. Interest income recorded each period reflects the amount of accretable yield recognized and not the coupon interest payments received on the underlying loans. The difference between contractually required principal and interest payments and the cash flows expected to be collected is referred to as the “non-accretable difference,” and includes estimates of both the effect of prepayments and expected credit losses over the life of the underlying loans.

A decrease in expected cash flows in subsequent periods may indicate impairment at the pool and/or individual loan level thus requiring the establishment of an allowance for loan losses by a charge to the provision for loan losses. The allowance for loan losses represents the present value of cash flows expected at acquisition, adjusted for any increases due to changes in estimated cash flows, that are subsequently no longer expected to be received at the relevant measurement date. A significant increase in expected cash flows in subsequent periods first reduces any previously recognized allowance for loan losses and then will result in a recalculation in the amount of accretable yield. The adjustment of accretable yield due to a significant increase in expected cash flows is accounted for prospectively as a change in estimate and results in reclassification from nonaccretable difference to accretable yield. (See Notes 4 and 17)

Residential Whole Loans at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Given the significant uncertainty associated with estimating the timing of and amount of cash flows associated with these loans that will be collected, and that the cash flows ultimately collected may be dependent on the value of the property securing the loan, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns from these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations.

Cash received reflecting coupon payments on residential whole loans held at fair value is not included in Interest Income, but rather is presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. (See Notes 4 and 16)

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less.  Cash and cash equivalents may also include cash pledged as collateral to the Company by its repurchase agreement and/or Swap counterparties as a result of reverse margin calls (i.e., margin calls made by the Company).  The Company did not hold any cash pledged by its counterparties at December 31, 2015 or 2014.  The Company’s investments in overnight money market funds, which are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency were $120.4 million and $182.4 million at December 31, 2015 and 2014, respectively.  (See Notes 9 and 16)

Restricted Cash

Restricted Cash

Restricted cash represents the Company’s cash held by its counterparties as collateral or otherwise in connection with the Company’s Swaps and/or repurchase agreements.  Restricted cash is not available to the Company for general corporate purposes, but may be applied against amounts due to counterparties to the Company’s repurchase agreements and/or Swaps, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the Swap or repurchase agreement.  The Company had aggregate restricted cash held as collateral or otherwise in connection with its Swaps and repurchase agreements of $71.5 million and $67.3 million at December 31, 2015 and 2014, respectively. (See Notes 6, 8, 9 and 16)

Goodwill

Goodwill

At December 31, 2015 and 2014, the Company had goodwill of $7.2 million, which represents the unamortized portion of the excess of the fair value of its common stock issued over the fair value of net assets acquired in connection with its formation in 1998.  Goodwill is tested for impairment at least annually, or more frequently under certain circumstances, at the entity level.  Through December 31, 2015, the Company had not recognized any impairment against its goodwill.

Real Estate Owned (REO)

Real Estate Owned (“REO”)

REO represents real estate acquired by the Company, including through foreclosure or deed in lieu of foreclosure, and is initially recorded at fair value less estimated selling costs. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Prepaid and other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported value of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on the Company’s consolidated statements of operations. (See Note 7)

Depreciation

Depreciation

Leasehold Improvements and Other Depreciable Assets

Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term.  Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase.

Resecuritization and Senior Notes Related Costs

Resecuritization and Senior Notes Related Costs

Resecuritization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various resecuritization transactions completed by the Company.  Senior Notes related costs are costs incurred by the Company in connection with the issuance of its Senior Notes in April, 2012.  These costs may include underwriting, rating agency, legal, accounting and other fees.  Such costs, which reflect deferred charges, are included on the Company’s consolidated balance sheets in Prepaid and other assets.  These deferred charges are amortized as an adjustment to interest expense using the effective interest method, based upon the actual repayments of the associated beneficial interests issued to third parties and over the stated legal maturity of the Senior Notes. The Company periodically reviews the recoverability of these deferred costs and in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

Repurchase Agreements and Other Advances

Repurchase Agreements and Other Advances

Repurchase Agreements

The Company finances the holdings of a significant portion of its MBS and CRT securities with repurchase agreements.  Under repurchase agreements, the Company sells securities to a lender and agrees to repurchase the same securities in the future for a price that is higher than the original sale price.  The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender.  Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements, the Company pledges its securities as collateral to secure the borrowing, which is equal in value to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral.  At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan including any accrued interest and concurrently receives back its pledged collateral from the lender.  With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms.  Margin calls, whereby a lender requires that the Company pledge additional securities or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the MBS pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions.  The Company also may make margin calls on counterparties when collateral values increase.

The Company’s repurchase financings typically have terms ranging from one month to six months at inception, but may also have longer or shorter terms.  Should a counterparty decide not to renew a repurchase financing at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation.  If, during the term of a repurchase financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable on such collateral.  (See Notes 8, 9 and 16)

In addition to the repurchase agreement financing arrangements discussed above, as part of its financing strategy for Non-Agency MBS, the Company has entered into contemporaneous repurchase and reverse repurchase agreements with a single counterparty.  Under a typical reverse repurchase agreement, the Company buys securities from a borrower for cash and agrees to sell the same securities in the future for a price that is higher than the original purchase price.  The difference between the purchase price the Company originally paid and the sale price represents interest received from the borrower.  In contrast, the contemporaneous repurchase and reverse repurchase transactions effectively resulted in the Company pledging Non-Agency MBS as collateral to the counterparty in connection with the repurchase agreement financing and obtaining U.S. Treasury securities as collateral from the same counterparty in connection with the reverse repurchase agreement.  No net cash was exchanged between the Company and counterparty at the inception of the transactions.  Securities obtained and pledged as collateral are recorded as an asset on the Company’s consolidated balance sheets.  Interest income is recorded on the reverse repurchase agreement and interest expense is recorded on the repurchase agreement on an accrual basis.  Both the Company and the counterparty have the right to make daily margin calls based on changes in the value of the collateral obtained and/or pledged.  The Company’s liability to the counterparty in connection with this financing arrangement is recorded on the Company’s consolidated balance sheets and disclosed as “Obligation to return securities obtained as collateral, at fair value.”  (See Note 2(c))

Federal Home Loan Bank (“FHLB”) Advances

Federal Home Loan Bank (“FHLB”) Advances

FHLB advances are secured financing transactions and are carried at their contractual amounts. The ability to borrow from the FHLB is subject to the Company’s continued creditworthiness, pledging of sufficient eligible collateral to secure advances, and compliance with certain agreements with the FHLB. The amount of collateral pledged to the FHLB to secure advances is subject to periodic adjustment based on changes in the fair value of the collateral. Accrued interest payable on FHLB advances is included in Accrued interest payable on the Company’s consolidated balance sheets. (See Notes 8, 9, 16 and 18)

In addition, as a condition to membership in the FHLB, the Company’s wholly-owned subsidiary, MFA Insurance, Inc. (“MFA Insurance”) is required to purchase and hold a certain amount of FHLB stock, which is based, in part, upon the outstanding principal balance of advances from the FHLB. FHLB stock is considered a non-marketable investment, is carried at cost and is subject to recoverability testing under applicable accounting standards. This stock can only be redeemed or sold at its par value, and only to the FHLB. Accordingly, when evaluating FHLB stock for impairment, the Company considers the ultimate recoverability of the par value rather than recognizing temporary declines in value. FHLB stock is included in Prepaid and other assets on the Company’s consolidated balance sheets.

Equity-Based Compensation

Equity-Based Compensation

Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date.  With respect to awards granted in 2009 and prior years, the Company applied a zero forfeiture rate for these awards, as they were granted to a limited number of employees, and historical forfeitures have been minimal.  Forfeitures, or an indication that forfeitures are expected to occur, may result in a revised forfeiture rate and would be accounted for prospectively as a change in estimate.

During 2010, the Company granted certain restricted stock units (“RSUs”) that vested after either two or four years of service and provided that certain criteria were met, which were based on a formula that included changes in the Company’s closing stock price over a two- or four-year period and dividends declared on the Company’s common stock during those periods.  From 2011 through 2013, the Company granted certain RSUs that vested annually over a one or three-year period, provided that certain criteria were met, which were based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period. During 2014 and 2015, the Company made grants of RSUs certain of which cliff vest after a three-year period and certain of which cliff vest after a three-year period, subject to the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period. The features in these awards related to the attainment of total stockholder return over a specified period constitute a “market condition” which impacts the amount of compensation expense recognized for these awards. Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which in addition to estimates regarding the amount of RSUs expected to be forfeited during the associated service period, determined the amount of compensation expense recognized.  The amount of compensation expense recognized was not dependent on whether the market condition was or will be achieved, while differences in actual forfeiture experience relative to estimated forfeitures results in adjustments to the timing and amount of compensation expense recognized.

The Company has awarded dividend equivalents that may be granted as a separate instrument or may be a right associated with the grant of another equity-based award.  Compensation expense for separately awarded dividend equivalents is based on the grant date fair value of such awards and is recognized over the vesting period.  Payments pursuant to these dividend equivalents are charged to Stockholders’ Equity.  Payments pursuant to dividend equivalents that are attached to equity-based awards are charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest.  Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards do not or are not expected to vest and grantees are not required to return payments of dividends or dividend equivalents to the Company.  (See Notes 2(m) and 15)

Earnings per Common Share ("EPS")

Earnings per Common Share (“EPS”)

Basic EPS is computed using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and other securities that participate in dividends, such as the Company’s unvested restricted stock and RSUs that have non-forfeitable rights to dividends and dividend equivalents attached to/associated with RSUs and vested stock options to arrive at total common equivalent shares.  In applying the two-class method, earnings are allocated to both shares of common stock and securities that participate in dividends based on their respective weighted-average shares outstanding for the period.  For the diluted EPS calculation, common equivalent shares are further adjusted for the effect of dilutive unexercised stock options and RSUs outstanding that are unvested and have dividends that are subject to forfeiture using the treasury stock method.  Under the treasury stock method, common equivalent shares are calculated assuming that all dilutive common stock equivalents are exercised and the proceeds, along with future compensation expenses associated with such instruments, are used to repurchase shares of the Company’s outstanding common stock at the average market price during the reported period.  (See Note 14)

Comprehensive Income/(Loss)

Comprehensive Income/(Loss)

The Company’s comprehensive income/(loss) available to common stock and participating securities includes net income, the change in net unrealized gains/(losses) on its AFS securities and derivative hedging instruments, (to the extent that such changes are not recorded in earnings), adjusted by realized net gains/(losses) reclassified out of AOCI for sold AFS securities and de-designated derivative hedging instruments and is reduced by dividends declared on the Company’s preferred stock and issuance costs of redeemed preferred stock.

U.S. Federal Income Taxes

U.S. Federal Income Taxes

The Company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code of 1986, as amended, (the “Code”) and the corresponding provisions of state law.  The Company expects to operate in a manner that will enable it to satisfy the various requirements to maintain its status as a REIT. In order to maintain its status as a REIT, the Company must, among other things, distribute at least 90% of its REIT taxable income (excluding net long-term capital gains) to stockholders in the timeframe permitted by the Code.  As long as the Company maintains its status as a REIT, the Company will not be subject to regular federal income tax to the extent that it distributes 100% of its REIT taxable income (including net long-term capital gains) to its stockholders within the permitted timeframe.  Should this not occur, the Company would be subject to federal taxes at prevailing corporate tax rates on the difference between its REIT taxable income and the amounts deemed to be distributed for that tax year.  As the Company’s objective is to distribute 100% of its REIT taxable income to its stockholders within the permitted timeframe, no provision for current or deferred income taxes has been made in the accompanying consolidated financial statements.  Should the Company incur a liability for corporate income tax, such amounts would be recorded as REIT income tax expense on the Company’s consolidated statements of operations. Furthermore, if the Company fails to distribute during each calendar year, or by the end of January following the calendar year in the case of distributions with declaration and record dates falling in the last three months of the calendar year, at least the sum of (i) 85% its REIT ordinary income for such year, (ii) 95% of its REIT capital gain income for such year, and (iii) any undistributed taxable income from prior periods, the Company would be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed. To the extent that the Company incurs interest, penalties or related excise taxes in connection with its tax obligations, including as a result of its assessment of uncertain tax positions, such amounts will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

In addition, the Company has elected to treat certain of its subsidiaries as a TRS. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of the Company’s business may be conducted through one or more TRS, its income earned by TRS may be subject to corporate income taxation. To maintain the Company’s REIT election, no more than 25% (or, for 2018 and subsequent taxable years, 20%) of the value of a REIT’s assets at the end of each calendar quarter may consist of stock or securities in TRS. For purposes of the determination of U. S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as a TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. No deferred tax benefit was recorded by the Company in 2015 or 2014, as a valuation allowance for the full amount of the associated deferred tax asset was recognized as its recovery is not considered more likely than not.

Based on its analysis of any potential uncertain tax positions, the Company concluded that it does not have any material uncertain tax positions that meet the relevant recognition or measurement criteria as of December 31, 2015, 2014 or 2013. The Company filed its 2014 tax return prior to September 15, 2015. The Company’s tax returns for tax years 2010 through 2014 are open to examination.

Derivative Financial Instruments

Derivative Financial Instruments

The Company may use a variety of derivative instruments to economically hedge a portion of its exposure to market risks, including interest rate risk and prepayment risk. The objective of the Company’s risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, the Company attempts to mitigate the risk of the cost of its variable rate liabilities increasing during a period of rising interest rates. The Company’s derivative instruments are currently comprised of Swaps, which are designated as cash flow hedges against the interest rate risk associated with certain of its borrowings. Prior to 2015, the Company’s derivative financial instruments also included Linked Transactions, which were not designated as hedging instruments. New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 6) During 2013, the Company also entered into forward contracts for the sale of Agency MBS securities on a generic pool, or to-be-announced basis (“TBA short positions”) which were not designated as hedging instruments.

Linked Transactions

Prior to 2015, it was presumed that the initial transfer of a financial asset (i.e., the purchase of an MBS by the Company) and contemporaneous repurchase financing of such security with the same counterparty were considered part of the same arrangement, or a “linked transaction,” unless certain criteria were met.  The two components of a linked transaction (security purchase and repurchase financing) were not reported separately but were evaluated on a combined basis and reported as a forward (derivative) contract and were presented as “Linked Transactions” on the Company’s consolidated balance sheets.  Changes in the fair value of the assets and liabilities underlying Linked Transactions and associated interest income and expense were reported as “Unrealized net gains/(losses) and net interest income from Linked Transactions” on the Company’s consolidated statements of operations and were not included in OCI.  However, if certain criteria were met, the initial transfer (i.e., the purchase of a security by the Company) and repurchase financing were not treated as a Linked Transaction and would have been evaluated and reported separately as an MBS purchase and MBS repurchase financing.  When or if a transaction was no longer considered to be linked, the security and repurchase financing were reported on a gross basis.  In this case, the fair value of the MBS at the time the transactions were no longer considered linked became the cost basis of the MBS, and the income recognition yield for such MBS was calculated prospectively using this new cost basis. 

New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting as described above. This resulted in changes subsequent to January 1, 2015 to the presentation of assets and liabilities, and revenues and expenses of Non-Agency MBS and associated repurchase agreements that had been accounted for as Linked Transactions prior to that date. The changes include the presentation of Non-Agency MBS and associated repurchase agreements as separate assets and liabilities, rather than on a combined basis on the Company’s consolidated balance sheets. In addition, starting in 2015, interest income related to the securities and interest expense related to the associated repurchase agreements are separately presented and included in the determination of the Company’s net interest income on its consolidated statement of operations. Further, the previous treatment of Linked Transactions as forward (derivative) instruments recorded at fair value at the end of each period, with changes in fair value included in net income, was discontinued and effective January 1, 2015 MBS that were previously accounted for as components of Linked Transactions are accounted for on a consistent basis with other MBS held by the Company as AFS securities.  (See Notes 2(t), 6 and 16)

Swaps

The Company documents its risk-management policies, including objectives and strategies, as they relate to its hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions.  The Company assesses, both at inception of a hedge and on a quarterly basis thereafter, whether or not the hedge is “highly effective.”

Swaps are carried on the Company’s consolidated balance sheets at fair value, as assets, if their fair value is positive, or as liabilities, if their fair value is negative.  Changes in the fair value of the Company’s Swaps designated in hedging transactions are recorded in OCI provided that the hedge remains effective.  Changes in fair value for any ineffective amount of a Swap are recognized in earnings.  The Company has not recognized any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness.

The Company discontinues hedge accounting on a prospective basis and recognizes changes in the fair value through earnings when:  (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate.

Although permitted under certain circumstances, the Company does not offset cash collateral receivables or payables against its net derivative positions.  (See Notes 6, 9 and 16)

TBA Short Positions

During 2013, the Company entered into TBA short positions as a means of managing interest rate risk and MBS basis risk associated with its investment and financing activities. A TBA short position is a forward contract for the sale of Agency MBS at a predetermined price, face amount, issuer, coupon and maturity on an agreed-upon future date. The specific Agency MBS that could be delivered into the contract upon the settlement date, published each month by the Securities Industry and Financial Markets Association (“SIFMA”), are not known at the time of the transaction.

TBA short positions were accounted for as derivative instruments since the Company could not assert that it was probable at inception and throughout the term of the TBA contract, that it would physically deliver the Agency security upon settlement of the contract. TBA short positions were presented as either derivative assets or liabilities, at fair value on its consolidated balance sheets. Gains and losses associated with TBA short positions were reported in Other Income, net on the Company’s consolidated statements of operations. (See Note 6)

The Company did not have any TBA short positions at December 31, 2015 and 2014.

Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities

Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities

The Company’s presentation of fair value for its financial assets and liabilities is determined within a framework that stipulates that the fair value of a financial asset or liability is an exchange price in an orderly transaction between market participants to sell the asset or transfer the liability in the market in which the reporting entity would transact for the asset or liability, that is, the principal or most advantageous market for the asset or liability.  The transaction to sell the asset or transfer the liability is a hypothetical transaction at the measurement date, considered from the perspective of a market participant that holds the asset or owes the liability.  This definition of fair value focuses on exit price and prioritizes the use of market-based inputs over entity-specific inputs when determining fair value.  In addition, the framework for measuring fair value establishes a three-level hierarchy for fair value measurements based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. 

In addition to the financial instruments that it is required to report at fair value, the Company has elected the fair value option for certain of its residential whole loans and CRT securities at time of acquisition. Subsequent changes in the fair value of these loans and CRT securities are reported in Net gain on residential whole loans held at fair value and Other Income, net respectively on the Company’s consolidated statements of operations.  A decision to elect the fair value option for an eligible financial instrument, which may be made on an instrument by instrument basis, is irrevocable. (See Notes 2(d), 4 and 16)

Variable Interest Entities

Variable Interest Entities

An entity is referred to as a VIE if it meets at least one of the following criteria:  (i) the entity has equity that is insufficient to permit the entity to finance its activities without additional subordinated financial support of other parties; or (ii) as a group, the holders of the equity investment at risk lack (a) the power to direct the activities of an entity that most significantly impact the entity’s economic performance; (b) the obligation to absorb the expected losses; or (c) the right to receive the expected residual returns; or (iii) have disproportional voting rights and the entity’s activities are conducted on behalf of the investor that has disproportionally few voting rights.

The Company consolidates a VIE when it has both the power to direct the activities that most significantly impact the economic performance of the VIE and a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.   The Company is required to reconsider its evaluation of whether to consolidate a VIE each reporting period, based upon changes in the facts and circumstances pertaining to the VIE.

The Company has entered into resecuritization transactions which result in the Company consolidating the VIEs that were created to facilitate the transactions and to which the underlying assets in connection with the resecuritizations were transferred.  In determining the accounting treatment to be applied to these resecuritization transactions, the Company concluded that the entities used to facilitate these transactions were VIEs and that they should be consolidated. If the Company had determined that consolidation was not required, it would have then assessed whether the transfer of the underlying assets would qualify as a sale or should be accounted for as secured financings under GAAP.

Prior to the completion of its initial resecuritization transaction in October 2010, the Company had not transferred assets to VIEs or Qualifying Special Purpose Entities (“QSPEs”) and other than acquiring MBS issued by such entities, had no other involvement with VIEs or QSPEs.  (See Note 17)

The Company also includes in its consolidated balance sheets certain financial assets and liabilities that are acquired/issued by trusts and /or other special purpose entities that have been evaluated as being required to be consolidated by the Company under the applicable accounting guidance.

Offering Costs Related to Issuance and Redemption of Preferred Stock

Offering Costs Related to Issuance and Redemption of Preferred Stock

Offering costs related to issuance of preferred stock are recorded as a reduction in Additional paid-in capital, a component of Stockholders’ Equity, at the time such preferred stock is issued. On redemption of preferred stock, any excess of the fair value of the consideration transferred to the holders of the preferred stock over the carrying amount of the preferred stock in the Company’s consolidated balance sheets is included in the determination of Net Income Available to Common Stock and Participating Securities in the calculation of EPS. (See Notes 13 and 14)

New Accounting Standards and Interpretations

New Accounting Standards and Interpretations

Accounting Standards Adopted in 2015

Receivables - Recognition of Residential Real Estate upon Foreclosure

In January 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-04, Reclassification of Residential Real Estate Collateralized Consumer Mortgage Loans upon Foreclosure (“ASU 2014-04”).  This ASU applies to all creditors who obtain physical possession (resulting from an in substance repossession or foreclosure) of residential real estate property collateralizing a consumer mortgage loan in satisfaction of a receivable.  The ASU clarifies that an in substance repossession or foreclosure occurs, and a creditor is considered to have received physical possession of residential real estate property collateralizing a consumer mortgage loan, upon either (i) the creditor obtaining legal title to the residential real estate property upon completion of a foreclosure or (ii) the borrower conveying all interest in the residential real estate property to the creditor to satisfy that loan through completion of a deed in lieu of foreclosure or through a similar legal agreement. Additionally, the amendments require interim and annual disclosure of both (i) the amount of foreclosed residential real estate property held by the creditor and (ii) the recorded investment in consumer mortgage loans collateralized by residential real estate property that are in the process of foreclosure according to local requirements of the applicable jurisdiction.

ASU 2014-04 was effective for the Company for reporting periods beginning after December 15, 2014.  The Company has elected to adopt the amendments in this ASU using a prospective transition method.  The Company’s adoption of ASU 2014-04 beginning on January 1, 2015, did not have a material impact on the Company’s consolidated financial statements.

Transfers and Servicing

In June 2014, the FASB issued ASU 2014-11, Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures (“ASU 2014-11”). The amendments of ASU 2014-11 require two accounting changes. First, the amendments in this ASU change the accounting for repurchase-to-maturity transactions to secured borrowing accounting. Second, for repurchase financing arrangements, the amendments require separate accounting for a transfer of a financial asset executed contemporaneously with a repurchase agreement with the same counterparty, which will result in secured borrowing accounting for the repurchase agreement. In addition, the amendments in ASU 2014-11 require disclosures for certain transactions comprising (i) a transfer of a financial asset accounted for as a sale and (ii) an agreement with the same transferee entered into in contemplation of the initial transfer that results in the transferor retaining substantially all of the exposure to the economic return on the transferred asset throughout the term of the transaction. ASU 2014-11 also requires disclosures for repurchase agreements, securities lending transactions, and repurchase-to-maturity transactions that are accounted for as secured borrowings.

ASU 2014-11 was effective for the Company for reporting periods beginning after December 15, 2014. An entity is required to present changes in accounting for transactions outstanding on the effective date as a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. Accordingly, on adoption of the new standard on January 1, 2015, the Company reclassified $1.913 billion of Non-Agency MBS and $4.6 million of CRT securities, that were previously reported on the Company’s consolidated balance sheets as a component of Linked Transactions to Non-Agency MBS and CRT securities, respectively. In addition, liabilities of $1.520 billion that were previously presented on the Company’s consolidated balance sheets as a component of Linked Transactions were reclassified to Repurchase agreements. Furthermore, an amount of $4.5 million representing net unrealized gains on securities previously reported as a component of Linked Transactions as of December 31, 2014 was reclassified from Accumulated deficit to AOCI. These reclassification adjustments had no net impact on the Company’s overall Total Stockholders’ Equity. While the Company’s adoption of this new standard beginning on January 1, 2015, did not have a material impact on the Company’s consolidated financial statements, it did result in changes, subsequent to adoption, to the presentation of assets and liabilities and revenues and expenses of Non-Agency MBS and CRT securities and associated repurchase agreements that had been accounted for as MBS Linked Transactions prior to that date. These changes include the presentation, as noted above, of Non-Agency MBS and CRT securities and associated repurchase agreements as separate assets and liabilities, rather than on a combined basis. In addition, subsequent to the date of adoption the interest income related to the securities and the interest expense related to the associated repurchase agreements are separately presented and included in the determination of the Company’s Net Interest Income. Further, the prior accounting requirement for MBS Linked Transactions, which involved treating the combined transaction as a derivative that was recorded at fair value each period, with changes in fair value included in net income, was discontinued and effective January 1, 2015. MBS that were previously accounted for as components of Linked Transactions are accounted for in a manner consistent with other MBS held by the Company as AFS securities.

XML

MBS and CRT Securities (Tables)

12 Months Ended

Dec. 31, 2015

Investments, Debt and Equity Securities [Abstract]

Schedule of information about MBS and CRT Securities

The following tables present certain information about the Company’s MBS and CRT securities at December 31, 2015 and 2014:

December 31, 2015

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts			Discount Designated as Credit Reserve and  OTTI (1)			Amortized Cost (2)		Fair Value		Gross Unrealized Gains		Gross Unrealized Losses			Net Unrealized Gain/(Loss)
Agency MBS:
Fannie Mae	$	3,690,020	$	139,243	$	(59	)	$	—		$	3,829,204	$	3,865,485	$	62,111	$	(25,830	)	$	36,281
Freddie Mac	851,087		32,680		—			—			884,798		877,109		6,906		(14,595		)	(7,689		)
Ginnie Mae	9,296		164		—			—			9,460		9,650		190		—			190
Total Agency MBS	4,550,403		172,087		(59		)	—			4,723,462		4,752,244		69,207		(40,425		)	28,782
Non-Agency MBS:
Expected to Recover Par (3)(4)	2,906,878		73		(31,576		)	—			2,875,375		2,878,532		23,300		(20,143		)	3,157
Expected to Recover Less than Par (3)	4,054,615		—		(280,606		)	(787,541		)	2,986,468		3,542,285		564,031		(8,214		)	555,817
Total Non-Agency MBS (5)	6,961,493		73		(312,182		)	(787,541		)	5,861,843		6,420,817		587,331		(28,357		)	558,974
Total MBS	11,511,896		172,160		(312,241		)	(787,541		)	10,585,305		11,173,061		656,538		(68,782		)	587,756
CRT securities (6)	192,000		—		(5,689		)	—			186,311		183,582		418		(3,147		)	(2,729		)
Total MBS and CRT securities	$	11,703,896	$	172,160	$	(317,930	)	$	(787,541	)	$	10,771,616	$	11,356,643	$	656,956	$	(71,929	)	$	585,027

December 31, 2014

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts			Discount Designated as Credit Reserve and  OTTI (1)			Amortized Cost (2)		Fair Value		Gross Unrealized Gains		Gross Unrealized Losses			Net Unrealized Gain/(Loss)
Agency MBS:
Fannie Mae	$	4,587,823	$	174,245	$	(71	)	$	—		$	4,761,997	$	4,843,084	$	102,187	$	(21,100	)	$	81,087
Freddie Mac	1,011,659		38,895		—			—			1,051,096		1,049,854		11,280		(12,522		)	(1,242		)
Ginnie Mae	10,811		189		—			—			11,000		11,269		269		—			269
Total Agency MBS	5,610,293		213,329		(71		)	—			5,824,093		5,904,207		113,736		(33,622		)	80,114
Non-Agency MBS:
Expected to Recover Par (3)(4)	431,788		461		(29,501		)	—			402,748		428,431		26,735		(1,052		)	25,683
Expected to Recover Less than Par (3)	4,888,113		—		(370,063		)	(900,557		)	3,617,493		4,327,001		712,168		(2,660		)	709,508
Total Non-Agency MBS (5)	5,319,901		461		(399,564		)	(900,557		)	4,020,241		4,755,432		738,903		(3,712		)	735,191
Total MBS	10,930,194		213,790		(399,635		)	(900,557		)	9,844,334		10,659,639		852,639		(37,334		)	815,305
CRT securities	109,500		—		(4,727		)	—			104,773		102,983		324		(2,114		)	(1,790		)
Total MBS and CRT securities	$	11,039,694	$	213,790	$	(404,362	)	$	(900,557	)	$	9,949,107	$	10,762,622	$	852,963	$	(39,448	)	$	813,515

(1) Discount designated as Credit Reserve and amounts related to OTTI are generally not expected to be accreted into interest income. Amounts disclosed at December 31, 2015 reflect Credit Reserve of $766.0 million and OTTI of $21.5 million. Amounts disclosed at December 31, 2014 reflect Credit Reserve of $877.6 million and OTTI of $23.0 million.

(2) Includes principal payments receivable of $1.0 million and $542,000 at December 31, 2015 and 2014, respectively, which are not included in the Principal/Current Face.

(3) Based on management’s current estimates of future principal cash flows expected to be received.

(4) At December 31, 2015 RPL/NPL MBS had a $2.648 billion Principal/Current face, $2.645 billion amortized cost and $2.626 billion fair value. At December 31, 2014, RPL/NPL MBS had a $161.0 million Principal/Current face, $161.0 million amortized cost and $161.0 million fair value (excludes RPL/NPL MBS with $1.850 billion Principal/Current face, $1.847 billion amortized cost and $1.847 billion fair value that were presented as a component of Linked Transactions at December 31, 2014).

(5) At December 31, 2015 and 2014, the Company expected to recover approximately 89% and 83%, respectively, of the then-current face amount of Non-Agency MBS.

(6) Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $62.2 million for which the fair value option has been elected. Such securities have gross unrealized gains of approximately $332,000, gross unrealized losses of approximately $555,000 and net unrealized losses of approximately $223,000 at December 31, 2015.

Schedule of information about MBS and CRT Securities that were in an unrealized loss position

The following table presents information about the Company’s MBS and CRT securities that were in an unrealized loss position at December 31, 2015:

	Unrealized Loss Position For:
	Less than 12 Months					12 Months or more					Total
(Dollars in Thousands)	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses
Agency MBS:
Fannie Mae	$	856,602	$	7,548	121	$	813,485	$	18,282	109	$	1,670,087	$	25,830
Freddie Mac	298,768		5,463		42	315,566		9,132		64	614,334		14,595
Total Agency MBS	1,155,370		13,011		163	1,129,051		27,414		173	2,284,421		40,425
Non-Agency MBS:
Expected to Recover Par (1)	2,239,418		16,717		59	212,584		3,426		12	2,452,002		20,143
Expected to Recover Less than Par (1)	184,664		4,348		35	64,081		3,866		11	248,745		8,214
Total Non-Agency MBS	2,424,082		21,065		94	276,665		7,292		23	2,700,747		28,357
Total MBS	3,579,452		34,076		257	1,405,716		34,706		196	4,985,168		68,782
CRT securities (2)	137,585		2,672		33	4,525		475		1	142,110		3,147
Total MBS and CRT securities	$	3,717,037	$	36,748	290	$	1,410,241	$	35,181	197	$	5,127,278	$	71,929

(1) Based on management’s current estimates of future principal cash flows expected to be received.  

(2) Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $54.1 million for which the fair value option has been elected. Such securities have unrealized losses of $555,000 at December 31, 2015.

Schedule of composition of OTTI charges recorded

The following table presents the composition of OTTI charges recorded by the Company for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014		2013
Total OTTI losses	$	(525	)	$	—	$	—
OTTI reclassified from OCI	(180		)	—		—
OTTI recognized in earnings	$	(705	)	$	—	$	—

Schedule of changes in credit loss component of OTTI

The following table presents a roll-forward of the credit loss component of OTTI on the Company’s Non-Agency MBS for which a non-credit component of OTTI was previously recognized in OCI.  Changes in the credit loss component of OTTI are presented based upon whether the current period is the first time OTTI was recorded on a security or a subsequent OTTI charge was recorded.

	For the Year Ended December 31,
(In Thousands)	2015		2014		2013
Credit loss component of OTTI at beginning of period	$	36,115	$	36,115	$	36,115
Additions for credit related OTTI not previously recognized	461		—		—
Subsequent additional credit related OTTI recorded	244		—		—
Credit loss component of OTTI at end of period	$	36,820	$	36,115	$	36,115

Schedule of changes in the components of the purchase discount on Non-Agency MBS

The following table presents the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and OTTI and accretable purchase discount for the years ended December 31, 2015 and 2014:

	For the Year Ended December 31,
	2015						2014
(In Thousands)	Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)			Discount Designated as Credit Reserve and OTTI (2)			Accretable Discount (1)(2)
Balance at beginning of period	$	(900,557	)	$	(399,564	)	$	(1,043,037	)	$	(460,039	)
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	(15,543		)	1,832			—			—
Accretion of discount	—			93,173			—			103,653
Realized credit losses	80,821			—			89,481			—
Purchases	(1,200		)	(4,925		)	(80,256		)	30,003
Sales	8,525			38,420			44,692			20,360
Net impairment losses recognized in earnings	(705		)	—			—			—
Unlinking of Linked Transactions	—			—			(6,414		)	1,436
Transfers/release of credit reserve	41,118			(41,118		)	94,977			(94,977		)
Balance at end of period	$	(787,541	)	$	(312,182	)	$	(900,557	)	$	(399,564	)

(1) Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.

(2)  The Company reallocated $218,000 of purchase discount designated as Credit Reserve to accretable purchase discount on Non-Agency MBS underlying Linked Transactions for the year ended December 31, 2014.

Schedule of impact of Available-for-Sale Securities on AOCI

The following table presents the impact of the Company’s AFS securities on its AOCI for the years ended December 31, 2015, 2014, and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014			2013
AOCI from AFS securities:
Unrealized gain on AFS securities at beginning of period	$	813,515		$	752,912		$	824,808
Unrealized (loss)/gain on Agency MBS, net	(51,332		)	65,739			(186,568		)
Unrealized (loss)/gain on Non-Agency MBS, net	(143,558		)	29,812			134,505
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	4,537			—			—
Reclassification adjustment for MBS sales included in net income	(37,207		)	(34,948		)	(19,833		)
Reclassification adjustment for OTTI included in net income	(705		)	—			—
Change in AOCI from AFS securities	(228,265		)	60,603			(71,896		)
Balance at end of period	$	585,250		$	813,515		$	752,912

Schedule of interest income on MBS and CRT Securities

The following table presents components of interest income on the Company’s MBS and CRT securities for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014			2013
Agency MBS
Coupon interest	$	147,066		$	189,355		$	213,995
Effective yield adjustment (1)	(41,231		)	(46,812		)	(57,949		)
Interest income	$	105,835		$	142,543		$	156,046
Legacy Non-Agency MBS
Coupon interest	$	183,349		$	212,073		$	253,560
Effective yield adjustment (2)	91,003			103,491			73,189
Interest income	$	274,352		$	315,564		$	326,749
RPL/NPL MBS
Coupon interest	$	87,429		$	898		$	21
Effective yield adjustment (2)	1,789			(132		)	—
Interest income	$	89,218		$	766		$	21
CRT securities
Coupon interest	$	5,844		$	665		$	—
Effective yield adjustment (2)	728			107			—
Interest income	$	6,572		$	772		$	—

(1)  Includes amortization of premium paid net of accretion of purchase discount.  For Agency MBS, interest income is recorded at an effective yield, which reflects net premium amortization based on actual prepayment activity.

(2)  The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield.

XML

Residential Whole Loans (Tables)

12 Months Ended

Dec. 31, 2015

Residential Whole Loans [Abstract]

Schedule of Accounts, Notes, Loans and Financing Receivable

The following table presents the activity in the Company’s allowance for loan losses on its residential whole loan pools at carrying value for the years ended December 31, 2015 and 2014:

(In Thousands)	For the Year Ended December 31,
	2015		2014
Balance at the beginning of period	$	137	$	—
Provisions for loan losses	1,028		137
Balance at the end of period	$	1,165	$	137

Certain Loans Acquired in Transfer Not Accounted for as Debt Securities Acquired During Period

The following table presents information regarding estimates of the contractually required payments, the cash flows expected to be collected, and the estimated fair value of the residential whole loans held at carrying value acquired by the Company for the years ended December 31, 2015 and 2014:

(In Thousands)	For the Year Ended December 31,
	2015			2014
Contractually required principal and interest	$	160,806		$	448,453
Contractual cash flows not expected to be collected (non-accretable yield)	(27,040		)	(100,466		)
Expected cash flows to be collected	133,766			347,987
Interest component of expected cash flows (accretable yield)	(51,413		)	(135,425		)
Fair value at the date of acquisition	$	82,353		$	212,562

Certain Loans Acquired in Transfer Accounted for as Debt Securities, Accretable Yield Movement

The following table presents accretable yield activity for the Company’s residential whole loans held at carrying value for the years ended December 31, 2015 and 2014:

(In Thousands)	For the Year Ended December 31,
	2015			2014
Balance at beginning of period	$	133,012		$	—
Additions	51,413			135,425
Accretion	(15,511		)	(3,996		)
Reclassifications to non-accretable difference, net	6,357			1,583
Balance at end of period	$	175,271		$	133,012

Residential Whole Loans, Fair Value

The following table presents information regarding the Company’s residential whole loans at fair value at December 31, 2015 and 2014:

(Dollars in Thousands)	December 31, 2015		December 31, 2014
Outstanding principal balance	$	786,330	$	182,613
Aggregate fair value	$	623,276	$	143,472
Number of loans	3,143		885

Residential Whole Loans, Fair Vale, Component of Net Income

The following table presents the components of Net gain on residential whole loans held at fair value for the years ended December 31, 2015 and 2014:

	For the Year Ended December 31,
(In Thousands)	2015		2014
Coupon payments and other income received	$	9,303	$	504
Net unrealized gains	6,540		(427		)
Net gain on payoff/liquidation of loans	1,879		39
Total	$	17,722	$	116

XML

Interest Receivable (Tables)

12 Months Ended

Dec. 31, 2015

Receivables [Abstract]

Schedule of company's interest receivable by investment category

The following table presents the Company’s interest receivable by investment category at December 31, 2015 and 2014:

	December 31,
(In Thousands)	2015		2014
MBS interest receivable:
Fannie Mae	$	8,999	$	11,761
Freddie Mac	2,177		2,598
Ginnie Mae	15		17
Non-Agency MBS	15,438		16,794
Total MBS interest receivable	26,629		31,170
Residential whole loans	2,259		1,324
CRT securities	92		66
Money market and other investments	22		21
Total interest receivable	$	29,002	$	32,581

XML

Derivative Instruments (Tables)

12 Months Ended

Dec. 31, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of derivative instruments and balance sheet location

The following table presents the fair value of the Company’s derivative instruments and their balance sheet location at December 31, 2015 and 2014:

			December 31,
			2015					2014
Derivative Instrument	Designation	Balance Sheet Location	Notional Amount		Fair Value			Notional Amount		Fair Value
(In Thousands)
Linked Transactions	Non-Hedging	Assets	N/A		N/A			N/A		$	398,336
Non-cleared legacy Swaps (1)	Hedging	Assets	$	450,000	$	1,127		$	450,000	$	3,136
Non-cleared legacy Swaps (1)	Hedging	Liabilities	$	50,000	$	(59	)	$	760,170	$	(4,263	)
Cleared Swaps (2)	Hedging	Liabilities	$	2,550,000	$	(70,467	)	$	2,550,000	$	(57,935	)

(1)  Non-cleared legacy Swaps include Swaps executed and settled bilaterally with counterparties without the use of an organized exchange or central clearing house.

(2) Cleared Swaps include Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties.

Schedule of information about the Non-Agency MBS and repurchase agreements underlying the Linked Transactions

The following tables present certain information about the Legacy Non-Agency MBS, RPL/NPL MBS, CRT securities and repurchase agreements underlying the Company’s Linked Transactions at December 31, 2014:

Linked Transactions at December 31, 2014

Linked Repurchase Agreements					Linked MBS/CRT Securities
Maturity or Repricing	Balance		Weighted Average Interest Rate			Fair Value		Amortized Cost		Par/Current Face		Weighted Average Coupon Rate
(Dollars in Thousands)					(Dollars in Thousands)
Within 30 days	$	1,514,393	1.47	%	Legacy Non-Agency MBS	$	66,382	$	61,658	$	72,513	4.20	%
>30 days to 90 days	5,200		1.35		RPL/NPL MBS	1,846,807		1,847,118		1,849,974		3.49
Total	$	1,519,593	1.47	%	CRT securities	4,624		4,500		4,500		4.56
					Total	$	1,917,813	$	1,913,276	$	1,926,987	3.52	%

Schedule of information about the components of the unrealized net gains/(losses) and net interest income from Linked Transactions

The following table presents certain information about the components of the unrealized net gains and net interest income from Linked Transactions included in the Company’s consolidated statements of operations for the years ended December 31, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2014			2013
Interest income attributable to MBS underlying Linked Transactions	$	24,443		$	3,869
Interest expense attributable to linked repurchase agreement borrowings underlying Linked Transactions	(8,028		)	(925		)
Change in fair value of Linked Transactions included in earnings	677			281
Unrealized net gains and net interest income from Linked Transactions	$	17,092		$	3,225

Schedule of assets pledged as collateral against derivative contracts

The following table presents the assets pledged as collateral against the Company’s Swap contracts at December 31, 2015 and December 31, 2014:

	December 31,
(In Thousands)	2015		2014
Agency MBS, at fair value	$	38,569	$	57,247
Restricted cash	70,573		66,486
Total assets pledged against Swaps	$	109,142	$	123,733

Schedule of information about Swap activity

The following table presents certain information with respect to the Company’s Swap activity during the year ended December 31, 2015:

(Dollars in Thousands)	December 31, 2015
New Swaps:
Aggregate notional amount	$	—
Weighted average fixed-pay rate	—		%
Initial maturity date	N/A
Number of new Swaps	—
Swaps amortized/expired:
Aggregate notional amount	$	710,170
Weighted average fixed-pay rate	1.96		%

Schedule of information about swaps

The following table presents information about the Company’s Swaps at December 31, 2015 and 2014:

	December 31, 2015						December 31, 2014
Maturity (1)	Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)		Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)
(Dollars in Thousands)
Within 30 days	$	50,000	2.13	%	0.42	%	$	22,290	3.63	%	0.23	%
Over 30 days to 3 months	—		—		—		387,880		1.80		0.16
Over 3 months to 6 months	—		—		—		300,000		2.06		0.17
Over 6 months to 12 months	100,000		0.48		0.32		—		—		—
Over 12 months to 24 months	350,000		0.58		0.27		150,000		1.03		0.16
Over 24 months to 36 months	550,000		1.49		0.32		350,000		0.58		0.16
Over 36 months to 48 months	200,000		1.71		0.42		550,000		1.49		0.16
Over 48 months to 60 months	1,500,000		2.22		0.36		200,000		1.71		0.17
Over 60 months to 72 months	200,000		2.20		0.30		1,500,000		2.22		0.16
Over 72 months to 84 months	—		—		—		200,000		2.20		0.17
Over 84 months (3)	100,000		2.75		0.40		100,000		2.75		0.16
Total Swaps	$	3,050,000	1.82	%	0.34	%	$	3,760,170	1.85	%	0.16	%

(1)  Each maturity category reflects contractual amortization and/or maturity of notional amounts.

(2)  Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively. 

(3) Reflects one Swap with a maturity date of July 2023.

Schedule of interest expense and the weighted average interest rate paid and received on swaps

The following table presents the net impact of the Company’s derivative hedging instruments on its interest expense and the weighted average interest rate paid and received for such Swaps for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(Dollars in Thousands)	2015			2014			2013
Interest expense attributable to Swaps	$	53,759		$	69,842		$	59,031
Weighted average Swap rate paid	1.86		%	1.93		%	2.08		%
Weighted average Swap rate received	0.19		%	0.16		%	0.19		%

Schedule of impact of hedging instruments on AOCI

The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014			2013
AOCI from derivative hedging instruments:
Balance at beginning of period	$	(59,062	)	$	(15,217	)	$	(62,831	)
Unrealized (loss)/gain on Swaps, net	(10,337		)	(44,292		)	47,614
Reclassification of unrealized loss on de-designated Swaps	—			447			—
Balance at end of period	$	(69,399	)	$	(59,062	)	$	(15,217	)

XML

Real Estate Owned (Tables)

12 Months Ended

Dec. 31, 2015

Real Estate [Abstract]

Schedule of Activity for Real Estate Owned

The following table presents the activity in the Company’s REO for the years ended December 31, 2015 and 2014. The Company did not have REO prior to 2014.

	For the Year Ended December 31,
(In Thousands)	2015			2014
Balance at beginning of period	$	5,492		$	—
Adjustments to record at lower of cost or fair value	(3,475		)	—
Transfer from residential whole loans (1)	30,104			2,904
Purchases and capital improvements	2,461			2,588
Disposals	(6,556		)	—
Balance at end of period	$	28,026		$	5,492

(1)  Includes net gain recorded on transfer of approximately $1.7 million and $331,000, respectively, for the years ended December 31, 2015 and 2014.

XML

Repurchase Agreements and Other Advances (Tables)

12 Months Ended

Dec. 31, 2015

Repurchase Agreements

Schedule of Company's borrowings under repurchase agreements and associated assets pledged as collateral

The following table presents information with respect to the Company’s borrowings under repurchase agreements and associated assets pledged as collateral at December 31, 2015 and 2014:

(Dollars in Thousands)	December 31, 2015			December 31, 2014
Repurchase agreement borrowings secured by Agency MBS	$	2,727,542		$	5,177,835
Fair value of Agency MBS pledged as collateral under repurchase agreements	$	2,881,049		$	5,462,566
Weighted average haircut on Agency MBS (1)	4.67		%	4.79		%
Repurchase agreement borrowings secured by Legacy Non-Agency MBS (2)	$	1,960,222		$	2,233,236
Fair value of Legacy Non-Agency MBS pledged as collateral under repurchase   agreements (2)(3)	$	2,818,968		$	3,491,312
Weighted average haircut on Legacy Non-Agency MBS (1)	25.42		%	28.88		%
Repurchase agreement borrowings secured by RPL/NPL MBS (2)	$	2,080,163		$	130,919
Fair value of RPL/NPL MBS pledged as collateral under repurchase agreements (2)	$	2,625,866		$	160,688
Weighted average haircut on RPL/NPL MBS (1)	21.37		%	20.00		%
Repurchase agreements secured by U.S. Treasuries	$	504,760		$	507,114
Fair value of U.S. Treasuries pledged as collateral under repurchase agreements	$	507,443		$	512,105
Weighted average haircut on U.S. Treasuries (1)	1.60		%	1.62		%
Repurchase agreements secured by CRT securities (2)	$	128,465		$	75,960
Fair value of CRT securities pledged as collateral under repurchase agreements (2)	$	170,352		$	94,610
Weighted average haircut on CRT securities (1)	25.04		%	25.00		%
Repurchase agreements secured by residential whole loans	$	487,750		$	142,324
Fair value of residential whole loans pledged as collateral under repurchase agreements	$	684,136		$	212,986
Weighted average haircut on residential whole loans (1)	27.69		%	33.43		%

(1)  Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount.

(2)  Does not reflect Legacy Non-Agency MBS, RPL/NPL MBS, CRT securities and repurchase agreement borrowings that were components of Linked Transactions at December 31, 2014. As previously discussed, new accounting guidance effective January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 6)

(3)  Includes $570.5 million and $1.275 billion of Legacy Non-Agency MBS acquired from consolidated VIEs at December 31, 2015 and 2014, respectively, that are eliminated from the Company’s consolidated balance sheets.

Schedule of repricing information about borrowings under repurchase agreements

The following table presents repricing information about the Company’s borrowings under repurchase agreements, which does not reflect the impact of associated derivative hedging instruments, at December 31, 2015 and 2014:

	December 31, 2015				December 31, 2014
Time Until Interest Rate Reset	Balance		Weighted Average Interest Rate		Balance (1)		Weighted Average Interest Rate
(Dollars in Thousands)
Within 30 days	$	7,054,483	1.44	%	$	7,144,737	0.72	%
Over 30 days to 3 months	734,955		1.79		1,000,313		1.12
Over 3 months to 12 months	99,464		2.36		122,338		1.98
Total	$	7,888,902	1.48	%	$	8,267,388	0.79	%

(1)  At December 31, 2014, the Company had repurchase agreements of $1.520 billion that were linked to securities purchased and accounted for as Linked Transactions, and as such, the linked repurchase agreements are not included in the above table. As previously discussed, new accounting guidance effective January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 6)

Schedule of contractual maturity information about repurchase agreements

The following table presents contractual maturity information about the Company’s borrowings under repurchase agreements, all of which are accounted for as secured borrowings, at December 31, 2015 and does not reflect the impact of derivative contracts that hedge such repurchase agreements:

	December 31, 2015
Contractual Maturity	Agency MBS		Legacy Non-Agency MBS		RPL/NPL MBS		U.S. Treasuries		CRT Securities		Residential Whole Loans		Total		Weighted  Average Interest Rate
(Dollars in Thousands)
Overnight	$	—	$	—	$	—	$	—	$	—	$	—	$	—	—	%
Within 30 days	2,563,741		892,341		1,670,586		504,760		110,921		—		5,742,349		1.27
Over 30 days to 3 months	163,801		613,131		143,705		—		17,544		—		938,181		1.71
Over 3 months to 12 months	—		454,750		265,872		—		—		293,641		1,014,263		2.19
Over 12 months	—		—		—		—		—		194,109		194,109		3.11
Total	$	2,727,542	$	1,960,222	$	2,080,163	$	504,760	$	128,465	$	487,750	$	7,888,902	1.48	%
Gross amount of recognized liabilities for repurchase agreements in Note 10													$	7,888,902
Amounts related to repurchase agreements not included in offsetting disclosure in Note 10													$	—

Schedule of information about counterparty for repurchase agreements for which the entity had greater than 5% of stockholders' equity at risk

The following table presents information with respect to each counterparty under repurchase agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at December 31, 2015:

	December 31, 2015
Counterparty	Counterparty Rating (1)	Amount at Risk (2)		Weighted Average Months to Maturity for Repurchase Agreements	Percent of Stockholders’ Equity
(Dollars in Thousands)
Credit Suisse	BBB+/Aa2/A	$	410,814	1	13.8	%
Wells Fargo (3)	AA-/Aa2/AA	334,613		6	11.3
RBC (4)	AA-/Aa3/AA	327,400		2	11.0
UBS (5)	A/A1/A	214,107		19	7.2
Goldman Sachs	BBB+/A3/A	152,055		9	5.1

(1) As rated at December 31, 2015 by S&P, Moody’s and Fitch, Inc., respectively.  The counterparty rating presented is the lowest published for these entities.

(2) The amount at risk reflects the difference between (a) the amount loaned to the Company through repurchase agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities.

(3)  Includes $269.7 million at risk with Wells Fargo Bank, NA and $64.9 million at risk with Wells Fargo Securities LLC. 

(4) Includes $309.8 million at risk with RBC Barbados, $10.7 million at risk with Royal Bank of Canada and $6.8 million at risk with RBC Capital Markets LLC. Counterparty ratings are not published for RBC Barbados and RBC Capital Markets LLC.

(5) Includes Non-Agency MBS pledged as collateral with contemporaneous repurchase and reverse repurchase agreements.

XML

Collateral Positions (Tables)

12 Months Ended

Dec. 31, 2015

Collateral Positions

Schedule of fair value of collateral pledged and collateral held

The following table summarizes the fair value of the Company’s collateral positions, which includes collateral pledged and collateral held, with respect to its borrowings under repurchase agreements, reverse repurchase agreements, derivative hedging instruments and FHLB advances at December 31, 2015 and 2014: 

	December 31, 2015				December 31, 2014
(In Thousands)	Assets Pledged		Collateral Held		Assets Pledged		Collateral Held
Derivative Hedging Instruments:
Agency MBS	$	38,569	$	—	$	57,247	$	—
Cash (1)	70,573		—		66,486		—
	109,142		—		123,733		—
Repurchase Agreement Borrowings:
Agency MBS	2,881,049		—		5,462,566		—
Legacy Non-Agency MBS (2)(3)	2,818,968		—		3,491,312		—
RPL/NPL MBS	2,625,866		—		160,688		—
U.S. Treasury securities	507,443		—		512,105		—
CRT securities	170,352		—		94,610		—
Residential whole loans	684,136		—		212,986		—
Cash (1)	965		—		769		—
	9,688,779		—		9,935,036		—
FHLB Advances:
Agency MBS	1,612,476		—		—		—
	1,612,476		—		—		—
Reverse Repurchase Agreements:
U.S. Treasury securities	—		507,443		—		512,105
	—		507,443		—		512,105
Total	$	11,410,397	$	507,443	$	10,058,769	$	512,105

(1) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets.

(2) Includes $570.5 million and $1.275 billion of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at December 31, 2015 and 2014, respectively, that are eliminated from the Company’s consolidated balance sheets.

(3) In addition, at December 31, 2015 and 2014, $726.7 million and $731.0 million of Legacy Non-Agency MBS, respectively, are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty.

Schedule of additional information about assets Pledged as collateral pursuant to borrowings under repurchase agreements and Derivative Hedging Contracts

The following table presents detailed information about the Company’s assets pledged as collateral pursuant to its borrowings under repurchase agreements and other advances, and derivative hedging instruments at December 31, 2015:

	December 31, 2015
	Assets Pledged Under Repurchase Agreements and Other Advances						Assets Pledged Against Derivative Hedging Instruments						Total Fair Value of Assets Pledged and Accrued Interest
(In Thousands)	Fair Value		Amortized Cost		Accrued Interest on Pledged Assets		Fair Value/ Carrying Value		Amortized Cost		Accrued Interest on Pledged Assets
Agency MBS (1)	$	4,493,525	$	4,465,081	$	10,593	$	38,569	$	39,460	$	80	$	4,542,767
Legacy Non-Agency MBS(2)(3)	2,818,968		2,278,870		10,241		—		—		—		2,829,209
RPL/NPL MBS	2,625,866		2,644,797		1,592		—		—		—		2,627,458
U.S. Treasuries	507,443		507,443		—		—		—		—		507,443
CRT securities	170,352		173,367		83		—		—		—		170,435
Residential whole loans	684,136		673,788		952		—		—		—		685,088
Cash (4)	965		965		—		70,573		70,573		—		71,538
Total	$	11,301,255	$	10,744,311	$	23,461	$	109,142	$	110,033	$	80	$	11,433,938

(1)  Includes Agency MBS pledged under FHLB advances with an aggregate fair value of $1.612 billion, aggregate amortized cost of $1.606 billion and aggregate accrued interest of approximately $3.9 million at December 31, 2015.

(2) Includes $570.5 million of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at December 31, 2015, that are eliminated from the Company’s consolidated balance sheets.

(3)  In addition, at December 31, 2015, $726.7 million of Legacy Non-Agency MBS are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty.

(4) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets.

XML

Offsetting Assets and Liabilities (Tables)

12 Months Ended

Dec. 31, 2015

Offsetting [Abstract]

Schedule of information about certain assets that are subject to master netting arrangements (or similar agreements)

The following tables present information about certain assets and liabilities that are subject to master netting arrangements (or similar agreements) and may potentially be offset on the Company’s consolidated balance sheets at December 31, 2015 and 2014:

Offsetting of Financial Assets and Derivative Assets

	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Consolidated Balance Sheets		Net Amounts of Assets Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in  the Consolidated Balance Sheets					Net Amount
(In Thousands)							Financial Instruments			Cash  Collateral  Received
December 31, 2015
Swaps, at fair value	$	1,127	$	—	$	1,127	$	(1,127	)	$	—	$	—
Total	$	1,127	$	—	$	1,127	$	(1,127	)	$	—	$	—
December 31, 2014
Swaps, at fair value	$	3,136	$	—	$	3,136	$	(3,136	)	$	—	$	—
Total	$	3,136	$	—	$	3,136	$	(3,136	)	$	—	$	—

Schedule of information about certain liabilities that are subject to master netting arrangements (or similar agreements)

Offsetting of Financial Liabilities and Derivative Liabilities

	Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Consolidated Balance Sheets		Net Amounts of Liabilities Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in the  Consolidated Balance Sheets						Net Amount
(In Thousands)							Financial  Instruments (1)			Cash  Collateral  Pledged (1)
December 31, 2015
Swaps, at fair value (2)	$	70,526	$	—	$	70,526	$	—		$	(70,526	)	$	—
Repurchase agreements and   other advances (3)	9,388,902		—		9,388,902		(9,387,937		)	(965		)	—
Total	$	9,459,428	$	—	$	9,459,428	$	(9,387,937	)	$	(71,491	)	$	—
December 31, 2014
Swaps, at fair value (2)	$	62,198	$	—	$	62,198	$	—		$	(62,198	)	$	—
Repurchase agreements (3)	8,267,388		—		8,267,388		(8,266,619		)	(769		)	—
Total	$	8,329,586	$	—	$	8,329,586	$	(8,266,619	)	$	(62,967	)	$	—

(1) Amounts disclosed in the Financial Instruments column of the table above represent collateral pledged that is available to be offset against liability balances associated with repurchase agreements and other advances, and derivative transactions.  Amounts disclosed in the Cash Collateral Pledged column of the table above represent amounts pledged as collateral against derivative transactions and repurchase agreements, and exclude excess collateral of $47,000 and $4.3 million at December 31, 2015 and 2014, respectively.

(2) The fair value of securities pledged against the Company’s Swaps was $38.6 million and $57.2 million at December 31, 2015 and 2014, respectively.

(3) The fair value of financial instruments pledged against the Company’s repurchase agreements and other advances was $11.300 billion and $9.934 billion at December 31, 2015 and 2014, respectively.

XML

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Schedule of contractual minimum rental payments

At December 31, 2015, the contractual minimum rental payments (exclusive of possible rent escalation charges and normal recurring charges for maintenance, insurance and taxes) were as follows:

Year Ended December 31,	Minimum Rental Payments
(In Thousands)
2016	$	2,552
2017	2,522
2018	2,522
2019	2,522
2020	1,050
Total	$	11,168

XML

Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2015

Stockholders' Equity Note [Abstract]

Schedule of cash dividends declared on Series B preferred stock

The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2013 through December 31, 2015:

Year	Declaration Date	Record Date	Payment Date	Dividend Per Share
2015	November 19, 2015	December 3, 2015	December 31, 2015	$0.46875
	August 24, 2015	September 9, 2015	September 30, 2015	0.46875
	May 18, 2015	June 2, 2015	June 30, 2015	0.46875
	February 13, 2015	February 27, 2015	March 31, 2015	0.46875
2014	November 21, 2014	December 5, 2014	December 31, 2014	$0.46875
	August 25, 2014	September 8, 2014	September 30, 2014	0.46875
	May 19, 2014	June 10, 2014	June 30, 2014	0.46875
	February 14, 2014	February 28, 2014	March 31, 2014	0.46875
2013	November 19, 2013	December 3, 2013	December 31, 2013	$0.46875
	August 22, 2013	September 5, 2013	September 30, 2013	0.46875
	May 20, 2013	June 3, 2013	July 1, 2013	0.39583

Schedule of cash dividends declared on common stock

The following table presents cash dividends declared by the Company on its common stock from January 1, 2013 through December 31, 2015:

Year	Declaration Date	Record Date	Payment Date	Dividend Per Share
2015	December 9, 2015	December 28, 2015	January 29, 2016	$0.20	(1)
	September 17, 2015	September 29, 2015	October 30, 2015	0.20
	June 15, 2015	June 29, 2015	July 31, 2015	0.20
	March 13, 2015	March 27, 2015	April 30, 2015	0.20
2014	December 9, 2014	December 26, 2014	January 30, 2015	$0.20
	September 17, 2014	September 29, 2014	October 31, 2014	0.20
	June 13, 2014	June 27, 2014	July 31, 2014	0.20
	March 10, 2014	March 28, 2014	April 30, 2014	0.20
2013	December 11, 2013	December 31, 2013	January 31, 2014	$0.20
	September 26, 2013	October 11, 2013	October 31, 2013	0.22
	August 1, 2013	August 12, 2013	August 30, 2013	0.28	(2)
	June 28, 2013	July 12, 2013	July 31, 2013	0.22
	March 28, 2013	April 12, 2013	April 30, 2013	0.22
	March 4, 2013	March 18, 2013	April 10, 2013	0.50	(3)

(1)  At December 31, 2015, the Company had accrued dividends and dividend equivalents payable of $74.6 million related to the common stock dividend declared on December 9, 2015.

(2) Reflects the special cash dividend on common stock declared on August 1, 2013.

(3) Reflects the special cash dividend on common stock declared on March 4, 2013.

Schedule of changes in balances in each component of the entity's AOCI

The following table presents changes in the balances of each component of the Company’s AOCI for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
	2015									2014									2013
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities			Net  Unrealized Gain/(Loss) on Swaps			Total  AOCI			Net  Unrealized Gain/(Loss) on AFS Securities			Net  Unrealized Gain/(Loss) on Swaps			Total  AOCI			Net  Unrealized Gain/(Loss) on AFS Securities			Net  Unrealized Gain/(Loss) on Swaps			Total  AOCI
Balance at beginning of period	$	813,515		$	(59,062	)	$	754,453		$	752,912		$	(15,217	)	$	737,695		$	824,808		$	(62,831	)	$	761,977
OCI before reclassifications	(194,890		)	(10,337		)	(205,227		)	95,551			(44,292		)	51,259			(52,063		)	47,614			(4,449		)
Amounts reclassified from   AOCI (1)	(37,912		)	—			(37,912		)	(34,948		)	447			(34,501		)	(19,833		)	—			(19,833		)
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	4,537			—			4,537			—			—			—			—			—			—
Net OCI during period (2)	(228,265		)	(10,337		)	(238,602		)	60,603			(43,845		)	16,758			(71,896		)	47,614			(24,282		)
Balance at end of period	$	585,250		$	(69,399	)	$	515,851		$	813,515		$	(59,062	)	$	754,453		$	752,912		$	(15,217	)	$	737,695

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

Information about the significant amounts reclassified out of the entity's AOCI

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the years ended December 31, 2015, 2014, and 2013:

	For the Year Ended December 31,
	2015			2014			2013
Details about AOCI Components	Amounts Reclassified from AOCI									Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(37,207	)	$	(34,948	)	$	(19,833	)	Gain on sales of MBS and U.S. Treasury securities, net
OTTI recognized in earnings	(705		)	—			—			Net impairment losses recognized in earnings
Total AFS Securities	(37,912		)	(34,948		)	(19,833		)
Swaps designated as cash flow hedges:
De-designated Swaps	—			447			—			Other, net
Total Swaps designated as cash flow hedges	—			447			—
Total reclassifications for period	$	(37,912	)	$	(34,501	)	$	(19,833	)

XML

EPS Calculation (Tables)

12 Months Ended

Dec. 31, 2015

Earnings Per Share [Abstract]

Schedule of reconciliation of the earnings and shares used in calculating basic and diluted EPS

The following table presents a reconciliation of the earnings and shares used in calculating basic and diluted EPS for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands, Except Per Share Amounts)	2015			2014			2013
Numerator:
Net income	$	313,226		$	313,504		$	302,709
Dividends declared on preferred stock	(15,000		)	(15,000		)	(13,750		)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities	(1,539		)	(1,106		)	(1,080		)
Issuance costs of redeemed preferred stock (1)	—			—			(3,947		)
Net income available to common stockholders - basic and diluted	$	296,687		$	297,398		$	283,932
Denominator:
Weighted average common shares for basic and diluted earnings per share (2)	372,114			369,048			362,399
Basic and diluted earnings per share	$	0.80		$	0.81		$	0.78

(1) Issuance costs of redeemed preferred stock represent the original offering costs related to the Series A Preferred Stock, which was redeemed on May 16, 2013. (See Note 13)

(2) At December 31, 2015, the Company had an aggregate of 2.0 million equity instruments outstanding that were not included in the calculation of diluted EPS for the year ended December 31, 2015, as their inclusion would have been anti-dilutive.  These equity instruments were comprised of approximately 111,000 shares of restricted common stock with a weighted average grant date fair value of $7.41 and approximately $1.9 million RSUs with a weighted average grant date fair value of $6.90.  These equity instruments may have a dilutive impact on future EPS.

XML

Equity Compensation, Employment Agreements and Other Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2015

Compensation Related Costs [Abstract]

Schedule of dividend equivalent rights activity

The following table presents information about the Company’s dividend equivalents rights awarded as separate instruments at and for each of the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
	2015		2014		2013
	Number of Dividend Equivalent Rights
Outstanding at beginning of year:	24,402		218,225		266,075
Granted	—		—		—
Cancelled, forfeited or expired	(16,187	)	(193,823	)	(47,850	)
Outstanding at end of year	8,215		24,402		218,225

Schedule of stock options activity

The following table presents information about the Company’s Options at and for each of the years ended December 31, 2014 and 2013:

	For the Year Ended December 31,
	2014				2013
	Number of Options		Weighted Average Exercise Price		Number of Options		Weighted Average Exercise Price
Outstanding at beginning of year:	5,000		$	8.40	427,000		$	10.14
Granted	—		—		—		—
Cancelled, forfeited or expired	(5,000	)	8.40		(402,000	)	10.25
Exercised (1)	—		—		(20,000	)	8.40
Outstanding at end of year	—		$	—	5,000		$	8.40
Options exercisable at end of year	—		$	—	5,000		$	8.40

(1) For the year ended December 31, 2013, the intrinsic value of Options exercised was approximately $19,000

Schedule of restricted stock activity

The following table presents information with respect to the Company’s restricted stock for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
	2015				2014				2013
	Shares of Restricted Stock		Weighted Average Grant Date Fair Value (1)		Shares of Restricted Stock		Weighted Average Grant Date Fair Value (1)		Shares of Restricted Stock		Weighted Average Grant Date Fair Value (1)
Outstanding at beginning of year:	243,948		$	7.48	443,967		$	7.50	483,442		$	7.74
Granted	497,007		6.83		491,797		8.29		231,531		7.33
Vested (2)	(629,212	)	6.98		(690,397	)	8.07		(270,456	)	7.77
Cancelled/forfeited	(823	)	7.74		(1,419	)	7.58		(550	)	7.72
Outstanding at end of year	110,920		$	7.41	243,948		$	7.48	443,967		$	7.50

(1) The grant date fair value of restricted stock awards is based on the closing market price of the Company’s common stock at the grant date.

(2) All restrictions associated with restricted stock are removed on vesting.

Schedule of restricted stock units activity

The following table presents information with respect to the Company’s RSUs during the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31, 2015
	RSUs With Service Condition		Weighted Average Grant Date Fair Value		RSUs With Market and Service Conditions		Weighted Average Grant Date Fair Value		Total RSUs		Total  Weighted Average  Grant Date  Fair Value
Outstanding at beginning of year:	769,174		$	7.55	449,300		$	5.61	1,218,474		$	6.84
Granted (1)	390,804		7.96		291,250		5.73		682,054		7.01
Settled	(17,298	)	6.60		—		—		(17,298	)	6.60
Cancelled/forfeited	(3,750	)	7.97		(3,750	)	5.73		(7,500	)	6.85
Outstanding at end of year	1,138,930		$	7.71	736,800		$	5.66	1,875,730		$	6.90
RSUs vested but not settled at end of year	554,023		$	7.83	175,500		$	5.21	729,523		$	7.20
RSUs unvested at end of year	584,907		$	7.59	561,300		$	5.80	1,146,207		$	6.71

	For the Year Ended December 31, 2014
	RSUs With Service Condition		Weighted Average Grant Date Fair Value		RSUs With Market and Service Conditions		Weighted Average Grant Date Fair Value		Total RSUs		Total  Weighted Average  Grant Date  Fair Value
Outstanding at beginning of year:	490,099		$	7.75	287,719		$	4.32	777,818		$	6.48
Granted (2)	357,015		7.22		273,800		5.87		630,815		6.64
Settled	(72,873	)	7.28		(14,465	)	4.71		(87,338	)	6.86
Cancelled/forfeited	(5,067	)	7.36		(97,754	)	2.67		(102,821	)	2.90
Outstanding at end of year	769,174		$	7.55	449,300		$	5.61	1,218,474		$	6.84
RSUs vested but not settled at end of year	467,638		$	7.81	175,500		$	5.21	643,138		$	7.10
RSUs unvested at end of year	301,536		$	7.15	273,800		$	5.87	575,336		$	6.54

	For the Year Ended December 31, 2013
	RSUs With Service Condition		Weighted Average Grant Date Fair Value		RSUs With Market and Service Conditions		Weighted Average Grant Date Fair Value		Total RSUs		Total  Weighted Average  Grant Date  Fair Value
Outstanding at beginning of year:	448,141		$	7.61	279,507		$	4.55	727,648		$	6.43
Granted (3)	64,483		8.23		48,341		2.59		112,824		5.82
Settled	(21,025	)	6.20		(32,066	)	2.80		(53,091	)	4.15
Cancelled/forfeited	(1,500	)	7.77		(8,063	)	7.89		(9,563	)	7.88
Outstanding at end of year	490,099		$	7.75	287,719		$	4.32	777,818		$	6.48
RSUs vested but not settled at end of year	84,199		$	8.50	14,625		$	4.69	98,824		$	7.93
RSUs unvested at end of year	405,900		$	7.60	273,094		$	4.30	678,994		$	6.27

(1) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs.  In determining the fair value for 582,500 of these awards granted in 2015, the Company applied:  (i) a weighted average volatility estimate of approximately 18%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.90% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 9%.  The weighted average grant date fair value for the remaining 99,554 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date ranging from $7.93 to $7.97. There are no post vesting conditions on these awards.

(2) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs.  In determining the fair value for 547,600 of these awards granted in 2014, the Company applied:  (i) a weighted average volatility estimate of approximately 22%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.73% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 8%.  The weighted average grant date fair value for the remaining 83,215 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date ranging from $7.19 to $8.16. There are no post vesting conditions on these awards.

(3) The determination of the weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs.  In determining the fair value for awards granted in 2013, the Company applied:  (i) a weighted average volatility estimate of approximately 23%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.65% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 13%.  There are no post vesting conditions on these awards.

Schedule of expenses related to equity-based compensation

The following table presents the Company’s expenses related to its equity-based compensation instruments for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015		2014		2013
Restricted shares of common stock	$	4,373	$	5,553	$	2,150
RSUs (1)	3,377		2,886		1,813
Dividend equivalent rights	82		146		195
Total	$	7,832	$	8,585	$	4,158

(1) RSU expense for the year ended December 31, 2014 includes approximately $500,000 for a one-time grant to the Company’s chief executive officer.

Schedule of expenses related to deferred compensation plans

The following table presents the Company’s expenses related to its Deferred Plans for its non-employee directors and senior officers for the years ended December 31, 2015, 2014 and 2013:

	For the Year Ended December 31,
(In Thousands)	2015			2014		2013
Non-employee directors	$	(59	)	$	69	$	17
Total	$	(59	)	$	69	$	17

Schedule of aggregate income deferred by participants and associated liability under deferred compensation plans

The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through December 31, 2015 and 2014 that had not been distributed and the Company’s associated liability for such deferrals at December 31, 2015 and 2014:

	December 31, 2015				December 31, 2014
(In Thousands)	Undistributed Income Deferred (1)		Liability Under Deferred Plans		Undistributed Income Deferred (1)		Liability Under Deferred Plans
Non-employee directors	$	601	$	614	$	324	$	446
Total	$	601	$	614	$	324	$	446

(1)  Represents the cumulative amounts that were deferred by participants through December 31, 2015 and 2014, which had not been distributed through such respective date.

XML

Fair Value of Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2015

Fair Value Disclosures [Abstract]

Schedule of financial instruments carried at fair value by valuation hierarchy

The following table presents the Company’s financial instruments carried at fair value on a recurring basis as of December 31, 2015 and 2014, on the consolidated balance sheets by the valuation hierarchy, as previously described:

Fair Value at December 31, 2015

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Agency MBS	$	—	$	4,752,244	$	—	$	4,752,244
Non-Agency MBS, including MBS transferred to consolidated VIEs	—		6,420,817		—		6,420,817
CRT securities	—		183,582		—		183,582
Securities obtained and pledged as collateral	507,443		—		—		507,443
Residential whole loans, at fair value	—		—		623,276		623,276
Swaps	—		1,127		—		1,127
Total assets carried at fair value	$	507,443	$	11,357,770	$	623,276	$	12,488,489
Liabilities:
Swaps	$	—	$	70,526	$	—	$	70,526
Obligation to return securities obtained as collateral	507,443		—		—		507,443
Total liabilities carried at fair value	$	507,443	$	70,526	$	—	$	577,969

Fair Value at December 31, 2014

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Agency MBS	$	—	$	5,904,207	$	—	$	5,904,207
Non-Agency MBS, including MBS transferred to consolidated VIEs	—		4,755,432		—		4,755,432
CRT securities	—		102,983		—		102,983
Securities obtained and pledged as collateral	512,105		—		—		512,105
Residential whole loans, at fair value	—		—		143,472		143,472
Linked Transactions	—		398,336		—		398,336
Swaps	—		3,136		—		3,136
Total assets carried at fair value	$	512,105	$	11,164,094	$	143,472	$	11,819,671
Liabilities:
Swaps	$	—	$	62,198	$	—	$	62,198
Obligation to return securities obtained as collateral	512,105		—		—		512,105
Total liabilities carried at fair value	$	512,105	$	62,198	$	—	$	574,303

Schedule of significant unobservable inputs used in fair value measurement of residential whole loans

The following table presents additional information for the years ended December 31, 2015 and 2014 about the Company’s Residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis.

Changes in Level 3 Assets Measured at Fair Value on a Recurring Basis

	Residential Whole Loans, at Fair Value
	For the Year Ended December 31,
(In Thousands)	2015			2014
Balance at beginning of period	$	143,472		$	—
Purchases and capitalized advances	534,574			147,471
Changes in fair value recorded in Net gain on residential whole loans held at fair value	6,539			(388		)
Collection of principal, net of liquidation gains/losses	(34,767		)	(1,038		)
Transfer to REO	(26,542		)	(2,573		)
Balance at end of period	$	623,276		$	143,472

Schedule of quantitative information about significant unobservable inputs

The following table presents a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of December 31, 2015 and 2014:

Fair Value Methodology for Level 3 Financial Instruments

	December 31, 2015
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Range	Weighted Average
Residential whole loans, at fair value	$	113,166	Discounted cash flow	Discount rate	6.00-8.70%	7.00		%
				Prepayment rate	0.25-11.10%	6.59		%
				Default rate	0.00-9.10%	3.10		%
				Loss severity	10.00-79.40%	17.03		%
	$	392,557	Liquidation model	Discount rate	6.75-10.02%	6.85		%
				Annual change in home prices	(5.51)-6.08%	1.28		%
				Liquidation timeline (in years)	0.67-4.42	1.56
				Current value of underlying properties	$14-$3,500		$626
Total	$	505,723

(1) Excludes approximately $117.6 million of loans for which management considers the purchase price continues to reflect the fair value of such loans at December 31, 2015.

	December 31, 2014
(Dollars in Thousands)	Fair Value		Valuation Technique	Unobservable Input	Range	Weighted Average
Residential whole loans, at fair value	$	36,101	Discounted cash flow	Discount rate	6.00-8.00%	7.52		%
				Prepayment rate	0.25-8.20%	4.79		%
				Default rate	0.00-20.30%	7.01		%
				Loss severity	10.00-61.69%	18.88		%
	$	107,371	Liquidation model	Discount rate	7.00-7.00%	7.00		%
				Annual change in home prices	(4.73)-3.56%	0.26		%
				Liquidation timeline (in years)	0.83-4.42	1.94
				Current value of underlying properties	$29-$4,000		$397
Total	$	143,472

Schedule of residential whole loans, fair value and aggregate unpaid principal, fair value option elected

The following table presents the difference between the fair value and the aggregate unpaid principal balance of the Company’s residential whole loans for which the fair value option was elected at December 31, 2015 and 2014:

	December 31, 2015							December 31, 2014
(In Thousands)	Fair Value		Unpaid Principal Balance		Difference			Fair Value		Unpaid Principal Balance		Difference
Residential whole loans, at fair value
Total loans	$	623,276	$	786,330	$	(163,054	)	$	143,472	$	182,613	$	(39,141	)
Loans 90 days or more past due	$	493,640	$	637,459	$	(143,819	)	$	128,591	$	165,358	$	(36,767	)

Schedule of carrying value and fair value of financial instruments

The following table presents the carrying values and estimated fair values of the Company’s financial instruments at December 31, 2015 and 2014:

	December 31, 2015				December 31, 2014
(In Thousands)	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
Financial Assets:
Agency MBS	$	4,752,244	$	4,752,244	$	5,904,207	$	5,904,207
Non-Agency MBS, including MBS transferred to consolidated VIEs	6,420,817		6,420,817		4,755,432		4,755,432
CRT securities	183,582		183,582		102,983		102,983
Securities obtained and pledged as collateral	507,443		507,443		512,105		512,105
Residential whole loans, at carrying value	271,845		289,696		207,923		217,386
Residential whole loans, at fair value	623,276		623,276		143,472		143,472
Cash and cash equivalents	165,007		165,007		182,437		182,437
Restricted cash	71,538		71,538		67,255		67,255
Linked Transactions	—		—		398,336		398,336
Swaps	1,127		1,127		3,136		3,136
Financial Liabilities:
Repurchase agreements	7,888,902		7,828,115		8,267,388		8,266,699
FHLB advances	1,500,000		1,500,000		—		—
Securitized debt	22,057		22,057		110,574		110,791
Obligation to return securities obtained as collateral	507,443		507,443		512,105		512,105
Senior Notes	100,000		99,391		100,000		103,031
Swaps	70,526		70,526		62,198		62,198

XML

Use of Special Purpose Entities and Variable Interest Entities (Tables)

12 Months Ended

Dec. 31, 2015

Use of Special Purpose Entities and Variable Interest Entities

Summary of key details related to resecuritization transactions

The following table summarizes the key details of the resecuritization transactions in which the Company participated as of December 31, 2015:

(Dollars in Thousands)	February 2012			October 2010
Name of Trust (Consolidated as a VIE)	WFMLT Series 2012-RR1			DMSI 2010-RS2
Principal value of Non-Agency MBS sold	$	433,347		$	985,228
Face amount of Bonds issued by the VIE and purchased by 3rd party investors (1)	$	186,691		$	373,577
Outstanding amount of Senior Bonds at December 31, 2015 (1)	$	22,057		$	—
Pass-through rate for Senior Bonds issued	2.85		%	—		%
Face amount of Senior Support Certificates received by the Company (2)	$	217,103		$	455,063
Cash received	$	186,691		$	375,621
Notional amount acquired of non-rated, interest only senior certificates (1)	$	186,691		$	—
Unamortized deferred costs	$	190		$	—

(1) Amount disclosed reflects principal balances of the DMSI 2010-RS A1, A2 and A3 bonds. The DMSI 2010-RS2 A2 and A3 bonds were sold to third party investors during 2013. The principal balance of the DMSI 2010-RS2 A1 Bond and associated interest only Senior certificate was paid off during 2013. The principal balances of the DMSI 2010-RS2 A2 and A3 Bonds were paid off in January 2015 and September 2015, respectively.

(2)  Provides credit support for the sequential Senior Non-Agency MBS sold to third-party investors in resecuritization transactions (“Senior Bonds”).

XML

Summary of Quarterly Results of Operations (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2015

Quarterly Financial Information Disclosure [Abstract]

Summary of quarterly results of operations (unaudited)

	2015 Quarter Ended
(In Thousands, Except per Share Amounts)	March 31			June 30			September 30			December 31
Interest income	$	129,943		$	123,995		$	119,706		$	118,499
Interest expense	(43,940		)	(42,849		)	(43,703		)	(46,456		)
Net interest income	86,003			81,146			76,003			72,043
Net impairment losses recognized in earnings	(407		)	(298		)	—			—
Gain on sales of MBS	6,435			7,617			11,196			9,652
Net gain on residential whole loans held at fair value	2,034			3,224			5,565			6,899
Other income/(loss)	311			(678		)	(259		)	(831		)
Operating and other expense	(12,202		)	(12,940		)	(12,995		)	(14,292		)
Net income	82,174			78,071			79,510			73,471
Preferred stock dividends	(3,750		)	(3,750		)	(3,750		)	(3,750		)
Net income available to common stock and participating securities	$	78,424		$	74,321		$	75,760		$	69,721
Earnings per Common Share - Basic and Diluted	$	0.21		$	0.20		$	0.20		$	0.19

	2014 Quarter Ended
(In Thousands, Except per Share Amounts)	March 31			June 30			September 30			December 31
Interest income	$	121,174		$	119,294		$	112,157		$	111,192
Interest expense	(40,921		)	(40,569		)	(39,358		)	(38,960		)
Net interest income	80,253			78,725			72,799			72,232
Gain on sales of MBS	3,571			7,852			13,880			12,194
Unrealized net gains and net interest income from Linked Transactions	3,251			3,776			2,559			7,506
Net gain on residential whole loans held at fair value	—			—			—			116
Other (loss)/income	(416		)	56			54			386
Operating and other expense	(10,471		)	(11,683		)	(10,410		)	(12,726		)
Net income	76,188			78,726			78,882			79,708
Preferred stock dividends	(3,750		)	(3,750		)	(3,750		)	(3,750		)
Net income available to common stock and participating securities	$	72,438		$	74,976		$	75,132		$	75,958
Earnings per Common Share - Basic and Diluted	$	0.20		$	0.20		$	0.20		$	0.20

XML

Summary of Significant Accounting Policies - Residential Whole Loans, Cash and Goodwill (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2015 USD ($) segment	Dec. 31, 2014 USD ($)
Accounting Policies [Abstract]
Number of reportable segments | segment	1
Number of days considered to classify loans delinquent (less than)	60 days
LTV percentage (or less)	80.00%
Overnight money market funds	$ 120,400	$ 182,400
Restricted cash	71,538	67,255
Goodwill	$ 7,189	$ 7,189

XML

Summary of Significant Accounting Policies - Depreciation (Details) - Furniture, fixtures, computers and related hardwares	12 Months Ended
	Dec. 31, 2015
Low end of range
Estimated useful life of long-lived assets
Estimated useful life	5 years
High end of range
Estimated useful life of long-lived assets
Estimated useful life	8 years

XML

Summary of Significant Accounting Policies - Repurchase Agreements (Details)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Repurchase financing period, low end of range	1 month
Repurchase financing period, high end of range	6 months

XML

Summary of Significant Accounting Policies - Equity-Based Compensation, Taxes, Derivatives (Details)	12 Months Ended			36 Months Ended
	Dec. 31, 2015 USD ($) Component	Dec. 31, 2014	Dec. 31, 2010	Dec. 31, 2013
Share based compensation
Forfeiture rate assumption for equity based awards granted in 2009 and prior years (as a percent)	0.00%
Income Tax Disclosure
Percentage of annual REIT taxable income intended to be distributed to stockholders	100.00%
Income tax expense | $	$ 0
Derivative Instruments
Number of components of linked transactions | Component	2
Restricted Stock Units
Share based compensation
Vesting period of restricted share units (RSUs)	3 years	3 years
Restricted Stock Units | Minimum
Share based compensation
Vesting period of restricted share units (RSUs)			2 years	1 year
Period for measuring market condition of award			2 years
Restricted Stock Units | Maximum
Share based compensation
Vesting period of restricted share units (RSUs)			4 years	3 years
Period for measuring market condition of award			4 years

XML

Summary of Significant Accounting Policies-New Accounting Standards and Interpretations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accounting Policies [Abstract]
MBS securities recorded upon adoption of revised accounting standard for repurchase agreement financing	$ 1,913,000
CRT securities recorded upon adoption of revised accounting standard for repurchase agreement financing	4,600
Repurchase agreements recorded upon adoption of revised accounting standard for repurchase agreement financing	1,519,593	$ 0	$ 0
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	$ 4,537	$ 0	$ 0

XML

MBS and CRT Securities (Details) - USD ($)		12 Months Ended
		Dec. 31, 2015		Dec. 31, 2014	Dec. 31, 2013
Information about MBS and CRT securities
Minimum term of fixed rate mortgages underlying MBS		15 years
AFS fair value		$ 5,127,278,000
Principal/ Current Face		11,703,896,000		$ 11,039,694,000
Purchase Premiums		172,160,000		213,790,000
Accretable Purchase Discounts		(317,930,000)		(404,362,000)
Discount Designated as Credit Reserve and OTTI	[1]	(787,541,000)		(900,557,000)
Amortized Cost	[2]	10,771,616,000		9,949,107,000
Fair Value		11,356,643,000		10,762,622,000
Gross Unrealized Gains		656,956,000		852,963,000
Gross Unrealized Losses		71,929,000		39,448,000
AFS accumulated unrealized loss position		71,929,000
Net Unrealized Gain/(Loss)		585,027,000		813,515,000
Principal payments receivable		1,000,000		542,000
Total MBS
Information about MBS and CRT securities
AFS fair value		4,985,168,000
Principal/ Current Face		11,511,896,000		10,930,194,000
Purchase Premiums		172,160,000		213,790,000
Accretable Purchase Discounts		(312,241,000)		(399,635,000)
Discount Designated as Credit Reserve and OTTI	[1]	(787,541,000)		(900,557,000)
Amortized Cost	[2]	10,585,305,000		9,844,334,000
Fair Value		11,173,061,000		10,659,639,000
Gross Unrealized Gains		656,538,000		852,639,000
Gross Unrealized Losses		68,782,000		37,334,000
AFS accumulated unrealized loss position		68,782,000
Net Unrealized Gain/(Loss)		587,756,000		815,305,000
Agency MBS
Information about MBS and CRT securities
AFS fair value		2,284,421,000
Principal/ Current Face		4,550,403,000		5,610,293,000
Purchase Premiums		172,087,000		213,329,000
Accretable Purchase Discounts		(59,000)		(71,000)
Discount Designated as Credit Reserve and OTTI	[1]	0		0
Amortized Cost	[2]	4,723,462,000		5,824,093,000
Fair Value		4,752,244,000		5,904,207,000
Gross Unrealized Gains		69,207,000		113,736,000
Gross Unrealized Losses		40,425,000		33,622,000
AFS accumulated unrealized loss position		40,425,000
Net Unrealized Gain/(Loss)		28,782,000		80,114,000
Agency MBS | Fannie Mae
Information about MBS and CRT securities
AFS fair value		1,670,087,000
Principal/ Current Face		3,690,020,000		4,587,823,000
Purchase Premiums		139,243,000		174,245,000
Accretable Purchase Discounts		(59,000)		(71,000)
Discount Designated as Credit Reserve and OTTI	[1]	0		0
Amortized Cost	[2]	3,829,204,000		4,761,997,000
Fair Value		3,865,485,000		4,843,084,000
Gross Unrealized Gains		62,111,000		102,187,000
Gross Unrealized Losses		25,830,000		21,100,000
AFS accumulated unrealized loss position		25,830,000
Net Unrealized Gain/(Loss)		36,281,000		81,087,000
Agency MBS | Freddie Mac
Information about MBS and CRT securities
AFS fair value		614,334,000
Principal/ Current Face		851,087,000		1,011,659,000
Purchase Premiums		32,680,000		38,895,000
Accretable Purchase Discounts		0		0
Discount Designated as Credit Reserve and OTTI	[1]	0		0
Amortized Cost	[2]	884,798,000		1,051,096,000
Fair Value		877,109,000		1,049,854,000
Gross Unrealized Gains		6,906,000		11,280,000
Gross Unrealized Losses		14,595,000		12,522,000
AFS accumulated unrealized loss position		14,595,000
Net Unrealized Gain/(Loss)		(7,689,000)		(1,242,000)
Agency MBS | Ginnie Mae
Information about MBS and CRT securities
Principal/ Current Face		9,296,000		10,811,000
Purchase Premiums		164,000		189,000
Accretable Purchase Discounts		0		0
Discount Designated as Credit Reserve and OTTI	[1]	0		0
Amortized Cost	[2]	9,460,000		11,000,000
Fair Value		9,650,000		11,269,000
Gross Unrealized Gains		190,000		269,000
Gross Unrealized Losses		0		0
Net Unrealized Gain/(Loss)		190,000		269,000
Non-Agency MBS
Information about MBS and CRT securities
AFS fair value		2,700,747,000
Principal/ Current Face	[3]	6,961,493,000		5,319,901,000
Purchase Premiums	[3]	73,000		461,000
Accretable Purchase Discounts	[3]	(312,182,000)		(399,564,000)
Discount Designated as Credit Reserve and OTTI	[1],[3]	(787,541,000)		(900,557,000)
Amortized Cost	[2],[3]	5,861,843,000		4,020,241,000
Fair Value	[3]	6,420,817,000		4,755,432,000
Gross Unrealized Gains	[3]	587,331,000		738,903,000
Gross Unrealized Losses	[3]	28,357,000		3,712,000
AFS accumulated unrealized loss position		28,357,000
Net Unrealized Gain/(Loss)	[3]	558,974,000		735,191,000
Credit Reserve		766,000,000		877,600,000
OTTI		21,500,000		23,000,000
Credit-related OTTI losses		705,000		0	$ 0
Non-Agency MBS | Expected to Recover Par
Information about MBS and CRT securities
AFS fair value	[4]	2,452,002,000
Principal/ Current Face	[5],[6]	2,906,878,000		431,788,000
Purchase Premiums	[5],[6]	73,000		461,000
Accretable Purchase Discounts	[5],[6]	(31,576,000)		(29,501,000)
Discount Designated as Credit Reserve and OTTI	[1],[5],[6]	0		0
Amortized Cost	[2],[5],[6]	2,875,375,000		402,748,000
Fair Value	[5],[6]	2,878,532,000		428,431,000
Gross Unrealized Gains	[5],[6]	23,300,000		26,735,000
Gross Unrealized Losses	[5],[6]	20,143,000		1,052,000
AFS accumulated unrealized loss position	[4]	20,143,000
Net Unrealized Gain/(Loss)	[5],[6]	3,157,000		25,683,000
Non-Agency MBS | Expected to Recover Less Than Par
Information about MBS and CRT securities
AFS fair value	[4]	248,745,000
Principal/ Current Face	[6]	4,054,615,000		4,888,113,000
Purchase Premiums	[6]	0		0
Accretable Purchase Discounts	[6]	(280,606,000)		(370,063,000)
Discount Designated as Credit Reserve and OTTI	[1],[6]	(787,541,000)		(900,557,000)
Amortized Cost	[2],[6]	2,986,468,000		3,617,493,000
Fair Value	[6]	3,542,285,000		4,327,001,000
Gross Unrealized Gains	[6]	564,031,000		712,168,000
Gross Unrealized Losses	[6]	8,214,000		2,660,000
AFS accumulated unrealized loss position	[4]	8,214,000
Net Unrealized Gain/(Loss)	[6]	$ 555,817,000		$ 709,508,000
Current face amount of non-Agency MBS expected to be recovered (percent)		89.00%		83.00%
CRT securities
Information about MBS and CRT securities
AFS fair value	[7]	$ 142,110,000
Principal/ Current Face		192,000,000	[8]	$ 109,500,000
Purchase Premiums		0	[8]	0
Accretable Purchase Discounts		(5,689,000)	[8]	(4,727,000)
Discount Designated as Credit Reserve and OTTI	[1]	0	[8]	0
Amortized Cost	[2]	186,311,000	[8]	104,773,000
Fair Value		183,582,000	[8]	102,983,000
Gross Unrealized Gains		418,000	[8]	324,000
Gross Unrealized Losses		3,147,000	[8]	2,114,000
AFS accumulated unrealized loss position	[7]	3,147,000
Net Unrealized Gain/(Loss)		$ (2,729,000)	[8]	(1,790,000)
RPL/NPL MBS
Information about MBS and CRT securities
Basis points for coupon step-up		300.00%
Coupon step-up period		36 months
Principal/ Current Face		$ 2,648,000,000		161,000,000
Amortized Cost		2,645,000,000		161,000,000
Fair Value		2,626,000,000		161,000,000
Gross Unrealized Losses	[3]	19,300,000
Legacy Non-Agency MBS
Information about MBS and CRT securities
Gross Unrealized Losses	[3]	9,100,000
Linked Transactions
Information about MBS and CRT securities
Par/Current Face				1,926,987,000
Amortized Cost				1,913,276,000
Fair Value				1,917,813,000
Linked Transactions | CRT securities
Information about MBS and CRT securities
Par/Current Face				4,500,000
Amortized Cost				4,500,000
Fair Value				4,624,000
Linked Transactions | RPL/NPL MBS
Information about MBS and CRT securities
Par/Current Face				1,849,974,000
Amortized Cost				1,847,118,000
Fair Value				1,846,807,000
Linked Transactions | Legacy Non-Agency MBS
Information about MBS and CRT securities
Par/Current Face				72,513,000
Amortized Cost				61,658,000
Fair Value				$ 66,382,000
Debt Securities | CRT securities
Information about MBS and CRT securities
AFS fair value		54,100,000
Fair Value		62,200,000
Gross Unrealized Gains		332,000
Gross Unrealized Losses		555,000
Net Unrealized Gain/(Loss)		$ 223,000

[1] Discount designated as Credit Reserve and amounts related to OTTI are generally not expected to be accreted into interest income. Amounts disclosed at December 31, 2015 reflect Credit Reserve of $766.0 million and OTTI of $21.5 million. Amounts disclosed at December 31, 2014 reflect Credit Reserve of $877.6 million and OTTI of $23.0 million.

[2] Includes principal payments receivable of $1.0 million and $542,000 at December 31, 2015 and 2014, respectively, which are not included in the Principal/Current Face.

[3] At December 31, 2015 and 2014, the Company expected to recover approximately 89% and 83%, respectively, of the then-current face amount of Non-Agency MBS.

[4] Based on management’s current estimates of future principal cash flows expected to be received.

[5] At December 31, 2015 RPL/NPL MBS had a $2.648 billion Principal/Current face, $2.645 billion amortized cost and $2.626 billion fair value. At December 31, 2014, RPL/NPL MBS had a $161.0 million Principal/Current face, $161.0 million amortized cost and $161.0 million fair value (excludes RPL/NPL MBS with $1.850 billion Principal/Current face, $1.847 billion amortized cost and $1.847 billion fair value that were presented as a component of Linked Transactions at December 31, 2014).

[6] Based on management’s current estimates of future principal cash flows expected to be received.

[7] Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $54.1 million for which the fair value option has been elected. Such securities have unrealized losses of $555,000 at December 31, 2015.

[8] Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $62.2 million for which the fair value option has been elected. Such securities have gross unrealized gains of approximately $332,000, gross unrealized losses of approximately $555,000 and net unrealized losses of approximately $223,000 at December 31, 2015.

XML

MBS and CRT Securities (Details 2)		3 Months Ended				12 Months Ended
		Dec. 31, 2015 USD ($) Security	Sep. 30, 2015 USD ($)	Jun. 30, 2015 USD ($)	Mar. 31, 2015 USD ($)	Dec. 31, 2015 USD ($) Security	Dec. 31, 2014 USD ($)		Dec. 31, 2013 USD ($)
Fair Value
Less than 12 months		$ 3,717,037,000				$ 3,717,037,000
12 months or more		1,410,241,000				1,410,241,000
Total		5,127,278,000				5,127,278,000
Unrealized Losses
Less than 12 months		36,748,000				36,748,000
12 months or more		35,181,000				35,181,000
Total		$ 71,929,000				$ 71,929,000
Number of Securities
Less than 12 Months | Security		290				290
12 Months or more | Security		197				197
OTTI charges recorded
Total OTTI losses						$ (525,000)	$ 0		$ 0
OTTI reclassified from OCI						(180,000)	0		0
Net Impairment Losses Recognized in Earnings		$ 0	$ 0	$ (298,000)	$ (407,000)	(705,000)	0		0
Roll-forward of the credit loss component of OTTI
Credit loss component of OTTI at beginning of period					36,115,000	36,115,000	36,115,000		36,115,000
Additions for credit related OTTI not previously recognized						461,000	0		0
Subsequent additional credit related OTTI recorded						244,000	0		0
Credit loss component of OTTI at end of period		36,820,000				36,820,000	36,115,000		36,115,000
Changes in the components of the purchase discount on Non-Agency MBS
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing						4,537,000	0		0
Accumulated other comprehensive income from MBS and CRT securities:
Unrealized gain on AFS securities at beginning of period					813,515,000	813,515,000	752,912,000		824,808,000
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing						4,537,000	0		0
Reclassification adjustment for MBS sales included in net income						(37,207,000)	(34,948,000)		(19,833,000)
Reclassification adjustment for OTTI included in net income						(705,000)	0		0
Change in AOCI from AFS securities						(228,265,000)	60,603,000		(71,896,000)
Balance at end of period		585,250,000				585,250,000	813,515,000		752,912,000
Total MBS
Fair Value
Less than 12 months		3,579,452,000				3,579,452,000
12 months or more		1,405,716,000				1,405,716,000
Total		4,985,168,000				4,985,168,000
Unrealized Losses
Less than 12 months		34,076,000				34,076,000
12 months or more		34,706,000				34,706,000
Total		$ 68,782,000				$ 68,782,000
Number of Securities
Less than 12 Months | Security		257				257
12 Months or more | Security		196				196
Agency MBS
Fair Value
Less than 12 months		$ 1,155,370,000				$ 1,155,370,000
12 months or more		1,129,051,000				1,129,051,000
Total		2,284,421,000				2,284,421,000
Unrealized Losses
Less than 12 months		13,011,000				13,011,000
12 months or more		27,414,000				27,414,000
Total		$ 40,425,000				$ 40,425,000
Number of Securities
Less than 12 Months | Security		163				163
12 Months or more | Security		173				173
Accumulated other comprehensive income from MBS and CRT securities:
Unrealized (loss)/gain on MBS and CRT securities, net						$ (51,332,000)	65,739,000		(186,568,000)
MBS and CRT securities Interest Income
Coupon interest						147,066,000	189,355,000		213,995,000
Effective yield adjustment	[1]					(41,231,000)	(46,812,000)		(57,949,000)
Interest income						105,835,000	142,543,000		156,046,000
Agency MBS | Fannie Mae
Fair Value
Less than 12 months		$ 856,602,000				856,602,000
12 months or more		813,485,000				813,485,000
Total		1,670,087,000				1,670,087,000
Unrealized Losses
Less than 12 months		7,548,000				7,548,000
12 months or more		18,282,000				18,282,000
Total		$ 25,830,000				$ 25,830,000
Number of Securities
Less than 12 Months | Security		121				121
12 Months or more | Security		109				109
Agency MBS | Freddie Mac
Fair Value
Less than 12 months		$ 298,768,000				$ 298,768,000
12 months or more		315,566,000				315,566,000
Total		614,334,000				614,334,000
Unrealized Losses
Less than 12 months		5,463,000				5,463,000
12 months or more		9,132,000				9,132,000
Total		$ 14,595,000				$ 14,595,000
Number of Securities
Less than 12 Months | Security		42				42
12 Months or more | Security		64				64
Non-Agency MBS
Fair Value
Less than 12 months		$ 2,424,082,000				$ 2,424,082,000
12 months or more		276,665,000				276,665,000
Total		2,700,747,000				2,700,747,000
Unrealized Losses
Less than 12 months		21,065,000				21,065,000
12 months or more		7,292,000				7,292,000
Total		$ 28,357,000				$ 28,357,000
Number of Securities
Less than 12 Months | Security		94				94
12 Months or more | Security		23				23
Credit-related OTTI losses						$ 705,000	0		0
Changes in the components of the purchase discount on Non-Agency MBS
Purchase discount pertaining to linked transactions designated as accretable purchase discount reallocated to credit reserve							218,000
Accumulated other comprehensive income from MBS and CRT securities:
Unrealized (loss)/gain on MBS and CRT securities, net						(143,558,000)	29,812,000		134,505,000
Sales of MBS
Proceeds from Sale of Mortgage Backed Securities (MBS) categorized as Available-for-sale						70,700,000	123,900,000		152,600,000
Gain (Loss) on Sales of Mortgage Backed Securities (MBS)						34,900,000	37,500,000		25,800,000
Non-Agency MBS | Discount Designated as Credit Reserve and OTTI
Changes in the components of the purchase discount on Non-Agency MBS
Balance at beginning of period	[2]				(900,557,000)	(900,557,000)	(1,043,037,000)
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing						(15,543,000)	0	[2]
Accretion of discount						0	0	[2]
Realized credit losses						80,821,000	89,481,000	[2]
Purchases						(1,200,000)	(80,256,000)	[2]
Sales						8,525,000	44,692,000	[2]
Unlinking of Linked Transactions						0	(6,414,000)	[2]
Transfers/release of credit reserve						41,118,000	94,977,000	[2]
Balance at end of period		$ (787,541,000)				(787,541,000)	(900,557,000)	[2]	(1,043,037,000)	[2]
Accumulated other comprehensive income from MBS and CRT securities:
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing						(15,543,000)	0	[2]
MBS and CRT securities Interest Income
Available For Sale Securities Changes in Purchase Discount Due to Net Impairment Losses Recognized in Earnings						(705,000)	0	[2]
Non-Agency MBS | Accretable Discount
Changes in the components of the purchase discount on Non-Agency MBS
Balance at beginning of period	[2],[3]				$ (399,564,000)	(399,564,000)	(460,039,000)
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	[3]					1,832,000	0	[2]
Accretion of discount	[3]					93,173,000	103,653,000	[2]
Realized credit losses	[3]					0	0	[2]
Purchases	[3]					(4,925,000)	30,003,000	[2]
Sales	[3]					38,420,000	20,360,000	[2]
Unlinking of Linked Transactions	[3]					0	1,436,000	[2]
Transfers/release of credit reserve	[3]					(41,118,000)	(94,977,000)	[2]
Balance at end of period	[3]	(312,182,000)				(312,182,000)	(399,564,000)	[2]	(460,039,000)	[2]
Accumulated other comprehensive income from MBS and CRT securities:
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	[3]					1,832,000	0	[2]
MBS and CRT securities Interest Income
Available For Sale Securities Changes in Purchase Discount Due to Net Impairment Losses Recognized in Earnings	[3]					0	0	[2]
Non-Agency MBS | Expected to Recover Par
Fair Value
Less than 12 months	[4]	2,239,418,000				2,239,418,000
12 months or more	[4]	212,584,000				212,584,000
Total	[4]	2,452,002,000				2,452,002,000
Unrealized Losses
Less than 12 months	[4]	16,717,000				16,717,000
12 months or more	[4]	3,426,000				3,426,000
Total	[4]	$ 20,143,000				$ 20,143,000
Number of Securities
Less than 12 Months | Security	[4]	59				59
12 Months or more | Security	[4]	12				12
Non-Agency MBS | Expected to Recover Less Than Par
Fair Value
Less than 12 months	[4]	$ 184,664,000				$ 184,664,000
12 months or more	[4]	64,081,000				64,081,000
Total	[4]	248,745,000				248,745,000
Unrealized Losses
Less than 12 months	[4]	4,348,000				4,348,000
12 months or more	[4]	3,866,000				3,866,000
Total	[4]	$ 8,214,000				$ 8,214,000
Number of Securities
Less than 12 Months | Security	[4]	35				35
12 Months or more | Security	[4]	11				11
Legacy Non-Agency MBS
MBS and CRT securities Interest Income
Coupon interest						$ 183,349,000	212,073,000		253,560,000
Effective yield adjustment	[5]					91,003,000	103,491,000		73,189,000
Interest income						274,352,000	315,564,000		326,749,000
CRT securities
Fair Value
Less than 12 months	[6]	$ 137,585,000				137,585,000
12 months or more	[6]	4,525,000				4,525,000
Total	[6]	142,110,000				142,110,000
Unrealized Losses
Less than 12 months	[6]	2,672,000				2,672,000
12 months or more	[6]	475,000				475,000
Total	[6]	$ 3,147,000				$ 3,147,000
Number of Securities
Less than 12 Months | Security	[6]	33				33
12 Months or more | Security	[6]	1				1
MBS and CRT securities Interest Income
Coupon interest						$ 5,844,000	665,000		0
Effective yield adjustment	[5]					728,000	107,000		0
Interest income						6,572,000	772,000		0
RPL/NPL MBS
MBS and CRT securities Interest Income
Coupon interest						87,429,000	898,000		21,000
Effective yield adjustment	[5]					1,789,000	(132,000)		0
Interest income						$ 89,218,000	$ 766,000		$ 21,000

[1] Includes amortization of premium paid net of accretion of purchase discount. For Agency MBS, interest income is recorded at an effective yield, which reflects net premium amortization based on actual prepayment activity.

[2] The Company reallocated $218,000 of purchase discount designated as Credit Reserve to accretable purchase discount on Non-Agency MBS underlying Linked Transactions for the year ended December 31, 2014.

[3] Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.

[4] Based on management’s current estimates of future principal cash flows expected to be received.

[5] The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield.

[6] Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $54.1 million for which the fair value option has been elected. Such securities have unrealized losses of $555,000 at December 31, 2015.

XML

Residential Whole Loans - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Residential Whole Loans [Abstract]
Residential Whole Loans	$ 895,100				$ 351,400				$ 895,100	$ 351,400
Equity interest in certificates (percent)	100.00%								100.00%
Residential whole loans at carrying value	$ 271,845				207,923				$ 271,845	207,923
Provisions for loan losses									1,028	137
Net gain on residential whole loans held at fair value	$ 6,899	$ 5,565	$ 3,224	$ 2,034	$ 116	$ 0	$ 0	$ 0	$ 17,722	$ 116	$ 0

XML

Residential Whole Loans at Carrying Value-Provision for Loan Losses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Allowance for Loan and Lease Losses [Roll Forward]
Balance at the beginning of period	$ 1,165	$ 137	$ 0
Provisions for loan losses	1,028	137
Balance at the end of period	$ 1,165	$ 137

XML

Residential Whole Loans at Carrying Value (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Residential Whole Loans [Abstract]
Contractually required principal and interest	$ 160,806	$ 448,453
Contractual cash flows not expected to be collected (non-accretable yield)	(27,040)	(100,466)
Expected cash flows to be collected	133,766	347,987
Interest component of expected cash flows (accretable yield)	(51,413)	(135,425)
Fair value at the date of acquisition	$ 82,353	$ 212,562

XML

Residential Whole Loans at Carrying Value Accretable Yield Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Residential Whole Loans [Roll Forward]
Accretable yield, beginning balance	$ 133,012	$ 0
Additions	51,413	135,425
Accretion	(15,511)	(3,996)
Reclassifications to non-accretable difference, net	6,357	1,583
Accretable yield, ending balance	$ 175,271	$ 133,012

XML

Residential Whole Loans - Fair Value (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2015 USD ($) loan	Dec. 31, 2014 USD ($) loan
Residential Whole Loans [Abstract]
Outstanding principal balance	$ 786,330	$ 182,613
Aggregate fair value	$ 623,276	$ 143,472
Number of loans | loan	3,143	885

XML

Residential Whole Loans-Fair Value Components of Net Income (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Residential Whole Loans [Abstract]
Coupon payments and other income received									$ 9,303	$ 504
Net unrealized gains									6,540	(427)
Net gain on payoff/liquidation of loans									1,879	39
Total	$ 6,899	$ 5,565	$ 3,224	$ 2,034	$ 116	$ 0	$ 0	$ 0	$ 17,722	$ 116	$ 0

XML

Interest Receivable (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Interest receivable by investment category
Interest receivable	$ 29,002	$ 32,581
Total MBS
Interest receivable by investment category
Interest receivable	26,629	31,170
Fannie Mae
Interest receivable by investment category
Interest receivable	8,999	11,761
Freddie Mac
Interest receivable by investment category
Interest receivable	2,177	2,598
Ginnie Mae
Interest receivable by investment category
Interest receivable	15	17
Non-Agency MBS
Interest receivable by investment category
Interest receivable	15,438	16,794
Residential Whole Loans
Interest receivable by investment category
Interest receivable	2,259	1,324
CRT securities
Interest receivable by investment category
Interest receivable	92	66
Money market and other investments
Interest receivable by investment category
Interest receivable	$ 22	$ 21

XML

Derivative Instruments (Details) - USD ($) $ in Thousands		Dec. 31, 2015	Dec. 31, 2014
Derivatives
Derivative assets, Fair Value		$ 1,127	$ 3,136
Linked Transactions | Non-Hedging | Assets
Derivatives
Linked Transactions, Fair Value			398,336
Swaps | Hedging | Assets | Non-cleared legacy swaps
Derivatives
Derivative assets, Notional Amount	[1]	450,000	450,000
Derivative assets, Fair Value	[1]	1,127	3,136
Swaps | Hedging | Liability | Non-cleared legacy swaps
Derivatives
Derivative liabilities, Notional Amount	[1]	50,000	760,170
Derivative liabilities, Fair Value	[1]	(59)	(4,263)
Swaps | Hedging | Liability | Cleared swaps
Derivatives
Derivative liabilities, Notional Amount	[2]	2,550,000	2,550,000
Derivative liabilities, Fair Value	[2]	$ (70,467)	$ (57,935)

[1] Non-cleared legacy Swaps include Swaps executed and settled bilaterally with counterparties without the use of an organized exchange or central clearing house.

[2] Cleared Swaps include Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties.

XML

Derivative Instruments (Details 2) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Derivatives
MBS securities recorded upon adoption of revised accounting standard for repurchase agreement financing	$ 1,913,000
CRT securities recorded upon adoption of revised accounting standard for repurchase agreement financing	4,600
Repurchase agreements recorded upon adoption of revised accounting standard for repurchase agreement financing	1,519,593	$ 0	$ 0
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing	4,537	0	0
Components of unrealized net gains and interest income from Linked Transactions
Change in fair value of Linked Transactions included in earnings	0	1,673	1,111
Legacy Non-Agency MBS
Components of unrealized net gains and interest income from Linked Transactions
Interest income attributable to MBS underlying Linked Transactions	274,352	315,564	326,749
RPL/NPL MBS
Components of unrealized net gains and interest income from Linked Transactions
Interest income attributable to MBS underlying Linked Transactions	89,218	766	21
CRT securities
Components of unrealized net gains and interest income from Linked Transactions
Interest income attributable to MBS underlying Linked Transactions	$ 6,572	772	0
Linked Transactions
Linked Repurchase Agreements
Balance		$ 1,519,593
Weighted Average Interest Rate		1.47%
Linked MBS
Fair Value		$ 1,917,813
Amortized Cost		1,913,276
Par/Current Face		$ 1,926,987
Weighted Average Coupon Rate		3.52%
Accrued interest receivable		$ 1,300
Accrued interest payable		1,100
Components of unrealized net gains and interest income from Linked Transactions
Interest income attributable to MBS underlying Linked Transactions		24,443	3,869
Interest expense attributable to linked repurchase agreement borrowings underlying Linked Transactions		(8,028)	(925)
Change in fair value of Linked Transactions included in earnings		677	281
Unrealized net gains and net interest income from Linked Transactions		17,092	$ 3,225
Linked Transactions | Legacy Non-Agency MBS
Linked MBS
Fair Value		66,382
Amortized Cost		61,658
Par/Current Face		$ 72,513
Weighted Average Coupon Rate		4.20%
Linked Transactions | RPL/NPL MBS
Linked MBS
Fair Value		$ 1,846,807
Amortized Cost		1,847,118
Par/Current Face		$ 1,849,974
Weighted Average Coupon Rate		3.49%
Linked Transactions | CRT securities
Linked MBS
Fair Value		$ 4,624
Amortized Cost		4,500
Par/Current Face		$ 4,500
Weighted Average Coupon Rate		4.56%
Linked Transactions | Within 30 days
Linked Repurchase Agreements
Balance		$ 1,514,393
Weighted Average Interest Rate		1.47%
Linked Transactions | Over 30 days to 90 days
Linked Repurchase Agreements
Balance		$ 5,200
Weighted Average Interest Rate		1.35%

XML

Derivative Instruments (Details 3)		3 Months Ended								12 Months Ended
		Dec. 31, 2015 USD ($)	Sep. 30, 2015 USD ($)	Jun. 30, 2015 USD ($)	Mar. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Sep. 30, 2014 USD ($)	Jun. 30, 2014 USD ($)	Mar. 31, 2014 USD ($)	Dec. 31, 2015 USD ($) derivative	Dec. 31, 2014 USD ($) derivative	Dec. 31, 2013 USD ($)
Derivatives
Assets pledged		$ 11,410,397,000				$ 10,058,769,000				$ 11,410,397,000	$ 10,058,769,000
Number of derivatives terminated | derivative										0	0
Interest expense attributable to Swaps		46,456,000	$ 43,703,000	$ 42,849,000	$ 43,940,000	38,960,000	$ 39,358,000	$ 40,569,000	$ 40,921,000	$ 176,948,000	$ 159,808,000	$ 164,013,000
(Losses)/gains on TBA short positions										0	0	7,517,000
AOCI from derivative hedging instruments
Balance at beginning of period					$ (59,062,000)				$ (15,217,000)	(59,062,000)	(15,217,000)	(62,831,000)
Unrealized (loss)/gain on Swaps, net										(10,337,000)	(44,292,000)	47,614,000
Reclassification of unrealized loss on de-designated derivative hedging instruments										0	447,000	0
Balance at end of period		(69,399,000)				(59,062,000)				(69,399,000)	(59,062,000)	(15,217,000)
TBA | Non-Hedging
Derivatives
Aggregate notional amount of derivatives		0				0				0	0	$ 350,000,000
Debt instrument, term												15 years
Stated interest rate (as a percent)												2.50%
(Losses)/gains on TBA short positions												$ 7,500,000
Swap contracts
Derivatives
Aggregate fair value of assets needed to immediately settle		72,000,000								72,000,000
Associated accrued interest payable		1,500,000								1,500,000
Assets pledged		109,142,000				123,733,000				109,142,000	123,733,000
Swap contracts | Agency MBS, at fair value
Derivatives
Assets pledged		38,569,000				57,247,000				38,569,000	57,247,000
Swap contracts | Restricted cash
Derivatives
Assets pledged		70,573,000				66,486,000				$ 70,573,000	66,486,000
Swaps
Derivatives
Average maturity term of swaps										45 months
Maximum maturity term of swaps										92 months
Aggregate notional amount of derivatives	[1]	$ 3,050,000,000				$ 3,760,170,000				$ 3,050,000,000	$ 3,760,170,000
Weighted Average Fixed-Pay Interest Rate (as a percent)	[1]	1.82%				1.85%				1.82%	1.85%
Weighted Average Variable Interest Rate (as a percent)	[1],[2]	0.34%				0.16%				0.34%	0.16%
Interest expense attributable to Swaps										$ 53,759,000	$ 69,842,000	$ 59,031,000
Weighted average Swap rate paid										1.86%	1.93%	2.08%
Weighted average Swap rate received										0.19%	0.16%	0.19%
Swaps | Hedging
AOCI from derivative hedging instruments
Balance at end of period		$ (69,400,000)								$ (69,400,000)
Swaps | Within 30 days
Derivatives
Aggregate notional amount of derivatives	[1]	$ 50,000,000				$ 22,290,000				$ 50,000,000	$ 22,290,000
Weighted Average Fixed-Pay Interest Rate (as a percent)	[1]	2.13%				3.63%				2.13%	3.63%
Weighted Average Variable Interest Rate (as a percent)	[1],[2]	0.42%				0.23%				0.42%	0.23%
Swaps | Over 30 days to 3 months
Derivatives
Aggregate notional amount of derivatives	[1]	$ 0				$ 387,880,000				$ 0	$ 387,880,000
Weighted Average Fixed-Pay Interest Rate (as a percent)	[1]	0.00%				1.80%				0.00%	1.80%
Weighted Average Variable Interest Rate (as a percent)	[1],[2]	0.00%				0.16%				0.00%	0.16%
Swaps | Over 3 months to 6 months
Derivatives
Aggregate notional amount of derivatives	[1]	$ 0				$ 300,000,000				$ 0	$ 300,000,000
Weighted Average Fixed-Pay Interest Rate (as a percent)	[1]	0.00%				2.06%				0.00%	2.06%
Weighted Average Variable Interest Rate (as a percent)	[1],[2]	0.00%				0.17%				0.00%	0.17%
Swaps | Over 6 months to 12 months
Derivatives
Aggregate notional amount of derivatives	[1]	$ 100,000,000				$ 0				$ 100,000,000	$ 0
Weighted Average Fixed-Pay Interest Rate (as a percent)	[1]	0.48%				0.00%				0.48%	0.00%
Weighted Average Variable Interest Rate (as a percent)	[1],[2]	0.32%				0.00%				0.32%	0.00%
Swaps | Over 12 months to 24 months
Derivatives
Aggregate notional amount of derivatives	[1]	$ 350,000,000				$ 150,000,000				$ 350,000,000	$ 150,000,000
Weighted Average Fixed-Pay Interest Rate (as a percent)	[1]	0.58%				1.03%				0.58%	1.03%
Weighted Average Variable Interest Rate (as a percent)	[1],[2]	0.27%				0.16%				0.27%	0.16%
Swaps | Over 24 months to 36 months
Derivatives
Aggregate notional amount of derivatives	[1]	$ 550,000,000				$ 350,000,000				$ 550,000,000	$ 350,000,000
Weighted Average Fixed-Pay Interest Rate (as a percent)	[1]	1.49%				0.58%				1.49%	0.58%
Weighted Average Variable Interest Rate (as a percent)	[1],[2]	0.32%				0.16%				0.32%	0.16%
Swaps | Over 36 months to 48 months
Derivatives
Aggregate notional amount of derivatives	[1]	$ 200,000,000				$ 550,000,000				$ 200,000,000	$ 550,000,000
Weighted Average Fixed-Pay Interest Rate (as a percent)	[1]	1.71%				1.49%				1.71%	1.49%
Weighted Average Variable Interest Rate (as a percent)	[1],[2]	0.42%				0.16%				0.42%	0.16%
Swaps | Over 48 months to 60 months
Derivatives
Aggregate notional amount of derivatives	[1]	$ 1,500,000,000				$ 200,000,000				$ 1,500,000,000	$ 200,000,000
Weighted Average Fixed-Pay Interest Rate (as a percent)	[1]	2.22%				1.71%				2.22%	1.71%
Weighted Average Variable Interest Rate (as a percent)	[1],[2]	0.36%				0.17%				0.36%	0.17%
Swaps | Over 60 months to 72 months
Derivatives
Aggregate notional amount of derivatives	[1]	$ 200,000,000				$ 1,500,000,000				$ 200,000,000	$ 1,500,000,000
Weighted Average Fixed-Pay Interest Rate (as a percent)	[1]	2.20%				2.22%				2.20%	2.22%
Weighted Average Variable Interest Rate (as a percent)	[1],[2]	0.30%				0.16%				0.30%	0.16%
Swaps | Over 72 months to 84 months
Derivatives
Aggregate notional amount of derivatives	[1]	$ 0				$ 200,000,000				$ 0	$ 200,000,000
Weighted Average Fixed-Pay Interest Rate (as a percent)	[1]	0.00%				2.20%				0.00%	2.20%
Weighted Average Variable Interest Rate (as a percent)	[1],[2]	0.00%				0.17%				0.00%	0.17%
Swaps | Over 84 months
Derivatives
Aggregate notional amount of derivatives	[1],[3]	$ 100,000,000				$ 100,000,000				$ 100,000,000	$ 100,000,000
Weighted Average Fixed-Pay Interest Rate (as a percent)	[1],[3]	2.75%				2.75%				2.75%	2.75%
Weighted Average Variable Interest Rate (as a percent)	[1],[2],[3]	0.40%				0.16%				0.40%	0.16%
Swaps | New Swaps
Derivatives
Notional amount of derivative entered										$ 0
Number of new derivatives | derivative										0
Weighted Average Fixed-Pay Interest Rate (as a percent)		0.00%								0.00%
Swaps | Swaps amortized expired
Derivatives
Aggregate notional amount of derivatives expired										$ 710,170,000
Swaps | Minimum | London Interbank Offered Rate (LIBOR)
Derivatives
Derivative, variable interest rate, term										1 month
Swaps | Maximum | London Interbank Offered Rate (LIBOR)
Derivatives
Derivative, variable interest rate, term										3 months
YTD | Swaps | Swaps amortized expired
Derivatives
Weighted Average Fixed-Pay Interest Rate (as a percent)		1.96%								1.96%

[1] Each maturity category reflects contractual amortization and/or maturity of notional amounts.

[2] Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively.

[3] Reflects one Swap with a maturity date of July 2023.

XML

Real Estate Owned (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2015 USD ($) property		Dec. 31, 2014 USD ($) property		Dec. 31, 2013 USD ($)
Real Estate Properties [Line Items]
Number of real estate properties owned | property	182		46
Other Real Estate	$ 28,000
Number of real estate properties acquired during period | property	13		24
Number of real estate properties transferred during period | property	186		22
Real estate acquired through foreclosure	$ 26,100
Number of Real Estate Properties Sold During Period | property	63
Proceeds from Sale of Real Estate	$ 6,500
Gains (losses) on sales of other real estate	76
Real Estate Owned [Roll Forward]
Balance at beginning of period	5,492		$ 0
Adjustments to record at lower of cost or fair value	(3,475)		0
Transfer from residential whole loans (1)	30,104	[1]	2,904	[1]	$ 0
Purchases and capital improvements	2,461		2,588
Disposals	(6,556)		0
Balance at end of period	28,026		5,492		$ 0
Gain recorded on transfer from residential whole loans to real estate owned	1,700		331
Fair value
Real Estate Properties [Line Items]
Foreclosure in process	394,900
Real Estate Owned [Roll Forward]
Transfer from residential whole loans (1)	30,100		2,900
Carrying value
Real Estate Properties [Line Items]
Foreclosure in process	17,300
Residential Real Estate
Real Estate Owned [Roll Forward]
Purchases and capital improvements	$ 1,700		$ 2,600

[1] Includes net gain recorded on transfer of approximately $1.7 million and $331,000, respectively, for the years ended December 31, 2015 and 2014.

XML

Repurchase Agreements and Other Advances (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014
Repurchase agreements
Repurchase Agreements
Weighted average remaining term-to-interest rate reset of borrowings under repurchase agreements		21 days	25 days
Effective repricing period		18 months	21 months
Balance of repurchase agreements		$ 7,888,902	$ 8,267,388	[1]
Weighted Average Interest Rate		1.48%	0.79%
Repurchase agreements | Overnight
Repurchase Agreements
Balance of repurchase agreements		$ 0
Weighted Average Interest Rate		0.00%
Repurchase agreements | Within 30 days
Repurchase Agreements
Balance of repurchase agreements		$ 5,742,349
Weighted Average Interest Rate		1.27%
Repurchase agreements | Over 30 days to 90 days
Repurchase Agreements
Balance of repurchase agreements		$ 938,181
Weighted Average Interest Rate		1.71%
Repurchase agreements | Over 90 days to 12 months
Repurchase Agreements
Balance of repurchase agreements		$ 1,014,263
Weighted Average Interest Rate		2.19%
Repurchase agreements | Over 12 Months
Repurchase Agreements
Balance of repurchase agreements		$ 194,109
Weighted Average Interest Rate		3.11%
Repurchase agreements | Interest Rate Reset within 30 Days
Repurchase Agreements
Balance of repurchase agreements		$ 7,054,483	$ 7,144,737	[1]
Weighted Average Interest Rate		1.44%	0.72%
Repurchase agreements | Interest Rate Reset Over 30 Days to 3 Months
Repurchase Agreements
Balance of repurchase agreements		$ 734,955	$ 1,000,313	[1]
Weighted Average Interest Rate		1.79%	1.12%
Repurchase agreements | Interest Rate Reset Over 6 Months to 12 Months
Repurchase Agreements
Balance of repurchase agreements		$ 99,464	$ 122,338	[1]
Weighted Average Interest Rate		2.36%	1.98%
Repurchase agreements | Agency MBS
Repurchase Agreements
Balance of repurchase agreements		$ 2,727,542	$ 5,177,835
Fair Value of assets pledged as collateral under repurchase agreements		$ 2,881,049	$ 5,462,566
Weighted average haircut (as a percent)	[2]	4.67%	4.79%
Repurchase agreements | Agency MBS | Overnight
Repurchase Agreements
Balance of repurchase agreements		$ 0
Repurchase agreements | Agency MBS | Within 30 days
Repurchase Agreements
Balance of repurchase agreements		2,563,741
Repurchase agreements | Agency MBS | Over 30 days to 90 days
Repurchase Agreements
Balance of repurchase agreements		163,801
Repurchase agreements | Agency MBS | Over 90 days to 12 months
Repurchase Agreements
Balance of repurchase agreements		0
Repurchase agreements | Agency MBS | Over 12 Months
Repurchase Agreements
Balance of repurchase agreements		0
Repurchase agreements | Legacy Non-Agency MBS
Repurchase Agreements
Balance of repurchase agreements	[3]	1,960,222	$ 2,233,236
Fair Value of assets pledged as collateral under repurchase agreements	[3],[4]	$ 2,818,968	$ 3,491,312
Weighted average haircut (as a percent)	[2]	25.42%	28.88%
Repurchase agreements | RPL/NPL MBS
Repurchase Agreements
Balance of repurchase agreements	[3]	$ 2,080,163	$ 130,919
Fair Value of assets pledged as collateral under repurchase agreements	[3]	$ 2,625,866	$ 160,688
Weighted average haircut (as a percent)	[2]	21.37%	20.00%
Repurchase agreements | RPL/NPL MBS | Overnight
Repurchase Agreements
Balance of repurchase agreements		$ 0
Repurchase agreements | RPL/NPL MBS | Within 30 days
Repurchase Agreements
Balance of repurchase agreements		1,670,586
Repurchase agreements | RPL/NPL MBS | Over 30 days to 90 days
Repurchase Agreements
Balance of repurchase agreements		143,705
Repurchase agreements | RPL/NPL MBS | Over 90 days to 12 months
Repurchase Agreements
Balance of repurchase agreements		265,872
Repurchase agreements | RPL/NPL MBS | Over 12 Months
Repurchase Agreements
Balance of repurchase agreements		0
Repurchase agreements | Non-Agency MBS
Repurchase Agreements
Balance of repurchase agreements		1,960,222
Repurchase agreements | Non-Agency MBS | Overnight
Repurchase Agreements
Balance of repurchase agreements		0
Repurchase agreements | Non-Agency MBS | Within 30 days
Repurchase Agreements
Balance of repurchase agreements		892,341
Repurchase agreements | Non-Agency MBS | Over 30 days to 90 days
Repurchase Agreements
Balance of repurchase agreements		613,131
Repurchase agreements | Non-Agency MBS | Over 90 days to 12 months
Repurchase Agreements
Balance of repurchase agreements		454,750
Repurchase agreements | Non-Agency MBS | Over 12 Months
Repurchase Agreements
Balance of repurchase agreements		0
Repurchase agreements | U.S. Treasuries
Repurchase Agreements
Balance of repurchase agreements		504,760	$ 507,114
Fair Value of assets pledged as collateral under repurchase agreements		$ 507,443	$ 512,105
Weighted average haircut (as a percent)	[2]	1.60%	1.62%
Repurchase agreements | U.S. Treasuries | Overnight
Repurchase Agreements
Balance of repurchase agreements		$ 0
Repurchase agreements | U.S. Treasuries | Within 30 days
Repurchase Agreements
Balance of repurchase agreements		504,760
Repurchase agreements | U.S. Treasuries | Over 30 days to 90 days
Repurchase Agreements
Balance of repurchase agreements		0
Repurchase agreements | U.S. Treasuries | Over 90 days to 12 months
Repurchase Agreements
Balance of repurchase agreements		0
Repurchase agreements | U.S. Treasuries | Over 12 Months
Repurchase Agreements
Balance of repurchase agreements		0
Repurchase agreements | CRT securities
Repurchase Agreements
Balance of repurchase agreements	[3]	128,465	$ 75,960
Fair Value of assets pledged as collateral under repurchase agreements	[3]	$ 170,352	$ 94,610
Weighted average haircut (as a percent)	[2]	25.04%	25.00%
Repurchase agreements | CRT securities | Overnight
Repurchase Agreements
Balance of repurchase agreements		$ 0
Repurchase agreements | CRT securities | Within 30 days
Repurchase Agreements
Balance of repurchase agreements		110,921
Repurchase agreements | CRT securities | Over 30 days to 90 days
Repurchase Agreements
Balance of repurchase agreements		17,544
Repurchase agreements | CRT securities | Over 90 days to 12 months
Repurchase Agreements
Balance of repurchase agreements		0
Repurchase agreements | CRT securities | Over 12 Months
Repurchase Agreements
Balance of repurchase agreements		0
Repurchase agreements | Residential whole loans
Repurchase Agreements
Balance of repurchase agreements		487,750	$ 142,324
Fair Value of assets pledged as collateral under repurchase agreements		$ 684,136	$ 212,986
Weighted average haircut (as a percent)	[2]	27.69%	33.43%
Repurchase agreements | Residential whole loans | Overnight
Repurchase Agreements
Balance of repurchase agreements		$ 0
Repurchase agreements | Residential whole loans | Within 30 days
Repurchase Agreements
Balance of repurchase agreements		0
Repurchase agreements | Residential whole loans | Over 30 days to 90 days
Repurchase Agreements
Balance of repurchase agreements		0
Repurchase agreements | Residential whole loans | Over 90 days to 12 months
Repurchase Agreements
Balance of repurchase agreements		293,641
Repurchase agreements | Residential whole loans | Over 12 Months
Repurchase Agreements
Balance of repurchase agreements		194,109
Repurchase agreements | Non-Agency MBS
Repurchase Agreements
Non-Agency MBS acquired from consolidated VIEs		$ 570,500	$ 1,275,000
Linked Transactions | Non-Agency MBS
Repurchase Agreements
Linked repurchase agreements			$ 1,520,000

[1] At December 31, 2014, the Company had repurchase agreements of $1.520 billion that were linked to securities purchased and accounted for as Linked Transactions, and as such, the linked repurchase agreements are not included in the above table. As previously discussed, new accounting guidance effective January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 6)

[2] Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount.

[3] Does not reflect Legacy Non-Agency MBS, RPL/NPL MBS, CRT securities and repurchase agreement borrowings that were components of Linked Transactions at December 31, 2014. As previously discussed, new accounting guidance effective January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 6)

[4] Includes $570.5 million and $1.275 billion of Legacy Non-Agency MBS acquired from consolidated VIEs at December 31, 2015 and 2014, respectively, that are eliminated from the Company’s consolidated balance sheets.

XML

Repurchase Agreements and Other Advances (Details 2) $ in Thousands		Dec. 31, 2015 USD ($) counterparty	Dec. 31, 2014 USD ($) counterparty
Information about MBS and CRT securities
Gross Amounts of Recognized Liabilities		$ 7,888,902
Repurchase agreements, amounts not included in offsetting disclosure		$ 0
Repurchase agreements, number of counterparties | counterparty		27	25
Threshold percent of stockholders' equity at risk with single counterparty to repurchase agreements or Linked Transactions (greater than)		5.00%
Repurchase agreements
Information about MBS and CRT securities
Repurchase agreements		$ 7,888,902	$ 8,267,388	[1]
Weighted Average Interest Rate		1.48%	0.79%
Repurchase agreements | Agency MBS
Information about MBS and CRT securities
Repurchase agreements		$ 2,727,542	$ 5,177,835
Repurchase agreements | Non-Agency MBS
Information about MBS and CRT securities
Repurchase agreements		1,960,222
Repurchase agreements | RPL/NPL MBS
Information about MBS and CRT securities
Repurchase agreements	[2]	2,080,163	130,919
Repurchase agreements | U.S. Treasuries
Information about MBS and CRT securities
Repurchase agreements		504,760	507,114
Repurchase agreements | CRT securities
Information about MBS and CRT securities
Repurchase agreements	[2]	128,465	75,960
Repurchase agreements | Residential whole loans
Information about MBS and CRT securities
Repurchase agreements		487,750	$ 142,324
Repurchase agreements | Overnight
Information about MBS and CRT securities
Repurchase agreements		$ 0
Weighted Average Interest Rate		0.00%
Repurchase agreements | Overnight | Agency MBS
Information about MBS and CRT securities
Repurchase agreements		$ 0
Repurchase agreements | Overnight | Non-Agency MBS
Information about MBS and CRT securities
Repurchase agreements		0
Repurchase agreements | Overnight | RPL/NPL MBS
Information about MBS and CRT securities
Repurchase agreements		0
Repurchase agreements | Overnight | U.S. Treasuries
Information about MBS and CRT securities
Repurchase agreements		0
Repurchase agreements | Overnight | CRT securities
Information about MBS and CRT securities
Repurchase agreements		0
Repurchase agreements | Overnight | Residential whole loans
Information about MBS and CRT securities
Repurchase agreements		$ 0

[1] At December 31, 2014, the Company had repurchase agreements of $1.520 billion that were linked to securities purchased and accounted for as Linked Transactions, and as such, the linked repurchase agreements are not included in the above table. As previously discussed, new accounting guidance effective January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 6)

[2] Does not reflect Legacy Non-Agency MBS, RPL/NPL MBS, CRT securities and repurchase agreement borrowings that were components of Linked Transactions at December 31, 2014. As previously discussed, new accounting guidance effective January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 6)

XML

Repurchase Agreements and Other Advances (Details 3) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014
FHLB Advances
Long-term federal home loan bank advances		$ 1,500,000
Federal home loan bank, weighted average interest rate		0.50%
Federal home loan bank, advances, maturity period, variable rate		4 years 9 months 15 days
Accrued interest payable		$ 16,949	$ 13,095
Credit Suisse
Repurchase agreements counterparty risk
Amount at risk	[1]	$ 410,814
Weighted Average Months to Maturity for Repurchase Agreements		1 month
Percent of Stockholders’ Equity		13.80%
Wells Fargo
Repurchase agreements counterparty risk
Amount at risk	[1],[2]	$ 334,613
Weighted Average Months to Maturity for Repurchase Agreements	[2]	6 months
Percent of Stockholders’ Equity	[2]	11.30%
Wells Fargo Bank
Repurchase agreements counterparty risk
Amount at risk		$ 269,700
Wells Fargo Securities LLC
Repurchase agreements counterparty risk
Amount at risk		64,900
RBC
Repurchase agreements counterparty risk
Amount at risk	[1],[3]	$ 327,400
Weighted Average Months to Maturity for Repurchase Agreements		2 months
Percent of Stockholders’ Equity	[3]	11.00%
RBC Barbados
Repurchase agreements counterparty risk
Amount at risk		$ 309,800
Royal Bank of Canada
Repurchase agreements counterparty risk
Amount at risk		10,700
RBC Capital Markets LLC
Repurchase agreements counterparty risk
Amount at risk		6,800
UBS
Repurchase agreements counterparty risk
Amount at risk	[1],[2]	$ 214,107
Weighted Average Months to Maturity for Repurchase Agreements	[2]	19 months
Percent of Stockholders’ Equity	[2]	7.20%
Goldman Sachs
Repurchase agreements counterparty risk
Amount at risk	[1]	$ 152,055
Weighted Average Months to Maturity for Repurchase Agreements		9 months
Percent of Stockholders’ Equity		5.10%
Federal Home Loan Bank Advances
FHLB Advances
Accrued interest payable		$ 508

[1] The amount at risk reflects the difference between (a) the amount loaned to the Company through repurchase agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities.

[2] Includes $269.7 million at risk with Wells Fargo Bank, NA and $64.9 million at risk with Wells Fargo Securities LLC.

[3] Includes $309.8 million at risk with RBC Barbados, $10.7 million at risk with Royal Bank of Canada and $6.8 million at risk with RBC Capital Markets LLC. Counterparty ratings are not published for RBC Barbados and RBC Capital Markets LLC.

XML

Collateral Positions (Details) - USD ($) $ in Thousands		Dec. 31, 2015	Dec. 31, 2014
Collateral Positions
Assets pledged		$ 11,410,397	$ 10,058,769
Collateral Held		507,443	512,105
Derivative Hedging Instruments
Collateral Positions
Assets pledged		109,142	123,733
Collateral Held		0	0
Derivative Hedging Instruments | Agency MBS
Collateral Positions
Assets pledged		38,569	57,247
Collateral Held		0	0
Derivative Hedging Instruments | Cash
Collateral Positions
Assets pledged	[1]	70,573	66,486
Collateral Held	[1]	0	0
Repurchase Agreement Borrowings
Collateral Positions
Assets pledged		9,688,779	9,935,036
Collateral Held		0	0
Repurchase Agreement Borrowings | Agency MBS
Collateral Positions
Assets pledged		2,881,049	5,462,566
Collateral Held		0	0
Repurchase Agreement Borrowings | Legacy Non-Agency MBS
Collateral Positions
Assets pledged	[2],[3]	2,818,968	3,491,312
Collateral Held	[2],[3]	0	0
Repurchase Agreement Borrowings | RPL/NPL MBS
Collateral Positions
Assets pledged		2,625,866	160,688
Collateral Held		0	0
Repurchase Agreement Borrowings | Non-Agency MBS
Collateral Positions
Non-Agency MBS acquired from consolidated VIEs		570,500	1,275,000
Non-Agency MBS pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty		726,700	731,000
Repurchase Agreement Borrowings | U.S. Treasury securities
Collateral Positions
Assets pledged		507,443	512,105
Collateral Held		0	0
Repurchase Agreement Borrowings | CRT securities
Collateral Positions
Assets pledged		170,352	94,610
Collateral Held		0	0
Repurchase Agreement Borrowings | Residential whole loans
Collateral Positions
Assets pledged		684,136	212,986
Collateral Held		0	0
Repurchase Agreement Borrowings | Cash
Collateral Positions
Assets pledged	[1]	965	769
Collateral Held	[1]	0	0
Federal Home Loan Bank Advances
Collateral Positions
Assets pledged		1,612,476	0
Collateral Held		0	0
Federal Home Loan Bank Advances | Agency MBS
Collateral Positions
Assets pledged		1,612,476	0
Collateral Held		0	0
Reverse Repurchase Agreements
Collateral Positions
Assets pledged		0	0
Collateral Held		507,443	512,105
Reverse Repurchase Agreements | U.S. Treasury securities
Collateral Positions
Assets pledged		0	0
Collateral Held		$ 507,443	$ 512,105

[1] Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets.

[2] In addition, at December 31, 2015 and 2014, $726.7 million and $731.0 million of Legacy Non-Agency MBS, respectively, are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty.

[3] Includes $570.5 million and $1.275 billion of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at December 31, 2015 and 2014, respectively, that are eliminated from the Company’s consolidated balance sheets.

XML

Collateral Positions (Details 2) - USD ($) $ in Thousands		Dec. 31, 2015	Dec. 31, 2014
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest		$ 11,433,938
Agency MBS
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest	[1]	4,542,767
Legacy Non-Agency MBS
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest	[2],[3]	2,829,209
RPL/NPL MBS
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest		2,627,458
U.S. Treasury securities
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest		507,443
CRT securities
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest		170,435
Residential whole loans
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest		685,088
Cash
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest	[4]	71,538
Securities Sold under Agreements to Repurchase and Other Advances
Collateral Positions
Fair Value		11,301,255
Amortized Cost		10,744,311
Accrued Interest on Pledged Assets		23,461
Securities Sold under Agreements to Repurchase and Other Advances | Agency MBS
Collateral Positions
Fair Value	[1]	4,493,525
Amortized Cost	[1]	4,465,081
Accrued Interest on Pledged Assets	[1]	10,593
Securities Sold under Agreements to Repurchase and Other Advances | Legacy Non-Agency MBS
Collateral Positions
Fair Value	[2],[3]	2,818,968
Amortized Cost	[2],[3]	2,278,870
Accrued Interest on Pledged Assets	[2],[3]	10,241
Non-Agency MBS acquired from consolidated VIEs in connection with resecuritization transactions		570,500
Non-Agency MBS pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty		726,700
Securities Sold under Agreements to Repurchase and Other Advances | RPL/NPL MBS
Collateral Positions
Fair Value		2,625,866
Amortized Cost		2,644,797
Accrued Interest on Pledged Assets		1,592
Securities Sold under Agreements to Repurchase and Other Advances | U.S. Treasury securities
Collateral Positions
Fair Value		507,443
Amortized Cost		507,443
Accrued Interest on Pledged Assets		0
Securities Sold under Agreements to Repurchase and Other Advances | CRT securities
Collateral Positions
Fair Value		170,352
Amortized Cost		173,367
Accrued Interest on Pledged Assets		83
Securities Sold under Agreements to Repurchase and Other Advances | Residential whole loans
Collateral Positions
Fair Value		684,136
Amortized Cost		673,788
Accrued Interest on Pledged Assets		952
Securities Sold under Agreements to Repurchase and Other Advances | Cash
Collateral Positions
Fair Value	[4]	965
Amortized Cost	[4]	965
Accrued Interest on Pledged Assets	[4]	0
Derivative Hedging Instruments
Collateral Positions
Fair Value		109,142
Amortized Cost		110,033
Accrued Interest on Pledged Assets		80
Derivative Hedging Instruments | Agency MBS
Collateral Positions
Fair Value	[1]	38,569
Amortized Cost	[1]	39,460
Accrued Interest on Pledged Assets	[1]	80
Derivative Hedging Instruments | Legacy Non-Agency MBS
Collateral Positions
Fair Value	[2],[3]	0
Amortized Cost	[2],[3]	0
Accrued Interest on Pledged Assets	[2],[3]	0
Derivative Hedging Instruments | RPL/NPL MBS
Collateral Positions
Fair Value		0
Amortized Cost		0
Accrued Interest on Pledged Assets		0
Derivative Hedging Instruments | U.S. Treasury securities
Collateral Positions
Fair Value		0
Amortized Cost		0
Accrued Interest on Pledged Assets		0
Derivative Hedging Instruments | CRT securities
Collateral Positions
Fair Value		0
Amortized Cost		0
Accrued Interest on Pledged Assets		0
Derivative Hedging Instruments | Residential whole loans
Collateral Positions
Fair Value		0
Amortized Cost		0
Accrued Interest on Pledged Assets		0
Derivative Hedging Instruments | Cash
Collateral Positions
Fair Value	[4]	70,573
Amortized Cost	[4]	70,573
Accrued Interest on Pledged Assets	[4]	0
Repurchase Agreements | Non-Agency MBS
Collateral Positions
Non-Agency MBS acquired from consolidated VIEs in connection with resecuritization transactions		570,500	$ 1,275,000
Non-Agency MBS pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty		726,700	$ 731,000
Federal Home Loan Bank Advances | Securities Sold under Agreements to Repurchase and Other Advances | Agency MBS
Collateral Positions
Fair Value		1,612,000
Amortized Cost		1,606,000
Accrued Interest on Pledged Assets		$ 3,900

[1] Includes Agency MBS pledged under FHLB advances with an aggregate fair value of $1.612 billion, aggregate amortized cost of $1.606 billion and aggregate accrued interest of approximately $3.9 million at December 31, 2015.

[2] In addition, at December 31, 2015, $726.7 million of Legacy Non-Agency MBS are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty.

[3] Includes $570.5 million of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at December 31, 2015, that are eliminated from the Company’s consolidated balance sheets.

[4] Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets.

XML

Offsetting Assets and Liabilities (Details) $ in Thousands		12 Months Ended
		Dec. 31, 2015 USD ($) counterparty	Dec. 31, 2014 USD ($)
Derivative hedging instruments, at fair value
Gross Amounts of Recognized Assets		$ 1,127	$ 3,136
Gross Amounts Offset in the Consolidated Balance Sheets		0	0
Net Amounts of Assets Presented in the Consolidated Balance Sheets		1,127	3,136
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments		(1,127)	(3,136)
Cash Collateral Received		0	0
Net Amount		0	0
Swaps, at fair value
Gross Amounts of Recognized Liabilities	[1]	70,526	62,198
Gross Amounts Offset in the Consolidated Balance Sheets	[1]	0	0
Net Amounts of Liabilities Presented in the Consolidated Balance Sheets	[1]	70,526	62,198
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	[1],[2]	0	0
Cash Collateral Pledged	[1],[2]	(70,526)	(62,198)
Net Amount	[1]	0	0
Repurchase agreements and other advances
Gross Amounts of Recognized Liabilities	[3]	9,388,902	8,267,388
Gross Amounts Offset in the Consolidated Balance Sheets	[3]	0	0
Repurchase agreements and other advances	[3]	9,388,902	8,267,388
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	[2],[3]	(9,387,937)	(8,266,619)
Cash Collateral Pledged	[2],[3]	(965)	(769)
Net Amount	[3]	0	0
Total
Gross Amounts of Recognized Liabilities		9,459,428	8,329,586
Gross Amounts Offset in the Consolidated Balance Sheets		0	0
Net Amounts of Liabilities Presented in the Consolidated Balance Sheets		9,459,428	8,329,586
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	[2]	(9,387,937)	(8,266,619)
Cash Collateral Pledged	[2]	(71,491)	(62,967)
Net Amount		0	0
Additional disclosures
Derivatives, excess collateral		47	4,300
Fair value of securities pledged against the swaps		38,600	57,200
Fair value of securities pledged against the repurchase agreements		$ 11,300,000	9,934,000
Number of repurchase agreement counterparties with unconditional right of setoff | counterparty		1
Swaps
Derivative hedging instruments, at fair value
Gross Amounts of Recognized Assets		$ 1,127	3,136
Gross Amounts Offset in the Consolidated Balance Sheets		0	0
Net Amounts of Assets Presented in the Consolidated Balance Sheets		1,127	3,136
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments		(1,127)	(3,136)
Cash Collateral Received		0	0
Net Amount		$ 0	$ 0

[1] The fair value of securities pledged against the Company’s Swaps was $38.6 million and $57.2 million at December 31, 2015 and 2014, respectively.

[2] Amounts disclosed in the Financial Instruments column of the table above represent collateral pledged that is available to be offset against liability balances associated with repurchase agreements and other advances, and derivative transactions. Amounts disclosed in the Cash Collateral Pledged column of the table above represent amounts pledged as collateral against derivative transactions and repurchase agreements, and exclude excess collateral of $47,000 and $4.3 million at December 31, 2015 and 2014, respectively.

[3] The fair value of financial instruments pledged against the Company’s repurchase agreements and other advances was $11.300 billion and $9.934 billion at December 31, 2015 and 2014, respectively.

XML

Senior Notes (Details) - Senior Unsecured Notes - USD ($)		12 Months Ended
	Apr. 11, 2012	Dec. 31, 2015
Senior Notes
Aggregate principal amount	$ 100,000,000.0
Proceed from senior notes net of offering expenses and underwriting discount	$ 96,600,000
Stated interest rate (as a percent)		8.00%
Redemption price as percentage of principal amount		100.00%

XML

Commitments and Contingencies (Details)	12 Months Ended
	Dec. 31, 2015 USD ($) lease	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
Lease Commitments
Number of operating leases | lease	2
Lease expense	$ 2,600,000	$ 2,500,000	$ 2,700,000
Minimum Rental Payments
2016	2,552,000
2017	2,522,000
2018	2,522,000
2019	2,522,000
2020	1,050,000
Total	11,168,000
Corporate headquarters
Lease Commitments
Aggregate cash payments, operating leases	2,500,000
Irrevocable standby letter of credit provided to landlord	785,000
Off-site back-up facility
Lease Commitments
Aggregate cash payments, operating leases	$ 30,000

XML

Stockholders' Equity (Details) $ / shares in Units, $ in Thousands																																12 Months Ended			148 Months Ended
	Dec. 09, 2015 $ / shares	[1]	Nov. 19, 2015 $ / shares	Sep. 17, 2015 $ / shares	Aug. 24, 2015 $ / shares	Jun. 15, 2015 $ / shares	May. 18, 2015 $ / shares	Mar. 13, 2015 $ / shares	Feb. 13, 2015 $ / shares	Dec. 09, 2014 $ / shares	Nov. 21, 2014 $ / shares	Sep. 17, 2014 $ / shares	Aug. 25, 2014 $ / shares	Jun. 13, 2014 $ / shares	May. 19, 2014 $ / shares	Mar. 10, 2014 $ / shares	Feb. 14, 2014 $ / shares	Dec. 11, 2013 $ / shares	Nov. 19, 2013 $ / shares	Sep. 26, 2013 $ / shares	Aug. 22, 2013 $ / shares	Aug. 01, 2013 $ / shares	[2]	Jul. 01, 2013 $ / shares	Jun. 28, 2013 $ / shares	May. 20, 2013 $ / shares	May. 16, 2013 USD ($) $ / shares shares	Apr. 15, 2013 USD ($) $ / shares shares	Mar. 28, 2013 $ / shares	Mar. 04, 2013 $ / shares	[3]	Dec. 31, 2015 USD ($) director $ / shares shares	Dec. 31, 2014 USD ($) $ / shares shares	Dec. 31, 2013 USD ($) $ / shares shares	Dec. 31, 2015 USD ($) $ / shares shares	Aug. 08, 2013 shares	Aug. 31, 2005 shares
Dividends on Preferred Stock
Preferred stock, dividend rate (as a percent)																																7.50%	7.50%
Preferred stock, shares issued (in shares) | shares																																8,000,000	8,000,000		8,000,000
Preferred stock, par value (in dollars per share) | $ / shares																																$ 0.01	$ 0.01		$ 0.01
Proceeds from sale of Series B preferred stock | $																																$ 0	$ 0	$ 200,000
Minimum percentage of preferred shareholders required for approval																																66.67%
Dividends on Common Stock
Common stock, cash dividends declared (in dollars per share) | $ / shares	$ 0.20			$ 0.20		$ 0.20		$ 0.20		$ 0.20		$ 0.20		$ 0.20		$ 0.20		$ 0.20		$ 0.22		$ 0.28			$ 0.22				$ 0.22	$ 0.50
Common stock, accrued dividends and DERs payable | $																																$ 74,600			$ 74,600
Common stock, shares authorized (in shares) | shares																																886,950,000	886,950,000		886,950,000
Number of shares authorized to be repurchased under the Repurchase Program (in shares) | shares																																		10,000,000.0			4,000,000.0
Number of shares repurchased through the Company's publicly announced stock repurchase program (in shares) | shares																																0	0	2,143,354
Value of shares repurchased through the Company's publicly announced stock repurchase program (in dollars) | $																																		$ 15,400
Average cost per share (in dollars per share) | $ / shares																																		$ 7.20
Number of Remaining shares authorized to be repurchased under the Repurchase Program (in shares) | shares																																6,616,355			6,616,355
DRSPP
Dividends on Common Stock
Common stock, shares authorized (in shares) | shares																																				15,000,000
Shares of common stock authorized and available for issuance | shares																																6,800,000			6,800,000
Shares issued | shares																																162,373	4,526,855	9,511,739	30,728,992
Net proceeds | $																																$ 1,200	$ 35,600	$ 77,600	$ 258,300
Series A Preferred Stock
Dividends on Preferred Stock
Preferred stock, dividend rate (as a percent)																																		8.50%
Preferred stock, aggregate redemption price | $																																		$ 92,053
Preferred stock, liquidation preference (in dollars per share) | $ / shares																																		$ 25
Series B Preferred Stock
Dividends on Preferred Stock
Preferred stock, dividend rate (as a percent)																																7.50%	7.50%	7.50%
Preferred stock, liquidation preference (in dollars per share) | $ / shares																																$ 25.00	$ 25.00	$ 25	$ 25.00
Preferred stock, cash dividends declared (in dollars per share) | $ / shares			$ 0.46875		$ 0.46875		$ 0.46875		$ 0.46875		$ 0.46875		$ 0.46875		$ 0.46875		$ 0.46875		$ 0.46875		$ 0.46875					$ 0.39583
Preferred Stock | Series A Preferred Stock
Dividends on Preferred Stock
Preferred stock, dividend rate (as a percent)																																8.50%
Redemption of Series A Preferred Stock (in shares) | shares																											3,840,000							3,840,000
Preferred stock, aggregate redemption price | $																											$ 97,000							$ 38
Preferred stock, redemption price (in dollars per share) | $ / shares																											$ 25.27153
Preferred stock, amount redemption value exceeds carrying value | $																											$ 3,900
Preferred stock, cash dividends (in dollars per share) | $ / shares																											$ 0.27153
Preferred Stock | Series B Preferred Stock
Dividends on Preferred Stock
Preferred stock, dividend rate (as a percent)																												7.50%				7.50%
Preferred stock, redemption price (in dollars per share) | $ / shares																												$ 25.00
Preferred stock, cash dividends (in dollars per share) | $ / shares																								$ 0.39583
Stock reclassified during period (in shares) | shares																												8,050,000
Preferred stock, shares issued (in shares) | shares																												8,000,000.0
Preferred stock, par value (in dollars per share) | $ / shares																												$ 0.01
Preferred stock, liquidation preference (in dollars per share) | $ / shares																												$ 25.00
Proceeds from sale of Series B preferred stock | $																												$ 193,300
Preferred stock, voting rights, available if company fails to pay dividend, minimum term																																1 year 6 months
Number of additional directors that can be elected by preferred stock holders | director																																2
Dividends on Common Stock
Shares issued | shares																																		8,000,000

[1] At December 31, 2015, the Company had accrued dividends and dividend equivalents payable of $74.6 million related to the common stock dividend declared on December 9, 2015.

[2] Reflects the special cash dividend on common stock declared on August 1, 2013.

[3] Reflects the special cash dividend on common stock declared on March 4, 2013.

XML

Stockholders' Equity - AOCI (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Components of Accumulated Other Comprehensive Income (Loss)
AOCI, beginning balance		$ 754,453
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing		4,537	$ 0	$ 0
AOCI, ending balance		515,851	754,453
Reclassification out of Accumulated Other Comprehensive Income
Components of Accumulated Other Comprehensive Income (Loss)
Amounts reclassified from AOCI		(37,912)	(34,501)	(19,833)
Net Unrealized Gain/(Loss) on AFS Securities
Components of Accumulated Other Comprehensive Income (Loss)
AOCI, beginning balance		813,515	752,912	824,808
OCI before reclassifications		(194,890)	95,551	(52,063)
Amounts reclassified from AOCI	[1]	(37,912)	(34,948)	(19,833)
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing		4,537	0	0
Net OCI during the period	[2]	(228,265)	60,603	(71,896)
AOCI, ending balance		585,250	813,515	752,912
Net Unrealized Gain/(Loss) on Swaps
Components of Accumulated Other Comprehensive Income (Loss)
AOCI, beginning balance		(59,062)	(15,217)	(62,831)
OCI before reclassifications		(10,337)	(44,292)	47,614
Amounts reclassified from AOCI	[1]	0	447	0
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing		0	0	0
Net OCI during the period	[2]	(10,337)	(43,845)	47,614
AOCI, ending balance		(69,399)	(59,062)	(15,217)
Accumulated Other Comprehensive Income
Components of Accumulated Other Comprehensive Income (Loss)
AOCI, beginning balance		754,453	737,695	761,977
OCI before reclassifications		(205,227)	51,259	(4,449)
Amounts reclassified from AOCI	[1]	(37,912)	(34,501)	(19,833)
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing		4,537	0	0
Net OCI during the period	[2]	(238,602)	16,758	(24,282)
AOCI, ending balance		$ 515,851	$ 754,453	$ 737,695

[1] See separate table below for details about these reclassifications.

[2] For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

XML

Stockholders' Equity - AOCI Reclassifications (Details) - USD ($) $ in Thousands	3 Months Ended				12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Stockholders' Equity [Line Items]
Realized gain on sale of securities					$ (37,207)	$ (34,948)	$ (19,833)
OTTI recognized in earnings	$ 0	$ 0	$ (298)	$ (407)	(705)	0	0
Total Swaps designated as cash flow hedges					0	447	0
Accumulated Other Comprehensive Income/(Loss)
Other-than-temporary impairments recognized in accumulated other comprehensive(loss)/income	$ 1,300				1,300	629
Reclassification out of Accumulated Other Comprehensive Income
Stockholders' Equity [Line Items]
Realized gain on sale of securities					(37,207)	(34,948)	(19,833)
OTTI recognized in earnings					(705)	0	0
Total AFS Securities					(37,912)	(34,948)	(19,833)
Total Swaps designated as cash flow hedges					0	447	0
Total reclassifications for period					(37,912)	(34,501)	(19,833)
Reclassification out of Accumulated Other Comprehensive Income | De-designated Swaps
Stockholders' Equity [Line Items]
Total Swaps designated as cash flow hedges					$ 0	$ 447	$ 0

XML

EPS Calculation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		3 Months Ended								12 Months Ended
		Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Numerator:
Net income		$ 73,471	$ 79,510	$ 78,071	$ 82,174	$ 79,708	$ 78,882	$ 78,726	$ 76,188	$ 313,226	$ 313,504	$ 302,709
Dividends declared on preferred stock										(15,000)	(15,000)	(13,750)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities										(1,539)	(1,106)	(1,080)
Issuance costs of redeemed preferred stock	[1]									0	0	(3,947)
Net income available to common stockholders - basic and diluted										$ 296,687	$ 297,398	$ 283,932
Denominator:
Weighted average common shares for basic and diluted earnings per share	[2]									372,114	369,048	362,399
Basic and diluted earnings per share (in dollars per share)		$ 0.19	$ 0.20	$ 0.20	$ 0.21	$ 0.20	$ 0.20	$ 0.20	$ 0.20	$ 0.80	$ 0.81	$ 0.78
Anti-dilutive securities excluded from diluted earnings per share calculations (in shares)										2,000
Restricted common stock
Denominator:
Anti-dilutive securities excluded from diluted earnings per share calculations (in shares)										111
Weighted average grant date fair value (in dollars per share)		7.41								$ 7.41
Restricted Stock Units
Denominator:
Anti-dilutive securities excluded from diluted earnings per share calculations (in shares)										1,900
Weighted average grant date fair value (in dollars per share)		$ 6.90								$ 6.90

[1] Issuance costs of redeemed preferred stock represent the original offering costs related to the Series A Preferred Stock, which was redeemed on May 16, 2013. (See Note 13)

[2] At December 31, 2015, the Company had an aggregate of 2.0 million equity instruments outstanding that were not included in the calculation of diluted EPS for the year ended December 31, 2015, as their inclusion would have been anti-dilutive. These equity instruments were comprised of approximately 111,000 shares of restricted common stock with a weighted average grant date fair value of $7.41 and approximately $1.9 million RSUs with a weighted average grant date fair value of $6.90. These equity instruments may have a dilutive impact on future EPS.

XML

Equity Compensation, Employment Agreements and Other Benefit Plans (Details) - USD ($)		12 Months Ended
		Dec. 31, 2015		Dec. 31, 2014		Dec. 31, 2013
Share based compensation
Maximum shares authorized for grant (in shares)		12,000,000
Shares available for grant		9,400,000
Accrued Dividends Payable		$ 74,575,000		$ 74,529,000		$ 73,643,000
Expense related to equity-based compensation instruments		7,832,000		8,585,000		4,158,000
DER
Share based compensation
Payments attributable to DERs		$ 16,000		69,000		$ 412,000
Special cash dividends paid (in dollars per share)						$ 0.78
Special cash dividends paid, amount						$ 194,000
Average forfeiture rate assumed on DERs outstanding		0.00%
Weighted average period over which DERs are scheduled to elapse		6 months
Unrecognized compensation cost		$ 44,000
Expense related to equity-based compensation instruments		$ 82,000		$ 146,000		$ 195,000
Activity and related information
Outstanding at beginning of year (in shares)		24,402		218,225		266,075
Granted (in shares)		0		0		0
Cancelled, forfeited or expired (in shares)		(16,187)		(193,823)		(47,850)
Outstanding at end of year (in shares)		8,215		24,402		218,225
Weighted Average Grant Date Fair Value
Granted (in dollars per share)	[1]	$ 2.77
Fair value assumptions
Weighted average volatility estimated (as a percent)		31.00%
Expected term		6 years
Weighted average risk-free rate (as a percent)		2.23%
Estimated annual dividend yield (as a percent)		13.00%
Stock options
Share based compensation
Period to determine market value of the common stock to qualify as an incentive stock option for tax purposes		1 year
Maximum grant date market value of the common stock to be received upon exercise of options in one calendar year		$ 100,000
Exercise price of an ISO relative to fair market value on the grant date, minimum (as a percent)		100.00%
Exercise price of an ISO granted to a 10% stockholder relative to fair market value on the grant date, minimum (as a percent)		110.00%
Percentage of stockholders to whom 110% of ISO is granted		10.00%
Maximum period for exercise of stock options		10 years
Aggregate intrinsic value of total stock options Outstanding		$ 0
Intrinsic value of options exercised						$ 19,000
Stock options activity
Outstanding at beginning of year (in shares)		0		5,000		427,000
Granted (in shares)				0		0
Cancelled, forfeited or expired (in shares)				(5,000)		(402,000)
Exercised (in shares)	[2]			0		(20,000)
Outstanding at end of year (in shares)				0		5,000
Options exercisable at end of year (in shares)				0		5,000
Weighted Average Exercise Price
Outstanding at beginning of year (in dollars per share)		$ 0.00		$ 8.40		$ 10.14
Granted (in dollars per share)				0.00		0.00
Cancelled, forfeited or expired (in dollars per share)				8.40		10.25
Exercised (in dollars per share)	[2]			0.00		8.40
Outstanding at end of year (in dollars per share)				0.00		8.40
Options exercisable at end of year (in dollars per share)				$ 0.00		$ 8.40
Restricted Stock
Share based compensation
Unrecognized compensation cost		$ 800,000		$ 1,800,000
Accrued Dividends Payable		193,000		312,000
Total fair value of stock vested		$ 4,300,000		5,700,000		$ 2,100,000
Period for recognizing unrecognized compensation cost		1 year 6 months
Expense related to equity-based compensation instruments		$ 4,373,000		$ 5,553,000		$ 2,150,000
Activity and related information
Outstanding at beginning of year (in shares)		243,948		443,967		483,442
Granted (in shares)		497,007		491,797		231,531
Vested (in shares)	[3]	(629,212)		(690,397)		(270,456)
Cancelled, forfeited or expired (in shares)		(823)		(1,419)		(550)
Outstanding at end of year (in shares)		110,920		243,948		443,967
Weighted Average Grant Date Fair Value
Outstanding at beginning of year (in dollars per share)	[4]	$ 7.48		$ 7.50		$ 7.74
Granted (in dollars per share)	[4]	6.83		8.29		7.33
Vested (in dollars per share)	[3],[4]	6.98		8.07		7.77
Cancelled/forfeited (in dollars per share)	[4]	7.74		7.58		7.72
Outstanding at end of year (in dollars per share)	[4]	$ 7.41		$ 7.48		$ 7.50
Restricted Stock Units
Share based compensation
Unrecognized compensation cost		$ 4,000,000		$ 2,700,000
Period for recognizing unrecognized compensation cost		1 year 8 months 5 days
Weighted average forfeiture rate of unvested RSUs (as a percent)		0.00%
Expense related to equity-based compensation instruments	[5]	$ 3,377,000		$ 2,886,000		$ 1,813,000
Activity and related information
Outstanding at beginning of year (in shares)		1,218,474		777,818		727,648
Granted (in shares)		682,054	[1]	630,815	[6]	112,824	[7]
Settled (in shares)		(17,298)		(87,338)		(53,091)
Cancelled, forfeited or expired (in shares)		(7,500)		(102,821)		(9,563)
Outstanding at end of year (in shares)		1,875,730		1,218,474		777,818
Vested but not settled at end of year		729,523		643,138		98,824
Unvested at end of period (in shares)		1,146,207		575,336		678,994
Weighted Average Grant Date Fair Value
Outstanding at beginning of year (in dollars per share)		$ 6.84		$ 6.48		$ 6.43
Granted (in dollars per share)		7.01	[1]	6.64	[6]	5.82	[7]
Settled (in dollars per share)		6.60		6.86		4.15
Cancelled/forfeited (in dollars per share)		6.85		2.90		7.88
Outstanding at end of year (in dollars per share)		6.90		6.84		6.48
Vested but not settled at end of year (in dollars per share)		7.20		7.10		7.93
Unvested at end of year (in dollars per share)		$ 6.71		$ 6.54		$ 6.27
Restricted Stock Units | Chief Executive Officer
Share based compensation
Expense related to equity-based compensation instruments				$ 500,000
RSUs with Service Condition
Activity and related information
Outstanding at beginning of year (in shares)		769,174		490,099		448,141
Granted (in shares)		390,804	[1]	357,015	[6]	64,483	[7]
Settled (in shares)		(17,298)		(72,873)		(21,025)
Cancelled, forfeited or expired (in shares)		(3,750)		(5,067)		(1,500)
Outstanding at end of year (in shares)		1,138,930		769,174		490,099
Vested but not settled at end of year		554,023		467,638		84,199
Unvested at end of period (in shares)		584,907		301,536		405,900
Weighted Average Grant Date Fair Value
Outstanding at beginning of year (in dollars per share)		$ 7.55		$ 7.75		$ 7.61
Granted (in dollars per share)		7.96	[1]	7.22	[6]	8.23	[7]
Settled (in dollars per share)		6.60		7.28		6.20
Cancelled/forfeited (in dollars per share)		7.97		7.36		7.77
Outstanding at end of year (in dollars per share)		7.71		7.55		7.75
Vested but not settled at end of year (in dollars per share)		7.83		7.81		8.50
Unvested at end of year (in dollars per share)		$ 7.59		$ 7.15		$ 7.60
RSUs with Market and Service Conditions
Activity and related information
Outstanding at beginning of year (in shares)		449,300		287,719		279,507
Granted (in shares)		291,250	[1]	273,800	[6]	48,341	[7]
Settled (in shares)		0		(14,465)		(32,066)
Cancelled, forfeited or expired (in shares)		(3,750)		(97,754)		(8,063)
Outstanding at end of year (in shares)		736,800		449,300		287,719
Vested but not settled at end of year		175,500		175,500		14,625
Unvested at end of period (in shares)		561,300		273,800		273,094
Weighted Average Grant Date Fair Value
Outstanding at beginning of year (in dollars per share)		$ 5.61		$ 4.32		$ 4.55
Granted (in dollars per share)		5.73	[1]	5.87	[6]	2.59	[7]
Settled (in dollars per share)		0.00		4.71		2.80
Cancelled/forfeited (in dollars per share)		5.73		2.67		7.89
Outstanding at end of year (in dollars per share)		5.66		5.61		4.32
Vested but not settled at end of year (in dollars per share)		5.21		5.21		4.69
Unvested at end of year (in dollars per share)		$ 5.80		$ 5.87		$ 4.30
RSUs with Service Condition and both Service and Market Conditions
Activity and related information
Granted (in shares)		582,500		547,600
Fair value assumptions
Weighted average volatility estimated (as a percent)		18.00%		22.00%		23.00%
Expected term		3 years		3 years		3 years
Weighted average risk-free rate (as a percent)		0.90%		0.73%		0.65%
Estimated annual dividend yield (as a percent)		9.00%		8.00%		13.00%
RSUs with Service Condition, weighted average grant date fair value based on share closing price
Activity and related information
Granted (in shares)		99,554		83,215
RSUs with Service Condition, weighted average grant date fair value based on share closing price | Minimum
Fair value assumptions
Common stock, closing price (in dollars per share)		$ 7.93		$ 7.19
RSUs with Service Condition, weighted average grant date fair value based on share closing price | Maximum
Fair value assumptions
Common stock, closing price (in dollars per share)		$ 7.97		$ 8.16
Equity Compensation Plan
Share based compensation
Maximum number of common shares that can be granted to participant in any one year (in shares)		1,500,000
Period during which a participant can be awarded the maximum number of shares allowable under the Plan		1 year
Maximum percentage of common shares that can be owned or deemed to be owned by a participant (more than)		9.80%

[1] The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs. In determining the fair value for 582,500 of these awards granted in 2015, the Company applied: (i) a weighted average volatility estimate of approximately 18%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.90% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 9%. The weighted average grant date fair value for the remaining 99,554 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date ranging from $7.93 to $7.97. There are no post vesting conditions on these awards.

[2] For the year ended December 31, 2013, the intrinsic value of Options exercised was approximately $19,000.

[3] All restrictions associated with restricted stock are removed on vesting.

[4] The grant date fair value of restricted stock awards is based on the closing market price of the Company’s common stock at the grant date.

[5] RSU expense for the year ended December 31, 2014 includes approximately $500,000 for a one-time grant to the Company’s chief executive officer.

[6] The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs. In determining the fair value for 547,600 of these awards granted in 2014, the Company applied: (i) a weighted average volatility estimate of approximately 22%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.73% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 8%. The weighted average grant date fair value for the remaining 83,215 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date ranging from $7.19 to $8.16. There are no post vesting conditions on these awards.

[7] The determination of the weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs. In determining the fair value for awards granted in 2013, the Company applied: (i) a weighted average volatility estimate of approximately 23%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.65% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 13%. There are no post vesting conditions on these awards.

XML

Equity Compensation, Employment Agreements and Other Benefit Plans - Deferred Compensation and Savings Plans (Details) $ in Thousands		12 Months Ended
		Dec. 31, 2015 USD ($) officer	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
Deferred compensation activity
Number of officers having employment agreements with the company | officer		4
Deferred Compensation Plans
Deferred compensation activity
Deferrable compensation by the employee, maximum (as a percent)		100.00%
Expenses related to Deferred Plans		$ (59)	$ 69	$ 17
Cash distributed to the participants		109	119	12
Undistributed income deferred	[1]	601	324
Liability Under Deferred Plans		614	446
Deferred Compensation Plans | Non-employee directors
Deferred compensation activity
Expenses related to Deferred Plans		(59)	69	17
Undistributed income deferred	[1]	601	324
Liability Under Deferred Plans		$ 614	446
Savings Plan
Deferred compensation activity
Employer contribution percentage on first 3 percent of eligible compensation deferred by employees		100.00%
Percentage of eligible compensation deferred by employees qualifying for 100 percent matching contribution		3.00%
Employer contribution percentage on next 2 percent of eligible compensation deferred by employees		50.00%
Percentage of eligible compensation deferred by employees qualifying for 50 percent matching contribution		2.00%
Percentage of employer matching contributions that vest immediately		100.00%
Expenses for matching contributions		$ 309	$ 237	$ 250

[1] Represents the cumulative amounts that were deferred by participants through December 31, 2015 and 2014, which had not been distributed through such respective date.

XML

Fair Value of Financial Instruments - Assets and Liabilities on Recurring Basis (Details) - USD ($)		Dec. 31, 2015		Dec. 31, 2014
Assets:
MBS and CRT securities		$ 11,356,643,000		$ 10,762,622,000
Securities obtained and pledged as collateral		507,443,000		512,105,000
Residential whole loans, at fair value		623,276,000		143,472,000
Linked Transactions		0		398,336,000
Swaps		1,127,000		3,136,000
Liabilities:
Obligation to return securities obtained as collateral		507,443,000		512,105,000
Agency MBS
Assets:
MBS and CRT securities		4,752,244,000		5,904,207,000
Non-Agency MBS
Assets:
MBS and CRT securities	[1]	6,420,817,000		4,755,432,000
CRT securities
Assets:
MBS and CRT securities		183,582,000	[2]	102,983,000
Level 2
Components of financial instruments carried at fair value
Derivative credit risk valuation adjustment		0
Recurring basis
Assets:
Securities obtained and pledged as collateral		507,443,000		512,105,000
Linked Transactions				398,336,000
Swaps		1,127,000		3,136,000
Assets, Fair Value Disclosure		12,488,489,000		11,819,671,000
Liabilities:
Swaps		70,526,000		62,198,000
Obligation to return securities obtained as collateral		507,443,000		512,105,000
Financial and Nonfinancial Liabilities, Fair Value Disclosure		577,969,000		574,303,000
Recurring basis | Agency MBS
Assets:
MBS and CRT securities		4,752,244,000		5,904,207,000
Recurring basis | Non-Agency MBS
Assets:
MBS and CRT securities		6,420,817,000		4,755,432,000
Recurring basis | CRT securities
Assets:
MBS and CRT securities		183,582,000		102,983,000
Recurring basis | Residential whole loans
Assets:
Residential whole loans, at fair value		623,276,000		143,472,000
Recurring basis | Level 1
Assets:
Securities obtained and pledged as collateral		507,443,000		512,105,000
Linked Transactions				0
Swaps		0		0
Assets, Fair Value Disclosure		507,443,000		512,105,000
Liabilities:
Swaps		0		0
Obligation to return securities obtained as collateral		507,443,000		512,105,000
Financial and Nonfinancial Liabilities, Fair Value Disclosure		507,443,000		512,105,000
Recurring basis | Level 1 | Agency MBS
Assets:
MBS and CRT securities		0		0
Recurring basis | Level 1 | Non-Agency MBS
Assets:
MBS and CRT securities		0		0
Recurring basis | Level 1 | CRT securities
Assets:
MBS and CRT securities		0		0
Recurring basis | Level 1 | Residential whole loans
Assets:
Residential whole loans, at fair value		0		0
Recurring basis | Level 2
Assets:
Securities obtained and pledged as collateral		0		0
Linked Transactions				398,336,000
Swaps		1,127,000		3,136,000
Assets, Fair Value Disclosure		11,357,770,000		11,164,094,000
Liabilities:
Swaps		70,526,000		62,198,000
Obligation to return securities obtained as collateral		0		0
Financial and Nonfinancial Liabilities, Fair Value Disclosure		70,526,000		62,198,000
Recurring basis | Level 2 | Agency MBS
Assets:
MBS and CRT securities		4,752,244,000		5,904,207,000
Recurring basis | Level 2 | Non-Agency MBS
Assets:
MBS and CRT securities		6,420,817,000		4,755,432,000
Recurring basis | Level 2 | CRT securities
Assets:
MBS and CRT securities		183,582,000		102,983,000
Recurring basis | Level 2 | Residential whole loans
Assets:
Residential whole loans, at fair value		0		0
Recurring basis | Level 3
Assets:
Securities obtained and pledged as collateral		0		0
Linked Transactions				0
Swaps		0		0
Assets, Fair Value Disclosure		623,276,000		143,472,000
Liabilities:
Swaps		0		0
Obligation to return securities obtained as collateral		0		0
Financial and Nonfinancial Liabilities, Fair Value Disclosure		0		0
Recurring basis | Level 3 | Agency MBS
Assets:
MBS and CRT securities		0		0
Recurring basis | Level 3 | Non-Agency MBS
Assets:
MBS and CRT securities		0		0
Recurring basis | Level 3 | CRT securities
Assets:
MBS and CRT securities		0		0
Recurring basis | Level 3 | Residential whole loans
Assets:
Residential whole loans, at fair value		$ 623,276,000		$ 143,472,000

[1] At December 31, 2015 and 2014, the Company expected to recover approximately 89% and 83%, respectively, of the then-current face amount of Non-Agency MBS.

[2] Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $62.2 million for which the fair value option has been elected. Such securities have gross unrealized gains of approximately $332,000, gross unrealized losses of approximately $555,000 and net unrealized losses of approximately $223,000 at December 31, 2015.

XML

Fair Value of Financial Instruments - Level 3 (Details) - Residential whole loans - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	$ 143,472	$ 0
Purchases and capitalized advances	534,574	147,471
Changes in fair value recorded in Net gain on residential whole loans held at fair value	6,539	(388)
Collection of principal, net of liquidation gains/losses	(34,767)	(1,038)
Transfer to REO	(26,542)	(2,573)
Balance at end of period	$ 623,276	$ 143,472

XML

Fair Value of Financial Instruments - Fair Value Methodology for Level 3 (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015		Dec. 31, 2014
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Residential whole loans, at fair value	$ 505,723	[1]	$ 143,472
Unobservable Input
Loans which management considers the purchase price continues to reflect the fair value	117,600
Discounted cash flow
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Residential whole loans, at fair value	113,166	[1]	36,101
Liquidation model
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Residential whole loans, at fair value	$ 392,557	[1]	$ 107,371
Residential whole loans | Level 3 | Discounted cash flow | Minimum
Unobservable Input
Discount rate	6.00%		6.00%
Prepayment rate	0.25%		0.25%
Default rate	0.00%		0.00%
Loss severity	10.00%		10.00%
Residential whole loans | Level 3 | Discounted cash flow | Maximum
Unobservable Input
Discount rate	8.70%		8.00%
Prepayment rate	11.10%		8.20%
Default rate	9.10%		20.30%
Loss severity	79.40%		61.69%
Residential whole loans | Level 3 | Discounted cash flow | Weighted Average
Unobservable Input
Discount rate	7.00%		7.52%
Prepayment rate	6.59%		4.79%
Default rate	3.10%		7.01%
Loss severity	17.03%		18.88%
Residential whole loans | Level 3 | Liquidation model | Minimum
Unobservable Input
Discount rate	6.75%		7.00%
Annual change in home prices	(5.51%)		(4.73%)
Liquidation timeline	8 months 1 day		9 months 29 days
Current value of underlying properties	$ 14		$ 29
Residential whole loans | Level 3 | Liquidation model | Maximum
Unobservable Input
Discount rate	10.02%		7.00%
Annual change in home prices	6.08%		3.56%
Liquidation timeline	4 years 5 months 1 day		4 years 5 months 1 day
Current value of underlying properties	$ 3,500		$ 4,000
Residential whole loans | Level 3 | Liquidation model | Weighted Average
Unobservable Input
Discount rate	6.85%		7.00%
Annual change in home prices	1.28%		0.26%
Liquidation timeline	1 year 6 months 22 days		1 year 11 months 9 days
Current value of underlying properties	$ 626		$ 397

[1] Excludes approximately $117.6 million of loans for which management considers the purchase price continues to reflect the fair value of such loans at December 31, 2015.

XML

Fair Value of Financial Instruments - Difference Between Fair Value and Unpaid Principal Balance (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Option, Quantitative Disclosures [Line Items]
Total loans, Fair Value	$ 623,276	$ 143,472
Total loans, Unpaid Principal Balance	786,330	182,613
Residential whole loans
Fair Value, Option, Quantitative Disclosures [Line Items]
Total loans, Fair Value	623,276	143,472
Total loans, Unpaid Principal Balance	786,330	182,613
Total loans, Difference	(163,054)	(39,141)
Loans 90 days or more past due, Fair Value	493,640	128,591
Loans 90 days or more past due, Unpaid Principal Balance	637,459	165,358
Loans 90 days or more past due, Difference	$ (143,819)	$ (36,767)

XML

Fair Value of Financial Instruments - Carrying Value and Estimated Fair Value (Details) - USD ($) $ in Thousands		Dec. 31, 2015		Dec. 31, 2014
Financial Assets:
MBS and CRT securities		$ 11,356,643		$ 10,762,622
Securities obtained and pledged as collateral		507,443		512,105
Residential whole loans, at carrying value		271,845		207,923
Residential whole loans, at fair value		623,276		143,472
Restricted cash		71,538		67,255
Linked Transactions		0		398,336
Swaps		1,127		3,136
Financial Liabilities:
Securitized debt	[1]	22,057		110,574
Obligation to return securities obtained as collateral		507,443		512,105
Senior Notes		100,000		100,000
Carrying value
Financial Assets:
Securities obtained and pledged as collateral		507,443		512,105
Cash and cash equivalents		165,007		182,437
Restricted cash		71,538		67,255
Linked Transactions		0		398,336
Swaps		1,127		3,136
Financial Liabilities:
Repurchase agreements		7,888,902		8,267,388
FHLB advances		1,500,000		0
Securitized debt		22,057		110,574
Obligation to return securities obtained as collateral		507,443		512,105
Senior Notes		100,000		100,000
Swaps		70,526		62,198
Estimated fair value
Financial Assets:
Securities obtained and pledged as collateral		507,443		512,105
Cash and cash equivalents		165,007		182,437
Restricted cash		71,538		67,255
Linked Transactions		0		398,336
Swaps		1,127		3,136
Financial Liabilities:
Repurchase agreements		7,828,115		8,266,699
FHLB advances		1,500,000		0
Securitized debt		22,057		110,791
Obligation to return securities obtained as collateral		507,443		512,105
Senior Notes		99,391		103,031
Swaps		70,526		62,198
Agency MBS
Financial Assets:
MBS and CRT securities		4,752,244		5,904,207
Agency MBS | Carrying value
Financial Assets:
MBS and CRT securities		4,752,244		5,904,207
Agency MBS | Estimated fair value
Financial Assets:
MBS and CRT securities		4,752,244		5,904,207
Non-Agency MBS
Financial Assets:
MBS and CRT securities	[2]	6,420,817		4,755,432
Non-Agency MBS | Carrying value
Financial Assets:
MBS and CRT securities		6,420,817		4,755,432
Non-Agency MBS | Estimated fair value
Financial Assets:
MBS and CRT securities		6,420,817		4,755,432
CRT securities
Financial Assets:
MBS and CRT securities		183,582	[3]	102,983
CRT securities | Carrying value
Financial Assets:
MBS and CRT securities		183,582		102,983
CRT securities | Estimated fair value
Financial Assets:
MBS and CRT securities		183,582		102,983
Residential whole loans | Carrying value
Financial Assets:
Residential whole loans, at carrying value		271,845		207,923
Residential whole loans, at fair value		623,276		143,472
Residential whole loans | Estimated fair value
Financial Assets:
Residential whole loans, at carrying value		289,696		217,386
Residential whole loans, at fair value		$ 623,276		$ 143,472

[1] Securitized Debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that eliminate on consolidation. The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company. (See Notes 12 and 17 for further discussion.)

[2] At December 31, 2015 and 2014, the Company expected to recover approximately 89% and 83%, respectively, of the then-current face amount of Non-Agency MBS.

[3] Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $62.2 million for which the fair value option has been elected. Such securities have gross unrealized gains of approximately $332,000, gross unrealized losses of approximately $555,000 and net unrealized losses of approximately $223,000 at December 31, 2015.

XML

Use of Special Purpose Entities and Variable Interest Entities (Details) - USD ($) $ in Thousands		1 Months Ended		3 Months Ended								12 Months Ended
		Feb. 29, 2012	Oct. 31, 2010	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Special purpose entities and variable interest entities
Securitized debt	[1]			$ 22,057				$ 110,574				$ 22,057	$ 110,574
Residential Whole Loans				895,100				351,400				895,100	351,400
MBS and CRT securities				11,356,643				10,762,622				11,356,643	10,762,622
Residential whole loans, at carrying value				271,845				207,923				271,845	207,923
Residential whole loans, at fair value				$ 623,276				143,472				$ 623,276	143,472
Ownership percentage, parent (percent)				100.00%								100.00%
Interest income residential whole loans												$ 16,036	4,083	$ 0
Net gain on residential whole loans held at fair value				$ 6,899	$ 5,565	$ 3,224	$ 2,034	116	$ 0	$ 0	$ 0	17,722	116	$ 0
Non-Agency MBS
Special purpose entities and variable interest entities
MBS and CRT securities	[2]			6,420,817				4,755,432				6,420,817	4,755,432
WFMLT Series 2012-RR1
Special purpose entities and variable interest entities
Principal value of Non-Agency MBS sold		$ 433,347
Face amount of Senior Bonds issued by the VIE and purchased by 3rd party investors	[3]	$ 186,691
Securitized debt	[3]			22,057								22,057
Pass-through rate for Senior Bonds issued (as a percent)		2.85%
Proceeds from Issuance of Secured Debt		$ 186,691
Notional amount acquired of non-rated, interest only senior certificates	[3]	$ 186,691
Expenses incurred												190
WFMLT Series 2012-RR1 | Senior-support certificates
Special purpose entities and variable interest entities
Face amount of Senior Support Certificates received by the Company	[4]			217,103								217,103
DMSI Series 2010-RS2
Special purpose entities and variable interest entities
Principal value of Non-Agency MBS sold			$ 985,228
Face amount of Senior Bonds issued by the VIE and purchased by 3rd party investors	[3]		$ 373,577
Securitized debt	[3]			0								0
Pass-through rate for Senior Bonds issued (as a percent)			0.00%
Proceeds from Issuance of Secured Debt			$ 375,621
Notional amount acquired of non-rated, interest only senior certificates	[3]		$ 0
Expenses incurred												0
DMSI Series 2010-RS2 | Senior-support certificates
Special purpose entities and variable interest entities
Face amount of Senior Support Certificates received by the Company	[4]			455,063								455,063
Non-Agency MBS Transfered to Consolidated VIEs | Non-Agency MBS
Special purpose entities and variable interest entities
MBS and CRT securities				$ 598,300				$ 1,397,000				$ 598,300	$ 1,397,000
Trust, Ownership in Residential Whole Loans
Special purpose entities and variable interest entities
Ownership percentage, parent (percent)				100.00%								100.00%

[1] Securitized Debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that eliminate on consolidation. The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company. (See Notes 12 and 17 for further discussion.)

[2] At December 31, 2015 and 2014, the Company expected to recover approximately 89% and 83%, respectively, of the then-current face amount of Non-Agency MBS.

[3] Amount disclosed reflects principal balances of the DMSI 2010-RS A1, A2 and A3 bonds. The DMSI 2010-RS2 A2 and A3 bonds were sold to third party investors during 2013. The principal balance of the DMSI 2010-RS2 A1 Bond and associated interest only Senior certificate was paid off during 2013. The principal balances of the DMSI 2010-RS2 A2 and A3 Bonds were paid off in January 2015 and September 2015, respectively.

[4] Provides credit support for the sequential Senior Non-Agency MBS sold to third-party investors in resecuritization transactions (“Senior Bonds”).

XML

Subsequent Events (Details) - Non-Agency MBS - Non-Agency MBS - Subsequent Event $ / shares in Units, $ in Millions	Feb. 09, 2016 USD ($) $ / shares
Subsequent Event [Line Items]
Taxable income recognized from unwind of resecuritization structure	$ 70.9
Per share amount of taxable income recognized from unwind of resecuritization structure (in usd per share) | $ / shares	$ 0.19
Increase in available sources of liquidity	$ 90.0

XML

Summary of Quarterly Results of Operations (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]
Interest income	$ 118,499	$ 119,706	$ 123,995	$ 129,943	$ 111,192	$ 112,157	$ 119,294	$ 121,174	$ 492,143	$ 463,817	$ 482,940
Interest expense	(46,456)	(43,703)	(42,849)	(43,940)	(38,960)	(39,358)	(40,569)	(40,921)	(176,948)	(159,808)	(164,013)
Net Interest Income	72,043	76,003	81,146	86,003	72,232	72,799	78,725	80,253	315,195	304,009	318,927
Net Impairment Losses Recognized in Earnings	0	0	(298)	(407)					(705)	0	0
Gain on sales of MBS and U.S. Treasury securities, net	9,652	11,196	7,617	6,435	12,194	13,880	7,852	3,571	34,900	37,497	25,825
Unrealized net gains and net interest income from Linked Transactions					7,506	2,559	3,776	3,251	0	17,092	3,225
Net gain on residential whole loans held at fair value	6,899	5,565	3,224	2,034	116	0	0	0	17,722	116	0
Other income/(loss)	(831)	(259)	(678)	311	386	54	56	(416)
Operating and other expense	(14,292)	(12,995)	(12,940)	(12,202)	(12,726)	(10,410)	(11,683)	(10,471)	(52,429)	(45,290)	(37,970)
Net Income	73,471	79,510	78,071	82,174	79,708	78,882	78,726	76,188	313,226	313,504	302,709
Preferred stock dividends	(3,750)	(3,750)	(3,750)	(3,750)	(3,750)	(3,750)	(3,750)	(3,750)	(15,000)	(15,000)	(13,750)
Net Income Available to Common Stock and Participating Securities	$ 69,721	$ 75,760	$ 74,321	$ 78,424	$ 75,958	$ 75,132	$ 74,976	$ 72,438	$ 298,226	$ 298,504	$ 285,012
Earnings per Common Share - Basic and Diluted (in dollars per share)	$ 0.19	$ 0.20	$ 0.20	$ 0.21	$ 0.20	$ 0.20	$ 0.20	$ 0.20	$ 0.80	$ 0.81	$ 0.78

XML

Schedule IV - Mortgage Loans on Real Estate (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2015 USD ($) loan	Dec. 31, 2014 USD ($) loan
Mortgage Loans on Real Estate [Line Items]
Number (loans) | loan	3,143	885
Movement in Mortgage Loans on Real Estate [Roll Forward]
Residential whole loans, at carrying value, beginning balance	$ 207,923
Residential whole loans, at fair value, beginning balance	143,472
Residential whole loans, at carrying value, ending balance	271,845	$ 207,923
Residential whole loans, at fair value, ending balance	623,276	143,472
Residential whole loans
Mortgage Loans on Real Estate [Line Items]
Principal Amount of Loans Subject to Delinquent Principal or Interest	795,723
Residential whole loans, gross, Balance Sheet Reported Amount	$ 895,121
Residential whole loans | Carrying value
Mortgage Loans on Real Estate [Line Items]
Number (loans) | loan	1,993
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 116,370
Movement in Mortgage Loans on Real Estate [Roll Forward]
Residential whole loans, at carrying value, beginning balance	207,923
Purchases and capitalized advances	82,338
Accretion of purchase discount	15,511
Collection of principal	(17,029)
Collection of interest	(14,053)
Provision for loan loss	(1,028)
Transfer to REO	(1,817)
Residential whole loans, at carrying value, ending balance	$ 271,845	207,923
Residential whole loans | Carrying value | Minimum
Mortgage Loans on Real Estate [Line Items]
Interest Rate (percent)	0.00%
Residential whole loans | Carrying value | Maximum
Mortgage Loans on Real Estate [Line Items]
Interest Rate (percent)	14.00%
Residential whole loans | Fair value
Mortgage Loans on Real Estate [Line Items]
Number (loans) | loan	3,143
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 679,353
Movement in Mortgage Loans on Real Estate [Roll Forward]
Residential whole loans, at fair value, beginning balance	143,472
Purchases and capitalized advances	534,574
Collection of principal	(34,767)
Collection of interest	0
Changes in fair value recorded in gain/(loss) on loans recorded at fair value	6,539
Transfer to REO	(26,542)
Residential whole loans, at fair value, ending balance	$ 623,276	$ 143,472
Residential whole loans | Fair value | Minimum
Mortgage Loans on Real Estate [Line Items]
Interest Rate (percent)	1.00%
Residential whole loans | Fair value | Maximum
Mortgage Loans on Real Estate [Line Items]
Interest Rate (percent)	14.00%